data_1de1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1de1 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.65 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 31.4 ttp . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.872 0.368 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.437 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 96.3 m-85 -82.71 143.35 30.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.068 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.708 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -117.14 122.56 44.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.719 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.508 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 7.7 t -111.03 130.06 65.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.464 0.65 . . . . 0.0 111.7 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.501 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 20.1 m-85 -111.95 101.76 10.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.651 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 66' ' ' PRO . . . -163.89 -139.42 2.63 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.653 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.477 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 85.1 m-85 -123.19 159.52 28.45 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.711 0.291 . . . . 0.0 111.254 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.8 -65.76 1.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.254 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 t 168.79 -32.53 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 110.792 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -65.53 -47.27 76.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.122 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.7 mp -91.32 -44.99 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.019 0.437 . . . . 0.0 110.934 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.477 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 23.4 t60 -143.2 155.96 44.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.39 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -80.98 171.24 15.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.854 0.359 . . . . 0.0 111.264 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.0 p -179.37 115.36 0.06 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.973 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 m -90.86 -36.67 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.298 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -80.25 -15.45 56.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.655 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.0 p -66.25 -42.4 88.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.928 0.394 . . . . 0.0 110.621 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.2 -41.92 66.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.409 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -56.86 -48.14 78.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.484 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.88 -47.32 83.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.134 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -49.66 -31.72 11.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.944 0.402 . . . . 0.0 110.376 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -74.33 -34.6 63.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.195 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.496 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -55.52 -51.72 66.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.254 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.29 -54.17 49.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.848 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 m -49.22 -36.01 18.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.718 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.6 t -69.33 -29.75 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.802 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -16.84 27.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.347 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt 71.67 65.05 0.15 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.987 0.422 . . . . 0.0 110.682 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -130.81 142.3 45.04 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.65 128.58 11.08 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.414 2.076 . . . . 0.0 111.641 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.65 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 16.0 p90 -158.88 167.7 28.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.97 147.04 27.39 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.105 0.479 . . . . 0.0 111.35 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.508 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 7.8 t80 -89.47 156.42 18.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.007 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.2 mt -145.85 119.99 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.409 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -74.92 109.81 8.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.687 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.7 pt -72.84 -13.64 16.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.301 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.507 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -119.86 80.66 25.48 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.76 0.314 . . . . 0.0 111.088 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.37 -9.86 24.79 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.632 2.221 . . . . 0.0 111.9 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -139.53 136.67 34.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.469 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -60.94 -8.74 3.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.232 0.539 . . . . 0.0 112.0 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.09 -62.06 2.15 Favored Glycine 0 C--N 1.312 -0.774 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.338 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -150.4 154.91 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.765 0.316 . . . . 0.0 111.45 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -59.75 169.97 1.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.613 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -82.32 100.44 9.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.943 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.27 -27.01 43.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.05 -54.98 29.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 110.875 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -73.81 -33.29 64.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.526 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.2 mm -71.57 -31.67 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.649 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.31 -56.32 11.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -59.37 -30.01 68.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.939 0.399 . . . . 0.0 110.226 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.501 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.0 tt -59.67 -58.59 7.92 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.571 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.516 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 73.9 mt -45.93 -42.59 13.02 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.593 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 m -70.92 -31.12 67.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.661 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 1.8 tttp -60.8 -48.34 82.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.419 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.516 ' CD1' ' HA ' ' A' ' 52' ' ' LEU . 1.2 mp -59.32 -59.63 5.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.049 0.452 . . . . 0.0 111.065 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.35 -114.2 0.29 Allowed Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.048 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.9 mtt85 -150.64 28.07 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.98 0.419 . . . . 0.0 111.004 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -121.7 -156.63 0.69 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.113 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.5 t -121.17 167.41 12.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.686 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.442 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . 6.2 pt20 -130.2 98.84 4.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 110.828 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.5 tp -82.07 85.57 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.177 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.09 23.8 5.97 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.485 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.442 ' CD2' ' HB2' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -60.84 127.02 29.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.34 . . . . 0.0 110.557 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 p -92.28 163.42 13.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.241 0.543 . . . . 0.0 111.481 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.403 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -118.48 160.77 38.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.665 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.2 Cg_exo -83.94 149.75 60.35 Favored 'Cis proline' 0 C--N 1.344 0.335 0 C-N-CA 124.428 -1.072 . . . . 0.0 113.123 0.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -101.77 120.18 39.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.903 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.708 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 6.2 t -98.72 159.65 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.035 0.445 . . . . 0.0 111.615 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 54' ' ' LYS . 31.8 m-85 -142.9 133.15 24.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.765 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.95 149.62 89.84 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.604 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.582 ' HB3' ' N ' ' A' ' 1' ' ' MET . 68.0 Cg_exo -44.8 -52.54 6.07 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.37 2.714 . . . . 0.0 112.747 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -30.03 65.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.189 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.26 67.95 0.44 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.388 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.4 m -147.79 157.07 43.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.84 0.353 . . . . 0.0 110.648 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.417 ' CE1' HD21 ' A' ' 55' ' ' LEU . 7.9 t-160 -84.09 115.1 22.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.973 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.422 HG12 ' CD2' ' A' ' 85' ' ' TYR . 19.8 mt -93.58 -49.14 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.972 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 123.15 -154.18 17.14 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.93 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -90.97 -132.24 5.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.472 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.496 ' CE1' ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -79.66 -70.08 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.654 0.227 . . . . 0.0 111.114 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -51.08 -49.12 61.26 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.331 0.586 . . . . 0.0 110.478 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -57.41 -42.2 81.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.701 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.531 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.3 tt -76.3 -32.26 58.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.582 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -33.78 40.6 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -66.47 -35.87 81.34 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.164 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 82' ' ' LEU . 14.7 t80 -63.2 -34.08 76.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.35 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.531 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.4 m-85 -84.29 -66.39 0.9 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.995 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.91 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.583 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 30.1 ttm . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.784 0.326 . . . . 0.0 111.527 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.499 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 69.3 m-85 -61.8 169.57 2.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.357 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -143.72 116.29 8.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.743 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.451 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 87.5 t -110.44 141.27 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.168 0.508 . . . . 0.0 111.02 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.438 ' CE1' HD13 ' A' ' 34' ' ' ILE . 6.6 m-85 -123.31 99.3 6.27 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.89 -144.54 4.05 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.541 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -113.51 151.07 32.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.748 0.309 . . . . 0.0 111.426 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.5 t70 -81.98 0.46 40.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.983 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.3 OUTLIER 83.81 -13.76 0.73 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -85.33 -39.12 18.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.759 0.314 . . . . 0.0 111.082 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.423 HD11 ' O ' ' A' ' 37' ' ' MET . 3.7 mt -92.56 -31.1 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.283 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 9' ' ' SER . 7.8 t60 -142.07 142.15 32.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.099 0.476 . . . . 0.0 110.987 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.2 145.02 11.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.315 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.3 t -179.26 88.93 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.13 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.8 m -79.01 -27.08 13.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.897 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -75.1 -21.53 58.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.798 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.5 m -59.71 -58.59 7.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.205 0.526 . . . . 0.0 110.265 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.96 -23.59 13.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.334 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 3.9 m-80 -77.14 -54.08 6.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.091 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.49 -48.7 76.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 111.078 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.424 ' HD2' ' CE2' ' A' ' 31' ' ' PHE . 2.2 tptt -58.23 -54.06 51.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.697 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -60.84 -36.76 79.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.554 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.424 HD23 ' CD2' ' A' ' 86' ' ' PHE . 3.1 tt -58.88 -52.97 63.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.509 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mt -57.78 -46.86 83.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.794 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 m -57.63 -36.28 71.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.478 . . . . 0.0 110.234 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.3 t -79.71 -30.7 13.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.766 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -77.77 -11.08 59.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.131 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt 70.34 54.07 0.32 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.996 0.427 . . . . 0.0 111.045 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -134.42 132.77 21.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.092 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 1' ' ' MET . 98.5 Cg_endo -78.41 137.33 14.77 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.474 2.116 . . . . 0.0 111.114 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.583 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 17.1 p90 -156.21 170.19 22.8 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -136.79 131.63 33.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.011 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.451 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 1.2 t80 -95.74 129.81 42.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.97 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.438 HD13 ' CE1' ' A' ' 5' ' ' TYR . 7.3 mt -113.33 110.39 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.383 0.611 . . . . 0.0 110.432 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -77.46 113.76 15.59 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.105 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 pt -71.94 -28.48 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.002 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.545 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 22.2 ttm -121.45 91.13 48.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.891 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.8 Cg_endo -82.59 1.66 9.0 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.693 2.262 . . . . 0.0 112.692 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -139.81 140.29 36.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 110.875 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -66.68 -7.09 18.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.254 0.549 . . . . 0.0 111.779 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.77 -67.13 1.01 Allowed Glycine 0 C--N 1.315 -0.608 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.694 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 t -136.21 133.82 50.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.71 0.29 . . . . 0.0 111.07 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -63.37 170.29 3.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.466 -179.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.431 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -94.65 99.94 11.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.064 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -54.37 -19.93 6.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.782 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -58.47 -56.28 24.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.031 0.444 . . . . 0.0 110.521 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -67.75 -31.69 71.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.307 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.1 mm -59.84 -48.34 88.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.611 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.11 -49.27 77.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.805 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.31 -35.89 70.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.579 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.421 HD13 ' CG ' ' A' ' 5' ' ' TYR . 26.4 tp -61.32 -52.99 62.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.652 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.5 mt -49.72 -45.16 48.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.131 0.491 . . . . 0.0 111.277 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.5 m -64.08 -32.47 74.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.108 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.433 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 9.3 tttp -68.9 -29.99 68.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.465 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.06 -37.62 72.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.048 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.83 33.58 6.32 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.278 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -150.07 -176.9 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.8 0.334 . . . . 0.0 110.742 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -105.11 -30.8 9.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.025 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 t -111.05 163.79 13.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.052 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -106.47 99.14 8.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.596 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.5 mm -80.67 87.82 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.556 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.92 31.55 79.94 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.44 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -42.35 134.71 2.87 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.83 0.347 . . . . 0.0 111.207 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.58 153.11 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.088 0.47 . . . . 0.0 111.671 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.12 152.12 72.84 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.406 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.1 Cg_exo -79.31 128.72 16.86 Favored 'Cis proline' 0 C--N 1.344 0.328 0 C-N-CA 124.053 -1.228 . . . . 0.0 112.934 0.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.407 ' HG3' ' NE2' ' A' ' 75' ' ' HIS . 3.7 tp60 -90.6 117.87 29.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.225 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 10.2 t -97.48 161.24 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.95 0.405 . . . . 0.0 111.906 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 97.0 m-85 -142.84 149.26 38.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.022 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.468 ' HA ' HD13 ' A' ' 76' ' ' ILE . . . -61.81 159.35 35.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.773 -0.648 . . . . 0.0 112.411 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.534 ' HB3' ' N ' ' A' ' 1' ' ' MET . 31.7 Cg_exo -63.74 58.85 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.577 2.851 . . . . 0.0 111.547 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 71' ' ' PRO . 0.5 OUTLIER 90.49 29.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.345 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -111.75 -92.65 2.1 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.526 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.39 -175.97 5.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.033 0.444 . . . . 0.0 110.96 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.431 ' HA ' ' CD1' ' A' ' 69' ' ' PHE . 16.4 t-80 -68.14 126.62 30.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.156 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 70' ' ' ALA . 4.8 mt -91.82 -45.43 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.177 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.16 -150.04 19.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.635 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.83 -150.74 22.47 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.62 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 40.4 t80 -70.79 -70.55 0.3 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.68 0.276 . . . . 0.0 110.951 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -55.46 -45.53 76.88 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.009 0.433 . . . . 0.0 110.579 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -54.91 -33.93 62.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.298 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.483 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.3 tt -80.08 -36.58 35.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.368 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -51.51 -29.98 18.64 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.3 -35.0 73.41 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.129 178.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 82' ' ' LEU . 11.9 t80 -63.12 -34.35 77.42 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.267 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.483 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.9 m-85 -87.87 -70.18 0.65 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.292 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.8 mttm . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.044 -179.98 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.576 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 49.7 ttm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.861 0.362 . . . . 0.0 111.639 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.5 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 74.6 m-85 -58.33 155.22 12.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.866 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.636 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -128.19 120.43 27.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.669 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.489 HG12 ' CE1' ' A' ' 33' ' ' PHE . 55.4 t -116.09 142.18 30.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.333 0.587 . . . . 0.0 111.813 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.482 ' CZ ' HD12 ' A' ' 34' ' ' ILE . 2.1 m-85 -121.67 99.89 6.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.58 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.24 -137.96 2.36 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.75 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.411 ' CZ ' ' CD1' ' A' ' 36' ' ' ILE . 31.5 m-85 -122.95 144.15 49.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 120.591 0.234 . . . . 0.0 110.962 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -108.47 29.02 7.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.336 . . . . 0.0 110.863 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m 63.04 14.57 7.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -85.77 -56.98 3.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.1 0.476 . . . . 0.0 110.622 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 40' ' ' LYS . 13.4 mm -104.15 -27.23 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.017 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -141.45 152.12 43.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.613 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.77 171.69 12.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.178 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.4 t -178.68 108.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.952 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.2 m -85.66 -32.8 7.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.956 0.407 . . . . 0.0 111.207 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -71.23 -16.08 62.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.289 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.9 m -72.13 -55.92 6.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.996 0.426 . . . . 0.0 110.683 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -52.18 -28.04 16.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.094 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 74.8 m-20 -75.52 -51.77 12.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.016 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.88 -48.6 79.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.243 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -59.89 -55.43 34.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.781 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -55.4 -44.93 76.63 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.346 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.423 ' CD2' ' C ' ' A' ' 23' ' ' LEU . 0.7 OUTLIER -59.04 -50.59 73.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.16 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 8.7 mt -60.51 -43.61 96.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.065 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.6 m -57.17 -40.15 76.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.107 0.48 . . . . 0.0 109.82 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.7 t -80.13 -27.17 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.449 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.514 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 3.3 tptp -73.42 -13.31 61.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.081 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt 66.53 54.72 0.86 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.448 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -137.12 134.44 18.92 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.019 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.415 ' O ' ' HA ' ' A' ' 1' ' ' MET . 85.9 Cg_endo -78.58 134.09 12.11 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.337 2.024 . . . . 0.0 110.909 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.576 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 26.9 p90 -148.51 170.0 19.03 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -136.91 133.23 35.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.729 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.489 ' CE1' HG12 ' A' ' 4' ' ' VAL . 9.4 t80 -89.43 163.01 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.25 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.482 HD12 ' CZ ' ' A' ' 5' ' ' TYR . 19.1 mt -145.69 119.61 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.444 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -82.22 122.76 28.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.098 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.411 ' CD1' ' CZ ' ' A' ' 7' ' ' TYR . 7.2 pt -93.4 -16.7 7.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.479 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.417 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -124.84 85.65 57.06 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.735 0.302 . . . . 0.0 111.556 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.445 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 97.0 Cg_endo -79.05 -5.82 14.68 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.851 2.368 . . . . 0.0 111.73 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -139.66 135.33 33.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.288 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.437 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 20.0 tttp -61.34 -8.45 3.93 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.26 0.552 . . . . 0.0 111.873 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.3 -63.72 2.11 Favored Glycine 0 C--N 1.312 -0.786 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.067 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -150.7 159.03 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.759 0.314 . . . . 0.0 111.548 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -63.47 159.31 18.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.33 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.445 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -82.18 125.6 31.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.88 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -68.07 -23.85 64.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.761 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -60.04 -55.5 33.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.37 . . . . 0.0 110.651 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.48 -39.6 85.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.271 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.3 mt -54.12 -46.39 66.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.441 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.48 -50.33 71.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.636 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -59.82 -31.96 70.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.577 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.43 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 18.7 tp -66.28 -63.92 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.292 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.2 mt -45.66 -40.81 9.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.153 0.502 . . . . 0.0 111.314 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.1 m -67.34 -34.29 77.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.872 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.436 ' HG3' ' CE2' ' A' ' 69' ' ' PHE . 50.0 tptt -66.47 -49.27 67.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.486 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.43 ' CD1' ' O ' ' A' ' 51' ' ' LEU . 4.9 mp -59.31 -25.07 63.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.248 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.1 30.17 13.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.499 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.15 -178.04 6.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.781 0.324 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.43 -47.36 3.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.997 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.2 t -92.73 160.1 15.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.54 99.36 8.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.678 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -79.91 83.61 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.255 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.81 23.1 78.21 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.513 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.61 131.42 43.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.875 0.369 . . . . 0.0 110.809 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.29 170.55 14.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.282 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.78 154.15 40.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.762 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.08 135.31 31.12 Favored 'Cis proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.701 -1.374 . . . . 0.0 112.846 0.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -90.7 117.01 29.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.503 179.321 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.7 t -103.19 160.72 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.157 0.503 . . . . 0.0 112.142 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.436 ' CE2' ' HG3' ' A' ' 54' ' ' LYS . 95.3 m-85 -142.8 155.65 44.85 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.982 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 76' ' ' ILE . . . -66.3 156.41 85.23 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.356 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HB3' ' N ' ' A' ' 1' ' ' MET . 44.9 Cg_exo -58.28 -38.92 88.7 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.055 2.504 . . . . 0.0 111.808 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -91.42 -16.18 27.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.094 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.76 87.95 1.16 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.651 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.04 124.04 2.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.945 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.415 ' CD2' ' OE1' ' A' ' 67' ' ' GLN . 20.0 t-160 -58.17 110.83 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.006 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 70' ' ' ALA . 18.7 mt -89.95 -49.9 13.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.51 -154.25 19.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.434 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.29 -144.16 7.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.299 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 32.7 t80 -71.17 -60.42 2.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 0.0 110.764 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -54.44 -37.21 64.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.829 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -60.77 -41.21 95.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.58 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -64.04 -50.87 66.73 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.351 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 87' ' ' LYS . 1.3 tpt180 -51.62 -28.38 14.14 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -79.79 -33.76 40.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 82' ' ' LEU . 17.1 t80 -67.57 -32.14 72.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.323 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.514 ' CD1' ' HG2' ' A' ' 27' ' ' LYS . 30.3 m-85 -96.17 -70.74 0.7 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.487 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 83' ' ' ARG . 6.4 tttt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.634 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.568 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 40.6 ttp . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -76.51 152.04 36.2 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.244 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.5 mptp? -113.34 119.99 39.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.466 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.445 HG11 ' CE1' ' A' ' 33' ' ' PHE . 39.9 t -113.13 134.19 56.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.363 0.601 . . . . 0.0 112.066 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.6 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 18.9 m-85 -111.66 99.51 8.22 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.959 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.11 -139.64 2.73 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.517 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.442 ' CE1' ' HE2' ' A' ' 37' ' ' MET . 63.5 m-85 -123.28 157.38 33.3 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.858 0.361 . . . . 0.0 111.376 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.41 -76.21 0.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.976 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 174.53 -34.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.907 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -71.34 -24.64 62.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.267 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.94 -40.15 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.86 0.362 . . . . 0.0 110.864 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -155.87 160.63 40.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.4 pttp -80.39 173.65 12.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.997 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 9.2 p -163.99 120.37 1.65 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.962 0.41 . . . . 0.0 110.758 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.4 -43.39 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.944 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -88.9 -9.01 53.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.936 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -87.41 -36.43 17.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.758 0.313 . . . . 0.0 110.672 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -68.09 -36.06 79.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.718 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -75.71 -48.38 22.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.125 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.22 69.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.056 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -60.33 -54.18 48.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.617 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.03 -34.58 72.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.679 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.431 HD22 ' CD2' ' A' ' 86' ' ' PHE . 4.9 tt -60.14 -54.99 39.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.613 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.6 mt -55.25 -46.04 76.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.948 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.1 m -57.8 -36.5 72.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.041 0.448 . . . . 0.0 110.157 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -79.03 -35.46 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.682 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -72.85 -9.97 59.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.184 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.16 42.48 0.34 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.861 0.363 . . . . 0.0 110.792 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -131.89 133.44 24.07 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.025 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.553 ' O ' ' HA ' ' A' ' 1' ' ' MET . 58.9 Cg_endo -81.93 158.82 18.39 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.567 2.178 . . . . 0.0 111.481 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 5.6 p90 -161.47 171.25 18.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.801 0.334 . . . . 0.0 111.663 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -129.55 119.71 24.12 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.564 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.445 ' CE1' HG11 ' A' ' 4' ' ' VAL . 17.4 t80 -89.34 153.12 21.12 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.185 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.9 mt -147.4 121.61 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.509 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -81.17 109.74 16.01 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.539 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 pt -63.86 -19.65 24.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.563 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 2.8 ttp -123.08 90.27 50.45 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.812 0.339 . . . . 0.0 111.52 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.86 0.98 9.65 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.697 2.265 . . . . 0.0 112.289 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -139.68 140.4 36.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.696 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -67.9 -8.55 37.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.226 0.536 . . . . 0.0 111.842 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.71 -64.76 1.25 Allowed Glycine 0 C--N 1.313 -0.74 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.347 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 t -140.82 139.47 34.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.733 0.301 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -65.56 169.49 6.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 0.0 111.112 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -86.71 115.18 23.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.033 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -74.83 -22.91 58.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.298 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.3 -52.77 63.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.756 0.312 . . . . 0.0 110.804 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -69.64 -38.31 77.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.128 0.49 . . . . 0.0 110.022 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 55.1 mt -64.79 -34.87 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.369 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.44 -48.7 80.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.394 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.83 -34.39 69.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.998 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.6 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.7 tt -58.58 -53.01 63.17 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.2 mt -50.33 -41.87 51.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.453 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.5 m -56.6 -49.14 75.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.523 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -61.03 -39.98 91.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.313 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.13 -48.48 81.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.589 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.99 -165.97 31.84 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.162 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 64.3 mtt-85 -95.51 35.33 1.35 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.972 0.415 . . . . 0.0 110.817 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -120.88 -147.21 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.459 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -120.49 170.9 8.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.766 0.317 . . . . 0.0 110.786 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -69.19 98.21 1.0 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.402 0.62 . . . . 0.0 110.207 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.2 tt -73.58 79.16 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.133 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 43.09 26.24 0.48 Allowed Glycine 0 C--N 1.333 0.398 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.862 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.57 144.19 38.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.838 0.351 . . . . 0.0 110.887 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 p -110.45 156.94 20.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.428 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -105.28 152.47 39.84 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.654 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.8 Cg_exo -82.34 144.28 56.12 Favored 'Cis proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.969 -1.263 . . . . 0.0 112.702 0.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -98.63 132.24 44.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.826 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.5 t -104.23 157.02 5.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.171 0.51 . . . . 0.0 111.992 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.432 ' CZ ' ' CD2' ' A' ' 75' ' ' HIS . 46.2 m-85 -143.67 139.14 29.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.685 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -53.27 152.45 8.21 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.406 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.568 ' HB3' ' N ' ' A' ' 1' ' ' MET . 7.4 Cg_exo -70.14 -8.99 24.96 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.855 2.37 . . . . 0.0 112.353 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.61 -17.7 14.03 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.098 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.6 89.27 1.1 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.663 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.0 t 179.92 152.76 0.47 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.777 0.323 . . . . 0.0 110.723 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.432 ' CD2' ' CZ ' ' A' ' 69' ' ' PHE . 6.0 t-160 -90.22 113.37 25.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.865 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 mt -92.58 -48.68 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.977 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 138.9 -155.42 23.77 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.709 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.82 -136.82 8.9 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.641 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -71.56 -70.66 0.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.82 0.343 . . . . 0.0 111.223 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -59.67 -48.68 80.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.983 0.421 . . . . 0.0 110.729 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -51.3 -39.48 56.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.605 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.489 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.1 tt -78.66 -33.86 46.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.336 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -50.64 -30.13 12.73 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -68.08 -35.79 78.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.229 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 82' ' ' LEU . 13.5 t80 -63.02 -34.05 76.74 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.262 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.489 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.9 m-85 -90.06 -19.65 24.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.304 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.268 -0.873 . . . . 0.0 111.021 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.576 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 49.5 ttm . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.91 0.386 . . . . 0.0 111.561 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.563 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 84.3 m-85 -53.53 158.27 1.86 Allowed 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -135.23 117.44 15.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.486 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.485 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 30.9 t -99.87 127.18 53.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.656 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.533 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 2.9 m-30 -104.39 99.08 8.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.351 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.94 -139.62 2.7 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.45 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.539 ' CD2' ' HD2' ' A' ' 12' ' ' HIS . 85.6 m-85 -120.71 159.79 24.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.075 0.464 . . . . 0.0 111.733 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.15 -81.08 0.06 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.746 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 p 174.12 -41.91 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.227 0.536 . . . . 0.0 111.042 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -74.12 -31.72 62.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.236 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 39' ' ' GLU . 50.9 mm -93.07 -35.7 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.733 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.539 ' HD2' ' CD2' ' A' ' 7' ' ' TYR . 31.3 t60 -154.76 152.39 29.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.33 159.68 3.45 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 t -174.66 73.82 0.03 OUTLIER 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.49 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.8 m -91.28 -37.82 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.571 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -62.5 -28.93 70.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.721 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.8 p -72.19 -44.18 63.4 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.651 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.32 -32.51 49.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.816 0.341 . . . . 0.0 110.921 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -70.16 -55.99 7.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.848 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.69 -31.09 66.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.035 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.45 ' HG2' ' CE1' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -60.94 -56.19 24.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.665 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -60.42 -34.2 73.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.59 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 tt -59.05 -53.82 54.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.317 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 mt -55.47 -44.15 76.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.671 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 m -57.52 -35.92 70.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.176 0.513 . . . . 0.0 109.925 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -79.72 -29.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.431 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.61 -13.14 59.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.052 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt 69.4 62.28 0.29 Allowed 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.95 0.405 . . . . 0.0 110.841 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -142.3 138.87 16.98 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.023 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.417 ' O ' ' HA ' ' A' ' 1' ' ' MET . 77.2 Cg_endo -79.97 136.29 11.69 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.536 2.157 . . . . 0.0 111.43 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.576 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 33.9 p90 -152.37 170.54 19.84 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -148.1 146.04 28.65 Favored 'General case' 0 N--CA 1.46 0.048 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.864 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.485 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 25.5 t80 -89.34 159.5 17.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.16 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.9 mt -145.37 120.56 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.521 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -94.42 118.85 32.26 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.063 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.445 ' CD1' ' CZ ' ' A' ' 43' ' ' PHE . 35.6 pt -78.33 -17.71 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.032 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.538 ' HE2' ' CE1' ' A' ' 7' ' ' TYR . 31.6 ttm -122.11 92.01 48.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.524 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -84.23 18.21 1.58 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.884 2.389 . . . . 0.0 113.028 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.554 ' O ' HG22 ' A' ' 11' ' ' ILE . 9.8 mt-10 -139.53 165.44 27.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.374 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -61.13 -7.76 2.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.88 48.17 0.07 OUTLIER Glycine 0 C--N 1.313 -0.737 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.877 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 39' ' ' GLU . 5.7 t -150.48 115.21 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.327 0.584 . . . . 0.0 112.33 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.469 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 1.1 m-85 -68.44 153.14 44.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.822 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -97.48 93.67 6.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.951 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -49.93 -26.24 3.98 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.716 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.93 -48.81 78.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.851 0.358 . . . . 0.0 110.812 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -77.5 -46.12 23.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.42 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.0 mp -55.03 -42.36 64.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.76 -54.71 34.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 110.653 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.78 -38.28 87.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.48 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.452 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -57.43 -51.27 70.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.535 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.4 mt -50.09 -47.25 53.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.197 0.522 . . . . 0.0 110.586 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -70.21 -35.14 73.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.754 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -61.39 -31.37 71.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.411 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 mt -72.65 -38.72 67.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.683 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.33 -107.14 0.31 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.99 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.7 mtt-85 -150.53 30.87 0.66 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.929 0.395 . . . . 0.0 110.542 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.0 -151.34 0.48 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.355 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -120.61 170.17 9.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.696 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.93 98.37 10.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.241 0.544 . . . . 0.0 110.098 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pt -79.76 84.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.431 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.47 23.95 61.07 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.705 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.57 121.28 5.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.838 0.351 . . . . 0.0 110.594 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.2 p -99.84 161.39 13.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.153 0.502 . . . . 0.0 111.544 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -110.58 154.37 43.14 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.484 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.0 Cg_exo -81.78 145.18 62.98 Favored 'Cis proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.935 -1.277 . . . . 0.0 112.82 0.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -106.72 115.02 29.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -87.18 164.66 2.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.236 0.541 . . . . 0.0 111.953 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.4 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 12.2 m-85 -142.2 130.22 21.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.467 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.41 ' HA ' HD12 ' A' ' 76' ' ' ILE . . . -46.43 144.26 3.43 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.934 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.455 ' CB ' ' N ' ' A' ' 1' ' ' MET . 19.7 Cg_endo -67.76 -13.58 39.09 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.316 2.011 . . . . 0.0 111.767 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -99.4 -23.91 14.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.573 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.02 84.94 0.6 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.866 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.1 m -178.11 162.74 1.63 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.837 0.351 . . . . 0.0 111.133 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -90.37 110.89 21.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 70' ' ' ALA . 35.3 mt -84.86 -51.38 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.004 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.3 -153.5 19.54 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.475 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.18 -152.08 19.42 Favored Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.556 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -63.88 -63.25 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.824 0.345 . . . . 0.0 110.776 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -53.66 -41.82 67.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -56.04 -42.29 76.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.465 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.452 HD23 ' CD2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -63.3 -48.19 79.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.428 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -51.09 -29.15 12.36 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -76.26 -34.14 59.14 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.277 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.423 ' N ' ' O ' ' A' ' 82' ' ' LEU . 7.6 t80 -66.98 -32.57 73.9 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.319 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.452 ' CD2' HD23 ' A' ' 82' ' ' LEU . 6.5 m-85 -90.65 -69.8 0.71 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.072 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.877 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.582 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 48.0 ttm . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -77.92 145.56 36.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.267 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.619 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.2 mppp? -108.11 120.68 43.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.528 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.459 HG12 ' CE1' ' A' ' 33' ' ' PHE . 7.8 t -105.05 131.04 55.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.29 0.567 . . . . 0.0 111.786 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.543 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.9 m-30 -106.59 98.96 8.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.168 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.91 -137.87 2.29 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.811 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.449 ' CZ ' ' CD1' ' A' ' 36' ' ' ILE . 85.1 m-85 -127.73 157.86 39.21 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 120.776 0.322 . . . . 0.0 111.425 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -88.2 -68.38 0.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.127 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 166.73 -33.15 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.998 0.428 . . . . 0.0 110.899 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -71.54 -42.14 68.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.514 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.412 ' CG2' ' HG2' ' A' ' 37' ' ' MET . 27.5 mm -89.47 -39.55 12.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.051 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -150.51 154.08 36.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.351 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -76.86 162.71 27.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.58 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.9 t -172.14 108.32 0.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.785 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.0 m -88.81 -36.69 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.077 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -68.64 -19.74 64.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.002 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.9 m -64.36 -55.74 19.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.938 0.399 . . . . 0.0 110.29 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -57.8 -32.77 67.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.161 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -68.43 -58.46 4.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.273 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.87 -42.37 65.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.91 0.386 . . . . 0.0 111.305 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.426 ' HG2' ' CZ ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -56.26 -50.95 69.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.751 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -60.54 -40.85 93.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.585 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.0 tt -57.36 -51.9 67.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.431 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 mt -59.8 -50.37 74.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.584 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 m -53.27 -38.62 63.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.324 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.5 t -76.29 -36.64 30.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.599 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.515 ' CD ' ' HB3' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -73.7 -9.89 59.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.041 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.19 59.45 0.33 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.983 0.421 . . . . 0.0 111.006 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -144.88 132.42 10.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.142 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.582 ' O ' ' HA ' ' A' ' 1' ' ' MET . 69.6 Cg_endo -79.42 159.27 25.87 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.482 2.121 . . . . 0.0 110.972 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 7.9 p90 -161.43 171.38 18.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.86 0.362 . . . . 0.0 111.788 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -134.3 134.87 42.36 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.523 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.459 ' CE1' HG12 ' A' ' 4' ' ' VAL . 6.8 t80 -89.28 156.69 18.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.168 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.407 HD11 ' CE1' ' A' ' 5' ' ' TYR . 18.0 mt -146.03 121.05 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.468 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -85.65 114.93 23.02 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.936 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.449 ' CD1' ' CZ ' ' A' ' 7' ' ' TYR . 2.1 pt -75.08 -21.05 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.967 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.517 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.7 tpp -116.35 108.67 45.2 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.809 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.429 ' HG3' ' HB3' ' A' ' 44' ' ' ASP . 79.8 Cg_endo -76.05 -28.18 7.74 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.648 2.232 . . . . 0.0 112.101 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -139.57 151.66 46.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.623 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -64.64 -8.5 14.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.255 0.55 . . . . 0.0 111.839 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.59 -55.83 2.77 Favored Glycine 0 C--N 1.313 -0.73 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.814 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -149.06 141.99 18.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 2.2 m-85 -59.4 170.29 1.03 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.843 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.429 ' HB3' ' HG3' ' A' ' 38' ' ' PRO . 1.4 p30 -88.73 140.58 29.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.031 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -78.4 -11.07 59.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.522 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.35 -62.99 1.18 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.791 0.329 . . . . 0.0 111.261 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -42.88 66.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.961 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.424 ' N ' ' CD1' ' A' ' 48' ' ' ILE . 0.8 OUTLIER -56.64 -39.09 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.744 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.26 -55.38 6.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -36.12 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.46 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.429 HD11 ' CE2' ' A' ' 5' ' ' TYR . 20.1 tp -57.08 -51.66 68.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.694 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.3 mt -52.01 -46.91 65.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.149 0.5 . . . . 0.0 111.317 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.8 m -70.16 -42.41 72.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.594 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -60.29 -40.2 89.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.941 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.17 -69.08 0.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.804 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.62 -40.75 0.72 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.2 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -89.78 -174.89 4.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.33 . . . . 0.0 110.709 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -103.26 -30.3 10.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.072 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.4 t -111.19 169.73 8.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.081 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -110.56 99.65 8.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.564 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.4 mt -80.26 87.42 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.558 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.65 29.66 64.47 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.682 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -47.0 147.41 1.37 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.804 0.335 . . . . 0.0 111.007 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.4 p -121.32 153.49 37.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.079 0.466 . . . . 0.0 111.652 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -122.47 152.8 61.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.518 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -80.92 149.7 77.37 Favored 'Cis proline' 0 C--N 1.344 0.324 0 C-N-CA 124.073 -1.22 . . . . 0.0 112.725 0.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -105.32 119.61 39.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.848 178.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -91.41 161.41 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.362 0.601 . . . . 0.0 112.193 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -143.13 140.74 30.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.277 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.37 147.23 28.97 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.139 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.576 ' HB3' ' N ' ' A' ' 1' ' ' MET . 15.7 Cg_exo -65.48 -14.45 44.95 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.694 2.262 . . . . 0.0 112.317 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.56 -23.01 13.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.018 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.36 74.61 0.28 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.568 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.64 113.08 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.757 0.313 . . . . 0.0 110.739 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -53.66 120.94 6.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.994 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.5 mt -97.41 -45.97 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.768 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.401 ' HA3' ' CB ' ' A' ' 81' ' ' GLN . . . 135.13 -156.23 22.47 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.585 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.28 -138.25 7.22 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.575 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -72.87 -61.16 1.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -55.19 -45.34 75.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.04 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.401 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 8.4 mp0 -56.01 -48.28 76.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.475 ' CD2' ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -64.28 -43.0 96.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.434 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -51.54 -29.88 18.59 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -75.01 -35.17 61.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.404 ' N ' ' O ' ' A' ' 82' ' ' LEU . 12.0 t80 -62.9 -35.38 79.87 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.515 ' HB3' ' CD ' ' A' ' 27' ' ' LYS . 5.3 m-85 -87.64 -70.38 0.63 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.216 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.944 179.942 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.642 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 28.4 ttp . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.85 0.357 . . . . 0.0 111.541 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.446 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 87.7 m-85 -79.19 153.35 30.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.156 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.648 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -131.59 121.44 24.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.888 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.468 HG13 ' CE1' ' A' ' 33' ' ' PHE . 7.0 t -104.22 124.32 58.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.147 0.498 . . . . 0.0 111.374 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.562 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.3 m-30 -100.09 99.15 9.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.324 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.34 -137.2 2.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.837 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.574 ' CD2' ' CB ' ' A' ' 12' ' ' HIS . 6.7 m-85 -123.63 146.39 48.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.372 0.13 . . . . 0.0 110.949 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.81 17.79 7.31 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 0.9 OUTLIER 71.72 2.16 4.17 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.589 0.233 . . . . 0.0 111.617 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -85.19 -53.41 5.27 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.967 0.413 . . . . 0.0 110.654 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 mt -111.33 9.5 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.385 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.652 ' CD2' ' HE1' ' A' ' 37' ' ' MET . 11.1 t-80 -169.82 138.19 1.77 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.139 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.34 22.79 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.011 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 p -175.61 123.78 0.21 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.041 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.4 m -91.1 -37.35 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.58 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -75.52 -18.64 59.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.552 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.4 p -70.45 -36.36 73.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.813 0.34 . . . . 0.0 111.004 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.2 -27.11 62.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.335 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -76.86 -49.49 15.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.062 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.02 -46.55 71.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.267 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -60.31 -52.75 63.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.955 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -38.9 85.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.37 -54.02 51.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.636 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mt -56.15 -46.83 79.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.889 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.7 m -56.58 -36.78 69.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.12 0.486 . . . . 0.0 110.152 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.15 -27.68 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.727 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -11.37 58.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.245 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.08 61.14 0.5 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.106 0.479 . . . . 0.0 110.716 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -136.69 140.76 32.98 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.183 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.94 131.94 11.41 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.553 2.169 . . . . 0.0 111.592 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.642 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 11.8 p90 -156.31 169.45 24.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.999 0.428 . . . . 0.0 111.957 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -147.12 148.04 31.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.804 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.468 ' CE1' HG13 ' A' ' 4' ' ' VAL . 7.5 t80 -89.42 161.15 16.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.393 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.419 HD13 ' CE1' ' A' ' 5' ' ' TYR . 21.9 mt -145.58 119.55 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.308 0.575 . . . . 0.0 110.511 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -81.21 125.34 30.18 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.025 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.403 ' CD1' ' CZ ' ' A' ' 7' ' ' TYR . 2.7 pt -99.48 -11.97 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.297 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.652 ' HE1' ' CD2' ' A' ' 12' ' ' HIS . 14.5 ttm -117.57 92.2 40.22 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.742 0.306 . . . . 0.0 111.146 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 44' ' ' ASP . 54.5 Cg_endo -69.37 -28.43 27.13 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.562 2.175 . . . . 0.0 111.671 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -139.85 147.42 40.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.032 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -8.54 6.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.213 0.53 . . . . 0.0 111.783 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.16 -56.62 2.99 Favored Glycine 0 C--N 1.313 -0.72 0 CA-C-N 115.278 -0.873 . . . . 0.0 112.704 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.7 t -148.14 146.42 17.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.924 0.392 . . . . 0.0 111.967 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -61.07 166.51 3.53 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.505 179.47 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.429 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . 10.1 p30 -78.41 99.48 6.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.948 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -55.26 -22.75 19.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.554 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -60.28 -53.7 54.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.886 0.374 . . . . 0.0 110.755 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -69.45 -47.26 64.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.667 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -50.11 -37.45 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.716 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.99 -59.74 4.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.06 0.457 . . . . 0.0 110.506 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.69 -34.45 72.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.229 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.447 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -59.64 -52.63 64.7 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.505 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.5 mt -48.28 -45.07 34.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.264 0.554 . . . . 0.0 110.734 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.7 m -67.15 -35.84 80.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.002 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -64.62 -33.91 77.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.493 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.53 -50.12 40.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.605 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.08 -163.39 35.4 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.945 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 mtt180 -93.9 31.35 1.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.946 0.403 . . . . 0.0 110.921 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -121.15 -153.46 0.55 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.275 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -120.97 170.38 9.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.734 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.46 98.48 6.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.357 0.599 . . . . 0.0 110.028 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.1 mm -73.08 82.28 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.514 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 50.16 25.95 8.53 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -55.39 156.96 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 111.157 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.42 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 37.2 p -139.58 163.59 32.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -98.93 158.62 32.02 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.862 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.1 Cg_exo -83.88 140.79 36.82 Favored 'Cis proline' 0 C--N 1.345 0.348 0 C-N-CA 124.151 -1.187 . . . . 0.0 112.759 0.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 64' ' ' THR . 15.0 mm-40 -105.39 114.05 28.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.046 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.7 t -86.93 163.64 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.264 0.554 . . . . 0.0 112.087 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.4 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 20.3 m-85 -142.96 132.66 23.87 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.278 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.38 146.34 91.73 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.262 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.589 ' HB3' ' N ' ' A' ' 1' ' ' MET . 54.7 Cg_exo -42.15 -52.36 4.2 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.372 2.715 . . . . 0.0 113.008 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.42 -27.84 66.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.203 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.46 73.26 0.64 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.363 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.14 143.2 18.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 111.044 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -70.22 110.82 5.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.764 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 mt -83.4 -49.21 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.144 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.18 -153.47 20.77 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.268 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.83 -143.35 8.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.33 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -73.07 -67.17 0.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 0.0 110.755 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -53.08 -38.74 62.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.874 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -60.37 -39.41 87.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.49 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.459 HD22 ' CD2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -69.65 -45.02 69.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.35 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -51.32 -31.43 21.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.48 -35.78 65.72 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.164 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 82' ' ' LEU . 12.3 t80 -63.85 -33.66 76.19 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.275 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.459 ' CD2' HD22 ' A' ' 82' ' ' LEU . 6.2 m-85 -87.97 -70.34 0.64 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.132 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.931 -179.938 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.586 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 64.3 ttp . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 120.878 0.37 . . . . 0.0 111.672 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.487 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 80.2 m-85 -60.37 153.43 22.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.646 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.697 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -129.66 122.68 29.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.458 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.48 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 10.0 t -105.37 136.79 37.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.09 0.471 . . . . 0.0 111.614 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.494 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 5.2 m-85 -115.42 99.62 7.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.189 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.48 -135.51 1.93 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.554 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.51 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 75.5 m-85 -120.16 146.66 45.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.948 0.404 . . . . 0.0 111.665 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -94.58 139.7 30.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.465 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.5 p -51.79 -24.71 6.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.563 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -73.16 -43.32 61.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.547 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.3 mm -89.8 -43.95 14.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.785 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 78.8 t60 -144.68 158.32 43.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.744 0.307 . . . . 0.0 111.131 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.2 mmmt -80.0 161.38 25.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.174 0.512 . . . . 0.0 111.614 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.2 p -167.92 113.7 0.69 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.358 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 m -90.46 -28.75 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.422 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -85.57 -17.27 36.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.129 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.5 p -67.25 -39.84 86.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.038 0.447 . . . . 0.0 110.153 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.4 -26.68 68.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.049 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -69.47 -55.58 9.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.123 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.8 -44.16 66.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.977 0.417 . . . . 0.0 111.133 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -60.32 -52.57 64.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -56.64 -37.99 71.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.417 HD23 ' CD2' ' A' ' 86' ' ' PHE . 0.9 OUTLIER -58.55 -52.58 65.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.548 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.51 -47.19 82.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 m -56.13 -33.39 65.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.029 0.442 . . . . 0.0 110.375 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.3 t -78.36 -30.42 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.794 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm -82.13 -10.85 59.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.226 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? 68.39 60.99 0.38 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.914 0.388 . . . . 0.0 110.739 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -141.42 139.63 19.2 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.07 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.426 ' O ' ' HA ' ' A' ' 1' ' ' MET . 77.9 Cg_endo -80.28 139.89 13.45 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.52 2.146 . . . . 0.0 111.231 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.586 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 51.3 p90 -153.22 170.56 20.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -141.81 142.12 33.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.956 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.48 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 38.2 t80 -89.83 158.58 17.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.236 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.494 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 7.8 mt -147.18 120.29 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.128 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -99.63 127.31 45.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.671 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.9 pt -80.97 -8.61 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.238 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.563 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 8.2 ttp -125.98 95.3 39.83 Favored Pre-proline 0 N--CA 1.456 -0.133 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.146 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.38 1.33 9.35 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.746 2.297 . . . . 0.0 112.568 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -139.71 135.62 33.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.604 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -62.79 -9.24 8.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.175 0.512 . . . . 0.0 112.183 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.99 -63.74 1.65 Allowed Glycine 0 C--N 1.311 -0.841 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.917 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.1 t -146.83 151.89 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.692 0.282 . . . . 0.0 110.993 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -68.0 167.03 14.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 111.109 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.26 114.87 28.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.018 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -58.11 -18.2 23.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.471 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -57.82 -54.94 41.22 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.857 0.361 . . . . 0.0 110.696 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -70.59 -37.41 73.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.208 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.6 mm -55.31 -46.79 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.895 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.7 -53.37 58.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.693 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -57.4 -40.68 78.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.338 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.427 HD12 ' CE2' ' A' ' 5' ' ' TYR . 9.3 tp -55.37 -48.67 73.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.653 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.1 mt -54.18 -49.42 69.38 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.06 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.3 m -61.94 -33.92 75.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.215 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -67.44 -29.65 69.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.631 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.93 -26.49 62.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.109 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.49 32.57 15.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.396 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.5 mtt-85 -150.06 -168.86 3.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 0.0 110.827 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.78 -50.11 2.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.032 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -102.95 165.44 11.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -95.38 98.74 10.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.122 0.487 . . . . 0.0 110.503 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.8 mt -80.33 85.53 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.275 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.48 27.05 73.53 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.455 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.5 tt -55.42 150.57 11.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.895 0.379 . . . . 0.0 111.191 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.0 p -148.5 164.81 33.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.405 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -119.19 146.37 40.48 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.573 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -84.63 150.71 57.05 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.993 -1.253 . . . . 0.0 112.828 0.368 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' TYR . 1.3 tp60 -109.44 117.9 35.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.221 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -92.83 166.73 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.829 0.347 . . . . 0.0 111.59 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 74' ' ' SER . 73.5 m-85 -142.49 140.17 31.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.028 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.82 150.07 10.46 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.278 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.497 ' HB3' ' N ' ' A' ' 1' ' ' MET . 42.8 Cg_exo -58.96 -30.71 93.99 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.097 2.531 . . . . 0.0 112.026 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -91.48 -23.72 19.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.245 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.62 90.27 0.8 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.653 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 15.9 t -171.63 158.98 5.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.761 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.426 ' NE2' ' CG ' ' A' ' 67' ' ' GLN . 17.7 t-160 -88.64 110.07 20.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.985 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.42 HG12 ' CD2' ' A' ' 85' ' ' TYR . 10.8 mt -85.05 -50.84 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.093 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.85 -154.77 19.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.563 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.01 -145.75 7.74 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.669 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -71.28 -70.03 0.34 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.742 0.306 . . . . 0.0 110.892 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.99 -46.1 71.61 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.969 0.414 . . . . 0.0 110.562 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -34.43 63.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.114 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 85' ' ' TYR . 2.7 tt -74.79 -39.63 61.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.012 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' A' ' 87' ' ' LYS . 24.2 ttp180 -51.77 -29.08 17.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -71.63 -33.42 68.93 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.392 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.453 ' N ' ' O ' ' A' ' 82' ' ' LEU . 9.0 t80 -66.62 -31.64 72.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.588 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.417 ' CD2' HD23 ' A' ' 23' ' ' LEU . 25.1 m-85 -95.62 -70.37 0.72 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.498 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 83' ' ' ARG . 15.2 mtmt . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.954 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.581 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 4.6 ttm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -80.4 149.15 30.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.187 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -109.87 117.14 33.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.413 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.466 HG12 ' CE1' ' A' ' 33' ' ' PHE . 8.1 t -102.16 125.21 56.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.242 0.544 . . . . 0.0 111.347 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.611 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.3 m-30 -101.95 99.09 9.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.402 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.94 -137.12 2.12 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.287 -0.959 . . . . 0.0 112.647 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 87.5 m-85 -126.02 147.25 49.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.736 0.303 . . . . 0.0 110.932 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -101.92 21.39 14.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.415 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.2 t 66.83 9.14 6.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.567 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -85.55 -46.43 10.83 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.868 0.366 . . . . 0.0 110.667 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.441 ' CD1' ' N ' ' A' ' 11' ' ' ILE . 1.3 mp -109.33 -33.36 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.974 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.435 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 20.4 t60 -139.35 152.4 47.13 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.653 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.36 173.16 12.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.481 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.5 p -175.04 119.0 0.19 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.774 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 m -90.34 -26.33 5.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.307 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -86.72 -16.47 36.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.413 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.3 p -72.54 -41.66 65.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.934 0.397 . . . . 0.0 110.644 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -66.75 -33.23 75.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 86.5 m-20 -73.54 -52.78 12.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.506 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.76 -42.42 68.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.382 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -60.61 -52.36 65.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.766 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -58.44 -34.54 70.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.747 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.425 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 1.6 tt -59.46 -56.63 19.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.327 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.467 ' CD2' ' CE2' ' A' ' 86' ' ' PHE . 46.5 mt -61.47 -40.25 93.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.711 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.2 m -60.71 -35.5 76.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.155 0.503 . . . . 0.0 109.7 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.9 t -80.09 -33.11 14.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.467 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 9.3 mmtt -72.23 -10.19 59.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.211 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER 68.99 40.87 1.54 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.881 0.372 . . . . 0.0 111.125 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.93 136.64 29.31 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.432 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.547 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.1 Cg_endo -78.84 155.77 26.94 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.543 2.162 . . . . 0.0 111.867 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -161.35 170.84 19.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.802 0.334 . . . . 0.0 111.338 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -132.51 137.36 47.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.625 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.466 ' CE1' HG12 ' A' ' 4' ' ' VAL . 6.1 t80 -89.22 158.35 17.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.296 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.412 HD12 ' CE1' ' A' ' 5' ' ' TYR . 20.4 mt -147.27 122.56 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.468 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -92.4 126.02 37.3 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.985 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.5 pt -92.11 -6.31 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.448 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.405 ' HG2' HG23 ' A' ' 11' ' ' ILE . 3.3 tpp -127.63 82.59 68.02 Favored Pre-proline 0 N--CA 1.454 -0.271 0 CA-C-O 120.76 0.314 . . . . 0.0 110.882 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 97.2 Cg_endo -89.86 27.34 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.047 2.498 . . . . 0.0 112.648 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.433 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -139.32 165.25 27.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.382 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -58.79 -8.0 1.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 169.77 47.59 0.03 OUTLIER Glycine 0 C--N 1.312 -0.791 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.848 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.9 t -150.59 127.2 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.959 0.409 . . . . 0.0 111.397 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.407 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 2.5 m-30 -63.22 168.74 4.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.645 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.415 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 7.5 t70 -98.93 106.69 18.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.914 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -60.99 -23.95 65.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.542 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.6 -59.22 3.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.684 0.278 . . . . 0.0 111.287 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -67.3 -45.14 77.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 110.885 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.41 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 1.5 mp -57.06 -29.42 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.814 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.65 -61.78 1.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.956 0.408 . . . . 0.0 110.887 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -59.61 -32.42 70.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.31 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.438 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -59.72 -53.03 62.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.341 179.49 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 48' ' ' ILE . 69.2 mt -47.72 -44.99 28.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.356 0.598 . . . . 0.0 110.628 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.8 m -70.15 -35.67 74.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.83 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.65 -29.34 70.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.61 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -74.33 -65.82 0.8 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.009 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.89 -29.18 0.26 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.511 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.25 -167.6 1.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.883 0.373 . . . . 0.0 110.806 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -98.35 -29.88 12.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.944 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -94.5 162.69 13.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.968 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -102.37 99.25 9.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.0 110.611 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pt -79.16 84.3 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.342 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.77 23.3 76.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.621 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.29 131.11 49.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.309 . . . . 0.0 110.682 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.89 170.01 15.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.079 0.466 . . . . 0.0 111.348 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -118.87 150.21 48.1 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.649 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.3 Cg_endo -83.29 139.04 34.89 Favored 'Cis proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.923 -1.282 . . . . 0.0 112.559 0.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -101.7 118.69 37.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.875 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.6 t -90.75 159.76 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.417 0.627 . . . . 0.0 112.499 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.45 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 30.7 m-85 -143.36 145.98 33.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.255 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.472 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -61.17 156.68 48.19 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.25 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.581 ' HB3' ' N ' ' A' ' 1' ' ' MET . 3.0 Cg_exo -73.87 -5.37 16.92 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.97 2.447 . . . . 0.0 112.425 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.19 -8.15 11.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.208 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.2 89.6 1.86 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.55 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.2 m -179.23 156.53 0.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.83 0.348 . . . . 0.0 110.925 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -90.2 120.81 31.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.472 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 1.2 mp -102.11 -36.04 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.625 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.5 -161.78 16.55 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.714 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.9 -134.75 6.97 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.619 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 10.9 t80 -74.36 -70.2 0.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 111.017 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -55.95 -48.63 75.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.936 0.398 . . . . 0.0 110.557 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.25 -38.98 66.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.601 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.457 HD22 ' CE2' ' A' ' 86' ' ' PHE . 3.8 tt -74.8 -38.3 62.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.077 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 87' ' ' LYS . 8.0 ttt85 -51.34 -29.27 14.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -71.91 -34.3 68.99 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.409 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.444 ' N ' ' O ' ' A' ' 82' ' ' LEU . 18.8 t80 -67.01 -30.68 70.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.483 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.467 ' CE2' ' CD2' ' A' ' 24' ' ' LEU . 30.3 m-85 -96.33 -16.6 21.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.563 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 83' ' ' ARG . 11.8 mtmm . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.98 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.599 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 40.0 ttp . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -76.14 147.35 38.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.319 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 3.7 mptt -107.85 119.35 39.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.405 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.505 ' CG1' ' CE2' ' A' ' 33' ' ' PHE . 38.4 t -109.26 133.58 53.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.403 0.621 . . . . 0.0 112.104 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 19.7 m-85 -113.73 99.16 7.5 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.592 177.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.63 -127.18 1.16 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.149 -1.024 . . . . 0.0 112.946 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.424 ' CD2' ' CD2' ' A' ' 12' ' ' HIS . 28.3 m-85 -137.15 108.31 6.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 120.901 0.382 . . . . 0.0 111.926 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.466 ' HB2' ' CE1' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -105.08 -27.25 11.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.257 179.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.1 m -60.49 163.7 5.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.54 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.02 3.86 44.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.64 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.435 ' CD1' ' HG3' ' A' ' 37' ' ' MET . 0.1 OUTLIER -88.55 -17.49 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.424 ' CD2' ' CD2' ' A' ' 7' ' ' TYR . 1.9 t60 -140.96 141.13 34.49 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.503 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.29 177.27 9.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.839 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 p -175.95 111.65 0.11 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.035 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 m -90.64 -34.23 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.576 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-30 -82.71 -16.45 48.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.381 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.9 p -63.04 -37.36 86.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.07 0.462 . . . . 0.0 110.262 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.87 -27.01 63.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.316 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -74.1 -54.68 7.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.375 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.24 -45.28 72.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.304 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.65 -52.81 63.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.761 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -58.67 -42.64 88.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.461 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.411 HD22 ' CD2' ' A' ' 86' ' ' PHE . 2.2 tt -58.89 -54.73 43.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.179 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.7 -48.16 78.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.72 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.4 m -55.91 -39.87 72.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.146 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.97 -32.47 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.593 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -9.36 58.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.073 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 68.69 42.57 1.43 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.051 0.453 . . . . 0.0 110.63 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -127.97 132.5 24.38 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.902 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.599 ' O ' ' HA ' ' A' ' 1' ' ' MET . 64.2 Cg_endo -79.92 154.17 22.76 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.479 2.119 . . . . 0.0 111.217 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 5.5 p90 -161.51 171.26 18.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.717 0.294 . . . . 0.0 111.446 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -137.35 121.7 18.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.899 0.38 . . . . 0.0 110.759 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.505 ' CE2' ' CG1' ' A' ' 4' ' ' VAL . 35.1 t80 -89.32 157.9 18.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.44 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.8 mt -143.95 120.38 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.27 0.557 . . . . 0.0 111.038 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -83.99 109.27 17.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.08 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 43' ' ' PHE . 11.6 pt -97.72 66.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.05 0.453 . . . . 0.0 111.605 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.435 ' HG3' ' CD1' ' A' ' 11' ' ' ILE . 22.0 tpp -160.73 73.4 2.79 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.413 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 35.0 Cg_exo -59.97 -22.61 69.74 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.128 1.885 . . . . 0.0 110.859 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -151.2 152.77 33.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.052 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.404 ' HA ' HD13 ' A' ' 11' ' ' ILE . 14.3 mttt -64.1 -7.54 9.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.344 0.592 . . . . 0.0 111.622 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.79 -55.42 3.36 Favored Glycine 0 C--N 1.311 -0.827 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.953 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -149.19 147.13 16.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 12.3 m-85 -59.74 170.45 1.11 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.088 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.404 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 5.0 t0 -77.89 108.4 11.12 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.687 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.03 -24.25 23.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.723 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.65 -56.36 14.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.817 0.341 . . . . 0.0 111.323 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -34.37 77.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.157 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.85 -31.38 30.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.552 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.64 -55.01 39.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.962 0.41 . . . . 0.0 110.287 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.14 -33.31 75.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.045 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.1 tt -59.11 -51.69 68.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.284 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.1 mt -52.68 -44.51 66.27 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.999 0.428 . . . . 0.0 111.381 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.6 m -57.9 -48.79 78.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.576 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -58.78 -38.77 79.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.618 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.9 -56.04 26.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.722 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.93 -115.6 0.58 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.097 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.6 ttp-105 -150.33 31.03 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 110.662 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -121.07 -143.72 0.35 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.321 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 t -120.02 170.29 9.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.692 0.282 . . . . 0.0 110.671 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -77.83 98.34 5.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.271 0.558 . . . . 0.0 110.649 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -80.13 84.32 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.115 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.1 25.45 66.3 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.449 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.81 134.63 36.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.9 0.381 . . . . 0.0 110.893 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.54 164.1 15.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.101 0.477 . . . . 0.0 111.419 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.07 154.74 47.18 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.66 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.3 Cg_endo -87.54 136.82 16.61 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.116 -1.202 . . . . 0.0 112.679 0.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -90.01 142.79 27.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.927 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -115.97 158.06 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.077 0.465 . . . . 0.0 111.56 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 75' ' ' HIS . 46.6 m-85 -142.83 138.66 30.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.146 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.92 133.36 29.21 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.409 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.575 ' HB3' ' N ' ' A' ' 1' ' ' MET . 33.4 Cg_exo -52.92 -21.96 16.97 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.555 2.17 . . . . 0.0 111.948 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.23 39.79 0.1 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.19 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.4 -110.16 0.8 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.957 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.07 -172.4 3.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.168 0.509 . . . . 0.0 111.321 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.462 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 24.4 t-80 -65.18 126.1 27.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.068 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.6 mt -95.91 -45.26 13.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.784 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.02 -155.32 21.77 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.521 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.77 -142.07 9.1 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.572 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -70.56 -68.76 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.778 0.323 . . . . 0.0 110.943 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -54.74 -46.46 74.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.838 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -54.41 -36.26 63.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.627 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.475 HD23 ' CD2' ' A' ' 86' ' ' PHE . 0.9 OUTLIER -75.27 -38.93 60.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.28 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -51.93 -29.63 21.05 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -71.25 -35.47 71.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.154 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 82' ' ' LEU . 20.7 t80 -63.46 -33.63 75.98 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.275 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.475 ' CD2' HD23 ' A' ' 82' ' ' LEU . 6.5 m-85 -87.15 -69.53 0.68 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.122 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.646 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 16.1 ttm . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.782 0.325 . . . . 0.0 111.682 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.433 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 91.8 m-85 -85.62 142.38 29.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.991 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -117.04 127.69 54.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.909 -179.424 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.508 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 15.7 t -110.76 133.81 55.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.391 0.615 . . . . 0.0 111.559 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.531 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 21.6 m-30 -116.39 99.86 7.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.368 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.439 ' HA3' ' HB3' ' A' ' 66' ' ' PRO . . . -161.8 -139.13 2.57 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.771 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.472 ' CE1' ' HE1' ' A' ' 37' ' ' MET . 45.4 m-85 -123.71 156.22 36.37 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 120.889 0.376 . . . . 0.0 111.364 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -74.38 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 t 173.62 -36.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.734 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -85.11 -20.7 29.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.28 -38.22 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.004 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -150.29 151.6 33.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.464 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 14' ' ' CYS . 13.7 tptt -75.74 157.33 33.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.18 0.514 . . . . 0.0 112.177 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 28.3 p 177.43 113.15 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.545 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.447 ' CG2' ' N ' ' A' ' 16' ' ' TYR . 1.3 m -90.88 -39.11 11.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.899 0.857 . . . . 0.0 110.026 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.569 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -77.97 -10.74 59.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.698 -179.212 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 14' ' ' CYS . 20.5 p -73.76 -41.72 62.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.047 0.451 . . . . 0.0 110.045 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.53 -34.09 71.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.747 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -65.06 -46.74 79.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.97 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.79 -50.39 72.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.962 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.0 ttpt -53.16 -44.09 67.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.841 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.47 -40.89 92.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.78 -53.1 61.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.564 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.0 mt -56.52 -47.5 79.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.85 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.2 m -55.18 -36.51 65.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.136 0.493 . . . . 0.0 110.091 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.4 t -78.14 -28.14 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.675 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.7 -21.25 44.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.927 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt 71.65 63.52 0.15 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.962 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -132.02 142.31 44.65 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.053 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.65 124.49 8.24 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.477 2.118 . . . . 0.0 111.266 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.646 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 6.3 p90 -157.17 164.56 37.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.046 0.451 . . . . 0.0 112.168 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.66 144.03 31.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.993 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.508 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 17.9 t80 -89.2 152.76 21.41 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.004 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 mt -143.92 119.62 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.358 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -72.94 109.93 6.86 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.776 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 pp -69.79 -24.8 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 5.8 ttp -126.69 91.44 47.3 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.111 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.71 0.61 9.9 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.57 2.18 . . . . 0.0 112.231 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -139.65 138.45 36.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.652 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -66.28 -8.71 26.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.246 0.546 . . . . 0.0 111.852 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.13 -63.75 1.64 Allowed Glycine 0 C--N 1.311 -0.815 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.098 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -150.28 139.42 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.617 0.246 . . . . 0.0 111.118 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.6 OUTLIER -58.79 169.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.932 0.396 . . . . 0.0 111.353 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.406 ' O ' ' CD1' ' A' ' 48' ' ' ILE . 1.2 t0 -80.07 105.86 11.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.302 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -59.88 -17.63 38.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.815 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.33 -61.22 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 111.212 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.55 -36.21 83.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.054 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.406 ' CD1' ' O ' ' A' ' 44' ' ' ASP . 1.9 mp -70.48 -29.85 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.409 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.7 -54.69 39.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.435 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.54 -34.51 74.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.134 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.531 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 2.9 tt -55.84 -51.13 68.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.264 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.6 mt -54.03 -47.24 71.75 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.331 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.1 m -62.54 -45.16 94.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.612 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -56.56 -40.73 75.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.587 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 mt -59.96 -47.88 83.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.572 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.49 -112.48 0.49 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.196 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.34 33.64 0.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.055 0.455 . . . . 0.0 110.433 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -120.92 -146.88 0.38 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.9 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.3 t -120.26 172.99 7.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.741 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.28 98.61 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.494 0.664 . . . . 0.0 109.755 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.5 mt -75.08 78.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.875 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.59 26.88 0.45 Allowed Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.007 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.2 139.88 46.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.873 0.368 . . . . 0.0 111.022 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.5 p -106.42 170.7 7.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.398 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.425 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -108.15 156.29 38.64 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.896 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.8 Cg_exo -84.08 143.2 42.08 Favored 'Cis proline' 0 C--N 1.346 0.4 0 C-N-CA 124.258 -1.142 . . . . 0.0 113.064 0.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -96.33 132.29 41.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.565 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -102.5 162.51 3.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.441 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.414 ' N ' HD13 ' A' ' 76' ' ' ILE . 19.5 m-85 -142.25 130.88 22.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.7 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.76 147.46 98.72 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.385 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.566 ' HB3' ' N ' ' A' ' 1' ' ' MET . 74.6 Cg_exo -45.44 -38.72 16.13 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.292 2.662 . . . . 0.0 112.615 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.66 -38.84 70.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.158 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.83 78.53 0.31 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.505 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.3 m -164.05 148.3 10.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.73 0.3 . . . . 0.0 110.878 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -75.94 106.97 7.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.414 HD13 ' N ' ' A' ' 69' ' ' PHE . 4.7 mt -74.8 -50.46 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.191 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 131.59 -153.06 20.27 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.799 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.06 -136.34 8.75 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.772 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.467 ' HB2' ' CE1' ' A' ' 16' ' ' TYR . 46.3 t80 -72.05 -70.76 0.31 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.755 0.312 . . . . 0.0 111.13 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -57.43 -40.97 79.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.979 0.418 . . . . 0.0 110.722 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -58.58 -38.46 77.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.831 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.478 HD23 ' CD2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -75.37 -41.63 55.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.368 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.23 -30.34 17.17 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -70.9 -36.22 72.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.253 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.42 ' N ' ' O ' ' A' ' 82' ' ' LEU . 11.4 t80 -63.99 -33.29 75.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.216 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.478 ' CD2' HD23 ' A' ' 82' ' ' LEU . 6.6 m-85 -89.58 -13.21 37.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.257 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 68.0 mttt . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.796 179.918 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.604 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 22.9 ttm . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.816 0.341 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.477 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 77.0 m-85 -76.66 158.73 30.82 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.637 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -138.86 120.6 15.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.786 -179.408 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.476 HG11 ' CE1' ' A' ' 33' ' ' PHE . 7.8 t -104.79 133.02 50.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.294 0.569 . . . . 0.0 111.681 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 2.3 m-85 -109.33 99.21 8.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.139 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.53 -137.34 2.19 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.878 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.594 ' CG ' ' HB3' ' A' ' 12' ' ' HIS . 88.6 m-85 -115.8 160.13 20.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 111.888 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -83.47 -73.0 0.43 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.606 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 p 171.79 -38.75 0.0 OUTLIER 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.963 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -85.82 -19.66 30.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.726 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 mt -95.19 -38.79 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.751 ' HD2' ' HE1' ' A' ' 37' ' ' MET . 2.7 t-80 -150.9 174.08 13.52 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.526 ' H ' ' HD1' ' A' ' 12' ' ' HIS . 11.1 ptmt -79.65 157.68 27.2 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.949 -0.469 . . . . 0.0 111.75 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -165.97 87.35 0.37 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.3 m -90.5 -41.93 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.757 0.313 . . . . 0.0 111.165 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -77.64 -15.67 59.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.638 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.7 m -70.56 -50.63 35.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.106 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -55.99 -30.66 62.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 111.07 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -70.71 -50.67 33.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.026 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.6 -46.88 80.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.107 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.8 tttt -59.9 -53.42 58.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.74 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -35.45 73.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.567 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.416 HD22 ' CD2' ' A' ' 86' ' ' PHE . 1.3 tt -58.3 -53.31 59.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.41 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 mt -55.77 -45.71 78.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.69 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.38 -35.26 67.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.17 0.509 . . . . 0.0 110.094 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.1 t -78.05 -30.59 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.558 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -19.35 50.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.948 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 73.81 63.75 0.09 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.932 0.396 . . . . 0.0 110.904 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -142.27 139.27 17.53 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.11 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -74.6 136.11 20.83 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.423 2.082 . . . . 0.0 111.616 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.604 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 21.3 p90 -158.3 170.66 21.75 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -146.05 147.09 31.25 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.968 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.476 ' CE1' HG11 ' A' ' 4' ' ' VAL . 13.6 t80 -89.53 158.56 17.61 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.166 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.8 mt -147.25 121.65 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.456 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -91.79 122.81 34.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.069 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 pp -89.0 -23.24 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.751 ' HE1' ' HD2' ' A' ' 12' ' ' HIS . 2.5 ttp -119.25 92.99 46.51 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.306 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.12 0.52 9.27 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.745 2.297 . . . . 0.0 113.295 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -139.11 140.85 38.08 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -9.2 12.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.232 0.539 . . . . 0.0 111.645 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.95 -67.0 0.9 Allowed Glycine 0 C--N 1.315 -0.625 0 CA-C-N 115.272 -0.876 . . . . 0.0 113.147 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.1 t -128.73 138.47 54.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -72.57 170.51 14.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.501 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -87.86 115.32 25.23 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.147 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.3 p30 -66.92 -18.89 65.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.605 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -58.58 -55.08 39.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.923 0.392 . . . . 0.0 110.702 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 mmtm -69.35 -39.06 78.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.144 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.421 HD13 ' CD1' ' A' ' 43' ' ' PHE . 66.7 mt -54.12 -44.88 65.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.87 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.66 -55.17 36.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.54 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.72 -38.5 81.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.218 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.461 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -59.57 -50.62 73.19 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.477 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.7 mt -47.78 -43.11 27.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.299 0.571 . . . . 0.0 110.701 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.1 m -68.55 -35.78 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.827 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.412 ' HE3' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -65.86 -30.6 71.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.428 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -75.98 -48.47 21.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.658 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.25 -39.95 1.59 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.111 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -97.26 169.11 10.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 110.823 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -94.05 -25.87 17.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.763 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -98.72 161.24 13.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.75 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -110.48 99.83 8.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.805 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.6 mt -79.62 84.61 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.78 25.8 64.21 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.51 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.17 126.65 23.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.866 0.365 . . . . 0.0 110.857 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.6 p -128.67 170.38 13.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.161 0.505 . . . . 0.0 111.59 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.56 157.15 38.25 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.625 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.2 Cg_endo -86.67 149.78 40.72 Favored 'Cis proline' 0 C--N 1.346 0.395 0 C-N-CA 124.384 -1.09 . . . . 0.0 112.94 0.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -119.27 115.59 24.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.98 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.637 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.9 t -91.59 165.92 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.219 0.533 . . . . 0.0 112.24 -178.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 34.5 m-85 -142.29 133.51 26.2 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.155 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.24 138.02 81.51 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.604 ' HB3' ' N ' ' A' ' 1' ' ' MET . 21.2 Cg_exo -34.61 -56.14 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.799 2.999 . . . . 0.0 113.195 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -140.38 29.35 1.99 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.615 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.13 -87.93 1.85 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.549 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -177.45 175.47 1.43 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.893 0.378 . . . . 0.0 110.571 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 20.0 t-80 -49.95 109.18 0.26 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.687 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.3 mt -73.86 -48.77 37.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.493 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.7 -154.29 20.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.598 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.52 -149.66 7.17 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.604 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -72.04 -53.97 11.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.78 0.324 . . . . 0.0 110.769 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -54.78 -44.39 73.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.846 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -58.67 -45.59 89.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.67 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -61.85 -49.47 76.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.595 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -51.11 -30.71 16.98 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -75.37 -34.5 61.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.177 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.422 ' N ' ' O ' ' A' ' 82' ' ' LEU . 6.3 t80 -65.45 -32.97 74.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.278 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.416 ' CD2' HD21 ' A' ' 82' ' ' LEU . 9.4 m-85 -91.85 -24.27 19.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.348 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.9 pttt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.317 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.562 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 4.5 tpp . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.411 ' CD1' HD21 ' A' ' 24' ' ' LEU . 79.6 m-85 -77.53 143.92 38.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.879 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -105.59 121.97 45.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 -179.159 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.454 HG12 ' CE1' ' A' ' 33' ' ' PHE . 53.9 t -111.66 140.94 28.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.348 0.594 . . . . 0.0 111.934 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.512 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 4.9 m-85 -119.88 99.62 6.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.453 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.8 -140.18 2.87 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.124 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.472 ' CE1' ' HE2' ' A' ' 37' ' ' MET . 30.0 m-85 -126.06 159.93 31.47 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.626 -0.287 . . . . 0.0 111.228 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.406 ' O ' ' CB ' ' A' ' 9' ' ' SER . 11.3 t70 -69.87 -67.41 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.527 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.7 OUTLIER 166.36 -39.35 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.129 179.641 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -85.55 -17.93 34.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.174 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.438 ' CD1' ' N ' ' A' ' 11' ' ' ILE . 2.6 mp -89.11 -42.51 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.042 0.449 . . . . 0.0 109.799 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.4 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 5.3 t60 -149.52 158.17 43.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.201 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.37 146.65 2.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.831 0.348 . . . . 0.0 111.454 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -175.15 65.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.274 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.6 m -90.57 -48.12 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -76.87 -11.35 59.81 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.465 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 27.4 p -73.95 -45.04 52.79 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -55.31 -24.86 31.0 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.464 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 10.2 m-80 -73.3 -45.79 53.43 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.989 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.91 -29.69 69.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.335 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? -70.35 -62.45 1.38 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.808 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -54.24 -30.29 49.73 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.93 0.395 . . . . 0.0 110.379 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 tt -58.16 -54.26 48.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.817 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.411 HD21 ' CD1' ' A' ' 2' ' ' PHE . 6.0 mt -54.44 -45.41 73.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.455 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 m -54.79 -36.28 64.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.655 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.3 t -79.67 -32.28 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.308 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -11.95 60.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.834 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.37 45.52 0.1 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.948 0.404 . . . . 0.0 110.95 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -144.04 134.04 11.85 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.338 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.562 ' O ' ' HA ' ' A' ' 1' ' ' MET . 64.5 Cg_endo -81.54 166.19 17.87 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.611 2.207 . . . . 0.0 111.308 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.525 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 8.4 p90 -161.49 171.08 18.75 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.89 0.329 . . . . 0.0 111.89 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.72 136.64 39.16 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.806 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.454 ' CE1' HG12 ' A' ' 4' ' ' VAL . 6.0 t80 -89.22 160.77 16.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.502 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.512 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 20.3 mt -144.52 119.41 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.259 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -83.09 121.89 27.63 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.481 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.4 ' HB ' HD11 ' A' ' 48' ' ' ILE . 1.3 pt -98.1 -20.06 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.796 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.472 ' HE2' ' CE1' ' A' ' 7' ' ' TYR . 32.6 ttm -124.75 83.26 59.23 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.811 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.436 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 55.7 Cg_endo -70.17 -13.94 34.23 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.653 2.236 . . . . 0.0 111.981 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -139.8 145.27 37.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.747 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.84 -8.0 44.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.304 0.573 . . . . 0.0 111.498 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.26 -58.54 2.57 Favored Glycine 0 C--N 1.312 -0.799 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.4 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.1 t -149.48 140.71 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 111.374 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.4 OUTLIER -60.01 160.18 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.533 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.436 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 62.6 t0 -71.78 132.2 44.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.952 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -71.54 -28.26 63.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 0.0 110.761 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.93 -56.43 10.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.984 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -65.31 -46.18 81.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.836 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 44' ' ' ASP . 1.1 mp -58.1 -38.14 65.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.372 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.46 -56.57 5.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.152 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -60.21 -31.31 70.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.629 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.408 HD11 ' CD2' ' A' ' 5' ' ' TYR . 13.3 tp -59.71 -52.18 66.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.288 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.5 mt -51.59 -45.82 63.29 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.107 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.0 m -65.53 -31.44 72.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.331 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.425 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 19.8 tttp -66.96 -31.87 72.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.556 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.91 -42.7 94.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.8 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.75 -106.47 0.29 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.05 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -149.68 28.65 0.78 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.112 0.482 . . . . 0.0 110.679 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -121.3 -147.14 0.38 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.401 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.5 t -120.28 170.24 9.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.69 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.29 98.26 8.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.271 0.558 . . . . 0.0 110.355 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.3 mt -80.06 84.52 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.191 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.77 25.76 45.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.469 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -57.64 144.3 38.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.897 0.379 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.9 p -123.53 168.51 12.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.229 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.403 ' O ' ' OH ' ' A' ' 16' ' ' TYR . 1.2 mpt? -113.12 156.12 43.36 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.791 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -80.59 140.57 52.0 Favored 'Cis proline' 0 C--N 1.344 0.298 0 C-N-CA 123.741 -1.358 . . . . 0.0 112.978 0.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.412 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -96.42 123.16 39.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.055 179.051 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 10.1 t -99.39 159.42 3.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.174 0.512 . . . . 0.0 111.97 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.479 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 90.9 m-85 -143.35 148.53 36.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.54 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -60.72 146.69 85.74 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.665 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.557 ' HB3' ' N ' ' A' ' 1' ' ' MET . 14.6 Cg_exo -65.6 -13.4 39.61 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.534 2.156 . . . . 0.0 112.087 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.72 -25.8 14.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.765 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.98 92.72 0.7 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.783 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.9 m 176.67 155.67 0.25 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 111.005 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.413 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 7.2 t-160 -90.68 113.52 25.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.2 mt -94.42 -49.37 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.981 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.03 -154.66 21.65 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.698 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.81 -142.66 12.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.674 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -67.71 -70.87 0.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.694 0.283 . . . . 0.0 110.917 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -58.74 -45.54 89.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.998 0.428 . . . . 0.0 110.707 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -52.47 -38.98 60.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.573 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.523 HD22 ' CE2' ' A' ' 86' ' ' PHE . 4.8 tt -79.41 -33.56 42.56 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.313 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -51.21 -29.51 14.41 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -70.33 -35.39 73.58 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.454 ' N ' ' O ' ' A' ' 82' ' ' LEU . 6.6 t80 -63.19 -34.46 77.69 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.523 ' CE2' HD22 ' A' ' 82' ' ' LEU . 5.1 m-85 -87.98 -70.46 0.63 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.296 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.981 -179.972 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.58 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 7.1 tpp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -77.67 146.63 35.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.89 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.9 mptt -109.66 122.03 46.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.787 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.479 HG13 ' CE1' ' A' ' 33' ' ' PHE . 50.7 t -110.33 129.59 65.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.277 0.56 . . . . 0.0 111.854 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.558 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 17.5 m-85 -107.68 99.32 8.82 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.833 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.6 -143.7 3.73 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.246 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.709 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 5.0 m-85 -127.9 154.98 44.9 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 120.619 0.247 . . . . 0.0 111.239 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.07 -79.56 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.008 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 m 175.42 -34.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.835 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -62.57 -50.89 69.5 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.223 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.418 HD11 ' N ' ' A' ' 11' ' ' ILE . 0.5 OUTLIER -89.92 -39.79 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.936 0.398 . . . . 0.0 111.177 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.709 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 57.0 t-80 -139.88 139.65 36.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.005 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.95 174.23 11.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.257 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 19.8 p 175.11 113.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.896 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.0 m -90.08 -30.14 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.839 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -83.87 -15.91 46.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.407 ' HB3' ' HB2' ' A' ' 14' ' ' CYS . 14.4 p -71.31 -43.65 66.65 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.811 0.338 . . . . 0.0 110.714 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.1 -38.3 78.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.752 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -57.65 -48.53 79.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.899 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.407 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -64.59 -40.01 94.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.81 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.403 ' HD2' ' CE2' ' A' ' 31' ' ' PHE . 2.2 mmmm -49.97 -37.75 33.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.14 0.495 . . . . 0.0 110.188 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -75.07 -29.24 60.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.312 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.506 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -54.56 -55.7 26.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.304 179.386 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mt -62.77 -47.49 83.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.766 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.3 m -56.01 -35.26 66.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.461 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.8 t -78.06 -27.56 14.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.965 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HD3' ' CG ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -78.81 -11.45 59.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.308 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 72.59 38.43 0.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.929 0.395 . . . . 0.0 110.812 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.01 142.43 44.41 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.567 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.534 ' O ' ' HA ' ' A' ' 1' ' ' MET . 67.5 Cg_endo -79.5 155.81 24.79 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.526 2.151 . . . . 0.0 111.616 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.445 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 46.1 p90 -161.46 170.83 19.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.278 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -137.11 129.48 29.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.833 0.349 . . . . 0.0 110.943 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.479 ' CE1' HG13 ' A' ' 4' ' ' VAL . 17.3 t80 -89.22 154.94 19.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.005 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.0 mt -147.11 119.69 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.261 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -86.26 109.7 19.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.786 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.434 ' O ' ' HB3' ' A' ' 43' ' ' PHE . 11.8 pt -85.69 58.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.31 0.576 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.474 ' HE2' ' CD2' ' A' ' 12' ' ' HIS . 26.6 ttm -173.21 89.49 0.38 Allowed Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.334 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.1 -22.42 35.14 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.29 1.993 . . . . 0.0 111.408 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 41' ' ' GLY . 5.5 tp10 -145.04 143.07 30.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.381 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.411 ' HB3' HG22 ' A' ' 11' ' ' ILE . 11.4 pttt -57.08 -9.07 0.78 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.171 0.51 . . . . 0.0 112.139 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 39' ' ' GLU . . . -77.42 -55.2 4.37 Favored Glycine 0 C--N 1.312 -0.783 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.042 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -148.94 144.23 18.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 1.0 OUTLIER -58.77 170.97 0.71 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.029 179.157 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.32 103.81 15.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.908 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -58.11 -25.2 61.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.361 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -64.62 -59.14 4.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.897 0.379 . . . . 0.0 110.635 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -65.01 -35.6 81.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.27 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.3 mm -70.27 -32.85 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.343 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.18 -51.93 67.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.636 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.27 -36.52 83.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.928 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.558 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 3.5 tt -59.43 -53.19 60.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.392 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.0 mt -51.42 -44.59 62.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.149 0.5 . . . . 0.0 111.517 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.0 m -64.18 -49.41 72.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.571 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -54.87 -34.95 63.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.793 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -61.8 2.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.97 -26.71 0.25 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.549 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.74 -173.75 4.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.698 0.285 . . . . 0.0 110.684 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -98.9 19.29 15.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.308 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 t -120.19 158.63 26.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.881 0.372 . . . . 0.0 110.969 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -116.7 99.84 7.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.014 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 pt -78.84 84.13 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.999 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.73 26.61 57.81 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.195 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -56.81 135.74 55.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.899 0.381 . . . . 0.0 111.077 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.7 p -124.99 167.1 15.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.172 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.3 154.24 51.91 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.799 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.6 Cg_endo -85.72 142.43 31.56 Favored 'Cis proline' 0 N--CA 1.461 -0.388 0 C-N-CA 124.098 -1.209 . . . . 0.0 112.745 0.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -99.79 139.95 34.7 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -107.88 159.47 7.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.407 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 75' ' ' HIS . 30.8 m-85 -143.06 135.83 27.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.127 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.73 133.32 20.39 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.286 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.58 ' HB3' ' N ' ' A' ' 1' ' ' MET . 29.3 Cg_exo -54.65 -21.11 23.7 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.48 2.12 . . . . 0.0 111.851 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.3 38.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.189 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.3 -109.63 0.78 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.988 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 87.4 p -142.76 -176.33 4.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.135 0.493 . . . . 0.0 111.291 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.499 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 19.5 t-80 -57.85 123.42 15.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.203 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.5 mt -91.88 -46.27 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.733 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.37 -156.29 21.22 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.828 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -89.27 -139.3 7.14 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.332 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.506 ' CE1' ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -75.49 -70.11 0.44 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.769 0.285 . . . . 0.0 110.871 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -49.1 -42.9 40.57 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.239 0.542 . . . . 0.0 110.437 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -64.01 -43.84 94.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.847 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.449 HD21 ' CD2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -71.79 -40.87 68.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.605 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -51.43 -34.06 33.28 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -67.72 -35.94 79.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.16 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.428 ' N ' ' O ' ' A' ' 82' ' ' LEU . 35.2 t80 -62.94 -34.02 76.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.432 178.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.449 ' CD2' HD21 ' A' ' 82' ' ' LEU . 8.8 m-85 -87.32 -70.32 0.63 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.194 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 69.6 mttt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.962 179.939 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.573 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.9 ttm . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.669 0.271 . . . . 0.0 111.662 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.493 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 83.1 m-85 -59.17 161.29 5.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.875 0.369 . . . . 0.0 110.122 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.621 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -137.78 120.67 16.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.827 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.535 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 75.3 t -110.74 150.99 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.418 0.628 . . . . 0.0 111.703 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 40.4 m-85 -133.72 102.5 5.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.17 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -166.47 -136.78 2.08 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.535 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.409 ' O ' ' CZ ' ' A' ' 33' ' ' PHE . 49.2 m-85 -106.91 157.96 17.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.848 0.356 . . . . 0.0 110.885 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -98.94 -71.74 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.008 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 p 169.59 -32.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.996 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -74.68 -38.3 62.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.689 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.7 mm -89.12 -49.48 14.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -140.01 149.9 43.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.387 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.92 157.53 26.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.12 0.486 . . . . 0.0 112.018 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -172.32 93.53 0.13 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.488 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.8 m -71.44 -39.53 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.838 0.351 . . . . 0.0 111.023 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.19 -24.02 66.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.882 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.2 m -66.39 -60.69 2.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.5 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -51.77 -39.18 58.15 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.3 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -63.88 -40.64 97.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.373 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.556 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -66.76 -50.48 62.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.059 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -49.51 -36.36 22.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.856 0.36 . . . . 0.0 110.583 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -41.79 93.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.293 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.99 -53.04 62.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.251 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.1 mt -57.86 -45.22 86.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.673 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 51.7 m -57.62 -34.93 69.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.046 0.451 . . . . 0.0 110.113 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.9 t -80.05 -33.96 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.603 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -11.54 60.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.053 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.62 48.56 1.07 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.061 0.457 . . . . 0.0 110.537 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -128.72 130.61 23.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.308 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' A' ' 1' ' ' MET . 83.8 Cg_endo -76.81 142.93 23.06 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.444 2.096 . . . . 0.0 111.105 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.573 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 9.9 p90 -158.35 170.72 21.6 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.544 -0.462 . . . . 0.0 112.209 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -142.01 129.15 20.93 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.073 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.535 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 50.6 t80 -89.69 162.33 15.64 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.863 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.432 HD11 ' CZ ' ' A' ' 5' ' ' TYR . 14.4 mt -146.94 122.41 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.265 0.555 . . . . 0.0 110.675 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -79.04 136.19 37.1 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.052 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 pt -97.18 -27.15 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.172 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 5.4 ttp -124.15 95.16 44.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.413 ' CG ' ' HB2' ' A' ' 44' ' ' ASP . 85.8 Cg_endo -80.93 4.84 6.63 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.67 2.247 . . . . 0.0 112.75 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -139.44 137.79 35.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.661 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -65.18 -9.0 19.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.206 0.527 . . . . 0.0 111.909 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.04 -65.18 1.28 Allowed Glycine 0 C--N 1.311 -0.811 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.247 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.3 t -139.63 155.93 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.751 0.31 . . . . 0.0 111.17 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -75.18 168.1 20.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.821 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.413 ' HB2' ' CG ' ' A' ' 38' ' ' PRO . 19.0 t70 -100.42 114.51 28.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.255 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -54.83 -23.37 18.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.449 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.92 -53.41 58.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.883 0.373 . . . . 0.0 110.795 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -71.11 -28.52 64.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.385 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.7 mm -71.92 -39.65 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.659 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.42 -55.63 22.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.168 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -56.13 -33.49 65.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.57 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.1 tp -63.1 -49.47 74.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.075 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.1 mt -52.25 -44.21 64.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.207 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -64.8 -32.3 73.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.091 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.436 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 2.3 ttmm -67.15 -29.5 69.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.368 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.445 ' N ' HD22 ' A' ' 55' ' ' LEU . 1.2 mt -68.18 -58.03 5.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.683 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.13 -108.69 0.27 Allowed Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.059 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -150.48 33.1 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.034 0.445 . . . . 0.0 110.653 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -120.85 -148.05 0.4 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.378 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 t -116.63 170.19 8.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.812 0.339 . . . . 0.0 110.641 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -86.75 98.44 11.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.298 0.57 . . . . 0.0 110.575 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 pt -80.49 83.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.173 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.9 26.66 41.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.58 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.15 150.09 6.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.752 0.311 . . . . 0.0 111.074 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 p -127.62 170.07 13.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.214 0.53 . . . . 0.0 111.742 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.38 158.12 56.87 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.576 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.4 Cg_exo -79.29 143.53 70.03 Favored 'Cis proline' 0 C--N 1.344 0.32 0 C-N-CA 124.084 -1.215 . . . . 0.0 112.866 0.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 9.9 tt0 -104.08 123.11 46.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.466 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 16.5 t -100.31 162.22 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.934 0.397 . . . . 0.0 111.659 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.478 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 85.9 m-85 -142.24 141.84 32.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.073 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -54.87 146.65 36.29 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.447 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.542 ' HB3' ' N ' ' A' ' 1' ' ' MET . 50.1 Cg_exo -56.44 -26.61 63.99 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.132 2.555 . . . . 0.0 112.215 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -93.48 -28.58 16.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.227 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.3 91.53 0.6 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.702 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 2.6 m -178.8 163.86 1.47 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.684 0.278 . . . . 0.0 110.596 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.407 ' NE2' ' CG ' ' A' ' 67' ' ' GLN . 14.3 t-160 -90.19 108.7 19.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.113 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.1 mt -86.3 -53.39 10.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.765 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.61 -153.16 20.1 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.08 -137.72 7.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.155 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.556 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -76.29 -70.19 0.46 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.702 0.251 . . . . 0.0 110.773 179.597 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -49.26 -44.03 43.46 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.256 0.55 . . . . 0.0 110.32 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -36.53 81.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.482 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 85' ' ' TYR . 2.0 tt -79.47 -38.52 34.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.594 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.91 -32.75 21.61 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -67.53 -35.62 79.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.237 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 82' ' ' LEU . 8.6 t80 -63.44 -34.44 77.75 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.31 178.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.444 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.8 m-85 -89.3 -21.93 22.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.341 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.991 -179.945 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.647 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.39 0.138 . . . . 0.0 111.045 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.4 ' HB3' ' CG1' ' A' ' 68' ' ' VAL . 75.1 m-85 -39.71 120.9 1.17 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.694 0.759 . . . . 0.0 111.867 -177.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.747 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -90.8 124.1 34.87 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.147 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.456 HG13 ' CE1' ' A' ' 33' ' ' PHE . 7.7 t -102.15 128.31 54.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.238 0.542 . . . . 0.0 111.47 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.615 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 2.8 m-30 -104.96 98.92 8.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.969 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.54 -139.71 2.71 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.293 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.407 ' CG ' ' HB3' ' A' ' 12' ' ' HIS . 91.6 m-85 -124.36 153.75 41.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.891 0.377 . . . . 0.0 111.582 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.88 -77.24 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.915 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 170.07 -32.63 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.017 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -80.43 -30.19 37.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.983 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.6 mp -90.39 -47.15 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.117 0.484 . . . . 0.0 110.59 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.407 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 33.7 t60 -147.76 153.81 39.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.558 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.3 149.61 50.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.077 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 7' ' ' TYR . 42.6 t -164.99 87.56 0.44 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.063 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.39 -27.52 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -64.1 -32.37 73.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.331 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.1 p -77.92 -45.46 23.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.329 . . . . 0.0 110.543 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.08 -37.98 36.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.627 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -69.12 -55.05 11.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.724 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.08 -38.32 56.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.19 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.435 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 15.3 ttmt -58.32 -52.36 65.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.342 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -61.14 -37.26 82.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.155 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.404 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -59.82 -53.85 53.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.103 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.434 HD23 ' CZ ' ' A' ' 86' ' ' PHE . 7.1 mt -56.22 -44.12 79.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.665 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 m -60.09 -41.55 92.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.109 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.8 t -72.93 -35.82 49.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.595 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 2.6 tmtm? -75.23 -13.0 60.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.31 52.65 0.18 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.888 0.375 . . . . 0.0 110.736 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -145.2 111.52 4.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.239 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.647 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 82.2 Cg_exo -49.53 178.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.324 2.016 . . . . 0.0 111.628 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.435 ' CE2' ' HG3' ' A' ' 21' ' ' LYS . 5.3 p90 -164.25 170.18 16.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.983 0.42 . . . . 0.0 111.227 178.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 5.4 mm-40 -136.39 121.0 18.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.625 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.456 ' CE1' HG13 ' A' ' 4' ' ' VAL . 9.9 t80 -89.71 152.96 21.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.111 0.481 . . . . 0.0 111.639 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.416 HD12 ' CE1' ' A' ' 5' ' ' TYR . 29.0 mt -150.1 126.54 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.407 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -92.58 129.4 38.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.08 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 pp -87.4 -19.53 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.268 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.6 ttp -124.19 94.74 44.82 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.761 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.17 -14.63 28.76 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.421 2.081 . . . . 0.0 112.653 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -139.83 142.25 36.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 110.844 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -65.23 -8.77 19.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.227 0.536 . . . . 0.0 111.877 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.4 -60.22 2.26 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.178 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.6 t -150.1 129.83 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.713 0.292 . . . . 0.0 111.157 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.519 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -59.15 169.65 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.941 0.4 . . . . 0.0 110.921 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.28 93.5 8.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.127 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -52.4 -22.2 4.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.891 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -55.54 -50.21 70.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 0.0 110.898 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -40.74 60.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.571 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.6 mp -52.67 -30.5 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.762 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.95 -57.72 3.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.722 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -61.07 -29.84 69.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.276 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.48 HD21 HD11 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -61.46 -57.92 10.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.951 179.315 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.451 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 72.2 mt -43.14 -45.91 5.66 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.316 0.579 . . . . 0.0 110.919 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.2 m -70.42 -32.4 70.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.272 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.15 -39.93 93.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.328 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.48 HD11 HD21 ' A' ' 51' ' ' LEU . 4.4 mp -59.58 -64.36 0.97 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.868 0.366 . . . . 0.0 110.945 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.65 -48.02 0.21 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.229 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.42 -165.11 1.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 110.865 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -105.43 -30.6 9.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.927 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.3 t -95.71 168.51 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.18 99.76 7.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.772 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 61' ' ' ILE . 30.1 mt -79.05 84.6 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.047 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.37 26.29 67.8 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.316 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.06 125.15 22.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 111.002 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.421 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 34.4 p -128.23 170.14 13.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.994 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.88 159.06 31.29 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.746 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.615 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.9 Cg_endo -84.26 144.75 45.24 Favored 'Cis proline' 0 C--N 1.345 0.343 0 C-N-CA 124.326 -1.114 . . . . 0.0 112.933 0.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' A' ' 5' ' ' TYR . 16.3 mm100 -112.41 121.19 44.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.104 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.747 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -95.23 160.06 2.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.414 ' CE1' ' HD2' ' A' ' 54' ' ' LYS . 46.1 m-85 -141.97 138.3 31.82 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.264 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.469 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -52.47 142.73 29.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.181 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -31.9 -37.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.718 2.945 . . . . 0.0 112.835 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.29 34.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.111 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.78 -105.12 2.58 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.921 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.5 t -131.84 178.04 7.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.167 0.508 . . . . 0.0 111.269 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -65.36 129.65 40.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.674 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.469 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 1.3 mp -103.87 -40.89 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.674 0.273 . . . . 0.0 110.94 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' A' ' 81' ' ' GLN . . . 130.95 -166.92 22.5 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.898 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.6 -137.12 4.74 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.907 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -72.13 -67.96 0.5 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 0.0 111.261 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -54.16 -44.4 71.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.007 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.405 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -57.34 -48.35 79.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.81 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.479 HD22 ' CD2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -67.09 -42.7 84.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.531 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -51.09 -30.25 15.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.52 -35.86 68.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.219 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 82' ' ' LEU . 11.0 t80 -63.72 -33.67 76.17 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.479 ' CD2' HD22 ' A' ' 82' ' ' LEU . 6.3 m-85 -87.96 -28.26 21.58 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.068 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.919 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.55 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.7 ttp . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.746 0.308 . . . . 0.0 111.633 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.506 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 86.0 m-85 -58.9 154.4 15.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.937 0.399 . . . . 0.0 110.427 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.68 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -130.31 123.09 29.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.713 -179.359 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.482 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 54.8 t -113.64 145.05 20.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.377 0.608 . . . . 0.0 111.881 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.507 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 8.2 m-85 -123.78 102.97 8.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.792 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.78 -137.98 2.31 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.098 -1.048 . . . . 0.0 112.769 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.415 ' CE1' ' SD ' ' A' ' 37' ' ' MET . 56.7 m-85 -112.34 152.66 28.31 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.742 0.306 . . . . 0.0 110.899 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 9' ' ' SER . 19.1 m-20 -88.54 3.75 49.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.709 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.3 OUTLIER 81.09 -10.94 1.16 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.56 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -85.14 -35.08 21.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.908 0.385 . . . . 0.0 110.753 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.516 HG23 ' HA ' ' A' ' 40' ' ' LYS . 2.5 mp -94.32 -42.61 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.52 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -139.34 147.04 41.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.518 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -76.46 159.6 30.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.0 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 p -174.29 122.12 0.28 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.629 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.8 m -90.09 -29.87 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.844 0.354 . . . . 0.0 111.175 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.471 ' CD2' ' HB3' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -77.84 -22.08 50.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.101 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.3 p -73.27 -41.88 63.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 110.92 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -28.42 57.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.324 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 81.4 m-20 -74.88 -39.46 61.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.223 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.18 -38.14 78.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.044 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -60.13 -55.94 27.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.648 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER -61.48 -30.45 70.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.362 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.451 ' CD2' ' CD2' ' A' ' 86' ' ' PHE . 4.0 tt -53.79 -46.18 70.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.333 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.443 HD22 ' CD1' ' A' ' 2' ' ' PHE . 2.6 mt -66.23 -48.58 70.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.635 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.4 m -56.2 -36.52 68.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.505 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.69 -31.93 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.733 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.22 -9.87 57.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.201 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm 71.24 57.91 0.19 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.983 0.42 . . . . 0.0 110.903 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -135.63 139.03 29.79 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.082 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.426 ' O ' ' HA ' ' A' ' 1' ' ' MET . 91.8 Cg_endo -79.59 142.08 16.03 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.569 2.179 . . . . 0.0 111.572 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.55 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 32.0 p90 -158.69 170.62 21.75 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -141.48 135.56 30.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.162 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.482 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 32.1 t80 -89.81 159.8 16.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.086 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 19.0 mt -139.23 116.53 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.436 0.636 . . . . 0.0 110.431 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -87.24 121.23 29.41 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.474 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 4.2 pt -100.2 32.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.849 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.415 ' SD ' ' CE1' ' A' ' 7' ' ' TYR . 3.0 mtt -142.64 84.39 11.0 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.157 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.516 ' HD2' ' O ' ' A' ' 42' ' ' VAL . 39.9 Cg_endo -67.33 -8.48 22.16 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.684 2.256 . . . . 0.0 112.62 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.452 ' O ' HG22 ' A' ' 11' ' ' ILE . 1.9 mt-10 -138.8 170.58 15.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.881 0.372 . . . . 0.0 111.011 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.516 ' HA ' HG23 ' A' ' 11' ' ' ILE . 4.4 mptp? -65.4 -6.62 10.75 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.52 35.02 0.25 Allowed Glycine 0 C--N 1.313 -0.733 0 C-N-CA 120.711 -0.756 . . . . 0.0 113.043 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.516 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 t -149.22 125.91 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.635 0.255 . . . . 0.0 110.738 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 1.3 m-85 -76.25 169.91 17.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.041 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.436 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -99.91 112.02 24.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.856 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -54.49 -33.09 59.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.826 0.346 . . . . 0.0 110.612 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.26 -51.37 61.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.595 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -64.61 -43.47 93.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.41 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.93 -36.17 77.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.184 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.87 -58.32 4.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.093 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.74 -34.75 71.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.781 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tp -58.18 -51.49 69.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.38 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.7 -45.88 63.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.166 0.508 . . . . 0.0 111.204 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.7 m -70.2 -35.15 73.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.149 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -29.98 71.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.395 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.66 -70.05 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.781 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.58 -41.2 0.59 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.196 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -98.52 -168.59 1.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 110.847 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -96.65 -30.92 12.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.2 t -109.54 167.5 10.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -104.58 99.52 9.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.553 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.7 tp -62.88 81.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.261 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.22 23.26 39.86 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.773 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.13 140.7 58.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 110.783 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.34 166.3 16.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.247 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.7 mmt -105.67 152.21 40.04 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.61 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.1 Cg_exo -80.79 144.8 67.73 Favored 'Cis proline' 0 C--N 1.345 0.352 0 C-N-CA 123.985 -1.256 . . . . 0.0 112.894 0.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 5.2 mt-30 -99.05 119.57 38.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.641 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 4.6 t -97.51 162.71 2.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.744 0.307 . . . . 0.0 111.428 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 89.3 m-85 -142.22 142.69 32.66 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.24 0.543 . . . . 0.0 111.464 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.438 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.66 137.95 62.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.264 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.507 ' HB3' ' N ' ' A' ' 1' ' ' MET . 84.3 Cg_exo -46.61 -28.07 6.01 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.104 2.536 . . . . 0.0 112.001 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.79 37.05 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.043 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.29 -109.85 1.1 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.949 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.407 ' N ' ' HB1' ' A' ' 70' ' ' ALA . 2.0 p -135.67 -178.07 4.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.122 0.487 . . . . 0.0 111.318 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.437 ' CD2' ' O ' ' A' ' 68' ' ' VAL . 41.2 t-80 -60.4 122.79 15.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.036 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.438 HD11 ' HA ' ' A' ' 70' ' ' ALA . 2.3 mt -85.24 -45.68 17.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.963 0.411 . . . . 0.0 111.159 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.04 -147.92 18.29 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.392 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.1 -149.88 24.11 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.927 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.471 ' HB3' ' CD2' ' A' ' 16' ' ' TYR . 18.9 t80 -71.8 -70.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.833 0.349 . . . . 0.0 111.008 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -55.9 -48.97 74.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -53.56 -35.12 60.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.08 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.501 HD22 ' CE2' ' A' ' 86' ' ' PHE . 6.5 tt -83.45 -30.79 26.98 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.042 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.1 ttp85 -50.73 -33.13 21.75 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -66.19 -35.0 79.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' A' ' 82' ' ' LEU . 5.2 t80 -63.04 -34.9 78.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.189 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.501 ' CE2' HD22 ' A' ' 82' ' ' LEU . 6.6 m-85 -92.4 -13.68 29.73 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.657 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.923 179.913 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.594 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 50.3 ttp . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -74.69 153.15 39.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.201 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -114.22 120.81 41.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.714 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.435 HG11 ' CE1' ' A' ' 33' ' ' PHE . 7.0 t -104.41 128.02 58.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.202 0.525 . . . . 0.0 111.498 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 4.3 m-30 -103.83 98.84 8.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.154 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.29 -138.4 2.43 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.471 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.62 ' CD2' ' CG ' ' A' ' 12' ' ' HIS . 11.5 m-85 -120.35 144.49 47.84 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 120.676 0.274 . . . . 0.0 111.578 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.585 ' HB3' ' CE2' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -136.81 64.22 1.55 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.337 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.88 -179.01 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.271 0.558 . . . . 0.0 112.016 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -86.39 1.51 50.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.62 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.5 tt -86.54 -6.58 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.061 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.62 ' CG ' ' CD2' ' A' ' 7' ' ' TYR . 30.0 t-80 -156.98 161.92 39.59 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.015 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.76 166.0 24.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.615 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 176.67 73.03 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.888 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 m -89.22 -49.03 14.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.726 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.8 -12.88 61.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 110.972 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.3 m -70.37 -53.0 18.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.534 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -53.65 -26.22 21.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.103 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.53 -59.41 2.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.032 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.82 -38.26 64.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.489 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -52.92 63.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 110.658 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -60.75 -37.63 82.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.482 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.437 HD21 ' CD2' ' A' ' 86' ' ' PHE . 3.3 tt -60.18 -53.33 58.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.64 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 mt -56.99 -48.71 77.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.951 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.2 m -54.53 -37.93 65.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.106 0.479 . . . . 0.0 110.244 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.1 t -79.54 -32.58 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.598 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.435 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -72.91 -11.59 60.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.112 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm 72.86 43.93 0.39 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.892 0.377 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -132.17 127.96 21.14 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.002 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.564 ' O ' ' HA ' ' A' ' 1' ' ' MET . 96.9 Cg_endo -77.98 158.56 30.81 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.476 2.118 . . . . 0.0 110.876 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 6.1 p90 -161.51 171.26 18.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.997 0.427 . . . . 0.0 112.021 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.39 133.5 38.75 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.488 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.585 ' CE2' ' HB3' ' A' ' 8' ' ' ASP . 12.2 t80 -89.15 159.79 17.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.168 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.5 mt -149.29 122.26 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.229 0.537 . . . . 0.0 110.753 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -86.25 120.5 27.68 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.829 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -94.53 0.31 10.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.476 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.528 ' HE2' ' CD2' ' A' ' 12' ' ' HIS . 6.9 tpp -120.08 97.25 49.36 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.627 0.251 . . . . 0.0 111.332 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 76.7 Cg_endo -77.35 -23.21 10.32 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.295 1.996 . . . . 0.0 111.339 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -142.52 148.52 37.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.384 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -7.72 11.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.304 0.573 . . . . 0.0 111.738 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.67 -57.32 2.75 Favored Glycine 0 C--N 1.313 -0.737 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.722 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.7 t -148.27 146.38 17.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.885 0.374 . . . . 0.0 111.791 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.436 ' CD1' ' HE3' ' A' ' 37' ' ' MET . 0.5 OUTLIER -59.85 170.32 1.19 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.631 179.365 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.416 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -74.5 98.67 3.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -50.69 -23.99 3.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.553 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -64.94 -59.21 4.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.337 . . . . 0.0 110.799 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.84 -39.06 76.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.502 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.459 ' O ' ' CD1' ' A' ' 52' ' ' LEU . 29.1 mm -50.08 -46.76 24.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.639 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.459 ' O ' HD13 ' A' ' 52' ' ' LEU . . . -63.04 -54.44 38.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.131 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -64.08 -21.25 66.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.664 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.505 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 3.4 tt -62.34 -61.01 2.75 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.159 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.459 ' CD1' ' O ' ' A' ' 48' ' ' ILE . 0.8 OUTLIER -51.34 -49.28 61.71 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.196 0.522 . . . . 0.0 110.241 179.622 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.3 m -53.19 -40.59 64.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.242 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -38.92 84.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.249 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.409 HD23 ' CG ' ' A' ' 75' ' ' HIS . 1.4 mt -59.89 -38.11 81.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.284 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.82 -111.83 0.38 Allowed Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.686 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.3 ttm-85 -150.38 27.11 0.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.075 0.464 . . . . 0.0 110.709 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -121.77 -144.85 0.35 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.415 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.6 t -120.05 170.64 9.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.639 0.257 . . . . 0.0 110.381 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -73.85 98.06 2.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.274 0.559 . . . . 0.0 110.42 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.3 mt -80.11 80.37 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.223 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.67 26.11 7.43 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.555 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.436 ' N ' HD13 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -48.27 166.79 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.845 0.355 . . . . 0.0 111.308 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.0 p -127.09 160.31 31.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.109 0.48 . . . . 0.0 111.391 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.2 mtm -120.23 155.39 55.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.619 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.609 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.9 Cg_exo -76.23 142.97 75.04 Favored 'Cis proline' 0 C--N 1.345 0.354 0 C-N-CA 123.874 -1.303 . . . . 0.0 112.762 0.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -98.03 120.24 38.08 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -92.52 158.83 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.426 0.631 . . . . 0.0 112.31 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 74.6 m-85 -142.53 148.39 37.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.005 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.452 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -61.24 153.75 66.13 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.854 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.594 ' HB3' ' N ' ' A' ' 1' ' ' MET . 19.6 Cg_exo -68.09 59.44 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.344 2.696 . . . . 0.0 112.044 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 71' ' ' PRO . 0.3 OUTLIER 100.37 25.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.85 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -112.18 -97.15 2.33 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.525 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.5 t -147.5 -174.9 4.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.803 0.335 . . . . 0.0 110.612 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.409 ' CG ' HD23 ' A' ' 55' ' ' LEU . 20.6 t-80 -71.82 132.34 44.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.835 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.452 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 1.4 mp -109.09 -41.33 4.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.627 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.87 -165.04 24.94 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.741 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.32 -136.52 4.93 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.737 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -72.33 -70.57 0.33 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.708 0.29 . . . . 0.0 111.332 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -56.4 -47.3 79.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.99 0.424 . . . . 0.0 110.857 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -51.06 -44.14 61.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.472 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.523 HD23 ' CE2' ' A' ' 86' ' ' PHE . 6.0 tt -74.77 -32.92 62.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.243 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.5 ttt85 -51.37 -30.08 17.67 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.93 -35.39 76.74 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.155 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LEU . 22.3 t80 -62.28 -34.3 76.3 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.273 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.523 ' CE2' HD23 ' A' ' 82' ' ' LEU . 6.7 m-85 -86.14 -38.84 17.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.266 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.2 mttm . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.952 -179.999 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.603 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 49.3 ttm . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -77.0 144.31 38.78 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.183 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -106.45 121.21 43.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.662 -179.325 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.462 HG13 ' CE1' ' A' ' 33' ' ' PHE . 40.6 t -107.83 138.25 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.285 0.564 . . . . 0.0 111.887 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.1 m-85 -113.43 99.62 7.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.816 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.44 -139.6 2.71 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.296 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.457 ' OH ' ' CZ ' ' A' ' 43' ' ' PHE . 84.1 m-85 -125.18 148.34 48.65 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.796 0.332 . . . . 0.0 111.253 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -64.55 -75.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.705 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 167.07 -32.87 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.974 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -82.92 -23.9 33.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.839 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 39' ' ' GLU . 2.6 mp -93.41 -46.03 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.476 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -147.44 153.64 39.83 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 pttm -62.39 165.26 6.25 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.877 0.37 . . . . 0.0 111.284 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.4 t -176.6 82.23 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.306 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.43 -19.23 7.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.065 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -76.19 -28.23 57.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.508 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.6 p -77.5 -46.03 23.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.715 0.293 . . . . 0.0 110.831 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.23 -35.39 17.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 110.718 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -70.78 -60.78 2.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.572 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.16 -33.3 51.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.181 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -59.14 -54.96 41.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.54 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -59.73 -35.19 74.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.554 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.439 HD22 ' CD2' ' A' ' 86' ' ' PHE . 3.1 tt -60.81 -54.61 43.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.565 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mt -55.48 -48.05 75.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.855 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.0 m -56.03 -37.74 69.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.166 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -77.08 -36.09 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.646 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -72.54 -10.03 59.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.096 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.65 50.8 0.17 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.861 0.362 . . . . 0.0 110.693 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -139.53 128.53 13.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.27 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.603 ' O ' ' HA ' ' A' ' 1' ' ' MET . 81.0 Cg_endo -79.61 161.81 24.77 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.581 2.187 . . . . 0.0 110.749 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 6.9 p90 -161.23 171.16 18.9 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -135.36 136.79 41.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.292 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.462 ' CE1' HG13 ' A' ' 4' ' ' VAL . 8.6 t80 -89.28 157.0 18.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.174 0.512 . . . . 0.0 111.732 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.488 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 14.7 mt -143.88 119.47 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.714 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -98.26 135.98 39.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.737 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.429 HD11 ' CE1' ' A' ' 43' ' ' PHE . 1.4 pp -97.65 -14.22 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.018 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -123.48 80.39 54.02 Favored Pre-proline 0 N--CA 1.455 -0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.403 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 64.8 Cg_endo -88.44 31.08 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.032 2.488 . . . . 0.0 112.449 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 11' ' ' ILE . 2.2 tp10 -139.08 164.78 28.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.534 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.65 -8.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 39' ' ' GLU . . . 162.49 53.8 0.02 OUTLIER Glycine 0 C--N 1.312 -0.776 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.231 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.3 t -149.83 125.95 2.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.029 0.442 . . . . 0.0 111.944 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.457 ' CZ ' ' OH ' ' A' ' 7' ' ' TYR . 2.0 m-85 -63.78 143.94 57.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.358 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.444 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -99.04 121.79 41.43 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.822 0.344 . . . . 0.0 111.505 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -66.84 -24.62 66.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.332 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -58.42 -52.17 66.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.794 0.33 . . . . 0.0 110.816 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -38.31 54.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.364 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.407 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 41.2 mt -59.32 -40.5 81.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.855 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.47 -58.0 6.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.269 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -60.15 -28.16 67.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.973 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 tp -59.32 -56.26 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.381 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 48' ' ' ILE . 3.0 mt -51.94 -47.51 64.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.984 0.421 . . . . 0.0 110.886 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.6 m -66.04 -35.0 79.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.291 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -66.49 -39.86 88.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.504 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.82 -49.1 79.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.439 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.58 -106.25 0.25 Allowed Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.818 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.2 mtt180 -150.62 27.6 0.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.02 0.438 . . . . 0.0 110.84 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.59 -156.71 0.7 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.207 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -121.24 161.73 21.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.676 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 7.3 pt20 -120.14 98.89 6.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.992 0.425 . . . . 0.0 110.694 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.5 mt -81.55 88.32 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.707 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.94 32.73 5.77 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.536 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 60' ' ' GLN . 2.8 tm? -47.73 121.91 4.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.824 0.345 . . . . 0.0 110.77 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -103.86 151.51 23.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.28 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -112.71 156.4 42.54 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.908 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -86.97 141.52 24.14 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.067 -1.222 . . . . 0.0 112.56 0.503 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.402 ' O ' ' N ' ' A' ' 5' ' ' TYR . 2.7 mm-40 -100.24 124.19 45.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.138 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.3 t -96.61 159.69 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.33 0.586 . . . . 0.0 112.478 -178.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.471 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 80.1 m-85 -143.73 146.62 33.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.289 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.49 156.3 23.71 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.89 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.583 ' HB3' ' N ' ' A' ' 1' ' ' MET . 3.0 Cg_exo -73.71 -3.72 14.22 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.876 2.384 . . . . 0.0 112.566 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -115.33 -9.65 12.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.226 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.23 89.08 1.67 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.548 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 t -179.2 152.12 0.53 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -90.19 116.62 28.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.2 mt -96.8 -48.45 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.879 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 138.17 -156.02 23.69 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.726 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.07 -138.69 8.88 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.668 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -70.89 -70.66 0.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.782 0.325 . . . . 0.0 110.918 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -59.43 -45.3 91.94 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.023 0.44 . . . . 0.0 110.551 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -50.87 -40.0 55.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.437 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.518 HD22 ' CE2' ' A' ' 86' ' ' PHE . 6.4 tt -78.65 -31.93 47.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.265 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -51.13 -30.9 17.75 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -35.43 79.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.093 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 82' ' ' LEU . 10.8 t80 -62.68 -34.14 76.51 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.344 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.518 ' CE2' HD22 ' A' ' 82' ' ' LEU . 7.0 m-85 -88.96 -70.24 0.66 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.312 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.939 179.951 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.603 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 17.5 ttm . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -78.13 147.26 34.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.308 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -106.9 121.45 44.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.337 -179.697 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.458 HG12 ' CE1' ' A' ' 33' ' ' PHE . 52.3 t -112.99 131.95 63.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.56 0.695 . . . . 0.0 112.62 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.574 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 17.3 m-85 -110.09 99.13 8.27 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.181 177.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.418 ' O ' HG12 ' A' ' 36' ' ' ILE . . . -153.91 -139.82 2.92 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.006 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.484 ' CD1' ' HB3' ' A' ' 37' ' ' MET . 43.7 m-85 -147.28 99.84 3.2 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.528 ' CB ' ' CE2' ' A' ' 33' ' ' PHE . 27.7 t70 -108.87 55.95 0.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.422 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.78 -168.04 2.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.165 0.507 . . . . 0.0 111.637 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -85.96 0.61 52.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.839 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 11' ' ' ILE . 1.3 mm -88.26 -13.51 9.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.981 0.419 . . . . 0.0 109.901 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -175.72 118.09 0.15 Allowed 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.704 0.764 . . . . 0.0 111.172 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -82.52 168.56 17.27 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.885 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -176.58 107.79 0.07 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.24 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 m -70.32 -16.56 20.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.671 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -82.96 -25.69 32.08 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.846 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.2 m -59.85 -55.27 36.28 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.35 0.595 . . . . 0.0 109.647 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.27 -18.58 64.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.503 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.67 -62.51 1.35 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.851 0.357 . . . . 0.0 110.89 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.0 -38.37 67.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.09 -50.4 72.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.74 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -38.75 88.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.624 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.417 HD21 ' CE2' ' A' ' 86' ' ' PHE . 1.2 tt -59.16 -53.0 63.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.532 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 mt -56.97 -49.28 76.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.792 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.9 m -54.32 -38.44 65.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.075 0.464 . . . . 0.0 110.161 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.06 -32.36 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.622 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.14 -15.72 61.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.976 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 76.11 49.85 0.07 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.055 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -138.04 131.85 16.84 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.13 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.603 ' O ' ' HA ' ' A' ' 1' ' ' MET . 77.6 Cg_endo -79.52 161.26 25.25 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.408 2.072 . . . . 0.0 111.027 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 6.5 p90 -161.23 171.56 18.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.753 0.311 . . . . 0.0 111.716 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -133.28 123.83 26.21 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.094 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.528 ' CE2' ' CB ' ' A' ' 8' ' ' ASP . 10.6 t80 -89.12 157.91 18.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.445 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.0 mt -148.1 125.21 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.283 0.564 . . . . 0.0 111.143 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -75.58 115.81 15.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.639 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 6' ' ' GLY . 4.6 mm -90.2 -19.06 7.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.921 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.484 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -120.28 84.41 34.53 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.696 0.284 . . . . 0.0 111.181 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.24 -16.49 39.78 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.46 2.107 . . . . 0.0 111.904 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -139.99 136.64 33.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.395 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.33 -9.06 1.99 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.164 0.507 . . . . 0.0 111.956 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.12 -59.65 3.32 Favored Glycine 0 C--N 1.312 -0.797 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.355 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -150.62 154.36 8.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.981 0.42 . . . . 0.0 111.852 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -63.92 170.63 3.35 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.384 179.255 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -89.35 100.83 13.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -52.51 -27.92 18.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.481 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -61.8 -58.04 9.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.96 0.409 . . . . 0.0 110.556 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -65.07 -32.96 74.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.302 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.8 mm -69.8 -37.42 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.573 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.72 71.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.623 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -61.82 -34.08 75.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.334 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.574 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.4 tt -58.95 -52.51 65.43 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.309 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.9 mt -53.16 -41.35 65.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.589 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.1 m -58.49 -47.53 83.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.605 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.41 ' CB ' ' CE1' ' A' ' 69' ' ' PHE . 4.0 mtpp -61.74 -33.27 73.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.784 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 mt -59.92 -54.25 48.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.781 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 166.8 -112.69 0.51 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.186 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -150.23 31.24 0.68 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.071 0.462 . . . . 0.0 110.596 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -121.0 -142.27 0.34 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.335 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 t -117.0 170.4 8.66 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.793 0.33 . . . . 0.0 110.645 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -69.57 98.35 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.358 0.599 . . . . 0.0 110.359 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 pt -80.12 87.31 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.439 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.33 30.92 72.28 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.326 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -41.31 129.47 2.98 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.894 0.378 . . . . 0.0 111.331 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.83 153.65 45.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.359 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.5 mmt -113.63 146.48 35.55 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.628 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.3 Cg_endo -84.63 134.55 20.57 Favored 'Cis proline' 0 N--CA 1.46 -0.454 0 C-N-CA 124.006 -1.248 . . . . 0.0 112.57 0.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -90.11 133.33 34.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.96 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.7 t -107.46 156.53 7.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.263 0.554 . . . . 0.0 111.851 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.41 ' CE1' ' CB ' ' A' ' 54' ' ' LYS . 39.2 m-85 -142.95 136.43 28.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.665 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.57 149.22 8.33 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.368 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.57 ' HB3' ' N ' ' A' ' 1' ' ' MET . 9.3 Cg_exo -68.86 -11.61 32.31 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.709 2.273 . . . . 0.0 112.133 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -106.42 -18.74 13.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.994 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.2 85.31 0.96 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.63 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -179.75 117.71 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.793 0.33 . . . . 0.0 110.833 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -58.51 116.63 3.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.971 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.4 mt -91.81 -46.51 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.811 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.68 -156.38 22.75 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.491 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.6 -140.95 8.2 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.505 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -70.12 -69.02 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.698 0.285 . . . . 0.0 110.906 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -54.37 -43.48 71.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.963 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -55.32 -37.92 68.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.678 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.475 HD21 ' CD2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -71.99 -41.58 67.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.378 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.01 -29.95 23.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -72.85 -35.31 67.2 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' LEU . 34.2 t80 -63.49 -33.95 76.7 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.206 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.475 ' CD2' HD21 ' A' ' 82' ' ' LEU . 6.3 m-85 -87.14 -26.88 23.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.133 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.878 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.644 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 40.0 ttp . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.435 ' CD1' HD22 ' A' ' 24' ' ' LEU . 87.0 m-85 -77.39 147.58 35.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.054 179.001 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.706 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.5 mptt -111.5 121.0 44.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.589 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.483 HG12 ' CE1' ' A' ' 33' ' ' PHE . 8.4 t -103.4 129.22 55.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.24 0.543 . . . . 0.0 111.676 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.485 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 3.9 m-30 -105.68 99.4 9.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.504 178.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.36 -136.58 2.03 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.64 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.407 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 90.0 m-85 -116.44 144.28 44.5 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.918 0.39 . . . . 0.0 111.518 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' A' ' 9' ' ' SER . 22.6 t0 -73.1 -9.16 58.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.2 t 84.8 -14.11 0.63 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.577 0.351 . . . . 0.0 111.507 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -85.27 -31.19 23.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.693 0.282 . . . . 0.0 111.324 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.432 ' CD1' ' N ' ' A' ' 11' ' ' ILE . 2.4 mp -100.0 -38.38 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.645 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.407 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 15.2 t60 -139.41 179.47 6.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.355 -179.015 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -70.07 166.21 20.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.619 0.247 . . . . 0.0 110.8 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 t -176.91 71.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.19 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.0 m -90.64 -21.1 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.722 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -81.08 -23.11 38.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.3 p -77.68 -45.14 25.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 110.573 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -50.78 -34.07 25.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.704 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -73.07 -59.7 2.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.67 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.53 -41.32 69.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.426 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 70.3 tttt -54.57 -49.73 69.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.328 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -64.62 -31.43 72.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.276 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.3 tt -56.45 -51.05 69.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.394 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.435 HD22 ' CD1' ' A' ' 2' ' ' PHE . 2.9 mt -60.02 -51.94 67.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.72 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.3 m -51.03 -38.95 54.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.584 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.81 -31.58 54.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.677 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -86.59 -9.2 56.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.138 179.709 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 3.2 mptp? 70.59 52.33 0.32 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.067 0.461 . . . . 0.0 110.831 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -130.77 136.03 28.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.72 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.644 ' O ' ' HA ' ' A' ' 1' ' ' MET . 58.1 Cg_endo -80.96 157.09 20.58 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.596 2.197 . . . . 0.0 111.381 179.443 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 8.4 p90 -161.51 171.31 18.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.823 0.344 . . . . 0.0 111.774 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -133.98 134.55 42.64 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.483 ' CE1' HG12 ' A' ' 4' ' ' VAL . 23.0 t80 -89.36 154.54 19.99 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.093 0.473 . . . . 0.0 111.54 -179.566 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.401 HD11 ' CE1' ' A' ' 5' ' ' TYR . 8.4 mt -146.41 119.36 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.187 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -100.15 135.66 41.24 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.244 -179.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 44' ' ' ASP . 31.8 pt -97.91 20.43 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.191 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.43 ' CG ' HG21 ' A' ' 11' ' ' ILE . 15.1 tpp -144.33 70.94 16.07 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.658 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -87.82 34.2 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.026 2.484 . . . . 0.0 112.818 -179.482 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -139.74 170.42 15.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.612 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -63.22 -7.82 6.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.203 0.525 . . . . 0.0 111.931 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.73 55.24 0.02 OUTLIER Glycine 0 C--N 1.312 -0.757 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.403 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.9 t -150.02 131.7 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.001 0.429 . . . . 0.0 111.413 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.0 160.4 33.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.818 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 36' ' ' ILE . 3.7 t70 -97.63 89.25 4.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.081 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.81 -20.85 38.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.614 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -64.34 -59.2 4.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.816 0.341 . . . . 0.0 110.67 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -71.12 -41.05 71.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.399 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 54.8 mt -51.91 -44.08 37.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.694 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.62 -55.78 26.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.435 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.77 -31.84 71.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.296 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 1.5 tt -56.34 -52.94 62.68 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.008 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 2.2 mt -52.91 -48.62 67.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.722 179.152 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -62.33 -44.49 96.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.295 179.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.79 -39.09 83.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.552 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.74 -53.9 52.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.32 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.3 -108.99 0.27 Allowed Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.773 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -150.45 26.56 0.76 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.073 0.463 . . . . 0.0 110.862 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -121.62 -150.78 0.46 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.265 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.2 t -120.8 170.27 9.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.594 179.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -82.52 98.35 8.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.24 0.543 . . . . 0.0 110.314 179.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.448 ' CG2' ' O ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -80.09 87.23 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.879 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.67 28.06 56.04 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.478 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.87 143.54 16.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.8 p -111.55 158.17 19.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.16 0.505 . . . . 0.0 111.312 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.91 153.01 47.03 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.611 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.0 Cg_exo -81.1 156.12 83.38 Favored 'Cis proline' 0 C--N 1.344 0.309 0 C-N-CA 124.025 -1.24 . . . . 0.0 112.806 0.29 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -113.29 115.83 28.78 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.859 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.706 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -87.57 164.19 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.035 0.445 . . . . 0.0 111.792 -178.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.466 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 45.1 m-85 -142.33 140.49 32.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.528 -179.683 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.43 132.77 53.55 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.285 -179.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.578 ' HB3' ' N ' ' A' ' 1' ' ' MET . 31.6 Cg_exo -53.25 -22.37 19.93 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.594 2.196 . . . . 0.0 112.133 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.95 39.77 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.341 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.23 -109.86 0.68 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.987 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.8 p -138.91 178.41 7.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.075 0.464 . . . . 0.0 111.211 -179.546 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.466 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 32.8 t-80 -55.84 127.09 28.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.061 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.3 mt -96.03 -45.02 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.987 0.422 . . . . 0.0 110.734 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.87 -158.44 23.3 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.462 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.74 -141.13 9.06 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.688 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -71.08 -61.14 1.87 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.73 0.3 . . . . 0.0 110.825 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -56.94 -48.3 78.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.85 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -56.99 -45.7 82.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.793 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.481 HD21 ' CD2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -66.42 -41.62 88.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.398 179.918 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -51.76 -31.66 27.65 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -71.94 -35.8 69.72 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.104 178.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 82' ' ' LEU . 23.8 t80 -63.37 -33.78 76.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.165 178.33 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.481 ' CD2' HD21 ' A' ' 82' ' ' LEU . 6.2 m-85 -87.96 -27.31 22.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.135 179.472 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.961 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.596 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 28.0 ttm . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.75 0.31 . . . . 0.0 111.756 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.471 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 77.6 m-85 -66.83 152.11 46.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.96 0.409 . . . . 0.0 110.445 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.65 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 3.0 mptt -126.6 124.29 39.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.224 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.496 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 16.9 t -103.43 132.45 49.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.273 0.558 . . . . 0.0 111.528 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.1 m-85 -109.23 98.98 8.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.066 178.42 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.23 -137.99 2.39 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 119.995 -1.098 . . . . 0.0 112.355 -179.362 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.634 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 3.4 m-85 -128.86 120.69 26.7 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 120.54 0.209 . . . . 0.0 111.296 -178.642 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.474 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -117.52 69.32 0.77 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.595 0.236 . . . . 0.0 111.62 -179.601 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 36.9 t 177.87 -172.0 0.11 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.085 0.469 . . . . 0.0 111.767 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.87 7.59 26.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.831 179.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.431 HG12 ' HB3' ' A' ' 9' ' ' SER . 1.0 OUTLIER -87.53 -17.87 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.905 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 37.3 t-80 -165.41 122.7 1.5 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.658 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.57 154.09 32.68 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.993 -178.1 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.6 t -159.64 95.31 1.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.925 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.7 m -74.61 -35.99 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.955 0.407 . . . . 0.0 110.563 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -65.9 -20.14 66.12 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.534 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.7 m -66.94 -60.94 2.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.791 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.42 -42.57 67.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.169 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -61.91 -52.75 62.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.081 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.517 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -58.87 -49.66 76.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.979 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -50.01 -32.67 15.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.58 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -69.68 -38.62 77.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.629 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.424 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -58.23 -54.09 50.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.659 179.491 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mt -54.69 -43.31 72.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.928 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.3 m -58.47 -33.09 69.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.031 0.443 . . . . 0.0 109.974 179.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -78.81 -30.65 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.711 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -9.78 59.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.137 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt 64.68 56.87 1.13 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.071 0.462 . . . . 0.0 110.611 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.419 ' NE2' ' HD2' ' A' ' 30' ' ' PRO . 11.1 mm100 -132.6 130.33 21.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.089 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.428 ' O ' ' HA ' ' A' ' 1' ' ' MET . 86.3 Cg_endo -73.84 138.28 25.84 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.24 1.96 . . . . 0.0 110.924 178.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.596 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 48.1 p90 -155.1 170.64 21.33 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -141.63 144.0 33.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.048 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.496 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 33.2 t80 -89.71 162.1 15.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.05 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.477 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 7.1 mt -148.75 119.81 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.258 0.551 . . . . 0.0 110.816 179.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -89.81 139.34 30.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.042 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.428 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -99.72 -26.11 3.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.215 -179.989 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.584 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 10.2 ttm -119.38 88.93 39.24 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.753 0.311 . . . . 0.0 111.64 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.49 -6.95 15.74 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.525 2.15 . . . . 0.0 112.245 179.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -139.39 141.87 37.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.57 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -69.2 -7.78 39.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.282 0.563 . . . . 0.0 111.964 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.25 -60.46 1.92 Allowed Glycine 0 C--N 1.311 -0.853 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.895 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 t -150.48 128.87 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.553 0.216 . . . . 0.0 110.561 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.584 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -57.94 170.09 0.68 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.207 -179.641 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.414 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -78.87 87.24 4.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.476 -179.066 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -54.15 -22.67 11.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.275 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -56.0 -51.48 67.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.891 0.377 . . . . 0.0 110.572 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -73.06 -32.81 65.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.276 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 44' ' ' ASP . 40.0 mm -57.2 -50.89 75.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.79 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.25 70.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.536 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.26 -32.14 69.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.318 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.483 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.99 -57.22 13.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.236 179.933 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.476 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 16.4 mt -44.54 -45.84 9.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.265 0.555 . . . . 0.0 111.125 178.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.2 m -70.11 -30.59 67.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.362 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -66.46 -41.28 89.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.121 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.483 ' CD1' ' O ' ' A' ' 51' ' ' LEU . 3.3 mp -62.28 -54.75 36.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.057 0.456 . . . . 0.0 110.81 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.33 -115.17 0.37 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.061 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -150.64 30.92 0.65 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.065 0.46 . . . . 0.0 110.687 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -121.04 -145.75 0.36 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.352 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.8 t -115.85 170.25 8.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.677 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -70.03 98.14 1.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.314 0.578 . . . . 0.0 110.55 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -80.26 84.41 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.861 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.4 27.37 47.35 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.184 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.428 HD12 ' CD2' ' A' ' 55' ' ' LEU . 1.6 mm? -55.5 135.65 50.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.892 0.377 . . . . 0.0 111.349 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.75 159.9 40.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.161 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -102.19 152.14 38.21 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.958 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.9 Cg_exo -81.48 143.29 57.89 Favored 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 123.945 -1.273 . . . . 0.0 112.666 0.18 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -108.17 118.22 36.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.014 179.06 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.3 t -92.34 166.32 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.029 0.442 . . . . 0.0 111.899 -178.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -141.91 134.78 28.71 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.788 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.455 ' HA ' HD12 ' A' ' 76' ' ' ILE . . . -49.67 150.15 3.86 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.529 -179.211 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.548 ' HB3' ' N ' ' A' ' 1' ' ' MET . 45.6 Cg_exo -58.67 -33.77 98.48 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.216 2.611 . . . . 0.0 112.268 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -90.16 -21.67 22.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.365 -179.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.76 88.98 0.86 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.73 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.23 162.1 6.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.337 . . . . 0.0 110.543 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.461 ' CE1' HD21 ' A' ' 55' ' ' LEU . 8.0 t-160 -90.52 115.64 27.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.102 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.455 HD12 ' HA ' ' A' ' 70' ' ' ALA . 6.8 mt -91.78 -49.41 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.011 0.434 . . . . 0.0 110.983 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.61 -154.01 16.53 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.276 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.12 -143.54 5.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.294 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.517 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -77.01 -69.57 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.58 0.19 . . . . 0.0 110.738 179.76 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -48.2 -45.46 33.87 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.25 0.548 . . . . 0.0 110.327 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -35.37 76.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.175 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 85' ' ' TYR . 4.0 tt -78.38 -38.13 42.48 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.406 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 87' ' ' LYS . 11.4 mtm180 -50.78 -32.14 18.99 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -68.43 -34.8 76.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.16 178.117 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 82' ' ' LEU . 8.0 t80 -63.67 -34.36 77.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.36 178.415 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.453 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.1 m-85 -89.91 -70.48 0.66 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.392 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.906 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.768 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 6.3 tpt . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.465 ' H ' ' HG3' ' A' ' 1' ' ' MET . 92.4 m-85 -39.56 116.99 0.68 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.74 0.781 . . . . 0.0 111.455 -177.276 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -90.16 128.53 36.37 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.39 -179.163 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.463 HG11 ' CE1' ' A' ' 33' ' ' PHE . 37.1 t -115.81 127.12 73.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.26 0.552 . . . . 0.0 111.548 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.559 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 18.6 m-85 -103.93 98.13 8.02 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' A' ' 36' ' ' ILE . . . -155.56 -139.8 2.85 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.891 -179.004 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.463 ' CE2' ' HE3' ' A' ' 37' ' ' MET . 17.1 m-85 -131.75 158.39 41.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -178.3 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.403 ' O ' ' CB ' ' A' ' 9' ' ' SER . 41.9 t0 -70.74 -69.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.595 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 3.2 t 164.09 -31.41 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.606 179.642 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -83.0 -26.88 30.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.546 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.45 ' CG2' ' O ' ' A' ' 39' ' ' GLU . 4.2 mp -88.21 -49.3 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.997 179.391 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -144.49 153.97 42.42 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.901 179.052 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -48.55 156.58 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.642 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.27 62.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.916 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 m -80.11 -48.8 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.049 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.29 -20.46 65.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.513 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 m -65.34 -47.68 75.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.291 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -55.53 -26.01 40.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.737 179.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -73.08 -42.97 62.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.471 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.05 -40.74 78.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.098 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -62.81 -56.76 14.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.737 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.95 -34.22 71.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.221 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.87 -51.48 69.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.896 179.146 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.445 HD21 ' CZ ' ' A' ' 86' ' ' PHE . 6.7 mt -57.9 -42.84 85.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.638 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.7 m -60.54 -39.26 87.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.932 179.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.1 t -74.25 -39.24 49.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.534 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 1.7 tmtm? -74.29 -12.79 60.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.949 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt 68.56 49.16 0.77 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.938 0.399 . . . . 0.0 110.643 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -137.56 102.31 8.74 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.378 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.768 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 86.8 Cg_exo -44.91 171.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.518 2.145 . . . . 0.0 112.65 179.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 4.0 p90 -163.28 170.29 17.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.6 178.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 3.4 tt0 -132.54 112.49 12.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.686 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.463 ' CE1' HG11 ' A' ' 4' ' ' VAL . 9.9 t80 -89.1 153.84 20.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.17 0.51 . . . . 0.0 111.266 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.9 mt -149.98 121.74 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.331 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -70.56 109.4 4.83 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.499 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.451 ' CG2' ' CE2' ' A' ' 7' ' ' TYR . 18.7 tt -72.4 -19.29 19.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.583 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.5 ttp -134.59 94.94 16.44 Favored Pre-proline 0 N--CA 1.454 -0.227 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.974 179.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -85.93 24.06 0.78 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.677 2.251 . . . . 0.0 112.105 179.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.45 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 6.7 tt0 -139.49 165.82 26.2 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.754 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -62.72 -7.54 5.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -179.054 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.65 35.58 0.06 OUTLIER Glycine 0 C--N 1.313 -0.705 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.825 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.464 ' N ' ' SD ' ' A' ' 37' ' ' MET . 4.3 t -147.72 121.13 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.906 0.384 . . . . 0.0 111.081 178.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -79.28 150.78 31.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.742 179.752 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -78.11 99.82 6.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.132 -179.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -48.52 -29.75 4.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.537 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -60.52 -54.38 46.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.959 0.409 . . . . 0.0 110.773 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -68.92 -41.91 77.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.847 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 43' ' ' PHE . 2.7 mp -63.22 -36.06 74.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.129 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.24 -52.49 65.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.659 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.01 -33.07 72.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.302 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.559 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.1 tt -60.15 -51.98 67.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.308 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 1.9 mt -52.38 -44.49 65.33 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.344 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.7 m -58.19 -49.19 77.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.734 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.6 mtpp -59.53 -36.59 76.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.689 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.96 -52.23 66.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.567 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.05 -118.5 0.66 Allowed Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.054 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -141.35 27.9 1.88 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.199 0.524 . . . . 0.0 110.589 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -121.5 -147.23 0.38 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.257 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.4 t -120.26 170.19 9.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.695 0.283 . . . . 0.0 110.603 179.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -69.95 98.01 1.22 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.348 0.594 . . . . 0.0 110.423 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -80.36 84.25 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.084 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.72 26.51 60.28 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.395 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -50.33 148.24 3.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 111.072 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.1 p -122.92 165.22 17.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.427 -179.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -118.46 153.64 51.96 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.734 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -86.81 136.28 17.8 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.318 -1.117 . . . . 0.0 112.495 0.203 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -91.76 129.6 37.7 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.4 t -103.2 154.29 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.123 0.487 . . . . 0.0 112.006 -179.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 44.5 m-85 -142.63 138.08 30.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.801 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 72' ' ' ASP . . . -48.16 164.04 0.28 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.755 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.503 ' HB3' ' HA ' ' A' ' 1' ' ' MET . 32.5 Cg_endo -62.88 58.93 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.742 2.294 . . . . 0.0 111.453 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 86.61 29.96 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.88 -178.665 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.66 -91.07 2.11 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.857 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.68 -169.19 3.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.015 0.436 . . . . 0.0 110.998 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 17.1 t-80 -83.31 125.07 31.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.162 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 70' ' ' ALA . 13.7 mt -96.92 -45.89 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.95 0.405 . . . . 0.0 110.741 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 137.97 -156.62 23.9 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.659 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.01 -139.97 8.54 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.733 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -72.53 -70.57 0.34 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.718 0.294 . . . . 0.0 111.048 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -56.42 -48.01 77.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.917 0.389 . . . . 0.0 110.809 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -52.09 -41.44 62.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.644 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.467 HD23 ' CE2' ' A' ' 86' ' ' PHE . 6.2 tt -76.57 -34.23 58.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.208 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -51.52 -28.95 15.05 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -69.22 -34.07 74.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.216 178.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 82' ' ' LEU . 6.8 t80 -64.75 -33.25 75.54 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.446 178.508 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.467 ' CE2' HD23 ' A' ' 82' ' ' LEU . 7.1 m-85 -90.52 -66.89 0.89 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.584 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.8 pttt . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.137 -0.935 . . . . 0.0 110.917 -179.906 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.571 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 25.7 ttp . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.774 0.321 . . . . 0.0 111.669 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.475 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 80.9 m-85 -67.32 151.26 47.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.95 0.405 . . . . 0.0 110.529 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.67 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 3.3 mptt -127.11 120.39 28.77 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.569 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.49 HG13 ' CE1' ' A' ' 33' ' ' PHE . 14.5 t -106.79 130.82 58.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.251 0.548 . . . . 0.0 111.805 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.6 m-30 -106.39 99.4 8.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.408 178.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.41 -137.36 2.17 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.842 -1.17 . . . . 0.0 112.985 -179.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -118.5 147.25 43.84 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.825 0.345 . . . . 0.0 110.936 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -90.73 13.13 17.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.607 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 0.3 OUTLIER 71.95 4.88 5.18 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.629 0.252 . . . . 0.0 111.44 179.931 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -85.79 -58.21 2.74 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.906 0.384 . . . . 0.0 111.033 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.5 mt -91.65 -27.03 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.544 -179.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.468 ' O ' ' HA ' ' A' ' 9' ' ' SER . 30.9 t60 -139.49 145.21 38.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.676 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.39 158.07 34.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.566 -179.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.5 t -175.78 96.11 0.06 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -80.88 -32.15 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.011 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -70.47 -23.17 62.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.596 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.5 m -62.52 -52.81 62.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.268 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.02 -27.28 52.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.301 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -71.16 -49.59 42.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.254 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.06 -47.22 71.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.177 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HD3' ' CE2' ' A' ' 31' ' ' PHE . 1.1 tppt? -59.65 -52.95 63.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.715 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.36 -41.25 79.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.767 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 tt -58.49 -54.25 49.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.388 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 mt -57.31 -46.42 83.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.769 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 m -57.73 -37.09 72.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.093 0.473 . . . . 0.0 110.228 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.96 -29.6 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.695 179.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -16.8 54.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.142 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.54 56.36 0.11 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.926 0.393 . . . . 0.0 110.9 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -136.96 141.62 35.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.444 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.9 Cg_endo -80.43 137.13 11.54 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.584 2.189 . . . . 0.0 111.647 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.571 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 32.0 p90 -158.32 170.61 21.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.847 0.356 . . . . 0.0 111.773 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -147.26 145.68 29.5 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.035 0.445 . . . . 0.0 111.167 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.49 ' CE1' HG13 ' A' ' 4' ' ' VAL . 10.2 t80 -89.5 163.58 15.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.168 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.43 HD12 ' CE1' ' A' ' 5' ' ' TYR . 11.5 mt -148.22 121.3 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.527 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -81.84 127.67 33.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.263 -179.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 pt -95.57 -16.27 7.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.185 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.49 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 43.9 ttm -119.0 102.99 48.58 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.933 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 76.9 Cg_endo -76.2 -25.89 9.61 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.632 2.221 . . . . 0.0 112.035 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -139.96 151.01 45.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.767 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.21 -8.48 24.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.262 0.553 . . . . 0.0 111.656 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.71 -57.81 2.65 Favored Glycine 0 C--N 1.313 -0.725 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.671 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -148.73 139.11 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.642 0.258 . . . . 0.0 111.523 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -60.07 170.55 1.2 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.598 179.648 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.428 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 28.8 t0 -86.34 104.16 15.59 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -57.02 -22.65 40.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.434 179.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -58.05 -51.74 68.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.799 0.333 . . . . 0.0 110.686 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -74.86 -40.63 60.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.346 179.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.7 mm -55.13 -47.48 77.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.771 179.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.03 -47.08 78.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.435 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.78 -37.88 85.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.381 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.42 HD11 ' CE2' ' A' ' 5' ' ' TYR . 19.8 tp -56.01 -51.27 68.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.732 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.9 mt -53.43 -47.58 69.52 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.227 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.7 m -65.24 -38.06 89.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.274 179.333 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.7 mtpp -63.91 -39.11 93.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.588 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -47.32 86.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.397 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 166.28 -109.64 0.36 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.987 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -150.72 31.54 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.034 0.445 . . . . 0.0 110.527 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.98 -149.96 0.44 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.7 t -120.38 170.33 9.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.694 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -80.4 98.44 7.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.271 0.558 . . . . 0.0 110.408 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.6 mm -78.6 83.65 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.78 24.79 50.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.369 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.21 141.05 56.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.874 0.368 . . . . 0.0 110.872 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.7 p -125.63 169.0 12.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.1 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.26 157.19 36.98 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.664 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.0 Cg_exo -81.82 143.45 56.38 Favored 'Cis proline' 0 C--N 1.344 0.292 0 C-N-CA 123.843 -1.315 . . . . 0.0 112.933 0.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 5' ' ' TYR . 19.0 mt-30 -99.85 114.73 28.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.106 178.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.67 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.8 t -90.28 164.19 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.073 0.463 . . . . 0.0 111.712 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.422 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 41.3 m-85 -142.48 131.49 23.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.62 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -48.38 152.28 1.63 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.439 -178.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.535 ' HB3' ' N ' ' A' ' 1' ' ' MET . 45.0 Cg_exo -58.39 -22.53 58.93 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.116 2.544 . . . . 0.0 112.218 179.168 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.0 -24.79 14.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.13 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.26 94.29 0.99 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.75 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.1 t -179.61 143.5 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.82 0.343 . . . . 0.0 110.774 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -72.9 106.13 4.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.965 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.6 mt -79.97 -52.06 15.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.65 -153.77 20.99 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.471 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.62 -147.3 12.41 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.335 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -69.95 -58.09 4.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.805 0.336 . . . . 0.0 110.624 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -55.88 -44.56 78.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.794 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -57.86 -43.36 85.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.471 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.434 HD23 ' CD2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -61.83 -48.8 78.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.391 179.636 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -51.13 -30.21 15.81 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.98 -34.77 62.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.261 178.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 82' ' ' LEU . 12.7 t80 -65.99 -32.39 73.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.343 178.439 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.434 ' CD2' HD23 ' A' ' 82' ' ' LEU . 8.1 m-85 -90.02 -70.15 0.68 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.212 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.918 -179.941 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.601 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 15.5 ttm . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -75.45 146.68 40.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.992 178.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.5 mptm? -110.5 122.01 46.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.719 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 67' ' ' GLN . 67.8 t -114.26 133.72 59.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.329 0.585 . . . . 0.0 112.316 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.588 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 18.5 m-85 -111.68 100.72 9.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.176 178.088 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.09 -141.57 3.16 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.51 -179.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.596 ' CD2' ' CB ' ' A' ' 12' ' ' HIS . 52.5 m-85 -117.27 159.18 23.09 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.236 0.214 . . . . 0.0 110.426 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -106.29 17.12 23.91 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.074 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 1.0 OUTLIER 73.18 -1.81 2.93 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 179.936 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -84.99 -46.82 10.85 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.18 0.514 . . . . 0.0 110.507 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.4 0.6 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.589 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.685 ' CD2' ' HE1' ' A' ' 37' ' ' MET . 11.9 t-80 -166.96 135.17 2.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.397 -177.784 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.48 164.51 22.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.945 -179.066 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 p 177.73 125.65 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.96 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.2 m -91.4 -30.44 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.123 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -77.2 -21.9 53.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.351 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.1 p -72.95 -41.46 64.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.974 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.67 -36.93 84.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.072 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -63.61 -55.48 23.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.69 -28.92 36.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.88 0.371 . . . . 0.0 110.908 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -61.95 -55.14 32.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.021 0.439 . . . . 0.0 110.11 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -29.4 69.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.565 179.402 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.39 -50.74 64.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.536 179.445 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.467 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -64.55 -50.21 68.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.603 179.846 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 m -56.71 -41.25 77.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.807 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.7 t -69.94 -35.16 63.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.931 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.42 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 3.9 mmtt -74.02 -10.96 60.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.303 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt 70.87 36.99 1.38 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.08 0.467 . . . . 0.0 110.724 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -126.37 138.26 31.96 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.549 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.601 ' O ' ' HA ' ' A' ' 1' ' ' MET . 86.8 Cg_endo -78.34 161.55 28.69 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.458 2.106 . . . . 0.0 111.456 179.601 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 6.5 p90 -161.61 171.31 18.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.328 . . . . 0.0 111.513 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -134.29 121.79 21.78 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.768 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.441 ' CE1' HG11 ' A' ' 4' ' ' VAL . 18.2 t80 -89.44 157.96 17.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 20.1 mt -148.49 120.64 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.635 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -71.24 110.87 6.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.379 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 7' ' ' TYR . 1.1 pp -74.0 -29.35 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.398 -179.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.685 ' HE1' ' CD2' ' A' ' 12' ' ' HIS . 20.7 ttm -118.28 86.7 27.95 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.661 0.267 . . . . 0.0 110.598 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.446 ' HG3' ' HB3' ' A' ' 44' ' ' ASP . 93.0 Cg_endo -79.54 5.15 6.06 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.571 2.181 . . . . 0.0 112.674 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -139.79 141.25 36.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.113 0.482 . . . . 0.0 111.357 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -63.68 -7.41 7.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.019 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.25 -67.22 0.64 Allowed Glycine 0 C--N 1.314 -0.67 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.188 -179.227 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.6 t -125.59 136.92 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.726 0.298 . . . . 0.0 111.62 -179.259 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -71.61 170.35 13.62 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.052 179.783 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.446 ' HB3' ' HG3' ' A' ' 38' ' ' PRO . 4.8 p30 -77.78 124.66 28.24 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.089 0.471 . . . . 0.0 111.711 -179.428 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.24 -26.39 39.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.71 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -61.19 -51.44 68.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 111.291 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.95 -37.55 67.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.858 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.451 ' N ' HD13 ' A' ' 48' ' ' ILE . 1.2 mp -72.09 -25.81 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 179.614 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.84 -52.68 40.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.563 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.87 -34.71 73.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.185 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.588 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 3.4 tt -57.52 -52.04 67.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.478 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.1 mt -52.78 -45.0 66.94 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.586 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.7 m -63.42 -44.82 93.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.418 179.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -59.62 -33.09 71.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.711 179.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.33 -66.66 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.25 -28.48 0.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.598 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.28 -165.09 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.742 0.306 . . . . 0.0 110.808 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -103.65 -25.83 13.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.038 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -87.33 164.69 16.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.871 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.417 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . 13.0 mt-30 -109.44 99.28 8.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.001 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pt -80.25 84.39 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.126 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.08 26.01 74.21 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.283 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.417 ' CB ' ' HB3' ' A' ' 60' ' ' GLN . 1.7 tm? -62.57 130.59 45.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.861 0.362 . . . . 0.0 110.965 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.68 152.79 50.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -104.43 152.91 39.39 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.624 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.8 Cg_exo -82.4 140.52 43.29 Favored 'Cis proline' 0 C--N 1.344 0.305 0 C-N-CA 124.025 -1.24 . . . . 0.0 112.817 0.32 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 1.1 mm-40 -99.97 135.85 40.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.078 179.096 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.3 t -106.85 158.73 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.05 0.452 . . . . 0.0 111.875 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.485 ' CE2' ' HB2' ' A' ' 75' ' ' HIS . 34.0 m-85 -143.08 138.51 29.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.192 -179.582 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.19 133.05 51.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.171 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.586 ' HB3' ' N ' ' A' ' 1' ' ' MET . 39.1 Cg_exo -54.38 -21.46 23.52 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.543 2.162 . . . . 0.0 112.133 179.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.24 40.08 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.337 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.34 -109.38 0.66 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.884 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.68 -178.07 5.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.11 0.481 . . . . 0.0 111.236 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.485 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 29.7 t-80 -56.61 122.64 12.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.053 -179.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.3 mt -91.08 -47.31 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.689 179.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.11 -155.49 22.44 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.673 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.65 -141.03 9.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.663 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -70.39 -70.76 0.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.72 0.295 . . . . 0.0 110.982 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.76 -49.45 77.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.981 0.419 . . . . 0.0 110.439 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -50.73 -36.18 35.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.445 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.548 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.2 tt -82.23 -32.04 29.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.292 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -50.95 -30.6 15.33 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -35.7 79.41 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.134 178.287 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LEU . 16.1 t80 -63.55 -33.53 75.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.399 178.437 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.548 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.5 m-85 -86.11 -70.34 0.61 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.113 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.954 179.939 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.557 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 35.8 ttp . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.78 0.324 . . . . 0.0 111.562 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.43 ' CZ ' ' CZ ' ' A' ' 86' ' ' PHE . 70.2 m-85 -59.46 148.79 31.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 -179.292 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.667 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -119.0 123.39 44.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.209 -179.057 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.534 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 8.0 t -114.72 139.6 39.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.319 0.581 . . . . 0.0 111.688 179.424 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -122.49 99.77 6.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.454 178.491 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' A' ' 66' ' ' PRO . . . -158.52 -141.71 3.22 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.435 -179.454 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.43 ' CE1' ' CD1' ' A' ' 36' ' ' ILE . 54.8 m-85 -123.13 160.4 26.52 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.826 0.346 . . . . 0.0 111.467 -179.091 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.7 p-10 -93.66 -65.47 0.99 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.9 OUTLIER 162.28 -37.71 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.251 179.88 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -63.82 -45.08 91.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.806 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 40' ' ' LYS . 4.2 mm -89.02 -41.47 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.059 0.456 . . . . 0.0 110.544 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -147.75 138.23 23.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.255 179.183 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.72 155.09 26.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.716 -178.782 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.5 p -162.5 119.11 1.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.392 179.382 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.4 m -88.78 -22.98 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.534 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -90.45 -15.47 30.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.453 -179.749 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.3 p -74.62 -43.65 54.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.79 0.328 . . . . 0.0 110.859 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.48 -46.61 82.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.929 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -55.94 -45.35 78.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.116 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.76 -38.82 92.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.924 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.22 -42.62 61.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.033 0.444 . . . . 0.0 110.379 179.424 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -73.24 -26.1 60.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.566 179.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.511 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -57.26 -55.94 28.29 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.327 179.657 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.409 HD12 ' CG ' ' A' ' 31' ' ' PHE . 10.6 mt -62.42 -46.82 86.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.628 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.0 m -53.5 -33.08 53.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.042 0.448 . . . . 0.0 110.266 179.462 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -75.7 -30.29 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.653 179.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.52 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 3.4 mmtm -78.21 -9.86 59.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.402 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 64.62 40.49 5.91 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 111.386 179.818 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -122.35 145.17 43.73 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.287 179.332 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.408 ' O ' ' HA ' ' A' ' 1' ' ' MET . 92.6 Cg_endo -78.59 135.43 13.03 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.287 1.991 . . . . 0.0 111.908 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.557 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 17.0 p90 -146.25 167.66 22.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.907 0.384 . . . . 0.0 111.797 179.681 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -136.11 122.06 20.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.2 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.534 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 42.0 t80 -89.76 150.38 22.31 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.229 179.437 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.4 mt -143.77 119.53 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.157 0.503 . . . . 0.0 110.936 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -78.13 109.65 12.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.869 179.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.43 ' CD1' ' CE1' ' A' ' 7' ' ' TYR . 13.9 pt -59.64 -29.01 41.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.397 -179.291 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.558 ' HB2' ' HB3' ' A' ' 43' ' ' PHE . 3.2 ttp -121.82 87.04 46.22 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.706 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.43 -4.04 14.74 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.732 2.288 . . . . 0.0 112.797 -179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -139.58 135.61 33.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.817 0.341 . . . . 0.0 110.694 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.42 ' N ' HG23 ' A' ' 11' ' ' ILE . 5.4 ttmt -65.16 -7.65 13.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.291 0.567 . . . . 0.0 112.055 -179.595 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.47 -64.6 1.38 Allowed Glycine 0 C--N 1.312 -0.766 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.815 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.7 t -141.03 129.91 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.066 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.558 ' HB3' ' HB2' ' A' ' 37' ' ' MET . 0.0 OUTLIER -69.0 166.76 17.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.138 0.494 . . . . 0.0 112.184 -178.719 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.456 ' O ' ' CD1' ' A' ' 48' ' ' ILE . 10.4 t70 -82.24 97.2 8.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.886 -178.764 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -67.49 -15.89 63.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.837 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.437 ' HB2' ' OD1' ' A' ' 44' ' ' ASP . 2.9 mm-40 -63.53 -51.05 67.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.71 0.291 . . . . 0.0 110.647 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -71.11 -37.67 72.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.348 179.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.487 HD12 ' CD2' ' A' ' 43' ' ' PHE . 1.5 mp -67.58 -35.36 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.882 179.239 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.38 -47.12 86.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.712 179.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.8 -39.08 87.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.316 179.674 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.433 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 10.5 tp -56.75 -51.41 68.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.443 179.686 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.3 mt -50.82 -45.71 59.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.489 179.715 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.0 m -61.57 -42.22 98.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.614 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.61 -38.57 85.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.704 179.819 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.91 -59.04 6.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.924 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.09 -26.2 0.62 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.06 -179.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -135.83 -162.12 1.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.55 23.24 12.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.58 0.229 . . . . 0.0 111.293 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.7 t -120.89 143.16 49.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.911 0.386 . . . . 0.0 111.804 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -96.7 99.57 11.17 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.575 178.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -72.27 77.52 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.43 -178.403 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 36.09 30.03 0.02 OUTLIER Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.056 178.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 61' ' ' ILE . 0.8 OUTLIER -65.74 162.23 19.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.008 0.432 . . . . 0.0 111.265 -179.466 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.2 158.6 17.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.081 -179.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.2 mtm -116.2 156.93 46.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.564 179.596 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . 4.8 Cg_exo -80.92 147.26 73.45 Favored 'Cis proline' 0 C--N 1.346 0.406 0 C-N-CA 124.244 -1.149 . . . . 0.0 112.991 0.511 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.54 135.66 34.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.039 178.748 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.1 t -113.5 159.09 13.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.948 0.404 . . . . 0.0 111.659 -179.494 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.459 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 40.0 m-85 -142.43 147.02 35.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.637 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.461 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -56.11 157.97 7.91 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.55 -178.464 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.505 ' HB3' ' N ' ' A' ' 1' ' ' MET . 32.3 Cg_exo -60.67 -25.98 82.01 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.262 2.642 . . . . 0.0 112.258 179.288 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -20.67 17.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.443 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.23 89.01 1.11 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.665 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.25 145.76 3.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.655 0.264 . . . . 0.0 110.386 179.845 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -78.43 115.41 18.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.835 0.35 . . . . 0.0 110.937 -179.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.461 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 1.8 mp -102.13 -46.05 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.711 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.32 -159.47 22.39 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.874 179.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.53 -123.24 3.24 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.5 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.511 ' CE1' ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -83.39 -67.72 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.779 -0.247 . . . . 0.0 110.947 179.769 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -50.51 -48.02 57.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.274 0.559 . . . . 0.0 110.463 179.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -60.5 -47.43 86.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.847 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.439 HD22 ' CE2' ' A' ' 86' ' ' PHE . 1.1 tt -66.62 -41.77 87.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.551 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.46 ' O ' ' N ' ' A' ' 87' ' ' LYS . 7.1 ttt180 -51.67 -31.38 25.53 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.826 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -71.25 -32.78 69.15 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.513 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.444 ' CD2' HG12 ' A' ' 76' ' ' ILE . 49.2 t80 -70.26 -29.22 65.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.016 178.853 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.439 ' CE2' HD22 ' A' ' 82' ' ' LEU . 26.4 m-85 -99.66 -70.85 0.72 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.558 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 83' ' ' ARG . 15.2 pttp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.413 179.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.625 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 10.5 ttm . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.829 0.347 . . . . 0.0 111.675 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.472 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 85.4 m-85 -83.85 145.81 28.44 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.226 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.71 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -123.99 126.51 46.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 -179.26 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.454 HG11 ' CE1' ' A' ' 33' ' ' PHE . 70.2 t -114.04 132.52 62.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.393 0.616 . . . . 0.0 111.49 179.273 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.512 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 18.6 m-85 -110.57 99.64 8.58 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.06 178.256 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.0 -144.31 3.93 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.979 -179.092 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.409 ' CE1' ' HE3' ' A' ' 37' ' ' MET . 29.6 m-85 -125.8 150.16 48.02 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 120.744 0.307 . . . . 0.0 111.123 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.95 -74.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.995 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.3 t 175.29 -34.34 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.761 0.315 . . . . 0.0 111.321 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -81.2 -24.36 37.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.298 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' A' ' 11' ' ' ILE . 2.6 mp -91.12 -42.12 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.897 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.401 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 29.2 t60 -155.8 153.3 29.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.271 -179.62 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -55.71 145.37 24.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.079 0.466 . . . . 0.0 111.518 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 t -167.49 75.67 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.028 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.1 m -90.61 -20.38 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.272 179.559 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -75.47 -27.53 58.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.393 -179.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.8 p -79.87 -40.91 27.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.324 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.04 -41.81 48.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.112 0.482 . . . . 0.0 110.786 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -72.78 -49.23 32.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.65 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.29 -41.73 72.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.964 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -52.38 65.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.619 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -59.05 -36.61 75.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.656 179.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.43 HD22 ' CD2' ' A' ' 86' ' ' PHE . 2.4 tt -60.4 -54.82 41.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.466 179.535 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 mt -54.78 -45.6 74.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.71 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.9 m -56.81 -35.58 68.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.173 0.511 . . . . 0.0 109.96 179.291 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.0 t -79.99 -29.86 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.683 179.304 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -11.74 59.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.031 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt 67.97 56.61 0.53 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.876 0.369 . . . . 0.0 110.951 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -134.33 135.85 24.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.76 132.75 12.18 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.461 2.108 . . . . 0.0 111.705 179.36 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.625 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 22.9 p90 -156.03 169.76 23.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.65 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -148.16 139.06 23.14 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.438 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.454 ' CE1' HG11 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -89.88 150.96 21.97 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.708 179.916 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.2 mt -140.95 121.96 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.063 0.458 . . . . 0.0 110.387 179.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -78.35 109.49 12.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.587 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 pt -73.71 -7.05 9.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.43 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.467 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -126.21 80.52 68.38 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-O 120.844 0.354 . . . . 0.0 111.076 -179.679 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.51 -20.38 69.55 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.705 2.27 . . . . 0.0 111.817 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -139.65 140.09 36.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.369 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.25 -8.75 2.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.217 0.532 . . . . 0.0 111.881 -179.647 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.4 -58.35 3.37 Favored Glycine 0 C--N 1.312 -0.772 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.706 179.803 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -150.55 150.13 13.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.81 0.338 . . . . 0.0 111.754 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -63.14 170.68 2.7 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.484 179.266 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -86.15 100.59 12.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.873 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.78 -25.29 40.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.488 -179.647 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -65.49 -60.43 2.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.943 0.401 . . . . 0.0 110.542 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -65.22 -33.74 76.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.345 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.8 mm -73.79 -29.69 26.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.647 179.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.68 -55.85 26.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.991 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -62.47 -35.26 78.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.308 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.512 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 2.9 tt -56.72 -50.89 70.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.273 179.603 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.3 mt -52.82 -48.82 66.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.115 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.0 m -63.72 -38.14 89.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.023 179.302 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.5 -43.01 88.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.382 179.436 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 mt -59.94 -47.24 86.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 172.37 -113.93 0.5 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.053 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -150.53 30.56 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.047 0.451 . . . . 0.0 110.745 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.04 -148.33 0.41 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.324 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 t -120.21 165.78 14.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.715 0.293 . . . . 0.0 110.626 179.624 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.444 ' CG ' ' O ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -69.69 98.82 1.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.726 0.774 . . . . 0.0 110.594 179.96 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.1 mt -79.68 83.08 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.037 -179.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.29 24.44 44.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.458 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.76 152.11 43.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.8 p -133.72 170.12 16.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.493 . . . . 0.0 111.691 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.86 160.46 26.73 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.31 179.405 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -82.7 144.46 54.37 Favored 'Cis proline' 0 C--N 1.344 0.312 0 C-N-CA 124.406 -1.081 . . . . 0.0 113.188 0.608 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.407 ' OE1' ' CE1' ' A' ' 75' ' ' HIS . 2.1 mm100 -105.74 125.55 51.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.969 178.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.71 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 4.0 t -98.9 160.72 3.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.909 0.385 . . . . 0.0 111.746 -179.301 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.422 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 28.5 m-85 -142.95 131.54 22.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.895 -179.843 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.403 ' HA ' HD12 ' A' ' 76' ' ' ILE . . . -64.0 142.78 98.22 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.463 -178.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.585 ' HB3' ' N ' ' A' ' 1' ' ' MET . 45.3 Cg_exo -41.37 -30.97 0.92 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.28 2.653 . . . . 0.0 112.677 179.234 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -164.26 35.16 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.594 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.02 -97.84 1.89 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.566 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.8 m -165.32 175.6 9.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.96 0.41 . . . . 0.0 110.889 -179.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.422 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 14.2 t-80 -50.04 101.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.997 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 70' ' ' ALA . 3.3 mt -67.32 -52.78 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.405 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 138.64 -150.83 21.31 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.753 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.4 -142.01 11.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.748 -179.719 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -70.12 -70.81 0.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.771 0.32 . . . . 0.0 110.948 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -58.97 -44.03 91.44 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.018 0.437 . . . . 0.0 110.437 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -53.11 -36.01 60.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.417 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.496 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.6 tt -80.42 -34.63 36.02 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.296 179.639 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -51.23 -29.81 15.45 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -69.0 -35.06 76.26 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.22 178.159 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 82' ' ' LEU . 9.1 t80 -63.24 -34.19 77.13 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.288 178.397 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.496 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.4 m-85 -88.0 -70.16 0.65 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.276 179.761 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.864 -179.996 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.609 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 59.0 ttp . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 120.713 0.292 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 76.9 m-85 -80.15 154.51 27.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.02 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.722 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -133.6 130.46 38.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.484 -178.794 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.484 HG11 ' CE1' ' A' ' 33' ' ' PHE . 27.0 t -114.09 138.31 44.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.195 0.522 . . . . 0.0 111.694 179.306 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 4.2 m-85 -115.89 99.47 7.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.997 178.276 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 35' ' ' ASN . . . -158.61 -138.58 2.5 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.446 -179.228 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -117.92 154.67 31.51 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 120.865 0.364 . . . . 0.0 111.021 -179.517 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.49 -77.9 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.788 -179.853 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 t 170.78 -37.88 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.955 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.49 -29.56 52.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.26 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.452 HG23 HD11 ' A' ' 11' ' ' ILE . 10.4 mm -89.03 -40.36 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.059 0.457 . . . . 0.0 110.631 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -150.32 148.54 28.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.573 179.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -78.37 160.04 28.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.302 -179.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.1 t -174.63 103.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.722 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 m -79.98 -37.88 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.217 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.46 -22.92 66.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.16 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.2 m -65.77 -57.72 7.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.909 0.385 . . . . 0.0 110.837 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -53.44 -25.98 18.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.316 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -70.39 -63.29 1.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.611 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.4 -27.04 62.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.796 179.551 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.2 tttm -59.59 -56.53 20.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.475 179.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -61.51 -25.5 67.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.523 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.4 HD11 ' CG ' ' A' ' 83' ' ' ARG . 1.0 OUTLIER -59.53 -55.42 34.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.451 179.626 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.5 mt -63.52 -43.0 98.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.8 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.2 m -58.75 -41.25 86.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.175 0.512 . . . . 0.0 109.986 179.243 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.8 t -78.86 -25.03 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.456 179.25 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.506 ' HG2' ' CE1' ' A' ' 86' ' ' PHE . 12.4 tppt? -71.75 -18.81 62.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.226 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt 69.86 53.76 0.37 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 111.11 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -143.7 145.92 33.01 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.996 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.33 138.88 22.81 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.557 2.171 . . . . 0.0 111.919 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.609 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 4.2 p90 -158.36 169.6 24.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.058 0.456 . . . . 0.0 112.154 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -144.18 143.14 30.94 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.789 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.484 ' CE1' HG11 ' A' ' 4' ' ' VAL . 21.0 t80 -89.41 158.45 17.74 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.318 -179.749 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.489 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 11.7 mt -145.67 119.75 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.168 179.26 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.0 p30 -90.6 133.04 35.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.544 -179.176 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.8 pt -90.28 -22.5 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.056 179.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.594 ' HB2' ' HB3' ' A' ' 43' ' ' PHE . 2.9 ttp -123.68 91.34 49.8 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.05 -4.36 15.3 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.891 2.394 . . . . 0.0 112.569 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 37' ' ' MET . 0.1 OUTLIER -139.62 136.98 34.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.74 0.305 . . . . 0.0 110.805 -179.837 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.421 ' HA ' HG21 ' A' ' 11' ' ' ILE . 4.0 ttpm? -63.69 -8.9 11.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.144 0.497 . . . . 0.0 112.102 -179.749 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.56 -64.6 1.43 Allowed Glycine 0 C--N 1.312 -0.774 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.164 179.583 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.8 t -141.24 139.91 32.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.611 0.243 . . . . 0.0 110.86 179.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.594 ' HB3' ' HB2' ' A' ' 37' ' ' MET . 0.1 OUTLIER -68.83 169.92 10.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.986 0.422 . . . . 0.0 111.379 -179.73 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.58 107.94 19.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.161 -179.678 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -56.29 -22.01 27.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.304 179.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -57.44 -51.19 70.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.838 0.351 . . . . 0.0 110.928 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -76.85 -35.15 57.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.308 179.632 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.6 mm -62.46 -44.36 99.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.873 179.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.96 -56.81 9.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.245 -179.487 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -57.75 -33.16 68.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.585 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.415 HD13 ' CD2' ' A' ' 5' ' ' TYR . 10.4 tp -57.72 -51.74 68.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.382 179.574 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.2 mt -52.47 -45.85 66.27 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.196 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.6 m -67.19 -35.63 80.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.32 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -62.67 -32.16 73.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.495 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.08 -53.54 48.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.84 179.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.62 -41.93 1.24 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.297 -179.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -98.76 -165.5 1.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.882 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -104.0 -32.83 9.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 t -110.54 166.32 11.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -110.62 99.47 8.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 179.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 pt -68.17 80.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.199 179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.95 17.75 73.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.668 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.42 ' CD1' ' NE2' ' A' ' 67' ' ' GLN . 0.3 OUTLIER -79.96 139.28 37.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.908 180.0 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.67 171.35 14.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.489 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.72 156.37 47.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.651 179.475 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.0 Cg_exo -76.58 147.66 87.27 Favored 'Cis proline' 0 C--N 1.345 0.36 0 C-N-CA 123.865 -1.306 . . . . 0.0 113.073 0.4 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.46 ' HG3' ' NE2' ' A' ' 75' ' ' HIS . 0.4 OUTLIER -107.73 111.55 23.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.406 179.314 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.722 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 5.6 t -93.65 161.1 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.933 0.397 . . . . 0.0 111.821 -179.319 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.427 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 96.0 m-85 -142.05 146.6 35.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.409 ' HA ' HD12 ' A' ' 76' ' ' ILE . . . -84.31 137.68 39.44 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.242 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.558 ' HB3' ' N ' ' A' ' 1' ' ' MET . 39.0 Cg_exo -34.94 -36.88 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.634 2.889 . . . . 0.0 112.183 178.674 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -166.6 31.02 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.124 179.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.72 15.91 9.01 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.761 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 p 73.36 179.93 0.21 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.125 0.488 . . . . 0.0 111.412 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.46 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 24.4 t-80 -52.57 125.71 17.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.502 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 70' ' ' ALA . 26.7 mt -94.76 -47.9 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.657 179.538 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.5 -151.71 20.95 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.657 -179.71 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.44 -144.95 17.87 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.592 -179.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -70.65 -70.6 0.29 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.771 0.32 . . . . 0.0 110.775 -179.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -59.18 -47.22 86.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.958 0.408 . . . . 0.0 110.477 179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -41.15 63.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.264 179.582 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 85' ' ' TYR . 4.5 tt -76.23 -35.39 59.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.051 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.459 ' O ' ' N ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -51.52 -28.05 12.5 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.755 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -72.29 -33.61 67.55 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.367 178.352 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.457 ' N ' ' O ' ' A' ' 82' ' ' LEU . 6.2 t80 -65.64 -32.85 74.64 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.399 178.568 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.506 ' CE1' ' HG2' ' A' ' 27' ' ' LYS . 10.7 m-85 -95.13 -70.19 0.72 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.521 179.718 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.818 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.603 ' HG3' ' HA ' ' A' ' 31' ' ' PHE . 2.5 tpp . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.799 0.333 . . . . 0.0 111.637 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.504 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 82.9 m-85 -68.82 148.42 50.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.958 0.408 . . . . 0.0 110.538 -179.786 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.682 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -120.25 118.51 30.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.157 -179.973 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.2 t -105.28 122.74 58.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.343 0.592 . . . . 0.0 111.921 -179.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 2.6 m-30 -99.95 99.39 10.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.923 178.659 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.74 -138.07 2.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.369 -179.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.448 ' CE2' ' HE2' ' A' ' 37' ' ' MET . 77.8 m-85 -131.07 104.09 6.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.56 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 8' ' ' ASP . 0.5 OUTLIER -108.8 22.84 15.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.604 0.24 . . . . 0.0 110.465 178.53 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.1 t -116.07 175.16 5.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.42 0.629 . . . . 0.0 111.774 -179.103 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -87.37 8.26 25.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.22 179.059 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.2 mm -87.66 -16.28 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.382 179.333 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -153.51 144.92 23.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.471 179.18 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.34 166.79 20.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.048 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.3 p 179.19 116.9 0.04 OUTLIER 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.831 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.7 m -90.84 -35.8 7.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.87 0.367 . . . . 0.0 111.134 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -77.41 -19.32 56.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.49 -179.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.6 p -65.76 -43.41 88.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 0.0 110.634 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.31 -38.24 63.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.858 179.752 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -68.74 -41.14 79.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.432 -179.428 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.49 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -67.04 -40.03 87.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.774 0.321 . . . . 0.0 111.487 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.417 ' HD2' ' CZ ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -57.3 -48.55 78.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.836 0.35 . . . . 0.0 110.491 179.753 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.7 ptt85 -64.93 -33.42 75.99 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.979 0.418 . . . . 0.0 110.503 179.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.468 ' HB3' ' O ' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -55.45 -49.75 71.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.325 179.285 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.4 -47.51 78.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.447 179.266 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 m -54.24 -36.98 64.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.003 179.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.46 -27.92 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.414 179.251 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 -11.57 57.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.093 179.787 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 70.27 57.71 0.27 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.907 0.384 . . . . 0.0 111.245 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -135.37 137.75 27.14 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.113 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.429 ' O ' ' HA ' ' A' ' 1' ' ' MET . 54.8 Cg_endo -80.8 134.32 9.58 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.598 2.199 . . . . 0.0 111.123 179.111 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.603 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 28.9 p90 -159.44 169.88 22.97 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.12 -0.632 . . . . 0.0 112.547 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -144.56 142.68 30.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.27 -179.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.501 ' HD1' ' N ' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -89.8 133.9 34.47 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.071 -179.935 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.501 ' N ' ' HD1' ' A' ' 33' ' ' PHE . 7.6 mt -115.42 109.93 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.174 0.511 . . . . 0.0 110.22 178.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -74.1 134.08 42.88 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.048 -179.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 pt -100.12 -6.93 9.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.987 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.448 ' HE2' ' CE2' ' A' ' 7' ' ' TYR . 30.7 ttm -122.93 95.29 46.42 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.653 0.263 . . . . 0.0 111.62 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.0 -24.46 17.32 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.475 2.117 . . . . 0.0 111.842 179.485 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -140.86 147.72 39.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.644 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -64.4 -8.42 13.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.253 0.549 . . . . 0.0 111.801 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.0 -56.37 3.08 Favored Glycine 0 C--N 1.312 -0.753 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.61 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -147.95 145.09 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.981 0.42 . . . . 0.0 111.815 -179.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -68.21 170.66 8.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.559 179.434 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.29 84.1 5.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.45 -27.92 7.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.362 179.889 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -56.73 -50.3 72.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.939 0.4 . . . . 0.0 110.574 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -40.03 64.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.226 179.343 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 mm -52.24 -44.61 42.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.851 179.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.4 -56.74 12.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.57 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -57.76 -34.74 69.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.355 179.507 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.474 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -59.86 -56.69 18.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.238 179.863 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.455 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 66.8 mt -43.4 -45.5 6.23 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.384 0.611 . . . . 0.0 110.884 179.11 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.4 m -70.39 -33.33 71.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.166 178.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -64.32 -39.86 94.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.305 179.918 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.474 ' CD1' ' O ' ' A' ' 51' ' ' LEU . 4.4 mp -59.76 -66.99 0.43 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.899 0.38 . . . . 0.0 111.08 -179.739 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 158.24 -34.95 0.52 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.405 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.58 -164.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.774 0.321 . . . . 0.0 110.903 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -99.74 -33.12 10.71 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.787 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 t -119.65 170.11 9.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.815 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.406 ' HB2' ' CB ' ' A' ' 63' ' ' LEU . 4.0 pt20 -113.17 99.81 8.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.0 0.428 . . . . 0.0 110.909 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mt -79.93 80.85 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.389 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.36 -18.63 56.75 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.854 179.683 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.406 ' CB ' ' HB2' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -59.48 136.17 57.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 0.0 110.915 -179.959 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.06 171.33 14.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.353 -179.465 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.45 153.2 48.19 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.565 179.56 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.9 Cg_exo -77.13 138.78 55.53 Favored 'Cis proline' 0 C--N 1.344 0.339 0 C-N-CA 123.877 -1.301 . . . . 0.0 112.954 0.263 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -100.91 112.96 25.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.996 179.054 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.682 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.9 t -91.08 163.74 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 0.0 111.752 -179.213 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 28.5 m-85 -142.1 132.1 24.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.348 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -48.56 149.45 2.92 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.635 -178.663 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.6 ' HB3' ' N ' ' A' ' 1' ' ' MET . 52.9 Cg_exo -57.27 -29.02 82.35 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.106 2.537 . . . . 0.0 111.882 179.156 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -94.41 -23.13 17.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.034 179.818 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.56 79.02 0.51 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.568 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.5 119.13 1.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.833 0.349 . . . . 0.0 110.904 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -51.37 111.3 0.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.051 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.0 mt -88.51 -50.43 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.987 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.99 -154.48 19.39 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.624 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -87.1 -144.83 8.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.281 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.49 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -72.81 -68.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.725 0.262 . . . . 0.0 110.849 179.75 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -47.09 -42.33 18.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.156 0.503 . . . . 0.0 110.39 179.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -40.03 95.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.372 179.507 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.498 ' CD2' ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -72.49 -43.68 63.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.346 179.741 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.13 -33.42 18.8 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.792 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -69.9 -36.55 75.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.202 178.339 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 82' ' ' LEU . 10.2 t80 -63.51 -33.77 76.3 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.465 178.39 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.498 ' CE2' ' CD2' ' A' ' 82' ' ' LEU . 5.4 m-85 -86.34 -70.36 0.61 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.047 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.885 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.606 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 11.2 tpp . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.307 0.098 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.439 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 76.8 m-85 -39.53 123.75 1.53 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.61 0.719 . . . . 0.0 111.74 -177.243 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.672 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -89.54 125.22 35.12 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.152 -179.316 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.497 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 51.5 t -116.77 147.24 20.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.253 0.549 . . . . 0.0 110.959 179.187 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.657 ' CG ' ' HG ' ' A' ' 51' ' ' LEU . 85.7 m-85 -129.06 99.67 5.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.061 178.761 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.438 ' O ' HD11 ' A' ' 36' ' ' ILE . . . -159.68 -142.38 3.38 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.13 -179.06 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.49 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 60.2 m-85 -115.37 145.17 42.78 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.565 0.221 . . . . 0.0 110.831 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -106.05 27.57 8.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.942 0.401 . . . . 0.0 110.438 179.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.2 p 64.02 10.74 5.59 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.313 -179.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -86.19 -63.88 1.24 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.894 0.378 . . . . 0.0 110.891 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.449 HG21 ' N ' ' A' ' 40' ' ' LYS . 18.4 mm -96.62 -17.66 6.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.376 -179.051 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.49 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 30.7 t60 -153.32 160.52 42.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.984 0.421 . . . . 0.0 111.644 -179.441 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -46.55 156.94 0.16 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.188 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.9 t -153.64 69.28 0.8 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.037 -179.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.401 HG22 ' N ' ' A' ' 16' ' ' TYR . 27.5 m -91.78 -43.15 13.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.401 ' N ' HG22 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -70.75 -22.65 62.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.453 -179.204 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.07 -42.71 14.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.692 179.826 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -52.28 -31.56 33.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.408 179.548 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -78.49 -56.46 4.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.644 179.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . . . -55.39 -45.26 76.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.875 0.369 . . . . 0.0 111.076 179.841 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.43 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 27.2 ttpt -58.92 -45.7 89.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.598 179.744 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -63.21 -37.27 86.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.556 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.401 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -56.98 -53.03 62.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.239 179.499 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 5.7 mt -56.51 -44.86 81.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.602 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.0 m -58.27 -39.07 78.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.967 179.353 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.7 t -73.0 -39.96 58.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.555 179.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -10.14 59.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.999 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 69.41 49.95 0.56 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.935 0.398 . . . . 0.0 110.375 -179.674 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.17 112.26 8.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.394 -179.634 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.606 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 83.4 Cg_exo -49.96 179.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.341 2.027 . . . . 0.0 111.585 179.052 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.43 ' CE2' ' HG3' ' A' ' 21' ' ' LYS . 4.8 p90 -164.54 170.13 16.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.077 0.465 . . . . 0.0 111.346 178.111 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 2.7 tt0 -134.55 109.49 8.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.628 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.497 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 7.9 t80 -91.94 159.89 15.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.206 0.527 . . . . 0.0 111.82 -179.446 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.45 ' CD1' ' CZ ' ' A' ' 5' ' ' TYR . 20.6 mt -150.1 122.93 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.075 179.152 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -80.0 124.39 28.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.09 -179.639 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -88.7 -18.04 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.17 179.652 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -125.22 83.4 60.92 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.667 179.864 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.482 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 57.7 Cg_endo -70.82 -12.98 31.67 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.62 2.213 . . . . 0.0 111.708 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -139.55 136.93 34.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.912 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.449 ' N ' HG21 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -61.63 -8.28 4.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.312 0.577 . . . . 0.0 111.543 -179.59 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.5 -60.43 3.24 Favored Glycine 0 C--N 1.313 -0.737 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.543 179.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.3 t -151.41 160.44 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.434 ' CZ ' HG13 ' A' ' 36' ' ' ILE . 1.7 m-30 -60.05 170.4 1.24 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.587 178.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.482 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 66.6 t0 -99.91 96.96 7.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.513 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -48.66 -34.35 11.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.273 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -65.5 -58.09 6.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.817 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -32.26 71.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.651 179.749 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.4 mp -75.4 -29.67 21.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.523 179.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.35 -54.4 46.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.877 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -64.17 -35.19 79.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 110.224 179.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.657 ' HG ' ' CG ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -62.03 -59.47 5.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.476 179.057 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.515 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 69.2 mt -44.88 -41.3 7.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.114 179.092 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.6 m -70.62 -32.29 69.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.575 -179.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.466 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 19.8 mtpp -64.84 -45.08 87.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.75 -179.193 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.515 ' CD1' ' HA ' ' A' ' 52' ' ' LEU . 1.3 mp -59.52 -39.4 83.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.859 0.361 . . . . 0.0 111.168 -179.645 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.86 -120.46 0.83 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.343 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -146.99 30.27 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.054 0.454 . . . . 0.0 110.619 179.522 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -121.18 -146.29 0.37 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.258 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -120.39 168.55 11.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.689 0.281 . . . . 0.0 110.599 179.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -87.73 98.89 11.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.254 0.55 . . . . 0.0 110.484 179.628 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pt -79.9 84.68 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.161 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.52 26.2 64.16 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.382 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -54.02 153.12 5.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.872 0.368 . . . . 0.0 110.787 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.5 p -119.19 161.08 20.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.133 0.492 . . . . 0.0 111.466 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.7 mmt -108.69 153.68 42.12 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.393 179.552 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -86.17 146.01 36.2 Favored 'Cis proline' 0 N--CA 1.461 -0.396 0 C-N-CA 124.268 -1.138 . . . . 0.0 112.912 0.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 5.3 tp-100 -97.05 122.29 39.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.877 178.768 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.672 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 8.2 t -104.46 157.79 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.759 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.593 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 92.7 m-85 -142.49 164.26 30.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.039 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.447 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -64.49 157.59 71.57 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.771 -179.519 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.26 -21.62 67.41 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.896 2.397 . . . . 0.0 112.418 179.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -109.72 -16.46 13.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.617 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.69 97.76 1.11 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.798 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 15.2 t -178.57 151.74 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.674 0.273 . . . . 0.0 110.34 179.623 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.46 ' CE1' HD21 ' A' ' 55' ' ' LEU . 9.1 t-160 -85.63 113.73 22.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.146 -179.603 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 1.7 mp -103.17 -39.54 6.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.865 0.364 . . . . 0.0 110.658 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.04 -160.4 23.88 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.704 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.16 -134.53 7.99 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.615 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 9.2 t80 -70.63 -70.67 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.72 0.295 . . . . 0.0 111.422 -179.597 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -60.51 -44.49 95.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.994 0.426 . . . . 0.0 110.999 -179.813 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -52.14 -41.15 62.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.698 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.507 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.2 tt -74.85 -34.04 62.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.217 179.786 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -51.15 -31.46 19.89 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.618 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.64 -35.16 79.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.208 178.257 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.462 ' N ' ' O ' ' A' ' 82' ' ' LEU . 13.5 t80 -63.59 -33.57 75.89 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.337 178.459 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.507 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.6 m-85 -86.76 -70.24 0.62 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.275 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.975 -179.956 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.65 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 31.4 ttp . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.872 0.368 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.437 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 96.3 m-85 -82.71 143.35 30.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.068 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.708 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -117.14 122.56 44.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.719 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.508 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 7.7 t -111.03 130.06 65.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.464 0.65 . . . . 0.0 111.7 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.501 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 20.1 m-85 -111.95 101.76 10.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.651 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 66' ' ' PRO . . . -163.89 -139.42 2.63 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.653 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.477 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 85.1 m-85 -123.19 159.52 28.45 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.711 0.291 . . . . 0.0 111.254 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.8 -65.76 1.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.254 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 t 168.79 -32.53 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 110.792 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -65.53 -47.27 76.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.122 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.7 mp -91.32 -44.99 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.019 0.437 . . . . 0.0 110.934 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.477 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 23.4 t60 -143.2 155.96 44.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.39 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -80.98 171.24 15.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.854 0.359 . . . . 0.0 111.264 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.0 p -179.37 115.36 0.06 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.973 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 m -90.86 -36.67 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.298 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -80.25 -15.45 56.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.655 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.0 p -66.25 -42.4 88.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.928 0.394 . . . . 0.0 110.621 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.2 -41.92 66.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.409 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -56.86 -48.14 78.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.484 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.88 -47.32 83.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.134 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -49.66 -31.72 11.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.944 0.402 . . . . 0.0 110.376 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -74.33 -34.6 63.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.195 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.496 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -55.52 -51.72 66.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.254 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.29 -54.17 49.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.848 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 m -49.22 -36.01 18.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.718 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.6 t -69.33 -29.75 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.802 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -16.84 27.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.347 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt 71.67 65.05 0.15 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.987 0.422 . . . . 0.0 110.682 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -130.81 142.3 45.04 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.65 128.58 11.08 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.414 2.076 . . . . 0.0 111.641 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.65 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 16.0 p90 -158.88 167.7 28.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.97 147.04 27.39 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.105 0.479 . . . . 0.0 111.35 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.508 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 7.8 t80 -89.47 156.42 18.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.007 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.2 mt -145.85 119.99 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.409 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -74.92 109.81 8.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.687 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.7 pt -72.84 -13.64 16.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.301 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.507 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -119.86 80.66 25.48 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.76 0.314 . . . . 0.0 111.088 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.37 -9.86 24.79 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.632 2.221 . . . . 0.0 111.9 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -139.53 136.67 34.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.469 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -60.94 -8.74 3.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.232 0.539 . . . . 0.0 112.0 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.09 -62.06 2.15 Favored Glycine 0 C--N 1.312 -0.774 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.338 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -150.4 154.91 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.765 0.316 . . . . 0.0 111.45 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -59.75 169.97 1.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.613 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -82.32 100.44 9.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.943 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.27 -27.01 43.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.05 -54.98 29.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 110.875 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -73.81 -33.29 64.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.526 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.2 mm -71.57 -31.67 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.649 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.31 -56.32 11.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -59.37 -30.01 68.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.939 0.399 . . . . 0.0 110.226 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.501 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 2.0 tt -59.67 -58.59 7.92 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.571 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.516 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 73.9 mt -45.93 -42.59 13.02 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.593 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 m -70.92 -31.12 67.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.661 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 1.8 tttp -60.8 -48.34 82.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.419 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.516 ' CD1' ' HA ' ' A' ' 52' ' ' LEU . 1.2 mp -59.32 -59.63 5.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.049 0.452 . . . . 0.0 111.065 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.35 -114.2 0.29 Allowed Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.048 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.9 mtt85 -150.64 28.07 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.98 0.419 . . . . 0.0 111.004 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -121.7 -156.63 0.69 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.113 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.5 t -121.17 167.41 12.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.686 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.442 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . 6.2 pt20 -130.2 98.84 4.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 110.828 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.5 tp -82.07 85.57 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.177 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.09 23.8 5.97 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.485 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.442 ' CD2' ' HB2' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -60.84 127.02 29.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.34 . . . . 0.0 110.557 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 p -92.28 163.42 13.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.241 0.543 . . . . 0.0 111.481 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.403 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -118.48 160.77 38.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.665 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.2 Cg_exo -83.94 149.75 60.35 Favored 'Cis proline' 0 C--N 1.344 0.335 0 C-N-CA 124.428 -1.072 . . . . 0.0 113.123 0.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -101.77 120.18 39.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.903 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.708 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 6.2 t -98.72 159.65 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.035 0.445 . . . . 0.0 111.615 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 54' ' ' LYS . 31.8 m-85 -142.9 133.15 24.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.765 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.95 149.62 89.84 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.604 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.582 ' HB3' ' N ' ' A' ' 1' ' ' MET . 68.0 Cg_exo -44.8 -52.54 6.07 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.37 2.714 . . . . 0.0 112.747 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -30.03 65.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.189 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.26 67.95 0.44 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.388 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.4 m -147.79 157.07 43.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.84 0.353 . . . . 0.0 110.648 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.417 ' CE1' HD21 ' A' ' 55' ' ' LEU . 7.9 t-160 -84.09 115.1 22.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.973 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.422 HG12 ' CD2' ' A' ' 85' ' ' TYR . 19.8 mt -93.58 -49.14 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.972 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 123.15 -154.18 17.14 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.93 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -90.97 -132.24 5.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.472 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.496 ' CE1' ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -79.66 -70.08 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.654 0.227 . . . . 0.0 111.114 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -51.08 -49.12 61.26 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.331 0.586 . . . . 0.0 110.478 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -57.41 -42.2 81.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.701 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.531 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.3 tt -76.3 -32.26 58.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.582 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -33.78 40.6 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -66.47 -35.87 81.34 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.164 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 82' ' ' LEU . 14.7 t80 -63.2 -34.08 76.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.35 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.531 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.4 m-85 -84.29 -66.39 0.9 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.995 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.91 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.583 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 30.1 ttm . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.784 0.326 . . . . 0.0 111.527 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.499 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 69.3 m-85 -61.8 169.57 2.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.357 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -143.72 116.29 8.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.743 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.451 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 87.5 t -110.44 141.27 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.168 0.508 . . . . 0.0 111.02 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.438 ' CE1' HD13 ' A' ' 34' ' ' ILE . 6.6 m-85 -123.31 99.3 6.27 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.89 -144.54 4.05 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.541 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -113.51 151.07 32.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.748 0.309 . . . . 0.0 111.426 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.5 t70 -81.98 0.46 40.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.983 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.3 OUTLIER 83.81 -13.76 0.73 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -85.33 -39.12 18.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.759 0.314 . . . . 0.0 111.082 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.423 HD11 ' O ' ' A' ' 37' ' ' MET . 3.7 mt -92.56 -31.1 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.283 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 9' ' ' SER . 7.8 t60 -142.07 142.15 32.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.099 0.476 . . . . 0.0 110.987 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.2 145.02 11.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.315 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.3 t -179.26 88.93 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.13 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.8 m -79.01 -27.08 13.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.897 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -75.1 -21.53 58.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.798 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.5 m -59.71 -58.59 7.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.205 0.526 . . . . 0.0 110.265 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.96 -23.59 13.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.334 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 3.9 m-80 -77.14 -54.08 6.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.091 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.49 -48.7 76.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 111.078 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' HD2' ' CE2' ' A' ' 31' ' ' PHE . 2.2 tptt -58.23 -54.06 51.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.697 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -60.84 -36.76 79.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.554 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.424 HD23 ' CD2' ' A' ' 86' ' ' PHE . 3.1 tt -58.88 -52.97 63.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.509 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mt -57.78 -46.86 83.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.794 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 m -57.63 -36.28 71.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.478 . . . . 0.0 110.234 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.3 t -79.71 -30.7 13.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.766 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -77.77 -11.08 59.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.131 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt 70.34 54.07 0.32 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.996 0.427 . . . . 0.0 111.045 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -134.42 132.77 21.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.092 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 1' ' ' MET . 98.5 Cg_endo -78.41 137.33 14.77 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.474 2.116 . . . . 0.0 111.114 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.583 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 17.1 p90 -156.21 170.19 22.8 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -136.79 131.63 33.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.011 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.451 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 1.2 t80 -95.74 129.81 42.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.97 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.438 HD13 ' CE1' ' A' ' 5' ' ' TYR . 7.3 mt -113.33 110.39 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.383 0.611 . . . . 0.0 110.432 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -77.46 113.76 15.59 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.105 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 pt -71.94 -28.48 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.002 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.545 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 22.2 ttm -121.45 91.13 48.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.891 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.8 Cg_endo -82.59 1.66 9.0 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.693 2.262 . . . . 0.0 112.692 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -139.81 140.29 36.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 110.875 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -66.68 -7.09 18.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.254 0.549 . . . . 0.0 111.779 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.77 -67.13 1.01 Allowed Glycine 0 C--N 1.315 -0.608 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.694 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 t -136.21 133.82 50.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.71 0.29 . . . . 0.0 111.07 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -63.37 170.29 3.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.466 -179.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.431 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -94.65 99.94 11.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.064 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -54.37 -19.93 6.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.782 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -58.47 -56.28 24.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.031 0.444 . . . . 0.0 110.521 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -67.75 -31.69 71.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.307 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.1 mm -59.84 -48.34 88.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.611 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.11 -49.27 77.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.805 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.31 -35.89 70.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.579 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.421 HD13 ' CG ' ' A' ' 5' ' ' TYR . 26.4 tp -61.32 -52.99 62.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.652 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.5 mt -49.72 -45.16 48.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.131 0.491 . . . . 0.0 111.277 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.5 m -64.08 -32.47 74.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.108 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.433 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 9.3 tttp -68.9 -29.99 68.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.465 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.06 -37.62 72.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.048 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.83 33.58 6.32 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.278 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -150.07 -176.9 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.8 0.334 . . . . 0.0 110.742 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -105.11 -30.8 9.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.025 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 t -111.05 163.79 13.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.052 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -106.47 99.14 8.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.596 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.5 mm -80.67 87.82 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.556 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.92 31.55 79.94 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.44 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -42.35 134.71 2.87 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.83 0.347 . . . . 0.0 111.207 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.58 153.11 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.088 0.47 . . . . 0.0 111.671 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.12 152.12 72.84 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.406 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.1 Cg_exo -79.31 128.72 16.86 Favored 'Cis proline' 0 C--N 1.344 0.328 0 C-N-CA 124.053 -1.228 . . . . 0.0 112.934 0.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.407 ' HG3' ' NE2' ' A' ' 75' ' ' HIS . 3.7 tp60 -90.6 117.87 29.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.225 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 10.2 t -97.48 161.24 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.95 0.405 . . . . 0.0 111.906 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 97.0 m-85 -142.84 149.26 38.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.022 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.468 ' HA ' HD13 ' A' ' 76' ' ' ILE . . . -61.81 159.35 35.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.773 -0.648 . . . . 0.0 112.411 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.534 ' HB3' ' N ' ' A' ' 1' ' ' MET . 31.7 Cg_exo -63.74 58.85 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.577 2.851 . . . . 0.0 111.547 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 71' ' ' PRO . 0.5 OUTLIER 90.49 29.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.345 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -111.75 -92.65 2.1 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.526 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.39 -175.97 5.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.033 0.444 . . . . 0.0 110.96 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.431 ' HA ' ' CD1' ' A' ' 69' ' ' PHE . 16.4 t-80 -68.14 126.62 30.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.156 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 70' ' ' ALA . 4.8 mt -91.82 -45.43 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.177 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.16 -150.04 19.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.635 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.83 -150.74 22.47 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.62 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 40.4 t80 -70.79 -70.55 0.3 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.68 0.276 . . . . 0.0 110.951 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -55.46 -45.53 76.88 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.009 0.433 . . . . 0.0 110.579 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -54.91 -33.93 62.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.298 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.483 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.3 tt -80.08 -36.58 35.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.368 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -51.51 -29.98 18.64 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.3 -35.0 73.41 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.129 178.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 82' ' ' LEU . 11.9 t80 -63.12 -34.35 77.42 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.267 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.483 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.9 m-85 -87.87 -70.18 0.65 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.292 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.8 mttm . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.044 -179.98 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.576 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 49.7 ttm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.861 0.362 . . . . 0.0 111.639 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.5 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 74.6 m-85 -58.33 155.22 12.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.866 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.636 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -128.19 120.43 27.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.669 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.489 HG12 ' CE1' ' A' ' 33' ' ' PHE . 55.4 t -116.09 142.18 30.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.333 0.587 . . . . 0.0 111.813 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.482 ' CZ ' HD12 ' A' ' 34' ' ' ILE . 2.1 m-85 -121.67 99.89 6.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.58 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.24 -137.96 2.36 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.75 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.411 ' CZ ' ' CD1' ' A' ' 36' ' ' ILE . 31.5 m-85 -122.95 144.15 49.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 120.591 0.234 . . . . 0.0 110.962 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -108.47 29.02 7.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.336 . . . . 0.0 110.863 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m 63.04 14.57 7.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -85.77 -56.98 3.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.1 0.476 . . . . 0.0 110.622 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 40' ' ' LYS . 13.4 mm -104.15 -27.23 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.017 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -141.45 152.12 43.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.613 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.77 171.69 12.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.178 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.4 t -178.68 108.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.952 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.2 m -85.66 -32.8 7.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.956 0.407 . . . . 0.0 111.207 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -71.23 -16.08 62.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.289 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.9 m -72.13 -55.92 6.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.996 0.426 . . . . 0.0 110.683 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -52.18 -28.04 16.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.094 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 74.8 m-20 -75.52 -51.77 12.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.016 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.88 -48.6 79.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.243 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -59.89 -55.43 34.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.781 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -55.4 -44.93 76.63 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.346 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.423 ' CD2' ' C ' ' A' ' 23' ' ' LEU . 0.7 OUTLIER -59.04 -50.59 73.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.16 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 8.7 mt -60.51 -43.61 96.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.065 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.6 m -57.17 -40.15 76.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.107 0.48 . . . . 0.0 109.82 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.7 t -80.13 -27.17 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.449 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.514 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 3.3 tptp -73.42 -13.31 61.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.081 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt 66.53 54.72 0.86 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.448 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -137.12 134.44 18.92 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.019 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.415 ' O ' ' HA ' ' A' ' 1' ' ' MET . 85.9 Cg_endo -78.58 134.09 12.11 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.337 2.024 . . . . 0.0 110.909 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.576 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 26.9 p90 -148.51 170.0 19.03 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -136.91 133.23 35.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.729 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.489 ' CE1' HG12 ' A' ' 4' ' ' VAL . 9.4 t80 -89.43 163.01 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.25 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.482 HD12 ' CZ ' ' A' ' 5' ' ' TYR . 19.1 mt -145.69 119.61 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.444 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -82.22 122.76 28.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.098 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.411 ' CD1' ' CZ ' ' A' ' 7' ' ' TYR . 7.2 pt -93.4 -16.7 7.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.479 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.417 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -124.84 85.65 57.06 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.735 0.302 . . . . 0.0 111.556 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.445 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 97.0 Cg_endo -79.05 -5.82 14.68 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.851 2.368 . . . . 0.0 111.73 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -139.66 135.33 33.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.288 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.437 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 20.0 tttp -61.34 -8.45 3.93 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.26 0.552 . . . . 0.0 111.873 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.3 -63.72 2.11 Favored Glycine 0 C--N 1.312 -0.786 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.067 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -150.7 159.03 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.759 0.314 . . . . 0.0 111.548 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -63.47 159.31 18.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.33 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.445 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -82.18 125.6 31.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.88 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -68.07 -23.85 64.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.761 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -60.04 -55.5 33.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.37 . . . . 0.0 110.651 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.48 -39.6 85.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.271 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.3 mt -54.12 -46.39 66.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.441 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.48 -50.33 71.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.636 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -59.82 -31.96 70.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.577 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.43 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 18.7 tp -66.28 -63.92 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.292 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.2 mt -45.66 -40.81 9.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.153 0.502 . . . . 0.0 111.314 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.1 m -67.34 -34.29 77.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.872 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.436 ' HG3' ' CE2' ' A' ' 69' ' ' PHE . 50.0 tptt -66.47 -49.27 67.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.486 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.43 ' CD1' ' O ' ' A' ' 51' ' ' LEU . 4.9 mp -59.31 -25.07 63.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.248 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.1 30.17 13.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.499 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.15 -178.04 6.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.781 0.324 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.43 -47.36 3.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.997 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.2 t -92.73 160.1 15.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.54 99.36 8.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.678 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -79.91 83.61 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.255 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.81 23.1 78.21 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.513 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.61 131.42 43.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.875 0.369 . . . . 0.0 110.809 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.29 170.55 14.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.282 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.78 154.15 40.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.762 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.08 135.31 31.12 Favored 'Cis proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.701 -1.374 . . . . 0.0 112.846 0.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -90.7 117.01 29.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.503 179.321 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.7 t -103.19 160.72 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.157 0.503 . . . . 0.0 112.142 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.436 ' CE2' ' HG3' ' A' ' 54' ' ' LYS . 95.3 m-85 -142.8 155.65 44.85 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.982 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 76' ' ' ILE . . . -66.3 156.41 85.23 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.356 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HB3' ' N ' ' A' ' 1' ' ' MET . 44.9 Cg_exo -58.28 -38.92 88.7 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.055 2.504 . . . . 0.0 111.808 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -91.42 -16.18 27.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.094 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.76 87.95 1.16 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.651 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.04 124.04 2.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.945 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.415 ' CD2' ' OE1' ' A' ' 67' ' ' GLN . 20.0 t-160 -58.17 110.83 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.006 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 70' ' ' ALA . 18.7 mt -89.95 -49.9 13.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.51 -154.25 19.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.434 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.29 -144.16 7.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.299 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 32.7 t80 -71.17 -60.42 2.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 0.0 110.764 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -54.44 -37.21 64.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.829 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -60.77 -41.21 95.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.58 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -64.04 -50.87 66.73 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.351 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 87' ' ' LYS . 1.3 tpt180 -51.62 -28.38 14.14 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -79.79 -33.76 40.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 82' ' ' LEU . 17.1 t80 -67.57 -32.14 72.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.323 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.514 ' CD1' ' HG2' ' A' ' 27' ' ' LYS . 30.3 m-85 -96.17 -70.74 0.7 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.487 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 83' ' ' ARG . 6.4 tttt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.634 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.568 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 40.6 ttp . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -76.51 152.04 36.2 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.244 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.5 mptp? -113.34 119.99 39.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.466 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.445 HG11 ' CE1' ' A' ' 33' ' ' PHE . 39.9 t -113.13 134.19 56.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.363 0.601 . . . . 0.0 112.066 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.6 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 18.9 m-85 -111.66 99.51 8.22 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.959 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.11 -139.64 2.73 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.517 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.442 ' CE1' ' HE2' ' A' ' 37' ' ' MET . 63.5 m-85 -123.28 157.38 33.3 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.858 0.361 . . . . 0.0 111.376 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.41 -76.21 0.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.976 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 174.53 -34.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.907 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -71.34 -24.64 62.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.267 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.94 -40.15 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.86 0.362 . . . . 0.0 110.864 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -155.87 160.63 40.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.4 pttp -80.39 173.65 12.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.997 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 9.2 p -163.99 120.37 1.65 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.962 0.41 . . . . 0.0 110.758 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.4 -43.39 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.944 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -88.9 -9.01 53.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.936 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -87.41 -36.43 17.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.758 0.313 . . . . 0.0 110.672 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -68.09 -36.06 79.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.718 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -75.71 -48.38 22.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.125 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.22 69.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.056 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -60.33 -54.18 48.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.617 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.03 -34.58 72.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.679 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.431 HD22 ' CD2' ' A' ' 86' ' ' PHE . 4.9 tt -60.14 -54.99 39.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.613 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.6 mt -55.25 -46.04 76.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.948 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.1 m -57.8 -36.5 72.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.041 0.448 . . . . 0.0 110.157 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -79.03 -35.46 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.682 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -72.85 -9.97 59.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.184 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.16 42.48 0.34 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.861 0.363 . . . . 0.0 110.792 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -131.89 133.44 24.07 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.025 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.553 ' O ' ' HA ' ' A' ' 1' ' ' MET . 58.9 Cg_endo -81.93 158.82 18.39 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.567 2.178 . . . . 0.0 111.481 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 5.6 p90 -161.47 171.25 18.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.801 0.334 . . . . 0.0 111.663 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -129.55 119.71 24.12 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.564 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.445 ' CE1' HG11 ' A' ' 4' ' ' VAL . 17.4 t80 -89.34 153.12 21.12 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.185 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.9 mt -147.4 121.61 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.509 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -81.17 109.74 16.01 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.539 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 pt -63.86 -19.65 24.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.563 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 2.8 ttp -123.08 90.27 50.45 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.812 0.339 . . . . 0.0 111.52 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.86 0.98 9.65 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.697 2.265 . . . . 0.0 112.289 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -139.68 140.4 36.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.696 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -67.9 -8.55 37.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.226 0.536 . . . . 0.0 111.842 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.71 -64.76 1.25 Allowed Glycine 0 C--N 1.313 -0.74 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.347 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 t -140.82 139.47 34.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.733 0.301 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -65.56 169.49 6.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 0.0 111.112 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -86.71 115.18 23.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.033 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -74.83 -22.91 58.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.298 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.3 -52.77 63.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.756 0.312 . . . . 0.0 110.804 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -69.64 -38.31 77.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.128 0.49 . . . . 0.0 110.022 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 55.1 mt -64.79 -34.87 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.369 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.44 -48.7 80.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.394 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.83 -34.39 69.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.998 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.6 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.7 tt -58.58 -53.01 63.17 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.2 mt -50.33 -41.87 51.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.453 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.5 m -56.6 -49.14 75.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.523 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -61.03 -39.98 91.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.313 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.13 -48.48 81.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.589 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.99 -165.97 31.84 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.162 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 64.3 mtt-85 -95.51 35.33 1.35 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.972 0.415 . . . . 0.0 110.817 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -120.88 -147.21 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.459 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -120.49 170.9 8.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.766 0.317 . . . . 0.0 110.786 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -69.19 98.21 1.0 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.402 0.62 . . . . 0.0 110.207 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.2 tt -73.58 79.16 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.133 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 43.09 26.24 0.48 Allowed Glycine 0 C--N 1.333 0.398 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.862 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.57 144.19 38.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.838 0.351 . . . . 0.0 110.887 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 p -110.45 156.94 20.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.428 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -105.28 152.47 39.84 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.654 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.8 Cg_exo -82.34 144.28 56.12 Favored 'Cis proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.969 -1.263 . . . . 0.0 112.702 0.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -98.63 132.24 44.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.826 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.5 t -104.23 157.02 5.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.171 0.51 . . . . 0.0 111.992 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.432 ' CZ ' ' CD2' ' A' ' 75' ' ' HIS . 46.2 m-85 -143.67 139.14 29.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.685 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -53.27 152.45 8.21 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.406 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.568 ' HB3' ' N ' ' A' ' 1' ' ' MET . 7.4 Cg_exo -70.14 -8.99 24.96 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.855 2.37 . . . . 0.0 112.353 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.61 -17.7 14.03 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.098 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.6 89.27 1.1 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.663 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.0 t 179.92 152.76 0.47 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.777 0.323 . . . . 0.0 110.723 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.432 ' CD2' ' CZ ' ' A' ' 69' ' ' PHE . 6.0 t-160 -90.22 113.37 25.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.865 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 mt -92.58 -48.68 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.977 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 138.9 -155.42 23.77 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.709 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.82 -136.82 8.9 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.641 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -71.56 -70.66 0.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.82 0.343 . . . . 0.0 111.223 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -59.67 -48.68 80.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.983 0.421 . . . . 0.0 110.729 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -51.3 -39.48 56.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.605 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.489 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.1 tt -78.66 -33.86 46.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.336 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -50.64 -30.13 12.73 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -68.08 -35.79 78.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.229 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 82' ' ' LEU . 13.5 t80 -63.02 -34.05 76.74 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.262 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.489 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.9 m-85 -90.06 -19.65 24.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.304 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.268 -0.873 . . . . 0.0 111.021 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.576 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 49.5 ttm . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.91 0.386 . . . . 0.0 111.561 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.563 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 84.3 m-85 -53.53 158.27 1.86 Allowed 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -135.23 117.44 15.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.486 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.485 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 30.9 t -99.87 127.18 53.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.656 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.533 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 2.9 m-30 -104.39 99.08 8.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.351 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.94 -139.62 2.7 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.45 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.539 ' CD2' ' HD2' ' A' ' 12' ' ' HIS . 85.6 m-85 -120.71 159.79 24.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.075 0.464 . . . . 0.0 111.733 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.15 -81.08 0.06 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.746 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 p 174.12 -41.91 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.227 0.536 . . . . 0.0 111.042 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -74.12 -31.72 62.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.236 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 39' ' ' GLU . 50.9 mm -93.07 -35.7 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.733 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.539 ' HD2' ' CD2' ' A' ' 7' ' ' TYR . 31.3 t60 -154.76 152.39 29.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.33 159.68 3.45 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 t -174.66 73.82 0.03 OUTLIER 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.49 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.8 m -91.28 -37.82 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.571 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -62.5 -28.93 70.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.721 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.8 p -72.19 -44.18 63.4 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.651 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.32 -32.51 49.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.816 0.341 . . . . 0.0 110.921 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -70.16 -55.99 7.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.848 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.69 -31.09 66.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.035 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.45 ' HG2' ' CE1' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -60.94 -56.19 24.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.665 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -60.42 -34.2 73.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.59 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 tt -59.05 -53.82 54.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.317 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 mt -55.47 -44.15 76.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.671 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 m -57.52 -35.92 70.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.176 0.513 . . . . 0.0 109.925 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -79.72 -29.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.431 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.61 -13.14 59.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.052 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt 69.4 62.28 0.29 Allowed 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.95 0.405 . . . . 0.0 110.841 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -142.3 138.87 16.98 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.023 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.417 ' O ' ' HA ' ' A' ' 1' ' ' MET . 77.2 Cg_endo -79.97 136.29 11.69 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.536 2.157 . . . . 0.0 111.43 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.576 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 33.9 p90 -152.37 170.54 19.84 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -148.1 146.04 28.65 Favored 'General case' 0 N--CA 1.46 0.048 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.864 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.485 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 25.5 t80 -89.34 159.5 17.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.16 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.9 mt -145.37 120.56 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.521 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -94.42 118.85 32.26 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.063 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.445 ' CD1' ' CZ ' ' A' ' 43' ' ' PHE . 35.6 pt -78.33 -17.71 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.032 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.538 ' HE2' ' CE1' ' A' ' 7' ' ' TYR . 31.6 ttm -122.11 92.01 48.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.524 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -84.23 18.21 1.58 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.884 2.389 . . . . 0.0 113.028 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.554 ' O ' HG22 ' A' ' 11' ' ' ILE . 9.8 mt-10 -139.53 165.44 27.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.374 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -61.13 -7.76 2.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.88 48.17 0.07 OUTLIER Glycine 0 C--N 1.313 -0.737 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.877 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 39' ' ' GLU . 5.7 t -150.48 115.21 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.327 0.584 . . . . 0.0 112.33 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.469 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 1.1 m-85 -68.44 153.14 44.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.822 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -97.48 93.67 6.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.951 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -49.93 -26.24 3.98 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.716 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.93 -48.81 78.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.851 0.358 . . . . 0.0 110.812 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -77.5 -46.12 23.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.42 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.0 mp -55.03 -42.36 64.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.76 -54.71 34.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 110.653 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.78 -38.28 87.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.48 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.452 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -57.43 -51.27 70.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.535 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.4 mt -50.09 -47.25 53.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.197 0.522 . . . . 0.0 110.586 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -70.21 -35.14 73.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.754 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -61.39 -31.37 71.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.411 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 mt -72.65 -38.72 67.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.683 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.33 -107.14 0.31 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.99 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.7 mtt-85 -150.53 30.87 0.66 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.929 0.395 . . . . 0.0 110.542 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.0 -151.34 0.48 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.355 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -120.61 170.17 9.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.696 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.93 98.37 10.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.241 0.544 . . . . 0.0 110.098 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pt -79.76 84.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.431 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.47 23.95 61.07 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.705 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.57 121.28 5.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.838 0.351 . . . . 0.0 110.594 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.2 p -99.84 161.39 13.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.153 0.502 . . . . 0.0 111.544 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -110.58 154.37 43.14 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.484 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.0 Cg_exo -81.78 145.18 62.98 Favored 'Cis proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.935 -1.277 . . . . 0.0 112.82 0.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -106.72 115.02 29.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -87.18 164.66 2.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.236 0.541 . . . . 0.0 111.953 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.4 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 12.2 m-85 -142.2 130.22 21.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.467 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.41 ' HA ' HD12 ' A' ' 76' ' ' ILE . . . -46.43 144.26 3.43 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.934 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.455 ' CB ' ' N ' ' A' ' 1' ' ' MET . 19.7 Cg_endo -67.76 -13.58 39.09 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.316 2.011 . . . . 0.0 111.767 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -99.4 -23.91 14.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.573 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.02 84.94 0.6 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.866 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.1 m -178.11 162.74 1.63 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.837 0.351 . . . . 0.0 111.133 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -90.37 110.89 21.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 70' ' ' ALA . 35.3 mt -84.86 -51.38 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.004 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.3 -153.5 19.54 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.475 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.18 -152.08 19.42 Favored Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.556 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -63.88 -63.25 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.824 0.345 . . . . 0.0 110.776 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -53.66 -41.82 67.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -56.04 -42.29 76.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.465 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.452 HD23 ' CD2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -63.3 -48.19 79.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.428 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -51.09 -29.15 12.36 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -76.26 -34.14 59.14 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.277 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.423 ' N ' ' O ' ' A' ' 82' ' ' LEU . 7.6 t80 -66.98 -32.57 73.9 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.319 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.452 ' CD2' HD23 ' A' ' 82' ' ' LEU . 6.5 m-85 -90.65 -69.8 0.71 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.072 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.877 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.582 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 48.0 ttm . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -77.92 145.56 36.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.267 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.619 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.2 mppp? -108.11 120.68 43.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.528 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.459 HG12 ' CE1' ' A' ' 33' ' ' PHE . 7.8 t -105.05 131.04 55.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.29 0.567 . . . . 0.0 111.786 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.543 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.9 m-30 -106.59 98.96 8.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.168 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.91 -137.87 2.29 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.811 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.449 ' CZ ' ' CD1' ' A' ' 36' ' ' ILE . 85.1 m-85 -127.73 157.86 39.21 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 120.776 0.322 . . . . 0.0 111.425 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -88.2 -68.38 0.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.127 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 166.73 -33.15 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.998 0.428 . . . . 0.0 110.899 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -71.54 -42.14 68.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.514 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.412 ' CG2' ' HG2' ' A' ' 37' ' ' MET . 27.5 mm -89.47 -39.55 12.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.051 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -150.51 154.08 36.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.351 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -76.86 162.71 27.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.58 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.9 t -172.14 108.32 0.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.785 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.0 m -88.81 -36.69 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.077 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -68.64 -19.74 64.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.002 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.9 m -64.36 -55.74 19.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.938 0.399 . . . . 0.0 110.29 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -57.8 -32.77 67.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.161 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -68.43 -58.46 4.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.273 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.87 -42.37 65.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.91 0.386 . . . . 0.0 111.305 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.426 ' HG2' ' CZ ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -56.26 -50.95 69.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.751 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -60.54 -40.85 93.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.585 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.0 tt -57.36 -51.9 67.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.431 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 mt -59.8 -50.37 74.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.584 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 m -53.27 -38.62 63.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.324 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.5 t -76.29 -36.64 30.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.599 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.515 ' CD ' ' HB3' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -73.7 -9.89 59.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.041 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.19 59.45 0.33 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.983 0.421 . . . . 0.0 111.006 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -144.88 132.42 10.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.142 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.582 ' O ' ' HA ' ' A' ' 1' ' ' MET . 69.6 Cg_endo -79.42 159.27 25.87 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.482 2.121 . . . . 0.0 110.972 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 7.9 p90 -161.43 171.38 18.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.86 0.362 . . . . 0.0 111.788 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -134.3 134.87 42.36 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.523 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.459 ' CE1' HG12 ' A' ' 4' ' ' VAL . 6.8 t80 -89.28 156.69 18.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.168 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.407 HD11 ' CE1' ' A' ' 5' ' ' TYR . 18.0 mt -146.03 121.05 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.468 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -85.65 114.93 23.02 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.936 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.449 ' CD1' ' CZ ' ' A' ' 7' ' ' TYR . 2.1 pt -75.08 -21.05 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.967 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.517 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.7 tpp -116.35 108.67 45.2 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.809 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.429 ' HG3' ' HB3' ' A' ' 44' ' ' ASP . 79.8 Cg_endo -76.05 -28.18 7.74 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.648 2.232 . . . . 0.0 112.101 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -139.57 151.66 46.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.623 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -64.64 -8.5 14.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.255 0.55 . . . . 0.0 111.839 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.59 -55.83 2.77 Favored Glycine 0 C--N 1.313 -0.73 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.814 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -149.06 141.99 18.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 2.2 m-85 -59.4 170.29 1.03 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.843 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.429 ' HB3' ' HG3' ' A' ' 38' ' ' PRO . 1.4 p30 -88.73 140.58 29.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.031 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -78.4 -11.07 59.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.522 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.35 -62.99 1.18 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.791 0.329 . . . . 0.0 111.261 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -42.88 66.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.961 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.424 ' N ' ' CD1' ' A' ' 48' ' ' ILE . 0.8 OUTLIER -56.64 -39.09 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.744 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.26 -55.38 6.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -36.12 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.46 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.429 HD11 ' CE2' ' A' ' 5' ' ' TYR . 20.1 tp -57.08 -51.66 68.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.694 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.3 mt -52.01 -46.91 65.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.149 0.5 . . . . 0.0 111.317 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.8 m -70.16 -42.41 72.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.594 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -60.29 -40.2 89.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.941 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.17 -69.08 0.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.804 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.62 -40.75 0.72 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.2 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -89.78 -174.89 4.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.33 . . . . 0.0 110.709 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -103.26 -30.3 10.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.072 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.4 t -111.19 169.73 8.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.081 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -110.56 99.65 8.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.564 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.4 mt -80.26 87.42 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.558 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.65 29.66 64.47 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.682 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -47.0 147.41 1.37 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.804 0.335 . . . . 0.0 111.007 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.4 p -121.32 153.49 37.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.079 0.466 . . . . 0.0 111.652 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -122.47 152.8 61.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.518 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -80.92 149.7 77.37 Favored 'Cis proline' 0 C--N 1.344 0.324 0 C-N-CA 124.073 -1.22 . . . . 0.0 112.725 0.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -105.32 119.61 39.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.848 178.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -91.41 161.41 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.362 0.601 . . . . 0.0 112.193 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -143.13 140.74 30.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.277 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.37 147.23 28.97 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.139 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.576 ' HB3' ' N ' ' A' ' 1' ' ' MET . 15.7 Cg_exo -65.48 -14.45 44.95 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.694 2.262 . . . . 0.0 112.317 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.56 -23.01 13.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.018 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.36 74.61 0.28 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.568 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.64 113.08 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.757 0.313 . . . . 0.0 110.739 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -53.66 120.94 6.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.994 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.5 mt -97.41 -45.97 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.768 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.401 ' HA3' ' CB ' ' A' ' 81' ' ' GLN . . . 135.13 -156.23 22.47 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.585 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.28 -138.25 7.22 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.575 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -72.87 -61.16 1.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -55.19 -45.34 75.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.04 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.401 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 8.4 mp0 -56.01 -48.28 76.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.475 ' CD2' ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -64.28 -43.0 96.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.434 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -51.54 -29.88 18.59 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -75.01 -35.17 61.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.404 ' N ' ' O ' ' A' ' 82' ' ' LEU . 12.0 t80 -62.9 -35.38 79.87 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.515 ' HB3' ' CD ' ' A' ' 27' ' ' LYS . 5.3 m-85 -87.64 -70.38 0.63 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.216 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.944 179.942 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.642 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 28.4 ttp . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.85 0.357 . . . . 0.0 111.541 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.446 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 87.7 m-85 -79.19 153.35 30.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.156 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.648 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -131.59 121.44 24.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.888 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.468 HG13 ' CE1' ' A' ' 33' ' ' PHE . 7.0 t -104.22 124.32 58.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.147 0.498 . . . . 0.0 111.374 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.562 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.3 m-30 -100.09 99.15 9.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.324 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.34 -137.2 2.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.837 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.574 ' CD2' ' CB ' ' A' ' 12' ' ' HIS . 6.7 m-85 -123.63 146.39 48.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.372 0.13 . . . . 0.0 110.949 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.81 17.79 7.31 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 0.9 OUTLIER 71.72 2.16 4.17 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.589 0.233 . . . . 0.0 111.617 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -85.19 -53.41 5.27 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.967 0.413 . . . . 0.0 110.654 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 mt -111.33 9.5 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.385 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.652 ' CD2' ' HE1' ' A' ' 37' ' ' MET . 11.1 t-80 -169.82 138.19 1.77 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.139 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.34 22.79 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.011 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 p -175.61 123.78 0.21 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.041 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.4 m -91.1 -37.35 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.58 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -75.52 -18.64 59.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.552 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.4 p -70.45 -36.36 73.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.813 0.34 . . . . 0.0 111.004 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.2 -27.11 62.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.335 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -76.86 -49.49 15.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.062 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.02 -46.55 71.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.267 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -60.31 -52.75 63.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.955 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -38.9 85.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.37 -54.02 51.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.636 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mt -56.15 -46.83 79.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.889 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.7 m -56.58 -36.78 69.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.12 0.486 . . . . 0.0 110.152 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.15 -27.68 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.727 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -11.37 58.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.245 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.08 61.14 0.5 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.106 0.479 . . . . 0.0 110.716 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -136.69 140.76 32.98 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.183 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.94 131.94 11.41 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.553 2.169 . . . . 0.0 111.592 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.642 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 11.8 p90 -156.31 169.45 24.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.999 0.428 . . . . 0.0 111.957 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -147.12 148.04 31.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.804 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.468 ' CE1' HG13 ' A' ' 4' ' ' VAL . 7.5 t80 -89.42 161.15 16.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.393 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.419 HD13 ' CE1' ' A' ' 5' ' ' TYR . 21.9 mt -145.58 119.55 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.308 0.575 . . . . 0.0 110.511 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -81.21 125.34 30.18 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.025 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.403 ' CD1' ' CZ ' ' A' ' 7' ' ' TYR . 2.7 pt -99.48 -11.97 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.297 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.652 ' HE1' ' CD2' ' A' ' 12' ' ' HIS . 14.5 ttm -117.57 92.2 40.22 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.742 0.306 . . . . 0.0 111.146 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 44' ' ' ASP . 54.5 Cg_endo -69.37 -28.43 27.13 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.562 2.175 . . . . 0.0 111.671 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -139.85 147.42 40.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.032 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -8.54 6.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.213 0.53 . . . . 0.0 111.783 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.16 -56.62 2.99 Favored Glycine 0 C--N 1.313 -0.72 0 CA-C-N 115.278 -0.873 . . . . 0.0 112.704 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.7 t -148.14 146.42 17.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.924 0.392 . . . . 0.0 111.967 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -61.07 166.51 3.53 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.505 179.47 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.429 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . 10.1 p30 -78.41 99.48 6.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.948 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -55.26 -22.75 19.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.554 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -60.28 -53.7 54.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.886 0.374 . . . . 0.0 110.755 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -69.45 -47.26 64.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.667 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -50.11 -37.45 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.716 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.99 -59.74 4.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.06 0.457 . . . . 0.0 110.506 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.69 -34.45 72.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.229 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.447 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -59.64 -52.63 64.7 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.505 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.5 mt -48.28 -45.07 34.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.264 0.554 . . . . 0.0 110.734 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.7 m -67.15 -35.84 80.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.002 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -64.62 -33.91 77.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.493 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.53 -50.12 40.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.605 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.08 -163.39 35.4 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.945 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 mtt180 -93.9 31.35 1.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.946 0.403 . . . . 0.0 110.921 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -121.15 -153.46 0.55 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.275 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -120.97 170.38 9.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.734 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.46 98.48 6.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.357 0.599 . . . . 0.0 110.028 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.1 mm -73.08 82.28 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.514 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 50.16 25.95 8.53 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -55.39 156.96 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 111.157 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.42 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 37.2 p -139.58 163.59 32.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -98.93 158.62 32.02 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.862 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.1 Cg_exo -83.88 140.79 36.82 Favored 'Cis proline' 0 C--N 1.345 0.348 0 C-N-CA 124.151 -1.187 . . . . 0.0 112.759 0.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 64' ' ' THR . 15.0 mm-40 -105.39 114.05 28.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.046 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.7 t -86.93 163.64 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.264 0.554 . . . . 0.0 112.087 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.4 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 20.3 m-85 -142.96 132.66 23.87 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.278 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.38 146.34 91.73 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.262 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.589 ' HB3' ' N ' ' A' ' 1' ' ' MET . 54.7 Cg_exo -42.15 -52.36 4.2 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.372 2.715 . . . . 0.0 113.008 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.42 -27.84 66.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.203 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.46 73.26 0.64 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.363 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.14 143.2 18.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 111.044 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -70.22 110.82 5.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.764 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 mt -83.4 -49.21 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.144 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.18 -153.47 20.77 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.268 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.83 -143.35 8.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.33 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -73.07 -67.17 0.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 0.0 110.755 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -53.08 -38.74 62.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.874 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -60.37 -39.41 87.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.49 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.459 HD22 ' CD2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -69.65 -45.02 69.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.35 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -51.32 -31.43 21.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.48 -35.78 65.72 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.164 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 82' ' ' LEU . 12.3 t80 -63.85 -33.66 76.19 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.275 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.459 ' CD2' HD22 ' A' ' 82' ' ' LEU . 6.2 m-85 -87.97 -70.34 0.64 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.132 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.931 -179.938 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.586 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 64.3 ttp . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 120.878 0.37 . . . . 0.0 111.672 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.487 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 80.2 m-85 -60.37 153.43 22.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.646 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.697 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -129.66 122.68 29.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.458 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.48 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 10.0 t -105.37 136.79 37.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.09 0.471 . . . . 0.0 111.614 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.494 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 5.2 m-85 -115.42 99.62 7.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.189 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.48 -135.51 1.93 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.554 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.51 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 75.5 m-85 -120.16 146.66 45.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.948 0.404 . . . . 0.0 111.665 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -94.58 139.7 30.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.465 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.5 p -51.79 -24.71 6.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.563 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -73.16 -43.32 61.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.547 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 9.3 mm -89.8 -43.95 14.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.785 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 78.8 t60 -144.68 158.32 43.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.744 0.307 . . . . 0.0 111.131 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.2 mmmt -80.0 161.38 25.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.174 0.512 . . . . 0.0 111.614 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.2 p -167.92 113.7 0.69 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.358 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 m -90.46 -28.75 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.422 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -85.57 -17.27 36.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.129 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.5 p -67.25 -39.84 86.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.038 0.447 . . . . 0.0 110.153 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.4 -26.68 68.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.049 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -69.47 -55.58 9.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.123 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.8 -44.16 66.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.977 0.417 . . . . 0.0 111.133 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -60.32 -52.57 64.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -56.64 -37.99 71.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.417 HD23 ' CD2' ' A' ' 86' ' ' PHE . 0.9 OUTLIER -58.55 -52.58 65.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.548 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.51 -47.19 82.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 m -56.13 -33.39 65.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.029 0.442 . . . . 0.0 110.375 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.3 t -78.36 -30.42 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.794 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm -82.13 -10.85 59.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.226 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? 68.39 60.99 0.38 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.914 0.388 . . . . 0.0 110.739 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -141.42 139.63 19.2 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.07 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.426 ' O ' ' HA ' ' A' ' 1' ' ' MET . 77.9 Cg_endo -80.28 139.89 13.45 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.52 2.146 . . . . 0.0 111.231 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.586 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 51.3 p90 -153.22 170.56 20.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -141.81 142.12 33.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.956 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.48 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 38.2 t80 -89.83 158.58 17.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.236 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.494 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 7.8 mt -147.18 120.29 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.128 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -99.63 127.31 45.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.671 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.9 pt -80.97 -8.61 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.238 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.563 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 8.2 ttp -125.98 95.3 39.83 Favored Pre-proline 0 N--CA 1.456 -0.133 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.146 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.38 1.33 9.35 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.746 2.297 . . . . 0.0 112.568 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -139.71 135.62 33.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.604 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -62.79 -9.24 8.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.175 0.512 . . . . 0.0 112.183 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.99 -63.74 1.65 Allowed Glycine 0 C--N 1.311 -0.841 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.917 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.1 t -146.83 151.89 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.692 0.282 . . . . 0.0 110.993 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.563 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -68.0 167.03 14.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 111.109 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.26 114.87 28.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.018 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -58.11 -18.2 23.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.471 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -57.82 -54.94 41.22 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.857 0.361 . . . . 0.0 110.696 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -70.59 -37.41 73.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.208 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.6 mm -55.31 -46.79 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.895 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.7 -53.37 58.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.693 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -57.4 -40.68 78.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.338 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.427 HD12 ' CE2' ' A' ' 5' ' ' TYR . 9.3 tp -55.37 -48.67 73.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.653 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.1 mt -54.18 -49.42 69.38 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.06 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.3 m -61.94 -33.92 75.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.215 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -67.44 -29.65 69.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.631 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.93 -26.49 62.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.109 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.49 32.57 15.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.396 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.5 mtt-85 -150.06 -168.86 3.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 0.0 110.827 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.78 -50.11 2.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.032 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -102.95 165.44 11.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -95.38 98.74 10.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.122 0.487 . . . . 0.0 110.503 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.8 mt -80.33 85.53 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.275 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.48 27.05 73.53 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.455 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.5 tt -55.42 150.57 11.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.895 0.379 . . . . 0.0 111.191 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.0 p -148.5 164.81 33.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.405 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -119.19 146.37 40.48 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.573 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -84.63 150.71 57.05 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.993 -1.253 . . . . 0.0 112.828 0.368 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' TYR . 1.3 tp60 -109.44 117.9 35.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.221 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -92.83 166.73 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.829 0.347 . . . . 0.0 111.59 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 74' ' ' SER . 73.5 m-85 -142.49 140.17 31.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.028 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.82 150.07 10.46 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.278 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.497 ' HB3' ' N ' ' A' ' 1' ' ' MET . 42.8 Cg_exo -58.96 -30.71 93.99 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.097 2.531 . . . . 0.0 112.026 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -91.48 -23.72 19.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.245 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.62 90.27 0.8 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.653 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 15.9 t -171.63 158.98 5.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.761 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.426 ' NE2' ' CG ' ' A' ' 67' ' ' GLN . 17.7 t-160 -88.64 110.07 20.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.985 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.42 HG12 ' CD2' ' A' ' 85' ' ' TYR . 10.8 mt -85.05 -50.84 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.093 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.85 -154.77 19.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.563 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.01 -145.75 7.74 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.669 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -71.28 -70.03 0.34 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.742 0.306 . . . . 0.0 110.892 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.99 -46.1 71.61 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.969 0.414 . . . . 0.0 110.562 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -34.43 63.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.114 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 85' ' ' TYR . 2.7 tt -74.79 -39.63 61.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.012 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' A' ' 87' ' ' LYS . 24.2 ttp180 -51.77 -29.08 17.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -71.63 -33.42 68.93 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.392 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.453 ' N ' ' O ' ' A' ' 82' ' ' LEU . 9.0 t80 -66.62 -31.64 72.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.588 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.417 ' CD2' HD23 ' A' ' 23' ' ' LEU . 25.1 m-85 -95.62 -70.37 0.72 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.498 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 83' ' ' ARG . 15.2 mtmt . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.954 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.581 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 4.6 ttm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -80.4 149.15 30.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.187 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -109.87 117.14 33.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.413 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.466 HG12 ' CE1' ' A' ' 33' ' ' PHE . 8.1 t -102.16 125.21 56.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.242 0.544 . . . . 0.0 111.347 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.611 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.3 m-30 -101.95 99.09 9.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.402 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.94 -137.12 2.12 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.287 -0.959 . . . . 0.0 112.647 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 87.5 m-85 -126.02 147.25 49.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.736 0.303 . . . . 0.0 110.932 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -101.92 21.39 14.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.415 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.2 t 66.83 9.14 6.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.567 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -85.55 -46.43 10.83 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.868 0.366 . . . . 0.0 110.667 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.441 ' CD1' ' N ' ' A' ' 11' ' ' ILE . 1.3 mp -109.33 -33.36 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.974 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.435 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 20.4 t60 -139.35 152.4 47.13 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.653 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.36 173.16 12.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.481 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.5 p -175.04 119.0 0.19 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.774 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 m -90.34 -26.33 5.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.307 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -86.72 -16.47 36.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.413 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.3 p -72.54 -41.66 65.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.934 0.397 . . . . 0.0 110.644 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -66.75 -33.23 75.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 86.5 m-20 -73.54 -52.78 12.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.506 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.76 -42.42 68.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.382 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -60.61 -52.36 65.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.766 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -58.44 -34.54 70.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.747 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.425 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 1.6 tt -59.46 -56.63 19.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.327 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.467 ' CD2' ' CE2' ' A' ' 86' ' ' PHE . 46.5 mt -61.47 -40.25 93.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.711 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.2 m -60.71 -35.5 76.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.155 0.503 . . . . 0.0 109.7 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.9 t -80.09 -33.11 14.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.467 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 9.3 mmtt -72.23 -10.19 59.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.211 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER 68.99 40.87 1.54 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.881 0.372 . . . . 0.0 111.125 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.93 136.64 29.31 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.432 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.547 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.1 Cg_endo -78.84 155.77 26.94 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.543 2.162 . . . . 0.0 111.867 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -161.35 170.84 19.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.802 0.334 . . . . 0.0 111.338 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -132.51 137.36 47.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.625 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.466 ' CE1' HG12 ' A' ' 4' ' ' VAL . 6.1 t80 -89.22 158.35 17.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.296 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.412 HD12 ' CE1' ' A' ' 5' ' ' TYR . 20.4 mt -147.27 122.56 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.468 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -92.4 126.02 37.3 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.985 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.5 pt -92.11 -6.31 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.448 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.405 ' HG2' HG23 ' A' ' 11' ' ' ILE . 3.3 tpp -127.63 82.59 68.02 Favored Pre-proline 0 N--CA 1.454 -0.271 0 CA-C-O 120.76 0.314 . . . . 0.0 110.882 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 97.2 Cg_endo -89.86 27.34 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.047 2.498 . . . . 0.0 112.648 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.433 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -139.32 165.25 27.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.382 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -58.79 -8.0 1.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 169.77 47.59 0.03 OUTLIER Glycine 0 C--N 1.312 -0.791 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.848 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.9 t -150.59 127.2 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.959 0.409 . . . . 0.0 111.397 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.407 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 2.5 m-30 -63.22 168.74 4.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.645 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.415 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 7.5 t70 -98.93 106.69 18.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.914 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -60.99 -23.95 65.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.542 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.6 -59.22 3.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.684 0.278 . . . . 0.0 111.287 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -67.3 -45.14 77.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 110.885 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.41 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 1.5 mp -57.06 -29.42 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.814 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.65 -61.78 1.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.956 0.408 . . . . 0.0 110.887 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -59.61 -32.42 70.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.31 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.438 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -59.72 -53.03 62.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.341 179.49 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 48' ' ' ILE . 69.2 mt -47.72 -44.99 28.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.356 0.598 . . . . 0.0 110.628 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.8 m -70.15 -35.67 74.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.83 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.65 -29.34 70.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.61 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -74.33 -65.82 0.8 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.009 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.89 -29.18 0.26 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.511 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.25 -167.6 1.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.883 0.373 . . . . 0.0 110.806 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -98.35 -29.88 12.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.944 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -94.5 162.69 13.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.968 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -102.37 99.25 9.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.0 110.611 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pt -79.16 84.3 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.342 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.77 23.3 76.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.621 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.29 131.11 49.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.309 . . . . 0.0 110.682 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.89 170.01 15.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.079 0.466 . . . . 0.0 111.348 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -118.87 150.21 48.1 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.649 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.3 Cg_endo -83.29 139.04 34.89 Favored 'Cis proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.923 -1.282 . . . . 0.0 112.559 0.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -101.7 118.69 37.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.875 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.6 t -90.75 159.76 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.417 0.627 . . . . 0.0 112.499 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.45 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 30.7 m-85 -143.36 145.98 33.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.255 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.472 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -61.17 156.68 48.19 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.25 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.581 ' HB3' ' N ' ' A' ' 1' ' ' MET . 3.0 Cg_exo -73.87 -5.37 16.92 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.97 2.447 . . . . 0.0 112.425 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.19 -8.15 11.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.208 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.2 89.6 1.86 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.55 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.2 m -179.23 156.53 0.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.83 0.348 . . . . 0.0 110.925 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -90.2 120.81 31.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.472 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 1.2 mp -102.11 -36.04 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.625 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.5 -161.78 16.55 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.714 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.9 -134.75 6.97 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.619 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 10.9 t80 -74.36 -70.2 0.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 111.017 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -55.95 -48.63 75.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.936 0.398 . . . . 0.0 110.557 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.25 -38.98 66.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.601 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.457 HD22 ' CE2' ' A' ' 86' ' ' PHE . 3.8 tt -74.8 -38.3 62.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.077 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 87' ' ' LYS . 8.0 ttt85 -51.34 -29.27 14.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -71.91 -34.3 68.99 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.409 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.444 ' N ' ' O ' ' A' ' 82' ' ' LEU . 18.8 t80 -67.01 -30.68 70.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.483 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.467 ' CE2' ' CD2' ' A' ' 24' ' ' LEU . 30.3 m-85 -96.33 -16.6 21.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.563 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 83' ' ' ARG . 11.8 mtmm . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.98 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.599 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 40.0 ttp . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -76.14 147.35 38.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.319 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 3.7 mptt -107.85 119.35 39.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.405 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.505 ' CG1' ' CE2' ' A' ' 33' ' ' PHE . 38.4 t -109.26 133.58 53.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.403 0.621 . . . . 0.0 112.104 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.58 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 19.7 m-85 -113.73 99.16 7.5 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.592 177.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.63 -127.18 1.16 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.149 -1.024 . . . . 0.0 112.946 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.424 ' CD2' ' CD2' ' A' ' 12' ' ' HIS . 28.3 m-85 -137.15 108.31 6.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 120.901 0.382 . . . . 0.0 111.926 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.466 ' HB2' ' CE1' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -105.08 -27.25 11.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.257 179.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.1 m -60.49 163.7 5.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.54 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.02 3.86 44.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.64 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.435 ' CD1' ' HG3' ' A' ' 37' ' ' MET . 0.1 OUTLIER -88.55 -17.49 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.424 ' CD2' ' CD2' ' A' ' 7' ' ' TYR . 1.9 t60 -140.96 141.13 34.49 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.503 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.29 177.27 9.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.839 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 p -175.95 111.65 0.11 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.035 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 m -90.64 -34.23 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.576 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-30 -82.71 -16.45 48.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.381 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.9 p -63.04 -37.36 86.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.07 0.462 . . . . 0.0 110.262 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.87 -27.01 63.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.316 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -74.1 -54.68 7.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.375 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.24 -45.28 72.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.304 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.65 -52.81 63.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.761 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -58.67 -42.64 88.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.461 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.411 HD22 ' CD2' ' A' ' 86' ' ' PHE . 2.2 tt -58.89 -54.73 43.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.179 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.7 -48.16 78.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.72 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.4 m -55.91 -39.87 72.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.146 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.97 -32.47 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.593 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -9.36 58.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.073 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 68.69 42.57 1.43 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.051 0.453 . . . . 0.0 110.63 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -127.97 132.5 24.38 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.902 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.599 ' O ' ' HA ' ' A' ' 1' ' ' MET . 64.2 Cg_endo -79.92 154.17 22.76 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.479 2.119 . . . . 0.0 111.217 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 5.5 p90 -161.51 171.26 18.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.717 0.294 . . . . 0.0 111.446 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -137.35 121.7 18.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.899 0.38 . . . . 0.0 110.759 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.505 ' CE2' ' CG1' ' A' ' 4' ' ' VAL . 35.1 t80 -89.32 157.9 18.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.44 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.8 mt -143.95 120.38 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.27 0.557 . . . . 0.0 111.038 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -83.99 109.27 17.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.08 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 43' ' ' PHE . 11.6 pt -97.72 66.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.05 0.453 . . . . 0.0 111.605 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.435 ' HG3' ' CD1' ' A' ' 11' ' ' ILE . 22.0 tpp -160.73 73.4 2.79 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.413 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 35.0 Cg_exo -59.97 -22.61 69.74 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.128 1.885 . . . . 0.0 110.859 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -151.2 152.77 33.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.052 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.404 ' HA ' HD13 ' A' ' 11' ' ' ILE . 14.3 mttt -64.1 -7.54 9.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.344 0.592 . . . . 0.0 111.622 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.79 -55.42 3.36 Favored Glycine 0 C--N 1.311 -0.827 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.953 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -149.19 147.13 16.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 12.3 m-85 -59.74 170.45 1.11 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.088 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.404 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 5.0 t0 -77.89 108.4 11.12 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.687 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.03 -24.25 23.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.723 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.65 -56.36 14.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.817 0.341 . . . . 0.0 111.323 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -34.37 77.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.157 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.85 -31.38 30.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.552 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.64 -55.01 39.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.962 0.41 . . . . 0.0 110.287 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.14 -33.31 75.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.045 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.1 tt -59.11 -51.69 68.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.284 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.1 mt -52.68 -44.51 66.27 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.999 0.428 . . . . 0.0 111.381 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.6 m -57.9 -48.79 78.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.576 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -58.78 -38.77 79.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.618 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.9 -56.04 26.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.722 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.93 -115.6 0.58 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.097 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.6 ttp-105 -150.33 31.03 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 110.662 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -121.07 -143.72 0.35 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.321 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 t -120.02 170.29 9.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.692 0.282 . . . . 0.0 110.671 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -77.83 98.34 5.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.271 0.558 . . . . 0.0 110.649 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -80.13 84.32 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.115 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.1 25.45 66.3 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.449 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.81 134.63 36.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.9 0.381 . . . . 0.0 110.893 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.54 164.1 15.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.101 0.477 . . . . 0.0 111.419 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.07 154.74 47.18 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.66 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.3 Cg_endo -87.54 136.82 16.61 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.116 -1.202 . . . . 0.0 112.679 0.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -90.01 142.79 27.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.927 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -115.97 158.06 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.077 0.465 . . . . 0.0 111.56 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 75' ' ' HIS . 46.6 m-85 -142.83 138.66 30.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.146 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.92 133.36 29.21 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.409 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.575 ' HB3' ' N ' ' A' ' 1' ' ' MET . 33.4 Cg_exo -52.92 -21.96 16.97 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.555 2.17 . . . . 0.0 111.948 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.23 39.79 0.1 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.19 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.4 -110.16 0.8 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.957 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.07 -172.4 3.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.168 0.509 . . . . 0.0 111.321 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.462 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 24.4 t-80 -65.18 126.1 27.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.068 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.6 mt -95.91 -45.26 13.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.784 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.02 -155.32 21.77 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.521 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.77 -142.07 9.1 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.572 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -70.56 -68.76 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.778 0.323 . . . . 0.0 110.943 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -54.74 -46.46 74.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.838 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -54.41 -36.26 63.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.627 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.475 HD23 ' CD2' ' A' ' 86' ' ' PHE . 0.9 OUTLIER -75.27 -38.93 60.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.28 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -51.93 -29.63 21.05 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -71.25 -35.47 71.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.154 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 82' ' ' LEU . 20.7 t80 -63.46 -33.63 75.98 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.275 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.475 ' CD2' HD23 ' A' ' 82' ' ' LEU . 6.5 m-85 -87.15 -69.53 0.68 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.122 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.646 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 16.1 ttm . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.782 0.325 . . . . 0.0 111.682 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.433 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 91.8 m-85 -85.62 142.38 29.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.991 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -117.04 127.69 54.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.909 -179.424 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.508 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 15.7 t -110.76 133.81 55.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.391 0.615 . . . . 0.0 111.559 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.531 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 21.6 m-30 -116.39 99.86 7.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.368 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.439 ' HA3' ' HB3' ' A' ' 66' ' ' PRO . . . -161.8 -139.13 2.57 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.771 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.472 ' CE1' ' HE1' ' A' ' 37' ' ' MET . 45.4 m-85 -123.71 156.22 36.37 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 120.889 0.376 . . . . 0.0 111.364 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -74.38 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 t 173.62 -36.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.734 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -85.11 -20.7 29.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.28 -38.22 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.004 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -150.29 151.6 33.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.464 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 14' ' ' CYS . 13.7 tptt -75.74 157.33 33.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.18 0.514 . . . . 0.0 112.177 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 28.3 p 177.43 113.15 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.545 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.447 ' CG2' ' N ' ' A' ' 16' ' ' TYR . 1.3 m -90.88 -39.11 11.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.899 0.857 . . . . 0.0 110.026 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.569 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -77.97 -10.74 59.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.698 -179.212 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 14' ' ' CYS . 20.5 p -73.76 -41.72 62.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.047 0.451 . . . . 0.0 110.045 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.53 -34.09 71.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.747 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -65.06 -46.74 79.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.97 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.79 -50.39 72.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.962 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.0 ttpt -53.16 -44.09 67.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.841 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.47 -40.89 92.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.78 -53.1 61.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.564 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.0 mt -56.52 -47.5 79.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.85 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.2 m -55.18 -36.51 65.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.136 0.493 . . . . 0.0 110.091 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.4 t -78.14 -28.14 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.675 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.7 -21.25 44.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.927 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt 71.65 63.52 0.15 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.962 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -132.02 142.31 44.65 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.053 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.65 124.49 8.24 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.477 2.118 . . . . 0.0 111.266 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.646 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 6.3 p90 -157.17 164.56 37.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.046 0.451 . . . . 0.0 112.168 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.66 144.03 31.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.993 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.508 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 17.9 t80 -89.2 152.76 21.41 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.004 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 mt -143.92 119.62 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.358 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -72.94 109.93 6.86 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.776 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 pp -69.79 -24.8 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 5.8 ttp -126.69 91.44 47.3 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.111 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.71 0.61 9.9 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.57 2.18 . . . . 0.0 112.231 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -139.65 138.45 36.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.652 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -66.28 -8.71 26.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.246 0.546 . . . . 0.0 111.852 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.13 -63.75 1.64 Allowed Glycine 0 C--N 1.311 -0.815 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.098 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -150.28 139.42 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.617 0.246 . . . . 0.0 111.118 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.6 OUTLIER -58.79 169.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.932 0.396 . . . . 0.0 111.353 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.406 ' O ' ' CD1' ' A' ' 48' ' ' ILE . 1.2 t0 -80.07 105.86 11.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.302 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -59.88 -17.63 38.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.815 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.33 -61.22 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 111.212 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.55 -36.21 83.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.054 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.406 ' CD1' ' O ' ' A' ' 44' ' ' ASP . 1.9 mp -70.48 -29.85 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.409 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.7 -54.69 39.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.435 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.54 -34.51 74.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.134 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.531 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 2.9 tt -55.84 -51.13 68.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.264 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.6 mt -54.03 -47.24 71.75 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.331 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.1 m -62.54 -45.16 94.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.612 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -56.56 -40.73 75.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.587 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 mt -59.96 -47.88 83.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.572 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.49 -112.48 0.49 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.196 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.34 33.64 0.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.055 0.455 . . . . 0.0 110.433 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -120.92 -146.88 0.38 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.9 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.3 t -120.26 172.99 7.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.741 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.28 98.61 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.494 0.664 . . . . 0.0 109.755 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.5 mt -75.08 78.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.875 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.59 26.88 0.45 Allowed Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.007 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.2 139.88 46.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.873 0.368 . . . . 0.0 111.022 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.5 p -106.42 170.7 7.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.398 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.425 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -108.15 156.29 38.64 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.896 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.8 Cg_exo -84.08 143.2 42.08 Favored 'Cis proline' 0 C--N 1.346 0.4 0 C-N-CA 124.258 -1.142 . . . . 0.0 113.064 0.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -96.33 132.29 41.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.565 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -102.5 162.51 3.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.441 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.414 ' N ' HD13 ' A' ' 76' ' ' ILE . 19.5 m-85 -142.25 130.88 22.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.7 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.76 147.46 98.72 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.385 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.566 ' HB3' ' N ' ' A' ' 1' ' ' MET . 74.6 Cg_exo -45.44 -38.72 16.13 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.292 2.662 . . . . 0.0 112.615 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.66 -38.84 70.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.158 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.83 78.53 0.31 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.505 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.3 m -164.05 148.3 10.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.73 0.3 . . . . 0.0 110.878 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -75.94 106.97 7.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.414 HD13 ' N ' ' A' ' 69' ' ' PHE . 4.7 mt -74.8 -50.46 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.191 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 131.59 -153.06 20.27 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.799 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.06 -136.34 8.75 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.772 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.467 ' HB2' ' CE1' ' A' ' 16' ' ' TYR . 46.3 t80 -72.05 -70.76 0.31 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.755 0.312 . . . . 0.0 111.13 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -57.43 -40.97 79.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.979 0.418 . . . . 0.0 110.722 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -58.58 -38.46 77.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.831 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.478 HD23 ' CD2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -75.37 -41.63 55.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.368 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.23 -30.34 17.17 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -70.9 -36.22 72.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.253 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.42 ' N ' ' O ' ' A' ' 82' ' ' LEU . 11.4 t80 -63.99 -33.29 75.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.216 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.478 ' CD2' HD23 ' A' ' 82' ' ' LEU . 6.6 m-85 -89.58 -13.21 37.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.257 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 68.0 mttt . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.796 179.918 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.604 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 22.9 ttm . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.816 0.341 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.477 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 77.0 m-85 -76.66 158.73 30.82 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.637 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -138.86 120.6 15.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.786 -179.408 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.476 HG11 ' CE1' ' A' ' 33' ' ' PHE . 7.8 t -104.79 133.02 50.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.294 0.569 . . . . 0.0 111.681 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 2.3 m-85 -109.33 99.21 8.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.139 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.53 -137.34 2.19 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.878 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.594 ' CG ' ' HB3' ' A' ' 12' ' ' HIS . 88.6 m-85 -115.8 160.13 20.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 111.888 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -83.47 -73.0 0.43 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.606 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 p 171.79 -38.75 0.0 OUTLIER 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.963 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -85.82 -19.66 30.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.726 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 mt -95.19 -38.79 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.751 ' HD2' ' HE1' ' A' ' 37' ' ' MET . 2.7 t-80 -150.9 174.08 13.52 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.526 ' H ' ' HD1' ' A' ' 12' ' ' HIS . 11.1 ptmt -79.65 157.68 27.2 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.949 -0.469 . . . . 0.0 111.75 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -165.97 87.35 0.37 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.3 m -90.5 -41.93 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.757 0.313 . . . . 0.0 111.165 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -77.64 -15.67 59.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.638 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.7 m -70.56 -50.63 35.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.106 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -55.99 -30.66 62.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 111.07 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -70.71 -50.67 33.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.026 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.6 -46.88 80.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.107 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.8 tttt -59.9 -53.42 58.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.74 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -35.45 73.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.567 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.416 HD22 ' CD2' ' A' ' 86' ' ' PHE . 1.3 tt -58.3 -53.31 59.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.41 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 mt -55.77 -45.71 78.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.69 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.38 -35.26 67.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.17 0.509 . . . . 0.0 110.094 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.1 t -78.05 -30.59 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.558 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -19.35 50.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.948 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 73.81 63.75 0.09 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.932 0.396 . . . . 0.0 110.904 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -142.27 139.27 17.53 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.11 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -74.6 136.11 20.83 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.423 2.082 . . . . 0.0 111.616 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.604 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 21.3 p90 -158.3 170.66 21.75 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -146.05 147.09 31.25 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.968 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.476 ' CE1' HG11 ' A' ' 4' ' ' VAL . 13.6 t80 -89.53 158.56 17.61 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.166 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.8 mt -147.25 121.65 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.456 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -91.79 122.81 34.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.069 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 pp -89.0 -23.24 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.751 ' HE1' ' HD2' ' A' ' 12' ' ' HIS . 2.5 ttp -119.25 92.99 46.51 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.306 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.12 0.52 9.27 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.745 2.297 . . . . 0.0 113.295 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -139.11 140.85 38.08 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -9.2 12.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.232 0.539 . . . . 0.0 111.645 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.95 -67.0 0.9 Allowed Glycine 0 C--N 1.315 -0.625 0 CA-C-N 115.272 -0.876 . . . . 0.0 113.147 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.1 t -128.73 138.47 54.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -72.57 170.51 14.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.501 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -87.86 115.32 25.23 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.147 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.3 p30 -66.92 -18.89 65.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.605 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -58.58 -55.08 39.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.923 0.392 . . . . 0.0 110.702 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 mmtm -69.35 -39.06 78.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.144 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.421 HD13 ' CD1' ' A' ' 43' ' ' PHE . 66.7 mt -54.12 -44.88 65.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.87 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.66 -55.17 36.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.54 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.72 -38.5 81.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.218 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.461 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -59.57 -50.62 73.19 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.477 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.7 mt -47.78 -43.11 27.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.299 0.571 . . . . 0.0 110.701 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.1 m -68.55 -35.78 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.827 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.412 ' HE3' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -65.86 -30.6 71.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.428 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -75.98 -48.47 21.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.658 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.25 -39.95 1.59 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.111 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -97.26 169.11 10.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 110.823 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -94.05 -25.87 17.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.763 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -98.72 161.24 13.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.75 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -110.48 99.83 8.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.805 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.6 mt -79.62 84.61 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.78 25.8 64.21 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.51 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.17 126.65 23.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.866 0.365 . . . . 0.0 110.857 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.6 p -128.67 170.38 13.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.161 0.505 . . . . 0.0 111.59 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.56 157.15 38.25 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.625 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.2 Cg_endo -86.67 149.78 40.72 Favored 'Cis proline' 0 C--N 1.346 0.395 0 C-N-CA 124.384 -1.09 . . . . 0.0 112.94 0.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -119.27 115.59 24.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.98 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.637 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.9 t -91.59 165.92 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.219 0.533 . . . . 0.0 112.24 -178.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 34.5 m-85 -142.29 133.51 26.2 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.155 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.24 138.02 81.51 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.604 ' HB3' ' N ' ' A' ' 1' ' ' MET . 21.2 Cg_exo -34.61 -56.14 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.799 2.999 . . . . 0.0 113.195 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -140.38 29.35 1.99 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.615 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.13 -87.93 1.85 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.549 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -177.45 175.47 1.43 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.893 0.378 . . . . 0.0 110.571 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 20.0 t-80 -49.95 109.18 0.26 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.687 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.3 mt -73.86 -48.77 37.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.493 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.7 -154.29 20.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.598 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.52 -149.66 7.17 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.604 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -72.04 -53.97 11.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.78 0.324 . . . . 0.0 110.769 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -54.78 -44.39 73.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.846 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -58.67 -45.59 89.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.67 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -61.85 -49.47 76.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.595 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -51.11 -30.71 16.98 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -75.37 -34.5 61.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.177 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.422 ' N ' ' O ' ' A' ' 82' ' ' LEU . 6.3 t80 -65.45 -32.97 74.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.278 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.416 ' CD2' HD21 ' A' ' 82' ' ' LEU . 9.4 m-85 -91.85 -24.27 19.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.348 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.9 pttt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.317 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.562 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 4.5 tpp . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.411 ' CD1' HD21 ' A' ' 24' ' ' LEU . 79.6 m-85 -77.53 143.92 38.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.879 178.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -105.59 121.97 45.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 -179.159 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.454 HG12 ' CE1' ' A' ' 33' ' ' PHE . 53.9 t -111.66 140.94 28.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.348 0.594 . . . . 0.0 111.934 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.512 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 4.9 m-85 -119.88 99.62 6.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.453 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.8 -140.18 2.87 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.124 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.472 ' CE1' ' HE2' ' A' ' 37' ' ' MET . 30.0 m-85 -126.06 159.93 31.47 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.626 -0.287 . . . . 0.0 111.228 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.406 ' O ' ' CB ' ' A' ' 9' ' ' SER . 11.3 t70 -69.87 -67.41 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.527 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.7 OUTLIER 166.36 -39.35 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.129 179.641 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -85.55 -17.93 34.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.174 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.438 ' CD1' ' N ' ' A' ' 11' ' ' ILE . 2.6 mp -89.11 -42.51 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.042 0.449 . . . . 0.0 109.799 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.4 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 5.3 t60 -149.52 158.17 43.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.201 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.37 146.65 2.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.831 0.348 . . . . 0.0 111.454 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -175.15 65.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.274 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.6 m -90.57 -48.12 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -76.87 -11.35 59.81 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.465 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 27.4 p -73.95 -45.04 52.79 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -55.31 -24.86 31.0 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.464 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 10.2 m-80 -73.3 -45.79 53.43 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.989 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.91 -29.69 69.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.335 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? -70.35 -62.45 1.38 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.808 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -54.24 -30.29 49.73 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.93 0.395 . . . . 0.0 110.379 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 tt -58.16 -54.26 48.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.817 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.411 HD21 ' CD1' ' A' ' 2' ' ' PHE . 6.0 mt -54.44 -45.41 73.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.455 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 m -54.79 -36.28 64.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.655 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.3 t -79.67 -32.28 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.308 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -11.95 60.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.834 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.37 45.52 0.1 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.948 0.404 . . . . 0.0 110.95 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -144.04 134.04 11.85 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.338 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.562 ' O ' ' HA ' ' A' ' 1' ' ' MET . 64.5 Cg_endo -81.54 166.19 17.87 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.611 2.207 . . . . 0.0 111.308 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.525 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 8.4 p90 -161.49 171.08 18.75 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.89 0.329 . . . . 0.0 111.89 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.72 136.64 39.16 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.806 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.454 ' CE1' HG12 ' A' ' 4' ' ' VAL . 6.0 t80 -89.22 160.77 16.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.502 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.512 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 20.3 mt -144.52 119.41 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.259 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -83.09 121.89 27.63 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.481 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.4 ' HB ' HD11 ' A' ' 48' ' ' ILE . 1.3 pt -98.1 -20.06 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.796 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.472 ' HE2' ' CE1' ' A' ' 7' ' ' TYR . 32.6 ttm -124.75 83.26 59.23 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.811 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.436 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 55.7 Cg_endo -70.17 -13.94 34.23 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.653 2.236 . . . . 0.0 111.981 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -139.8 145.27 37.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.747 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.84 -8.0 44.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.304 0.573 . . . . 0.0 111.498 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.26 -58.54 2.57 Favored Glycine 0 C--N 1.312 -0.799 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.4 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.1 t -149.48 140.71 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 111.374 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.4 OUTLIER -60.01 160.18 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.533 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.436 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 62.6 t0 -71.78 132.2 44.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.952 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -71.54 -28.26 63.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 0.0 110.761 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.93 -56.43 10.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.984 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -65.31 -46.18 81.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.836 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 44' ' ' ASP . 1.1 mp -58.1 -38.14 65.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.372 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.46 -56.57 5.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.152 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -60.21 -31.31 70.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.629 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.408 HD11 ' CD2' ' A' ' 5' ' ' TYR . 13.3 tp -59.71 -52.18 66.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.288 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.5 mt -51.59 -45.82 63.29 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.107 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.0 m -65.53 -31.44 72.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.331 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.425 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 19.8 tttp -66.96 -31.87 72.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.556 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.91 -42.7 94.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.8 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.75 -106.47 0.29 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.05 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -149.68 28.65 0.78 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.112 0.482 . . . . 0.0 110.679 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -121.3 -147.14 0.38 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.401 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.5 t -120.28 170.24 9.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.69 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.29 98.26 8.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.271 0.558 . . . . 0.0 110.355 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.3 mt -80.06 84.52 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.191 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.77 25.76 45.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.469 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -57.64 144.3 38.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.897 0.379 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.9 p -123.53 168.51 12.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.229 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.403 ' O ' ' OH ' ' A' ' 16' ' ' TYR . 1.2 mpt? -113.12 156.12 43.36 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.791 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -80.59 140.57 52.0 Favored 'Cis proline' 0 C--N 1.344 0.298 0 C-N-CA 123.741 -1.358 . . . . 0.0 112.978 0.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.412 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -96.42 123.16 39.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.055 179.051 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 10.1 t -99.39 159.42 3.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.174 0.512 . . . . 0.0 111.97 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.479 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 90.9 m-85 -143.35 148.53 36.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.54 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -60.72 146.69 85.74 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.665 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.557 ' HB3' ' N ' ' A' ' 1' ' ' MET . 14.6 Cg_exo -65.6 -13.4 39.61 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.534 2.156 . . . . 0.0 112.087 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.72 -25.8 14.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.765 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.98 92.72 0.7 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.783 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.9 m 176.67 155.67 0.25 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 111.005 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.413 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 7.2 t-160 -90.68 113.52 25.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.2 mt -94.42 -49.37 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.981 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.03 -154.66 21.65 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.698 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.81 -142.66 12.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.674 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -67.71 -70.87 0.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.694 0.283 . . . . 0.0 110.917 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -58.74 -45.54 89.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.998 0.428 . . . . 0.0 110.707 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -52.47 -38.98 60.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.573 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.523 HD22 ' CE2' ' A' ' 86' ' ' PHE . 4.8 tt -79.41 -33.56 42.56 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.313 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -51.21 -29.51 14.41 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -70.33 -35.39 73.58 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.454 ' N ' ' O ' ' A' ' 82' ' ' LEU . 6.6 t80 -63.19 -34.46 77.69 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.523 ' CE2' HD22 ' A' ' 82' ' ' LEU . 5.1 m-85 -87.98 -70.46 0.63 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.296 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.981 -179.972 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.58 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 7.1 tpp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -77.67 146.63 35.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.89 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.9 mptt -109.66 122.03 46.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.787 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.479 HG13 ' CE1' ' A' ' 33' ' ' PHE . 50.7 t -110.33 129.59 65.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.277 0.56 . . . . 0.0 111.854 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.558 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 17.5 m-85 -107.68 99.32 8.82 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.833 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.6 -143.7 3.73 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.246 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.709 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 5.0 m-85 -127.9 154.98 44.9 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 120.619 0.247 . . . . 0.0 111.239 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.07 -79.56 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.008 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 m 175.42 -34.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.835 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -62.57 -50.89 69.5 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.223 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.418 HD11 ' N ' ' A' ' 11' ' ' ILE . 0.5 OUTLIER -89.92 -39.79 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.936 0.398 . . . . 0.0 111.177 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.709 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 57.0 t-80 -139.88 139.65 36.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.005 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.95 174.23 11.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.257 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 19.8 p 175.11 113.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.896 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.0 m -90.08 -30.14 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.839 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -83.87 -15.91 46.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.407 ' HB3' ' HB2' ' A' ' 14' ' ' CYS . 14.4 p -71.31 -43.65 66.65 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.811 0.338 . . . . 0.0 110.714 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.1 -38.3 78.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.752 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -57.65 -48.53 79.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.899 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.407 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -64.59 -40.01 94.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.81 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.403 ' HD2' ' CE2' ' A' ' 31' ' ' PHE . 2.2 mmmm -49.97 -37.75 33.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.14 0.495 . . . . 0.0 110.188 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -75.07 -29.24 60.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.312 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.506 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -54.56 -55.7 26.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.304 179.386 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mt -62.77 -47.49 83.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.766 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.3 m -56.01 -35.26 66.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.461 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.8 t -78.06 -27.56 14.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.965 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HD3' ' CG ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -78.81 -11.45 59.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.308 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 72.59 38.43 0.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.929 0.395 . . . . 0.0 110.812 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.01 142.43 44.41 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.567 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.534 ' O ' ' HA ' ' A' ' 1' ' ' MET . 67.5 Cg_endo -79.5 155.81 24.79 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.526 2.151 . . . . 0.0 111.616 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.445 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 46.1 p90 -161.46 170.83 19.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.278 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -137.11 129.48 29.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.833 0.349 . . . . 0.0 110.943 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.479 ' CE1' HG13 ' A' ' 4' ' ' VAL . 17.3 t80 -89.22 154.94 19.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.005 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.0 mt -147.11 119.69 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.261 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -86.26 109.7 19.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.786 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.434 ' O ' ' HB3' ' A' ' 43' ' ' PHE . 11.8 pt -85.69 58.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.31 0.576 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.474 ' HE2' ' CD2' ' A' ' 12' ' ' HIS . 26.6 ttm -173.21 89.49 0.38 Allowed Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.334 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.1 -22.42 35.14 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.29 1.993 . . . . 0.0 111.408 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 41' ' ' GLY . 5.5 tp10 -145.04 143.07 30.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.381 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.411 ' HB3' HG22 ' A' ' 11' ' ' ILE . 11.4 pttt -57.08 -9.07 0.78 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.171 0.51 . . . . 0.0 112.139 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 39' ' ' GLU . . . -77.42 -55.2 4.37 Favored Glycine 0 C--N 1.312 -0.783 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.042 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -148.94 144.23 18.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 1.0 OUTLIER -58.77 170.97 0.71 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.029 179.157 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.32 103.81 15.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.908 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -58.11 -25.2 61.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.361 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -64.62 -59.14 4.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.897 0.379 . . . . 0.0 110.635 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -65.01 -35.6 81.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.27 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.3 mm -70.27 -32.85 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.343 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.18 -51.93 67.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.636 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.27 -36.52 83.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.928 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.558 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 3.5 tt -59.43 -53.19 60.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.392 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.0 mt -51.42 -44.59 62.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.149 0.5 . . . . 0.0 111.517 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.0 m -64.18 -49.41 72.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.571 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -54.87 -34.95 63.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.793 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -61.8 2.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.97 -26.71 0.25 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.549 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.74 -173.75 4.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.698 0.285 . . . . 0.0 110.684 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -98.9 19.29 15.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.308 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 t -120.19 158.63 26.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.881 0.372 . . . . 0.0 110.969 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -116.7 99.84 7.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.014 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 pt -78.84 84.13 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.999 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.73 26.61 57.81 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.195 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -56.81 135.74 55.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.899 0.381 . . . . 0.0 111.077 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.7 p -124.99 167.1 15.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.172 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.3 154.24 51.91 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.799 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.6 Cg_endo -85.72 142.43 31.56 Favored 'Cis proline' 0 N--CA 1.461 -0.388 0 C-N-CA 124.098 -1.209 . . . . 0.0 112.745 0.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -99.79 139.95 34.7 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -107.88 159.47 7.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.407 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 75' ' ' HIS . 30.8 m-85 -143.06 135.83 27.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.127 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.73 133.32 20.39 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.286 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.58 ' HB3' ' N ' ' A' ' 1' ' ' MET . 29.3 Cg_exo -54.65 -21.11 23.7 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.48 2.12 . . . . 0.0 111.851 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.3 38.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.189 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.3 -109.63 0.78 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.988 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 87.4 p -142.76 -176.33 4.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.135 0.493 . . . . 0.0 111.291 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.499 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 19.5 t-80 -57.85 123.42 15.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.203 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.5 mt -91.88 -46.27 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.733 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.37 -156.29 21.22 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.828 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -89.27 -139.3 7.14 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.332 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.506 ' CE1' ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -75.49 -70.11 0.44 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.769 0.285 . . . . 0.0 110.871 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -49.1 -42.9 40.57 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.239 0.542 . . . . 0.0 110.437 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -64.01 -43.84 94.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.847 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.449 HD21 ' CD2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -71.79 -40.87 68.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.605 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -51.43 -34.06 33.28 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -67.72 -35.94 79.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.16 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.428 ' N ' ' O ' ' A' ' 82' ' ' LEU . 35.2 t80 -62.94 -34.02 76.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.432 178.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.449 ' CD2' HD21 ' A' ' 82' ' ' LEU . 8.8 m-85 -87.32 -70.32 0.63 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.194 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 69.6 mttt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.962 179.939 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.573 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.9 ttm . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.669 0.271 . . . . 0.0 111.662 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.493 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 83.1 m-85 -59.17 161.29 5.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.875 0.369 . . . . 0.0 110.122 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.621 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -137.78 120.67 16.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.827 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.535 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 75.3 t -110.74 150.99 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.418 0.628 . . . . 0.0 111.703 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 40.4 m-85 -133.72 102.5 5.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.17 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -166.47 -136.78 2.08 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.535 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.409 ' O ' ' CZ ' ' A' ' 33' ' ' PHE . 49.2 m-85 -106.91 157.96 17.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.848 0.356 . . . . 0.0 110.885 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -98.94 -71.74 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.008 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 p 169.59 -32.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.996 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -74.68 -38.3 62.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.689 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.7 mm -89.12 -49.48 14.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -140.01 149.9 43.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.387 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.92 157.53 26.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.12 0.486 . . . . 0.0 112.018 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -172.32 93.53 0.13 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.488 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.8 m -71.44 -39.53 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.838 0.351 . . . . 0.0 111.023 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.19 -24.02 66.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.882 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.2 m -66.39 -60.69 2.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.5 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -51.77 -39.18 58.15 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.3 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -63.88 -40.64 97.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.373 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.556 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -66.76 -50.48 62.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.059 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -49.51 -36.36 22.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.856 0.36 . . . . 0.0 110.583 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -41.79 93.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.293 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.99 -53.04 62.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.251 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.1 mt -57.86 -45.22 86.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.673 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 51.7 m -57.62 -34.93 69.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.046 0.451 . . . . 0.0 110.113 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.9 t -80.05 -33.96 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.603 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -11.54 60.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.053 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.62 48.56 1.07 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.061 0.457 . . . . 0.0 110.537 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -128.72 130.61 23.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.308 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' A' ' 1' ' ' MET . 83.8 Cg_endo -76.81 142.93 23.06 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.444 2.096 . . . . 0.0 111.105 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.573 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 9.9 p90 -158.35 170.72 21.6 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.544 -0.462 . . . . 0.0 112.209 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -142.01 129.15 20.93 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.073 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.535 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 50.6 t80 -89.69 162.33 15.64 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.863 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.432 HD11 ' CZ ' ' A' ' 5' ' ' TYR . 14.4 mt -146.94 122.41 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.265 0.555 . . . . 0.0 110.675 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -79.04 136.19 37.1 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.052 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 pt -97.18 -27.15 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.172 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 5.4 ttp -124.15 95.16 44.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.413 ' CG ' ' HB2' ' A' ' 44' ' ' ASP . 85.8 Cg_endo -80.93 4.84 6.63 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.67 2.247 . . . . 0.0 112.75 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -139.44 137.79 35.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.661 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -65.18 -9.0 19.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.206 0.527 . . . . 0.0 111.909 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.04 -65.18 1.28 Allowed Glycine 0 C--N 1.311 -0.811 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.247 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.3 t -139.63 155.93 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.751 0.31 . . . . 0.0 111.17 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -75.18 168.1 20.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.821 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.413 ' HB2' ' CG ' ' A' ' 38' ' ' PRO . 19.0 t70 -100.42 114.51 28.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.255 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -54.83 -23.37 18.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.449 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.92 -53.41 58.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.883 0.373 . . . . 0.0 110.795 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -71.11 -28.52 64.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.385 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.7 mm -71.92 -39.65 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.659 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.42 -55.63 22.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.168 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -56.13 -33.49 65.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.57 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.1 tp -63.1 -49.47 74.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.075 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.1 mt -52.25 -44.21 64.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.207 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -64.8 -32.3 73.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.091 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.436 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 2.3 ttmm -67.15 -29.5 69.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.368 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.445 ' N ' HD22 ' A' ' 55' ' ' LEU . 1.2 mt -68.18 -58.03 5.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.683 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.13 -108.69 0.27 Allowed Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.059 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -150.48 33.1 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.034 0.445 . . . . 0.0 110.653 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -120.85 -148.05 0.4 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.378 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 t -116.63 170.19 8.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.812 0.339 . . . . 0.0 110.641 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -86.75 98.44 11.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.298 0.57 . . . . 0.0 110.575 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 pt -80.49 83.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.173 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.9 26.66 41.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.58 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.15 150.09 6.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.752 0.311 . . . . 0.0 111.074 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 p -127.62 170.07 13.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.214 0.53 . . . . 0.0 111.742 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.38 158.12 56.87 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.576 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.4 Cg_exo -79.29 143.53 70.03 Favored 'Cis proline' 0 C--N 1.344 0.32 0 C-N-CA 124.084 -1.215 . . . . 0.0 112.866 0.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 9.9 tt0 -104.08 123.11 46.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.466 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 16.5 t -100.31 162.22 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.934 0.397 . . . . 0.0 111.659 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.478 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 85.9 m-85 -142.24 141.84 32.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.073 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -54.87 146.65 36.29 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.447 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.542 ' HB3' ' N ' ' A' ' 1' ' ' MET . 50.1 Cg_exo -56.44 -26.61 63.99 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.132 2.555 . . . . 0.0 112.215 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -93.48 -28.58 16.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.227 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.3 91.53 0.6 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.702 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 2.6 m -178.8 163.86 1.47 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.684 0.278 . . . . 0.0 110.596 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.407 ' NE2' ' CG ' ' A' ' 67' ' ' GLN . 14.3 t-160 -90.19 108.7 19.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.113 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.1 mt -86.3 -53.39 10.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.765 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.61 -153.16 20.1 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.08 -137.72 7.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.155 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.556 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -76.29 -70.19 0.46 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.702 0.251 . . . . 0.0 110.773 179.597 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -49.26 -44.03 43.46 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.256 0.55 . . . . 0.0 110.32 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -36.53 81.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.482 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 85' ' ' TYR . 2.0 tt -79.47 -38.52 34.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.594 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.91 -32.75 21.61 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -67.53 -35.62 79.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.237 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 82' ' ' LEU . 8.6 t80 -63.44 -34.44 77.75 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.31 178.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.444 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.8 m-85 -89.3 -21.93 22.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.341 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.991 -179.945 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.647 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.39 0.138 . . . . 0.0 111.045 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.4 ' HB3' ' CG1' ' A' ' 68' ' ' VAL . 75.1 m-85 -39.71 120.9 1.17 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.694 0.759 . . . . 0.0 111.867 -177.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.747 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -90.8 124.1 34.87 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.147 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.456 HG13 ' CE1' ' A' ' 33' ' ' PHE . 7.7 t -102.15 128.31 54.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.238 0.542 . . . . 0.0 111.47 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.615 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 2.8 m-30 -104.96 98.92 8.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.969 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.54 -139.71 2.71 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.293 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.407 ' CG ' ' HB3' ' A' ' 12' ' ' HIS . 91.6 m-85 -124.36 153.75 41.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.891 0.377 . . . . 0.0 111.582 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.88 -77.24 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.915 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 170.07 -32.63 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.017 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -80.43 -30.19 37.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.983 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.6 mp -90.39 -47.15 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.117 0.484 . . . . 0.0 110.59 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.407 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 33.7 t60 -147.76 153.81 39.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.558 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.3 149.61 50.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.077 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 7' ' ' TYR . 42.6 t -164.99 87.56 0.44 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.063 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.39 -27.52 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -64.1 -32.37 73.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.331 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.1 p -77.92 -45.46 23.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.329 . . . . 0.0 110.543 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.08 -37.98 36.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.627 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -69.12 -55.05 11.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.724 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.08 -38.32 56.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.19 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.435 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 15.3 ttmt -58.32 -52.36 65.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.342 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -61.14 -37.26 82.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.155 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.404 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -59.82 -53.85 53.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.103 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.434 HD23 ' CZ ' ' A' ' 86' ' ' PHE . 7.1 mt -56.22 -44.12 79.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.665 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 m -60.09 -41.55 92.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.109 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.8 t -72.93 -35.82 49.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.595 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 2.6 tmtm? -75.23 -13.0 60.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.31 52.65 0.18 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.888 0.375 . . . . 0.0 110.736 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -145.2 111.52 4.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.239 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.647 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 82.2 Cg_exo -49.53 178.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.324 2.016 . . . . 0.0 111.628 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.435 ' CE2' ' HG3' ' A' ' 21' ' ' LYS . 5.3 p90 -164.25 170.18 16.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.983 0.42 . . . . 0.0 111.227 178.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 5.4 mm-40 -136.39 121.0 18.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.625 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.456 ' CE1' HG13 ' A' ' 4' ' ' VAL . 9.9 t80 -89.71 152.96 21.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.111 0.481 . . . . 0.0 111.639 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.416 HD12 ' CE1' ' A' ' 5' ' ' TYR . 29.0 mt -150.1 126.54 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.407 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -92.58 129.4 38.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.08 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 pp -87.4 -19.53 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.268 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.6 ttp -124.19 94.74 44.82 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.761 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.17 -14.63 28.76 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.421 2.081 . . . . 0.0 112.653 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -139.83 142.25 36.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 110.844 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -65.23 -8.77 19.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.227 0.536 . . . . 0.0 111.877 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.4 -60.22 2.26 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.178 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.6 t -150.1 129.83 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.713 0.292 . . . . 0.0 111.157 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.519 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -59.15 169.65 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.941 0.4 . . . . 0.0 110.921 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.28 93.5 8.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.127 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -52.4 -22.2 4.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.891 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -55.54 -50.21 70.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 0.0 110.898 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -40.74 60.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.571 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.6 mp -52.67 -30.5 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.762 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.95 -57.72 3.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.722 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -61.07 -29.84 69.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.276 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.48 HD21 HD11 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -61.46 -57.92 10.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.951 179.315 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.451 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 72.2 mt -43.14 -45.91 5.66 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.316 0.579 . . . . 0.0 110.919 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.2 m -70.42 -32.4 70.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.272 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.15 -39.93 93.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.328 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.48 HD11 HD21 ' A' ' 51' ' ' LEU . 4.4 mp -59.58 -64.36 0.97 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.868 0.366 . . . . 0.0 110.945 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.65 -48.02 0.21 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.229 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.42 -165.11 1.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 110.865 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -105.43 -30.6 9.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.927 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.3 t -95.71 168.51 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.18 99.76 7.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.772 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 61' ' ' ILE . 30.1 mt -79.05 84.6 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.047 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.37 26.29 67.8 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.316 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.06 125.15 22.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 111.002 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.421 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 34.4 p -128.23 170.14 13.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.994 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.88 159.06 31.29 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.746 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.615 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.9 Cg_endo -84.26 144.75 45.24 Favored 'Cis proline' 0 C--N 1.345 0.343 0 C-N-CA 124.326 -1.114 . . . . 0.0 112.933 0.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' A' ' 5' ' ' TYR . 16.3 mm100 -112.41 121.19 44.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.104 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.747 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -95.23 160.06 2.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.414 ' CE1' ' HD2' ' A' ' 54' ' ' LYS . 46.1 m-85 -141.97 138.3 31.82 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.264 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.469 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -52.47 142.73 29.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.181 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -31.9 -37.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.718 2.945 . . . . 0.0 112.835 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.29 34.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.111 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.78 -105.12 2.58 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.921 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.5 t -131.84 178.04 7.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.167 0.508 . . . . 0.0 111.269 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -65.36 129.65 40.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.674 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.469 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 1.3 mp -103.87 -40.89 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.674 0.273 . . . . 0.0 110.94 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' A' ' 81' ' ' GLN . . . 130.95 -166.92 22.5 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.898 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.6 -137.12 4.74 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.907 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -72.13 -67.96 0.5 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 0.0 111.261 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -54.16 -44.4 71.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.007 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.405 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -57.34 -48.35 79.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.81 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.479 HD22 ' CD2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -67.09 -42.7 84.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.531 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -51.09 -30.25 15.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.52 -35.86 68.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.219 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 82' ' ' LEU . 11.0 t80 -63.72 -33.67 76.17 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.479 ' CD2' HD22 ' A' ' 82' ' ' LEU . 6.3 m-85 -87.96 -28.26 21.58 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.068 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.919 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.55 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.7 ttp . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.746 0.308 . . . . 0.0 111.633 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.506 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 86.0 m-85 -58.9 154.4 15.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.937 0.399 . . . . 0.0 110.427 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.68 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -130.31 123.09 29.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.713 -179.359 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.482 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 54.8 t -113.64 145.05 20.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.377 0.608 . . . . 0.0 111.881 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.507 ' CE1' ' CD1' ' A' ' 34' ' ' ILE . 8.2 m-85 -123.78 102.97 8.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.792 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.78 -137.98 2.31 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.098 -1.048 . . . . 0.0 112.769 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.415 ' CE1' ' SD ' ' A' ' 37' ' ' MET . 56.7 m-85 -112.34 152.66 28.31 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.742 0.306 . . . . 0.0 110.899 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 9' ' ' SER . 19.1 m-20 -88.54 3.75 49.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.709 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.3 OUTLIER 81.09 -10.94 1.16 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.56 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -85.14 -35.08 21.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.908 0.385 . . . . 0.0 110.753 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.516 HG23 ' HA ' ' A' ' 40' ' ' LYS . 2.5 mp -94.32 -42.61 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.52 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -139.34 147.04 41.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.518 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -76.46 159.6 30.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.0 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 p -174.29 122.12 0.28 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.629 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.8 m -90.09 -29.87 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.844 0.354 . . . . 0.0 111.175 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.471 ' CD2' ' HB3' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -77.84 -22.08 50.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.101 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.3 p -73.27 -41.88 63.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 110.92 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -28.42 57.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.324 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 81.4 m-20 -74.88 -39.46 61.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.223 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.18 -38.14 78.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.044 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -60.13 -55.94 27.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.648 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER -61.48 -30.45 70.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.362 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.451 ' CD2' ' CD2' ' A' ' 86' ' ' PHE . 4.0 tt -53.79 -46.18 70.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.333 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.443 HD22 ' CD1' ' A' ' 2' ' ' PHE . 2.6 mt -66.23 -48.58 70.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.635 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.4 m -56.2 -36.52 68.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.505 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.69 -31.93 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.733 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.22 -9.87 57.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.201 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm 71.24 57.91 0.19 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.983 0.42 . . . . 0.0 110.903 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -135.63 139.03 29.79 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.082 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.426 ' O ' ' HA ' ' A' ' 1' ' ' MET . 91.8 Cg_endo -79.59 142.08 16.03 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.569 2.179 . . . . 0.0 111.572 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.55 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 32.0 p90 -158.69 170.62 21.75 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -141.48 135.56 30.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.162 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.482 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 32.1 t80 -89.81 159.8 16.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.086 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 19.0 mt -139.23 116.53 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.436 0.636 . . . . 0.0 110.431 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -87.24 121.23 29.41 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.474 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 4.2 pt -100.2 32.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.849 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.415 ' SD ' ' CE1' ' A' ' 7' ' ' TYR . 3.0 mtt -142.64 84.39 11.0 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.157 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.516 ' HD2' ' O ' ' A' ' 42' ' ' VAL . 39.9 Cg_endo -67.33 -8.48 22.16 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.684 2.256 . . . . 0.0 112.62 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.452 ' O ' HG22 ' A' ' 11' ' ' ILE . 1.9 mt-10 -138.8 170.58 15.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.881 0.372 . . . . 0.0 111.011 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.516 ' HA ' HG23 ' A' ' 11' ' ' ILE . 4.4 mptp? -65.4 -6.62 10.75 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.52 35.02 0.25 Allowed Glycine 0 C--N 1.313 -0.733 0 C-N-CA 120.711 -0.756 . . . . 0.0 113.043 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.516 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 t -149.22 125.91 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.635 0.255 . . . . 0.0 110.738 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 1.3 m-85 -76.25 169.91 17.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.041 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.436 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -99.91 112.02 24.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.856 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -54.49 -33.09 59.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.826 0.346 . . . . 0.0 110.612 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.26 -51.37 61.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.595 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -64.61 -43.47 93.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.41 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.93 -36.17 77.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.184 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.87 -58.32 4.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.093 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.74 -34.75 71.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.781 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tp -58.18 -51.49 69.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.38 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.7 -45.88 63.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.166 0.508 . . . . 0.0 111.204 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.7 m -70.2 -35.15 73.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.149 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -29.98 71.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.395 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.66 -70.05 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.781 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.58 -41.2 0.59 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.196 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -98.52 -168.59 1.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 110.847 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -96.65 -30.92 12.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.2 t -109.54 167.5 10.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -104.58 99.52 9.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.553 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.7 tp -62.88 81.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.261 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.22 23.26 39.86 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.773 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.13 140.7 58.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 110.783 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.34 166.3 16.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.247 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.7 mmt -105.67 152.21 40.04 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.61 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.1 Cg_exo -80.79 144.8 67.73 Favored 'Cis proline' 0 C--N 1.345 0.352 0 C-N-CA 123.985 -1.256 . . . . 0.0 112.894 0.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 5.2 mt-30 -99.05 119.57 38.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.641 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 4.6 t -97.51 162.71 2.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.744 0.307 . . . . 0.0 111.428 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 89.3 m-85 -142.22 142.69 32.66 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.24 0.543 . . . . 0.0 111.464 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.438 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.66 137.95 62.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.264 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.507 ' HB3' ' N ' ' A' ' 1' ' ' MET . 84.3 Cg_exo -46.61 -28.07 6.01 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.104 2.536 . . . . 0.0 112.001 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.79 37.05 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.043 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.29 -109.85 1.1 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.949 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.407 ' N ' ' HB1' ' A' ' 70' ' ' ALA . 2.0 p -135.67 -178.07 4.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.122 0.487 . . . . 0.0 111.318 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.437 ' CD2' ' O ' ' A' ' 68' ' ' VAL . 41.2 t-80 -60.4 122.79 15.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.036 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.438 HD11 ' HA ' ' A' ' 70' ' ' ALA . 2.3 mt -85.24 -45.68 17.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.963 0.411 . . . . 0.0 111.159 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.04 -147.92 18.29 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.392 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.1 -149.88 24.11 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.927 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.471 ' HB3' ' CD2' ' A' ' 16' ' ' TYR . 18.9 t80 -71.8 -70.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.833 0.349 . . . . 0.0 111.008 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -55.9 -48.97 74.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -53.56 -35.12 60.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.08 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.501 HD22 ' CE2' ' A' ' 86' ' ' PHE . 6.5 tt -83.45 -30.79 26.98 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.042 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.1 ttp85 -50.73 -33.13 21.75 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -66.19 -35.0 79.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' A' ' 82' ' ' LEU . 5.2 t80 -63.04 -34.9 78.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.189 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.501 ' CE2' HD22 ' A' ' 82' ' ' LEU . 6.6 m-85 -92.4 -13.68 29.73 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.657 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.923 179.913 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.594 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 50.3 ttp . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -74.69 153.15 39.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.201 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -114.22 120.81 41.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.714 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.435 HG11 ' CE1' ' A' ' 33' ' ' PHE . 7.0 t -104.41 128.02 58.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.202 0.525 . . . . 0.0 111.498 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 4.3 m-30 -103.83 98.84 8.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.154 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.29 -138.4 2.43 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.471 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.62 ' CD2' ' CG ' ' A' ' 12' ' ' HIS . 11.5 m-85 -120.35 144.49 47.84 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 120.676 0.274 . . . . 0.0 111.578 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.585 ' HB3' ' CE2' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -136.81 64.22 1.55 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.337 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.88 -179.01 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.271 0.558 . . . . 0.0 112.016 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -86.39 1.51 50.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.62 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.5 tt -86.54 -6.58 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.061 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.62 ' CG ' ' CD2' ' A' ' 7' ' ' TYR . 30.0 t-80 -156.98 161.92 39.59 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.015 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.76 166.0 24.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.615 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 176.67 73.03 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.888 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 m -89.22 -49.03 14.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.726 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.8 -12.88 61.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 110.972 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.3 m -70.37 -53.0 18.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.534 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -53.65 -26.22 21.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.103 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.53 -59.41 2.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.032 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.82 -38.26 64.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.489 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -52.92 63.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 110.658 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -60.75 -37.63 82.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.482 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.437 HD21 ' CD2' ' A' ' 86' ' ' PHE . 3.3 tt -60.18 -53.33 58.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.64 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 mt -56.99 -48.71 77.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.951 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.2 m -54.53 -37.93 65.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.106 0.479 . . . . 0.0 110.244 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.1 t -79.54 -32.58 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.598 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.435 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -72.91 -11.59 60.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.112 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm 72.86 43.93 0.39 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.892 0.377 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -132.17 127.96 21.14 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.002 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.564 ' O ' ' HA ' ' A' ' 1' ' ' MET . 96.9 Cg_endo -77.98 158.56 30.81 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.476 2.118 . . . . 0.0 110.876 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 6.1 p90 -161.51 171.26 18.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.997 0.427 . . . . 0.0 112.021 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.39 133.5 38.75 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.488 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.585 ' CE2' ' HB3' ' A' ' 8' ' ' ASP . 12.2 t80 -89.15 159.79 17.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.168 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.5 mt -149.29 122.26 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.229 0.537 . . . . 0.0 110.753 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -86.25 120.5 27.68 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.829 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -94.53 0.31 10.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.476 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.528 ' HE2' ' CD2' ' A' ' 12' ' ' HIS . 6.9 tpp -120.08 97.25 49.36 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.627 0.251 . . . . 0.0 111.332 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 76.7 Cg_endo -77.35 -23.21 10.32 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.295 1.996 . . . . 0.0 111.339 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -142.52 148.52 37.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.384 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -7.72 11.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.304 0.573 . . . . 0.0 111.738 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.67 -57.32 2.75 Favored Glycine 0 C--N 1.313 -0.737 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.722 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.7 t -148.27 146.38 17.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.885 0.374 . . . . 0.0 111.791 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.436 ' CD1' ' HE3' ' A' ' 37' ' ' MET . 0.5 OUTLIER -59.85 170.32 1.19 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.631 179.365 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.416 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -74.5 98.67 3.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -50.69 -23.99 3.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.553 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -64.94 -59.21 4.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.337 . . . . 0.0 110.799 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.84 -39.06 76.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.502 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.459 ' O ' ' CD1' ' A' ' 52' ' ' LEU . 29.1 mm -50.08 -46.76 24.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.639 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.459 ' O ' HD13 ' A' ' 52' ' ' LEU . . . -63.04 -54.44 38.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.131 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -64.08 -21.25 66.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.664 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.505 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 3.4 tt -62.34 -61.01 2.75 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.159 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.459 ' CD1' ' O ' ' A' ' 48' ' ' ILE . 0.8 OUTLIER -51.34 -49.28 61.71 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.196 0.522 . . . . 0.0 110.241 179.622 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.3 m -53.19 -40.59 64.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.242 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -38.92 84.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.249 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.409 HD23 ' CG ' ' A' ' 75' ' ' HIS . 1.4 mt -59.89 -38.11 81.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.284 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.82 -111.83 0.38 Allowed Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.686 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.3 ttm-85 -150.38 27.11 0.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.075 0.464 . . . . 0.0 110.709 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -121.77 -144.85 0.35 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.415 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.6 t -120.05 170.64 9.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.639 0.257 . . . . 0.0 110.381 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -73.85 98.06 2.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.274 0.559 . . . . 0.0 110.42 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.3 mt -80.11 80.37 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.223 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.67 26.11 7.43 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.555 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.436 ' N ' HD13 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -48.27 166.79 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.845 0.355 . . . . 0.0 111.308 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.0 p -127.09 160.31 31.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.109 0.48 . . . . 0.0 111.391 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.2 mtm -120.23 155.39 55.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.619 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.609 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.9 Cg_exo -76.23 142.97 75.04 Favored 'Cis proline' 0 C--N 1.345 0.354 0 C-N-CA 123.874 -1.303 . . . . 0.0 112.762 0.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -98.03 120.24 38.08 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -92.52 158.83 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.426 0.631 . . . . 0.0 112.31 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 74.6 m-85 -142.53 148.39 37.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.005 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.452 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -61.24 153.75 66.13 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.854 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.594 ' HB3' ' N ' ' A' ' 1' ' ' MET . 19.6 Cg_exo -68.09 59.44 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.344 2.696 . . . . 0.0 112.044 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 71' ' ' PRO . 0.3 OUTLIER 100.37 25.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.85 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -112.18 -97.15 2.33 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.525 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.5 t -147.5 -174.9 4.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.803 0.335 . . . . 0.0 110.612 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.409 ' CG ' HD23 ' A' ' 55' ' ' LEU . 20.6 t-80 -71.82 132.34 44.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.835 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.452 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 1.4 mp -109.09 -41.33 4.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.627 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.87 -165.04 24.94 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.741 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.32 -136.52 4.93 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.737 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -72.33 -70.57 0.33 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.708 0.29 . . . . 0.0 111.332 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -56.4 -47.3 79.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.99 0.424 . . . . 0.0 110.857 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -51.06 -44.14 61.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.472 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.523 HD23 ' CE2' ' A' ' 86' ' ' PHE . 6.0 tt -74.77 -32.92 62.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.243 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.5 ttt85 -51.37 -30.08 17.67 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.93 -35.39 76.74 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.155 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LEU . 22.3 t80 -62.28 -34.3 76.3 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.273 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.523 ' CE2' HD23 ' A' ' 82' ' ' LEU . 6.7 m-85 -86.14 -38.84 17.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.266 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.2 mttm . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.952 -179.999 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.603 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 49.3 ttm . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -77.0 144.31 38.78 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.183 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -106.45 121.21 43.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.662 -179.325 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.462 HG13 ' CE1' ' A' ' 33' ' ' PHE . 40.6 t -107.83 138.25 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.285 0.564 . . . . 0.0 111.887 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.1 m-85 -113.43 99.62 7.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.816 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.44 -139.6 2.71 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.296 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.457 ' OH ' ' CZ ' ' A' ' 43' ' ' PHE . 84.1 m-85 -125.18 148.34 48.65 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.796 0.332 . . . . 0.0 111.253 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -64.55 -75.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.705 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 167.07 -32.87 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.974 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -82.92 -23.9 33.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.839 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 39' ' ' GLU . 2.6 mp -93.41 -46.03 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.476 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -147.44 153.64 39.83 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 pttm -62.39 165.26 6.25 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.877 0.37 . . . . 0.0 111.284 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.4 t -176.6 82.23 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.306 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.43 -19.23 7.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.065 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -76.19 -28.23 57.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.508 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.6 p -77.5 -46.03 23.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.715 0.293 . . . . 0.0 110.831 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.23 -35.39 17.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 110.718 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -70.78 -60.78 2.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.572 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.16 -33.3 51.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.181 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -59.14 -54.96 41.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.54 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -59.73 -35.19 74.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.554 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.439 HD22 ' CD2' ' A' ' 86' ' ' PHE . 3.1 tt -60.81 -54.61 43.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.565 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mt -55.48 -48.05 75.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.855 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.0 m -56.03 -37.74 69.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.166 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -77.08 -36.09 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.646 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -72.54 -10.03 59.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.096 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.65 50.8 0.17 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.861 0.362 . . . . 0.0 110.693 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -139.53 128.53 13.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.27 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.603 ' O ' ' HA ' ' A' ' 1' ' ' MET . 81.0 Cg_endo -79.61 161.81 24.77 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.581 2.187 . . . . 0.0 110.749 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 6.9 p90 -161.23 171.16 18.9 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -135.36 136.79 41.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.292 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.462 ' CE1' HG13 ' A' ' 4' ' ' VAL . 8.6 t80 -89.28 157.0 18.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.174 0.512 . . . . 0.0 111.732 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.488 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 14.7 mt -143.88 119.47 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.714 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -98.26 135.98 39.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.737 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.429 HD11 ' CE1' ' A' ' 43' ' ' PHE . 1.4 pp -97.65 -14.22 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.018 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -123.48 80.39 54.02 Favored Pre-proline 0 N--CA 1.455 -0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.403 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 64.8 Cg_endo -88.44 31.08 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.032 2.488 . . . . 0.0 112.449 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 11' ' ' ILE . 2.2 tp10 -139.08 164.78 28.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.534 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.65 -8.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 39' ' ' GLU . . . 162.49 53.8 0.02 OUTLIER Glycine 0 C--N 1.312 -0.776 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.231 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.3 t -149.83 125.95 2.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.029 0.442 . . . . 0.0 111.944 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.457 ' CZ ' ' OH ' ' A' ' 7' ' ' TYR . 2.0 m-85 -63.78 143.94 57.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.358 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.444 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -99.04 121.79 41.43 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.822 0.344 . . . . 0.0 111.505 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -66.84 -24.62 66.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.332 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -58.42 -52.17 66.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.794 0.33 . . . . 0.0 110.816 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -38.31 54.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.364 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.407 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 41.2 mt -59.32 -40.5 81.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.855 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.47 -58.0 6.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.269 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -60.15 -28.16 67.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.973 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 tp -59.32 -56.26 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.381 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 48' ' ' ILE . 3.0 mt -51.94 -47.51 64.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.984 0.421 . . . . 0.0 110.886 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.6 m -66.04 -35.0 79.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.291 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -66.49 -39.86 88.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.504 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.82 -49.1 79.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.439 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.58 -106.25 0.25 Allowed Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.818 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.2 mtt180 -150.62 27.6 0.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.02 0.438 . . . . 0.0 110.84 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.59 -156.71 0.7 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.207 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -121.24 161.73 21.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.676 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 7.3 pt20 -120.14 98.89 6.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.992 0.425 . . . . 0.0 110.694 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.5 mt -81.55 88.32 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.707 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.94 32.73 5.77 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.536 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 60' ' ' GLN . 2.8 tm? -47.73 121.91 4.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.824 0.345 . . . . 0.0 110.77 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -103.86 151.51 23.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.28 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -112.71 156.4 42.54 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.908 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -86.97 141.52 24.14 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.067 -1.222 . . . . 0.0 112.56 0.503 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.402 ' O ' ' N ' ' A' ' 5' ' ' TYR . 2.7 mm-40 -100.24 124.19 45.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.138 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.3 t -96.61 159.69 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.33 0.586 . . . . 0.0 112.478 -178.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.471 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 80.1 m-85 -143.73 146.62 33.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.289 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.49 156.3 23.71 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.89 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.583 ' HB3' ' N ' ' A' ' 1' ' ' MET . 3.0 Cg_exo -73.71 -3.72 14.22 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.876 2.384 . . . . 0.0 112.566 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -115.33 -9.65 12.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.226 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.23 89.08 1.67 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.548 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 t -179.2 152.12 0.53 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -90.19 116.62 28.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.2 mt -96.8 -48.45 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.879 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 138.17 -156.02 23.69 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.726 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.07 -138.69 8.88 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.668 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -70.89 -70.66 0.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.782 0.325 . . . . 0.0 110.918 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -59.43 -45.3 91.94 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.023 0.44 . . . . 0.0 110.551 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -50.87 -40.0 55.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.437 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.518 HD22 ' CE2' ' A' ' 86' ' ' PHE . 6.4 tt -78.65 -31.93 47.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.265 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -51.13 -30.9 17.75 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -35.43 79.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.093 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 82' ' ' LEU . 10.8 t80 -62.68 -34.14 76.51 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.344 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.518 ' CE2' HD22 ' A' ' 82' ' ' LEU . 7.0 m-85 -88.96 -70.24 0.66 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.312 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.939 179.951 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.603 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 17.5 ttm . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -78.13 147.26 34.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.308 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -106.9 121.45 44.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.337 -179.697 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.458 HG12 ' CE1' ' A' ' 33' ' ' PHE . 52.3 t -112.99 131.95 63.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.56 0.695 . . . . 0.0 112.62 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.574 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 17.3 m-85 -110.09 99.13 8.27 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.181 177.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.418 ' O ' HG12 ' A' ' 36' ' ' ILE . . . -153.91 -139.82 2.92 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.006 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.484 ' CD1' ' HB3' ' A' ' 37' ' ' MET . 43.7 m-85 -147.28 99.84 3.2 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.528 ' CB ' ' CE2' ' A' ' 33' ' ' PHE . 27.7 t70 -108.87 55.95 0.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.422 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.78 -168.04 2.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.165 0.507 . . . . 0.0 111.637 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -85.96 0.61 52.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.839 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 11' ' ' ILE . 1.3 mm -88.26 -13.51 9.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.981 0.419 . . . . 0.0 109.901 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -175.72 118.09 0.15 Allowed 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.704 0.764 . . . . 0.0 111.172 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -82.52 168.56 17.27 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.885 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -176.58 107.79 0.07 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.24 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 m -70.32 -16.56 20.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.671 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -82.96 -25.69 32.08 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.846 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.2 m -59.85 -55.27 36.28 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.35 0.595 . . . . 0.0 109.647 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.27 -18.58 64.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.503 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.67 -62.51 1.35 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.851 0.357 . . . . 0.0 110.89 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.0 -38.37 67.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.09 -50.4 72.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.74 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -38.75 88.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.624 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.417 HD21 ' CE2' ' A' ' 86' ' ' PHE . 1.2 tt -59.16 -53.0 63.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.532 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 mt -56.97 -49.28 76.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.792 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.9 m -54.32 -38.44 65.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.075 0.464 . . . . 0.0 110.161 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.06 -32.36 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.622 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.14 -15.72 61.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.976 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 76.11 49.85 0.07 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.055 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -138.04 131.85 16.84 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.13 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.603 ' O ' ' HA ' ' A' ' 1' ' ' MET . 77.6 Cg_endo -79.52 161.26 25.25 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.408 2.072 . . . . 0.0 111.027 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 6.5 p90 -161.23 171.56 18.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.753 0.311 . . . . 0.0 111.716 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -133.28 123.83 26.21 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.094 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.528 ' CE2' ' CB ' ' A' ' 8' ' ' ASP . 10.6 t80 -89.12 157.91 18.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.445 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.0 mt -148.1 125.21 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.283 0.564 . . . . 0.0 111.143 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -75.58 115.81 15.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.639 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 6' ' ' GLY . 4.6 mm -90.2 -19.06 7.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.921 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.484 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -120.28 84.41 34.53 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.696 0.284 . . . . 0.0 111.181 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.24 -16.49 39.78 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.46 2.107 . . . . 0.0 111.904 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -139.99 136.64 33.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.395 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.33 -9.06 1.99 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.164 0.507 . . . . 0.0 111.956 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.12 -59.65 3.32 Favored Glycine 0 C--N 1.312 -0.797 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.355 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -150.62 154.36 8.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.981 0.42 . . . . 0.0 111.852 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -63.92 170.63 3.35 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.384 179.255 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -89.35 100.83 13.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -52.51 -27.92 18.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.481 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -61.8 -58.04 9.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.96 0.409 . . . . 0.0 110.556 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -65.07 -32.96 74.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.302 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.8 mm -69.8 -37.42 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.573 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.72 71.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.623 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -61.82 -34.08 75.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.334 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.574 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.4 tt -58.95 -52.51 65.43 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.309 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.9 mt -53.16 -41.35 65.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.589 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.1 m -58.49 -47.53 83.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.605 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' CB ' ' CE1' ' A' ' 69' ' ' PHE . 4.0 mtpp -61.74 -33.27 73.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.784 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 mt -59.92 -54.25 48.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.781 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 166.8 -112.69 0.51 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.186 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -150.23 31.24 0.68 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.071 0.462 . . . . 0.0 110.596 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -121.0 -142.27 0.34 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.335 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 t -117.0 170.4 8.66 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.793 0.33 . . . . 0.0 110.645 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -69.57 98.35 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.358 0.599 . . . . 0.0 110.359 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 pt -80.12 87.31 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.439 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.33 30.92 72.28 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.326 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -41.31 129.47 2.98 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.894 0.378 . . . . 0.0 111.331 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.83 153.65 45.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.359 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.5 mmt -113.63 146.48 35.55 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.628 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.3 Cg_endo -84.63 134.55 20.57 Favored 'Cis proline' 0 N--CA 1.46 -0.454 0 C-N-CA 124.006 -1.248 . . . . 0.0 112.57 0.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -90.11 133.33 34.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.96 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.7 t -107.46 156.53 7.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.263 0.554 . . . . 0.0 111.851 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.41 ' CE1' ' CB ' ' A' ' 54' ' ' LYS . 39.2 m-85 -142.95 136.43 28.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.665 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.57 149.22 8.33 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.368 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.57 ' HB3' ' N ' ' A' ' 1' ' ' MET . 9.3 Cg_exo -68.86 -11.61 32.31 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.709 2.273 . . . . 0.0 112.133 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -106.42 -18.74 13.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.994 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.2 85.31 0.96 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.63 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -179.75 117.71 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.793 0.33 . . . . 0.0 110.833 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -58.51 116.63 3.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.971 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.4 mt -91.81 -46.51 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.811 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.68 -156.38 22.75 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.491 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.6 -140.95 8.2 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.505 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -70.12 -69.02 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.698 0.285 . . . . 0.0 110.906 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -54.37 -43.48 71.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.963 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -55.32 -37.92 68.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.678 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.475 HD21 ' CD2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -71.99 -41.58 67.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.378 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.01 -29.95 23.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -72.85 -35.31 67.2 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' LEU . 34.2 t80 -63.49 -33.95 76.7 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.206 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.475 ' CD2' HD21 ' A' ' 82' ' ' LEU . 6.3 m-85 -87.14 -26.88 23.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.133 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.878 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.644 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 40.0 ttp . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.435 ' CD1' HD22 ' A' ' 24' ' ' LEU . 87.0 m-85 -77.39 147.58 35.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.054 179.001 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.706 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.5 mptt -111.5 121.0 44.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.589 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.483 HG12 ' CE1' ' A' ' 33' ' ' PHE . 8.4 t -103.4 129.22 55.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.24 0.543 . . . . 0.0 111.676 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.485 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 3.9 m-30 -105.68 99.4 9.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.504 178.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.36 -136.58 2.03 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.64 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.407 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 90.0 m-85 -116.44 144.28 44.5 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.918 0.39 . . . . 0.0 111.518 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' A' ' 9' ' ' SER . 22.6 t0 -73.1 -9.16 58.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.2 t 84.8 -14.11 0.63 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.577 0.351 . . . . 0.0 111.507 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -85.27 -31.19 23.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.693 0.282 . . . . 0.0 111.324 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.432 ' CD1' ' N ' ' A' ' 11' ' ' ILE . 2.4 mp -100.0 -38.38 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.645 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.407 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 15.2 t60 -139.41 179.47 6.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.355 -179.015 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -70.07 166.21 20.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.619 0.247 . . . . 0.0 110.8 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 t -176.91 71.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.19 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.0 m -90.64 -21.1 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.722 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -81.08 -23.11 38.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.3 p -77.68 -45.14 25.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 110.573 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -50.78 -34.07 25.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.704 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -73.07 -59.7 2.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.67 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.53 -41.32 69.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.426 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 70.3 tttt -54.57 -49.73 69.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.328 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -64.62 -31.43 72.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.276 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.3 tt -56.45 -51.05 69.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.394 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.435 HD22 ' CD1' ' A' ' 2' ' ' PHE . 2.9 mt -60.02 -51.94 67.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.72 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.3 m -51.03 -38.95 54.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.584 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.81 -31.58 54.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.677 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -86.59 -9.2 56.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.138 179.709 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 3.2 mptp? 70.59 52.33 0.32 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.067 0.461 . . . . 0.0 110.831 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -130.77 136.03 28.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.72 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.644 ' O ' ' HA ' ' A' ' 1' ' ' MET . 58.1 Cg_endo -80.96 157.09 20.58 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.596 2.197 . . . . 0.0 111.381 179.443 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 8.4 p90 -161.51 171.31 18.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.823 0.344 . . . . 0.0 111.774 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -133.98 134.55 42.64 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.483 ' CE1' HG12 ' A' ' 4' ' ' VAL . 23.0 t80 -89.36 154.54 19.99 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.093 0.473 . . . . 0.0 111.54 -179.566 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.401 HD11 ' CE1' ' A' ' 5' ' ' TYR . 8.4 mt -146.41 119.36 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.187 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -100.15 135.66 41.24 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.244 -179.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 44' ' ' ASP . 31.8 pt -97.91 20.43 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.191 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.43 ' CG ' HG21 ' A' ' 11' ' ' ILE . 15.1 tpp -144.33 70.94 16.07 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.658 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -87.82 34.2 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.026 2.484 . . . . 0.0 112.818 -179.482 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -139.74 170.42 15.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.612 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -63.22 -7.82 6.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.203 0.525 . . . . 0.0 111.931 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.73 55.24 0.02 OUTLIER Glycine 0 C--N 1.312 -0.757 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.403 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.9 t -150.02 131.7 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.001 0.429 . . . . 0.0 111.413 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.0 160.4 33.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.818 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 36' ' ' ILE . 3.7 t70 -97.63 89.25 4.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.081 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.81 -20.85 38.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.614 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -64.34 -59.2 4.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.816 0.341 . . . . 0.0 110.67 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -71.12 -41.05 71.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.399 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 54.8 mt -51.91 -44.08 37.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.694 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.62 -55.78 26.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.435 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.77 -31.84 71.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.296 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 1.5 tt -56.34 -52.94 62.68 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.008 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 2.2 mt -52.91 -48.62 67.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.722 179.152 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -62.33 -44.49 96.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.295 179.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.79 -39.09 83.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.552 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.74 -53.9 52.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.32 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.3 -108.99 0.27 Allowed Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.773 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -150.45 26.56 0.76 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.073 0.463 . . . . 0.0 110.862 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -121.62 -150.78 0.46 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.265 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.2 t -120.8 170.27 9.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.594 179.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -82.52 98.35 8.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.24 0.543 . . . . 0.0 110.314 179.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.448 ' CG2' ' O ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -80.09 87.23 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.879 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.67 28.06 56.04 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.478 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.87 143.54 16.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.8 p -111.55 158.17 19.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.16 0.505 . . . . 0.0 111.312 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.91 153.01 47.03 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.611 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.0 Cg_exo -81.1 156.12 83.38 Favored 'Cis proline' 0 C--N 1.344 0.309 0 C-N-CA 124.025 -1.24 . . . . 0.0 112.806 0.29 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -113.29 115.83 28.78 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.859 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.706 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -87.57 164.19 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.035 0.445 . . . . 0.0 111.792 -178.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.466 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 45.1 m-85 -142.33 140.49 32.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.528 -179.683 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.43 132.77 53.55 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.285 -179.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.578 ' HB3' ' N ' ' A' ' 1' ' ' MET . 31.6 Cg_exo -53.25 -22.37 19.93 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.594 2.196 . . . . 0.0 112.133 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.95 39.77 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.341 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.23 -109.86 0.68 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.987 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.8 p -138.91 178.41 7.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.075 0.464 . . . . 0.0 111.211 -179.546 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.466 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 32.8 t-80 -55.84 127.09 28.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.061 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.3 mt -96.03 -45.02 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.987 0.422 . . . . 0.0 110.734 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.87 -158.44 23.3 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.462 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.74 -141.13 9.06 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.688 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -71.08 -61.14 1.87 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.73 0.3 . . . . 0.0 110.825 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -56.94 -48.3 78.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.85 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -56.99 -45.7 82.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.793 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.481 HD21 ' CD2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -66.42 -41.62 88.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.398 179.918 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -51.76 -31.66 27.65 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -71.94 -35.8 69.72 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.104 178.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 82' ' ' LEU . 23.8 t80 -63.37 -33.78 76.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.165 178.33 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.481 ' CD2' HD21 ' A' ' 82' ' ' LEU . 6.2 m-85 -87.96 -27.31 22.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.135 179.472 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.961 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.596 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 28.0 ttm . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.75 0.31 . . . . 0.0 111.756 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.471 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 77.6 m-85 -66.83 152.11 46.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.96 0.409 . . . . 0.0 110.445 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.65 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 3.0 mptt -126.6 124.29 39.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.224 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.496 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 16.9 t -103.43 132.45 49.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.273 0.558 . . . . 0.0 111.528 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.1 m-85 -109.23 98.98 8.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.066 178.42 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.23 -137.99 2.39 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 119.995 -1.098 . . . . 0.0 112.355 -179.362 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.634 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 3.4 m-85 -128.86 120.69 26.7 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 120.54 0.209 . . . . 0.0 111.296 -178.642 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.474 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -117.52 69.32 0.77 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.595 0.236 . . . . 0.0 111.62 -179.601 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 36.9 t 177.87 -172.0 0.11 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.085 0.469 . . . . 0.0 111.767 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.87 7.59 26.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.831 179.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.431 HG12 ' HB3' ' A' ' 9' ' ' SER . 1.0 OUTLIER -87.53 -17.87 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.905 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 37.3 t-80 -165.41 122.7 1.5 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.658 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.57 154.09 32.68 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.993 -178.1 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.6 t -159.64 95.31 1.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.925 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.7 m -74.61 -35.99 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.955 0.407 . . . . 0.0 110.563 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -65.9 -20.14 66.12 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.534 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.7 m -66.94 -60.94 2.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.791 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.42 -42.57 67.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.169 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -61.91 -52.75 62.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.081 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.517 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -58.87 -49.66 76.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.979 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -50.01 -32.67 15.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.58 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -69.68 -38.62 77.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.629 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.424 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -58.23 -54.09 50.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.659 179.491 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mt -54.69 -43.31 72.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.928 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.3 m -58.47 -33.09 69.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.031 0.443 . . . . 0.0 109.974 179.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -78.81 -30.65 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.711 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -9.78 59.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.137 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt 64.68 56.87 1.13 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.071 0.462 . . . . 0.0 110.611 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.419 ' NE2' ' HD2' ' A' ' 30' ' ' PRO . 11.1 mm100 -132.6 130.33 21.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.089 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.428 ' O ' ' HA ' ' A' ' 1' ' ' MET . 86.3 Cg_endo -73.84 138.28 25.84 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.24 1.96 . . . . 0.0 110.924 178.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.596 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 48.1 p90 -155.1 170.64 21.33 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -141.63 144.0 33.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.048 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.496 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 33.2 t80 -89.71 162.1 15.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.05 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.477 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 7.1 mt -148.75 119.81 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.258 0.551 . . . . 0.0 110.816 179.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -89.81 139.34 30.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.042 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.428 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -99.72 -26.11 3.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.215 -179.989 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.584 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 10.2 ttm -119.38 88.93 39.24 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.753 0.311 . . . . 0.0 111.64 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.49 -6.95 15.74 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.525 2.15 . . . . 0.0 112.245 179.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -139.39 141.87 37.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.57 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -69.2 -7.78 39.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.282 0.563 . . . . 0.0 111.964 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.25 -60.46 1.92 Allowed Glycine 0 C--N 1.311 -0.853 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.895 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 t -150.48 128.87 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.553 0.216 . . . . 0.0 110.561 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.584 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -57.94 170.09 0.68 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.207 -179.641 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.414 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -78.87 87.24 4.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.476 -179.066 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -54.15 -22.67 11.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.275 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -56.0 -51.48 67.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.891 0.377 . . . . 0.0 110.572 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -73.06 -32.81 65.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.276 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 44' ' ' ASP . 40.0 mm -57.2 -50.89 75.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.79 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.25 70.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.536 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.26 -32.14 69.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.318 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.483 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.99 -57.22 13.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.236 179.933 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.476 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 16.4 mt -44.54 -45.84 9.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.265 0.555 . . . . 0.0 111.125 178.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.2 m -70.11 -30.59 67.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.362 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -66.46 -41.28 89.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.121 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.483 ' CD1' ' O ' ' A' ' 51' ' ' LEU . 3.3 mp -62.28 -54.75 36.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.057 0.456 . . . . 0.0 110.81 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.33 -115.17 0.37 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.061 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -150.64 30.92 0.65 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.065 0.46 . . . . 0.0 110.687 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -121.04 -145.75 0.36 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.352 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.8 t -115.85 170.25 8.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.677 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -70.03 98.14 1.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.314 0.578 . . . . 0.0 110.55 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -80.26 84.41 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.861 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.4 27.37 47.35 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.184 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.428 HD12 ' CD2' ' A' ' 55' ' ' LEU . 1.6 mm? -55.5 135.65 50.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.892 0.377 . . . . 0.0 111.349 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.75 159.9 40.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.161 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -102.19 152.14 38.21 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.958 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.9 Cg_exo -81.48 143.29 57.89 Favored 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 123.945 -1.273 . . . . 0.0 112.666 0.18 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -108.17 118.22 36.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.014 179.06 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.3 t -92.34 166.32 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.029 0.442 . . . . 0.0 111.899 -178.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -141.91 134.78 28.71 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.788 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.455 ' HA ' HD12 ' A' ' 76' ' ' ILE . . . -49.67 150.15 3.86 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.529 -179.211 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.548 ' HB3' ' N ' ' A' ' 1' ' ' MET . 45.6 Cg_exo -58.67 -33.77 98.48 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.216 2.611 . . . . 0.0 112.268 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -90.16 -21.67 22.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.365 -179.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.76 88.98 0.86 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.73 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.23 162.1 6.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.337 . . . . 0.0 110.543 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.461 ' CE1' HD21 ' A' ' 55' ' ' LEU . 8.0 t-160 -90.52 115.64 27.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.102 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.455 HD12 ' HA ' ' A' ' 70' ' ' ALA . 6.8 mt -91.78 -49.41 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.011 0.434 . . . . 0.0 110.983 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.61 -154.01 16.53 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.276 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.12 -143.54 5.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.294 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.517 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -77.01 -69.57 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.58 0.19 . . . . 0.0 110.738 179.76 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -48.2 -45.46 33.87 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.25 0.548 . . . . 0.0 110.327 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -35.37 76.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.175 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 85' ' ' TYR . 4.0 tt -78.38 -38.13 42.48 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.406 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 87' ' ' LYS . 11.4 mtm180 -50.78 -32.14 18.99 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -68.43 -34.8 76.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.16 178.117 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 82' ' ' LEU . 8.0 t80 -63.67 -34.36 77.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.36 178.415 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.453 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.1 m-85 -89.91 -70.48 0.66 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.392 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.906 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.768 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 6.3 tpt . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.465 ' H ' ' HG3' ' A' ' 1' ' ' MET . 92.4 m-85 -39.56 116.99 0.68 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.74 0.781 . . . . 0.0 111.455 -177.276 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -90.16 128.53 36.37 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.39 -179.163 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.463 HG11 ' CE1' ' A' ' 33' ' ' PHE . 37.1 t -115.81 127.12 73.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.26 0.552 . . . . 0.0 111.548 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.559 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 18.6 m-85 -103.93 98.13 8.02 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' A' ' 36' ' ' ILE . . . -155.56 -139.8 2.85 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.891 -179.004 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.463 ' CE2' ' HE3' ' A' ' 37' ' ' MET . 17.1 m-85 -131.75 158.39 41.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -178.3 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.403 ' O ' ' CB ' ' A' ' 9' ' ' SER . 41.9 t0 -70.74 -69.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.595 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 3.2 t 164.09 -31.41 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.606 179.642 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -83.0 -26.88 30.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.546 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.45 ' CG2' ' O ' ' A' ' 39' ' ' GLU . 4.2 mp -88.21 -49.3 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.997 179.391 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -144.49 153.97 42.42 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.901 179.052 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -48.55 156.58 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.642 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.27 62.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.916 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 m -80.11 -48.8 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.049 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.29 -20.46 65.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.513 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 m -65.34 -47.68 75.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.291 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -55.53 -26.01 40.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.737 179.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -73.08 -42.97 62.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.471 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.05 -40.74 78.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.098 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -62.81 -56.76 14.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.737 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.95 -34.22 71.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.221 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.87 -51.48 69.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.896 179.146 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.445 HD21 ' CZ ' ' A' ' 86' ' ' PHE . 6.7 mt -57.9 -42.84 85.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.638 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.7 m -60.54 -39.26 87.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.932 179.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.1 t -74.25 -39.24 49.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.534 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 1.7 tmtm? -74.29 -12.79 60.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.949 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt 68.56 49.16 0.77 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.938 0.399 . . . . 0.0 110.643 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -137.56 102.31 8.74 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.378 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.768 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 86.8 Cg_exo -44.91 171.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.518 2.145 . . . . 0.0 112.65 179.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 4.0 p90 -163.28 170.29 17.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.6 178.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 3.4 tt0 -132.54 112.49 12.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.686 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.463 ' CE1' HG11 ' A' ' 4' ' ' VAL . 9.9 t80 -89.1 153.84 20.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.17 0.51 . . . . 0.0 111.266 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.9 mt -149.98 121.74 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.331 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -70.56 109.4 4.83 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.499 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.451 ' CG2' ' CE2' ' A' ' 7' ' ' TYR . 18.7 tt -72.4 -19.29 19.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.583 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.5 ttp -134.59 94.94 16.44 Favored Pre-proline 0 N--CA 1.454 -0.227 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.974 179.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -85.93 24.06 0.78 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.677 2.251 . . . . 0.0 112.105 179.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.45 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 6.7 tt0 -139.49 165.82 26.2 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.754 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -62.72 -7.54 5.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -179.054 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.65 35.58 0.06 OUTLIER Glycine 0 C--N 1.313 -0.705 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.825 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.464 ' N ' ' SD ' ' A' ' 37' ' ' MET . 4.3 t -147.72 121.13 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.906 0.384 . . . . 0.0 111.081 178.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.583 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -79.28 150.78 31.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.742 179.752 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -78.11 99.82 6.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.132 -179.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -48.52 -29.75 4.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.537 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -60.52 -54.38 46.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.959 0.409 . . . . 0.0 110.773 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -68.92 -41.91 77.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.847 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 43' ' ' PHE . 2.7 mp -63.22 -36.06 74.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.129 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.24 -52.49 65.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.659 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.01 -33.07 72.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.302 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.559 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.1 tt -60.15 -51.98 67.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.308 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 1.9 mt -52.38 -44.49 65.33 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.344 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.7 m -58.19 -49.19 77.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.734 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.6 mtpp -59.53 -36.59 76.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.689 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.96 -52.23 66.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.567 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.05 -118.5 0.66 Allowed Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.054 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -141.35 27.9 1.88 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.199 0.524 . . . . 0.0 110.589 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -121.5 -147.23 0.38 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.257 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.4 t -120.26 170.19 9.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.695 0.283 . . . . 0.0 110.603 179.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -69.95 98.01 1.22 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.348 0.594 . . . . 0.0 110.423 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -80.36 84.25 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.084 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.72 26.51 60.28 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.395 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -50.33 148.24 3.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 111.072 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.1 p -122.92 165.22 17.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.427 -179.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -118.46 153.64 51.96 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.734 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -86.81 136.28 17.8 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.318 -1.117 . . . . 0.0 112.495 0.203 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -91.76 129.6 37.7 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.4 t -103.2 154.29 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.123 0.487 . . . . 0.0 112.006 -179.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 44.5 m-85 -142.63 138.08 30.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.801 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 72' ' ' ASP . . . -48.16 164.04 0.28 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.755 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.503 ' HB3' ' HA ' ' A' ' 1' ' ' MET . 32.5 Cg_endo -62.88 58.93 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.742 2.294 . . . . 0.0 111.453 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 86.61 29.96 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.88 -178.665 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.66 -91.07 2.11 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.857 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.68 -169.19 3.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.015 0.436 . . . . 0.0 110.998 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 17.1 t-80 -83.31 125.07 31.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.162 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 70' ' ' ALA . 13.7 mt -96.92 -45.89 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.95 0.405 . . . . 0.0 110.741 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 137.97 -156.62 23.9 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.659 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.01 -139.97 8.54 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.733 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -72.53 -70.57 0.34 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.718 0.294 . . . . 0.0 111.048 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -56.42 -48.01 77.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.917 0.389 . . . . 0.0 110.809 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -52.09 -41.44 62.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.644 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.467 HD23 ' CE2' ' A' ' 86' ' ' PHE . 6.2 tt -76.57 -34.23 58.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.208 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -51.52 -28.95 15.05 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -69.22 -34.07 74.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.216 178.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 82' ' ' LEU . 6.8 t80 -64.75 -33.25 75.54 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.446 178.508 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.467 ' CE2' HD23 ' A' ' 82' ' ' LEU . 7.1 m-85 -90.52 -66.89 0.89 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.584 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.8 pttt . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.137 -0.935 . . . . 0.0 110.917 -179.906 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.571 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 25.7 ttp . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.774 0.321 . . . . 0.0 111.669 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.475 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 80.9 m-85 -67.32 151.26 47.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.95 0.405 . . . . 0.0 110.529 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.67 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 3.3 mptt -127.11 120.39 28.77 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.569 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.49 HG13 ' CE1' ' A' ' 33' ' ' PHE . 14.5 t -106.79 130.82 58.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.251 0.548 . . . . 0.0 111.805 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 3.6 m-30 -106.39 99.4 8.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.408 178.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.41 -137.36 2.17 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.842 -1.17 . . . . 0.0 112.985 -179.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -118.5 147.25 43.84 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.825 0.345 . . . . 0.0 110.936 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -90.73 13.13 17.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.607 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 0.3 OUTLIER 71.95 4.88 5.18 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.629 0.252 . . . . 0.0 111.44 179.931 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -85.79 -58.21 2.74 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.906 0.384 . . . . 0.0 111.033 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.5 mt -91.65 -27.03 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.544 -179.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.468 ' O ' ' HA ' ' A' ' 9' ' ' SER . 30.9 t60 -139.49 145.21 38.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.676 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.39 158.07 34.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.566 -179.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.5 t -175.78 96.11 0.06 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -80.88 -32.15 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.011 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -70.47 -23.17 62.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.596 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.5 m -62.52 -52.81 62.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.268 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.02 -27.28 52.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.301 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -71.16 -49.59 42.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.254 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.06 -47.22 71.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.177 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HD3' ' CE2' ' A' ' 31' ' ' PHE . 1.1 tppt? -59.65 -52.95 63.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.715 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.36 -41.25 79.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.767 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 tt -58.49 -54.25 49.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.388 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 mt -57.31 -46.42 83.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.769 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 m -57.73 -37.09 72.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.093 0.473 . . . . 0.0 110.228 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.96 -29.6 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.695 179.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -16.8 54.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.142 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.54 56.36 0.11 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.926 0.393 . . . . 0.0 110.9 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -136.96 141.62 35.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.444 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.9 Cg_endo -80.43 137.13 11.54 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.584 2.189 . . . . 0.0 111.647 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.571 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 32.0 p90 -158.32 170.61 21.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.847 0.356 . . . . 0.0 111.773 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -147.26 145.68 29.5 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.035 0.445 . . . . 0.0 111.167 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.49 ' CE1' HG13 ' A' ' 4' ' ' VAL . 10.2 t80 -89.5 163.58 15.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.168 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.43 HD12 ' CE1' ' A' ' 5' ' ' TYR . 11.5 mt -148.22 121.3 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.527 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -81.84 127.67 33.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.263 -179.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 pt -95.57 -16.27 7.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.185 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.49 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 43.9 ttm -119.0 102.99 48.58 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.933 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 76.9 Cg_endo -76.2 -25.89 9.61 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.632 2.221 . . . . 0.0 112.035 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -139.96 151.01 45.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.767 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.21 -8.48 24.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.262 0.553 . . . . 0.0 111.656 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.71 -57.81 2.65 Favored Glycine 0 C--N 1.313 -0.725 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.671 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -148.73 139.11 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.642 0.258 . . . . 0.0 111.523 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -60.07 170.55 1.2 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.598 179.648 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.428 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 28.8 t0 -86.34 104.16 15.59 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -57.02 -22.65 40.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.434 179.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -58.05 -51.74 68.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.799 0.333 . . . . 0.0 110.686 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -74.86 -40.63 60.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.346 179.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.7 mm -55.13 -47.48 77.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.771 179.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.03 -47.08 78.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.435 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.78 -37.88 85.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.381 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.42 HD11 ' CE2' ' A' ' 5' ' ' TYR . 19.8 tp -56.01 -51.27 68.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.732 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.9 mt -53.43 -47.58 69.52 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.227 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.7 m -65.24 -38.06 89.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.274 179.333 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.7 mtpp -63.91 -39.11 93.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.588 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -47.32 86.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.397 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 166.28 -109.64 0.36 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.987 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -150.72 31.54 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.034 0.445 . . . . 0.0 110.527 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.98 -149.96 0.44 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.7 t -120.38 170.33 9.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.694 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -80.4 98.44 7.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.271 0.558 . . . . 0.0 110.408 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.6 mm -78.6 83.65 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.78 24.79 50.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.369 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.21 141.05 56.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.874 0.368 . . . . 0.0 110.872 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.7 p -125.63 169.0 12.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.1 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.26 157.19 36.98 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.664 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.0 Cg_exo -81.82 143.45 56.38 Favored 'Cis proline' 0 C--N 1.344 0.292 0 C-N-CA 123.843 -1.315 . . . . 0.0 112.933 0.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 5' ' ' TYR . 19.0 mt-30 -99.85 114.73 28.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.106 178.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.67 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.8 t -90.28 164.19 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.073 0.463 . . . . 0.0 111.712 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.422 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 41.3 m-85 -142.48 131.49 23.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.62 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -48.38 152.28 1.63 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.439 -178.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.535 ' HB3' ' N ' ' A' ' 1' ' ' MET . 45.0 Cg_exo -58.39 -22.53 58.93 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.116 2.544 . . . . 0.0 112.218 179.168 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.0 -24.79 14.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.13 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.26 94.29 0.99 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.75 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.1 t -179.61 143.5 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.82 0.343 . . . . 0.0 110.774 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -72.9 106.13 4.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.965 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.6 mt -79.97 -52.06 15.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.65 -153.77 20.99 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.471 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.62 -147.3 12.41 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.335 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -69.95 -58.09 4.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.805 0.336 . . . . 0.0 110.624 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -55.88 -44.56 78.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.794 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -57.86 -43.36 85.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.471 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.434 HD23 ' CD2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -61.83 -48.8 78.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.391 179.636 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -51.13 -30.21 15.81 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.98 -34.77 62.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.261 178.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 82' ' ' LEU . 12.7 t80 -65.99 -32.39 73.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.343 178.439 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.434 ' CD2' HD23 ' A' ' 82' ' ' LEU . 8.1 m-85 -90.02 -70.15 0.68 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.212 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.918 -179.941 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.601 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 15.5 ttm . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -75.45 146.68 40.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.992 178.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.5 mptm? -110.5 122.01 46.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.719 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 67' ' ' GLN . 67.8 t -114.26 133.72 59.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.329 0.585 . . . . 0.0 112.316 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.588 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 18.5 m-85 -111.68 100.72 9.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.176 178.088 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.09 -141.57 3.16 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.51 -179.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.596 ' CD2' ' CB ' ' A' ' 12' ' ' HIS . 52.5 m-85 -117.27 159.18 23.09 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.236 0.214 . . . . 0.0 110.426 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -106.29 17.12 23.91 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.074 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 1.0 OUTLIER 73.18 -1.81 2.93 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 179.936 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -84.99 -46.82 10.85 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.18 0.514 . . . . 0.0 110.507 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.4 0.6 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.589 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.685 ' CD2' ' HE1' ' A' ' 37' ' ' MET . 11.9 t-80 -166.96 135.17 2.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.397 -177.784 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.48 164.51 22.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.945 -179.066 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 p 177.73 125.65 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.96 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.2 m -91.4 -30.44 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.123 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -77.2 -21.9 53.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.351 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.1 p -72.95 -41.46 64.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.974 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.67 -36.93 84.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.072 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -63.61 -55.48 23.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.69 -28.92 36.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.88 0.371 . . . . 0.0 110.908 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -61.95 -55.14 32.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.021 0.439 . . . . 0.0 110.11 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -29.4 69.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.565 179.402 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.39 -50.74 64.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.536 179.445 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.467 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -64.55 -50.21 68.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.603 179.846 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 m -56.71 -41.25 77.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.807 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.7 t -69.94 -35.16 63.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.931 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.42 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 3.9 mmtt -74.02 -10.96 60.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.303 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt 70.87 36.99 1.38 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.08 0.467 . . . . 0.0 110.724 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -126.37 138.26 31.96 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.549 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.601 ' O ' ' HA ' ' A' ' 1' ' ' MET . 86.8 Cg_endo -78.34 161.55 28.69 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.458 2.106 . . . . 0.0 111.456 179.601 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 6.5 p90 -161.61 171.31 18.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.328 . . . . 0.0 111.513 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -134.29 121.79 21.78 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.768 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.441 ' CE1' HG11 ' A' ' 4' ' ' VAL . 18.2 t80 -89.44 157.96 17.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 20.1 mt -148.49 120.64 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.635 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -71.24 110.87 6.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.379 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 7' ' ' TYR . 1.1 pp -74.0 -29.35 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.398 -179.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.685 ' HE1' ' CD2' ' A' ' 12' ' ' HIS . 20.7 ttm -118.28 86.7 27.95 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.661 0.267 . . . . 0.0 110.598 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.446 ' HG3' ' HB3' ' A' ' 44' ' ' ASP . 93.0 Cg_endo -79.54 5.15 6.06 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.571 2.181 . . . . 0.0 112.674 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -139.79 141.25 36.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.113 0.482 . . . . 0.0 111.357 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -63.68 -7.41 7.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.019 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.25 -67.22 0.64 Allowed Glycine 0 C--N 1.314 -0.67 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.188 -179.227 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.6 t -125.59 136.92 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.726 0.298 . . . . 0.0 111.62 -179.259 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -71.61 170.35 13.62 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.052 179.783 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.446 ' HB3' ' HG3' ' A' ' 38' ' ' PRO . 4.8 p30 -77.78 124.66 28.24 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.089 0.471 . . . . 0.0 111.711 -179.428 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.24 -26.39 39.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.71 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -61.19 -51.44 68.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 111.291 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.95 -37.55 67.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.858 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.451 ' N ' HD13 ' A' ' 48' ' ' ILE . 1.2 mp -72.09 -25.81 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 179.614 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.84 -52.68 40.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.563 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.87 -34.71 73.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.185 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.588 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 3.4 tt -57.52 -52.04 67.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.478 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.1 mt -52.78 -45.0 66.94 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.586 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.7 m -63.42 -44.82 93.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.418 179.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -59.62 -33.09 71.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.711 179.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.33 -66.66 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.25 -28.48 0.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.598 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.28 -165.09 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.742 0.306 . . . . 0.0 110.808 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -103.65 -25.83 13.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.038 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -87.33 164.69 16.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.871 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.417 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . 13.0 mt-30 -109.44 99.28 8.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.001 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pt -80.25 84.39 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.126 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.08 26.01 74.21 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.283 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.417 ' CB ' ' HB3' ' A' ' 60' ' ' GLN . 1.7 tm? -62.57 130.59 45.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.861 0.362 . . . . 0.0 110.965 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.68 152.79 50.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -104.43 152.91 39.39 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.624 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.8 Cg_exo -82.4 140.52 43.29 Favored 'Cis proline' 0 C--N 1.344 0.305 0 C-N-CA 124.025 -1.24 . . . . 0.0 112.817 0.32 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 1.1 mm-40 -99.97 135.85 40.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.078 179.096 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.3 t -106.85 158.73 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.05 0.452 . . . . 0.0 111.875 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.485 ' CE2' ' HB2' ' A' ' 75' ' ' HIS . 34.0 m-85 -143.08 138.51 29.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.192 -179.582 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.19 133.05 51.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.171 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.586 ' HB3' ' N ' ' A' ' 1' ' ' MET . 39.1 Cg_exo -54.38 -21.46 23.52 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.543 2.162 . . . . 0.0 112.133 179.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.24 40.08 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.337 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.34 -109.38 0.66 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.884 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.68 -178.07 5.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.11 0.481 . . . . 0.0 111.236 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.485 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 29.7 t-80 -56.61 122.64 12.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.053 -179.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.3 mt -91.08 -47.31 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.689 179.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.11 -155.49 22.44 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.673 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.65 -141.03 9.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.663 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -70.39 -70.76 0.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.72 0.295 . . . . 0.0 110.982 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.76 -49.45 77.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.981 0.419 . . . . 0.0 110.439 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -50.73 -36.18 35.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.445 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.548 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.2 tt -82.23 -32.04 29.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.292 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -50.95 -30.6 15.33 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -35.7 79.41 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.134 178.287 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LEU . 16.1 t80 -63.55 -33.53 75.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.399 178.437 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.548 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.5 m-85 -86.11 -70.34 0.61 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.113 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.954 179.939 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.557 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 35.8 ttp . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.78 0.324 . . . . 0.0 111.562 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.43 ' CZ ' ' CZ ' ' A' ' 86' ' ' PHE . 70.2 m-85 -59.46 148.79 31.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 -179.292 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.667 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -119.0 123.39 44.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.209 -179.057 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.534 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 8.0 t -114.72 139.6 39.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.319 0.581 . . . . 0.0 111.688 179.424 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -122.49 99.77 6.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.454 178.491 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' A' ' 66' ' ' PRO . . . -158.52 -141.71 3.22 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.435 -179.454 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.43 ' CE1' ' CD1' ' A' ' 36' ' ' ILE . 54.8 m-85 -123.13 160.4 26.52 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.826 0.346 . . . . 0.0 111.467 -179.091 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.7 p-10 -93.66 -65.47 0.99 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.9 OUTLIER 162.28 -37.71 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.251 179.88 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -63.82 -45.08 91.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.806 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 40' ' ' LYS . 4.2 mm -89.02 -41.47 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.059 0.456 . . . . 0.0 110.544 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -147.75 138.23 23.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.255 179.183 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.72 155.09 26.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.716 -178.782 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.5 p -162.5 119.11 1.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.392 179.382 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.4 m -88.78 -22.98 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.534 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -90.45 -15.47 30.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.453 -179.749 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.3 p -74.62 -43.65 54.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.79 0.328 . . . . 0.0 110.859 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.48 -46.61 82.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.929 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -55.94 -45.35 78.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.116 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.76 -38.82 92.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.924 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.22 -42.62 61.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.033 0.444 . . . . 0.0 110.379 179.424 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -73.24 -26.1 60.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.566 179.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.511 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -57.26 -55.94 28.29 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.327 179.657 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.409 HD12 ' CG ' ' A' ' 31' ' ' PHE . 10.6 mt -62.42 -46.82 86.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.628 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.0 m -53.5 -33.08 53.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.042 0.448 . . . . 0.0 110.266 179.462 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -75.7 -30.29 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.653 179.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.52 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 3.4 mmtm -78.21 -9.86 59.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.402 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 64.62 40.49 5.91 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 111.386 179.818 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -122.35 145.17 43.73 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.287 179.332 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.408 ' O ' ' HA ' ' A' ' 1' ' ' MET . 92.6 Cg_endo -78.59 135.43 13.03 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.287 1.991 . . . . 0.0 111.908 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.557 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 17.0 p90 -146.25 167.66 22.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.907 0.384 . . . . 0.0 111.797 179.681 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -136.11 122.06 20.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.2 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.534 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 42.0 t80 -89.76 150.38 22.31 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.229 179.437 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.4 mt -143.77 119.53 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.157 0.503 . . . . 0.0 110.936 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -78.13 109.65 12.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.869 179.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.43 ' CD1' ' CE1' ' A' ' 7' ' ' TYR . 13.9 pt -59.64 -29.01 41.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.397 -179.291 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.558 ' HB2' ' HB3' ' A' ' 43' ' ' PHE . 3.2 ttp -121.82 87.04 46.22 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.706 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.43 -4.04 14.74 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.732 2.288 . . . . 0.0 112.797 -179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -139.58 135.61 33.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.817 0.341 . . . . 0.0 110.694 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.42 ' N ' HG23 ' A' ' 11' ' ' ILE . 5.4 ttmt -65.16 -7.65 13.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.291 0.567 . . . . 0.0 112.055 -179.595 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.47 -64.6 1.38 Allowed Glycine 0 C--N 1.312 -0.766 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.815 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.7 t -141.03 129.91 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.066 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.558 ' HB3' ' HB2' ' A' ' 37' ' ' MET . 0.0 OUTLIER -69.0 166.76 17.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.138 0.494 . . . . 0.0 112.184 -178.719 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.456 ' O ' ' CD1' ' A' ' 48' ' ' ILE . 10.4 t70 -82.24 97.2 8.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.886 -178.764 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -67.49 -15.89 63.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.837 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.437 ' HB2' ' OD1' ' A' ' 44' ' ' ASP . 2.9 mm-40 -63.53 -51.05 67.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.71 0.291 . . . . 0.0 110.647 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -71.11 -37.67 72.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.348 179.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.487 HD12 ' CD2' ' A' ' 43' ' ' PHE . 1.5 mp -67.58 -35.36 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.882 179.239 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.38 -47.12 86.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.712 179.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.8 -39.08 87.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.316 179.674 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.433 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 10.5 tp -56.75 -51.41 68.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.443 179.686 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.3 mt -50.82 -45.71 59.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.489 179.715 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.0 m -61.57 -42.22 98.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.614 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.61 -38.57 85.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.704 179.819 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.91 -59.04 6.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.924 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.09 -26.2 0.62 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.06 -179.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -135.83 -162.12 1.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.55 23.24 12.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.58 0.229 . . . . 0.0 111.293 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.7 t -120.89 143.16 49.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.911 0.386 . . . . 0.0 111.804 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -96.7 99.57 11.17 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.575 178.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -72.27 77.52 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.43 -178.403 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 36.09 30.03 0.02 OUTLIER Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.056 178.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 61' ' ' ILE . 0.8 OUTLIER -65.74 162.23 19.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.008 0.432 . . . . 0.0 111.265 -179.466 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.2 158.6 17.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.081 -179.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.2 mtm -116.2 156.93 46.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.564 179.596 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . 4.8 Cg_exo -80.92 147.26 73.45 Favored 'Cis proline' 0 C--N 1.346 0.406 0 C-N-CA 124.244 -1.149 . . . . 0.0 112.991 0.511 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.54 135.66 34.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.039 178.748 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.667 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.1 t -113.5 159.09 13.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.948 0.404 . . . . 0.0 111.659 -179.494 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.459 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 40.0 m-85 -142.43 147.02 35.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.637 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.461 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -56.11 157.97 7.91 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.55 -178.464 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.505 ' HB3' ' N ' ' A' ' 1' ' ' MET . 32.3 Cg_exo -60.67 -25.98 82.01 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.262 2.642 . . . . 0.0 112.258 179.288 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -20.67 17.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.443 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.23 89.01 1.11 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.665 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.25 145.76 3.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.655 0.264 . . . . 0.0 110.386 179.845 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -78.43 115.41 18.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.835 0.35 . . . . 0.0 110.937 -179.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.461 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 1.8 mp -102.13 -46.05 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.711 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.32 -159.47 22.39 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.874 179.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.53 -123.24 3.24 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.5 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.511 ' CE1' ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -83.39 -67.72 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.779 -0.247 . . . . 0.0 110.947 179.769 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -50.51 -48.02 57.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.274 0.559 . . . . 0.0 110.463 179.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -60.5 -47.43 86.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.847 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.439 HD22 ' CE2' ' A' ' 86' ' ' PHE . 1.1 tt -66.62 -41.77 87.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.551 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.46 ' O ' ' N ' ' A' ' 87' ' ' LYS . 7.1 ttt180 -51.67 -31.38 25.53 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.826 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -71.25 -32.78 69.15 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.513 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.444 ' CD2' HG12 ' A' ' 76' ' ' ILE . 49.2 t80 -70.26 -29.22 65.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.016 178.853 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.439 ' CE2' HD22 ' A' ' 82' ' ' LEU . 26.4 m-85 -99.66 -70.85 0.72 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.558 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 83' ' ' ARG . 15.2 pttp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.413 179.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.625 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 10.5 ttm . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.829 0.347 . . . . 0.0 111.675 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.472 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 85.4 m-85 -83.85 145.81 28.44 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.226 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.71 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -123.99 126.51 46.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 -179.26 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.454 HG11 ' CE1' ' A' ' 33' ' ' PHE . 70.2 t -114.04 132.52 62.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.393 0.616 . . . . 0.0 111.49 179.273 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.512 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 18.6 m-85 -110.57 99.64 8.58 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.06 178.256 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.0 -144.31 3.93 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.979 -179.092 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.409 ' CE1' ' HE3' ' A' ' 37' ' ' MET . 29.6 m-85 -125.8 150.16 48.02 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 120.744 0.307 . . . . 0.0 111.123 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.95 -74.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.995 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.3 t 175.29 -34.34 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.761 0.315 . . . . 0.0 111.321 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -81.2 -24.36 37.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.298 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' A' ' 11' ' ' ILE . 2.6 mp -91.12 -42.12 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.897 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.401 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 29.2 t60 -155.8 153.3 29.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.271 -179.62 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -55.71 145.37 24.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.079 0.466 . . . . 0.0 111.518 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 t -167.49 75.67 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.028 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.1 m -90.61 -20.38 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.272 179.559 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -75.47 -27.53 58.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.393 -179.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.8 p -79.87 -40.91 27.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.324 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.04 -41.81 48.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.112 0.482 . . . . 0.0 110.786 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -72.78 -49.23 32.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.65 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.29 -41.73 72.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.964 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -52.38 65.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.619 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -59.05 -36.61 75.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.656 179.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.43 HD22 ' CD2' ' A' ' 86' ' ' PHE . 2.4 tt -60.4 -54.82 41.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.466 179.535 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 mt -54.78 -45.6 74.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.71 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.9 m -56.81 -35.58 68.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.173 0.511 . . . . 0.0 109.96 179.291 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.0 t -79.99 -29.86 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.683 179.304 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.49 -11.74 59.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.031 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt 67.97 56.61 0.53 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.876 0.369 . . . . 0.0 110.951 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -134.33 135.85 24.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.76 132.75 12.18 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.461 2.108 . . . . 0.0 111.705 179.36 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.625 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 22.9 p90 -156.03 169.76 23.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.65 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -148.16 139.06 23.14 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.438 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.454 ' CE1' HG11 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -89.88 150.96 21.97 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.708 179.916 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.2 mt -140.95 121.96 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.063 0.458 . . . . 0.0 110.387 179.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -78.35 109.49 12.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.587 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 pt -73.71 -7.05 9.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.43 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.467 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -126.21 80.52 68.38 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-O 120.844 0.354 . . . . 0.0 111.076 -179.679 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.51 -20.38 69.55 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.705 2.27 . . . . 0.0 111.817 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -139.65 140.09 36.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.369 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.25 -8.75 2.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.217 0.532 . . . . 0.0 111.881 -179.647 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.4 -58.35 3.37 Favored Glycine 0 C--N 1.312 -0.772 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.706 179.803 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -150.55 150.13 13.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.81 0.338 . . . . 0.0 111.754 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -63.14 170.68 2.7 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.484 179.266 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -86.15 100.59 12.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.873 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.78 -25.29 40.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.488 -179.647 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -65.49 -60.43 2.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.943 0.401 . . . . 0.0 110.542 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -65.22 -33.74 76.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.345 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.8 mm -73.79 -29.69 26.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.647 179.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.68 -55.85 26.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.991 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -62.47 -35.26 78.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.308 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.512 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 2.9 tt -56.72 -50.89 70.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.273 179.603 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.3 mt -52.82 -48.82 66.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.115 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.0 m -63.72 -38.14 89.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.023 179.302 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.5 -43.01 88.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.382 179.436 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 mt -59.94 -47.24 86.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 172.37 -113.93 0.5 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.053 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -150.53 30.56 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.047 0.451 . . . . 0.0 110.745 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.04 -148.33 0.41 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.324 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 t -120.21 165.78 14.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.715 0.293 . . . . 0.0 110.626 179.624 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.444 ' CG ' ' O ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -69.69 98.82 1.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.726 0.774 . . . . 0.0 110.594 179.96 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.1 mt -79.68 83.08 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.037 -179.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.29 24.44 44.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.458 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.76 152.11 43.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.8 p -133.72 170.12 16.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.493 . . . . 0.0 111.691 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.86 160.46 26.73 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.31 179.405 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -82.7 144.46 54.37 Favored 'Cis proline' 0 C--N 1.344 0.312 0 C-N-CA 124.406 -1.081 . . . . 0.0 113.188 0.608 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.407 ' OE1' ' CE1' ' A' ' 75' ' ' HIS . 2.1 mm100 -105.74 125.55 51.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.969 178.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.71 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 4.0 t -98.9 160.72 3.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.909 0.385 . . . . 0.0 111.746 -179.301 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.422 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 28.5 m-85 -142.95 131.54 22.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.895 -179.843 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.403 ' HA ' HD12 ' A' ' 76' ' ' ILE . . . -64.0 142.78 98.22 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.463 -178.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.585 ' HB3' ' N ' ' A' ' 1' ' ' MET . 45.3 Cg_exo -41.37 -30.97 0.92 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.28 2.653 . . . . 0.0 112.677 179.234 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -164.26 35.16 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.594 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.02 -97.84 1.89 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.566 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.8 m -165.32 175.6 9.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.96 0.41 . . . . 0.0 110.889 -179.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.422 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 14.2 t-80 -50.04 101.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.997 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 70' ' ' ALA . 3.3 mt -67.32 -52.78 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.405 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 138.64 -150.83 21.31 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.753 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.4 -142.01 11.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.748 -179.719 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -70.12 -70.81 0.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.771 0.32 . . . . 0.0 110.948 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -58.97 -44.03 91.44 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.018 0.437 . . . . 0.0 110.437 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -53.11 -36.01 60.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.417 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.496 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.6 tt -80.42 -34.63 36.02 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.296 179.639 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -51.23 -29.81 15.45 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -69.0 -35.06 76.26 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.22 178.159 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 82' ' ' LEU . 9.1 t80 -63.24 -34.19 77.13 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.288 178.397 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.496 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.4 m-85 -88.0 -70.16 0.65 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.276 179.761 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.864 -179.996 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.609 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 59.0 ttp . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 120.713 0.292 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 76.9 m-85 -80.15 154.51 27.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.02 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.722 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -133.6 130.46 38.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.484 -178.794 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.484 HG11 ' CE1' ' A' ' 33' ' ' PHE . 27.0 t -114.09 138.31 44.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.195 0.522 . . . . 0.0 111.694 179.306 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 4.2 m-85 -115.89 99.47 7.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.997 178.276 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 35' ' ' ASN . . . -158.61 -138.58 2.5 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.446 -179.228 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -117.92 154.67 31.51 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 120.865 0.364 . . . . 0.0 111.021 -179.517 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.49 -77.9 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.788 -179.853 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 t 170.78 -37.88 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.955 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.49 -29.56 52.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.26 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.452 HG23 HD11 ' A' ' 11' ' ' ILE . 10.4 mm -89.03 -40.36 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.059 0.457 . . . . 0.0 110.631 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -150.32 148.54 28.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.573 179.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -78.37 160.04 28.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.302 -179.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.1 t -174.63 103.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.722 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 m -79.98 -37.88 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.217 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.46 -22.92 66.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.16 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.2 m -65.77 -57.72 7.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.909 0.385 . . . . 0.0 110.837 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -53.44 -25.98 18.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.316 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -70.39 -63.29 1.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.611 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.4 -27.04 62.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.796 179.551 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.2 tttm -59.59 -56.53 20.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.475 179.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -61.51 -25.5 67.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.523 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.4 HD11 ' CG ' ' A' ' 83' ' ' ARG . 1.0 OUTLIER -59.53 -55.42 34.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.451 179.626 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.5 mt -63.52 -43.0 98.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.8 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.2 m -58.75 -41.25 86.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.175 0.512 . . . . 0.0 109.986 179.243 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.8 t -78.86 -25.03 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.456 179.25 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.506 ' HG2' ' CE1' ' A' ' 86' ' ' PHE . 12.4 tppt? -71.75 -18.81 62.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.226 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt 69.86 53.76 0.37 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 111.11 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -143.7 145.92 33.01 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.996 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.33 138.88 22.81 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.557 2.171 . . . . 0.0 111.919 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.609 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 4.2 p90 -158.36 169.6 24.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.058 0.456 . . . . 0.0 112.154 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -144.18 143.14 30.94 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.789 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.484 ' CE1' HG11 ' A' ' 4' ' ' VAL . 21.0 t80 -89.41 158.45 17.74 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.318 -179.749 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.489 ' CD1' ' CE1' ' A' ' 5' ' ' TYR . 11.7 mt -145.67 119.75 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.168 179.26 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.0 p30 -90.6 133.04 35.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.544 -179.176 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.8 pt -90.28 -22.5 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.056 179.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.594 ' HB2' ' HB3' ' A' ' 43' ' ' PHE . 2.9 ttp -123.68 91.34 49.8 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.05 -4.36 15.3 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.891 2.394 . . . . 0.0 112.569 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 37' ' ' MET . 0.1 OUTLIER -139.62 136.98 34.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.74 0.305 . . . . 0.0 110.805 -179.837 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.421 ' HA ' HG21 ' A' ' 11' ' ' ILE . 4.0 ttpm? -63.69 -8.9 11.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.144 0.497 . . . . 0.0 112.102 -179.749 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.56 -64.6 1.43 Allowed Glycine 0 C--N 1.312 -0.774 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.164 179.583 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.8 t -141.24 139.91 32.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.611 0.243 . . . . 0.0 110.86 179.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.594 ' HB3' ' HB2' ' A' ' 37' ' ' MET . 0.1 OUTLIER -68.83 169.92 10.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.986 0.422 . . . . 0.0 111.379 -179.73 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.58 107.94 19.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.161 -179.678 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -56.29 -22.01 27.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.304 179.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -57.44 -51.19 70.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.838 0.351 . . . . 0.0 110.928 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -76.85 -35.15 57.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.308 179.632 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.6 mm -62.46 -44.36 99.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.873 179.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.96 -56.81 9.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.245 -179.487 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -57.75 -33.16 68.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.585 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.415 HD13 ' CD2' ' A' ' 5' ' ' TYR . 10.4 tp -57.72 -51.74 68.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.382 179.574 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.2 mt -52.47 -45.85 66.27 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.196 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.6 m -67.19 -35.63 80.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.32 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -62.67 -32.16 73.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.495 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.08 -53.54 48.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.84 179.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.62 -41.93 1.24 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.297 -179.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -98.76 -165.5 1.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.882 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -104.0 -32.83 9.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 t -110.54 166.32 11.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -110.62 99.47 8.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 179.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 pt -68.17 80.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.199 179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.95 17.75 73.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.668 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.42 ' CD1' ' NE2' ' A' ' 67' ' ' GLN . 0.3 OUTLIER -79.96 139.28 37.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.908 180.0 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.67 171.35 14.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.489 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.72 156.37 47.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.651 179.475 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.0 Cg_exo -76.58 147.66 87.27 Favored 'Cis proline' 0 C--N 1.345 0.36 0 C-N-CA 123.865 -1.306 . . . . 0.0 113.073 0.4 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.46 ' HG3' ' NE2' ' A' ' 75' ' ' HIS . 0.4 OUTLIER -107.73 111.55 23.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.406 179.314 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.722 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 5.6 t -93.65 161.1 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.933 0.397 . . . . 0.0 111.821 -179.319 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.427 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 96.0 m-85 -142.05 146.6 35.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.409 ' HA ' HD12 ' A' ' 76' ' ' ILE . . . -84.31 137.68 39.44 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.242 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.558 ' HB3' ' N ' ' A' ' 1' ' ' MET . 39.0 Cg_exo -34.94 -36.88 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.634 2.889 . . . . 0.0 112.183 178.674 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -166.6 31.02 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.124 179.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.72 15.91 9.01 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.761 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 p 73.36 179.93 0.21 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.125 0.488 . . . . 0.0 111.412 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.46 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 24.4 t-80 -52.57 125.71 17.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.502 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 70' ' ' ALA . 26.7 mt -94.76 -47.9 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.657 179.538 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.5 -151.71 20.95 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.657 -179.71 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.44 -144.95 17.87 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.592 -179.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -70.65 -70.6 0.29 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.771 0.32 . . . . 0.0 110.775 -179.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -59.18 -47.22 86.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.958 0.408 . . . . 0.0 110.477 179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -41.15 63.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.264 179.582 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 85' ' ' TYR . 4.5 tt -76.23 -35.39 59.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.051 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.459 ' O ' ' N ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -51.52 -28.05 12.5 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.755 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -72.29 -33.61 67.55 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.367 178.352 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.457 ' N ' ' O ' ' A' ' 82' ' ' LEU . 6.2 t80 -65.64 -32.85 74.64 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.399 178.568 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.506 ' CE1' ' HG2' ' A' ' 27' ' ' LYS . 10.7 m-85 -95.13 -70.19 0.72 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.521 179.718 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.818 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.603 ' HG3' ' HA ' ' A' ' 31' ' ' PHE . 2.5 tpp . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.799 0.333 . . . . 0.0 111.637 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.504 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 82.9 m-85 -68.82 148.42 50.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.958 0.408 . . . . 0.0 110.538 -179.786 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.682 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -120.25 118.51 30.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.157 -179.973 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.2 t -105.28 122.74 58.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.343 0.592 . . . . 0.0 111.921 -179.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 2.6 m-30 -99.95 99.39 10.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.923 178.659 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.74 -138.07 2.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.369 -179.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.448 ' CE2' ' HE2' ' A' ' 37' ' ' MET . 77.8 m-85 -131.07 104.09 6.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.56 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 8' ' ' ASP . 0.5 OUTLIER -108.8 22.84 15.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.604 0.24 . . . . 0.0 110.465 178.53 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.1 t -116.07 175.16 5.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.42 0.629 . . . . 0.0 111.774 -179.103 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -87.37 8.26 25.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.22 179.059 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.2 mm -87.66 -16.28 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.382 179.333 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -153.51 144.92 23.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.471 179.18 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.34 166.79 20.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.048 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.3 p 179.19 116.9 0.04 OUTLIER 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.831 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.7 m -90.84 -35.8 7.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.87 0.367 . . . . 0.0 111.134 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -77.41 -19.32 56.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.49 -179.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.6 p -65.76 -43.41 88.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 0.0 110.634 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.31 -38.24 63.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.858 179.752 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -68.74 -41.14 79.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.432 -179.428 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.49 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -67.04 -40.03 87.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.774 0.321 . . . . 0.0 111.487 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.417 ' HD2' ' CZ ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -57.3 -48.55 78.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.836 0.35 . . . . 0.0 110.491 179.753 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.7 ptt85 -64.93 -33.42 75.99 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.979 0.418 . . . . 0.0 110.503 179.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.468 ' HB3' ' O ' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -55.45 -49.75 71.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.325 179.285 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.4 -47.51 78.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.447 179.266 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 m -54.24 -36.98 64.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.003 179.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.46 -27.92 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.414 179.251 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 -11.57 57.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.093 179.787 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 70.27 57.71 0.27 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.907 0.384 . . . . 0.0 111.245 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -135.37 137.75 27.14 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.113 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.429 ' O ' ' HA ' ' A' ' 1' ' ' MET . 54.8 Cg_endo -80.8 134.32 9.58 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.598 2.199 . . . . 0.0 111.123 179.111 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.603 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 28.9 p90 -159.44 169.88 22.97 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.12 -0.632 . . . . 0.0 112.547 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -144.56 142.68 30.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.27 -179.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.501 ' HD1' ' N ' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -89.8 133.9 34.47 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.071 -179.935 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.501 ' N ' ' HD1' ' A' ' 33' ' ' PHE . 7.6 mt -115.42 109.93 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.174 0.511 . . . . 0.0 110.22 178.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -74.1 134.08 42.88 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.048 -179.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 pt -100.12 -6.93 9.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.987 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.448 ' HE2' ' CE2' ' A' ' 7' ' ' TYR . 30.7 ttm -122.93 95.29 46.42 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.653 0.263 . . . . 0.0 111.62 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.0 -24.46 17.32 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.475 2.117 . . . . 0.0 111.842 179.485 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -140.86 147.72 39.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.644 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -64.4 -8.42 13.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.253 0.549 . . . . 0.0 111.801 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.0 -56.37 3.08 Favored Glycine 0 C--N 1.312 -0.753 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.61 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -147.95 145.09 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.981 0.42 . . . . 0.0 111.815 -179.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -68.21 170.66 8.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.559 179.434 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.29 84.1 5.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.45 -27.92 7.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.362 179.889 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -56.73 -50.3 72.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.939 0.4 . . . . 0.0 110.574 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -40.03 64.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.226 179.343 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 mm -52.24 -44.61 42.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.851 179.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.4 -56.74 12.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.57 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -57.76 -34.74 69.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.355 179.507 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.474 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -59.86 -56.69 18.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.238 179.863 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.455 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 66.8 mt -43.4 -45.5 6.23 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.384 0.611 . . . . 0.0 110.884 179.11 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.4 m -70.39 -33.33 71.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.166 178.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -64.32 -39.86 94.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.305 179.918 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.474 ' CD1' ' O ' ' A' ' 51' ' ' LEU . 4.4 mp -59.76 -66.99 0.43 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.899 0.38 . . . . 0.0 111.08 -179.739 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 158.24 -34.95 0.52 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.405 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.58 -164.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.774 0.321 . . . . 0.0 110.903 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -99.74 -33.12 10.71 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.787 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 t -119.65 170.11 9.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.815 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.406 ' HB2' ' CB ' ' A' ' 63' ' ' LEU . 4.0 pt20 -113.17 99.81 8.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.0 0.428 . . . . 0.0 110.909 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mt -79.93 80.85 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.389 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.36 -18.63 56.75 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.854 179.683 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.406 ' CB ' ' HB2' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -59.48 136.17 57.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 0.0 110.915 -179.959 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.06 171.33 14.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.353 -179.465 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.45 153.2 48.19 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.565 179.56 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.9 Cg_exo -77.13 138.78 55.53 Favored 'Cis proline' 0 C--N 1.344 0.339 0 C-N-CA 123.877 -1.301 . . . . 0.0 112.954 0.263 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -100.91 112.96 25.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.996 179.054 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.682 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.9 t -91.08 163.74 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 0.0 111.752 -179.213 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 28.5 m-85 -142.1 132.1 24.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.348 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -48.56 149.45 2.92 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.635 -178.663 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.6 ' HB3' ' N ' ' A' ' 1' ' ' MET . 52.9 Cg_exo -57.27 -29.02 82.35 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.106 2.537 . . . . 0.0 111.882 179.156 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -94.41 -23.13 17.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.034 179.818 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.56 79.02 0.51 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.568 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.5 119.13 1.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.833 0.349 . . . . 0.0 110.904 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -51.37 111.3 0.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.051 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.0 mt -88.51 -50.43 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.987 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.99 -154.48 19.39 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.624 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -87.1 -144.83 8.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.281 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.49 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -72.81 -68.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.725 0.262 . . . . 0.0 110.849 179.75 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -47.09 -42.33 18.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.156 0.503 . . . . 0.0 110.39 179.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -40.03 95.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.372 179.507 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.498 ' CD2' ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -72.49 -43.68 63.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.346 179.741 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.13 -33.42 18.8 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.792 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -69.9 -36.55 75.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.202 178.339 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 82' ' ' LEU . 10.2 t80 -63.51 -33.77 76.3 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.465 178.39 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.498 ' CE2' ' CD2' ' A' ' 82' ' ' LEU . 5.4 m-85 -86.34 -70.36 0.61 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.047 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.885 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.606 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 11.2 tpp . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.307 0.098 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.439 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 76.8 m-85 -39.53 123.75 1.53 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.61 0.719 . . . . 0.0 111.74 -177.243 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.672 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -89.54 125.22 35.12 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.152 -179.316 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.497 ' CG1' ' CE1' ' A' ' 33' ' ' PHE . 51.5 t -116.77 147.24 20.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.253 0.549 . . . . 0.0 110.959 179.187 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.657 ' CG ' ' HG ' ' A' ' 51' ' ' LEU . 85.7 m-85 -129.06 99.67 5.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.061 178.761 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.438 ' O ' HD11 ' A' ' 36' ' ' ILE . . . -159.68 -142.38 3.38 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.13 -179.06 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.49 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 60.2 m-85 -115.37 145.17 42.78 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.565 0.221 . . . . 0.0 110.831 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -106.05 27.57 8.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.942 0.401 . . . . 0.0 110.438 179.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.2 p 64.02 10.74 5.59 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.313 -179.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -86.19 -63.88 1.24 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.894 0.378 . . . . 0.0 110.891 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.449 HG21 ' N ' ' A' ' 40' ' ' LYS . 18.4 mm -96.62 -17.66 6.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.376 -179.051 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.49 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 30.7 t60 -153.32 160.52 42.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.984 0.421 . . . . 0.0 111.644 -179.441 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -46.55 156.94 0.16 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.188 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.9 t -153.64 69.28 0.8 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.037 -179.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.401 HG22 ' N ' ' A' ' 16' ' ' TYR . 27.5 m -91.78 -43.15 13.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.401 ' N ' HG22 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -70.75 -22.65 62.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.453 -179.204 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.07 -42.71 14.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.692 179.826 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -52.28 -31.56 33.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.408 179.548 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -78.49 -56.46 4.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.644 179.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . . . -55.39 -45.26 76.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.875 0.369 . . . . 0.0 111.076 179.841 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.43 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 27.2 ttpt -58.92 -45.7 89.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.598 179.744 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -63.21 -37.27 86.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.556 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.401 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -56.98 -53.03 62.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.239 179.499 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' A' ' 23' ' ' LEU . 5.7 mt -56.51 -44.86 81.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.602 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.0 m -58.27 -39.07 78.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.967 179.353 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.7 t -73.0 -39.96 58.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.555 179.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -10.14 59.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.999 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 69.41 49.95 0.56 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.935 0.398 . . . . 0.0 110.375 -179.674 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.17 112.26 8.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.394 -179.634 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.606 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 83.4 Cg_exo -49.96 179.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.341 2.027 . . . . 0.0 111.585 179.052 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.43 ' CE2' ' HG3' ' A' ' 21' ' ' LYS . 4.8 p90 -164.54 170.13 16.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.077 0.465 . . . . 0.0 111.346 178.111 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 2.7 tt0 -134.55 109.49 8.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.628 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.497 ' CE1' ' CG1' ' A' ' 4' ' ' VAL . 7.9 t80 -91.94 159.89 15.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.206 0.527 . . . . 0.0 111.82 -179.446 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.45 ' CD1' ' CZ ' ' A' ' 5' ' ' TYR . 20.6 mt -150.1 122.93 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.075 179.152 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -80.0 124.39 28.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.09 -179.639 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -88.7 -18.04 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.17 179.652 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -125.22 83.4 60.92 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.667 179.864 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.482 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 57.7 Cg_endo -70.82 -12.98 31.67 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.62 2.213 . . . . 0.0 111.708 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -139.55 136.93 34.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.912 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.449 ' N ' HG21 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -61.63 -8.28 4.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.312 0.577 . . . . 0.0 111.543 -179.59 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.5 -60.43 3.24 Favored Glycine 0 C--N 1.313 -0.737 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.543 179.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.3 t -151.41 160.44 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.434 ' CZ ' HG13 ' A' ' 36' ' ' ILE . 1.7 m-30 -60.05 170.4 1.24 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.587 178.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.482 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 66.6 t0 -99.91 96.96 7.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.513 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -48.66 -34.35 11.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.273 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -65.5 -58.09 6.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.817 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -32.26 71.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.651 179.749 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.4 mp -75.4 -29.67 21.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.523 179.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.35 -54.4 46.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.877 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -64.17 -35.19 79.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 110.224 179.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.657 ' HG ' ' CG ' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -62.03 -59.47 5.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.476 179.057 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.515 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 69.2 mt -44.88 -41.3 7.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.114 179.092 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.6 m -70.62 -32.29 69.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.575 -179.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.466 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 19.8 mtpp -64.84 -45.08 87.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.75 -179.193 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.515 ' CD1' ' HA ' ' A' ' 52' ' ' LEU . 1.3 mp -59.52 -39.4 83.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.859 0.361 . . . . 0.0 111.168 -179.645 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.86 -120.46 0.83 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.343 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -146.99 30.27 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.054 0.454 . . . . 0.0 110.619 179.522 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -121.18 -146.29 0.37 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.258 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -120.39 168.55 11.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.689 0.281 . . . . 0.0 110.599 179.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -87.73 98.89 11.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.254 0.55 . . . . 0.0 110.484 179.628 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pt -79.9 84.68 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.161 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.52 26.2 64.16 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.382 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -54.02 153.12 5.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.872 0.368 . . . . 0.0 110.787 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.5 p -119.19 161.08 20.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.133 0.492 . . . . 0.0 111.466 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.7 mmt -108.69 153.68 42.12 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.393 179.552 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -86.17 146.01 36.2 Favored 'Cis proline' 0 N--CA 1.461 -0.396 0 C-N-CA 124.268 -1.138 . . . . 0.0 112.912 0.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 5.3 tp-100 -97.05 122.29 39.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.877 178.768 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.672 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 8.2 t -104.46 157.79 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.759 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.593 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 92.7 m-85 -142.49 164.26 30.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.039 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.447 ' N ' ' CD1' ' A' ' 76' ' ' ILE . . . -64.49 157.59 71.57 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.771 -179.519 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.26 -21.62 67.41 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.896 2.397 . . . . 0.0 112.418 179.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -109.72 -16.46 13.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.617 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.69 97.76 1.11 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.798 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 15.2 t -178.57 151.74 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.674 0.273 . . . . 0.0 110.34 179.623 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.46 ' CE1' HD21 ' A' ' 55' ' ' LEU . 9.1 t-160 -85.63 113.73 22.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.146 -179.603 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 70' ' ' ALA . 1.7 mp -103.17 -39.54 6.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.865 0.364 . . . . 0.0 110.658 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.04 -160.4 23.88 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.704 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.16 -134.53 7.99 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.615 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 9.2 t80 -70.63 -70.67 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.72 0.295 . . . . 0.0 111.422 -179.597 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -60.51 -44.49 95.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.994 0.426 . . . . 0.0 110.999 -179.813 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -52.14 -41.15 62.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.698 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.507 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.2 tt -74.85 -34.04 62.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.217 179.786 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -51.15 -31.46 19.89 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.618 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.64 -35.16 79.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.208 178.257 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.462 ' N ' ' O ' ' A' ' 82' ' ' LEU . 13.5 t80 -63.59 -33.57 75.89 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.337 178.459 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.507 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.6 m-85 -86.76 -70.24 0.62 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.275 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.975 -179.956 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.688 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 31.4 ttp . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.872 0.368 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.526 ' HE1' HE21 ' A' ' 29' ' ' GLN . 96.3 m-85 -82.71 143.35 30.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.068 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.71 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -117.14 122.56 44.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.719 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.064 HG22 HG22 ' A' ' 68' ' ' VAL . 7.7 t -111.03 130.06 65.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.464 0.65 . . . . 0.0 111.7 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.512 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 20.1 m-85 -111.95 101.76 10.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.651 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 66' ' ' PRO . . . -163.89 -139.42 2.63 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.653 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.492 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 85.1 m-85 -123.19 159.52 28.45 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.711 0.291 . . . . 0.0 111.254 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.8 -65.76 1.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.254 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 t 168.79 -32.53 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 110.792 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -65.53 -47.27 76.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.122 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.563 ' H ' HD12 ' A' ' 11' ' ' ILE . 3.7 mp -91.32 -44.99 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.019 0.437 . . . . 0.0 110.934 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.492 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 4.4 t-80 -143.2 155.96 44.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.39 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -80.98 171.24 15.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.854 0.359 . . . . 0.0 111.264 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.0 p -179.37 115.36 0.06 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.973 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 m -90.86 -36.67 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.298 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -80.25 -15.45 56.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.655 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.0 p -66.25 -42.4 88.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.928 0.394 . . . . 0.0 110.621 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.2 -41.92 66.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.409 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -56.86 -48.14 78.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.484 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.88 -47.32 83.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.134 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -49.66 -31.72 11.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.944 0.402 . . . . 0.0 110.376 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.874 ' O ' HG23 ' A' ' 26' ' ' VAL . 22.0 ttp180 -74.33 -34.6 63.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.195 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.686 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -55.52 -51.72 66.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.254 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.29 -54.17 49.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.848 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 m -49.22 -36.01 18.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.718 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 22' ' ' ARG . 74.6 t -69.33 -29.75 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.802 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -16.84 27.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.347 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt 71.67 65.05 0.15 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.987 0.422 . . . . 0.0 110.682 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.526 HE21 ' HE1' ' A' ' 2' ' ' PHE . 4.6 mm100 -130.81 142.3 45.04 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.65 128.58 11.08 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.414 2.076 . . . . 0.0 111.641 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.688 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 16.0 p90 -158.88 167.7 28.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.97 147.04 27.39 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.105 0.479 . . . . 0.0 111.35 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.651 ' CE1' HG11 ' A' ' 4' ' ' VAL . 7.8 t80 -89.47 156.42 18.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.007 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.2 mt -145.85 119.99 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.409 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -74.92 109.81 8.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.687 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.7 pt -72.84 -13.64 16.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.301 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.522 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -119.86 80.66 25.48 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.76 0.314 . . . . 0.0 111.088 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 60.8 Cg_endo -72.37 -9.86 24.79 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.632 2.221 . . . . 0.0 111.9 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -139.53 136.67 34.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.469 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -60.94 -8.74 3.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.232 0.539 . . . . 0.0 112.0 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.09 -62.06 2.15 Favored Glycine 0 C--N 1.312 -0.774 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.338 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 43' ' ' PHE . 21.2 t -150.4 154.91 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.765 0.316 . . . . 0.0 111.45 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -59.75 169.97 1.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.613 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.418 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 6.3 t0 -82.32 100.44 9.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.943 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -55.27 -27.01 43.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.05 -54.98 29.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 110.875 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -73.81 -33.29 64.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.526 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.2 mm -71.57 -31.67 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.649 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -66.31 -56.32 11.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -59.37 -30.01 68.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.939 0.399 . . . . 0.0 110.226 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.651 ' O ' HD12 ' A' ' 55' ' ' LEU . 2.0 tt -59.67 -58.59 7.92 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.571 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.569 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 73.9 mt -45.93 -42.59 13.02 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.593 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 m -70.92 -31.12 67.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.661 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 1.8 tttp -60.8 -48.34 82.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.419 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.2 mp -59.32 -59.63 5.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.049 0.452 . . . . 0.0 111.065 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.35 -114.2 0.29 Allowed Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.048 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.9 mtt85 -150.64 28.07 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.98 0.419 . . . . 0.0 111.004 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -121.7 -156.63 0.69 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.113 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.5 t -121.17 167.41 12.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.686 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.832 ' CB ' HD23 ' A' ' 63' ' ' LEU . 6.2 pt20 -130.2 98.84 4.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 110.828 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.654 ' O ' HG23 ' A' ' 61' ' ' ILE . 8.5 tp -82.07 85.57 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.177 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.09 23.8 5.97 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.485 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.832 HD23 ' CB ' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -60.84 127.02 29.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.34 . . . . 0.0 110.557 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 p -92.28 163.42 13.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.241 0.543 . . . . 0.0 111.481 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.48 160.77 38.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.665 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.495 ' HB2' HG13 ' A' ' 4' ' ' VAL . 4.2 Cg_exo -83.94 149.75 60.35 Favored 'Cis proline' 0 C--N 1.344 0.335 0 C-N-CA 124.428 -1.072 . . . . 0.0 113.123 0.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -101.77 120.18 39.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.903 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.064 HG22 HG22 ' A' ' 4' ' ' VAL . 6.2 t -98.72 159.65 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.035 0.445 . . . . 0.0 111.615 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.459 ' N ' HG12 ' A' ' 68' ' ' VAL . 31.8 m-85 -142.9 133.15 24.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.765 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.612 ' CA ' HD11 ' A' ' 76' ' ' ILE . . . -62.95 149.62 89.84 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.604 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.58 ' HB3' ' N ' ' A' ' 1' ' ' MET . 68.0 Cg_exo -44.8 -52.54 6.07 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.37 2.714 . . . . 0.0 112.747 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -30.03 65.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.189 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.26 67.95 0.44 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.388 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.4 m -147.79 157.07 43.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.84 0.353 . . . . 0.0 110.648 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -84.09 115.1 22.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.973 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.612 HD11 ' CA ' ' A' ' 70' ' ' ALA . 19.8 mt -93.58 -49.14 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.972 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 123.15 -154.18 17.14 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.93 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -90.97 -132.24 5.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.472 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.686 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -79.66 -70.08 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.654 0.227 . . . . 0.0 111.114 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -51.08 -49.12 61.26 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.331 0.586 . . . . 0.0 110.478 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -57.41 -42.2 81.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.701 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.691 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.3 tt -76.3 -32.26 58.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.582 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -33.78 40.6 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -66.47 -35.87 81.34 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.164 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 82' ' ' LEU . 14.7 t80 -63.2 -34.08 76.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.35 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.691 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.4 m-85 -84.29 -66.39 0.9 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.995 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.91 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.632 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 30.1 ttm . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.784 0.326 . . . . 0.0 111.527 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.517 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 69.3 m-85 -61.8 169.57 2.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.357 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -143.72 116.29 8.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.743 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.0 HG22 HG22 ' A' ' 68' ' ' VAL . 87.5 t -110.44 141.27 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.168 0.508 . . . . 0.0 111.02 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.685 ' CE1' HD12 ' A' ' 34' ' ' ILE . 6.6 m-85 -123.31 99.3 6.27 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.89 -144.54 4.05 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.541 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.831 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 34.4 m-85 -113.51 151.07 32.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.748 0.309 . . . . 0.0 111.426 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.5 t70 -81.98 0.46 40.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.983 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.3 OUTLIER 83.81 -13.76 0.73 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -85.33 -39.12 18.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.759 0.314 . . . . 0.0 111.082 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.419 HD12 ' O ' ' A' ' 37' ' ' MET . 3.7 mt -92.56 -31.1 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.283 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.436 ' O ' ' HA ' ' A' ' 9' ' ' SER . 7.8 t60 -142.07 142.15 32.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.099 0.476 . . . . 0.0 110.987 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.2 145.02 11.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.315 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.3 t -179.26 88.93 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.13 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.8 m -79.01 -27.08 13.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.897 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -75.1 -21.53 58.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.798 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.5 m -59.71 -58.59 7.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.205 0.526 . . . . 0.0 110.265 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.96 -23.59 13.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.334 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 3.9 m-80 -77.14 -54.08 6.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.091 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.49 -48.7 76.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 111.078 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HD2' ' CE2' ' A' ' 31' ' ' PHE . 2.2 tptt -58.23 -54.06 51.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.697 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.836 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.4 mmp_? -60.84 -36.76 79.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.554 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 24' ' ' LEU . 3.1 tt -58.88 -52.97 63.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.509 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.618 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.9 mt -57.78 -46.86 83.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.794 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 m -57.63 -36.28 71.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.478 . . . . 0.0 110.234 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 22' ' ' ARG . 53.3 t -79.71 -30.7 13.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.766 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -77.77 -11.08 59.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.131 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt 70.34 54.07 0.32 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.996 0.427 . . . . 0.0 111.045 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -134.42 132.77 21.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.092 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.434 ' O ' ' HA ' ' A' ' 1' ' ' MET . 98.5 Cg_endo -78.41 137.33 14.77 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.474 2.116 . . . . 0.0 111.114 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.632 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 17.1 p90 -156.21 170.19 22.8 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -136.79 131.63 33.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.011 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.612 ' CE1' HG12 ' A' ' 4' ' ' VAL . 1.2 t80 -95.74 129.81 42.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.97 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.685 HD12 ' CE1' ' A' ' 5' ' ' TYR . 7.3 mt -113.33 110.39 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.383 0.611 . . . . 0.0 110.432 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -77.46 113.76 15.59 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.105 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.831 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 6.3 pt -71.94 -28.48 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.002 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.559 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 22.2 ttm -121.45 91.13 48.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.891 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.8 Cg_endo -82.59 1.66 9.0 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.693 2.262 . . . . 0.0 112.692 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -139.81 140.29 36.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 110.875 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -66.68 -7.09 18.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.254 0.549 . . . . 0.0 111.779 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.77 -67.13 1.01 Allowed Glycine 0 C--N 1.315 -0.608 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.694 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 t -136.21 133.82 50.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.71 0.29 . . . . 0.0 111.07 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -63.37 170.29 3.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.466 -179.505 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.45 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -94.65 99.94 11.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.064 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -54.37 -19.93 6.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.782 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -58.47 -56.28 24.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.031 0.444 . . . . 0.0 110.521 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -67.75 -31.69 71.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.307 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.405 HD11 ' HB ' ' A' ' 36' ' ' ILE . 25.1 mm -59.84 -48.34 88.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.611 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.11 -49.27 77.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.805 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.31 -35.89 70.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.579 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.47 HD13 ' CG ' ' A' ' 5' ' ' TYR . 26.4 tp -61.32 -52.99 62.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.652 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.5 mt -49.72 -45.16 48.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.131 0.491 . . . . 0.0 111.277 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.5 m -64.08 -32.47 74.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.108 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.427 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 9.3 tttp -68.9 -29.99 68.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.465 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.724 HD11 HD11 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -71.06 -37.62 72.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.048 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.83 33.58 6.32 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.278 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -150.07 -176.9 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.8 0.334 . . . . 0.0 110.742 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -105.11 -30.8 9.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.025 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 t -111.05 163.79 13.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.052 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.609 ' CA ' HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -106.47 99.14 8.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.596 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.5 mm -80.67 87.82 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.556 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.92 31.55 79.94 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.44 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.724 HD11 HD11 ' A' ' 55' ' ' LEU . 1.3 mm? -42.35 134.71 2.87 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.83 0.347 . . . . 0.0 111.207 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.58 153.11 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.088 0.47 . . . . 0.0 111.671 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.12 152.12 72.84 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.406 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.1 Cg_exo -79.31 128.72 16.86 Favored 'Cis proline' 0 C--N 1.344 0.328 0 C-N-CA 124.053 -1.228 . . . . 0.0 112.934 0.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.516 ' CD ' ' HE2' ' A' ' 75' ' ' HIS . 1.4 tp-100 -90.6 117.87 29.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.225 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.0 HG22 HG22 ' A' ' 4' ' ' VAL . 10.2 t -97.48 161.24 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.95 0.405 . . . . 0.0 111.906 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.537 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 97.0 m-85 -142.84 149.26 38.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.022 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.583 ' HB3' ' H ' ' A' ' 74' ' ' SER . . . -61.81 159.35 35.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.773 -0.648 . . . . 0.0 112.411 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.535 ' HB3' ' N ' ' A' ' 1' ' ' MET . 31.7 Cg_exo -63.74 58.85 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.577 2.851 . . . . 0.0 111.547 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER 90.49 29.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.345 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -111.75 -92.65 2.1 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.526 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.583 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -152.39 -175.97 5.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.033 0.444 . . . . 0.0 110.96 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.516 ' HE2' ' CD ' ' A' ' 67' ' ' GLN . 16.4 t-80 -68.14 126.62 30.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.156 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.569 HG23 ' CD2' ' A' ' 85' ' ' TYR . 4.8 mt -91.82 -45.43 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.177 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.16 -150.04 19.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.635 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.83 -150.74 22.47 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.62 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 40.4 t80 -70.79 -70.55 0.3 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.68 0.276 . . . . 0.0 110.951 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -55.46 -45.53 76.88 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.009 0.433 . . . . 0.0 110.579 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -54.91 -33.93 62.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.298 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.744 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.3 tt -80.08 -36.58 35.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.368 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -51.51 -29.98 18.64 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.3 -35.0 73.41 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.129 178.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.569 ' CD2' HG23 ' A' ' 76' ' ' ILE . 11.9 t80 -63.12 -34.35 77.42 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.267 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.744 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.9 m-85 -87.87 -70.18 0.65 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.292 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.8 mttm . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.044 -179.98 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.628 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 49.7 ttm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.861 0.362 . . . . 0.0 111.639 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.516 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 74.6 m-85 -58.33 155.22 12.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.866 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.638 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -128.19 120.43 27.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.669 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.909 HG22 HG22 ' A' ' 68' ' ' VAL . 55.4 t -116.09 142.18 30.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.333 0.587 . . . . 0.0 111.813 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.789 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.1 m-85 -121.67 99.89 6.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.58 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.24 -137.96 2.36 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.75 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.929 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 31.5 m-85 -122.95 144.15 49.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 120.591 0.234 . . . . 0.0 110.962 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -108.47 29.02 7.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.336 . . . . 0.0 110.863 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m 63.04 14.57 7.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -85.77 -56.98 3.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.1 0.476 . . . . 0.0 110.622 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.599 HG21 ' C ' ' A' ' 39' ' ' GLU . 13.4 mm -104.15 -27.23 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.017 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -141.45 152.12 43.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.613 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.77 171.69 12.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.178 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.4 t -178.68 108.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.952 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.2 m -85.66 -32.8 7.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.956 0.407 . . . . 0.0 111.207 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -71.23 -16.08 62.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.289 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.9 m -72.13 -55.92 6.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.996 0.426 . . . . 0.0 110.683 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -52.18 -28.04 16.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.094 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 74.8 m-20 -75.52 -51.77 12.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.016 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.88 -48.6 79.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.243 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -59.89 -55.43 34.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.781 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -55.4 -44.93 76.63 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.346 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.754 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -59.04 -50.59 73.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.16 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.754 ' N ' HD23 ' A' ' 23' ' ' LEU . 8.7 mt -60.51 -43.61 96.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.065 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.6 m -57.17 -40.15 76.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.107 0.48 . . . . 0.0 109.82 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.7 t -80.13 -27.17 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.449 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.537 ' HG2' ' CE1' ' A' ' 86' ' ' PHE . 3.3 tptp -73.42 -13.31 61.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.081 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt 66.53 54.72 0.86 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.448 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -137.12 134.44 18.92 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.019 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.436 ' O ' ' HA ' ' A' ' 1' ' ' MET . 85.9 Cg_endo -78.58 134.09 12.11 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.337 2.024 . . . . 0.0 110.909 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.628 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 26.9 p90 -148.51 170.0 19.03 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -136.91 133.23 35.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.729 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.513 ' HE1' HG11 ' A' ' 4' ' ' VAL . 9.4 t80 -89.43 163.01 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.25 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.789 HD12 ' CE1' ' A' ' 5' ' ' TYR . 19.1 mt -145.69 119.61 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.444 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -82.22 122.76 28.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.098 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.929 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 7.2 pt -93.4 -16.7 7.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.479 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -124.84 85.65 57.06 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.735 0.302 . . . . 0.0 111.556 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 97.0 Cg_endo -79.05 -5.82 14.68 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.851 2.368 . . . . 0.0 111.73 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.599 ' C ' HG21 ' A' ' 11' ' ' ILE . 28.0 mt-10 -139.66 135.33 33.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.288 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.445 ' HA ' HG22 ' A' ' 11' ' ' ILE . 20.0 tttp -61.34 -8.45 3.93 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.26 0.552 . . . . 0.0 111.873 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.3 -63.72 2.11 Favored Glycine 0 C--N 1.312 -0.786 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.067 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 43' ' ' PHE . 21.2 t -150.7 159.03 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.759 0.314 . . . . 0.0 111.548 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.708 ' HB2' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -63.47 159.31 18.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.33 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.46 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -82.18 125.6 31.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.88 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.526 ' HA ' HD12 ' A' ' 48' ' ' ILE . 2.1 p30 -68.07 -23.85 64.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.761 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -60.04 -55.5 33.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.37 . . . . 0.0 110.651 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.48 -39.6 85.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.271 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.708 HD11 ' HB2' ' A' ' 43' ' ' PHE . 46.3 mt -54.12 -46.39 66.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.441 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.48 -50.33 71.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.636 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -59.82 -31.96 70.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.577 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.888 ' O ' HD12 ' A' ' 55' ' ' LEU . 18.7 tp -66.28 -63.92 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.292 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 58' ' ' ASP . 62.2 mt -45.66 -40.81 9.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.153 0.502 . . . . 0.0 111.314 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.1 m -67.34 -34.29 77.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.872 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 69' ' ' PHE . 50.0 tptt -66.47 -49.27 67.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.486 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.888 HD12 ' O ' ' A' ' 51' ' ' LEU . 4.9 mp -59.31 -25.07 63.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.248 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.1 30.17 13.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.499 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.15 -178.04 6.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.781 0.324 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.454 ' O ' HD13 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -108.43 -47.36 3.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.997 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.2 t -92.73 160.1 15.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.54 99.36 8.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.678 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -79.91 83.61 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.255 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.81 23.1 78.21 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.513 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.443 HD11 ' CG ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -70.61 131.42 43.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.875 0.369 . . . . 0.0 110.809 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 65' ' ' MET . 0.4 OUTLIER -131.29 170.55 14.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.282 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.497 ' SD ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -106.78 154.15 40.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.762 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.4 Cg_exo -81.08 135.31 31.12 Favored 'Cis proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.701 -1.374 . . . . 0.0 112.846 0.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.443 ' CG ' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -90.7 117.01 29.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.503 179.321 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.909 HG22 HG22 ' A' ' 4' ' ' VAL . 2.7 t -103.19 160.72 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.157 0.503 . . . . 0.0 112.142 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.477 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 95.3 m-85 -142.8 155.65 44.85 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.982 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.517 ' HB3' ' N ' ' A' ' 74' ' ' SER . . . -66.3 156.41 85.23 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.356 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.46 ' HB3' ' N ' ' A' ' 1' ' ' MET . 44.9 Cg_exo -58.28 -38.92 88.7 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.055 2.504 . . . . 0.0 111.808 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -91.42 -16.18 27.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.094 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.76 87.95 1.16 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.651 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.517 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -164.04 124.04 2.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.945 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.525 ' CE1' HD23 ' A' ' 55' ' ' LEU . 20.0 t-160 -58.17 110.83 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.006 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.472 HD11 ' HA ' ' A' ' 70' ' ' ALA . 18.7 mt -89.95 -49.9 13.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.51 -154.25 19.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.434 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.29 -144.16 7.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.299 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 32.7 t80 -71.17 -60.42 2.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 0.0 110.764 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -54.44 -37.21 64.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.829 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -60.77 -41.21 95.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.58 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.428 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -64.04 -50.87 66.73 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.351 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -51.62 -28.38 14.14 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -79.79 -33.76 40.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 82' ' ' LEU . 17.1 t80 -67.57 -32.14 72.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.323 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.537 ' CE1' ' HG2' ' A' ' 27' ' ' LYS . 30.3 m-85 -96.17 -70.74 0.7 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.487 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.4 tttt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.634 -179.941 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.602 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 40.6 ttp . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -76.51 152.04 36.2 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.244 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.5 mptp? -113.34 119.99 39.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.466 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.68 HG22 HG22 ' A' ' 68' ' ' VAL . 39.9 t -113.13 134.19 56.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.363 0.601 . . . . 0.0 112.066 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.61 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 18.9 m-85 -111.66 99.51 8.22 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.959 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.11 -139.64 2.73 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.517 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.62 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 63.5 m-85 -123.28 157.38 33.3 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.858 0.361 . . . . 0.0 111.376 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.41 -76.21 0.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.976 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 174.53 -34.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.907 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -71.34 -24.64 62.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.267 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.666 ' H ' HD12 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -106.94 -40.15 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.86 0.362 . . . . 0.0 110.864 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -155.87 160.63 40.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.4 pttp -80.39 173.65 12.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.997 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 9.2 p -163.99 120.37 1.65 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.962 0.41 . . . . 0.0 110.758 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.4 -43.39 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.944 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -88.9 -9.01 53.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.936 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -87.41 -36.43 17.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.758 0.313 . . . . 0.0 110.672 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -68.09 -36.06 79.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.718 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -75.71 -48.38 22.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.125 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.22 69.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.056 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -60.33 -54.18 48.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.617 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.857 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -59.03 -34.58 72.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.679 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.631 ' C ' HD23 ' A' ' 23' ' ' LEU . 4.9 tt -60.14 -54.99 39.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.613 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.517 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.6 mt -55.25 -46.04 76.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.948 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.1 m -57.8 -36.5 72.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.041 0.448 . . . . 0.0 110.157 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.3 t -79.03 -35.46 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.682 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.426 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -72.85 -9.97 59.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.184 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.16 42.48 0.34 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.861 0.363 . . . . 0.0 110.792 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -131.89 133.44 24.07 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.025 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.587 ' O ' ' HA ' ' A' ' 1' ' ' MET . 58.9 Cg_endo -81.93 158.82 18.39 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.567 2.178 . . . . 0.0 111.481 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.492 ' CG ' HD13 ' A' ' 24' ' ' LEU . 5.6 p90 -161.47 171.25 18.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.801 0.334 . . . . 0.0 111.663 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -129.55 119.71 24.12 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.564 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.528 ' HE1' HG11 ' A' ' 4' ' ' VAL . 17.4 t80 -89.34 153.12 21.12 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.185 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.435 HD12 ' CE1' ' A' ' 5' ' ' TYR . 15.9 mt -147.4 121.61 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.509 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -81.17 109.74 16.01 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.539 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.62 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 10.7 pt -63.86 -19.65 24.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 2.8 ttp -123.08 90.27 50.45 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.812 0.339 . . . . 0.0 111.52 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.4 Cg_endo -80.86 0.98 9.65 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.697 2.265 . . . . 0.0 112.289 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -139.68 140.4 36.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.696 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -67.9 -8.55 37.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.226 0.536 . . . . 0.0 111.842 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.71 -64.76 1.25 Allowed Glycine 0 C--N 1.313 -0.74 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.347 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 t -140.82 139.47 34.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.733 0.301 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -65.56 169.49 6.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 0.0 111.112 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.523 ' O ' HD12 ' A' ' 48' ' ' ILE . 1.4 t0 -86.71 115.18 23.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.033 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -74.83 -22.91 58.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.298 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.3 -52.77 63.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.756 0.312 . . . . 0.0 110.804 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -69.64 -38.31 77.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.128 0.49 . . . . 0.0 110.022 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.523 HD12 ' O ' ' A' ' 44' ' ' ASP . 55.1 mt -64.79 -34.87 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.369 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.44 -48.7 80.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.394 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.83 -34.39 69.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.998 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.61 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.7 tt -58.58 -53.01 63.17 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.2 mt -50.33 -41.87 51.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.453 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.5 m -56.6 -49.14 75.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.523 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -61.03 -39.98 91.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.313 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.13 -48.48 81.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.589 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.99 -165.97 31.84 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.162 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 64.3 mtt-85 -95.51 35.33 1.35 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.972 0.415 . . . . 0.0 110.817 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -120.88 -147.21 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.459 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -120.49 170.9 8.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.766 0.317 . . . . 0.0 110.786 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -69.19 98.21 1.0 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.402 0.62 . . . . 0.0 110.207 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 61' ' ' ILE . 17.2 tt -73.58 79.16 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.133 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 43.09 26.24 0.48 Allowed Glycine 0 C--N 1.333 0.398 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.862 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.447 HD12 ' CG ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -57.57 144.19 38.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.838 0.351 . . . . 0.0 110.887 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 p -110.45 156.94 20.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.428 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -105.28 152.47 39.84 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.654 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.48 ' HB2' HG13 ' A' ' 4' ' ' VAL . 3.8 Cg_exo -82.34 144.28 56.12 Favored 'Cis proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.969 -1.263 . . . . 0.0 112.702 0.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.447 ' CG ' HD12 ' A' ' 63' ' ' LEU . 1.7 mp0 -98.63 132.24 44.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.826 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.68 HG22 HG22 ' A' ' 4' ' ' VAL . 3.5 t -104.23 157.02 5.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.171 0.51 . . . . 0.0 111.992 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.407 ' N ' HG12 ' A' ' 68' ' ' VAL . 46.2 m-85 -143.67 139.14 29.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.685 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.588 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -53.27 152.45 8.21 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.406 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.602 ' HB3' ' N ' ' A' ' 1' ' ' MET . 7.4 Cg_exo -70.14 -8.99 24.96 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.855 2.37 . . . . 0.0 112.353 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.61 -17.7 14.03 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.098 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.6 89.27 1.1 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.663 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.0 t 179.92 152.76 0.47 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.777 0.323 . . . . 0.0 110.723 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -90.22 113.37 25.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.865 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.588 HD11 ' HA ' ' A' ' 70' ' ' ALA . 19.9 mt -92.58 -48.68 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.977 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.558 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 138.9 -155.42 23.77 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.709 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.82 -136.82 8.9 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.641 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -71.56 -70.66 0.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.82 0.343 . . . . 0.0 111.223 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -59.67 -48.68 80.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.983 0.421 . . . . 0.0 110.729 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -51.3 -39.48 56.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.605 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.75 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.1 tt -78.66 -33.86 46.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.336 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -50.64 -30.13 12.73 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -68.08 -35.79 78.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.229 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 82' ' ' LEU . 13.5 t80 -63.02 -34.05 76.74 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.262 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.75 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.9 m-85 -90.06 -19.65 24.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.304 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.268 -0.873 . . . . 0.0 111.021 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.624 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 49.5 ttm . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.91 0.386 . . . . 0.0 111.561 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.582 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 84.3 m-85 -53.53 158.27 1.86 Allowed 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -135.23 117.44 15.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.486 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.52 HG11 ' CE1' ' A' ' 33' ' ' PHE . 30.9 t -99.87 127.18 53.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.656 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.553 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.9 m-30 -104.39 99.08 8.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.351 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.94 -139.62 2.7 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.45 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.469 ' OH ' ' CE1' ' A' ' 43' ' ' PHE . 85.6 m-85 -120.71 159.79 24.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.075 0.464 . . . . 0.0 111.733 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.15 -81.08 0.06 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.746 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 p 174.12 -41.91 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.227 0.536 . . . . 0.0 111.042 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -74.12 -31.72 62.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.236 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.699 HD12 ' HA ' ' A' ' 40' ' ' LYS . 50.9 mm -93.07 -35.7 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.733 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -154.76 152.39 29.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.33 159.68 3.45 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 t -174.66 73.82 0.03 OUTLIER 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.49 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.8 m -91.28 -37.82 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.571 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -62.5 -28.93 70.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.721 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.8 p -72.19 -44.18 63.4 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.651 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.32 -32.51 49.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.816 0.341 . . . . 0.0 110.921 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -70.16 -55.99 7.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.848 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.443 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . . . -57.69 -31.09 66.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.035 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HG2' ' CE1' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -60.94 -56.19 24.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.665 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.755 ' O ' HG23 ' A' ' 26' ' ' VAL . 23.6 ptt180 -60.42 -34.2 73.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.59 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.697 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.8 tt -59.05 -53.82 54.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.317 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.697 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.3 mt -55.47 -44.15 76.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.671 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 m -57.52 -35.92 70.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.176 0.513 . . . . 0.0 109.925 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 22' ' ' ARG . 43.5 t -79.72 -29.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.431 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.61 -13.14 59.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.052 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt 69.4 62.28 0.29 Allowed 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.95 0.405 . . . . 0.0 110.841 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -142.3 138.87 16.98 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.023 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.448 ' O ' ' HA ' ' A' ' 1' ' ' MET . 77.2 Cg_endo -79.97 136.29 11.69 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.536 2.157 . . . . 0.0 111.43 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.624 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 33.9 p90 -152.37 170.54 19.84 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -148.1 146.04 28.65 Favored 'General case' 0 N--CA 1.46 0.048 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.864 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.52 ' CE1' HG11 ' A' ' 4' ' ' VAL . 25.5 t80 -89.34 159.5 17.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.16 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.553 HD12 ' CE1' ' A' ' 5' ' ' TYR . 10.9 mt -145.37 120.56 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.521 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -94.42 118.85 32.26 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.063 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.576 HD12 ' CE2' ' A' ' 43' ' ' PHE . 35.6 pt -78.33 -17.71 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.032 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.488 ' HE3' ' HE1' ' A' ' 43' ' ' PHE . 31.6 ttm -122.11 92.01 48.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.524 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 98.6 Cg_endo -84.23 18.21 1.58 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.884 2.389 . . . . 0.0 113.028 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.525 ' O ' HG21 ' A' ' 11' ' ' ILE . 9.8 mt-10 -139.53 165.44 27.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.374 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.699 ' HA ' HD12 ' A' ' 11' ' ' ILE . 30.8 tttt -61.13 -7.76 2.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.88 48.17 0.07 OUTLIER Glycine 0 C--N 1.313 -0.737 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.877 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' A' ' 39' ' ' GLU . 5.7 t -150.48 115.21 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.327 0.584 . . . . 0.0 112.33 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.576 ' CE2' HD12 ' A' ' 36' ' ' ILE . 1.1 m-85 -68.44 153.14 44.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.822 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.662 ' O ' HD12 ' A' ' 48' ' ' ILE . 3.6 t0 -97.48 93.67 6.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.951 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -49.93 -26.24 3.98 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.716 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.93 -48.81 78.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.851 0.358 . . . . 0.0 110.812 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -77.5 -46.12 23.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.42 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 44' ' ' ASP . 3.0 mp -55.03 -42.36 64.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.76 -54.71 34.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 110.653 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.78 -38.28 87.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.48 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.467 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -57.43 -51.27 70.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.535 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.4 mt -50.09 -47.25 53.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.197 0.522 . . . . 0.0 110.586 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -70.21 -35.14 73.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.754 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -61.39 -31.37 71.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.411 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 mt -72.65 -38.72 67.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.683 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.33 -107.14 0.31 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.99 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.7 mtt-85 -150.53 30.87 0.66 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.929 0.395 . . . . 0.0 110.542 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.0 -151.34 0.48 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.355 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -120.61 170.17 9.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.696 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.93 98.37 10.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.241 0.544 . . . . 0.0 110.098 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pt -79.76 84.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.431 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.47 23.95 61.07 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.705 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.574 HD12 ' HG2' ' A' ' 67' ' ' GLN . 0.3 OUTLIER -50.57 121.28 5.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.838 0.351 . . . . 0.0 110.594 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.2 p -99.84 161.39 13.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.153 0.502 . . . . 0.0 111.544 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.403 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 1.8 mpt? -110.58 154.37 43.14 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.484 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.0 Cg_exo -81.78 145.18 62.98 Favored 'Cis proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.935 -1.277 . . . . 0.0 112.82 0.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.574 ' HG2' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -106.72 115.02 29.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.805 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -87.18 164.66 2.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.236 0.541 . . . . 0.0 111.953 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.476 ' H ' HG12 ' A' ' 68' ' ' VAL . 12.2 m-85 -142.2 130.22 21.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.467 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.789 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -46.43 144.26 3.43 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.934 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.455 ' CB ' ' N ' ' A' ' 1' ' ' MET . 19.7 Cg_endo -67.76 -13.58 39.09 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.316 2.011 . . . . 0.0 111.767 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.539 ' OD1' ' HB1' ' A' ' 70' ' ' ALA . 10.3 p-10 -99.4 -23.91 14.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.573 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.02 84.94 0.6 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.866 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 70' ' ' ALA . 3.1 m -178.11 162.74 1.63 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.837 0.351 . . . . 0.0 111.133 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -90.37 110.89 21.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.789 HD11 ' HA ' ' A' ' 70' ' ' ALA . 35.3 mt -84.86 -51.38 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.004 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.565 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 128.3 -153.5 19.54 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.475 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.18 -152.08 19.42 Favored Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.556 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.443 ' HD1' ' HB2' ' A' ' 20' ' ' ALA . 15.7 t80 -63.88 -63.25 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.824 0.345 . . . . 0.0 110.776 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -53.66 -41.82 67.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -56.04 -42.29 76.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.465 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.59 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -63.3 -48.19 79.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.428 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -51.09 -29.15 12.36 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -76.26 -34.14 59.14 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.277 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.423 ' N ' ' O ' ' A' ' 82' ' ' LEU . 7.6 t80 -66.98 -32.57 73.9 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.319 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.59 ' HE2' HD21 ' A' ' 82' ' ' LEU . 6.5 m-85 -90.65 -69.8 0.71 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.072 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.877 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.666 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 48.0 ttm . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -77.92 145.56 36.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.267 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.2 mppp? -108.11 120.68 43.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.528 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.602 HG22 HG22 ' A' ' 68' ' ' VAL . 7.8 t -105.05 131.04 55.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.29 0.567 . . . . 0.0 111.786 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.588 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.9 m-30 -106.59 98.96 8.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.168 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.91 -137.87 2.29 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.811 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.967 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 85.1 m-85 -127.73 157.86 39.21 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 120.776 0.322 . . . . 0.0 111.425 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -88.2 -68.38 0.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.127 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 166.73 -33.15 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.998 0.428 . . . . 0.0 110.899 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -71.54 -42.14 68.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.514 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.543 HG21 ' HG2' ' A' ' 37' ' ' MET . 27.5 mm -89.47 -39.55 12.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.051 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -150.51 154.08 36.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.351 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -76.86 162.71 27.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.58 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.9 t -172.14 108.32 0.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.785 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.0 m -88.81 -36.69 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.077 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -68.64 -19.74 64.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.002 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.9 m -64.36 -55.74 19.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.938 0.399 . . . . 0.0 110.29 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -57.8 -32.77 67.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.161 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -68.43 -58.46 4.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.273 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.87 -42.37 65.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.91 0.386 . . . . 0.0 111.305 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -56.26 -50.95 69.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.751 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.841 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.1 mtt180 -60.54 -40.85 93.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.585 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.802 HD21 ' CD2' ' A' ' 86' ' ' PHE . 2.0 tt -57.36 -51.9 67.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.431 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.662 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.2 mt -59.8 -50.37 74.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.584 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 m -53.27 -38.62 63.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.324 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 22' ' ' ARG . 56.5 t -76.29 -36.64 30.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.599 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.52 ' CD ' ' HB3' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -73.7 -9.89 59.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.041 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.19 59.45 0.33 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.983 0.421 . . . . 0.0 111.006 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -144.88 132.42 10.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.142 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.616 ' O ' ' HA ' ' A' ' 1' ' ' MET . 69.6 Cg_endo -79.42 159.27 25.87 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.482 2.121 . . . . 0.0 110.972 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.442 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 7.9 p90 -161.43 171.38 18.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.86 0.362 . . . . 0.0 111.788 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -134.3 134.87 42.36 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.523 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.494 ' HE1' HG11 ' A' ' 4' ' ' VAL . 6.8 t80 -89.28 156.69 18.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.168 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.588 HD12 ' CE1' ' A' ' 5' ' ' TYR . 18.0 mt -146.03 121.05 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.468 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -85.65 114.93 23.02 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.936 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.967 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 2.1 pt -75.08 -21.05 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.967 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.543 ' HG2' HG21 ' A' ' 11' ' ' ILE . 1.7 tpp -116.35 108.67 45.2 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.809 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' N ' ' A' ' 44' ' ' ASP . 79.8 Cg_endo -76.05 -28.18 7.74 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.648 2.232 . . . . 0.0 112.101 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -139.57 151.66 46.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.623 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -64.64 -8.5 14.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.255 0.55 . . . . 0.0 111.839 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.59 -55.83 2.77 Favored Glycine 0 C--N 1.313 -0.73 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.814 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -149.06 141.99 18.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 2.2 m-85 -59.4 170.29 1.03 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.843 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.427 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 1.4 p30 -88.73 140.58 29.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.031 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -78.4 -11.07 59.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.522 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.35 -62.99 1.18 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.791 0.329 . . . . 0.0 111.261 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -42.88 66.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.961 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.424 ' N ' ' CD1' ' A' ' 48' ' ' ILE . 0.8 OUTLIER -56.64 -39.09 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.744 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.26 -55.38 6.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -36.12 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.46 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.583 HD11 HD21 ' A' ' 55' ' ' LEU . 20.1 tp -57.08 -51.66 68.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.694 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 52' ' ' LEU . 81.3 mt -52.01 -46.91 65.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.149 0.5 . . . . 0.0 111.317 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.8 m -70.16 -42.41 72.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.594 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -60.29 -40.2 89.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.941 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.583 HD21 HD11 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -60.17 -69.08 0.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.804 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.62 -40.75 0.72 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.2 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -89.78 -174.89 4.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.33 . . . . 0.0 110.709 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -103.26 -30.3 10.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.072 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.4 t -111.19 169.73 8.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.081 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.5 mp0 -110.56 99.65 8.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.564 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.4 mt -80.26 87.42 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.558 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.65 29.66 64.47 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.682 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 60' ' ' GLN . 1.3 mm? -47.0 147.41 1.37 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.804 0.335 . . . . 0.0 111.007 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.4 p -121.32 153.49 37.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.079 0.466 . . . . 0.0 111.652 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -122.47 152.8 61.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.518 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -80.92 149.7 77.37 Favored 'Cis proline' 0 C--N 1.344 0.324 0 C-N-CA 124.073 -1.22 . . . . 0.0 112.725 0.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -105.32 119.61 39.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.848 178.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -91.41 161.41 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.362 0.601 . . . . 0.0 112.193 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.432 ' N ' HG12 ' A' ' 68' ' ' VAL . 60.6 m-85 -143.13 140.74 30.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.277 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.629 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.37 147.23 28.97 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.139 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.666 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 15.7 Cg_exo -65.48 -14.45 44.95 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.694 2.262 . . . . 0.0 112.317 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.56 -23.01 13.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.018 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.36 74.61 0.28 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.568 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.64 113.08 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.757 0.313 . . . . 0.0 110.739 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -53.66 120.94 6.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.994 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.629 HD11 ' HA ' ' A' ' 70' ' ' ALA . 15.5 mt -97.41 -45.97 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.768 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 81' ' ' GLN . . . 135.13 -156.23 22.47 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.585 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.28 -138.25 7.22 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.575 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -72.87 -61.16 1.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -55.19 -45.34 75.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.04 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.404 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 8.4 mp0 -56.01 -48.28 76.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.645 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -64.28 -43.0 96.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.434 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -51.54 -29.88 18.59 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -75.01 -35.17 61.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.404 ' N ' ' O ' ' A' ' 82' ' ' LEU . 12.0 t80 -62.9 -35.38 79.87 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.802 ' CD2' HD21 ' A' ' 23' ' ' LEU . 5.3 m-85 -87.64 -70.38 0.63 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.216 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.944 179.942 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.681 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 28.4 ttp . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.85 0.357 . . . . 0.0 111.541 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.461 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 87.7 m-85 -79.19 153.35 30.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.156 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.647 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -131.59 121.44 24.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.888 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.635 HG22 HG22 ' A' ' 68' ' ' VAL . 7.0 t -104.22 124.32 58.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.147 0.498 . . . . 0.0 111.374 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.687 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.3 m-30 -100.09 99.15 9.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.324 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.34 -137.2 2.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.837 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.913 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 6.7 m-85 -123.63 146.39 48.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.372 0.13 . . . . 0.0 110.949 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.81 17.79 7.31 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 0.9 OUTLIER 71.72 2.16 4.17 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.589 0.233 . . . . 0.0 111.617 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -85.19 -53.41 5.27 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.967 0.413 . . . . 0.0 110.654 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.478 HD12 ' O ' ' A' ' 37' ' ' MET . 1.3 mt -111.33 9.5 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.385 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.574 ' CB ' ' CD2' ' A' ' 7' ' ' TYR . 3.7 t60 -169.82 138.19 1.77 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.139 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.34 22.79 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.011 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 p -175.61 123.78 0.21 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.041 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.4 m -91.1 -37.35 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.58 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -75.52 -18.64 59.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.552 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.4 p -70.45 -36.36 73.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.813 0.34 . . . . 0.0 111.004 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.2 -27.11 62.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.335 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -76.86 -49.49 15.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.062 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.02 -46.55 71.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.267 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -60.31 -52.75 63.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.955 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.777 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -60.37 -38.9 85.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.63 ' C ' HD23 ' A' ' 23' ' ' LEU . 4.5 tt -58.37 -54.02 51.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.636 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.54 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.9 mt -56.15 -46.83 79.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.889 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.7 m -56.58 -36.78 69.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.12 0.486 . . . . 0.0 110.152 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 22' ' ' ARG . 54.3 t -78.15 -27.68 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.727 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -11.37 58.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.245 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.08 61.14 0.5 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.106 0.479 . . . . 0.0 110.716 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -136.69 140.76 32.98 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.183 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.94 131.94 11.41 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.553 2.169 . . . . 0.0 111.592 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.681 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 11.8 p90 -156.31 169.45 24.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.999 0.428 . . . . 0.0 111.957 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -147.12 148.04 31.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.804 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.481 ' HE1' HG11 ' A' ' 4' ' ' VAL . 7.5 t80 -89.42 161.15 16.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.393 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.687 HD12 ' CE1' ' A' ' 5' ' ' TYR . 21.9 mt -145.58 119.55 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.308 0.575 . . . . 0.0 110.511 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -81.21 125.34 30.18 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.025 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.913 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 2.7 pt -99.48 -11.97 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.297 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.613 ' HE3' ' HE2' ' A' ' 7' ' ' TYR . 14.5 ttm -117.57 92.2 40.22 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.742 0.306 . . . . 0.0 111.146 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 44' ' ' ASP . 54.5 Cg_endo -69.37 -28.43 27.13 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.562 2.175 . . . . 0.0 111.671 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -139.85 147.42 40.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.032 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -8.54 6.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.213 0.53 . . . . 0.0 111.783 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.16 -56.62 2.99 Favored Glycine 0 C--N 1.313 -0.72 0 CA-C-N 115.278 -0.873 . . . . 0.0 112.704 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.7 t -148.14 146.42 17.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.924 0.392 . . . . 0.0 111.967 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -61.07 166.51 3.53 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.505 179.47 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.455 ' O ' HD12 ' A' ' 48' ' ' ILE . 10.1 p30 -78.41 99.48 6.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.948 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -55.26 -22.75 19.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.554 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -60.28 -53.7 54.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.886 0.374 . . . . 0.0 110.755 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -69.45 -47.26 64.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.667 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.455 HD12 ' O ' ' A' ' 44' ' ' ASP . 1.7 mp -50.11 -37.45 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.716 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.99 -59.74 4.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.06 0.457 . . . . 0.0 110.506 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.69 -34.45 72.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.229 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.469 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -59.64 -52.63 64.7 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.505 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 52' ' ' LEU . 69.5 mt -48.28 -45.07 34.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.264 0.554 . . . . 0.0 110.734 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.7 m -67.15 -35.84 80.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.002 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -64.62 -33.91 77.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.493 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.1 mt -70.53 -50.12 40.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.605 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.08 -163.39 35.4 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.945 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 mtt180 -93.9 31.35 1.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.946 0.403 . . . . 0.0 110.921 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -121.15 -153.46 0.55 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.275 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -120.97 170.38 9.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.734 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.757 ' HB2' HD12 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -78.46 98.48 6.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.357 0.599 . . . . 0.0 110.028 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.1 mm -73.08 82.28 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.514 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 50.16 25.95 8.53 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.867 ' O ' HD13 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -55.39 156.96 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 111.157 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.713 ' N ' HD22 ' A' ' 63' ' ' LEU . 37.2 p -139.58 163.59 32.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -98.93 158.62 32.02 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.862 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.1 Cg_exo -83.88 140.79 36.82 Favored 'Cis proline' 0 C--N 1.345 0.348 0 C-N-CA 124.151 -1.187 . . . . 0.0 112.759 0.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . 15.0 mm-40 -105.39 114.05 28.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.046 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.7 t -86.93 163.64 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.264 0.554 . . . . 0.0 112.087 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.452 ' N ' HG12 ' A' ' 68' ' ' VAL . 20.3 m-85 -142.96 132.66 23.87 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.278 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -71.38 146.34 91.73 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.262 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.589 ' HB3' ' N ' ' A' ' 1' ' ' MET . 54.7 Cg_exo -42.15 -52.36 4.2 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.372 2.715 . . . . 0.0 113.008 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.42 -27.84 66.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.203 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.46 73.26 0.64 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.363 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.14 143.2 18.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 111.044 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -70.22 110.82 5.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.764 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 70' ' ' ALA . 19.9 mt -83.4 -49.21 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.144 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.18 -153.47 20.77 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.268 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.83 -143.35 8.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.33 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -73.07 -67.17 0.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 0.0 110.755 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -53.08 -38.74 62.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.874 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -60.37 -39.41 87.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.49 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.612 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -69.65 -45.02 69.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.35 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -51.32 -31.43 21.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.48 -35.78 65.72 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.164 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.51 ' CD2' HG23 ' A' ' 76' ' ' ILE . 12.3 t80 -63.85 -33.66 76.19 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.275 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.612 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.2 m-85 -87.97 -70.34 0.64 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.132 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.931 -179.938 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.633 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 64.3 ttp . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 120.878 0.37 . . . . 0.0 111.672 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.505 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 80.2 m-85 -60.37 153.43 22.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.646 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -129.66 122.68 29.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.458 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.695 HG22 HG22 ' A' ' 68' ' ' VAL . 10.0 t -105.37 136.79 37.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.09 0.471 . . . . 0.0 111.614 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.771 ' CE1' HD12 ' A' ' 34' ' ' ILE . 5.2 m-85 -115.42 99.62 7.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.189 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.48 -135.51 1.93 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.554 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.533 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 75.5 m-85 -120.16 146.66 45.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.948 0.404 . . . . 0.0 111.665 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -94.58 139.7 30.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.465 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.5 p -51.79 -24.71 6.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.563 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -73.16 -43.32 61.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.547 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.553 HG21 ' HG2' ' A' ' 37' ' ' MET . 9.3 mm -89.8 -43.95 14.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.785 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 78.8 t60 -144.68 158.32 43.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.744 0.307 . . . . 0.0 111.131 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.2 mmmt -80.0 161.38 25.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.174 0.512 . . . . 0.0 111.614 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.2 p -167.92 113.7 0.69 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.358 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 m -90.46 -28.75 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.422 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -85.57 -17.27 36.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.129 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.5 p -67.25 -39.84 86.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.038 0.447 . . . . 0.0 110.153 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.4 -26.68 68.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.049 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -69.47 -55.58 9.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.123 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.8 -44.16 66.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.977 0.417 . . . . 0.0 111.133 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -60.32 -52.57 64.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.879 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.8 ttt85 -56.64 -37.99 71.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.762 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -58.55 -52.58 65.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.548 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.762 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.8 mt -57.51 -47.19 82.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.875 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 m -56.13 -33.39 65.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.029 0.442 . . . . 0.0 110.375 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 22' ' ' ARG . 45.3 t -78.36 -30.42 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.794 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm -82.13 -10.85 59.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.226 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? 68.39 60.99 0.38 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.914 0.388 . . . . 0.0 110.739 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.406 ' OE1' ' HD2' ' A' ' 30' ' ' PRO . 8.1 mm100 -141.42 139.63 19.2 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.07 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.45 ' O ' ' HA ' ' A' ' 1' ' ' MET . 77.9 Cg_endo -80.28 139.89 13.45 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.52 2.146 . . . . 0.0 111.231 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.633 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 51.3 p90 -153.22 170.56 20.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -141.81 142.12 33.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.956 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.596 ' CE1' HG11 ' A' ' 4' ' ' VAL . 38.2 t80 -89.83 158.58 17.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.236 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.771 HD12 ' CE1' ' A' ' 5' ' ' TYR . 7.8 mt -147.18 120.29 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.128 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -99.63 127.31 45.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.671 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.9 pt -80.97 -8.61 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.238 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.588 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 8.2 ttp -125.98 95.3 39.83 Favored Pre-proline 0 N--CA 1.456 -0.133 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.146 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.38 1.33 9.35 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.746 2.297 . . . . 0.0 112.568 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -139.71 135.62 33.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.604 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -62.79 -9.24 8.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.175 0.512 . . . . 0.0 112.183 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.99 -63.74 1.65 Allowed Glycine 0 C--N 1.311 -0.841 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.917 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.1 t -146.83 151.89 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.692 0.282 . . . . 0.0 110.993 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.588 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -68.0 167.03 14.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 111.109 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.4 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -100.26 114.87 28.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.018 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -58.11 -18.2 23.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.471 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -57.82 -54.94 41.22 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.857 0.361 . . . . 0.0 110.696 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -70.59 -37.41 73.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.208 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 44' ' ' ASP . 36.6 mm -55.31 -46.79 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.895 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.7 -53.37 58.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.693 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -57.4 -40.68 78.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.338 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.75 HD13 ' CD2' ' A' ' 5' ' ' TYR . 9.3 tp -55.37 -48.67 73.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.653 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.1 mt -54.18 -49.42 69.38 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.06 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.3 m -61.94 -33.92 75.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.215 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.405 ' HG3' ' CE1' ' A' ' 69' ' ' PHE . 27.6 tptt -67.44 -29.65 69.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.631 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.707 HD11 HD12 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -71.93 -26.49 62.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.109 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.49 32.57 15.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.396 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.5 mtt-85 -150.06 -168.86 3.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 0.0 110.827 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.78 -50.11 2.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.032 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -102.95 165.44 11.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -95.38 98.74 10.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.122 0.487 . . . . 0.0 110.503 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.8 mt -80.33 85.53 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.275 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.48 27.05 73.53 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.455 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.707 HD12 HD11 ' A' ' 55' ' ' LEU . 7.5 tt -55.42 150.57 11.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.895 0.379 . . . . 0.0 111.191 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.0 p -148.5 164.81 33.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.405 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -119.19 146.37 40.48 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.573 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -84.63 150.71 57.05 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.993 -1.253 . . . . 0.0 112.828 0.368 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' TYR . 1.3 tp60 -109.44 117.9 35.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.221 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -92.83 166.73 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.829 0.347 . . . . 0.0 111.59 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.51 ' H ' HG12 ' A' ' 68' ' ' VAL . 73.5 m-85 -142.49 140.17 31.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.028 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.445 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -52.82 150.07 10.46 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.278 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.494 ' HB3' ' N ' ' A' ' 1' ' ' MET . 42.8 Cg_exo -58.96 -30.71 93.99 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.097 2.531 . . . . 0.0 112.026 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -91.48 -23.72 19.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.245 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.62 90.27 0.8 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.653 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 15.9 t -171.63 158.98 5.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.761 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.426 ' NE2' ' CG ' ' A' ' 67' ' ' GLN . 17.7 t-160 -88.64 110.07 20.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.985 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.445 HD11 ' HA ' ' A' ' 70' ' ' ALA . 10.8 mt -85.05 -50.84 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.093 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.85 -154.77 19.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.563 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.01 -145.75 7.74 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.669 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -71.28 -70.03 0.34 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.742 0.306 . . . . 0.0 110.892 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.99 -46.1 71.61 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.969 0.414 . . . . 0.0 110.562 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -34.43 63.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.114 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 85' ' ' TYR . 2.7 tt -74.79 -39.63 61.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.012 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 87' ' ' LYS . 24.2 ttp180 -51.77 -29.08 17.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -71.63 -33.42 68.93 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.392 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.453 ' N ' ' O ' ' A' ' 82' ' ' LEU . 9.0 t80 -66.62 -31.64 72.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.588 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.486 ' CD2' HD21 ' A' ' 23' ' ' LEU . 25.1 m-85 -95.62 -70.37 0.72 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.498 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 83' ' ' ARG . 15.2 mtmt . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.954 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.616 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 4.6 ttm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -80.4 149.15 30.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.187 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -109.87 117.14 33.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.413 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.472 HG11 ' HE1' ' A' ' 33' ' ' PHE . 8.1 t -102.16 125.21 56.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.242 0.544 . . . . 0.0 111.347 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.688 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.3 m-30 -101.95 99.09 9.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.402 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.94 -137.12 2.12 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.287 -0.959 . . . . 0.0 112.647 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.454 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 87.5 m-85 -126.02 147.25 49.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.736 0.303 . . . . 0.0 110.932 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -101.92 21.39 14.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.415 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.2 t 66.83 9.14 6.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.567 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -85.55 -46.43 10.83 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.868 0.366 . . . . 0.0 110.667 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.794 HG21 ' O ' ' A' ' 39' ' ' GLU . 1.3 mp -109.33 -33.36 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.974 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.454 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 20.4 t60 -139.35 152.4 47.13 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.653 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.36 173.16 12.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.481 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.5 p -175.04 119.0 0.19 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.774 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 m -90.34 -26.33 5.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.307 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -86.72 -16.47 36.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.413 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.3 p -72.54 -41.66 65.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.934 0.397 . . . . 0.0 110.644 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -66.75 -33.23 75.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 86.5 m-20 -73.54 -52.78 12.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.506 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.76 -42.42 68.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.382 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -60.61 -52.36 65.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.766 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.809 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.8 ttt180 -58.44 -34.54 70.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.747 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.734 ' CD2' HD23 ' A' ' 24' ' ' LEU . 1.6 tt -59.46 -56.63 19.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.327 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.734 HD23 ' CD2' ' A' ' 23' ' ' LEU . 46.5 mt -61.47 -40.25 93.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.711 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.2 m -60.71 -35.5 76.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.155 0.503 . . . . 0.0 109.7 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 22' ' ' ARG . 91.9 t -80.09 -33.11 14.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.467 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 9.3 mmtt -72.23 -10.19 59.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.211 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER 68.99 40.87 1.54 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.881 0.372 . . . . 0.0 111.125 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.93 136.64 29.31 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.432 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.585 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.1 Cg_endo -78.84 155.77 26.94 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.543 2.162 . . . . 0.0 111.867 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.4 ' HA ' ' HG2' ' A' ' 1' ' ' MET . 11.7 p90 -161.35 170.84 19.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.802 0.334 . . . . 0.0 111.338 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -132.51 137.36 47.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.625 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.472 ' HE1' HG11 ' A' ' 4' ' ' VAL . 6.1 t80 -89.22 158.35 17.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.296 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.688 HD12 ' CE1' ' A' ' 5' ' ' TYR . 20.4 mt -147.27 122.56 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.468 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -92.4 126.02 37.3 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.985 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.518 ' HB ' HD11 ' A' ' 48' ' ' ILE . 41.5 pt -92.11 -6.31 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.448 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.3 tpp -127.63 82.59 68.02 Favored Pre-proline 0 N--CA 1.454 -0.271 0 CA-C-O 120.76 0.314 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 97.2 Cg_endo -89.86 27.34 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.047 2.498 . . . . 0.0 112.648 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.794 ' O ' HG21 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -139.32 165.25 27.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.382 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -58.79 -8.0 1.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 169.77 47.59 0.03 OUTLIER Glycine 0 C--N 1.312 -0.791 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.848 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.9 t -150.59 127.2 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.959 0.409 . . . . 0.0 111.397 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -63.22 168.74 4.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.645 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.433 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 7.5 t70 -98.93 106.69 18.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.914 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -60.99 -23.95 65.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.542 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.6 -59.22 3.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.684 0.278 . . . . 0.0 111.287 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -67.3 -45.14 77.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 110.885 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.518 HD11 ' HB ' ' A' ' 36' ' ' ILE . 1.5 mp -57.06 -29.42 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.814 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.65 -61.78 1.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.956 0.408 . . . . 0.0 110.887 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -59.61 -32.42 70.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.31 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -59.72 -53.03 62.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.341 179.49 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 52' ' ' LEU . 69.2 mt -47.72 -44.99 28.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.356 0.598 . . . . 0.0 110.628 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.8 m -70.15 -35.67 74.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.83 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.405 ' HG2' ' CE1' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -62.65 -29.34 70.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.61 179.401 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -74.33 -65.82 0.8 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.009 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.89 -29.18 0.26 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.511 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.25 -167.6 1.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.883 0.373 . . . . 0.0 110.806 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.428 ' O ' HD22 ' A' ' 52' ' ' LEU . 1.5 p30 -98.35 -29.88 12.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.944 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -94.5 162.69 13.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.968 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -102.37 99.25 9.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.0 110.611 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pt -79.16 84.3 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.342 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.77 23.3 76.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.621 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.695 HD13 ' N ' ' A' ' 64' ' ' THR . 2.6 tm? -61.29 131.11 49.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.309 . . . . 0.0 110.682 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.695 ' N ' HD13 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -130.89 170.01 15.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.079 0.466 . . . . 0.0 111.348 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -118.87 150.21 48.1 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.649 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.3 Cg_endo -83.29 139.04 34.89 Favored 'Cis proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.923 -1.282 . . . . 0.0 112.559 0.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -101.7 118.69 37.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.875 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.6 t -90.75 159.76 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.417 0.627 . . . . 0.0 112.499 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.504 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 30.7 m-85 -143.36 145.98 33.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.255 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.738 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -61.17 156.68 48.19 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.25 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.616 ' HB3' ' N ' ' A' ' 1' ' ' MET . 3.0 Cg_exo -73.87 -5.37 16.92 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.97 2.447 . . . . 0.0 112.425 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.19 -8.15 11.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.208 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.2 89.6 1.86 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.55 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.2 m -179.23 156.53 0.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.83 0.348 . . . . 0.0 110.925 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -90.2 120.81 31.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.738 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.2 mp -102.11 -36.04 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.625 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 122.5 -161.78 16.55 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.714 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.9 -134.75 6.97 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.619 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 10.9 t80 -74.36 -70.2 0.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 111.017 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -55.95 -48.63 75.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.936 0.398 . . . . 0.0 110.557 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.25 -38.98 66.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.601 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.511 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.8 tt -74.8 -38.3 62.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.077 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 87' ' ' LYS . 8.0 ttt85 -51.34 -29.27 14.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -71.91 -34.3 68.99 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.409 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.444 ' N ' ' O ' ' A' ' 82' ' ' LEU . 18.8 t80 -67.01 -30.68 70.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.483 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.511 ' CE2' HD21 ' A' ' 82' ' ' LEU . 30.3 m-85 -96.33 -16.6 21.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.563 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 83' ' ' ARG . 11.8 mtmm . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.98 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.64 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 40.0 ttp . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -76.14 147.35 38.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.319 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 3.7 mptt -107.85 119.35 39.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.405 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.664 HG11 ' CE2' ' A' ' 33' ' ' PHE . 38.4 t -109.26 133.58 53.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.403 0.621 . . . . 0.0 112.104 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.588 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 19.7 m-85 -113.73 99.16 7.5 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.592 177.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.63 -127.18 1.16 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.149 -1.024 . . . . 0.0 112.946 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -137.15 108.31 6.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 120.901 0.382 . . . . 0.0 111.926 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.454 ' HB2' ' CE1' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -105.08 -27.25 11.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.257 179.146 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.636 ' HB3' HG23 ' A' ' 11' ' ' ILE . 21.1 m -60.49 163.7 5.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.54 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.02 3.86 44.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.64 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.912 HD11 ' HG3' ' A' ' 37' ' ' MET . 0.1 OUTLIER -88.55 -17.49 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -140.96 141.13 34.49 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.503 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.29 177.27 9.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.839 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 p -175.95 111.65 0.11 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.035 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 m -90.64 -34.23 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.576 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-30 -82.71 -16.45 48.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.381 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.9 p -63.04 -37.36 86.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.07 0.462 . . . . 0.0 110.262 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.87 -27.01 63.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.316 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -74.1 -54.68 7.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.375 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.24 -45.28 72.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.304 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.65 -52.81 63.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.761 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.825 ' O ' HG23 ' A' ' 26' ' ' VAL . 37.7 ttp180 -58.67 -42.64 88.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.461 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.688 HD23 ' N ' ' A' ' 24' ' ' LEU . 2.2 tt -58.89 -54.73 43.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.179 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.688 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.9 mt -56.7 -48.16 78.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.72 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.4 m -55.91 -39.87 72.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.146 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 22' ' ' ARG . 59.9 t -75.97 -32.47 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.593 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -73.76 -9.36 58.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.073 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 68.69 42.57 1.43 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.051 0.453 . . . . 0.0 110.63 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -127.97 132.5 24.38 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.902 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.633 ' O ' ' HA ' ' A' ' 1' ' ' MET . 64.2 Cg_endo -79.92 154.17 22.76 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.479 2.119 . . . . 0.0 111.217 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 5.5 p90 -161.51 171.26 18.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.717 0.294 . . . . 0.0 111.446 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -137.35 121.7 18.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.899 0.38 . . . . 0.0 110.759 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.664 ' CE2' HG11 ' A' ' 4' ' ' VAL . 35.1 t80 -89.32 157.9 18.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.44 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.636 HG21 ' HG2' ' A' ' 47' ' ' LYS . 21.8 mt -143.95 120.38 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.27 0.557 . . . . 0.0 111.038 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -83.99 109.27 17.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.08 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.612 HG22 ' HB2' ' A' ' 47' ' ' LYS . 11.6 pt -97.72 66.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.05 0.453 . . . . 0.0 111.605 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.912 ' HG3' HD11 ' A' ' 11' ' ' ILE . 22.0 tpp -160.73 73.4 2.79 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.413 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.97 -22.61 69.74 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.128 1.885 . . . . 0.0 110.859 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -151.2 152.77 33.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.052 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.617 ' HG3' HD12 ' A' ' 11' ' ' ILE . 14.3 mttt -64.1 -7.54 9.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.344 0.592 . . . . 0.0 111.622 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.79 -55.42 3.36 Favored Glycine 0 C--N 1.311 -0.827 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.953 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -149.19 147.13 16.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 12.3 m-85 -59.74 170.45 1.11 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.088 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -77.89 108.4 11.12 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.687 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.03 -24.25 23.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.723 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.65 -56.36 14.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.817 0.341 . . . . 0.0 111.323 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.636 ' HG2' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -66.58 -34.37 77.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.157 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.85 -31.38 30.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.552 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.64 -55.01 39.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.962 0.41 . . . . 0.0 110.287 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.14 -33.31 75.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.045 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.588 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.1 tt -59.11 -51.69 68.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.284 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.411 HD21 ' CG ' ' A' ' 60' ' ' GLN . 84.1 mt -52.68 -44.51 66.27 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.999 0.428 . . . . 0.0 111.381 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.6 m -57.9 -48.79 78.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.576 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -58.78 -38.77 79.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.618 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.9 -56.04 26.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.722 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.93 -115.6 0.58 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.097 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.6 ttp-105 -150.33 31.03 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 110.662 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -121.07 -143.72 0.35 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.321 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 t -120.02 170.29 9.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.692 0.282 . . . . 0.0 110.671 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.411 ' CG ' HD21 ' A' ' 52' ' ' LEU . 3.4 mm100 -77.83 98.34 5.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.271 0.558 . . . . 0.0 110.649 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -80.13 84.32 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.115 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.1 25.45 66.3 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.449 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.694 HD11 ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -52.81 134.63 36.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.9 0.381 . . . . 0.0 110.893 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.516 ' H ' HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -117.54 164.1 15.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.101 0.477 . . . . 0.0 111.419 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.07 154.74 47.18 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.66 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.506 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.3 Cg_endo -87.54 136.82 16.61 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.116 -1.202 . . . . 0.0 112.679 0.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.694 ' NE2' HD11 ' A' ' 63' ' ' LEU . 4.0 tp60 -90.01 142.79 27.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.927 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -115.97 158.06 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.077 0.465 . . . . 0.0 111.56 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.456 ' CE2' ' HB2' ' A' ' 75' ' ' HIS . 46.6 m-85 -142.83 138.66 30.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.146 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.659 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -50.92 133.36 29.21 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.409 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.64 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 33.4 Cg_exo -52.92 -21.96 16.97 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.555 2.17 . . . . 0.0 111.948 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.23 39.79 0.1 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.19 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.4 -110.16 0.8 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.957 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.461 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -137.07 -172.4 3.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.168 0.509 . . . . 0.0 111.321 -179.536 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.456 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 24.4 t-80 -65.18 126.1 27.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.068 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.659 HD11 ' HA ' ' A' ' 70' ' ' ALA . 14.6 mt -95.91 -45.26 13.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.784 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.569 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 134.02 -155.32 21.77 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.521 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.77 -142.07 9.1 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.572 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -70.56 -68.76 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.778 0.323 . . . . 0.0 110.943 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -54.74 -46.46 74.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.838 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -54.41 -36.26 63.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.627 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.723 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.9 OUTLIER -75.27 -38.93 60.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.28 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -51.93 -29.63 21.05 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -71.25 -35.47 71.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.154 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 82' ' ' LEU . 20.7 t80 -63.46 -33.63 75.98 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.275 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.723 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.5 m-85 -87.15 -69.53 0.68 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.122 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.684 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 16.1 ttm . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.782 0.325 . . . . 0.0 111.682 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.477 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 91.8 m-85 -85.62 142.38 29.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.991 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.644 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -117.04 127.69 54.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.909 -179.424 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.722 HG11 ' CE1' ' A' ' 33' ' ' PHE . 15.7 t -110.76 133.81 55.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.391 0.615 . . . . 0.0 111.559 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.537 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 21.6 m-30 -116.39 99.86 7.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.368 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.544 ' N ' HG23 ' A' ' 36' ' ' ILE . . . -161.8 -139.13 2.57 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.771 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.727 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 45.4 m-85 -123.71 156.22 36.37 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 120.889 0.376 . . . . 0.0 111.364 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -74.38 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 t 173.62 -36.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.734 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -85.11 -20.7 29.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.533 HD12 ' N ' ' A' ' 11' ' ' ILE . 4.2 mp -89.28 -38.22 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.004 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -150.29 151.6 33.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.464 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 14' ' ' CYS . 13.7 tptt -75.74 157.33 33.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.18 0.514 . . . . 0.0 112.177 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 28.3 p 177.43 113.15 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.545 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.447 ' CG2' ' N ' ' A' ' 16' ' ' TYR . 1.3 m -90.88 -39.11 11.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.899 0.857 . . . . 0.0 110.026 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.569 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -77.97 -10.74 59.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.698 -179.212 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 14' ' ' CYS . 20.5 p -73.76 -41.72 62.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.047 0.451 . . . . 0.0 110.045 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.53 -34.09 71.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.747 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -65.06 -46.74 79.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.97 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.79 -50.39 72.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.962 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.0 ttpt -53.16 -44.09 67.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.841 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.768 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -60.47 -40.89 92.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.801 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -57.78 -53.1 61.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.564 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.801 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.0 mt -56.52 -47.5 79.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.85 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.2 m -55.18 -36.51 65.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.136 0.493 . . . . 0.0 110.091 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.4 t -78.14 -28.14 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.675 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.7 -21.25 44.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.927 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt 71.65 63.52 0.15 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.962 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -132.02 142.31 44.65 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.053 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.65 124.49 8.24 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.477 2.118 . . . . 0.0 111.266 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.684 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 6.3 p90 -157.17 164.56 37.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.046 0.451 . . . . 0.0 112.168 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.66 144.03 31.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.993 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.722 ' CE1' HG11 ' A' ' 4' ' ' VAL . 17.9 t80 -89.2 152.76 21.41 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.004 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 mt -143.92 119.62 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.358 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -72.94 109.93 6.86 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.776 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.727 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 1.2 pp -69.79 -24.8 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.618 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 5.8 ttp -126.69 91.44 47.3 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.111 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.71 0.61 9.9 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.57 2.18 . . . . 0.0 112.231 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -139.65 138.45 36.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.652 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -66.28 -8.71 26.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.246 0.546 . . . . 0.0 111.852 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.13 -63.75 1.64 Allowed Glycine 0 C--N 1.311 -0.815 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.098 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -150.28 139.42 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.617 0.246 . . . . 0.0 111.118 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.6 OUTLIER -58.79 169.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.932 0.396 . . . . 0.0 111.353 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.406 ' O ' ' CD1' ' A' ' 48' ' ' ILE . 1.2 t0 -80.07 105.86 11.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.302 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 6.1 t70 -59.88 -17.63 38.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.815 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.33 -61.22 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 111.212 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.55 -36.21 83.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.054 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.406 ' CD1' ' O ' ' A' ' 44' ' ' ASP . 1.9 mp -70.48 -29.85 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.409 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -61.7 -54.69 39.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.435 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.54 -34.51 74.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.134 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.537 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 2.9 tt -55.84 -51.13 68.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.264 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.6 mt -54.03 -47.24 71.75 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.331 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.1 m -62.54 -45.16 94.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.612 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -56.56 -40.73 75.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.587 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 mt -59.96 -47.88 83.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.572 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.49 -112.48 0.49 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.196 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.34 33.64 0.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.055 0.455 . . . . 0.0 110.433 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -120.92 -146.88 0.38 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.9 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.3 t -120.26 172.99 7.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.741 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.28 98.61 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.494 0.664 . . . . 0.0 109.755 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.5 mt -75.08 78.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.875 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.59 26.88 0.45 Allowed Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.007 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.2 139.88 46.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.873 0.368 . . . . 0.0 111.022 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.5 p -106.42 170.7 7.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.398 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.663 ' CE ' HD13 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -108.15 156.29 38.64 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.896 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.8 Cg_exo -84.08 143.2 42.08 Favored 'Cis proline' 0 C--N 1.346 0.4 0 C-N-CA 124.258 -1.142 . . . . 0.0 113.064 0.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -96.33 132.29 41.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.565 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -102.5 162.51 3.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.441 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.43 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 19.5 m-85 -142.25 130.88 22.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.7 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.552 ' N ' HD11 ' A' ' 76' ' ' ILE . . . -65.76 147.46 98.72 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.385 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.562 ' HB3' ' N ' ' A' ' 1' ' ' MET . 74.6 Cg_exo -45.44 -38.72 16.13 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.292 2.662 . . . . 0.0 112.615 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.66 -38.84 70.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.158 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.83 78.53 0.31 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.505 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.3 m -164.05 148.3 10.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.73 0.3 . . . . 0.0 110.878 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -75.94 106.97 7.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.552 HD11 ' N ' ' A' ' 70' ' ' ALA . 4.7 mt -74.8 -50.46 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.191 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 131.59 -153.06 20.27 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.799 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.06 -136.34 8.75 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.772 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.484 ' HB2' ' CE1' ' A' ' 16' ' ' TYR . 46.3 t80 -72.05 -70.76 0.31 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.755 0.312 . . . . 0.0 111.13 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -57.43 -40.97 79.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.979 0.418 . . . . 0.0 110.722 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -58.58 -38.46 77.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.831 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.716 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -75.37 -41.63 55.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.368 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.23 -30.34 17.17 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -70.9 -36.22 72.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.253 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.503 ' CD2' HG23 ' A' ' 76' ' ' ILE . 11.4 t80 -63.99 -33.29 75.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.216 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.716 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.6 m-85 -89.58 -13.21 37.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.257 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 68.0 mttt . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.796 179.918 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.646 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 22.9 ttm . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.816 0.341 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.496 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 77.0 m-85 -76.66 158.73 30.82 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.635 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -138.86 120.6 15.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.786 -179.408 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.8 HG22 HG22 ' A' ' 68' ' ' VAL . 7.8 t -104.79 133.02 50.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.294 0.569 . . . . 0.0 111.681 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.679 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.3 m-85 -109.33 99.21 8.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.139 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.53 -137.34 2.19 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.878 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.624 ' HE1' ' HE3' ' A' ' 37' ' ' MET . 88.6 m-85 -115.8 160.13 20.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 111.888 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -83.47 -73.0 0.43 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.606 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 p 171.79 -38.75 0.0 OUTLIER 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.963 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -85.82 -19.66 30.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.726 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 mt -95.19 -38.79 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.664 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 1.7 t-160 -150.9 174.08 13.52 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.664 ' H ' ' HD2' ' A' ' 12' ' ' HIS . 11.1 ptmt -79.65 157.68 27.2 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.949 -0.469 . . . . 0.0 111.75 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -165.97 87.35 0.37 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.3 m -90.5 -41.93 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.757 0.313 . . . . 0.0 111.165 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -77.64 -15.67 59.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.638 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.7 m -70.56 -50.63 35.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.106 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -55.99 -30.66 62.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 111.07 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -70.71 -50.67 33.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.026 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.6 -46.88 80.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.107 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.8 tttt -59.9 -53.42 58.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.74 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.798 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -59.32 -35.45 73.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.567 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.717 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.3 tt -58.3 -53.31 59.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.41 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.717 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.7 mt -55.77 -45.71 78.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.69 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.38 -35.26 67.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.17 0.509 . . . . 0.0 110.094 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 22' ' ' ARG . 42.1 t -78.05 -30.59 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.558 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -19.35 50.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.948 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 73.81 63.75 0.09 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.932 0.396 . . . . 0.0 110.904 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -142.27 139.27 17.53 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.11 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 1' ' ' MET . 80.9 Cg_endo -74.6 136.11 20.83 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.423 2.082 . . . . 0.0 111.616 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.646 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 21.3 p90 -158.3 170.66 21.75 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -146.05 147.09 31.25 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.968 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.464 ' HE1' HG11 ' A' ' 4' ' ' VAL . 13.6 t80 -89.53 158.56 17.61 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.166 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.679 HD12 ' CE1' ' A' ' 5' ' ' TYR . 19.8 mt -147.25 121.65 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.456 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -91.79 122.81 34.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.069 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 pp -89.0 -23.24 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.642 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 2.5 ttp -119.25 92.99 46.51 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.306 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.4 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 72.6 Cg_endo -76.12 0.52 9.27 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.745 2.297 . . . . 0.0 113.295 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -139.11 140.85 38.08 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -9.2 12.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.232 0.539 . . . . 0.0 111.645 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.95 -67.0 0.9 Allowed Glycine 0 C--N 1.315 -0.625 0 CA-C-N 115.272 -0.876 . . . . 0.0 113.147 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.1 t -128.73 138.47 54.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -72.57 170.51 14.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.501 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.4 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 2.5 t70 -87.86 115.32 25.23 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.147 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.78 ' HA ' HD12 ' A' ' 48' ' ' ILE . 16.3 p30 -66.92 -18.89 65.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.605 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -58.58 -55.08 39.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.923 0.392 . . . . 0.0 110.702 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 mmtm -69.35 -39.06 78.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.144 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.78 HD12 ' HA ' ' A' ' 45' ' ' ASP . 66.7 mt -54.12 -44.88 65.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.87 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.66 -55.17 36.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.54 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.72 -38.5 81.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.218 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.479 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -59.57 -50.62 73.19 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.477 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 58' ' ' ASP . 72.7 mt -47.78 -43.11 27.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.299 0.571 . . . . 0.0 110.701 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.1 m -68.55 -35.78 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.827 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.434 ' HE3' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -65.86 -30.6 71.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.428 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.694 ' CD1' HD21 ' A' ' 63' ' ' LEU . 1.1 mt -75.98 -48.47 21.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.658 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.25 -39.95 1.59 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.111 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -97.26 169.11 10.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 110.823 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.467 ' O ' HD13 ' A' ' 52' ' ' LEU . 70.4 m-20 -94.05 -25.87 17.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.763 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -98.72 161.24 13.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.75 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -110.48 99.83 8.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.805 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.6 mt -79.62 84.61 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 64' ' ' THR . . . 60.78 25.8 64.21 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.51 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.694 HD21 ' CD1' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -54.17 126.65 23.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.866 0.365 . . . . 0.0 110.857 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 62' ' ' GLY . 59.6 p -128.67 170.38 13.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.161 0.505 . . . . 0.0 111.59 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.56 157.15 38.25 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.625 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.2 Cg_endo -86.67 149.78 40.72 Favored 'Cis proline' 0 C--N 1.346 0.395 0 C-N-CA 124.384 -1.09 . . . . 0.0 112.94 0.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.602 ' OE1' HD11 ' A' ' 63' ' ' LEU . 2.1 mm-40 -119.27 115.59 24.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.98 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.8 HG22 HG22 ' A' ' 4' ' ' VAL . 2.9 t -91.59 165.92 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.219 0.533 . . . . 0.0 112.24 -178.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.5 ' H ' HG12 ' A' ' 68' ' ' VAL . 34.5 m-85 -142.29 133.51 26.2 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.155 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.695 ' HB3' ' H ' ' A' ' 74' ' ' SER . . . -72.24 138.02 81.51 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.603 ' HB3' ' N ' ' A' ' 1' ' ' MET . 21.2 Cg_exo -34.61 -56.14 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.799 2.999 . . . . 0.0 113.195 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -140.38 29.35 1.99 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.615 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.13 -87.93 1.85 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.549 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.695 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 1.0 OUTLIER -177.45 175.47 1.43 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.893 0.378 . . . . 0.0 110.571 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.413 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 20.0 t-80 -49.95 109.18 0.26 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.687 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.559 HD11 ' HA ' ' A' ' 70' ' ' ALA . 14.3 mt -73.86 -48.77 37.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.493 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 128.7 -154.29 20.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.598 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.52 -149.66 7.17 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.604 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -72.04 -53.97 11.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.78 0.324 . . . . 0.0 110.769 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -54.78 -44.39 73.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.846 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -58.67 -45.59 89.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.67 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.639 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -61.85 -49.47 76.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.595 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -51.11 -30.71 16.98 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -75.37 -34.5 61.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.177 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.422 ' N ' ' O ' ' A' ' 82' ' ' LEU . 6.3 t80 -65.45 -32.97 74.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.278 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.639 ' HE2' HD21 ' A' ' 82' ' ' LEU . 9.4 m-85 -91.85 -24.27 19.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.348 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.9 pttt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.317 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.679 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 4.5 tpp . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -77.53 143.92 38.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.879 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -105.59 121.97 45.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 -179.159 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.814 HG22 HG22 ' A' ' 68' ' ' VAL . 53.9 t -111.66 140.94 28.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.348 0.594 . . . . 0.0 111.934 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.844 ' CE1' HD12 ' A' ' 34' ' ' ILE . 4.9 m-85 -119.88 99.62 6.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.453 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.8 -140.18 2.87 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.124 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.826 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 30.0 m-85 -126.06 159.93 31.47 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.626 -0.287 . . . . 0.0 111.228 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.406 ' O ' ' CB ' ' A' ' 9' ' ' SER . 11.3 t70 -69.87 -67.41 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.527 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.7 OUTLIER 166.36 -39.35 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.129 179.641 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -85.55 -17.93 34.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.174 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.684 HD12 ' N ' ' A' ' 11' ' ' ILE . 2.6 mp -89.11 -42.51 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.042 0.449 . . . . 0.0 109.799 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.412 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 5.3 t-160 -149.52 158.17 43.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.201 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.37 146.65 2.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.831 0.348 . . . . 0.0 111.454 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -175.15 65.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.274 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.6 m -90.57 -48.12 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -76.87 -11.35 59.81 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.465 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 27.4 p -73.95 -45.04 52.79 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -55.31 -24.86 31.0 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.477 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 10.2 m-80 -73.3 -45.79 53.43 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.989 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.42 ' HB2' ' CD1' ' A' ' 79' ' ' PHE . . . -60.91 -29.69 69.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.335 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? -70.35 -62.45 1.38 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.808 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.706 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.6 OUTLIER -54.24 -30.29 49.73 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.93 0.395 . . . . 0.0 110.379 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.743 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.4 tt -58.16 -54.26 48.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.817 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.743 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.0 mt -54.44 -45.41 73.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.455 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 m -54.79 -36.28 64.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.655 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 22' ' ' ARG . 44.3 t -79.67 -32.28 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.308 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.601 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -73.19 -11.95 60.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.834 179.516 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.37 45.52 0.1 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.948 0.404 . . . . 0.0 110.95 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -144.04 134.04 11.85 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.338 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.596 ' O ' ' HA ' ' A' ' 1' ' ' MET . 64.5 Cg_endo -81.54 166.19 17.87 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.611 2.207 . . . . 0.0 111.308 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.552 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 8.4 p90 -161.49 171.08 18.75 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.89 0.329 . . . . 0.0 111.89 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.72 136.64 39.16 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.806 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.512 ' HE1' HG11 ' A' ' 4' ' ' VAL . 6.0 t80 -89.22 160.77 16.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.502 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.844 HD12 ' CE1' ' A' ' 5' ' ' TYR . 20.3 mt -144.52 119.41 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.259 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -83.09 121.89 27.63 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.481 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.826 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 1.3 pt -98.1 -20.06 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.796 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.45 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 32.6 ttm -124.75 83.26 59.23 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.811 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.454 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 55.7 Cg_endo -70.17 -13.94 34.23 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.653 2.236 . . . . 0.0 111.981 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -139.8 145.27 37.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.747 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.84 -8.0 44.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.304 0.573 . . . . 0.0 111.498 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.26 -58.54 2.57 Favored Glycine 0 C--N 1.312 -0.799 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.4 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.1 t -149.48 140.71 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 111.374 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.4 OUTLIER -60.01 160.18 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.533 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.454 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 62.6 t0 -71.78 132.2 44.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.952 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -71.54 -28.26 63.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 0.0 110.761 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.93 -56.43 10.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.984 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -65.31 -46.18 81.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.836 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 44' ' ' ASP . 1.1 mp -58.1 -38.14 65.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.372 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.46 -56.57 5.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.152 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -60.21 -31.31 70.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.629 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.442 HD13 ' CD2' ' A' ' 5' ' ' TYR . 13.3 tp -59.71 -52.18 66.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.288 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.5 mt -51.59 -45.82 63.29 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.107 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.0 m -65.53 -31.44 72.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.331 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.424 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 19.8 tttp -66.96 -31.87 72.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.556 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.443 ' N ' HD23 ' A' ' 55' ' ' LEU . 1.3 mt -64.91 -42.7 94.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.8 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.75 -106.47 0.29 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.05 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -149.68 28.65 0.78 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.112 0.482 . . . . 0.0 110.679 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -121.3 -147.14 0.38 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.401 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.5 t -120.28 170.24 9.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.69 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.29 98.26 8.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.271 0.558 . . . . 0.0 110.355 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.3 mt -80.06 84.52 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.191 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.77 25.76 45.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.469 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.412 HD12 ' NE2' ' A' ' 67' ' ' GLN . 1.1 mm? -57.64 144.3 38.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.897 0.379 . . . . 0.0 110.85 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.9 p -123.53 168.51 12.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.229 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.593 ' CE ' HD13 ' A' ' 36' ' ' ILE . 1.2 mpt? -113.12 156.12 43.36 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.791 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -80.59 140.57 52.0 Favored 'Cis proline' 0 C--N 1.344 0.298 0 C-N-CA 123.741 -1.358 . . . . 0.0 112.978 0.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.412 ' NE2' HD12 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -96.42 123.16 39.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.055 179.051 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.814 HG22 HG22 ' A' ' 4' ' ' VAL . 10.1 t -99.39 159.42 3.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.174 0.512 . . . . 0.0 111.97 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.525 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 90.9 m-85 -143.35 148.53 36.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.54 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.609 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -60.72 146.69 85.74 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.665 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.679 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 14.6 Cg_exo -65.6 -13.4 39.61 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.534 2.156 . . . . 0.0 112.087 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.72 -25.8 14.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.765 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.98 92.72 0.7 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.783 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.9 m 176.67 155.67 0.25 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 111.005 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -90.68 113.52 25.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.609 HD11 ' HA ' ' A' ' 70' ' ' ALA . 29.2 mt -94.42 -49.37 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.981 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 135.03 -154.66 21.65 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.698 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.81 -142.66 12.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.674 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 20' ' ' ALA . 24.1 t80 -67.71 -70.87 0.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.694 0.283 . . . . 0.0 110.917 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -58.74 -45.54 89.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.998 0.428 . . . . 0.0 110.707 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -52.47 -38.98 60.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.573 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.705 HD21 ' CE2' ' A' ' 86' ' ' PHE . 4.8 tt -79.41 -33.56 42.56 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.313 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -51.21 -29.51 14.41 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -70.33 -35.39 73.58 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.454 ' N ' ' O ' ' A' ' 82' ' ' LEU . 6.6 t80 -63.19 -34.46 77.69 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.705 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.1 m-85 -87.98 -70.46 0.63 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.296 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.981 -179.972 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.746 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 7.1 tpp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -77.67 146.63 35.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.89 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.9 mptt -109.66 122.03 46.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.787 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 66' ' ' PRO . 50.7 t -110.33 129.59 65.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.277 0.56 . . . . 0.0 111.854 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.564 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 17.5 m-85 -107.68 99.32 8.82 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.833 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.6 -143.7 3.73 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.246 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.746 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 5.0 m-85 -127.9 154.98 44.9 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 120.619 0.247 . . . . 0.0 111.239 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.07 -79.56 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.008 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 m 175.42 -34.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.835 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -62.57 -50.89 69.5 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.223 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.587 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -89.92 -39.79 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.936 0.398 . . . . 0.0 111.177 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.746 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 57.0 t-80 -139.88 139.65 36.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.005 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.95 174.23 11.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.257 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.8 p 175.11 113.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.896 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.0 m -90.08 -30.14 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.839 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -83.87 -15.91 46.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 p -71.31 -43.65 66.65 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.811 0.338 . . . . 0.0 110.714 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.1 -38.3 78.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.752 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -57.65 -48.53 79.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.899 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.411 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -64.59 -40.01 94.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.81 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HD2' ' CE2' ' A' ' 31' ' ' PHE . 2.2 mmmm -49.97 -37.75 33.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.14 0.495 . . . . 0.0 110.188 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.78 ' O ' HG23 ' A' ' 26' ' ' VAL . 61.3 ttt180 -75.07 -29.24 60.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.312 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.672 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -54.56 -55.7 26.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.304 179.386 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.694 HD12 ' CG ' ' A' ' 31' ' ' PHE . 3.0 mt -62.77 -47.49 83.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.766 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.3 m -56.01 -35.26 66.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.461 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 22' ' ' ARG . 87.8 t -78.06 -27.56 14.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.965 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HD3' ' CG ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -78.81 -11.45 59.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.308 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 72.59 38.43 0.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.929 0.395 . . . . 0.0 110.812 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.01 142.43 44.41 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.567 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' O ' ' HA ' ' A' ' 1' ' ' MET . 67.5 Cg_endo -79.5 155.81 24.79 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.526 2.151 . . . . 0.0 111.616 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.694 ' CG ' HD12 ' A' ' 24' ' ' LEU . 46.1 p90 -161.46 170.83 19.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.278 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -137.11 129.48 29.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.833 0.349 . . . . 0.0 110.943 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.513 ' HE1' HG11 ' A' ' 4' ' ' VAL . 17.3 t80 -89.22 154.94 19.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.005 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.478 HG21 ' HD3' ' A' ' 47' ' ' LYS . 13.0 mt -147.11 119.69 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.261 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -86.26 109.7 19.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.786 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 43' ' ' PHE . 11.8 pt -85.69 58.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.31 0.576 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.499 ' HE3' ' CE2' ' A' ' 7' ' ' TYR . 26.6 ttm -173.21 89.49 0.38 Allowed Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.334 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 51.9 Cg_endo -69.1 -22.42 35.14 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.29 1.993 . . . . 0.0 111.408 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -145.04 143.07 30.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.381 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.4 pttt -57.08 -9.07 0.78 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.171 0.51 . . . . 0.0 112.139 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.42 -55.2 4.37 Favored Glycine 0 C--N 1.312 -0.783 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.042 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -148.94 144.23 18.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 1.0 OUTLIER -58.77 170.97 0.71 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.029 179.157 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.402 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -87.32 103.81 15.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.908 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 2.9 t70 -58.11 -25.2 61.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.361 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -64.62 -59.14 4.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.897 0.379 . . . . 0.0 110.635 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.478 ' HD3' HG21 ' A' ' 34' ' ' ILE . 11.3 mttp -65.01 -35.6 81.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.27 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.3 mm -70.27 -32.85 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.343 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -58.18 -51.93 67.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.636 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.27 -36.52 83.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.928 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 3.5 tt -59.43 -53.19 60.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.392 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.0 mt -51.42 -44.59 62.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.149 0.5 . . . . 0.0 111.517 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.0 m -64.18 -49.41 72.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.571 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -54.87 -34.95 63.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.793 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -61.8 2.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.97 -26.71 0.25 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.549 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.74 -173.75 4.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.698 0.285 . . . . 0.0 110.684 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -98.9 19.29 15.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.308 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 t -120.19 158.63 26.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.881 0.372 . . . . 0.0 110.969 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -116.7 99.84 7.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.014 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 pt -78.84 84.13 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.999 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.73 26.61 57.81 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.195 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -56.81 135.74 55.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.899 0.381 . . . . 0.0 111.077 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.7 p -124.99 167.1 15.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.172 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.4 ' HG2' HD11 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -118.3 154.24 51.91 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.799 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.536 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.6 Cg_endo -85.72 142.43 31.56 Favored 'Cis proline' 0 N--CA 1.461 -0.388 0 C-N-CA 124.098 -1.209 . . . . 0.0 112.745 0.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -99.79 139.95 34.7 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -107.88 159.47 7.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.407 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 75' ' ' HIS . 30.8 m-85 -143.06 135.83 27.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.127 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.623 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -49.73 133.32 20.39 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.286 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.746 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 29.3 Cg_exo -54.65 -21.11 23.7 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.48 2.12 . . . . 0.0 111.851 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.3 38.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.189 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.3 -109.63 0.78 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.988 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.48 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 87.4 p -142.76 -176.33 4.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.135 0.493 . . . . 0.0 111.291 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.496 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 19.5 t-80 -57.85 123.42 15.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.203 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.623 HD11 ' HA ' ' A' ' 70' ' ' ALA . 14.5 mt -91.88 -46.27 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.733 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 129.37 -156.29 21.22 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.828 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -89.27 -139.3 7.14 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.332 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.672 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -75.49 -70.11 0.44 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.769 0.285 . . . . 0.0 110.871 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -49.1 -42.9 40.57 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.239 0.542 . . . . 0.0 110.437 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -64.01 -43.84 94.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.847 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.704 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -71.79 -40.87 68.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.605 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -51.43 -34.06 33.28 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -67.72 -35.94 79.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.16 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.428 ' N ' ' O ' ' A' ' 82' ' ' LEU . 35.2 t80 -62.94 -34.02 76.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.432 178.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.704 ' CE2' HD21 ' A' ' 82' ' ' LEU . 8.8 m-85 -87.32 -70.32 0.63 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.194 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 69.6 mttt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.962 179.939 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.616 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.9 ttm . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.669 0.271 . . . . 0.0 111.662 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.508 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 83.1 m-85 -59.17 161.29 5.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.875 0.369 . . . . 0.0 110.122 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -137.78 120.67 16.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.827 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.996 HG22 HG22 ' A' ' 68' ' ' VAL . 75.3 t -110.74 150.99 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.418 0.628 . . . . 0.0 111.703 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.712 ' CE1' HD12 ' A' ' 34' ' ' ILE . 40.4 m-85 -133.72 102.5 5.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.17 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -166.47 -136.78 2.08 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.535 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.409 ' O ' ' CZ ' ' A' ' 33' ' ' PHE . 49.2 m-85 -106.91 157.96 17.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.848 0.356 . . . . 0.0 110.885 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -98.94 -71.74 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.008 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 p 169.59 -32.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.996 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -74.68 -38.3 62.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.689 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.553 HG21 ' O ' ' A' ' 37' ' ' MET . 44.7 mm -89.12 -49.48 14.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -140.01 149.9 43.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.387 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.92 157.53 26.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.12 0.486 . . . . 0.0 112.018 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -172.32 93.53 0.13 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.488 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.8 m -71.44 -39.53 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.838 0.351 . . . . 0.0 111.023 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.19 -24.02 66.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.882 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.2 m -66.39 -60.69 2.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.5 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -51.77 -39.18 58.15 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.3 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -63.88 -40.64 97.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.373 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.555 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -66.76 -50.48 62.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.059 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -49.51 -36.36 22.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.856 0.36 . . . . 0.0 110.583 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.79 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -65.42 -41.79 93.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.293 179.445 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.798 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -56.99 -53.04 62.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.251 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.798 ' N ' HD23 ' A' ' 23' ' ' LEU . 7.1 mt -57.86 -45.22 86.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.673 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 51.7 m -57.62 -34.93 69.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.046 0.451 . . . . 0.0 110.113 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.9 t -80.05 -33.96 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.603 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -11.54 60.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.053 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.62 48.56 1.07 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.061 0.457 . . . . 0.0 110.537 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -128.72 130.61 23.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.308 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.465 ' O ' ' HA ' ' A' ' 1' ' ' MET . 83.8 Cg_endo -76.81 142.93 23.06 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.444 2.096 . . . . 0.0 111.105 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.616 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 9.9 p90 -158.35 170.72 21.6 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.544 -0.462 . . . . 0.0 112.209 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -142.01 129.15 20.93 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.073 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.619 ' CE1' HG11 ' A' ' 4' ' ' VAL . 50.6 t80 -89.69 162.33 15.64 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.863 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.712 HD12 ' CE1' ' A' ' 5' ' ' TYR . 14.4 mt -146.94 122.41 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.265 0.555 . . . . 0.0 110.675 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -79.04 136.19 37.1 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.052 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.661 HD13 ' SD ' ' A' ' 65' ' ' MET . 2.6 pt -97.18 -27.15 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.172 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.553 ' O ' HG21 ' A' ' 11' ' ' ILE . 5.4 ttp -124.15 95.16 44.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.431 ' CG ' ' HB2' ' A' ' 44' ' ' ASP . 85.8 Cg_endo -80.93 4.84 6.63 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.67 2.247 . . . . 0.0 112.75 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.454 ' C ' HG23 ' A' ' 11' ' ' ILE . 1.7 mt-10 -139.44 137.79 35.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.661 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.426 ' N ' HG23 ' A' ' 11' ' ' ILE . 24.3 tttp -65.18 -9.0 19.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.206 0.527 . . . . 0.0 111.909 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.04 -65.18 1.28 Allowed Glycine 0 C--N 1.311 -0.811 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.247 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 43' ' ' PHE . 20.3 t -139.63 155.93 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.751 0.31 . . . . 0.0 111.17 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -75.18 168.1 20.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.821 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.431 ' HB2' ' CG ' ' A' ' 38' ' ' PRO . 19.0 t70 -100.42 114.51 28.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.255 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -54.83 -23.37 18.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.449 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.92 -53.41 58.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.883 0.373 . . . . 0.0 110.795 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -71.11 -28.52 64.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.385 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.7 mm -71.92 -39.65 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.659 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.42 -55.63 22.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.168 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -56.13 -33.49 65.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.57 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.427 HD13 ' CG ' ' A' ' 5' ' ' TYR . 24.1 tp -63.1 -49.47 74.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.075 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.1 mt -52.25 -44.21 64.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.207 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -64.8 -32.3 73.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.091 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.439 ' HD3' ' CD2' ' A' ' 69' ' ' PHE . 2.3 ttmm -67.15 -29.5 69.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.368 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.477 HD21 ' NE2' ' A' ' 67' ' ' GLN . 1.2 mt -68.18 -58.03 5.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.683 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.13 -108.69 0.27 Allowed Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.059 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -150.48 33.1 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.034 0.445 . . . . 0.0 110.653 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -120.85 -148.05 0.4 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.378 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 t -116.63 170.19 8.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.812 0.339 . . . . 0.0 110.641 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -86.75 98.44 11.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.298 0.57 . . . . 0.0 110.575 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 pt -80.49 83.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.173 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.9 26.66 41.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.58 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.642 HD12 ' OE1' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -53.15 150.09 6.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.752 0.311 . . . . 0.0 111.074 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 p -127.62 170.07 13.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.214 0.53 . . . . 0.0 111.742 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.661 ' SD ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -122.38 158.12 56.87 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.576 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.4 Cg_exo -79.29 143.53 70.03 Favored 'Cis proline' 0 C--N 1.344 0.32 0 C-N-CA 124.084 -1.215 . . . . 0.0 112.866 0.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.642 ' OE1' HD12 ' A' ' 63' ' ' LEU . 9.9 tt0 -104.08 123.11 46.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.466 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.996 HG22 HG22 ' A' ' 4' ' ' VAL . 16.5 t -100.31 162.22 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.934 0.397 . . . . 0.0 111.659 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.527 ' N ' HG12 ' A' ' 68' ' ' VAL . 85.9 m-85 -142.24 141.84 32.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.073 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.914 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.87 146.65 36.29 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.447 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.602 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 50.1 Cg_exo -56.44 -26.61 63.99 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.132 2.555 . . . . 0.0 112.215 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -93.48 -28.58 16.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.227 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.3 91.53 0.6 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.702 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 2.6 m -178.8 163.86 1.47 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.684 0.278 . . . . 0.0 110.596 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.422 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 14.3 t-160 -90.19 108.7 19.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.113 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.914 HD11 ' HA ' ' A' ' 70' ' ' ALA . 37.1 mt -86.3 -53.39 10.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.765 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 130.61 -153.16 20.1 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.08 -137.72 7.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.155 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.555 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -76.29 -70.19 0.46 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.702 0.251 . . . . 0.0 110.773 179.597 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -49.26 -44.03 43.46 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.256 0.55 . . . . 0.0 110.32 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -36.53 81.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.482 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.719 HD21 ' CE2' ' A' ' 86' ' ' PHE . 2.0 tt -79.47 -38.52 34.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.594 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.91 -32.75 21.61 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -67.53 -35.62 79.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.237 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 82' ' ' LEU . 8.6 t80 -63.44 -34.44 77.75 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.31 178.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.719 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.8 m-85 -89.3 -21.93 22.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.341 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.991 -179.945 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.626 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.39 0.138 . . . . 0.0 111.045 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.414 ' HB3' ' CG1' ' A' ' 68' ' ' VAL . 75.1 m-85 -39.71 120.9 1.17 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.694 0.759 . . . . 0.0 111.867 -177.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.738 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -90.8 124.1 34.87 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.147 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.629 HG22 HG22 ' A' ' 68' ' ' VAL . 7.7 t -102.15 128.31 54.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.238 0.542 . . . . 0.0 111.47 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 2.8 m-30 -104.96 98.92 8.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.969 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.54 -139.71 2.71 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.293 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.596 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 91.6 m-85 -124.36 153.75 41.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.891 0.377 . . . . 0.0 111.582 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.88 -77.24 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.915 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 170.07 -32.63 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.017 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -80.43 -30.19 37.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.983 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.592 ' H ' HD12 ' A' ' 11' ' ' ILE . 3.6 mp -90.39 -47.15 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.117 0.484 . . . . 0.0 110.59 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.414 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 6.4 t-80 -147.76 153.81 39.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.558 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.3 149.61 50.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.077 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 7' ' ' TYR . 42.6 t -164.99 87.56 0.44 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.063 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.39 -27.52 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -64.1 -32.37 73.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.331 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.1 p -77.92 -45.46 23.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.329 . . . . 0.0 110.543 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.08 -37.98 36.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.627 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -69.12 -55.05 11.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.724 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.413 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . . . -52.08 -38.32 56.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.19 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 15.3 ttmt -58.32 -52.36 65.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.342 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.845 ' O ' HG23 ' A' ' 26' ' ' VAL . 30.3 mmt180 -61.14 -37.26 82.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.155 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.797 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -59.82 -53.85 53.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.103 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.797 ' N ' HD23 ' A' ' 23' ' ' LEU . 7.1 mt -56.22 -44.12 79.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.665 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 m -60.09 -41.55 92.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.109 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 22' ' ' ARG . 44.8 t -72.93 -35.82 49.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.595 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 2.6 tmtm? -75.23 -13.0 60.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.31 52.65 0.18 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.888 0.375 . . . . 0.0 110.736 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -145.2 111.52 4.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.239 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.626 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 82.2 Cg_exo -49.53 178.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.324 2.016 . . . . 0.0 111.628 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.477 ' HB3' HD13 ' A' ' 24' ' ' LEU . 5.3 p90 -164.25 170.18 16.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.983 0.42 . . . . 0.0 111.227 178.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.593 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 5.4 mm-40 -136.39 121.0 18.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.625 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.526 ' HE1' HG11 ' A' ' 4' ' ' VAL . 9.9 t80 -89.71 152.96 21.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.111 0.481 . . . . 0.0 111.639 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 3' ' ' LYS . 29.0 mt -150.1 126.54 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.407 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -92.58 129.4 38.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.08 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.596 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 2.0 pp -87.4 -19.53 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.268 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.6 ttp -124.19 94.74 44.82 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.761 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.17 -14.63 28.76 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.421 2.081 . . . . 0.0 112.653 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -139.83 142.25 36.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 110.844 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -65.23 -8.77 19.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.227 0.536 . . . . 0.0 111.877 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.4 -60.22 2.26 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.178 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.6 t -150.1 129.83 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.713 0.292 . . . . 0.0 111.157 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -59.15 169.65 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.941 0.4 . . . . 0.0 110.921 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.467 ' O ' HD12 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -84.28 93.5 8.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.127 -179.609 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -52.4 -22.2 4.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.891 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -55.54 -50.21 70.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 0.0 110.898 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -75.02 -40.74 60.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.571 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 44' ' ' ASP . 2.6 mp -52.67 -30.5 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.762 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.95 -57.72 3.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.722 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -61.07 -29.84 69.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.276 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.962 HD13 HD11 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -61.46 -57.92 10.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.951 179.315 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.564 ' HA ' HD13 ' A' ' 55' ' ' LEU . 72.2 mt -43.14 -45.91 5.66 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.316 0.579 . . . . 0.0 110.919 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.2 m -70.42 -32.4 70.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.272 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.15 -39.93 93.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.328 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.962 HD11 HD13 ' A' ' 51' ' ' LEU . 4.4 mp -59.58 -64.36 0.97 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.868 0.366 . . . . 0.0 110.945 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.65 -48.02 0.21 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.229 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.424 ' HD2' HG22 ' A' ' 59' ' ' THR . 0.3 OUTLIER -99.42 -165.11 1.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 110.865 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -105.43 -30.6 9.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.927 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.424 HG22 ' HD2' ' A' ' 57' ' ' ARG . 10.3 t -95.71 168.51 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.18 99.76 7.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.772 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.1 mt -79.05 84.6 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.047 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 64' ' ' THR . . . 62.37 26.29 67.8 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.316 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.06 125.15 22.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 111.002 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.468 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 34.4 p -128.23 170.14 13.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.994 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.88 159.06 31.29 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.746 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.628 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.9 Cg_endo -84.26 144.75 45.24 Favored 'Cis proline' 0 C--N 1.345 0.343 0 C-N-CA 124.326 -1.114 . . . . 0.0 112.933 0.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.468 ' NE2' ' O ' ' A' ' 64' ' ' THR . 67.6 mm-40 -112.41 121.19 44.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.104 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.738 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -95.23 160.06 2.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.446 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 46.1 m-85 -141.97 138.3 31.82 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.264 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.931 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -52.47 142.73 29.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.181 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -31.9 -37.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.718 2.945 . . . . 0.0 112.835 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.29 34.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.111 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.78 -105.12 2.58 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.921 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.5 t -131.84 178.04 7.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.167 0.508 . . . . 0.0 111.269 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.435 ' HE1' ' HB3' ' A' ' 67' ' ' GLN . 15.3 t60 -65.36 129.65 40.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.674 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.931 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.3 mp -103.87 -40.89 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.674 0.273 . . . . 0.0 110.94 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' A' ' 81' ' ' GLN . . . 130.95 -166.92 22.5 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.898 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.6 -137.12 4.74 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.907 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.413 ' HD1' ' HB2' ' A' ' 20' ' ' ALA . 30.1 t80 -72.13 -67.96 0.5 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 0.0 111.261 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -54.16 -44.4 71.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.007 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.421 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -57.34 -48.35 79.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.81 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.691 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -67.09 -42.7 84.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.531 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -51.09 -30.25 15.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.52 -35.86 68.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.219 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 82' ' ' LEU . 11.0 t80 -63.72 -33.67 76.17 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.691 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.3 m-85 -87.96 -28.26 21.58 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.068 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.919 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.591 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.7 ttp . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.746 0.308 . . . . 0.0 111.633 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.523 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 86.0 m-85 -58.9 154.4 15.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.937 0.399 . . . . 0.0 110.427 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.679 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -130.31 123.09 29.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.713 -179.359 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.984 HG22 HG22 ' A' ' 68' ' ' VAL . 54.8 t -113.64 145.05 20.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.377 0.608 . . . . 0.0 111.881 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.904 ' CE1' HD12 ' A' ' 34' ' ' ILE . 8.2 m-85 -123.78 102.97 8.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.792 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.78 -137.98 2.31 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.098 -1.048 . . . . 0.0 112.769 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.415 ' CE1' ' SD ' ' A' ' 37' ' ' MET . 56.7 m-85 -112.34 152.66 28.31 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.742 0.306 . . . . 0.0 110.899 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 9' ' ' SER . 19.1 m-20 -88.54 3.75 49.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.709 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.3 OUTLIER 81.09 -10.94 1.16 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.56 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.663 ' OD1' HD12 ' A' ' 11' ' ' ILE . 19.8 p-10 -85.14 -35.08 21.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.908 0.385 . . . . 0.0 110.753 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.73 HG23 ' HA ' ' A' ' 40' ' ' LYS . 2.5 mp -94.32 -42.61 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.52 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -139.34 147.04 41.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.518 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -76.46 159.6 30.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.0 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 p -174.29 122.12 0.28 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.629 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.8 m -90.09 -29.87 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.844 0.354 . . . . 0.0 111.175 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -77.84 -22.08 50.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.101 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.3 p -73.27 -41.88 63.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 110.92 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -28.42 57.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.324 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 81.4 m-20 -74.88 -39.46 61.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.223 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.18 -38.14 78.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.044 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -60.13 -55.94 27.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.648 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.859 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -61.48 -30.45 70.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.362 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.823 HD12 ' CE1' ' A' ' 79' ' ' PHE . 4.0 tt -53.79 -46.18 70.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.333 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.718 HD13 ' CG ' ' A' ' 31' ' ' PHE . 2.6 mt -66.23 -48.58 70.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.635 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.4 m -56.2 -36.52 68.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.505 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 22' ' ' ARG . 49.0 t -72.69 -31.93 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.733 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.22 -9.87 57.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.201 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm 71.24 57.91 0.19 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.983 0.42 . . . . 0.0 110.903 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -135.63 139.03 29.79 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.082 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 1' ' ' MET . 91.8 Cg_endo -79.59 142.08 16.03 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.569 2.179 . . . . 0.0 111.572 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.718 ' CG ' HD13 ' A' ' 24' ' ' LEU . 32.0 p90 -158.69 170.62 21.75 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -141.48 135.56 30.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.162 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CE1' HG11 ' A' ' 4' ' ' VAL . 32.1 t80 -89.81 159.8 16.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.086 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.904 HD12 ' CE1' ' A' ' 5' ' ' TYR . 19.0 mt -139.23 116.53 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.436 0.636 . . . . 0.0 110.431 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -87.24 121.23 29.41 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.474 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.5 HG22 ' HB3' ' A' ' 47' ' ' LYS . 4.2 pt -100.2 32.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.849 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.432 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.0 mtt -142.64 84.39 11.0 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.157 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.511 ' HD2' ' O ' ' A' ' 42' ' ' VAL . 39.9 Cg_endo -67.33 -8.48 22.16 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.684 2.256 . . . . 0.0 112.62 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -138.8 170.58 15.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.881 0.372 . . . . 0.0 111.011 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.73 ' HA ' HG23 ' A' ' 11' ' ' ILE . 4.4 mptp? -65.4 -6.62 10.75 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.52 35.02 0.25 Allowed Glycine 0 C--N 1.313 -0.733 0 C-N-CA 120.711 -0.756 . . . . 0.0 113.043 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.511 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 t -149.22 125.91 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.635 0.255 . . . . 0.0 110.738 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 1.3 m-85 -76.25 169.91 17.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.041 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.449 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -99.91 112.02 24.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.856 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -54.49 -33.09 59.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.826 0.346 . . . . 0.0 110.612 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.26 -51.37 61.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.595 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.5 ' HB3' HG22 ' A' ' 36' ' ' ILE . 22.7 mmtm -64.61 -43.47 93.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.41 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 44' ' ' ASP . 1.7 mp -64.93 -36.17 77.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.184 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.87 -58.32 4.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.093 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.74 -34.75 71.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.781 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.447 HD13 ' CD2' ' A' ' 5' ' ' TYR . 9.5 tp -58.18 -51.49 69.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.38 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.7 -45.88 63.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.166 0.508 . . . . 0.0 111.204 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.7 m -70.2 -35.15 73.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.149 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -29.98 71.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.395 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.66 -70.05 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.781 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.58 -41.2 0.59 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.196 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -98.52 -168.59 1.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 110.847 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -96.65 -30.92 12.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.2 t -109.54 167.5 10.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -104.58 99.52 9.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.553 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.617 ' O ' HG23 ' A' ' 61' ' ' ILE . 7.7 tp -62.88 81.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.261 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.22 23.26 39.86 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.773 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.511 HD12 ' CG ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -65.13 140.7 58.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 110.783 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.34 166.3 16.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.247 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.7 mmt -105.67 152.21 40.04 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.61 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.1 Cg_exo -80.79 144.8 67.73 Favored 'Cis proline' 0 C--N 1.345 0.352 0 C-N-CA 123.985 -1.256 . . . . 0.0 112.894 0.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.614 ' HG2' ' CE1' ' A' ' 75' ' ' HIS . 5.2 mt-30 -99.05 119.57 38.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.641 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.984 HG22 HG22 ' A' ' 4' ' ' VAL . 4.6 t -97.51 162.71 2.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.744 0.307 . . . . 0.0 111.428 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 89.3 m-85 -142.22 142.69 32.66 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.24 0.543 . . . . 0.0 111.464 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.47 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.66 137.95 62.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.264 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.508 ' HB3' ' N ' ' A' ' 1' ' ' MET . 84.3 Cg_exo -46.61 -28.07 6.01 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.104 2.536 . . . . 0.0 112.001 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.79 37.05 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.043 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.29 -109.85 1.1 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.949 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.442 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 2.0 p -135.67 -178.07 4.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.122 0.487 . . . . 0.0 111.318 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.614 ' CE1' ' HG2' ' A' ' 67' ' ' GLN . 86.3 t60 -60.4 122.79 15.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.036 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.49 HG23 ' HD2' ' A' ' 85' ' ' TYR . 2.3 mt -85.24 -45.68 17.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.963 0.411 . . . . 0.0 111.159 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.04 -147.92 18.29 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.392 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.1 -149.88 24.11 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.927 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.823 ' CE1' HD12 ' A' ' 23' ' ' LEU . 18.9 t80 -71.8 -70.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.833 0.349 . . . . 0.0 111.008 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -55.9 -48.97 74.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -53.56 -35.12 60.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.08 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.728 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.5 tt -83.45 -30.79 26.98 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.042 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.1 ttp85 -50.73 -33.13 21.75 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -66.19 -35.0 79.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.49 ' HD2' HG23 ' A' ' 76' ' ' ILE . 5.2 t80 -63.04 -34.9 78.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.189 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.728 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.6 m-85 -92.4 -13.68 29.73 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.657 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.923 179.913 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.627 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 50.3 ttp . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -74.69 153.15 39.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.201 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -114.22 120.81 41.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.714 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 66' ' ' PRO . 7.0 t -104.41 128.02 58.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.202 0.525 . . . . 0.0 111.498 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.622 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 4.3 m-30 -103.83 98.84 8.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.154 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.29 -138.4 2.43 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.471 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.625 ' CD2' ' CD2' ' A' ' 12' ' ' HIS . 11.5 m-85 -120.35 144.49 47.84 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 120.676 0.274 . . . . 0.0 111.578 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.586 ' HB3' ' CE2' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -136.81 64.22 1.55 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.337 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.898 ' HB3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER 177.88 -179.01 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.271 0.558 . . . . 0.0 112.016 179.675 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -86.39 1.51 50.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.62 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.898 HG22 ' HB3' ' A' ' 9' ' ' SER . 2.5 tt -86.54 -6.58 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.061 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.625 ' CD2' ' CD2' ' A' ' 7' ' ' TYR . 6.0 t60 -156.98 161.92 39.59 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.015 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.76 166.0 24.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.615 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 176.67 73.03 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.888 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.492 HG23 ' N ' ' A' ' 16' ' ' TYR . 29.3 m -89.22 -49.03 14.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.726 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.492 ' N ' HG23 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -70.8 -12.88 61.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 110.972 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.3 m -70.37 -53.0 18.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.534 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -53.65 -26.22 21.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.103 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -70.53 -59.41 2.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.032 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.46 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . . . -53.82 -38.26 64.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.489 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -52.92 63.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 110.658 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.673 ' O ' HG23 ' A' ' 26' ' ' VAL . 14.7 tpt180 -60.75 -37.63 82.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.482 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.641 ' C ' HD23 ' A' ' 23' ' ' LEU . 3.3 tt -60.18 -53.33 58.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.64 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.593 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.2 mt -56.99 -48.71 77.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.951 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.2 m -54.53 -37.93 65.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.106 0.479 . . . . 0.0 110.244 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 22' ' ' ARG . 67.1 t -79.54 -32.58 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.598 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -72.91 -11.59 60.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.112 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm 72.86 43.93 0.39 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.892 0.377 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -132.17 127.96 21.14 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.002 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.601 ' O ' ' HA ' ' A' ' 1' ' ' MET . 96.9 Cg_endo -77.98 158.56 30.81 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.476 2.118 . . . . 0.0 110.876 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 6.1 p90 -161.51 171.26 18.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.997 0.427 . . . . 0.0 112.021 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.39 133.5 38.75 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.488 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.586 ' CE2' ' HB3' ' A' ' 8' ' ' ASP . 12.2 t80 -89.15 159.79 17.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.168 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.615 HG21 ' HE2' ' A' ' 47' ' ' LYS . 12.5 mt -149.29 122.26 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.229 0.537 . . . . 0.0 110.753 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -86.25 120.5 27.68 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.829 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.43 HD13 ' H ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -94.53 0.31 10.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.476 179.772 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.434 ' HE1' ' CD1' ' A' ' 43' ' ' PHE . 6.9 tpp -120.08 97.25 49.36 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.627 0.251 . . . . 0.0 111.332 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 76.7 Cg_endo -77.35 -23.21 10.32 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.295 1.996 . . . . 0.0 111.339 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -142.52 148.52 37.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.384 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -7.72 11.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.304 0.573 . . . . 0.0 111.738 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.67 -57.32 2.75 Favored Glycine 0 C--N 1.313 -0.737 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.722 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.7 t -148.27 146.38 17.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.885 0.374 . . . . 0.0 111.791 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.434 ' CD1' ' HE1' ' A' ' 37' ' ' MET . 0.5 OUTLIER -59.85 170.32 1.19 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.631 179.365 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.414 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -74.5 98.67 3.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -50.69 -23.99 3.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.553 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -64.94 -59.21 4.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.337 . . . . 0.0 110.799 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.615 ' HE2' HG21 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -69.84 -39.06 76.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.502 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.487 ' O ' HD12 ' A' ' 52' ' ' LEU . 29.1 mm -50.08 -46.76 24.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.639 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.408 ' O ' HD12 ' A' ' 52' ' ' LEU . . . -63.04 -54.44 38.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.131 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -64.08 -21.25 66.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.664 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.51 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 3.4 tt -62.34 -61.01 2.75 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.159 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 60' ' ' GLN . 0.8 OUTLIER -51.34 -49.28 61.71 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.196 0.522 . . . . 0.0 110.241 179.622 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.3 m -53.19 -40.59 64.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.242 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -38.92 84.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.249 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.417 HD22 ' CG ' ' A' ' 75' ' ' HIS . 1.4 mt -59.89 -38.11 81.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.284 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.82 -111.83 0.38 Allowed Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.686 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.3 ttm-85 -150.38 27.11 0.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.075 0.464 . . . . 0.0 110.709 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -121.77 -144.85 0.35 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.415 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.6 t -120.05 170.64 9.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.639 0.257 . . . . 0.0 110.381 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.559 ' N ' HD23 ' A' ' 52' ' ' LEU . 1.6 pt20 -73.85 98.06 2.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.274 0.559 . . . . 0.0 110.42 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.3 mt -80.11 80.37 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.223 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.67 26.11 7.43 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.555 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.787 HD22 ' N ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -48.27 166.79 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.845 0.355 . . . . 0.0 111.308 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.787 ' N ' HD22 ' A' ' 63' ' ' LEU . 30.0 p -127.09 160.31 31.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.109 0.48 . . . . 0.0 111.391 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.2 mtm -120.23 155.39 55.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.619 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.622 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.9 Cg_exo -76.23 142.97 75.04 Favored 'Cis proline' 0 C--N 1.345 0.354 0 C-N-CA 123.874 -1.303 . . . . 0.0 112.762 0.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.629 ' NE2' HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -98.03 120.24 38.08 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.711 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -92.52 158.83 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.426 0.631 . . . . 0.0 112.31 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.492 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 74.6 m-85 -142.53 148.39 37.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.005 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.917 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -61.24 153.75 66.13 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.854 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.627 ' HB3' ' N ' ' A' ' 1' ' ' MET . 19.6 Cg_exo -68.09 59.44 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.344 2.696 . . . . 0.0 112.044 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 71' ' ' PRO . 0.3 OUTLIER 100.37 25.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.85 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -112.18 -97.15 2.33 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.525 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.523 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 8.5 t -147.5 -174.9 4.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.803 0.335 . . . . 0.0 110.612 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.417 ' CG ' HD22 ' A' ' 55' ' ' LEU . 20.6 t-80 -71.82 132.34 44.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.835 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.917 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.4 mp -109.09 -41.33 4.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.627 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 135.87 -165.04 24.94 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.741 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.32 -136.52 4.93 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.737 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.46 ' HD1' ' HB2' ' A' ' 20' ' ' ALA . 31.7 t80 -72.33 -70.57 0.33 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.708 0.29 . . . . 0.0 111.332 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -56.4 -47.3 79.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.99 0.424 . . . . 0.0 110.857 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -51.06 -44.14 61.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.472 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.724 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.0 tt -74.77 -32.92 62.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.243 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.5 ttt85 -51.37 -30.08 17.67 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.93 -35.39 76.74 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.155 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LEU . 22.3 t80 -62.28 -34.3 76.3 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.273 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.724 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.7 m-85 -86.14 -38.84 17.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.266 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.2 mttm . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.952 -179.999 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.634 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 49.3 ttm . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -77.0 144.31 38.78 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.183 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -106.45 121.21 43.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.662 -179.325 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.609 HG22 HG22 ' A' ' 68' ' ' VAL . 40.6 t -107.83 138.25 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.285 0.564 . . . . 0.0 111.887 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.745 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.1 m-85 -113.43 99.62 7.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.816 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.44 -139.6 2.71 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.296 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.679 ' OH ' HD11 ' A' ' 36' ' ' ILE . 84.1 m-85 -125.18 148.34 48.65 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.796 0.332 . . . . 0.0 111.253 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -64.55 -75.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.705 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 167.07 -32.87 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.974 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -82.92 -23.9 33.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.839 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.643 HD12 ' N ' ' A' ' 11' ' ' ILE . 2.6 mp -93.41 -46.03 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.476 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -147.44 153.64 39.83 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 pttm -62.39 165.26 6.25 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.877 0.37 . . . . 0.0 111.284 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.4 t -176.6 82.23 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.306 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.43 -19.23 7.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.065 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -76.19 -28.23 57.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.508 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.6 p -77.5 -46.03 23.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.715 0.293 . . . . 0.0 110.831 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.23 -35.39 17.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 110.718 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -70.78 -60.78 2.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.572 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 79' ' ' PHE . . . -53.16 -33.3 51.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.181 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -59.14 -54.96 41.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.54 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.837 ' O ' HG23 ' A' ' 26' ' ' VAL . 33.2 ttt180 -59.73 -35.19 74.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.554 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.641 HD23 ' N ' ' A' ' 24' ' ' LEU . 3.1 tt -60.81 -54.61 43.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.565 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.641 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.9 mt -55.48 -48.05 75.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.855 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.0 m -56.03 -37.74 69.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.166 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 22' ' ' ARG . 61.4 t -77.08 -36.09 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.646 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -72.54 -10.03 59.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.096 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.65 50.8 0.17 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.861 0.362 . . . . 0.0 110.693 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -139.53 128.53 13.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.27 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.634 ' O ' ' HA ' ' A' ' 1' ' ' MET . 81.0 Cg_endo -79.61 161.81 24.77 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.581 2.187 . . . . 0.0 110.749 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 6.9 p90 -161.23 171.16 18.9 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -135.36 136.79 41.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.292 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.503 ' HE1' HG11 ' A' ' 4' ' ' VAL . 8.6 t80 -89.28 157.0 18.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.174 0.512 . . . . 0.0 111.732 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.745 HD12 ' CE1' ' A' ' 5' ' ' TYR . 14.7 mt -143.88 119.47 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.714 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -98.26 135.98 39.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.737 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.679 HD11 ' OH ' ' A' ' 7' ' ' TYR . 1.4 pp -97.65 -14.22 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.018 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -123.48 80.39 54.02 Favored Pre-proline 0 N--CA 1.455 -0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.403 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 64.8 Cg_endo -88.44 31.08 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.032 2.488 . . . . 0.0 112.449 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.431 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 2.2 tp10 -139.08 164.78 28.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.534 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.65 -8.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.49 53.8 0.02 OUTLIER Glycine 0 C--N 1.312 -0.776 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.231 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.3 t -149.83 125.95 2.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.029 0.442 . . . . 0.0 111.944 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.75 ' HB3' HD11 ' A' ' 48' ' ' ILE . 2.0 m-85 -63.78 143.94 57.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.358 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.521 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -99.04 121.79 41.43 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.822 0.344 . . . . 0.0 111.505 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.402 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 46.5 m-20 -66.84 -24.62 66.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.332 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -58.42 -52.17 66.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.794 0.33 . . . . 0.0 110.816 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -38.31 54.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.364 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.75 HD11 ' HB3' ' A' ' 43' ' ' PHE . 41.2 mt -59.32 -40.5 81.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.855 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.47 -58.0 6.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.269 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -60.15 -28.16 67.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.973 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.489 HD11 HD21 ' A' ' 55' ' ' LEU . 2.5 tp -59.32 -56.26 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.381 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.635 ' N ' HD23 ' A' ' 52' ' ' LEU . 3.0 mt -51.94 -47.51 64.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.984 0.421 . . . . 0.0 110.886 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.6 m -66.04 -35.0 79.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.291 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -66.49 -39.86 88.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.504 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.489 HD21 HD11 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -59.82 -49.1 79.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.439 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.58 -106.25 0.25 Allowed Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.818 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.2 mtt180 -150.62 27.6 0.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.02 0.438 . . . . 0.0 110.84 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.59 -156.71 0.7 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.207 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -121.24 161.73 21.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.676 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.423 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 7.3 pt20 -120.14 98.89 6.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.992 0.425 . . . . 0.0 110.694 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.5 mt -81.55 88.32 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.707 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.94 32.73 5.77 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.536 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.563 HD11 ' HG3' ' A' ' 67' ' ' GLN . 2.8 tm? -47.73 121.91 4.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.824 0.345 . . . . 0.0 110.77 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.504 ' N ' HD13 ' A' ' 63' ' ' LEU . 1.1 p -103.86 151.51 23.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.28 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -112.71 156.4 42.54 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.908 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -86.97 141.52 24.14 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.067 -1.222 . . . . 0.0 112.56 0.503 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.563 ' HG3' HD11 ' A' ' 63' ' ' LEU . 2.7 mm-40 -100.24 124.19 45.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.138 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.609 HG22 HG22 ' A' ' 4' ' ' VAL . 3.3 t -96.61 159.69 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.33 0.586 . . . . 0.0 112.478 -178.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.471 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 80.1 m-85 -143.73 146.62 33.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.289 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.567 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -58.49 156.3 23.71 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.616 ' HB3' ' N ' ' A' ' 1' ' ' MET . 3.0 Cg_exo -73.71 -3.72 14.22 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.876 2.384 . . . . 0.0 112.566 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -115.33 -9.65 12.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.226 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.23 89.08 1.67 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.548 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 t -179.2 152.12 0.53 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -90.19 116.62 28.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 70' ' ' ALA . 26.2 mt -96.8 -48.45 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.879 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 138.17 -156.02 23.69 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.726 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.07 -138.69 8.88 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.668 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CD1' ' HB2' ' A' ' 20' ' ' ALA . 19.4 t80 -70.89 -70.66 0.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.782 0.325 . . . . 0.0 110.918 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -59.43 -45.3 91.94 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.023 0.44 . . . . 0.0 110.551 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -50.87 -40.0 55.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.437 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.737 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.4 tt -78.65 -31.93 47.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.265 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -51.13 -30.9 17.75 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -35.43 79.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.093 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 82' ' ' LEU . 10.8 t80 -62.68 -34.14 76.51 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.344 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.737 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.0 m-85 -88.96 -70.24 0.66 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.312 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.939 179.951 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.683 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 17.5 ttm . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.424 ' CE2' HD13 ' A' ' 76' ' ' ILE . 79.5 m-85 -78.13 147.26 34.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.308 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -106.9 121.45 44.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.337 -179.697 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.555 HG11 ' HE1' ' A' ' 33' ' ' PHE . 52.3 t -112.99 131.95 63.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.56 0.695 . . . . 0.0 112.62 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.885 ' HA ' HD11 ' A' ' 36' ' ' ILE . 17.3 m-85 -110.09 99.13 8.27 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.181 177.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.444 ' O ' HG12 ' A' ' 36' ' ' ILE . . . -153.91 -139.82 2.92 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.006 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.503 ' CD1' ' HB3' ' A' ' 37' ' ' MET . 43.7 m-85 -147.28 99.84 3.2 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.55 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 27.7 t70 -108.87 55.95 0.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.422 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.78 -168.04 2.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.165 0.507 . . . . 0.0 111.637 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -85.96 0.61 52.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.839 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.463 HG23 ' HB3' ' A' ' 40' ' ' LYS . 1.3 mm -88.26 -13.51 9.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.981 0.419 . . . . 0.0 109.901 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -175.72 118.09 0.15 Allowed 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.704 0.764 . . . . 0.0 111.172 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -82.52 168.56 17.27 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.885 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -176.58 107.79 0.07 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.24 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 m -70.32 -16.56 20.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.671 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -82.96 -25.69 32.08 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.846 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.2 m -59.85 -55.27 36.28 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.35 0.595 . . . . 0.0 109.647 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.27 -18.58 64.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.503 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.67 -62.51 1.35 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.851 0.357 . . . . 0.0 110.89 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.0 -38.37 67.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.09 -50.4 72.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.74 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.805 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -61.65 -38.75 88.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.624 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.748 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.2 tt -59.16 -53.0 63.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.532 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.748 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.4 mt -56.97 -49.28 76.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.792 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.9 m -54.32 -38.44 65.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.075 0.464 . . . . 0.0 110.161 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.8 t -78.06 -32.36 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.622 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HB3' ' NE2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -74.14 -15.72 61.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.976 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 76.11 49.85 0.07 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.055 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.534 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 1.2 mp0 -138.04 131.85 16.84 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.13 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.635 ' O ' ' HA ' ' A' ' 1' ' ' MET . 77.6 Cg_endo -79.52 161.26 25.25 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.408 2.072 . . . . 0.0 111.027 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.459 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 6.5 p90 -161.23 171.56 18.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.753 0.311 . . . . 0.0 111.716 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -133.28 123.83 26.21 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.094 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.555 ' HE1' HG11 ' A' ' 4' ' ' VAL . 10.6 t80 -89.12 157.91 18.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.445 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.471 HD12 ' CE1' ' A' ' 5' ' ' TYR . 24.0 mt -148.1 125.21 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.283 0.564 . . . . 0.0 111.143 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -75.58 115.81 15.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.639 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.885 HD11 ' HA ' ' A' ' 5' ' ' TYR . 4.6 mm -90.2 -19.06 7.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.921 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.503 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -120.28 84.41 34.53 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.696 0.284 . . . . 0.0 111.181 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 53.1 Cg_endo -69.24 -16.49 39.78 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.46 2.107 . . . . 0.0 111.904 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -139.99 136.64 33.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.395 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.463 ' HB3' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -59.33 -9.06 1.99 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.164 0.507 . . . . 0.0 111.956 -179.731 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.12 -59.65 3.32 Favored Glycine 0 C--N 1.312 -0.797 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.355 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 43' ' ' PHE . 21.2 t -150.62 154.36 8.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.981 0.42 . . . . 0.0 111.852 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.411 ' N ' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -63.92 170.63 3.35 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.384 179.255 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.421 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 1.9 t70 -89.35 100.83 13.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -52.51 -27.92 18.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.481 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -61.8 -58.04 9.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.96 0.409 . . . . 0.0 110.556 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -65.07 -32.96 74.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.302 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.64 HD11 ' CG2' ' A' ' 36' ' ' ILE . 35.8 mm -69.8 -37.42 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.573 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.72 71.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.623 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -61.82 -34.08 75.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.334 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.585 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.4 tt -58.95 -52.51 65.43 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.309 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 52' ' ' LEU . 85.9 mt -53.16 -41.35 65.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.589 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.1 m -58.49 -47.53 83.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.605 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.41 ' CB ' ' CE1' ' A' ' 69' ' ' PHE . 4.0 mtpp -61.74 -33.27 73.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.784 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.71 HD11 HD21 ' A' ' 63' ' ' LEU . 2.1 mt -59.92 -54.25 48.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.781 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 166.8 -112.69 0.51 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.186 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -150.23 31.24 0.68 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.071 0.462 . . . . 0.0 110.596 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -121.0 -142.27 0.34 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.335 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 t -117.0 170.4 8.66 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.793 0.33 . . . . 0.0 110.645 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -69.57 98.35 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.358 0.599 . . . . 0.0 110.359 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 pt -80.12 87.31 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.439 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.33 30.92 72.28 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.326 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.71 HD21 HD11 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -41.31 129.47 2.98 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.894 0.378 . . . . 0.0 111.331 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.83 153.65 45.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.359 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.5 mmt -113.63 146.48 35.55 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.628 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.3 Cg_endo -84.63 134.55 20.57 Favored 'Cis proline' 0 N--CA 1.46 -0.454 0 C-N-CA 124.006 -1.248 . . . . 0.0 112.57 0.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.561 ' OE1' HD13 ' A' ' 63' ' ' LEU . 4.5 tp60 -90.11 133.33 34.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.96 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.7 t -107.46 156.53 7.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.263 0.554 . . . . 0.0 111.851 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.434 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 39.2 m-85 -142.95 136.43 28.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.665 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.609 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -51.57 149.22 8.33 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.368 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.683 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 9.3 Cg_exo -68.86 -11.61 32.31 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.709 2.273 . . . . 0.0 112.133 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -106.42 -18.74 13.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.994 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.2 85.31 0.96 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.63 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -179.75 117.71 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.793 0.33 . . . . 0.0 110.833 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -58.51 116.63 3.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.971 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.609 HD11 ' HA ' ' A' ' 70' ' ' ALA . 13.4 mt -91.81 -46.51 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.811 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.68 -156.38 22.75 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.491 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.6 -140.95 8.2 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.505 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -70.12 -69.02 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.698 0.285 . . . . 0.0 110.906 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -54.37 -43.48 71.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.963 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -55.32 -37.92 68.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.678 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.692 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -71.99 -41.58 67.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.378 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.01 -29.95 23.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -72.85 -35.31 67.2 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' LEU . 34.2 t80 -63.49 -33.95 76.7 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.206 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.692 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.3 m-85 -87.14 -26.88 23.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.133 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.878 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.677 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 40.0 ttp . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.423 ' CD1' ' CD2' ' A' ' 24' ' ' LEU . 87.0 m-85 -77.39 147.58 35.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.054 179.001 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.704 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.5 mptt -111.5 121.0 44.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.589 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.641 HG22 HG22 ' A' ' 68' ' ' VAL . 8.4 t -103.4 129.22 55.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.24 0.543 . . . . 0.0 111.676 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.613 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.9 m-30 -105.68 99.4 9.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.504 178.733 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.36 -136.58 2.03 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.64 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 90.0 m-85 -116.44 144.28 44.5 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.918 0.39 . . . . 0.0 111.518 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' A' ' 9' ' ' SER . 22.6 t0 -73.1 -9.16 58.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.2 t 84.8 -14.11 0.63 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.577 0.351 . . . . 0.0 111.507 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -85.27 -31.19 23.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.693 0.282 . . . . 0.0 111.324 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.675 HD12 ' N ' ' A' ' 11' ' ' ILE . 2.4 mp -100.0 -38.38 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.645 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.425 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 4.0 t-80 -139.41 179.47 6.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.355 -179.015 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -70.07 166.21 20.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.619 0.247 . . . . 0.0 110.8 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 t -176.91 71.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.19 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.0 m -90.64 -21.1 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.722 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -81.08 -23.11 38.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.3 p -77.68 -45.14 25.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 110.573 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -50.78 -34.07 25.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.704 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -73.07 -59.7 2.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.67 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.53 -41.32 69.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HG3' ' CZ ' ' A' ' 31' ' ' PHE . 70.3 tttt -54.57 -49.73 69.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.328 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.869 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.5 tpp180 -64.62 -31.43 72.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.276 179.428 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.799 HD12 ' CE1' ' A' ' 79' ' ' PHE . 3.3 tt -56.45 -51.05 69.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.394 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.741 HD23 ' HZ ' ' A' ' 86' ' ' PHE . 2.9 mt -60.02 -51.94 67.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.72 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.3 m -51.03 -38.95 54.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.584 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 22' ' ' ARG . 58.0 t -66.81 -31.58 54.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.677 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -86.59 -9.2 56.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.138 179.709 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 3.2 mptp? 70.59 52.33 0.32 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.067 0.461 . . . . 0.0 110.831 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -130.77 136.03 28.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.72 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.677 ' O ' ' HA ' ' A' ' 1' ' ' MET . 58.1 Cg_endo -80.96 157.09 20.58 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.596 2.197 . . . . 0.0 111.381 179.443 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.439 ' CZ ' ' HG3' ' A' ' 21' ' ' LYS . 8.4 p90 -161.51 171.31 18.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.823 0.344 . . . . 0.0 111.774 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -133.98 134.55 42.64 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.488 ' HE1' HG11 ' A' ' 4' ' ' VAL . 23.0 t80 -89.36 154.54 19.99 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.093 0.473 . . . . 0.0 111.54 -179.566 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.613 HD12 ' CE1' ' A' ' 5' ' ' TYR . 8.4 mt -146.41 119.36 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.187 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -100.15 135.66 41.24 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.244 -179.491 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 44' ' ' ASP . 31.8 pt -97.91 20.43 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.191 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.479 ' CG ' HG21 ' A' ' 11' ' ' ILE . 15.1 tpp -144.33 70.94 16.07 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.658 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -87.82 34.2 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.026 2.484 . . . . 0.0 112.818 -179.482 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -139.74 170.42 15.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.612 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -63.22 -7.82 6.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.203 0.525 . . . . 0.0 111.931 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.73 55.24 0.02 OUTLIER Glycine 0 C--N 1.312 -0.757 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.403 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.9 t -150.02 131.7 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.001 0.429 . . . . 0.0 111.413 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.0 160.4 33.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.818 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.54 ' C ' HD12 ' A' ' 48' ' ' ILE . 3.7 t70 -97.63 89.25 4.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.081 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.81 -20.85 38.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.614 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -64.34 -59.2 4.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.816 0.341 . . . . 0.0 110.67 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -71.12 -41.05 71.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.399 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.54 HD12 ' C ' ' A' ' 44' ' ' ASP . 54.8 mt -51.91 -44.08 37.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.694 179.601 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.62 -55.78 26.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.435 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.77 -31.84 71.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.296 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.501 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 1.5 tt -56.34 -52.94 62.68 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.008 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.676 ' N ' HD23 ' A' ' 52' ' ' LEU . 2.2 mt -52.91 -48.62 67.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.722 179.152 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -62.33 -44.49 96.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.295 179.345 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.79 -39.09 83.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.552 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.439 HD21 ' CD2' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -59.74 -53.9 52.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.32 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.3 -108.99 0.27 Allowed Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.773 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -150.45 26.56 0.76 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.073 0.463 . . . . 0.0 110.862 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -121.62 -150.78 0.46 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.265 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.2 t -120.8 170.27 9.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.594 179.602 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -82.52 98.35 8.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.24 0.543 . . . . 0.0 110.314 179.633 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.685 ' O ' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -80.09 87.23 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.879 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.67 28.06 56.04 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.478 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.87 143.54 16.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.8 p -111.55 158.17 19.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.16 0.505 . . . . 0.0 111.312 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.91 153.01 47.03 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.611 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.55 ' HB2' HG13 ' A' ' 4' ' ' VAL . 6.0 Cg_exo -81.1 156.12 83.38 Favored 'Cis proline' 0 C--N 1.344 0.309 0 C-N-CA 124.025 -1.24 . . . . 0.0 112.806 0.29 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -113.29 115.83 28.78 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.859 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -87.57 164.19 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.035 0.445 . . . . 0.0 111.792 -178.615 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.456 ' H ' HG12 ' A' ' 68' ' ' VAL . 45.1 m-85 -142.33 140.49 32.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.528 -179.683 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.651 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -53.43 132.77 53.55 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.285 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.615 ' HB3' ' N ' ' A' ' 1' ' ' MET . 31.6 Cg_exo -53.25 -22.37 19.93 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.594 2.196 . . . . 0.0 112.133 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.95 39.77 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.341 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.23 -109.86 0.68 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.987 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.489 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 86.8 p -138.91 178.41 7.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.075 0.464 . . . . 0.0 111.211 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.456 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 32.8 t-80 -55.84 127.09 28.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.061 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.651 HD11 ' HA ' ' A' ' 70' ' ' ALA . 12.3 mt -96.03 -45.02 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.987 0.422 . . . . 0.0 110.734 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 133.87 -158.44 23.3 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.462 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.74 -141.13 9.06 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.688 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.799 ' CE1' HD12 ' A' ' 23' ' ' LEU . 17.4 t80 -71.08 -61.14 1.87 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.73 0.3 . . . . 0.0 110.825 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -56.94 -48.3 78.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.85 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -56.99 -45.7 82.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.793 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.695 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -66.42 -41.62 88.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.398 179.918 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -51.76 -31.66 27.65 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -71.94 -35.8 69.72 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.104 178.324 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 82' ' ' LEU . 23.8 t80 -63.37 -33.78 76.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.165 178.33 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.741 ' HZ ' HD23 ' A' ' 24' ' ' LEU . 6.2 m-85 -87.96 -27.31 22.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.135 179.472 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.961 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.647 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 28.0 ttm . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.75 0.31 . . . . 0.0 111.756 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.488 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 77.6 m-85 -66.83 152.11 46.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.96 0.409 . . . . 0.0 110.445 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 3.0 mptt -126.6 124.29 39.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.224 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.655 HG11 ' CE1' ' A' ' 33' ' ' PHE . 16.9 t -103.43 132.45 49.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.273 0.558 . . . . 0.0 111.528 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.733 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.1 m-85 -109.23 98.98 8.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.066 178.42 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.23 -137.99 2.39 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 119.995 -1.098 . . . . 0.0 112.355 -179.362 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.675 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 3.4 m-85 -128.86 120.69 26.7 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 120.54 0.209 . . . . 0.0 111.296 -178.642 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.462 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -117.52 69.32 0.77 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.595 0.236 . . . . 0.0 111.62 -179.601 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 36.9 t 177.87 -172.0 0.11 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.085 0.469 . . . . 0.0 111.767 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.87 7.59 26.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.831 179.434 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.44 HG12 ' HB3' ' A' ' 9' ' ' SER . 1.0 OUTLIER -87.53 -17.87 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.905 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.675 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 5.3 t60 -165.41 122.7 1.5 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.658 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.57 154.09 32.68 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.993 -178.1 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.6 t -159.64 95.31 1.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.925 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.7 m -74.61 -35.99 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.955 0.407 . . . . 0.0 110.563 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -65.9 -20.14 66.12 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.534 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.7 m -66.94 -60.94 2.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.791 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.42 -42.57 67.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.169 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -61.91 -52.75 62.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.081 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.516 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -58.87 -49.66 76.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.979 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -50.01 -32.67 15.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.58 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.751 ' O ' HG23 ' A' ' 26' ' ' VAL . 5.6 tpm_? -69.68 -38.62 77.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.629 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.822 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -58.23 -54.09 50.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.659 179.491 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.822 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.9 mt -54.69 -43.31 72.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.928 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.3 m -58.47 -33.09 69.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.031 0.443 . . . . 0.0 109.974 179.145 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 22' ' ' ARG . 41.0 t -78.81 -30.65 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.711 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -9.78 59.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.137 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt 64.68 56.87 1.13 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.071 0.462 . . . . 0.0 110.611 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -132.6 130.33 21.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.089 -179.601 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.453 ' O ' ' HA ' ' A' ' 1' ' ' MET . 86.3 Cg_endo -73.84 138.28 25.84 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.24 1.96 . . . . 0.0 110.924 178.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.647 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 48.1 p90 -155.1 170.64 21.33 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -141.63 144.0 33.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.048 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.655 ' CE1' HG11 ' A' ' 4' ' ' VAL . 33.2 t80 -89.71 162.1 15.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.05 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.733 HD12 ' CE1' ' A' ' 5' ' ' TYR . 7.1 mt -148.75 119.81 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.258 0.551 . . . . 0.0 110.816 179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -89.81 139.34 30.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.042 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.632 HD11 ' OH ' ' A' ' 7' ' ' TYR . 1.0 OUTLIER -99.72 -26.11 3.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.215 -179.989 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.604 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 10.2 ttm -119.38 88.93 39.24 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.753 0.311 . . . . 0.0 111.64 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.49 -6.95 15.74 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.525 2.15 . . . . 0.0 112.245 179.44 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -139.39 141.87 37.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.57 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -69.2 -7.78 39.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.282 0.563 . . . . 0.0 111.964 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.25 -60.46 1.92 Allowed Glycine 0 C--N 1.311 -0.853 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.895 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 t -150.48 128.87 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.553 0.216 . . . . 0.0 110.561 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -57.94 170.09 0.68 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.207 -179.641 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.429 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -78.87 87.24 4.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.476 -179.066 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -54.15 -22.67 11.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.275 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -56.0 -51.48 67.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.891 0.377 . . . . 0.0 110.572 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -73.06 -32.81 65.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.276 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 44' ' ' ASP . 40.0 mm -57.2 -50.89 75.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.79 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.25 70.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.536 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.26 -32.14 69.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.318 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.936 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.99 -57.22 13.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.236 179.933 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.51 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 16.4 mt -44.54 -45.84 9.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.265 0.555 . . . . 0.0 111.125 178.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.2 m -70.11 -30.59 67.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.362 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -66.46 -41.28 89.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.121 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.936 HD12 ' O ' ' A' ' 51' ' ' LEU . 3.3 mp -62.28 -54.75 36.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.057 0.456 . . . . 0.0 110.81 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.33 -115.17 0.37 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.061 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -150.64 30.92 0.65 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.065 0.46 . . . . 0.0 110.687 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -121.04 -145.75 0.36 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.352 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.8 t -115.85 170.25 8.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.677 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.41 ' HG2' HD22 ' A' ' 52' ' ' LEU . 42.9 mt-30 -70.03 98.14 1.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.314 0.578 . . . . 0.0 110.55 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -80.26 84.41 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.861 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.4 27.37 47.35 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.184 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.433 HD11 ' CD2' ' A' ' 55' ' ' LEU . 1.6 mm? -55.5 135.65 50.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.892 0.377 . . . . 0.0 111.349 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.75 159.9 40.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.161 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -102.19 152.14 38.21 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.958 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.9 Cg_exo -81.48 143.29 57.89 Favored 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 123.945 -1.273 . . . . 0.0 112.666 0.18 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -108.17 118.22 36.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.014 179.06 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.3 t -92.34 166.32 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.029 0.442 . . . . 0.0 111.899 -178.734 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.52 ' H ' HG12 ' A' ' 68' ' ' VAL . 24.9 m-85 -141.91 134.78 28.71 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.788 -179.57 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.501 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -49.67 150.15 3.86 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.529 -179.211 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.568 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . 45.6 Cg_exo -58.67 -33.77 98.48 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.216 2.611 . . . . 0.0 112.268 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -90.16 -21.67 22.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.365 -179.654 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.76 88.98 0.86 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.73 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -171.23 162.1 6.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.337 . . . . 0.0 110.543 179.841 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.496 ' CE1' HD23 ' A' ' 55' ' ' LEU . 8.0 t-160 -90.52 115.64 27.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.102 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.501 HD11 ' HA ' ' A' ' 70' ' ' ALA . 6.8 mt -91.78 -49.41 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.011 0.434 . . . . 0.0 110.983 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.61 -154.01 16.53 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.276 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.12 -143.54 5.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.294 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.555 ' CE1' HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -77.01 -69.57 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.58 0.19 . . . . 0.0 110.738 179.76 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -48.2 -45.46 33.87 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.25 0.548 . . . . 0.0 110.327 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -35.37 76.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.175 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.702 HD21 ' CE2' ' A' ' 86' ' ' PHE . 4.0 tt -78.38 -38.13 42.48 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.406 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 87' ' ' LYS . 11.4 mtm180 -50.78 -32.14 18.99 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.675 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -68.43 -34.8 76.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.16 178.117 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 82' ' ' LEU . 8.0 t80 -63.67 -34.36 77.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.36 178.415 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.702 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.1 m-85 -89.91 -70.48 0.66 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.392 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.906 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.768 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 6.3 tpt . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.58 ' CE2' ' HE2' ' A' ' 1' ' ' MET . 92.4 m-85 -39.56 116.99 0.68 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.74 0.781 . . . . 0.0 111.455 -177.276 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -90.16 128.53 36.37 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.39 -179.163 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 68' ' ' VAL . 37.1 t -115.81 127.12 73.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.26 0.552 . . . . 0.0 111.548 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.574 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 18.6 m-85 -103.93 98.13 8.02 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.778 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.978 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -155.56 -139.8 2.85 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.891 -179.004 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.612 ' CE2' HG23 ' A' ' 36' ' ' ILE . 17.1 m-85 -131.75 158.39 41.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -178.3 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.403 ' O ' ' CB ' ' A' ' 9' ' ' SER . 41.9 t0 -70.74 -69.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.595 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 3.2 t 164.09 -31.41 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.606 179.642 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -83.0 -26.88 30.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.546 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 11' ' ' ILE . 4.2 mp -88.21 -49.3 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.997 179.391 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -144.49 153.97 42.42 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.901 179.052 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -48.55 156.58 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.642 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.27 62.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.916 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.446 HG23 ' N ' ' A' ' 16' ' ' TYR . 14.5 m -80.11 -48.8 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.049 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.446 ' N ' HG23 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -67.29 -20.46 65.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.513 179.544 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 m -65.34 -47.68 75.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.291 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -55.53 -26.01 40.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.737 179.511 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -73.08 -42.97 62.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.471 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.558 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . . . -69.05 -40.74 78.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.098 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -62.81 -56.76 14.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.737 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.792 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -58.95 -34.22 71.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.221 179.632 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.728 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -57.87 -51.48 69.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.896 179.146 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.728 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.7 mt -57.9 -42.84 85.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.638 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.7 m -60.54 -39.26 87.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.932 179.377 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 22' ' ' ARG . 41.1 t -74.25 -39.24 49.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.534 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 1.7 tmtm? -74.29 -12.79 60.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.949 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt 68.56 49.16 0.77 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.938 0.399 . . . . 0.0 110.643 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -137.56 102.31 8.74 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.378 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.768 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 86.8 Cg_exo -44.91 171.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.518 2.145 . . . . 0.0 112.65 179.409 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.64 ' CG ' HD13 ' A' ' 24' ' ' LEU . 4.0 p90 -163.28 170.29 17.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.6 178.466 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 3.4 tt0 -132.54 112.49 12.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.686 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.517 ' HE1' HG11 ' A' ' 4' ' ' VAL . 9.9 t80 -89.1 153.84 20.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.17 0.51 . . . . 0.0 111.266 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.469 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.9 mt -149.98 121.74 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.331 179.731 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -70.56 109.4 4.83 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.499 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.978 HG22 ' O ' ' A' ' 6' ' ' GLY . 18.7 tt -72.4 -19.29 19.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.606 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.5 ttp -134.59 94.94 16.44 Favored Pre-proline 0 N--CA 1.454 -0.227 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.974 179.347 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -85.93 24.06 0.78 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.677 2.251 . . . . 0.0 112.105 179.517 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.45 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 6.7 tt0 -139.49 165.82 26.2 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.754 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -62.72 -7.54 5.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -179.054 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.65 35.58 0.06 OUTLIER Glycine 0 C--N 1.313 -0.705 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.825 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.464 ' N ' ' SD ' ' A' ' 37' ' ' MET . 4.3 t -147.72 121.13 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.906 0.384 . . . . 0.0 111.081 178.909 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.606 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -79.28 150.78 31.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.742 179.752 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -78.11 99.82 6.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.132 -179.612 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -48.52 -29.75 4.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.537 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -60.52 -54.38 46.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.959 0.409 . . . . 0.0 110.773 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HD3' ' CG2' ' A' ' 34' ' ' ILE . 25.0 mttm -68.92 -41.91 77.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.847 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.491 ' CD1' ' HB2' ' A' ' 43' ' ' PHE . 2.7 mp -63.22 -36.06 74.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.129 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.24 -52.49 65.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.659 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.01 -33.07 72.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.302 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.574 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 4.1 tt -60.15 -51.98 67.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.308 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.685 ' N ' HD23 ' A' ' 52' ' ' LEU . 1.9 mt -52.38 -44.49 65.33 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.344 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.7 m -58.19 -49.19 77.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.734 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.6 mtpp -59.53 -36.59 76.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.689 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.96 -52.23 66.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.567 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.05 -118.5 0.66 Allowed Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.054 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -141.35 27.9 1.88 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.199 0.524 . . . . 0.0 110.589 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -121.5 -147.23 0.38 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.257 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.4 t -120.26 170.19 9.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.695 0.283 . . . . 0.0 110.603 179.633 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -69.95 98.01 1.22 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.348 0.594 . . . . 0.0 110.423 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -80.36 84.25 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.084 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.72 26.51 60.28 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.395 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -50.33 148.24 3.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 111.072 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.1 p -122.92 165.22 17.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.427 -179.766 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -118.46 153.64 51.96 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.734 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.0 OUTLIER -86.81 136.28 17.8 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.318 -1.117 . . . . 0.0 112.495 0.203 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -91.76 129.6 37.7 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.966 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 4' ' ' VAL . 3.4 t -103.2 154.29 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.123 0.487 . . . . 0.0 112.006 -179.176 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.459 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 44.5 m-85 -142.63 138.08 30.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.801 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.672 ' HB1' ' HD2' ' A' ' 71' ' ' PRO . . . -48.16 164.04 0.28 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.755 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.672 ' HD2' ' HB1' ' A' ' 70' ' ' ALA . 32.5 Cg_endo -62.88 58.93 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.742 2.294 . . . . 0.0 111.453 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 86.61 29.96 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.88 -178.665 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.66 -91.07 2.11 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.857 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.542 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -143.68 -169.19 3.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.015 0.436 . . . . 0.0 110.998 -179.734 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.459 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 17.1 t-80 -83.31 125.07 31.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.162 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.627 HD11 ' HA ' ' A' ' 70' ' ' ALA . 13.7 mt -96.92 -45.89 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.95 0.405 . . . . 0.0 110.741 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 137.97 -156.62 23.9 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.659 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.01 -139.97 8.54 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.733 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.558 ' HD1' ' HB2' ' A' ' 20' ' ' ALA . 60.6 t80 -72.53 -70.57 0.34 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.718 0.294 . . . . 0.0 111.048 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -56.42 -48.01 77.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.917 0.389 . . . . 0.0 110.809 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -52.09 -41.44 62.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.644 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.74 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.2 tt -76.57 -34.23 58.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.208 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -51.52 -28.95 15.05 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -69.22 -34.07 74.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.216 178.127 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 82' ' ' LEU . 6.8 t80 -64.75 -33.25 75.54 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.446 178.508 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.74 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.1 m-85 -90.52 -66.89 0.89 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.584 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.8 pttt . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.137 -0.935 . . . . 0.0 110.917 -179.906 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.61 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 25.7 ttp . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.774 0.321 . . . . 0.0 111.669 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.489 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 80.9 m-85 -67.32 151.26 47.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.95 0.405 . . . . 0.0 110.529 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.669 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 3.3 mptt -127.11 120.39 28.77 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.569 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.91 HG22 HG22 ' A' ' 68' ' ' VAL . 14.5 t -106.79 130.82 58.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.251 0.548 . . . . 0.0 111.805 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.638 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.6 m-30 -106.39 99.4 8.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.408 178.89 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.41 -137.36 2.17 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.842 -1.17 . . . . 0.0 112.985 -179.388 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -118.5 147.25 43.84 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.825 0.345 . . . . 0.0 110.936 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -90.73 13.13 17.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.607 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 0.3 OUTLIER 71.95 4.88 5.18 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.629 0.252 . . . . 0.0 111.44 179.931 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -85.79 -58.21 2.74 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.906 0.384 . . . . 0.0 111.033 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.673 HD12 ' O ' ' A' ' 37' ' ' MET . 29.5 mt -91.65 -27.03 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.544 -179.465 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.484 ' O ' ' HA ' ' A' ' 9' ' ' SER . 7.0 t-80 -139.49 145.21 38.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.676 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.39 158.07 34.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.566 -179.464 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.5 t -175.78 96.11 0.06 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -80.88 -32.15 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.011 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -70.47 -23.17 62.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.596 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.5 m -62.52 -52.81 62.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.268 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.02 -27.28 52.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.301 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -71.16 -49.59 42.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.254 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.06 -47.22 71.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.177 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HD3' ' CE2' ' A' ' 31' ' ' PHE . 1.1 tppt? -59.65 -52.95 63.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.715 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.829 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -57.36 -41.25 79.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.767 180.0 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 24' ' ' LEU . 3.1 tt -58.49 -54.25 49.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.388 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.679 HD13 ' CG ' ' A' ' 31' ' ' PHE . 5.9 mt -57.31 -46.42 83.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.769 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 m -57.73 -37.09 72.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.093 0.473 . . . . 0.0 110.228 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 22' ' ' ARG . 62.1 t -77.96 -29.6 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.695 179.479 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -16.8 54.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.142 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.54 56.36 0.11 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.926 0.393 . . . . 0.0 110.9 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -136.96 141.62 35.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.47 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.9 Cg_endo -80.43 137.13 11.54 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.584 2.189 . . . . 0.0 111.647 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.679 ' CG ' HD13 ' A' ' 24' ' ' LEU . 32.0 p90 -158.32 170.61 21.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.847 0.356 . . . . 0.0 111.773 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -147.26 145.68 29.5 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.035 0.445 . . . . 0.0 111.167 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.49 ' CE1' HG11 ' A' ' 4' ' ' VAL . 10.2 t80 -89.5 163.58 15.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.168 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.638 HD12 ' CE1' ' A' ' 5' ' ' TYR . 11.5 mt -148.22 121.3 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.527 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -81.84 127.67 33.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.263 -179.592 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 pt -95.57 -16.27 7.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.185 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.673 ' O ' HD12 ' A' ' 11' ' ' ILE . 43.9 ttm -119.0 102.99 48.58 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.933 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 76.9 Cg_endo -76.2 -25.89 9.61 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.632 2.221 . . . . 0.0 112.035 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -139.96 151.01 45.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.767 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.21 -8.48 24.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.262 0.553 . . . . 0.0 111.656 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.71 -57.81 2.65 Favored Glycine 0 C--N 1.313 -0.725 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.671 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -148.73 139.11 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.642 0.258 . . . . 0.0 111.523 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -60.07 170.55 1.2 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.598 179.648 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.446 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 28.8 t0 -86.34 104.16 15.59 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -57.02 -22.65 40.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.434 179.679 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -58.05 -51.74 68.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.799 0.333 . . . . 0.0 110.686 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HZ2' HG22 ' A' ' 34' ' ' ILE . 53.0 mttt -74.86 -40.63 60.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.346 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 44' ' ' ASP . 38.7 mm -55.13 -47.48 77.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.771 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.03 -47.08 78.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.435 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.78 -37.88 85.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.381 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.463 HD13 ' CD2' ' A' ' 5' ' ' TYR . 19.8 tp -56.01 -51.27 68.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.732 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.9 mt -53.43 -47.58 69.52 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.227 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.7 m -65.24 -38.06 89.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.274 179.333 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.7 mtpp -63.91 -39.11 93.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.588 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -47.32 86.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.397 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 166.28 -109.64 0.36 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.987 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -150.72 31.54 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.034 0.445 . . . . 0.0 110.527 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.98 -149.96 0.44 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.7 t -120.38 170.33 9.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.694 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -80.4 98.44 7.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.271 0.558 . . . . 0.0 110.408 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.6 mm -78.6 83.65 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.78 24.79 50.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.369 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.427 HD12 ' CD ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -60.21 141.05 56.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.874 0.368 . . . . 0.0 110.872 -179.959 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.7 p -125.63 169.0 12.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.1 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.26 157.19 36.98 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.664 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.0 Cg_exo -81.82 143.45 56.38 Favored 'Cis proline' 0 C--N 1.344 0.292 0 C-N-CA 123.843 -1.315 . . . . 0.0 112.933 0.565 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.427 ' CD ' HD12 ' A' ' 63' ' ' LEU . 19.0 mt-30 -99.85 114.73 28.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.106 178.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.91 HG22 HG22 ' A' ' 4' ' ' VAL . 3.8 t -90.28 164.19 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.073 0.463 . . . . 0.0 111.712 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.482 ' N ' HG12 ' A' ' 68' ' ' VAL . 41.3 m-85 -142.48 131.49 23.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.62 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.707 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -48.38 152.28 1.63 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.439 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.558 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . 45.0 Cg_exo -58.39 -22.53 58.93 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.116 2.544 . . . . 0.0 112.218 179.168 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.0 -24.79 14.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.13 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.26 94.29 0.99 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.75 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 41.1 t -179.61 143.5 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.82 0.343 . . . . 0.0 110.774 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -72.9 106.13 4.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.965 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.707 HD11 ' HA ' ' A' ' 70' ' ' ALA . 33.6 mt -79.97 -52.06 15.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.65 -153.77 20.99 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.471 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.62 -147.3 12.41 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.335 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -69.95 -58.09 4.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.805 0.336 . . . . 0.0 110.624 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -55.88 -44.56 78.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.794 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -57.86 -43.36 85.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.471 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.623 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -61.83 -48.8 78.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.391 179.636 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -51.13 -30.21 15.81 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.831 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.98 -34.77 62.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.261 178.484 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.438 ' CD2' HG23 ' A' ' 76' ' ' ILE . 12.7 t80 -65.99 -32.39 73.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.343 178.439 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.623 ' HE2' HD21 ' A' ' 82' ' ' LEU . 8.1 m-85 -90.02 -70.15 0.68 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.212 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.918 -179.941 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.662 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 15.5 ttm . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.408 ' HB2' ' CD1' ' A' ' 24' ' ' LEU . 88.8 m-85 -75.45 146.68 40.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.992 178.713 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.5 mptm? -110.5 122.01 46.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.719 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.522 HG22 HG22 ' A' ' 68' ' ' VAL . 67.8 t -114.26 133.72 59.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.329 0.585 . . . . 0.0 112.316 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.594 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 18.5 m-85 -111.68 100.72 9.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.176 178.088 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.406 ' N ' HG23 ' A' ' 36' ' ' ILE . . . -162.09 -141.57 3.16 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.51 -179.37 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 1.026 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 52.5 m-85 -117.27 159.18 23.09 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.236 0.214 . . . . 0.0 110.426 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -106.29 17.12 23.91 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.074 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 1.0 OUTLIER 73.18 -1.81 2.93 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 179.936 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -84.99 -46.82 10.85 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.18 0.514 . . . . 0.0 110.507 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.608 HD13 ' O ' ' A' ' 37' ' ' MET . 0.7 OUTLIER -111.4 0.6 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.589 -179.839 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.596 ' CB ' ' CD2' ' A' ' 7' ' ' TYR . 2.2 t60 -166.96 135.17 2.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.397 -177.784 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.48 164.51 22.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.945 -179.066 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 p 177.73 125.65 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.96 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.2 m -91.4 -30.44 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.123 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -77.2 -21.9 53.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.351 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.1 p -72.95 -41.46 64.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.974 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.67 -36.93 84.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.072 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -63.61 -55.48 23.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.69 -28.92 36.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.88 0.371 . . . . 0.0 110.908 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -61.95 -55.14 32.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.021 0.439 . . . . 0.0 110.11 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.778 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -67.21 -29.4 69.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.565 179.402 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.735 ' O ' HD12 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -53.39 -50.74 64.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.536 179.445 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.809 HD12 ' CG ' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -64.55 -50.21 68.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.603 179.846 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 m -56.71 -41.25 77.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.807 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 22' ' ' ARG . 99.7 t -69.94 -35.16 63.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.931 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 3.9 mmtt -74.02 -10.96 60.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.303 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt 70.87 36.99 1.38 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.08 0.467 . . . . 0.0 110.724 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -126.37 138.26 31.96 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.549 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.633 ' O ' ' HA ' ' A' ' 1' ' ' MET . 86.8 Cg_endo -78.34 161.55 28.69 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.458 2.106 . . . . 0.0 111.456 179.601 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.809 ' CG ' HD12 ' A' ' 24' ' ' LEU . 6.5 p90 -161.61 171.31 18.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.328 . . . . 0.0 111.513 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -134.29 121.79 21.78 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.768 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.486 ' HE1' HG11 ' A' ' 4' ' ' VAL . 18.2 t80 -89.44 157.96 17.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.549 HG21 ' HG2' ' A' ' 47' ' ' LYS . 20.1 mt -148.49 120.64 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.635 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -71.24 110.87 6.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.379 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.026 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 1.1 pp -74.0 -29.35 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.398 -179.429 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.651 ' HE3' ' CE2' ' A' ' 7' ' ' TYR . 20.7 ttm -118.28 86.7 27.95 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.661 0.267 . . . . 0.0 110.598 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.465 ' HG3' ' HB3' ' A' ' 44' ' ' ASP . 93.0 Cg_endo -79.54 5.15 6.06 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.571 2.181 . . . . 0.0 112.674 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -139.79 141.25 36.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.113 0.482 . . . . 0.0 111.357 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -63.68 -7.41 7.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.019 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.25 -67.22 0.64 Allowed Glycine 0 C--N 1.314 -0.67 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.188 -179.227 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.6 t -125.59 136.92 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.726 0.298 . . . . 0.0 111.62 -179.259 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.601 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -71.61 170.35 13.62 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.052 179.783 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.648 ' OD1' HD13 ' A' ' 48' ' ' ILE . 4.8 p30 -77.78 124.66 28.24 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.089 0.471 . . . . 0.0 111.711 -179.428 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 4.0 m-20 -80.24 -26.39 39.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.71 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -61.19 -51.44 68.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 111.291 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.549 ' HG2' HG21 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -72.95 -37.55 67.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.858 179.957 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.659 HD11 ' HB ' ' A' ' 36' ' ' ILE . 1.2 mp -72.09 -25.81 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 179.614 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -66.84 -52.68 40.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.563 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.87 -34.71 73.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.185 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.594 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 3.4 tt -57.52 -52.04 67.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.478 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 52' ' ' LEU . 77.1 mt -52.78 -45.0 66.94 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.586 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.7 m -63.42 -44.82 93.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.418 179.702 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -59.62 -33.09 71.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.711 179.7 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.412 HD11 HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -62.33 -66.66 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 179.763 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.25 -28.48 0.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.598 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.28 -165.09 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.742 0.306 . . . . 0.0 110.808 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -103.65 -25.83 13.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.038 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -87.33 164.69 16.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.871 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.427 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . 13.0 mt-30 -109.44 99.28 8.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.001 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pt -80.25 84.39 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.126 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.08 26.01 74.21 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.283 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.738 HD13 ' N ' ' A' ' 64' ' ' THR . 1.7 tm? -62.57 130.59 45.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.861 0.362 . . . . 0.0 110.965 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.738 ' N ' HD13 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -136.68 152.79 50.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 -179.978 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -104.43 152.91 39.39 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.624 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.8 Cg_exo -82.4 140.52 43.29 Favored 'Cis proline' 0 C--N 1.344 0.305 0 C-N-CA 124.025 -1.24 . . . . 0.0 112.817 0.32 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.519 ' CD ' HD21 ' A' ' 63' ' ' LEU . 1.1 mm-40 -99.97 135.85 40.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.078 179.096 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.632 HG11 ' CD1' ' A' ' 82' ' ' LEU . 3.3 t -106.85 158.73 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.05 0.452 . . . . 0.0 111.875 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 75' ' ' HIS . 34.0 m-85 -143.08 138.51 29.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.192 -179.582 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.772 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -53.19 133.05 51.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.171 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.662 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 39.1 Cg_exo -54.38 -21.46 23.52 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.543 2.162 . . . . 0.0 112.133 179.745 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.24 40.08 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.337 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.34 -109.38 0.66 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.884 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.467 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -140.68 -178.07 5.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.11 0.481 . . . . 0.0 111.236 -179.54 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.48 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 29.7 t-80 -56.61 122.64 12.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.053 -179.829 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.772 HD11 ' HA ' ' A' ' 70' ' ' ALA . 24.3 mt -91.08 -47.31 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.689 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 136.11 -155.49 22.44 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.673 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.65 -141.03 9.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.663 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -70.39 -70.76 0.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.72 0.295 . . . . 0.0 110.982 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.76 -49.45 77.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.981 0.419 . . . . 0.0 110.439 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -50.73 -36.18 35.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.445 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.714 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.2 tt -82.23 -32.04 29.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.292 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -50.95 -30.6 15.33 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -35.7 79.41 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.134 178.287 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LEU . 16.1 t80 -63.55 -33.53 75.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.399 178.437 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.714 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.5 m-85 -86.11 -70.34 0.61 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.113 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.954 179.939 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.589 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 35.8 ttp . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.78 0.324 . . . . 0.0 111.562 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 70.2 m-85 -59.46 148.79 31.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 -179.292 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -119.0 123.39 44.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.209 -179.057 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.769 HG11 ' CE1' ' A' ' 33' ' ' PHE . 8.0 t -114.72 139.6 39.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.319 0.581 . . . . 0.0 111.688 179.424 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.47 ' CE1' HD12 ' A' ' 34' ' ' ILE . 23.6 m-85 -122.49 99.77 6.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.454 178.491 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 66' ' ' PRO . . . -158.52 -141.71 3.22 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.435 -179.454 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.963 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 54.8 m-85 -123.13 160.4 26.52 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.826 0.346 . . . . 0.0 111.467 -179.091 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.7 p-10 -93.66 -65.47 0.99 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.9 OUTLIER 162.28 -37.71 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.251 179.88 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -63.82 -45.08 91.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.806 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 40' ' ' LYS . 4.2 mm -89.02 -41.47 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.059 0.456 . . . . 0.0 110.544 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -147.75 138.23 23.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.255 179.183 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.72 155.09 26.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.716 -178.782 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.5 p -162.5 119.11 1.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.392 179.382 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.4 m -88.78 -22.98 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.534 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -90.45 -15.47 30.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.453 -179.749 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.3 p -74.62 -43.65 54.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.79 0.328 . . . . 0.0 110.859 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.48 -46.61 82.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.929 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -55.94 -45.35 78.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.116 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.76 -38.82 92.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.924 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.22 -42.62 61.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.033 0.444 . . . . 0.0 110.379 179.424 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.5 ttt180 -73.24 -26.1 60.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.566 179.466 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.669 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -57.26 -55.94 28.29 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.327 179.657 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.576 HD12 ' CG ' ' A' ' 31' ' ' PHE . 10.6 mt -62.42 -46.82 86.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.628 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.0 m -53.5 -33.08 53.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.042 0.448 . . . . 0.0 110.266 179.462 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 22' ' ' ARG . 69.0 t -75.7 -30.29 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.653 179.54 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 3.4 mmtm -78.21 -9.86 59.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.402 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 64.62 40.49 5.91 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 111.386 179.818 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -122.35 145.17 43.73 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.287 179.332 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.43 ' O ' ' HA ' ' A' ' 1' ' ' MET . 92.6 Cg_endo -78.59 135.43 13.03 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.287 1.991 . . . . 0.0 111.908 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.589 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 17.0 p90 -146.25 167.66 22.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.907 0.384 . . . . 0.0 111.797 179.681 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -136.11 122.06 20.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.2 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.769 ' CE1' HG11 ' A' ' 4' ' ' VAL . 42.0 t80 -89.76 150.38 22.31 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.229 179.437 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.673 HG21 ' HG2' ' A' ' 47' ' ' LYS . 8.4 mt -143.77 119.53 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.157 0.503 . . . . 0.0 110.936 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -78.13 109.65 12.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.869 179.206 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.963 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 13.9 pt -59.64 -29.01 41.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.397 -179.291 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.589 ' HB2' ' HB3' ' A' ' 43' ' ' PHE . 3.2 ttp -121.82 87.04 46.22 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.706 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.43 -4.04 14.74 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.732 2.288 . . . . 0.0 112.797 -179.85 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -139.58 135.61 33.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.817 0.341 . . . . 0.0 110.694 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.465 ' N ' HG23 ' A' ' 11' ' ' ILE . 5.4 ttmt -65.16 -7.65 13.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.291 0.567 . . . . 0.0 112.055 -179.595 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.47 -64.6 1.38 Allowed Glycine 0 C--N 1.312 -0.766 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.815 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.7 t -141.03 129.91 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.066 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.589 ' HB3' ' HB2' ' A' ' 37' ' ' MET . 0.0 OUTLIER -69.0 166.76 17.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.138 0.494 . . . . 0.0 112.184 -178.719 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.86 ' O ' HD12 ' A' ' 48' ' ' ILE . 10.4 t70 -82.24 97.2 8.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.886 -178.764 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -67.49 -15.89 63.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.837 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' HB2' ' OD1' ' A' ' 44' ' ' ASP . 2.9 mm-40 -63.53 -51.05 67.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.71 0.291 . . . . 0.0 110.647 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.673 ' HG2' HG21 ' A' ' 34' ' ' ILE . 2.9 mptp? -71.11 -37.67 72.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.348 179.522 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.86 HD12 ' O ' ' A' ' 44' ' ' ASP . 1.5 mp -67.58 -35.36 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.882 179.239 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.38 -47.12 86.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.712 179.723 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.8 -39.08 87.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.316 179.674 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.595 HD13 ' CE1' ' A' ' 69' ' ' PHE . 10.5 tp -56.75 -51.41 68.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.443 179.686 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.613 HD21 ' HG2' ' A' ' 60' ' ' GLN . 80.3 mt -50.82 -45.71 59.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.489 179.715 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.0 m -61.57 -42.22 98.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.614 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.403 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -60.61 -38.57 85.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.704 179.819 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.91 -59.04 6.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.924 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.09 -26.2 0.62 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.06 -179.612 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -135.83 -162.12 1.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -115.55 23.24 12.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.58 0.229 . . . . 0.0 111.293 -179.811 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.7 t -120.89 143.16 49.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.911 0.386 . . . . 0.0 111.804 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.613 ' HG2' HD21 ' A' ' 52' ' ' LEU . 12.3 mt-30 -96.7 99.57 11.17 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.575 178.897 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 61' ' ' ILE . 0.8 OUTLIER -72.27 77.52 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.43 -178.403 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 36.09 30.03 0.02 OUTLIER Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.056 178.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 61' ' ' ILE . 0.8 OUTLIER -65.74 162.23 19.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.008 0.432 . . . . 0.0 111.265 -179.466 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.2 158.6 17.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.081 -179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.2 mtm -116.2 156.93 46.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.564 179.596 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.457 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . 4.8 Cg_exo -80.92 147.26 73.45 Favored 'Cis proline' 0 C--N 1.346 0.406 0 C-N-CA 124.244 -1.149 . . . . 0.0 112.991 0.511 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.54 135.66 34.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.039 178.748 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.726 HG22 HG22 ' A' ' 4' ' ' VAL . 3.1 t -113.5 159.09 13.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.948 0.404 . . . . 0.0 111.659 -179.494 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.595 ' CE1' HD13 ' A' ' 51' ' ' LEU . 40.0 m-85 -142.43 147.02 35.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.637 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.932 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -56.11 157.97 7.91 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.55 -178.464 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.507 ' HB3' ' N ' ' A' ' 1' ' ' MET . 32.3 Cg_exo -60.67 -25.98 82.01 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.262 2.642 . . . . 0.0 112.258 179.288 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -20.67 17.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.443 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.23 89.01 1.11 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.665 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.442 ' O ' HD12 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -169.25 145.76 3.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.655 0.264 . . . . 0.0 110.386 179.845 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -78.43 115.41 18.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.835 0.35 . . . . 0.0 110.937 -179.787 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.932 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.8 mp -102.13 -46.05 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.711 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.32 -159.47 22.39 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.874 179.359 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.53 -123.24 3.24 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.5 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.669 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -83.39 -67.72 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.779 -0.247 . . . . 0.0 110.947 179.769 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -50.51 -48.02 57.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.274 0.559 . . . . 0.0 110.463 179.766 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -60.5 -47.43 86.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.847 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.435 HD21 ' CE2' ' A' ' 86' ' ' PHE . 1.1 tt -66.62 -41.77 87.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.551 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 87' ' ' LYS . 7.1 ttt180 -51.67 -31.38 25.53 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.826 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -71.25 -32.78 69.15 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.513 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.47 ' CD2' HG12 ' A' ' 76' ' ' ILE . 49.2 t80 -70.26 -29.22 65.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.016 178.853 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.435 ' CE2' HD21 ' A' ' 82' ' ' LEU . 26.4 m-85 -99.66 -70.85 0.72 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.558 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.451 ' N ' ' O ' ' A' ' 83' ' ' ARG . 15.2 pttp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.413 179.983 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.667 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 10.5 ttm . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.829 0.347 . . . . 0.0 111.675 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.488 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 85.4 m-85 -83.85 145.81 28.44 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.226 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.712 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -123.99 126.51 46.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 -179.26 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 68' ' ' VAL . 70.2 t -114.04 132.52 62.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.393 0.616 . . . . 0.0 111.49 179.273 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.516 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 18.6 m-85 -110.57 99.64 8.58 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.06 178.256 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.0 -144.31 3.93 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.979 -179.092 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.471 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 29.6 m-85 -125.8 150.16 48.02 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 120.744 0.307 . . . . 0.0 111.123 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.95 -74.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.995 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.3 t 175.29 -34.34 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.761 0.315 . . . . 0.0 111.321 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -81.2 -24.36 37.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.298 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.679 HD12 ' N ' ' A' ' 11' ' ' ILE . 2.6 mp -91.12 -42.12 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.897 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.414 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 5.7 t-80 -155.8 153.3 29.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.271 -179.62 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -55.71 145.37 24.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.079 0.466 . . . . 0.0 111.518 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 t -167.49 75.67 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.028 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.1 m -90.61 -20.38 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.272 179.559 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -75.47 -27.53 58.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.393 -179.525 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.8 p -79.87 -40.91 27.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.324 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.04 -41.81 48.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.112 0.482 . . . . 0.0 110.786 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -72.78 -49.23 32.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.65 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.29 -41.73 72.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.964 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -52.38 65.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.619 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.786 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.7 tpt180 -59.05 -36.61 75.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.656 179.698 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.687 HD23 ' N ' ' A' ' 24' ' ' LEU . 2.4 tt -60.4 -54.82 41.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.466 179.535 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.687 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.4 mt -54.78 -45.6 74.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.71 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.9 m -56.81 -35.58 68.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.173 0.511 . . . . 0.0 109.96 179.291 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 22' ' ' ARG . 50.0 t -79.99 -29.86 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.683 179.304 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.49 -11.74 59.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.031 179.742 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt 67.97 56.61 0.53 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.876 0.369 . . . . 0.0 110.951 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -134.33 135.85 24.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.76 132.75 12.18 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.461 2.108 . . . . 0.0 111.705 179.36 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.667 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 22.9 p90 -156.03 169.76 23.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.65 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -148.16 139.06 23.14 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.438 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.655 ' HE1' HG12 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -89.88 150.96 21.97 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.708 179.916 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.443 HG21 ' HD3' ' A' ' 47' ' ' LYS . 17.2 mt -140.95 121.96 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.063 0.458 . . . . 0.0 110.387 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -78.35 109.49 12.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.587 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.511 ' HB ' HD11 ' A' ' 48' ' ' ILE . 1.8 pt -73.71 -7.05 9.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.43 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.477 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -126.21 80.52 68.38 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-O 120.844 0.354 . . . . 0.0 111.076 -179.679 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.51 -20.38 69.55 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.705 2.27 . . . . 0.0 111.817 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 37' ' ' MET . 34.1 mt-10 -139.65 140.09 36.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.369 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.25 -8.75 2.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.217 0.532 . . . . 0.0 111.881 -179.647 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.4 -58.35 3.37 Favored Glycine 0 C--N 1.312 -0.772 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.706 179.803 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -150.55 150.13 13.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.81 0.338 . . . . 0.0 111.754 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -63.14 170.68 2.7 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.484 179.266 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -86.15 100.59 12.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.873 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -55.78 -25.29 40.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.488 -179.647 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -65.49 -60.43 2.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.943 0.401 . . . . 0.0 110.542 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.443 ' HD3' HG21 ' A' ' 34' ' ' ILE . 24.2 mttt -65.22 -33.74 76.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.345 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.511 HD11 ' HB ' ' A' ' 36' ' ' ILE . 15.8 mm -73.79 -29.69 26.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.647 179.64 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -61.68 -55.85 26.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.991 -179.645 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -62.47 -35.26 78.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.308 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.516 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 2.9 tt -56.72 -50.89 70.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.273 179.603 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.3 mt -52.82 -48.82 66.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.115 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.0 m -63.72 -38.14 89.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.023 179.302 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.5 -43.01 88.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.382 179.436 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 mt -59.94 -47.24 86.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.668 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 172.37 -113.93 0.5 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.053 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -150.53 30.56 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.047 0.451 . . . . 0.0 110.745 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.04 -148.33 0.41 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.324 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 t -120.21 165.78 14.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.715 0.293 . . . . 0.0 110.626 179.624 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.482 ' O ' ' NE2' ' A' ' 60' ' ' GLN . 0.7 OUTLIER -69.69 98.82 1.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.726 0.774 . . . . 0.0 110.594 179.96 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.1 mt -79.68 83.08 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.037 -179.746 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.29 24.44 44.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.458 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.618 HD12 ' CD ' ' A' ' 67' ' ' GLN . 1.0 OUTLIER -64.76 152.11 43.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.927 -179.988 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.8 p -133.72 170.12 16.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.493 . . . . 0.0 111.691 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.86 160.46 26.73 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.31 179.405 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -82.7 144.46 54.37 Favored 'Cis proline' 0 C--N 1.344 0.312 0 C-N-CA 124.406 -1.081 . . . . 0.0 113.188 0.608 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.618 ' CD ' HD12 ' A' ' 63' ' ' LEU . 2.1 mm100 -105.74 125.55 51.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.969 178.815 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 4' ' ' VAL . 4.0 t -98.9 160.72 3.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.909 0.385 . . . . 0.0 111.746 -179.301 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.449 ' N ' HG12 ' A' ' 68' ' ' VAL . 28.5 m-85 -142.95 131.54 22.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.895 -179.843 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.568 ' N ' HD11 ' A' ' 76' ' ' ILE . . . -64.0 142.78 98.22 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.463 -178.742 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.585 ' HB3' ' N ' ' A' ' 1' ' ' MET . 45.3 Cg_exo -41.37 -30.97 0.92 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.28 2.653 . . . . 0.0 112.677 179.234 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -164.26 35.16 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.594 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.02 -97.84 1.89 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.566 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.8 m -165.32 175.6 9.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.96 0.41 . . . . 0.0 110.889 -179.795 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.422 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 14.2 t-80 -50.04 101.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.997 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.568 HD11 ' N ' ' A' ' 70' ' ' ALA . 3.3 mt -67.32 -52.78 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.405 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.533 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 138.64 -150.83 21.31 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.753 -179.69 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.4 -142.01 11.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.748 -179.719 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -70.12 -70.81 0.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.771 0.32 . . . . 0.0 110.948 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -58.97 -44.03 91.44 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.018 0.437 . . . . 0.0 110.437 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -53.11 -36.01 60.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.417 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.741 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.6 tt -80.42 -34.63 36.02 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.296 179.639 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -51.23 -29.81 15.45 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.647 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -69.0 -35.06 76.26 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.22 178.159 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 82' ' ' LEU . 9.1 t80 -63.24 -34.19 77.13 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.288 178.397 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.741 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.4 m-85 -88.0 -70.16 0.65 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.276 179.761 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.864 -179.996 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.647 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 59.0 ttp . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 120.713 0.292 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.509 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 76.9 m-85 -80.15 154.51 27.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.02 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.72 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -133.6 130.46 38.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.484 -178.794 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.922 HG22 HG22 ' A' ' 68' ' ' VAL . 27.0 t -114.09 138.31 44.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.195 0.522 . . . . 0.0 111.694 179.306 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.791 ' CE1' HD12 ' A' ' 34' ' ' ILE . 4.2 m-85 -115.89 99.47 7.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.997 178.276 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 35' ' ' ASN . . . -158.61 -138.58 2.5 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.446 -179.228 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.707 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 64.7 m-85 -117.92 154.67 31.51 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 120.865 0.364 . . . . 0.0 111.021 -179.517 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.49 -77.9 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.788 -179.853 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 t 170.78 -37.88 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.955 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.49 -29.56 52.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.26 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.496 HG23 ' N ' ' A' ' 40' ' ' LYS . 10.4 mm -89.03 -40.36 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.059 0.457 . . . . 0.0 110.631 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -150.32 148.54 28.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.573 179.518 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -78.37 160.04 28.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.302 -179.599 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.1 t -174.63 103.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.722 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 m -79.98 -37.88 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.217 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.46 -22.92 66.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.16 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.2 m -65.77 -57.72 7.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.909 0.385 . . . . 0.0 110.837 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -53.44 -25.98 18.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.316 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -70.39 -63.29 1.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.611 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.538 ' HB2' ' HB2' ' A' ' 79' ' ' PHE . . . -57.4 -27.04 62.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.796 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.2 tttm -59.59 -56.53 20.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.475 179.726 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.638 ' O ' HG23 ' A' ' 26' ' ' VAL . 8.9 ttt85 -61.51 -25.5 67.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.523 179.456 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.555 HD11 ' HG2' ' A' ' 83' ' ' ARG . 1.0 OUTLIER -59.53 -55.42 34.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.451 179.626 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.5 mt -63.52 -43.0 98.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.8 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.2 m -58.75 -41.25 86.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.175 0.512 . . . . 0.0 109.986 179.243 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 22' ' ' ARG . 95.8 t -78.86 -25.03 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.456 179.25 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.535 ' HG2' ' CE1' ' A' ' 86' ' ' PHE . 12.4 tppt? -71.75 -18.81 62.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.226 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt 69.86 53.76 0.37 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 111.11 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -143.7 145.92 33.01 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.996 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.33 138.88 22.81 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.557 2.171 . . . . 0.0 111.919 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.647 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 4.2 p90 -158.36 169.6 24.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.058 0.456 . . . . 0.0 112.154 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -144.18 143.14 30.94 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.789 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.51 ' HE1' HG11 ' A' ' 4' ' ' VAL . 21.0 t80 -89.41 158.45 17.74 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.318 -179.749 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.791 HD12 ' CE1' ' A' ' 5' ' ' TYR . 11.7 mt -145.67 119.75 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.168 179.26 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.0 p30 -90.6 133.04 35.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.544 -179.176 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.707 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 6.8 pt -90.28 -22.5 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.056 179.529 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.61 ' HB2' ' HB3' ' A' ' 43' ' ' PHE . 2.9 ttp -123.68 91.34 49.8 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.406 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 6.1 Cg_exo -74.05 -4.36 15.3 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.891 2.394 . . . . 0.0 112.569 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 37' ' ' MET . 0.1 OUTLIER -139.62 136.98 34.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.74 0.305 . . . . 0.0 110.805 -179.837 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.496 ' N ' HG23 ' A' ' 11' ' ' ILE . 4.0 ttpm? -63.69 -8.9 11.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.144 0.497 . . . . 0.0 112.102 -179.749 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.56 -64.6 1.43 Allowed Glycine 0 C--N 1.312 -0.774 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.164 179.583 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.8 t -141.24 139.91 32.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.611 0.243 . . . . 0.0 110.86 179.717 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.61 ' HB3' ' HB2' ' A' ' 37' ' ' MET . 0.1 OUTLIER -68.83 169.92 10.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.986 0.422 . . . . 0.0 111.379 -179.73 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.406 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -93.58 107.94 19.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.161 -179.678 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 1.8 p30 -56.29 -22.01 27.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.304 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -57.44 -51.19 70.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.838 0.351 . . . . 0.0 110.928 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -76.85 -35.15 57.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.308 179.632 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.534 HD11 ' HB ' ' A' ' 36' ' ' ILE . 32.6 mm -62.46 -44.36 99.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.873 179.672 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.96 -56.81 9.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.245 -179.487 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -57.75 -33.16 68.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.585 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.695 HD13 ' CD2' ' A' ' 5' ' ' TYR . 10.4 tp -57.72 -51.74 68.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.382 179.574 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.2 mt -52.47 -45.85 66.27 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.196 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.6 m -67.19 -35.63 80.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.32 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -62.67 -32.16 73.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.495 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.08 -53.54 48.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.84 179.747 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.62 -41.93 1.24 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.297 -179.848 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -98.76 -165.5 1.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.882 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -104.0 -32.83 9.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 t -110.54 166.32 11.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 18.4 mt-30 -110.62 99.47 8.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 pt -68.17 80.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.199 179.926 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.95 17.75 73.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.668 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.832 HD12 ' NE2' ' A' ' 67' ' ' GLN . 0.3 OUTLIER -79.96 139.28 37.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.908 180.0 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.67 171.35 14.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.489 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.43 ' SD ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -89.72 156.37 47.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.651 179.475 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.0 Cg_exo -76.58 147.66 87.27 Favored 'Cis proline' 0 C--N 1.345 0.36 0 C-N-CA 123.865 -1.306 . . . . 0.0 113.073 0.4 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.832 ' NE2' HD12 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -107.73 111.55 23.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.406 179.314 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.922 HG22 HG22 ' A' ' 4' ' ' VAL . 5.6 t -93.65 161.1 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.933 0.397 . . . . 0.0 111.821 -179.319 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.473 ' N ' HG12 ' A' ' 68' ' ' VAL . 96.0 m-85 -142.05 146.6 35.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.622 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -84.31 137.68 39.44 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.242 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.553 ' HB3' ' N ' ' A' ' 1' ' ' MET . 39.0 Cg_exo -34.94 -36.88 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.634 2.889 . . . . 0.0 112.183 178.674 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -166.6 31.02 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.124 179.683 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.72 15.91 9.01 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.761 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 p 73.36 179.93 0.21 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.125 0.488 . . . . 0.0 111.412 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.473 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 24.4 t-80 -52.57 125.71 17.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.502 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.622 HD11 ' HA ' ' A' ' 70' ' ' ALA . 26.7 mt -94.76 -47.9 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.657 179.538 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.5 -151.71 20.95 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.657 -179.71 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.44 -144.95 17.87 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.592 -179.792 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.538 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 11.1 t80 -70.65 -70.6 0.29 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.771 0.32 . . . . 0.0 110.775 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -59.18 -47.22 86.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.958 0.408 . . . . 0.0 110.477 179.926 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -41.15 63.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.264 179.582 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.587 HD21 ' CD2' ' A' ' 86' ' ' PHE . 4.5 tt -76.23 -35.39 59.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.051 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.555 ' HG2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.52 -28.05 12.5 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.755 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -72.29 -33.61 67.55 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.367 178.352 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.616 ' CD2' HG23 ' A' ' 76' ' ' ILE . 6.2 t80 -65.64 -32.85 74.64 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.399 178.568 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.587 ' CD2' HD21 ' A' ' 82' ' ' LEU . 10.7 m-85 -95.13 -70.19 0.72 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.521 179.718 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.818 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.645 ' HG3' ' HA ' ' A' ' 31' ' ' PHE . 2.5 tpp . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.799 0.333 . . . . 0.0 111.637 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.521 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 82.9 m-85 -68.82 148.42 50.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.958 0.408 . . . . 0.0 110.538 -179.786 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.683 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -120.25 118.51 30.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.157 -179.973 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.647 HG22 HG22 ' A' ' 68' ' ' VAL . 6.2 t -105.28 122.74 58.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.343 0.592 . . . . 0.0 111.921 -179.607 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.596 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.6 m-30 -99.95 99.39 10.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.923 178.659 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.74 -138.07 2.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.369 -179.068 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -131.07 104.09 6.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.56 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 8' ' ' ASP . 0.5 OUTLIER -108.8 22.84 15.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.604 0.24 . . . . 0.0 110.465 178.53 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.1 t -116.07 175.16 5.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.42 0.629 . . . . 0.0 111.774 -179.103 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -87.37 8.26 25.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.22 179.059 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.2 mm -87.66 -16.28 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.382 179.333 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -153.51 144.92 23.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.471 179.18 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.34 166.79 20.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.048 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.3 p 179.19 116.9 0.04 OUTLIER 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.831 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.7 m -90.84 -35.8 7.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.87 0.367 . . . . 0.0 111.134 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -77.41 -19.32 56.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.49 -179.647 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.6 p -65.76 -43.41 88.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 0.0 110.634 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.31 -38.24 63.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.858 179.752 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -68.74 -41.14 79.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.432 -179.428 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.491 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -67.04 -40.03 87.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.774 0.321 . . . . 0.0 111.487 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HD2' ' CZ ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -57.3 -48.55 78.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.836 0.35 . . . . 0.0 110.491 179.753 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.832 ' O ' HG23 ' A' ' 26' ' ' VAL . 41.7 ptt85 -64.93 -33.42 75.99 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.979 0.418 . . . . 0.0 110.503 179.624 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.734 HD13 ' N ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.45 -49.75 71.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.325 179.285 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.734 ' N ' HD13 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -64.4 -47.51 78.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.447 179.266 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 m -54.24 -36.98 64.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.003 179.328 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 22' ' ' ARG . 59.5 t -77.46 -27.92 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.414 179.251 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 -11.57 57.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.093 179.787 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 70.27 57.71 0.27 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.907 0.384 . . . . 0.0 111.245 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -135.37 137.75 27.14 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.113 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.461 ' O ' ' HA ' ' A' ' 1' ' ' MET . 54.8 Cg_endo -80.8 134.32 9.58 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.598 2.199 . . . . 0.0 111.123 179.111 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.645 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 28.9 p90 -159.44 169.88 22.97 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.12 -0.632 . . . . 0.0 112.547 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -144.56 142.68 30.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.27 -179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.505 ' HD1' ' N ' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -89.8 133.9 34.47 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.071 -179.935 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.596 HD12 ' CE1' ' A' ' 5' ' ' TYR . 7.6 mt -115.42 109.93 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.174 0.511 . . . . 0.0 110.22 178.939 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -74.1 134.08 42.88 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.048 -179.774 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 pt -100.12 -6.93 9.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.987 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 30.7 ttm -122.93 95.29 46.42 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.653 0.263 . . . . 0.0 111.62 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.0 -24.46 17.32 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.475 2.117 . . . . 0.0 111.842 179.485 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -140.86 147.72 39.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.644 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -64.4 -8.42 13.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.253 0.549 . . . . 0.0 111.801 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.0 -56.37 3.08 Favored Glycine 0 C--N 1.312 -0.753 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.61 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -147.95 145.09 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.981 0.42 . . . . 0.0 111.815 -179.614 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -68.21 170.66 8.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.559 179.434 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.29 84.1 5.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.45 -27.92 7.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.362 179.889 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -56.73 -50.3 72.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.939 0.4 . . . . 0.0 110.574 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -40.03 64.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.226 179.343 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 mm -52.24 -44.61 42.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.851 179.607 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.4 -56.74 12.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.57 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -57.76 -34.74 69.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.355 179.507 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.034 HD13 HD11 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -59.86 -56.69 18.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.238 179.863 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.588 ' HA ' HD13 ' A' ' 55' ' ' LEU . 66.8 mt -43.4 -45.5 6.23 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.384 0.611 . . . . 0.0 110.884 179.11 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.4 m -70.39 -33.33 71.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.166 178.85 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -64.32 -39.86 94.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.305 179.918 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.034 HD11 HD13 ' A' ' 51' ' ' LEU . 4.4 mp -59.76 -66.99 0.43 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.899 0.38 . . . . 0.0 111.08 -179.739 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 158.24 -34.95 0.52 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.405 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.58 -164.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.774 0.321 . . . . 0.0 110.903 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -99.74 -33.12 10.71 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.787 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 t -119.65 170.11 9.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.815 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.424 ' HB2' ' CB ' ' A' ' 63' ' ' LEU . 4.0 pt20 -113.17 99.81 8.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.0 0.428 . . . . 0.0 110.909 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mt -79.93 80.85 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.389 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.36 -18.63 56.75 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.854 179.683 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.424 ' CB ' ' HB2' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -59.48 136.17 57.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 0.0 110.915 -179.959 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 65' ' ' MET . 0.5 OUTLIER -143.06 171.33 14.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.353 -179.465 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.436 ' H ' HG22 ' A' ' 64' ' ' THR . 0.0 OUTLIER -89.45 153.2 48.19 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.565 179.56 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.9 Cg_exo -77.13 138.78 55.53 Favored 'Cis proline' 0 C--N 1.344 0.339 0 C-N-CA 123.877 -1.301 . . . . 0.0 112.954 0.263 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.68 ' OE1' HD11 ' A' ' 51' ' ' LEU . 5.3 mt-30 -100.91 112.96 25.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.996 179.054 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.9 t -91.08 163.74 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 0.0 111.752 -179.213 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.515 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 28.5 m-85 -142.1 132.1 24.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.348 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.823 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -48.56 149.45 2.92 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.635 -178.663 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.6 ' HB3' ' N ' ' A' ' 1' ' ' MET . 52.9 Cg_exo -57.27 -29.02 82.35 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.106 2.537 . . . . 0.0 111.882 179.156 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -94.41 -23.13 17.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.034 179.818 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.56 79.02 0.51 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.568 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.491 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -164.5 119.13 1.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.833 0.349 . . . . 0.0 110.904 179.931 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -51.37 111.3 0.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.051 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.823 HD11 ' HA ' ' A' ' 70' ' ' ALA . 27.0 mt -88.51 -50.43 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.987 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 126.99 -154.48 19.39 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.624 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -87.1 -144.83 8.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.281 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.491 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -72.81 -68.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.725 0.262 . . . . 0.0 110.849 179.75 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -47.09 -42.33 18.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.156 0.503 . . . . 0.0 110.39 179.611 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -40.03 95.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.372 179.507 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.633 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -72.49 -43.68 63.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.346 179.741 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.13 -33.42 18.8 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.792 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -69.9 -36.55 75.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.202 178.339 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 82' ' ' LEU . 10.2 t80 -63.51 -33.77 76.3 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.465 178.39 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.633 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.4 m-85 -86.34 -70.36 0.61 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.047 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.885 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.596 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 11.2 tpp . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.307 0.098 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 76.8 m-85 -39.53 123.75 1.53 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.61 0.719 . . . . 0.0 111.74 -177.243 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.673 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -89.54 125.22 35.12 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.152 -179.316 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 68' ' ' VAL . 51.5 t -116.77 147.24 20.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.253 0.549 . . . . 0.0 110.959 179.187 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.668 ' CZ ' HD12 ' A' ' 34' ' ' ILE . 85.7 m-85 -129.06 99.67 5.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.061 178.761 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.414 ' O ' HD13 ' A' ' 36' ' ' ILE . . . -159.68 -142.38 3.38 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.13 -179.06 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.686 ' CE1' HD11 ' A' ' 36' ' ' ILE . 60.2 m-85 -115.37 145.17 42.78 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.565 0.221 . . . . 0.0 110.831 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -106.05 27.57 8.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.942 0.401 . . . . 0.0 110.438 179.738 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.2 p 64.02 10.74 5.59 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.313 -179.722 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -86.19 -63.88 1.24 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.894 0.378 . . . . 0.0 110.891 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.426 HG21 ' N ' ' A' ' 40' ' ' LYS . 18.4 mm -96.62 -17.66 6.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.376 -179.051 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.51 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 6.1 t-80 -153.32 160.52 42.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.984 0.421 . . . . 0.0 111.644 -179.441 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -46.55 156.94 0.16 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.188 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.9 t -153.64 69.28 0.8 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.037 -179.76 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.444 HG23 ' N ' ' A' ' 16' ' ' TYR . 27.5 m -91.78 -43.15 13.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.444 ' N ' HG23 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -70.75 -22.65 62.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.453 -179.204 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.07 -42.71 14.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.692 179.826 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -52.28 -31.56 33.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.408 179.548 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -78.49 -56.46 4.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.644 179.605 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.448 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . . . -55.39 -45.26 76.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.875 0.369 . . . . 0.0 111.076 179.841 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 27.2 ttpt -58.92 -45.7 89.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.598 179.744 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.801 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.6 tmm_? -63.21 -37.27 86.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.556 179.737 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.791 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -56.98 -53.03 62.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.239 179.499 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.791 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.7 mt -56.51 -44.86 81.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.602 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.0 m -58.27 -39.07 78.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.967 179.353 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.7 t -73.0 -39.96 58.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.555 179.334 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -10.14 59.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.999 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 69.41 49.95 0.56 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.935 0.398 . . . . 0.0 110.375 -179.674 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.17 112.26 8.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.394 -179.634 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.596 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 83.4 Cg_exo -49.96 179.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.341 2.027 . . . . 0.0 111.585 179.052 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CE2' ' HG3' ' A' ' 21' ' ' LYS . 4.8 p90 -164.54 170.13 16.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.077 0.465 . . . . 0.0 111.346 178.111 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 2.7 tt0 -134.55 109.49 8.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.628 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.574 ' CE1' HG11 ' A' ' 4' ' ' VAL . 7.9 t80 -91.94 159.89 15.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.206 0.527 . . . . 0.0 111.82 -179.446 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.668 HD12 ' CZ ' ' A' ' 5' ' ' TYR . 20.6 mt -150.1 122.93 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.075 179.152 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -80.0 124.39 28.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.09 -179.639 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.686 HD11 ' CE1' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -88.7 -18.04 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.17 179.652 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -125.22 83.4 60.92 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.667 179.864 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.5 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 57.7 Cg_endo -70.82 -12.98 31.67 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.62 2.213 . . . . 0.0 111.708 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -139.55 136.93 34.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.912 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.426 ' N ' HG21 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -61.63 -8.28 4.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.312 0.577 . . . . 0.0 111.543 -179.59 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.5 -60.43 3.24 Favored Glycine 0 C--N 1.313 -0.737 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.543 179.659 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 43' ' ' PHE . 20.3 t -151.41 160.44 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.425 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.521 ' N ' HG12 ' A' ' 42' ' ' VAL . 1.7 m-30 -60.05 170.4 1.24 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.587 178.971 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.5 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 66.6 t0 -99.91 96.96 7.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.513 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -48.66 -34.35 11.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.273 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -65.5 -58.09 6.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.817 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -32.26 71.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.651 179.749 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.4 mp -75.4 -29.67 21.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.523 179.761 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.35 -54.4 46.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.877 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -64.17 -35.19 79.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 110.224 179.615 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.779 HD22 HD11 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -62.03 -59.47 5.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.476 179.057 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.576 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 69.2 mt -44.88 -41.3 7.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.114 179.092 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.6 m -70.62 -32.29 69.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.575 -179.561 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 19.8 mtpp -64.84 -45.08 87.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.75 -179.193 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.779 HD11 HD22 ' A' ' 51' ' ' LEU . 1.3 mp -59.52 -39.4 83.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.859 0.361 . . . . 0.0 111.168 -179.645 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.86 -120.46 0.83 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.343 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -146.99 30.27 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.054 0.454 . . . . 0.0 110.619 179.522 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -121.18 -146.29 0.37 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.258 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -120.39 168.55 11.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.689 0.281 . . . . 0.0 110.599 179.663 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.409 ' OE1' HD21 ' A' ' 52' ' ' LEU . 68.8 mt-30 -87.73 98.89 11.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.254 0.55 . . . . 0.0 110.484 179.628 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pt -79.9 84.68 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.161 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.52 26.2 64.16 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.382 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.598 HD12 ' OE1' ' A' ' 67' ' ' GLN . 1.4 mm? -54.02 153.12 5.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.872 0.368 . . . . 0.0 110.787 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.5 p -119.19 161.08 20.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.133 0.492 . . . . 0.0 111.466 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.7 mmt -108.69 153.68 42.12 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.393 179.552 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.557 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.4 Cg_endo -86.17 146.01 36.2 Favored 'Cis proline' 0 N--CA 1.461 -0.396 0 C-N-CA 124.268 -1.138 . . . . 0.0 112.912 0.517 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.598 ' OE1' HD12 ' A' ' 63' ' ' LEU . 29.2 tp60 -97.05 122.29 39.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.877 178.768 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 4' ' ' VAL . 8.2 t -104.46 157.79 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.759 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.627 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 92.7 m-85 -142.49 164.26 30.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.039 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.634 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -64.49 157.59 71.57 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.771 -179.519 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.26 -21.62 67.41 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.896 2.397 . . . . 0.0 112.418 179.593 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -109.72 -16.46 13.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.617 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.69 97.76 1.11 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.798 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 15.2 t -178.57 151.74 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.674 0.273 . . . . 0.0 110.34 179.623 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.483 ' NE2' ' NE2' ' A' ' 67' ' ' GLN . 9.1 t-160 -85.63 113.73 22.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.146 -179.603 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.634 HD12 ' N ' ' A' ' 70' ' ' ALA . 1.7 mp -103.17 -39.54 6.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.865 0.364 . . . . 0.0 110.658 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.04 -160.4 23.88 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.704 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.16 -134.53 7.99 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.615 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 9.2 t80 -70.63 -70.67 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.72 0.295 . . . . 0.0 111.422 -179.597 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -60.51 -44.49 95.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.994 0.426 . . . . 0.0 110.999 -179.813 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -52.14 -41.15 62.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.698 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.737 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.2 tt -74.85 -34.04 62.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.217 179.786 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -51.15 -31.46 19.89 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.618 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.64 -35.16 79.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.208 178.257 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.462 ' N ' ' O ' ' A' ' 82' ' ' LEU . 13.5 t80 -63.59 -33.57 75.89 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.337 178.459 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.737 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.6 m-85 -86.76 -70.24 0.62 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.275 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.975 -179.956 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.688 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 31.4 ttp . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.872 0.368 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.526 ' HE1' HE21 ' A' ' 29' ' ' GLN . 96.3 m-85 -82.71 143.35 30.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.068 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.71 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -117.14 122.56 44.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.719 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.064 HG22 HG22 ' A' ' 68' ' ' VAL . 7.7 t -111.03 130.06 65.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.464 0.65 . . . . 0.0 111.7 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.512 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 20.1 m-85 -111.95 101.76 10.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.651 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 66' ' ' PRO . . . -163.89 -139.42 2.63 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.653 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.492 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 85.1 m-85 -123.19 159.52 28.45 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.711 0.291 . . . . 0.0 111.254 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.8 -65.76 1.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.254 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 t 168.79 -32.53 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 110.792 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -65.53 -47.27 76.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.122 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.563 ' H ' HD12 ' A' ' 11' ' ' ILE . 3.7 mp -91.32 -44.99 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.019 0.437 . . . . 0.0 110.934 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.492 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 4.4 t-80 -143.2 155.96 44.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.39 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -80.98 171.24 15.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.854 0.359 . . . . 0.0 111.264 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.0 p -179.37 115.36 0.06 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.973 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 m -90.86 -36.67 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.298 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -80.25 -15.45 56.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.655 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.0 p -66.25 -42.4 88.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.928 0.394 . . . . 0.0 110.621 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.2 -41.92 66.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.409 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -56.86 -48.14 78.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.484 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.88 -47.32 83.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.134 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -49.66 -31.72 11.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.944 0.402 . . . . 0.0 110.376 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.874 ' O ' HG23 ' A' ' 26' ' ' VAL . 22.0 ttp180 -74.33 -34.6 63.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.195 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.686 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -55.52 -51.72 66.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.254 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.29 -54.17 49.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.848 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 m -49.22 -36.01 18.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.718 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 22' ' ' ARG . 74.6 t -69.33 -29.75 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.802 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -16.84 27.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.347 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt 71.67 65.05 0.15 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.987 0.422 . . . . 0.0 110.682 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.526 HE21 ' HE1' ' A' ' 2' ' ' PHE . 4.6 mm100 -130.81 142.3 45.04 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.65 128.58 11.08 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.414 2.076 . . . . 0.0 111.641 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.688 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 16.0 p90 -158.88 167.7 28.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.97 147.04 27.39 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.105 0.479 . . . . 0.0 111.35 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.651 ' CE1' HG11 ' A' ' 4' ' ' VAL . 7.8 t80 -89.47 156.42 18.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.007 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.2 mt -145.85 119.99 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.409 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -74.92 109.81 8.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.687 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.7 pt -72.84 -13.64 16.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.301 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.522 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -119.86 80.66 25.48 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.76 0.314 . . . . 0.0 111.088 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 60.8 Cg_endo -72.37 -9.86 24.79 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.632 2.221 . . . . 0.0 111.9 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -139.53 136.67 34.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.469 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -60.94 -8.74 3.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.232 0.539 . . . . 0.0 112.0 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.09 -62.06 2.15 Favored Glycine 0 C--N 1.312 -0.774 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.338 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 43' ' ' PHE . 21.2 t -150.4 154.91 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.765 0.316 . . . . 0.0 111.45 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -59.75 169.97 1.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.613 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.418 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 6.3 t0 -82.32 100.44 9.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.943 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -55.27 -27.01 43.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.05 -54.98 29.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 110.875 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -73.81 -33.29 64.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.526 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.2 mm -71.57 -31.67 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.649 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -66.31 -56.32 11.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -59.37 -30.01 68.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.939 0.399 . . . . 0.0 110.226 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.651 ' O ' HD12 ' A' ' 55' ' ' LEU . 2.0 tt -59.67 -58.59 7.92 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.571 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.569 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 73.9 mt -45.93 -42.59 13.02 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.593 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 m -70.92 -31.12 67.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.661 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 1.8 tttp -60.8 -48.34 82.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.419 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.2 mp -59.32 -59.63 5.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.049 0.452 . . . . 0.0 111.065 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.35 -114.2 0.29 Allowed Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.048 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.9 mtt85 -150.64 28.07 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.98 0.419 . . . . 0.0 111.004 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -121.7 -156.63 0.69 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.113 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.5 t -121.17 167.41 12.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.686 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.832 ' CB ' HD23 ' A' ' 63' ' ' LEU . 6.2 pt20 -130.2 98.84 4.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 110.828 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.654 ' O ' HG23 ' A' ' 61' ' ' ILE . 8.5 tp -82.07 85.57 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.177 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.09 23.8 5.97 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.485 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.832 HD23 ' CB ' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -60.84 127.02 29.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.34 . . . . 0.0 110.557 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 p -92.28 163.42 13.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.241 0.543 . . . . 0.0 111.481 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.48 160.77 38.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.665 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.495 ' HB2' HG13 ' A' ' 4' ' ' VAL . 4.2 Cg_exo -83.94 149.75 60.35 Favored 'Cis proline' 0 C--N 1.344 0.335 0 C-N-CA 124.428 -1.072 . . . . 0.0 113.123 0.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -101.77 120.18 39.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.903 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.064 HG22 HG22 ' A' ' 4' ' ' VAL . 6.2 t -98.72 159.65 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.035 0.445 . . . . 0.0 111.615 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.459 ' N ' HG12 ' A' ' 68' ' ' VAL . 31.8 m-85 -142.9 133.15 24.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.765 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.612 ' CA ' HD11 ' A' ' 76' ' ' ILE . . . -62.95 149.62 89.84 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.604 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.58 ' HB3' ' N ' ' A' ' 1' ' ' MET . 68.0 Cg_exo -44.8 -52.54 6.07 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.37 2.714 . . . . 0.0 112.747 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -30.03 65.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.189 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.26 67.95 0.44 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.388 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.4 m -147.79 157.07 43.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.84 0.353 . . . . 0.0 110.648 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -84.09 115.1 22.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.973 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.612 HD11 ' CA ' ' A' ' 70' ' ' ALA . 19.8 mt -93.58 -49.14 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.972 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 123.15 -154.18 17.14 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.93 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -90.97 -132.24 5.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.472 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.686 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -79.66 -70.08 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.654 0.227 . . . . 0.0 111.114 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -51.08 -49.12 61.26 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.331 0.586 . . . . 0.0 110.478 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -57.41 -42.2 81.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.701 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.691 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.3 tt -76.3 -32.26 58.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.582 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -33.78 40.6 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -66.47 -35.87 81.34 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.164 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 82' ' ' LEU . 14.7 t80 -63.2 -34.08 76.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.35 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.691 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.4 m-85 -84.29 -66.39 0.9 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.995 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.91 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.632 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 30.1 ttm . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.784 0.326 . . . . 0.0 111.527 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.517 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 69.3 m-85 -61.8 169.57 2.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.357 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -143.72 116.29 8.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.743 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.0 HG22 HG22 ' A' ' 68' ' ' VAL . 87.5 t -110.44 141.27 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.168 0.508 . . . . 0.0 111.02 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.685 ' CE1' HD12 ' A' ' 34' ' ' ILE . 6.6 m-85 -123.31 99.3 6.27 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.89 -144.54 4.05 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.541 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.831 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 34.4 m-85 -113.51 151.07 32.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.748 0.309 . . . . 0.0 111.426 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.5 t70 -81.98 0.46 40.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.983 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.3 OUTLIER 83.81 -13.76 0.73 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -85.33 -39.12 18.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.759 0.314 . . . . 0.0 111.082 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.419 HD12 ' O ' ' A' ' 37' ' ' MET . 3.7 mt -92.56 -31.1 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.283 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.436 ' O ' ' HA ' ' A' ' 9' ' ' SER . 7.8 t60 -142.07 142.15 32.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.099 0.476 . . . . 0.0 110.987 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.2 145.02 11.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.315 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.3 t -179.26 88.93 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.13 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.8 m -79.01 -27.08 13.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.897 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -75.1 -21.53 58.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.798 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.5 m -59.71 -58.59 7.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.205 0.526 . . . . 0.0 110.265 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.96 -23.59 13.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.334 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 3.9 m-80 -77.14 -54.08 6.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.091 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.49 -48.7 76.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 111.078 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HD2' ' CE2' ' A' ' 31' ' ' PHE . 2.2 tptt -58.23 -54.06 51.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.697 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.836 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.4 mmp_? -60.84 -36.76 79.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.554 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 24' ' ' LEU . 3.1 tt -58.88 -52.97 63.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.509 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.618 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.9 mt -57.78 -46.86 83.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.794 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 m -57.63 -36.28 71.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.478 . . . . 0.0 110.234 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 22' ' ' ARG . 53.3 t -79.71 -30.7 13.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.766 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -77.77 -11.08 59.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.131 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt 70.34 54.07 0.32 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.996 0.427 . . . . 0.0 111.045 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -134.42 132.77 21.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.092 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.434 ' O ' ' HA ' ' A' ' 1' ' ' MET . 98.5 Cg_endo -78.41 137.33 14.77 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.474 2.116 . . . . 0.0 111.114 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.632 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 17.1 p90 -156.21 170.19 22.8 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -136.79 131.63 33.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.011 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.612 ' CE1' HG12 ' A' ' 4' ' ' VAL . 1.2 t80 -95.74 129.81 42.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.97 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.685 HD12 ' CE1' ' A' ' 5' ' ' TYR . 7.3 mt -113.33 110.39 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.383 0.611 . . . . 0.0 110.432 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -77.46 113.76 15.59 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.105 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.831 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 6.3 pt -71.94 -28.48 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.002 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.559 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 22.2 ttm -121.45 91.13 48.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.891 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.8 Cg_endo -82.59 1.66 9.0 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.693 2.262 . . . . 0.0 112.692 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -139.81 140.29 36.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 110.875 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -66.68 -7.09 18.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.254 0.549 . . . . 0.0 111.779 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.77 -67.13 1.01 Allowed Glycine 0 C--N 1.315 -0.608 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.694 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 t -136.21 133.82 50.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.71 0.29 . . . . 0.0 111.07 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -63.37 170.29 3.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.466 -179.505 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.45 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -94.65 99.94 11.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.064 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -54.37 -19.93 6.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.782 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -58.47 -56.28 24.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.031 0.444 . . . . 0.0 110.521 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -67.75 -31.69 71.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.307 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.405 HD11 ' HB ' ' A' ' 36' ' ' ILE . 25.1 mm -59.84 -48.34 88.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.611 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.11 -49.27 77.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.805 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.31 -35.89 70.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.579 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.47 HD13 ' CG ' ' A' ' 5' ' ' TYR . 26.4 tp -61.32 -52.99 62.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.652 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.5 mt -49.72 -45.16 48.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.131 0.491 . . . . 0.0 111.277 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.5 m -64.08 -32.47 74.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.108 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.427 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 9.3 tttp -68.9 -29.99 68.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.465 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.724 HD11 HD11 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -71.06 -37.62 72.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.048 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.83 33.58 6.32 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.278 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -150.07 -176.9 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.8 0.334 . . . . 0.0 110.742 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -105.11 -30.8 9.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.025 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 t -111.05 163.79 13.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.052 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.609 ' CA ' HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -106.47 99.14 8.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.596 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.5 mm -80.67 87.82 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.556 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.92 31.55 79.94 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.44 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.724 HD11 HD11 ' A' ' 55' ' ' LEU . 1.3 mm? -42.35 134.71 2.87 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.83 0.347 . . . . 0.0 111.207 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.58 153.11 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.088 0.47 . . . . 0.0 111.671 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.12 152.12 72.84 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.406 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.1 Cg_exo -79.31 128.72 16.86 Favored 'Cis proline' 0 C--N 1.344 0.328 0 C-N-CA 124.053 -1.228 . . . . 0.0 112.934 0.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.516 ' CD ' ' HE2' ' A' ' 75' ' ' HIS . 1.4 tp-100 -90.6 117.87 29.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.225 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.0 HG22 HG22 ' A' ' 4' ' ' VAL . 10.2 t -97.48 161.24 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.95 0.405 . . . . 0.0 111.906 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.537 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 97.0 m-85 -142.84 149.26 38.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.022 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.583 ' HB3' ' H ' ' A' ' 74' ' ' SER . . . -61.81 159.35 35.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.773 -0.648 . . . . 0.0 112.411 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.535 ' HB3' ' N ' ' A' ' 1' ' ' MET . 31.7 Cg_exo -63.74 58.85 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.577 2.851 . . . . 0.0 111.547 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER 90.49 29.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.345 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -111.75 -92.65 2.1 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.526 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.583 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -152.39 -175.97 5.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.033 0.444 . . . . 0.0 110.96 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.516 ' HE2' ' CD ' ' A' ' 67' ' ' GLN . 16.4 t-80 -68.14 126.62 30.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.156 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.569 HG23 ' CD2' ' A' ' 85' ' ' TYR . 4.8 mt -91.82 -45.43 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.177 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.16 -150.04 19.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.635 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.83 -150.74 22.47 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.62 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 40.4 t80 -70.79 -70.55 0.3 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.68 0.276 . . . . 0.0 110.951 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -55.46 -45.53 76.88 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.009 0.433 . . . . 0.0 110.579 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -54.91 -33.93 62.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.298 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.744 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.3 tt -80.08 -36.58 35.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.368 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -51.51 -29.98 18.64 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.3 -35.0 73.41 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.129 178.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.569 ' CD2' HG23 ' A' ' 76' ' ' ILE . 11.9 t80 -63.12 -34.35 77.42 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.267 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.744 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.9 m-85 -87.87 -70.18 0.65 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.292 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.8 mttm . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.044 -179.98 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.628 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 49.7 ttm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.861 0.362 . . . . 0.0 111.639 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.516 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 74.6 m-85 -58.33 155.22 12.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.866 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.638 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -128.19 120.43 27.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.669 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.909 HG22 HG22 ' A' ' 68' ' ' VAL . 55.4 t -116.09 142.18 30.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.333 0.587 . . . . 0.0 111.813 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.789 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.1 m-85 -121.67 99.89 6.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.58 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.24 -137.96 2.36 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.75 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.929 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 31.5 m-85 -122.95 144.15 49.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 120.591 0.234 . . . . 0.0 110.962 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -108.47 29.02 7.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.336 . . . . 0.0 110.863 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m 63.04 14.57 7.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -85.77 -56.98 3.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.1 0.476 . . . . 0.0 110.622 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.599 HG21 ' C ' ' A' ' 39' ' ' GLU . 13.4 mm -104.15 -27.23 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.017 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -141.45 152.12 43.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.613 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.77 171.69 12.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.178 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.4 t -178.68 108.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.952 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.2 m -85.66 -32.8 7.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.956 0.407 . . . . 0.0 111.207 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -71.23 -16.08 62.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.289 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.9 m -72.13 -55.92 6.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.996 0.426 . . . . 0.0 110.683 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -52.18 -28.04 16.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.094 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 74.8 m-20 -75.52 -51.77 12.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.016 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.88 -48.6 79.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.243 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -59.89 -55.43 34.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.781 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -55.4 -44.93 76.63 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.346 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.754 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -59.04 -50.59 73.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.16 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.754 ' N ' HD23 ' A' ' 23' ' ' LEU . 8.7 mt -60.51 -43.61 96.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.065 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.6 m -57.17 -40.15 76.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.107 0.48 . . . . 0.0 109.82 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.7 t -80.13 -27.17 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.449 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.537 ' HG2' ' CE1' ' A' ' 86' ' ' PHE . 3.3 tptp -73.42 -13.31 61.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.081 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt 66.53 54.72 0.86 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.448 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -137.12 134.44 18.92 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.019 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.436 ' O ' ' HA ' ' A' ' 1' ' ' MET . 85.9 Cg_endo -78.58 134.09 12.11 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.337 2.024 . . . . 0.0 110.909 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.628 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 26.9 p90 -148.51 170.0 19.03 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -136.91 133.23 35.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.729 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.513 ' HE1' HG11 ' A' ' 4' ' ' VAL . 9.4 t80 -89.43 163.01 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.25 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.789 HD12 ' CE1' ' A' ' 5' ' ' TYR . 19.1 mt -145.69 119.61 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.444 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -82.22 122.76 28.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.098 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.929 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 7.2 pt -93.4 -16.7 7.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.479 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -124.84 85.65 57.06 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.735 0.302 . . . . 0.0 111.556 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 97.0 Cg_endo -79.05 -5.82 14.68 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.851 2.368 . . . . 0.0 111.73 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.599 ' C ' HG21 ' A' ' 11' ' ' ILE . 28.0 mt-10 -139.66 135.33 33.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.288 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.445 ' HA ' HG22 ' A' ' 11' ' ' ILE . 20.0 tttp -61.34 -8.45 3.93 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.26 0.552 . . . . 0.0 111.873 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.3 -63.72 2.11 Favored Glycine 0 C--N 1.312 -0.786 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.067 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 43' ' ' PHE . 21.2 t -150.7 159.03 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.759 0.314 . . . . 0.0 111.548 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.708 ' HB2' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -63.47 159.31 18.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.33 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.46 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -82.18 125.6 31.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.88 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.526 ' HA ' HD12 ' A' ' 48' ' ' ILE . 2.1 p30 -68.07 -23.85 64.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.761 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -60.04 -55.5 33.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.37 . . . . 0.0 110.651 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.48 -39.6 85.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.271 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.708 HD11 ' HB2' ' A' ' 43' ' ' PHE . 46.3 mt -54.12 -46.39 66.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.441 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.48 -50.33 71.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.636 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -59.82 -31.96 70.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.577 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.888 ' O ' HD12 ' A' ' 55' ' ' LEU . 18.7 tp -66.28 -63.92 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.292 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 58' ' ' ASP . 62.2 mt -45.66 -40.81 9.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.153 0.502 . . . . 0.0 111.314 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.1 m -67.34 -34.29 77.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.872 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 69' ' ' PHE . 50.0 tptt -66.47 -49.27 67.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.486 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.888 HD12 ' O ' ' A' ' 51' ' ' LEU . 4.9 mp -59.31 -25.07 63.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.248 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.1 30.17 13.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.499 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.15 -178.04 6.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.781 0.324 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.454 ' O ' HD13 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -108.43 -47.36 3.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.997 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.2 t -92.73 160.1 15.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.54 99.36 8.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.678 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -79.91 83.61 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.255 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.81 23.1 78.21 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.513 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.443 HD11 ' CG ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -70.61 131.42 43.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.875 0.369 . . . . 0.0 110.809 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 65' ' ' MET . 0.4 OUTLIER -131.29 170.55 14.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.282 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.497 ' SD ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -106.78 154.15 40.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.762 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.4 Cg_exo -81.08 135.31 31.12 Favored 'Cis proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.701 -1.374 . . . . 0.0 112.846 0.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.443 ' CG ' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -90.7 117.01 29.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.503 179.321 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.909 HG22 HG22 ' A' ' 4' ' ' VAL . 2.7 t -103.19 160.72 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.157 0.503 . . . . 0.0 112.142 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.477 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 95.3 m-85 -142.8 155.65 44.85 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.982 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.517 ' HB3' ' N ' ' A' ' 74' ' ' SER . . . -66.3 156.41 85.23 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.356 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.46 ' HB3' ' N ' ' A' ' 1' ' ' MET . 44.9 Cg_exo -58.28 -38.92 88.7 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.055 2.504 . . . . 0.0 111.808 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -91.42 -16.18 27.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.094 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.76 87.95 1.16 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.651 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.517 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -164.04 124.04 2.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.945 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.525 ' CE1' HD23 ' A' ' 55' ' ' LEU . 20.0 t-160 -58.17 110.83 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.006 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.472 HD11 ' HA ' ' A' ' 70' ' ' ALA . 18.7 mt -89.95 -49.9 13.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.51 -154.25 19.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.434 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.29 -144.16 7.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.299 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 32.7 t80 -71.17 -60.42 2.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 0.0 110.764 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -54.44 -37.21 64.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.829 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -60.77 -41.21 95.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.58 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.428 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -64.04 -50.87 66.73 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.351 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -51.62 -28.38 14.14 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -79.79 -33.76 40.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 82' ' ' LEU . 17.1 t80 -67.57 -32.14 72.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.323 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.537 ' CE1' ' HG2' ' A' ' 27' ' ' LYS . 30.3 m-85 -96.17 -70.74 0.7 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.487 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.4 tttt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.634 -179.941 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.602 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 40.6 ttp . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -76.51 152.04 36.2 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.244 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.5 mptp? -113.34 119.99 39.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.466 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.68 HG22 HG22 ' A' ' 68' ' ' VAL . 39.9 t -113.13 134.19 56.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.363 0.601 . . . . 0.0 112.066 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.61 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 18.9 m-85 -111.66 99.51 8.22 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.959 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.11 -139.64 2.73 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.517 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.62 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 63.5 m-85 -123.28 157.38 33.3 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.858 0.361 . . . . 0.0 111.376 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.41 -76.21 0.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.976 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 174.53 -34.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.907 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -71.34 -24.64 62.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.267 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.666 ' H ' HD12 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -106.94 -40.15 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.86 0.362 . . . . 0.0 110.864 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -155.87 160.63 40.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.4 pttp -80.39 173.65 12.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.997 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 9.2 p -163.99 120.37 1.65 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.962 0.41 . . . . 0.0 110.758 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.4 -43.39 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.944 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -88.9 -9.01 53.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.936 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -87.41 -36.43 17.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.758 0.313 . . . . 0.0 110.672 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -68.09 -36.06 79.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.718 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -75.71 -48.38 22.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.125 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.22 69.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.056 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -60.33 -54.18 48.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.617 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.857 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -59.03 -34.58 72.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.679 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.631 ' C ' HD23 ' A' ' 23' ' ' LEU . 4.9 tt -60.14 -54.99 39.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.613 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.517 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.6 mt -55.25 -46.04 76.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.948 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.1 m -57.8 -36.5 72.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.041 0.448 . . . . 0.0 110.157 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.3 t -79.03 -35.46 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.682 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.426 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -72.85 -9.97 59.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.184 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.16 42.48 0.34 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.861 0.363 . . . . 0.0 110.792 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -131.89 133.44 24.07 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.025 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.587 ' O ' ' HA ' ' A' ' 1' ' ' MET . 58.9 Cg_endo -81.93 158.82 18.39 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.567 2.178 . . . . 0.0 111.481 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.492 ' CG ' HD13 ' A' ' 24' ' ' LEU . 5.6 p90 -161.47 171.25 18.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.801 0.334 . . . . 0.0 111.663 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -129.55 119.71 24.12 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.564 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.528 ' HE1' HG11 ' A' ' 4' ' ' VAL . 17.4 t80 -89.34 153.12 21.12 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.185 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.435 HD12 ' CE1' ' A' ' 5' ' ' TYR . 15.9 mt -147.4 121.61 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.509 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -81.17 109.74 16.01 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.539 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.62 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 10.7 pt -63.86 -19.65 24.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 2.8 ttp -123.08 90.27 50.45 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.812 0.339 . . . . 0.0 111.52 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.4 Cg_endo -80.86 0.98 9.65 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.697 2.265 . . . . 0.0 112.289 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -139.68 140.4 36.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.696 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -67.9 -8.55 37.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.226 0.536 . . . . 0.0 111.842 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.71 -64.76 1.25 Allowed Glycine 0 C--N 1.313 -0.74 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.347 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 t -140.82 139.47 34.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.733 0.301 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -65.56 169.49 6.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 0.0 111.112 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.523 ' O ' HD12 ' A' ' 48' ' ' ILE . 1.4 t0 -86.71 115.18 23.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.033 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -74.83 -22.91 58.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.298 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.3 -52.77 63.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.756 0.312 . . . . 0.0 110.804 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -69.64 -38.31 77.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.128 0.49 . . . . 0.0 110.022 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.523 HD12 ' O ' ' A' ' 44' ' ' ASP . 55.1 mt -64.79 -34.87 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.369 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.44 -48.7 80.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.394 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.83 -34.39 69.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.998 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.61 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.7 tt -58.58 -53.01 63.17 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.2 mt -50.33 -41.87 51.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.453 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.5 m -56.6 -49.14 75.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.523 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -61.03 -39.98 91.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.313 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.13 -48.48 81.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.589 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.99 -165.97 31.84 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.162 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 64.3 mtt-85 -95.51 35.33 1.35 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.972 0.415 . . . . 0.0 110.817 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -120.88 -147.21 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.459 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -120.49 170.9 8.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.766 0.317 . . . . 0.0 110.786 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -69.19 98.21 1.0 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.402 0.62 . . . . 0.0 110.207 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 61' ' ' ILE . 17.2 tt -73.58 79.16 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.133 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 43.09 26.24 0.48 Allowed Glycine 0 C--N 1.333 0.398 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.862 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.447 HD12 ' CG ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -57.57 144.19 38.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.838 0.351 . . . . 0.0 110.887 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 p -110.45 156.94 20.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.428 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -105.28 152.47 39.84 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.654 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.48 ' HB2' HG13 ' A' ' 4' ' ' VAL . 3.8 Cg_exo -82.34 144.28 56.12 Favored 'Cis proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.969 -1.263 . . . . 0.0 112.702 0.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.447 ' CG ' HD12 ' A' ' 63' ' ' LEU . 1.7 mp0 -98.63 132.24 44.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.826 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.68 HG22 HG22 ' A' ' 4' ' ' VAL . 3.5 t -104.23 157.02 5.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.171 0.51 . . . . 0.0 111.992 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.407 ' N ' HG12 ' A' ' 68' ' ' VAL . 46.2 m-85 -143.67 139.14 29.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.685 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.588 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -53.27 152.45 8.21 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.406 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.602 ' HB3' ' N ' ' A' ' 1' ' ' MET . 7.4 Cg_exo -70.14 -8.99 24.96 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.855 2.37 . . . . 0.0 112.353 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.61 -17.7 14.03 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.098 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.6 89.27 1.1 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.663 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.0 t 179.92 152.76 0.47 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.777 0.323 . . . . 0.0 110.723 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -90.22 113.37 25.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.865 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.588 HD11 ' HA ' ' A' ' 70' ' ' ALA . 19.9 mt -92.58 -48.68 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.977 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.558 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 138.9 -155.42 23.77 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.709 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.82 -136.82 8.9 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.641 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -71.56 -70.66 0.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.82 0.343 . . . . 0.0 111.223 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -59.67 -48.68 80.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.983 0.421 . . . . 0.0 110.729 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -51.3 -39.48 56.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.605 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.75 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.1 tt -78.66 -33.86 46.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.336 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -50.64 -30.13 12.73 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -68.08 -35.79 78.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.229 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 82' ' ' LEU . 13.5 t80 -63.02 -34.05 76.74 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.262 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.75 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.9 m-85 -90.06 -19.65 24.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.304 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.268 -0.873 . . . . 0.0 111.021 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.624 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 49.5 ttm . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.91 0.386 . . . . 0.0 111.561 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.582 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 84.3 m-85 -53.53 158.27 1.86 Allowed 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -135.23 117.44 15.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.486 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.52 HG11 ' CE1' ' A' ' 33' ' ' PHE . 30.9 t -99.87 127.18 53.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.656 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.553 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.9 m-30 -104.39 99.08 8.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.351 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.94 -139.62 2.7 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.45 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.469 ' OH ' ' CE1' ' A' ' 43' ' ' PHE . 85.6 m-85 -120.71 159.79 24.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.075 0.464 . . . . 0.0 111.733 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.15 -81.08 0.06 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.746 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 p 174.12 -41.91 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.227 0.536 . . . . 0.0 111.042 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -74.12 -31.72 62.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.236 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.699 HD12 ' HA ' ' A' ' 40' ' ' LYS . 50.9 mm -93.07 -35.7 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.733 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -154.76 152.39 29.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.33 159.68 3.45 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 t -174.66 73.82 0.03 OUTLIER 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.49 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.8 m -91.28 -37.82 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.571 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -62.5 -28.93 70.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.721 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.8 p -72.19 -44.18 63.4 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.651 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.32 -32.51 49.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.816 0.341 . . . . 0.0 110.921 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -70.16 -55.99 7.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.848 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.443 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . . . -57.69 -31.09 66.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.035 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HG2' ' CE1' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -60.94 -56.19 24.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.665 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.755 ' O ' HG23 ' A' ' 26' ' ' VAL . 23.6 ptt180 -60.42 -34.2 73.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.59 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.697 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.8 tt -59.05 -53.82 54.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.317 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.697 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.3 mt -55.47 -44.15 76.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.671 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 m -57.52 -35.92 70.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.176 0.513 . . . . 0.0 109.925 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 22' ' ' ARG . 43.5 t -79.72 -29.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.431 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.61 -13.14 59.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.052 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt 69.4 62.28 0.29 Allowed 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.95 0.405 . . . . 0.0 110.841 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -142.3 138.87 16.98 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.023 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.448 ' O ' ' HA ' ' A' ' 1' ' ' MET . 77.2 Cg_endo -79.97 136.29 11.69 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.536 2.157 . . . . 0.0 111.43 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.624 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 33.9 p90 -152.37 170.54 19.84 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -148.1 146.04 28.65 Favored 'General case' 0 N--CA 1.46 0.048 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.864 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.52 ' CE1' HG11 ' A' ' 4' ' ' VAL . 25.5 t80 -89.34 159.5 17.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.16 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.553 HD12 ' CE1' ' A' ' 5' ' ' TYR . 10.9 mt -145.37 120.56 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.521 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -94.42 118.85 32.26 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.063 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.576 HD12 ' CE2' ' A' ' 43' ' ' PHE . 35.6 pt -78.33 -17.71 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.032 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.488 ' HE3' ' HE1' ' A' ' 43' ' ' PHE . 31.6 ttm -122.11 92.01 48.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.524 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 98.6 Cg_endo -84.23 18.21 1.58 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.884 2.389 . . . . 0.0 113.028 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.525 ' O ' HG21 ' A' ' 11' ' ' ILE . 9.8 mt-10 -139.53 165.44 27.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.374 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.699 ' HA ' HD12 ' A' ' 11' ' ' ILE . 30.8 tttt -61.13 -7.76 2.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.88 48.17 0.07 OUTLIER Glycine 0 C--N 1.313 -0.737 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.877 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' A' ' 39' ' ' GLU . 5.7 t -150.48 115.21 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.327 0.584 . . . . 0.0 112.33 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.576 ' CE2' HD12 ' A' ' 36' ' ' ILE . 1.1 m-85 -68.44 153.14 44.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.822 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.662 ' O ' HD12 ' A' ' 48' ' ' ILE . 3.6 t0 -97.48 93.67 6.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.951 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -49.93 -26.24 3.98 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.716 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.93 -48.81 78.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.851 0.358 . . . . 0.0 110.812 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -77.5 -46.12 23.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.42 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 44' ' ' ASP . 3.0 mp -55.03 -42.36 64.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.76 -54.71 34.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 110.653 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.78 -38.28 87.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.48 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.467 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -57.43 -51.27 70.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.535 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.4 mt -50.09 -47.25 53.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.197 0.522 . . . . 0.0 110.586 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -70.21 -35.14 73.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.754 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -61.39 -31.37 71.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.411 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 mt -72.65 -38.72 67.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.683 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.33 -107.14 0.31 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.99 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.7 mtt-85 -150.53 30.87 0.66 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.929 0.395 . . . . 0.0 110.542 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.0 -151.34 0.48 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.355 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -120.61 170.17 9.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.696 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.93 98.37 10.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.241 0.544 . . . . 0.0 110.098 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pt -79.76 84.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.431 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.47 23.95 61.07 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.705 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.574 HD12 ' HG2' ' A' ' 67' ' ' GLN . 0.3 OUTLIER -50.57 121.28 5.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.838 0.351 . . . . 0.0 110.594 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.2 p -99.84 161.39 13.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.153 0.502 . . . . 0.0 111.544 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.403 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 1.8 mpt? -110.58 154.37 43.14 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.484 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.0 Cg_exo -81.78 145.18 62.98 Favored 'Cis proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.935 -1.277 . . . . 0.0 112.82 0.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.574 ' HG2' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -106.72 115.02 29.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -87.18 164.66 2.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.236 0.541 . . . . 0.0 111.953 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.476 ' H ' HG12 ' A' ' 68' ' ' VAL . 12.2 m-85 -142.2 130.22 21.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.467 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.789 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -46.43 144.26 3.43 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.934 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.455 ' CB ' ' N ' ' A' ' 1' ' ' MET . 19.7 Cg_endo -67.76 -13.58 39.09 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.316 2.011 . . . . 0.0 111.767 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.539 ' OD1' ' HB1' ' A' ' 70' ' ' ALA . 10.3 p-10 -99.4 -23.91 14.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.573 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.02 84.94 0.6 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.866 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 70' ' ' ALA . 3.1 m -178.11 162.74 1.63 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.837 0.351 . . . . 0.0 111.133 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -90.37 110.89 21.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.789 HD11 ' HA ' ' A' ' 70' ' ' ALA . 35.3 mt -84.86 -51.38 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.004 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.565 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 128.3 -153.5 19.54 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.475 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.18 -152.08 19.42 Favored Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.556 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.443 ' HD1' ' HB2' ' A' ' 20' ' ' ALA . 15.7 t80 -63.88 -63.25 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.824 0.345 . . . . 0.0 110.776 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -53.66 -41.82 67.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -56.04 -42.29 76.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.465 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.59 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -63.3 -48.19 79.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.428 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -51.09 -29.15 12.36 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -76.26 -34.14 59.14 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.277 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.423 ' N ' ' O ' ' A' ' 82' ' ' LEU . 7.6 t80 -66.98 -32.57 73.9 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.319 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.59 ' HE2' HD21 ' A' ' 82' ' ' LEU . 6.5 m-85 -90.65 -69.8 0.71 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.072 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.877 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.666 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 48.0 ttm . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -77.92 145.56 36.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.267 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.2 mppp? -108.11 120.68 43.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.528 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.602 HG22 HG22 ' A' ' 68' ' ' VAL . 7.8 t -105.05 131.04 55.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.29 0.567 . . . . 0.0 111.786 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.588 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.9 m-30 -106.59 98.96 8.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.168 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.91 -137.87 2.29 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.811 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.967 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 85.1 m-85 -127.73 157.86 39.21 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 120.776 0.322 . . . . 0.0 111.425 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -88.2 -68.38 0.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.127 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 166.73 -33.15 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.998 0.428 . . . . 0.0 110.899 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -71.54 -42.14 68.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.514 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.543 HG21 ' HG2' ' A' ' 37' ' ' MET . 27.5 mm -89.47 -39.55 12.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.051 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -150.51 154.08 36.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.351 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -76.86 162.71 27.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.58 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.9 t -172.14 108.32 0.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.785 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.0 m -88.81 -36.69 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.077 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -68.64 -19.74 64.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.002 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.9 m -64.36 -55.74 19.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.938 0.399 . . . . 0.0 110.29 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -57.8 -32.77 67.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.161 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -68.43 -58.46 4.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.273 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.87 -42.37 65.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.91 0.386 . . . . 0.0 111.305 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -56.26 -50.95 69.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.751 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.841 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.1 mtt180 -60.54 -40.85 93.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.585 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.802 HD21 ' CD2' ' A' ' 86' ' ' PHE . 2.0 tt -57.36 -51.9 67.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.431 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.662 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.2 mt -59.8 -50.37 74.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.584 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 m -53.27 -38.62 63.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.324 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 22' ' ' ARG . 56.5 t -76.29 -36.64 30.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.599 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.52 ' CD ' ' HB3' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -73.7 -9.89 59.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.041 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.19 59.45 0.33 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.983 0.421 . . . . 0.0 111.006 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -144.88 132.42 10.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.142 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.616 ' O ' ' HA ' ' A' ' 1' ' ' MET . 69.6 Cg_endo -79.42 159.27 25.87 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.482 2.121 . . . . 0.0 110.972 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.442 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 7.9 p90 -161.43 171.38 18.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.86 0.362 . . . . 0.0 111.788 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -134.3 134.87 42.36 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.523 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.494 ' HE1' HG11 ' A' ' 4' ' ' VAL . 6.8 t80 -89.28 156.69 18.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.168 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.588 HD12 ' CE1' ' A' ' 5' ' ' TYR . 18.0 mt -146.03 121.05 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.468 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -85.65 114.93 23.02 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.936 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.967 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 2.1 pt -75.08 -21.05 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.967 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.543 ' HG2' HG21 ' A' ' 11' ' ' ILE . 1.7 tpp -116.35 108.67 45.2 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.809 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' N ' ' A' ' 44' ' ' ASP . 79.8 Cg_endo -76.05 -28.18 7.74 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.648 2.232 . . . . 0.0 112.101 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -139.57 151.66 46.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.623 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -64.64 -8.5 14.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.255 0.55 . . . . 0.0 111.839 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.59 -55.83 2.77 Favored Glycine 0 C--N 1.313 -0.73 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.814 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -149.06 141.99 18.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 2.2 m-85 -59.4 170.29 1.03 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.843 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.427 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 1.4 p30 -88.73 140.58 29.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.031 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -78.4 -11.07 59.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.522 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.35 -62.99 1.18 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.791 0.329 . . . . 0.0 111.261 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -42.88 66.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.961 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.424 ' N ' ' CD1' ' A' ' 48' ' ' ILE . 0.8 OUTLIER -56.64 -39.09 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.744 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.26 -55.38 6.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -36.12 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.46 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.583 HD11 HD21 ' A' ' 55' ' ' LEU . 20.1 tp -57.08 -51.66 68.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.694 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 52' ' ' LEU . 81.3 mt -52.01 -46.91 65.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.149 0.5 . . . . 0.0 111.317 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.8 m -70.16 -42.41 72.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.594 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -60.29 -40.2 89.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.941 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.583 HD21 HD11 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -60.17 -69.08 0.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.804 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.62 -40.75 0.72 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.2 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -89.78 -174.89 4.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.33 . . . . 0.0 110.709 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -103.26 -30.3 10.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.072 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.4 t -111.19 169.73 8.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.081 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.5 mp0 -110.56 99.65 8.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.564 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.4 mt -80.26 87.42 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.558 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.65 29.66 64.47 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.682 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 60' ' ' GLN . 1.3 mm? -47.0 147.41 1.37 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.804 0.335 . . . . 0.0 111.007 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.4 p -121.32 153.49 37.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.079 0.466 . . . . 0.0 111.652 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -122.47 152.8 61.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.518 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -80.92 149.7 77.37 Favored 'Cis proline' 0 C--N 1.344 0.324 0 C-N-CA 124.073 -1.22 . . . . 0.0 112.725 0.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -105.32 119.61 39.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.848 178.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -91.41 161.41 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.362 0.601 . . . . 0.0 112.193 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.432 ' N ' HG12 ' A' ' 68' ' ' VAL . 60.6 m-85 -143.13 140.74 30.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.277 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.629 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.37 147.23 28.97 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.139 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.666 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 15.7 Cg_exo -65.48 -14.45 44.95 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.694 2.262 . . . . 0.0 112.317 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.56 -23.01 13.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.018 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.36 74.61 0.28 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.568 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.64 113.08 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.757 0.313 . . . . 0.0 110.739 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -53.66 120.94 6.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.994 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.629 HD11 ' HA ' ' A' ' 70' ' ' ALA . 15.5 mt -97.41 -45.97 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.768 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 81' ' ' GLN . . . 135.13 -156.23 22.47 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.585 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.28 -138.25 7.22 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.575 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -72.87 -61.16 1.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -55.19 -45.34 75.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.04 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.404 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 8.4 mp0 -56.01 -48.28 76.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.645 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -64.28 -43.0 96.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.434 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -51.54 -29.88 18.59 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -75.01 -35.17 61.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.404 ' N ' ' O ' ' A' ' 82' ' ' LEU . 12.0 t80 -62.9 -35.38 79.87 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.802 ' CD2' HD21 ' A' ' 23' ' ' LEU . 5.3 m-85 -87.64 -70.38 0.63 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.216 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.944 179.942 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.681 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 28.4 ttp . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.85 0.357 . . . . 0.0 111.541 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.461 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 87.7 m-85 -79.19 153.35 30.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.156 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.647 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -131.59 121.44 24.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.888 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.635 HG22 HG22 ' A' ' 68' ' ' VAL . 7.0 t -104.22 124.32 58.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.147 0.498 . . . . 0.0 111.374 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.687 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.3 m-30 -100.09 99.15 9.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.324 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.34 -137.2 2.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.837 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.913 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 6.7 m-85 -123.63 146.39 48.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.372 0.13 . . . . 0.0 110.949 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.81 17.79 7.31 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 0.9 OUTLIER 71.72 2.16 4.17 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.589 0.233 . . . . 0.0 111.617 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -85.19 -53.41 5.27 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.967 0.413 . . . . 0.0 110.654 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.478 HD12 ' O ' ' A' ' 37' ' ' MET . 1.3 mt -111.33 9.5 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.385 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.574 ' CB ' ' CD2' ' A' ' 7' ' ' TYR . 3.7 t60 -169.82 138.19 1.77 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.139 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.34 22.79 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.011 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 p -175.61 123.78 0.21 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.041 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.4 m -91.1 -37.35 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.58 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -75.52 -18.64 59.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.552 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.4 p -70.45 -36.36 73.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.813 0.34 . . . . 0.0 111.004 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.2 -27.11 62.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.335 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -76.86 -49.49 15.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.062 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.02 -46.55 71.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.267 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -60.31 -52.75 63.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.955 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.777 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -60.37 -38.9 85.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.63 ' C ' HD23 ' A' ' 23' ' ' LEU . 4.5 tt -58.37 -54.02 51.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.636 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.54 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.9 mt -56.15 -46.83 79.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.889 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.7 m -56.58 -36.78 69.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.12 0.486 . . . . 0.0 110.152 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 22' ' ' ARG . 54.3 t -78.15 -27.68 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.727 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -11.37 58.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.245 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.08 61.14 0.5 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.106 0.479 . . . . 0.0 110.716 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -136.69 140.76 32.98 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.183 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.94 131.94 11.41 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.553 2.169 . . . . 0.0 111.592 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.681 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 11.8 p90 -156.31 169.45 24.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.999 0.428 . . . . 0.0 111.957 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -147.12 148.04 31.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.804 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.481 ' HE1' HG11 ' A' ' 4' ' ' VAL . 7.5 t80 -89.42 161.15 16.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.393 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.687 HD12 ' CE1' ' A' ' 5' ' ' TYR . 21.9 mt -145.58 119.55 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.308 0.575 . . . . 0.0 110.511 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -81.21 125.34 30.18 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.025 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.913 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 2.7 pt -99.48 -11.97 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.297 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.613 ' HE3' ' HE2' ' A' ' 7' ' ' TYR . 14.5 ttm -117.57 92.2 40.22 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.742 0.306 . . . . 0.0 111.146 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 44' ' ' ASP . 54.5 Cg_endo -69.37 -28.43 27.13 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.562 2.175 . . . . 0.0 111.671 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -139.85 147.42 40.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.032 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -8.54 6.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.213 0.53 . . . . 0.0 111.783 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.16 -56.62 2.99 Favored Glycine 0 C--N 1.313 -0.72 0 CA-C-N 115.278 -0.873 . . . . 0.0 112.704 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.7 t -148.14 146.42 17.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.924 0.392 . . . . 0.0 111.967 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -61.07 166.51 3.53 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.505 179.47 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.455 ' O ' HD12 ' A' ' 48' ' ' ILE . 10.1 p30 -78.41 99.48 6.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.948 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -55.26 -22.75 19.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.554 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -60.28 -53.7 54.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.886 0.374 . . . . 0.0 110.755 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -69.45 -47.26 64.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.667 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.455 HD12 ' O ' ' A' ' 44' ' ' ASP . 1.7 mp -50.11 -37.45 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.716 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.99 -59.74 4.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.06 0.457 . . . . 0.0 110.506 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.69 -34.45 72.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.229 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.469 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -59.64 -52.63 64.7 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.505 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 52' ' ' LEU . 69.5 mt -48.28 -45.07 34.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.264 0.554 . . . . 0.0 110.734 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.7 m -67.15 -35.84 80.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.002 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -64.62 -33.91 77.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.493 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.1 mt -70.53 -50.12 40.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.605 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.08 -163.39 35.4 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.945 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 mtt180 -93.9 31.35 1.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.946 0.403 . . . . 0.0 110.921 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -121.15 -153.46 0.55 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.275 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -120.97 170.38 9.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.734 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.757 ' HB2' HD12 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -78.46 98.48 6.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.357 0.599 . . . . 0.0 110.028 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.1 mm -73.08 82.28 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.514 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 50.16 25.95 8.53 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.867 ' O ' HD13 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -55.39 156.96 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 111.157 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.713 ' N ' HD22 ' A' ' 63' ' ' LEU . 37.2 p -139.58 163.59 32.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -98.93 158.62 32.02 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.862 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.1 Cg_exo -83.88 140.79 36.82 Favored 'Cis proline' 0 C--N 1.345 0.348 0 C-N-CA 124.151 -1.187 . . . . 0.0 112.759 0.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . 15.0 mm-40 -105.39 114.05 28.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.046 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.7 t -86.93 163.64 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.264 0.554 . . . . 0.0 112.087 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.452 ' N ' HG12 ' A' ' 68' ' ' VAL . 20.3 m-85 -142.96 132.66 23.87 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.278 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -71.38 146.34 91.73 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.262 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.589 ' HB3' ' N ' ' A' ' 1' ' ' MET . 54.7 Cg_exo -42.15 -52.36 4.2 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.372 2.715 . . . . 0.0 113.008 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.42 -27.84 66.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.203 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.46 73.26 0.64 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.363 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.14 143.2 18.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 111.044 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -70.22 110.82 5.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.764 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 70' ' ' ALA . 19.9 mt -83.4 -49.21 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.144 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.18 -153.47 20.77 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.268 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.83 -143.35 8.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.33 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -73.07 -67.17 0.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 0.0 110.755 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -53.08 -38.74 62.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.874 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -60.37 -39.41 87.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.49 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.612 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -69.65 -45.02 69.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.35 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -51.32 -31.43 21.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.48 -35.78 65.72 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.164 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.51 ' CD2' HG23 ' A' ' 76' ' ' ILE . 12.3 t80 -63.85 -33.66 76.19 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.275 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.612 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.2 m-85 -87.97 -70.34 0.64 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.132 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.931 -179.938 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.633 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 64.3 ttp . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 120.878 0.37 . . . . 0.0 111.672 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.505 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 80.2 m-85 -60.37 153.43 22.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.646 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -129.66 122.68 29.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.458 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.695 HG22 HG22 ' A' ' 68' ' ' VAL . 10.0 t -105.37 136.79 37.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.09 0.471 . . . . 0.0 111.614 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.771 ' CE1' HD12 ' A' ' 34' ' ' ILE . 5.2 m-85 -115.42 99.62 7.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.189 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.48 -135.51 1.93 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.554 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.533 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 75.5 m-85 -120.16 146.66 45.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.948 0.404 . . . . 0.0 111.665 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -94.58 139.7 30.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.465 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.5 p -51.79 -24.71 6.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.563 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -73.16 -43.32 61.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.547 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.553 HG21 ' HG2' ' A' ' 37' ' ' MET . 9.3 mm -89.8 -43.95 14.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.785 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 78.8 t60 -144.68 158.32 43.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.744 0.307 . . . . 0.0 111.131 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.2 mmmt -80.0 161.38 25.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.174 0.512 . . . . 0.0 111.614 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.2 p -167.92 113.7 0.69 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.358 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 m -90.46 -28.75 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.422 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -85.57 -17.27 36.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.129 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.5 p -67.25 -39.84 86.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.038 0.447 . . . . 0.0 110.153 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.4 -26.68 68.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.049 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -69.47 -55.58 9.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.123 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.8 -44.16 66.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.977 0.417 . . . . 0.0 111.133 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -60.32 -52.57 64.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.879 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.8 ttt85 -56.64 -37.99 71.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.762 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -58.55 -52.58 65.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.548 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.762 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.8 mt -57.51 -47.19 82.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.875 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 m -56.13 -33.39 65.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.029 0.442 . . . . 0.0 110.375 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 22' ' ' ARG . 45.3 t -78.36 -30.42 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.794 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm -82.13 -10.85 59.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.226 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? 68.39 60.99 0.38 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.914 0.388 . . . . 0.0 110.739 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.406 ' OE1' ' HD2' ' A' ' 30' ' ' PRO . 8.1 mm100 -141.42 139.63 19.2 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.07 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.45 ' O ' ' HA ' ' A' ' 1' ' ' MET . 77.9 Cg_endo -80.28 139.89 13.45 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.52 2.146 . . . . 0.0 111.231 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.633 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 51.3 p90 -153.22 170.56 20.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -141.81 142.12 33.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.956 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.596 ' CE1' HG11 ' A' ' 4' ' ' VAL . 38.2 t80 -89.83 158.58 17.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.236 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.771 HD12 ' CE1' ' A' ' 5' ' ' TYR . 7.8 mt -147.18 120.29 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.128 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -99.63 127.31 45.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.671 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.9 pt -80.97 -8.61 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.238 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.588 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 8.2 ttp -125.98 95.3 39.83 Favored Pre-proline 0 N--CA 1.456 -0.133 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.146 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.38 1.33 9.35 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.746 2.297 . . . . 0.0 112.568 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -139.71 135.62 33.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.604 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -62.79 -9.24 8.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.175 0.512 . . . . 0.0 112.183 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.99 -63.74 1.65 Allowed Glycine 0 C--N 1.311 -0.841 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.917 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.1 t -146.83 151.89 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.692 0.282 . . . . 0.0 110.993 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.588 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -68.0 167.03 14.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 111.109 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.4 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -100.26 114.87 28.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.018 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -58.11 -18.2 23.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.471 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -57.82 -54.94 41.22 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.857 0.361 . . . . 0.0 110.696 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -70.59 -37.41 73.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.208 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 44' ' ' ASP . 36.6 mm -55.31 -46.79 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.895 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.7 -53.37 58.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.693 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -57.4 -40.68 78.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.338 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.75 HD13 ' CD2' ' A' ' 5' ' ' TYR . 9.3 tp -55.37 -48.67 73.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.653 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.1 mt -54.18 -49.42 69.38 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.06 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.3 m -61.94 -33.92 75.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.215 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' HG3' ' CE1' ' A' ' 69' ' ' PHE . 27.6 tptt -67.44 -29.65 69.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.631 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.707 HD11 HD12 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -71.93 -26.49 62.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.109 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.49 32.57 15.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.396 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.5 mtt-85 -150.06 -168.86 3.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 0.0 110.827 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.78 -50.11 2.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.032 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -102.95 165.44 11.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -95.38 98.74 10.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.122 0.487 . . . . 0.0 110.503 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.8 mt -80.33 85.53 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.275 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.48 27.05 73.53 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.455 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.707 HD12 HD11 ' A' ' 55' ' ' LEU . 7.5 tt -55.42 150.57 11.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.895 0.379 . . . . 0.0 111.191 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.0 p -148.5 164.81 33.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.405 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -119.19 146.37 40.48 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.573 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -84.63 150.71 57.05 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.993 -1.253 . . . . 0.0 112.828 0.368 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' TYR . 1.3 tp60 -109.44 117.9 35.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.221 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -92.83 166.73 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.829 0.347 . . . . 0.0 111.59 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.51 ' H ' HG12 ' A' ' 68' ' ' VAL . 73.5 m-85 -142.49 140.17 31.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.028 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.445 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -52.82 150.07 10.46 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.278 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.494 ' HB3' ' N ' ' A' ' 1' ' ' MET . 42.8 Cg_exo -58.96 -30.71 93.99 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.097 2.531 . . . . 0.0 112.026 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -91.48 -23.72 19.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.245 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.62 90.27 0.8 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.653 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 15.9 t -171.63 158.98 5.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.761 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.426 ' NE2' ' CG ' ' A' ' 67' ' ' GLN . 17.7 t-160 -88.64 110.07 20.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.985 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.445 HD11 ' HA ' ' A' ' 70' ' ' ALA . 10.8 mt -85.05 -50.84 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.093 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.85 -154.77 19.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.563 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.01 -145.75 7.74 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.669 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -71.28 -70.03 0.34 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.742 0.306 . . . . 0.0 110.892 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.99 -46.1 71.61 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.969 0.414 . . . . 0.0 110.562 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -34.43 63.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.114 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 85' ' ' TYR . 2.7 tt -74.79 -39.63 61.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.012 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 87' ' ' LYS . 24.2 ttp180 -51.77 -29.08 17.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -71.63 -33.42 68.93 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.392 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.453 ' N ' ' O ' ' A' ' 82' ' ' LEU . 9.0 t80 -66.62 -31.64 72.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.588 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.486 ' CD2' HD21 ' A' ' 23' ' ' LEU . 25.1 m-85 -95.62 -70.37 0.72 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.498 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 83' ' ' ARG . 15.2 mtmt . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.954 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.616 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 4.6 ttm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -80.4 149.15 30.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.187 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -109.87 117.14 33.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.413 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.472 HG11 ' HE1' ' A' ' 33' ' ' PHE . 8.1 t -102.16 125.21 56.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.242 0.544 . . . . 0.0 111.347 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.688 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.3 m-30 -101.95 99.09 9.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.402 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.94 -137.12 2.12 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.287 -0.959 . . . . 0.0 112.647 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.454 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 87.5 m-85 -126.02 147.25 49.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.736 0.303 . . . . 0.0 110.932 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -101.92 21.39 14.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.415 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.2 t 66.83 9.14 6.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.567 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -85.55 -46.43 10.83 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.868 0.366 . . . . 0.0 110.667 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.794 HG21 ' O ' ' A' ' 39' ' ' GLU . 1.3 mp -109.33 -33.36 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.974 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.454 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 20.4 t60 -139.35 152.4 47.13 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.653 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.36 173.16 12.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.481 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.5 p -175.04 119.0 0.19 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.774 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 m -90.34 -26.33 5.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.307 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -86.72 -16.47 36.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.413 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.3 p -72.54 -41.66 65.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.934 0.397 . . . . 0.0 110.644 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -66.75 -33.23 75.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 86.5 m-20 -73.54 -52.78 12.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.506 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.76 -42.42 68.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.382 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -60.61 -52.36 65.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.766 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.809 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.8 ttt180 -58.44 -34.54 70.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.747 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.734 ' CD2' HD23 ' A' ' 24' ' ' LEU . 1.6 tt -59.46 -56.63 19.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.327 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.734 HD23 ' CD2' ' A' ' 23' ' ' LEU . 46.5 mt -61.47 -40.25 93.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.711 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.2 m -60.71 -35.5 76.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.155 0.503 . . . . 0.0 109.7 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 22' ' ' ARG . 91.9 t -80.09 -33.11 14.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.467 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 9.3 mmtt -72.23 -10.19 59.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.211 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER 68.99 40.87 1.54 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.881 0.372 . . . . 0.0 111.125 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.93 136.64 29.31 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.432 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.585 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.1 Cg_endo -78.84 155.77 26.94 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.543 2.162 . . . . 0.0 111.867 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.4 ' HA ' ' HG2' ' A' ' 1' ' ' MET . 11.7 p90 -161.35 170.84 19.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.802 0.334 . . . . 0.0 111.338 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -132.51 137.36 47.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.625 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.472 ' HE1' HG11 ' A' ' 4' ' ' VAL . 6.1 t80 -89.22 158.35 17.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.296 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.688 HD12 ' CE1' ' A' ' 5' ' ' TYR . 20.4 mt -147.27 122.56 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.468 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -92.4 126.02 37.3 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.985 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.518 ' HB ' HD11 ' A' ' 48' ' ' ILE . 41.5 pt -92.11 -6.31 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.448 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.3 tpp -127.63 82.59 68.02 Favored Pre-proline 0 N--CA 1.454 -0.271 0 CA-C-O 120.76 0.314 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 97.2 Cg_endo -89.86 27.34 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.047 2.498 . . . . 0.0 112.648 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.794 ' O ' HG21 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -139.32 165.25 27.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.382 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -58.79 -8.0 1.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 169.77 47.59 0.03 OUTLIER Glycine 0 C--N 1.312 -0.791 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.848 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.9 t -150.59 127.2 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.959 0.409 . . . . 0.0 111.397 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -63.22 168.74 4.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.645 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.433 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 7.5 t70 -98.93 106.69 18.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.914 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -60.99 -23.95 65.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.542 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.6 -59.22 3.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.684 0.278 . . . . 0.0 111.287 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -67.3 -45.14 77.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 110.885 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.518 HD11 ' HB ' ' A' ' 36' ' ' ILE . 1.5 mp -57.06 -29.42 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.814 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.65 -61.78 1.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.956 0.408 . . . . 0.0 110.887 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -59.61 -32.42 70.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.31 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -59.72 -53.03 62.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.341 179.49 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 52' ' ' LEU . 69.2 mt -47.72 -44.99 28.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.356 0.598 . . . . 0.0 110.628 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.8 m -70.15 -35.67 74.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.83 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' HG2' ' CE1' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -62.65 -29.34 70.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.61 179.401 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -74.33 -65.82 0.8 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.009 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.89 -29.18 0.26 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.511 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.25 -167.6 1.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.883 0.373 . . . . 0.0 110.806 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.428 ' O ' HD22 ' A' ' 52' ' ' LEU . 1.5 p30 -98.35 -29.88 12.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.944 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -94.5 162.69 13.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.968 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -102.37 99.25 9.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.0 110.611 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pt -79.16 84.3 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.342 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.77 23.3 76.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.621 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.695 HD13 ' N ' ' A' ' 64' ' ' THR . 2.6 tm? -61.29 131.11 49.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.309 . . . . 0.0 110.682 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.695 ' N ' HD13 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -130.89 170.01 15.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.079 0.466 . . . . 0.0 111.348 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -118.87 150.21 48.1 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.649 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.3 Cg_endo -83.29 139.04 34.89 Favored 'Cis proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.923 -1.282 . . . . 0.0 112.559 0.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -101.7 118.69 37.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.875 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.6 t -90.75 159.76 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.417 0.627 . . . . 0.0 112.499 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.504 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 30.7 m-85 -143.36 145.98 33.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.255 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.738 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -61.17 156.68 48.19 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.25 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.616 ' HB3' ' N ' ' A' ' 1' ' ' MET . 3.0 Cg_exo -73.87 -5.37 16.92 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.97 2.447 . . . . 0.0 112.425 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.19 -8.15 11.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.208 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.2 89.6 1.86 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.55 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.2 m -179.23 156.53 0.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.83 0.348 . . . . 0.0 110.925 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -90.2 120.81 31.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.738 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.2 mp -102.11 -36.04 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.625 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 122.5 -161.78 16.55 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.714 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.9 -134.75 6.97 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.619 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 10.9 t80 -74.36 -70.2 0.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 111.017 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -55.95 -48.63 75.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.936 0.398 . . . . 0.0 110.557 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.25 -38.98 66.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.601 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.511 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.8 tt -74.8 -38.3 62.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.077 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 87' ' ' LYS . 8.0 ttt85 -51.34 -29.27 14.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -71.91 -34.3 68.99 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.409 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.444 ' N ' ' O ' ' A' ' 82' ' ' LEU . 18.8 t80 -67.01 -30.68 70.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.483 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.511 ' CE2' HD21 ' A' ' 82' ' ' LEU . 30.3 m-85 -96.33 -16.6 21.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.563 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 83' ' ' ARG . 11.8 mtmm . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.98 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.64 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 40.0 ttp . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -76.14 147.35 38.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.319 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 3.7 mptt -107.85 119.35 39.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.405 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.664 HG11 ' CE2' ' A' ' 33' ' ' PHE . 38.4 t -109.26 133.58 53.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.403 0.621 . . . . 0.0 112.104 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.588 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 19.7 m-85 -113.73 99.16 7.5 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.592 177.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.63 -127.18 1.16 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.149 -1.024 . . . . 0.0 112.946 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -137.15 108.31 6.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 120.901 0.382 . . . . 0.0 111.926 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.454 ' HB2' ' CE1' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -105.08 -27.25 11.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.257 179.146 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.636 ' HB3' HG23 ' A' ' 11' ' ' ILE . 21.1 m -60.49 163.7 5.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.54 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.02 3.86 44.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.64 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.912 HD11 ' HG3' ' A' ' 37' ' ' MET . 0.1 OUTLIER -88.55 -17.49 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -140.96 141.13 34.49 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.503 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.29 177.27 9.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.839 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 p -175.95 111.65 0.11 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.035 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 m -90.64 -34.23 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.576 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-30 -82.71 -16.45 48.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.381 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.9 p -63.04 -37.36 86.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.07 0.462 . . . . 0.0 110.262 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.87 -27.01 63.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.316 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -74.1 -54.68 7.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.375 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.24 -45.28 72.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.304 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.65 -52.81 63.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.761 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.825 ' O ' HG23 ' A' ' 26' ' ' VAL . 37.7 ttp180 -58.67 -42.64 88.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.461 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.688 HD23 ' N ' ' A' ' 24' ' ' LEU . 2.2 tt -58.89 -54.73 43.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.179 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.688 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.9 mt -56.7 -48.16 78.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.72 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.4 m -55.91 -39.87 72.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.146 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 22' ' ' ARG . 59.9 t -75.97 -32.47 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.593 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -73.76 -9.36 58.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.073 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 68.69 42.57 1.43 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.051 0.453 . . . . 0.0 110.63 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -127.97 132.5 24.38 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.902 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.633 ' O ' ' HA ' ' A' ' 1' ' ' MET . 64.2 Cg_endo -79.92 154.17 22.76 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.479 2.119 . . . . 0.0 111.217 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 5.5 p90 -161.51 171.26 18.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.717 0.294 . . . . 0.0 111.446 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -137.35 121.7 18.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.899 0.38 . . . . 0.0 110.759 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.664 ' CE2' HG11 ' A' ' 4' ' ' VAL . 35.1 t80 -89.32 157.9 18.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.44 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.636 HG21 ' HG2' ' A' ' 47' ' ' LYS . 21.8 mt -143.95 120.38 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.27 0.557 . . . . 0.0 111.038 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -83.99 109.27 17.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.08 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.612 HG22 ' HB2' ' A' ' 47' ' ' LYS . 11.6 pt -97.72 66.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.05 0.453 . . . . 0.0 111.605 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.912 ' HG3' HD11 ' A' ' 11' ' ' ILE . 22.0 tpp -160.73 73.4 2.79 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.413 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.97 -22.61 69.74 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.128 1.885 . . . . 0.0 110.859 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -151.2 152.77 33.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.052 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.617 ' HG3' HD12 ' A' ' 11' ' ' ILE . 14.3 mttt -64.1 -7.54 9.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.344 0.592 . . . . 0.0 111.622 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.79 -55.42 3.36 Favored Glycine 0 C--N 1.311 -0.827 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.953 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -149.19 147.13 16.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 12.3 m-85 -59.74 170.45 1.11 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.088 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -77.89 108.4 11.12 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.687 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.03 -24.25 23.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.723 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.65 -56.36 14.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.817 0.341 . . . . 0.0 111.323 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.636 ' HG2' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -66.58 -34.37 77.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.157 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.85 -31.38 30.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.552 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.64 -55.01 39.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.962 0.41 . . . . 0.0 110.287 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.14 -33.31 75.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.045 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.588 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.1 tt -59.11 -51.69 68.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.284 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.411 HD21 ' CG ' ' A' ' 60' ' ' GLN . 84.1 mt -52.68 -44.51 66.27 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.999 0.428 . . . . 0.0 111.381 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.6 m -57.9 -48.79 78.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.576 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -58.78 -38.77 79.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.618 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.9 -56.04 26.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.722 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.93 -115.6 0.58 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.097 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.6 ttp-105 -150.33 31.03 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 110.662 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -121.07 -143.72 0.35 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.321 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 t -120.02 170.29 9.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.692 0.282 . . . . 0.0 110.671 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.411 ' CG ' HD21 ' A' ' 52' ' ' LEU . 3.4 mm100 -77.83 98.34 5.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.271 0.558 . . . . 0.0 110.649 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -80.13 84.32 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.115 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.1 25.45 66.3 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.449 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.694 HD11 ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -52.81 134.63 36.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.9 0.381 . . . . 0.0 110.893 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.516 ' H ' HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -117.54 164.1 15.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.101 0.477 . . . . 0.0 111.419 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.07 154.74 47.18 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.66 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.506 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.3 Cg_endo -87.54 136.82 16.61 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.116 -1.202 . . . . 0.0 112.679 0.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.694 ' NE2' HD11 ' A' ' 63' ' ' LEU . 4.0 tp60 -90.01 142.79 27.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.927 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -115.97 158.06 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.077 0.465 . . . . 0.0 111.56 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.456 ' CE2' ' HB2' ' A' ' 75' ' ' HIS . 46.6 m-85 -142.83 138.66 30.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.146 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.659 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -50.92 133.36 29.21 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.409 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.64 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 33.4 Cg_exo -52.92 -21.96 16.97 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.555 2.17 . . . . 0.0 111.948 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.23 39.79 0.1 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.19 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.4 -110.16 0.8 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.957 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.461 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -137.07 -172.4 3.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.168 0.509 . . . . 0.0 111.321 -179.536 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.456 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 24.4 t-80 -65.18 126.1 27.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.068 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.659 HD11 ' HA ' ' A' ' 70' ' ' ALA . 14.6 mt -95.91 -45.26 13.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.784 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.569 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 134.02 -155.32 21.77 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.521 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.77 -142.07 9.1 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.572 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -70.56 -68.76 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.778 0.323 . . . . 0.0 110.943 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -54.74 -46.46 74.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.838 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -54.41 -36.26 63.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.627 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.723 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.9 OUTLIER -75.27 -38.93 60.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.28 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -51.93 -29.63 21.05 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -71.25 -35.47 71.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.154 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 82' ' ' LEU . 20.7 t80 -63.46 -33.63 75.98 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.275 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.723 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.5 m-85 -87.15 -69.53 0.68 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.122 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.684 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 16.1 ttm . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.782 0.325 . . . . 0.0 111.682 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.477 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 91.8 m-85 -85.62 142.38 29.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.991 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.644 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -117.04 127.69 54.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.909 -179.424 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.722 HG11 ' CE1' ' A' ' 33' ' ' PHE . 15.7 t -110.76 133.81 55.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.391 0.615 . . . . 0.0 111.559 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.537 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 21.6 m-30 -116.39 99.86 7.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.368 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.544 ' N ' HG23 ' A' ' 36' ' ' ILE . . . -161.8 -139.13 2.57 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.771 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.727 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 45.4 m-85 -123.71 156.22 36.37 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 120.889 0.376 . . . . 0.0 111.364 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -74.38 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 t 173.62 -36.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.734 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -85.11 -20.7 29.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.533 HD12 ' N ' ' A' ' 11' ' ' ILE . 4.2 mp -89.28 -38.22 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.004 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -150.29 151.6 33.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.464 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 14' ' ' CYS . 13.7 tptt -75.74 157.33 33.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.18 0.514 . . . . 0.0 112.177 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 28.3 p 177.43 113.15 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.545 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.447 ' CG2' ' N ' ' A' ' 16' ' ' TYR . 1.3 m -90.88 -39.11 11.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.899 0.857 . . . . 0.0 110.026 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.569 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -77.97 -10.74 59.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.698 -179.212 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 14' ' ' CYS . 20.5 p -73.76 -41.72 62.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.047 0.451 . . . . 0.0 110.045 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.53 -34.09 71.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.747 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -65.06 -46.74 79.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.97 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.79 -50.39 72.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.962 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.0 ttpt -53.16 -44.09 67.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.841 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.768 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -60.47 -40.89 92.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.801 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -57.78 -53.1 61.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.564 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.801 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.0 mt -56.52 -47.5 79.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.85 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.2 m -55.18 -36.51 65.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.136 0.493 . . . . 0.0 110.091 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.4 t -78.14 -28.14 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.675 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.7 -21.25 44.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.927 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt 71.65 63.52 0.15 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.962 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -132.02 142.31 44.65 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.053 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.65 124.49 8.24 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.477 2.118 . . . . 0.0 111.266 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.684 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 6.3 p90 -157.17 164.56 37.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.046 0.451 . . . . 0.0 112.168 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.66 144.03 31.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.993 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.722 ' CE1' HG11 ' A' ' 4' ' ' VAL . 17.9 t80 -89.2 152.76 21.41 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.004 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 mt -143.92 119.62 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.358 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -72.94 109.93 6.86 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.776 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.727 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 1.2 pp -69.79 -24.8 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.618 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 5.8 ttp -126.69 91.44 47.3 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.111 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.71 0.61 9.9 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.57 2.18 . . . . 0.0 112.231 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -139.65 138.45 36.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.652 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -66.28 -8.71 26.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.246 0.546 . . . . 0.0 111.852 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.13 -63.75 1.64 Allowed Glycine 0 C--N 1.311 -0.815 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.098 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -150.28 139.42 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.617 0.246 . . . . 0.0 111.118 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.6 OUTLIER -58.79 169.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.932 0.396 . . . . 0.0 111.353 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.406 ' O ' ' CD1' ' A' ' 48' ' ' ILE . 1.2 t0 -80.07 105.86 11.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.302 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 6.1 t70 -59.88 -17.63 38.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.815 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.33 -61.22 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 111.212 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.55 -36.21 83.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.054 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.406 ' CD1' ' O ' ' A' ' 44' ' ' ASP . 1.9 mp -70.48 -29.85 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.409 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -61.7 -54.69 39.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.435 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.54 -34.51 74.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.134 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.537 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 2.9 tt -55.84 -51.13 68.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.264 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.6 mt -54.03 -47.24 71.75 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.331 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.1 m -62.54 -45.16 94.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.612 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -56.56 -40.73 75.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.587 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 mt -59.96 -47.88 83.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.572 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.49 -112.48 0.49 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.196 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.34 33.64 0.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.055 0.455 . . . . 0.0 110.433 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -120.92 -146.88 0.38 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.9 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.3 t -120.26 172.99 7.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.741 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.28 98.61 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.494 0.664 . . . . 0.0 109.755 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.5 mt -75.08 78.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.875 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.59 26.88 0.45 Allowed Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.007 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.2 139.88 46.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.873 0.368 . . . . 0.0 111.022 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.5 p -106.42 170.7 7.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.398 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.663 ' CE ' HD13 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -108.15 156.29 38.64 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.896 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.8 Cg_exo -84.08 143.2 42.08 Favored 'Cis proline' 0 C--N 1.346 0.4 0 C-N-CA 124.258 -1.142 . . . . 0.0 113.064 0.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -96.33 132.29 41.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.565 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -102.5 162.51 3.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.441 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.43 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 19.5 m-85 -142.25 130.88 22.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.7 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.552 ' N ' HD11 ' A' ' 76' ' ' ILE . . . -65.76 147.46 98.72 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.385 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.562 ' HB3' ' N ' ' A' ' 1' ' ' MET . 74.6 Cg_exo -45.44 -38.72 16.13 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.292 2.662 . . . . 0.0 112.615 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.66 -38.84 70.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.158 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.83 78.53 0.31 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.505 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.3 m -164.05 148.3 10.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.73 0.3 . . . . 0.0 110.878 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -75.94 106.97 7.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.552 HD11 ' N ' ' A' ' 70' ' ' ALA . 4.7 mt -74.8 -50.46 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.191 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 131.59 -153.06 20.27 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.799 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.06 -136.34 8.75 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.772 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.484 ' HB2' ' CE1' ' A' ' 16' ' ' TYR . 46.3 t80 -72.05 -70.76 0.31 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.755 0.312 . . . . 0.0 111.13 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -57.43 -40.97 79.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.979 0.418 . . . . 0.0 110.722 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -58.58 -38.46 77.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.831 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.716 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -75.37 -41.63 55.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.368 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.23 -30.34 17.17 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -70.9 -36.22 72.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.253 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.503 ' CD2' HG23 ' A' ' 76' ' ' ILE . 11.4 t80 -63.99 -33.29 75.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.216 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.716 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.6 m-85 -89.58 -13.21 37.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.257 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 68.0 mttt . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.796 179.918 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.646 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 22.9 ttm . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.816 0.341 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.496 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 77.0 m-85 -76.66 158.73 30.82 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.635 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -138.86 120.6 15.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.786 -179.408 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.8 HG22 HG22 ' A' ' 68' ' ' VAL . 7.8 t -104.79 133.02 50.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.294 0.569 . . . . 0.0 111.681 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.679 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.3 m-85 -109.33 99.21 8.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.139 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.53 -137.34 2.19 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.878 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.624 ' HE1' ' HE3' ' A' ' 37' ' ' MET . 88.6 m-85 -115.8 160.13 20.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 111.888 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -83.47 -73.0 0.43 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.606 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 p 171.79 -38.75 0.0 OUTLIER 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.963 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -85.82 -19.66 30.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.726 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 mt -95.19 -38.79 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.664 ' HD2' ' H ' ' A' ' 13' ' ' LYS . 1.7 t-160 -150.9 174.08 13.52 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.664 ' H ' ' HD2' ' A' ' 12' ' ' HIS . 11.1 ptmt -79.65 157.68 27.2 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.949 -0.469 . . . . 0.0 111.75 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -165.97 87.35 0.37 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.3 m -90.5 -41.93 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.757 0.313 . . . . 0.0 111.165 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -77.64 -15.67 59.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.638 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.7 m -70.56 -50.63 35.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.106 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -55.99 -30.66 62.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 111.07 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -70.71 -50.67 33.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.026 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.6 -46.88 80.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.107 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.8 tttt -59.9 -53.42 58.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.74 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.798 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -59.32 -35.45 73.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.567 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.717 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.3 tt -58.3 -53.31 59.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.41 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.717 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.7 mt -55.77 -45.71 78.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.69 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.38 -35.26 67.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.17 0.509 . . . . 0.0 110.094 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 22' ' ' ARG . 42.1 t -78.05 -30.59 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.558 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -19.35 50.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.948 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 73.81 63.75 0.09 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.932 0.396 . . . . 0.0 110.904 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -142.27 139.27 17.53 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.11 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 1' ' ' MET . 80.9 Cg_endo -74.6 136.11 20.83 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.423 2.082 . . . . 0.0 111.616 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.646 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 21.3 p90 -158.3 170.66 21.75 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -146.05 147.09 31.25 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.968 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.464 ' HE1' HG11 ' A' ' 4' ' ' VAL . 13.6 t80 -89.53 158.56 17.61 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.166 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.679 HD12 ' CE1' ' A' ' 5' ' ' TYR . 19.8 mt -147.25 121.65 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.456 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -91.79 122.81 34.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.069 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 pp -89.0 -23.24 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.642 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 2.5 ttp -119.25 92.99 46.51 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.306 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.4 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 72.6 Cg_endo -76.12 0.52 9.27 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.745 2.297 . . . . 0.0 113.295 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -139.11 140.85 38.08 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -9.2 12.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.232 0.539 . . . . 0.0 111.645 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.95 -67.0 0.9 Allowed Glycine 0 C--N 1.315 -0.625 0 CA-C-N 115.272 -0.876 . . . . 0.0 113.147 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.1 t -128.73 138.47 54.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -72.57 170.51 14.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.501 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.4 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 2.5 t70 -87.86 115.32 25.23 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.147 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.78 ' HA ' HD12 ' A' ' 48' ' ' ILE . 16.3 p30 -66.92 -18.89 65.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.605 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -58.58 -55.08 39.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.923 0.392 . . . . 0.0 110.702 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 mmtm -69.35 -39.06 78.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.144 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.78 HD12 ' HA ' ' A' ' 45' ' ' ASP . 66.7 mt -54.12 -44.88 65.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.87 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.66 -55.17 36.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.54 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.72 -38.5 81.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.218 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.479 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -59.57 -50.62 73.19 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.477 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 58' ' ' ASP . 72.7 mt -47.78 -43.11 27.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.299 0.571 . . . . 0.0 110.701 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.1 m -68.55 -35.78 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.827 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.434 ' HE3' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -65.86 -30.6 71.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.428 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.694 ' CD1' HD21 ' A' ' 63' ' ' LEU . 1.1 mt -75.98 -48.47 21.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.658 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.25 -39.95 1.59 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.111 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -97.26 169.11 10.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 110.823 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.467 ' O ' HD13 ' A' ' 52' ' ' LEU . 70.4 m-20 -94.05 -25.87 17.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.763 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -98.72 161.24 13.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.75 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -110.48 99.83 8.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.805 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.6 mt -79.62 84.61 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 64' ' ' THR . . . 60.78 25.8 64.21 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.51 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.694 HD21 ' CD1' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -54.17 126.65 23.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.866 0.365 . . . . 0.0 110.857 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 62' ' ' GLY . 59.6 p -128.67 170.38 13.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.161 0.505 . . . . 0.0 111.59 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.56 157.15 38.25 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.625 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.2 Cg_endo -86.67 149.78 40.72 Favored 'Cis proline' 0 C--N 1.346 0.395 0 C-N-CA 124.384 -1.09 . . . . 0.0 112.94 0.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.602 ' OE1' HD11 ' A' ' 63' ' ' LEU . 2.1 mm-40 -119.27 115.59 24.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.98 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.8 HG22 HG22 ' A' ' 4' ' ' VAL . 2.9 t -91.59 165.92 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.219 0.533 . . . . 0.0 112.24 -178.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.5 ' H ' HG12 ' A' ' 68' ' ' VAL . 34.5 m-85 -142.29 133.51 26.2 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.155 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.695 ' HB3' ' H ' ' A' ' 74' ' ' SER . . . -72.24 138.02 81.51 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.603 ' HB3' ' N ' ' A' ' 1' ' ' MET . 21.2 Cg_exo -34.61 -56.14 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.799 2.999 . . . . 0.0 113.195 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -140.38 29.35 1.99 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.615 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.13 -87.93 1.85 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.549 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.695 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 1.0 OUTLIER -177.45 175.47 1.43 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.893 0.378 . . . . 0.0 110.571 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.413 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 20.0 t-80 -49.95 109.18 0.26 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.687 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.559 HD11 ' HA ' ' A' ' 70' ' ' ALA . 14.3 mt -73.86 -48.77 37.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.493 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 128.7 -154.29 20.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.598 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.52 -149.66 7.17 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.604 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -72.04 -53.97 11.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.78 0.324 . . . . 0.0 110.769 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -54.78 -44.39 73.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.846 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -58.67 -45.59 89.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.67 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.639 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -61.85 -49.47 76.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.595 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -51.11 -30.71 16.98 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -75.37 -34.5 61.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.177 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.422 ' N ' ' O ' ' A' ' 82' ' ' LEU . 6.3 t80 -65.45 -32.97 74.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.278 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.639 ' HE2' HD21 ' A' ' 82' ' ' LEU . 9.4 m-85 -91.85 -24.27 19.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.348 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.9 pttt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.317 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.679 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 4.5 tpp . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -77.53 143.92 38.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.879 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -105.59 121.97 45.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 -179.159 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.814 HG22 HG22 ' A' ' 68' ' ' VAL . 53.9 t -111.66 140.94 28.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.348 0.594 . . . . 0.0 111.934 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.844 ' CE1' HD12 ' A' ' 34' ' ' ILE . 4.9 m-85 -119.88 99.62 6.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.453 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.8 -140.18 2.87 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.124 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.826 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 30.0 m-85 -126.06 159.93 31.47 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.626 -0.287 . . . . 0.0 111.228 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.406 ' O ' ' CB ' ' A' ' 9' ' ' SER . 11.3 t70 -69.87 -67.41 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.527 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.7 OUTLIER 166.36 -39.35 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.129 179.641 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -85.55 -17.93 34.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.174 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.684 HD12 ' N ' ' A' ' 11' ' ' ILE . 2.6 mp -89.11 -42.51 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.042 0.449 . . . . 0.0 109.799 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.412 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 5.3 t-160 -149.52 158.17 43.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.201 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.37 146.65 2.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.831 0.348 . . . . 0.0 111.454 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -175.15 65.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.274 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.6 m -90.57 -48.12 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -76.87 -11.35 59.81 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.465 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 27.4 p -73.95 -45.04 52.79 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -55.31 -24.86 31.0 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.477 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 10.2 m-80 -73.3 -45.79 53.43 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.989 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.42 ' HB2' ' CD1' ' A' ' 79' ' ' PHE . . . -60.91 -29.69 69.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.335 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? -70.35 -62.45 1.38 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.808 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.706 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.6 OUTLIER -54.24 -30.29 49.73 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.93 0.395 . . . . 0.0 110.379 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.743 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.4 tt -58.16 -54.26 48.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.817 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.743 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.0 mt -54.44 -45.41 73.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.455 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 m -54.79 -36.28 64.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.655 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 22' ' ' ARG . 44.3 t -79.67 -32.28 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.308 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.601 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -73.19 -11.95 60.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.834 179.516 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.37 45.52 0.1 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.948 0.404 . . . . 0.0 110.95 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -144.04 134.04 11.85 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.338 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.596 ' O ' ' HA ' ' A' ' 1' ' ' MET . 64.5 Cg_endo -81.54 166.19 17.87 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.611 2.207 . . . . 0.0 111.308 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.552 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 8.4 p90 -161.49 171.08 18.75 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.89 0.329 . . . . 0.0 111.89 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.72 136.64 39.16 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.806 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.512 ' HE1' HG11 ' A' ' 4' ' ' VAL . 6.0 t80 -89.22 160.77 16.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.502 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.844 HD12 ' CE1' ' A' ' 5' ' ' TYR . 20.3 mt -144.52 119.41 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.259 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -83.09 121.89 27.63 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.481 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.826 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 1.3 pt -98.1 -20.06 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.796 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.45 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 32.6 ttm -124.75 83.26 59.23 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.811 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.454 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 55.7 Cg_endo -70.17 -13.94 34.23 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.653 2.236 . . . . 0.0 111.981 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -139.8 145.27 37.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.747 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.84 -8.0 44.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.304 0.573 . . . . 0.0 111.498 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.26 -58.54 2.57 Favored Glycine 0 C--N 1.312 -0.799 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.4 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.1 t -149.48 140.71 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 111.374 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.4 OUTLIER -60.01 160.18 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.533 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.454 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 62.6 t0 -71.78 132.2 44.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.952 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -71.54 -28.26 63.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 0.0 110.761 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.93 -56.43 10.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.984 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -65.31 -46.18 81.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.836 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 44' ' ' ASP . 1.1 mp -58.1 -38.14 65.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.372 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.46 -56.57 5.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.152 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -60.21 -31.31 70.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.629 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.442 HD13 ' CD2' ' A' ' 5' ' ' TYR . 13.3 tp -59.71 -52.18 66.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.288 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.5 mt -51.59 -45.82 63.29 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.107 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.0 m -65.53 -31.44 72.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.331 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.424 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 19.8 tttp -66.96 -31.87 72.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.556 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.443 ' N ' HD23 ' A' ' 55' ' ' LEU . 1.3 mt -64.91 -42.7 94.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.8 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.75 -106.47 0.29 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.05 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -149.68 28.65 0.78 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.112 0.482 . . . . 0.0 110.679 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -121.3 -147.14 0.38 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.401 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.5 t -120.28 170.24 9.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.69 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.29 98.26 8.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.271 0.558 . . . . 0.0 110.355 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.3 mt -80.06 84.52 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.191 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.77 25.76 45.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.469 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.412 HD12 ' NE2' ' A' ' 67' ' ' GLN . 1.1 mm? -57.64 144.3 38.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.897 0.379 . . . . 0.0 110.85 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.9 p -123.53 168.51 12.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.229 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.593 ' CE ' HD13 ' A' ' 36' ' ' ILE . 1.2 mpt? -113.12 156.12 43.36 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.791 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -80.59 140.57 52.0 Favored 'Cis proline' 0 C--N 1.344 0.298 0 C-N-CA 123.741 -1.358 . . . . 0.0 112.978 0.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.412 ' NE2' HD12 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -96.42 123.16 39.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.055 179.051 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.814 HG22 HG22 ' A' ' 4' ' ' VAL . 10.1 t -99.39 159.42 3.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.174 0.512 . . . . 0.0 111.97 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.525 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 90.9 m-85 -143.35 148.53 36.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.54 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.609 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -60.72 146.69 85.74 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.665 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.679 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 14.6 Cg_exo -65.6 -13.4 39.61 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.534 2.156 . . . . 0.0 112.087 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.72 -25.8 14.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.765 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.98 92.72 0.7 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.783 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.9 m 176.67 155.67 0.25 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 111.005 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -90.68 113.52 25.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.609 HD11 ' HA ' ' A' ' 70' ' ' ALA . 29.2 mt -94.42 -49.37 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.981 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 135.03 -154.66 21.65 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.698 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.81 -142.66 12.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.674 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 20' ' ' ALA . 24.1 t80 -67.71 -70.87 0.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.694 0.283 . . . . 0.0 110.917 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -58.74 -45.54 89.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.998 0.428 . . . . 0.0 110.707 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -52.47 -38.98 60.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.573 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.705 HD21 ' CE2' ' A' ' 86' ' ' PHE . 4.8 tt -79.41 -33.56 42.56 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.313 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -51.21 -29.51 14.41 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -70.33 -35.39 73.58 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.454 ' N ' ' O ' ' A' ' 82' ' ' LEU . 6.6 t80 -63.19 -34.46 77.69 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.705 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.1 m-85 -87.98 -70.46 0.63 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.296 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.981 -179.972 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.746 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 7.1 tpp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -77.67 146.63 35.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.89 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.9 mptt -109.66 122.03 46.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.787 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 66' ' ' PRO . 50.7 t -110.33 129.59 65.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.277 0.56 . . . . 0.0 111.854 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.564 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 17.5 m-85 -107.68 99.32 8.82 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.833 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.6 -143.7 3.73 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.246 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.746 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 5.0 m-85 -127.9 154.98 44.9 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 120.619 0.247 . . . . 0.0 111.239 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.07 -79.56 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.008 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 m 175.42 -34.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.835 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -62.57 -50.89 69.5 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.223 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.587 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -89.92 -39.79 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.936 0.398 . . . . 0.0 111.177 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.746 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 57.0 t-80 -139.88 139.65 36.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.005 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.95 174.23 11.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.257 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.8 p 175.11 113.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.896 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.0 m -90.08 -30.14 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.839 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -83.87 -15.91 46.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 p -71.31 -43.65 66.65 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.811 0.338 . . . . 0.0 110.714 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.1 -38.3 78.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.752 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -57.65 -48.53 79.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.899 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.411 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -64.59 -40.01 94.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.81 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HD2' ' CE2' ' A' ' 31' ' ' PHE . 2.2 mmmm -49.97 -37.75 33.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.14 0.495 . . . . 0.0 110.188 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.78 ' O ' HG23 ' A' ' 26' ' ' VAL . 61.3 ttt180 -75.07 -29.24 60.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.312 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.672 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -54.56 -55.7 26.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.304 179.386 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.694 HD12 ' CG ' ' A' ' 31' ' ' PHE . 3.0 mt -62.77 -47.49 83.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.766 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.3 m -56.01 -35.26 66.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.461 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 22' ' ' ARG . 87.8 t -78.06 -27.56 14.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.965 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HD3' ' CG ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -78.81 -11.45 59.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.308 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 72.59 38.43 0.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.929 0.395 . . . . 0.0 110.812 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.01 142.43 44.41 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.567 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' O ' ' HA ' ' A' ' 1' ' ' MET . 67.5 Cg_endo -79.5 155.81 24.79 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.526 2.151 . . . . 0.0 111.616 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.694 ' CG ' HD12 ' A' ' 24' ' ' LEU . 46.1 p90 -161.46 170.83 19.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.278 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -137.11 129.48 29.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.833 0.349 . . . . 0.0 110.943 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.513 ' HE1' HG11 ' A' ' 4' ' ' VAL . 17.3 t80 -89.22 154.94 19.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.005 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.478 HG21 ' HD3' ' A' ' 47' ' ' LYS . 13.0 mt -147.11 119.69 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.261 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -86.26 109.7 19.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.786 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 43' ' ' PHE . 11.8 pt -85.69 58.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.31 0.576 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.499 ' HE3' ' CE2' ' A' ' 7' ' ' TYR . 26.6 ttm -173.21 89.49 0.38 Allowed Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.334 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 51.9 Cg_endo -69.1 -22.42 35.14 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.29 1.993 . . . . 0.0 111.408 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -145.04 143.07 30.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.381 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.4 pttt -57.08 -9.07 0.78 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.171 0.51 . . . . 0.0 112.139 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.42 -55.2 4.37 Favored Glycine 0 C--N 1.312 -0.783 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.042 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -148.94 144.23 18.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 1.0 OUTLIER -58.77 170.97 0.71 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.029 179.157 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.402 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -87.32 103.81 15.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.908 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 2.9 t70 -58.11 -25.2 61.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.361 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -64.62 -59.14 4.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.897 0.379 . . . . 0.0 110.635 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.478 ' HD3' HG21 ' A' ' 34' ' ' ILE . 11.3 mttp -65.01 -35.6 81.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.27 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.3 mm -70.27 -32.85 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.343 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -58.18 -51.93 67.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.636 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.27 -36.52 83.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.928 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 3.5 tt -59.43 -53.19 60.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.392 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.0 mt -51.42 -44.59 62.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.149 0.5 . . . . 0.0 111.517 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.0 m -64.18 -49.41 72.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.571 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -54.87 -34.95 63.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.793 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -61.8 2.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.97 -26.71 0.25 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.549 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.74 -173.75 4.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.698 0.285 . . . . 0.0 110.684 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -98.9 19.29 15.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.308 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 t -120.19 158.63 26.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.881 0.372 . . . . 0.0 110.969 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -116.7 99.84 7.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.014 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 pt -78.84 84.13 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.999 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.73 26.61 57.81 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.195 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -56.81 135.74 55.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.899 0.381 . . . . 0.0 111.077 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.7 p -124.99 167.1 15.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.172 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.4 ' HG2' HD11 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -118.3 154.24 51.91 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.799 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.536 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.6 Cg_endo -85.72 142.43 31.56 Favored 'Cis proline' 0 N--CA 1.461 -0.388 0 C-N-CA 124.098 -1.209 . . . . 0.0 112.745 0.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -99.79 139.95 34.7 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -107.88 159.47 7.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.407 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 75' ' ' HIS . 30.8 m-85 -143.06 135.83 27.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.127 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.623 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -49.73 133.32 20.39 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.286 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.746 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 29.3 Cg_exo -54.65 -21.11 23.7 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.48 2.12 . . . . 0.0 111.851 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.3 38.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.189 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.3 -109.63 0.78 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.988 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.48 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 87.4 p -142.76 -176.33 4.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.135 0.493 . . . . 0.0 111.291 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.496 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 19.5 t-80 -57.85 123.42 15.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.203 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.623 HD11 ' HA ' ' A' ' 70' ' ' ALA . 14.5 mt -91.88 -46.27 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.733 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 129.37 -156.29 21.22 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.828 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -89.27 -139.3 7.14 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.332 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.672 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -75.49 -70.11 0.44 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.769 0.285 . . . . 0.0 110.871 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -49.1 -42.9 40.57 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.239 0.542 . . . . 0.0 110.437 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -64.01 -43.84 94.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.847 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.704 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -71.79 -40.87 68.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.605 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -51.43 -34.06 33.28 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -67.72 -35.94 79.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.16 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.428 ' N ' ' O ' ' A' ' 82' ' ' LEU . 35.2 t80 -62.94 -34.02 76.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.432 178.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.704 ' CE2' HD21 ' A' ' 82' ' ' LEU . 8.8 m-85 -87.32 -70.32 0.63 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.194 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 69.6 mttt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.962 179.939 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.616 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.9 ttm . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.669 0.271 . . . . 0.0 111.662 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.508 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 83.1 m-85 -59.17 161.29 5.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.875 0.369 . . . . 0.0 110.122 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -137.78 120.67 16.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.827 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.996 HG22 HG22 ' A' ' 68' ' ' VAL . 75.3 t -110.74 150.99 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.418 0.628 . . . . 0.0 111.703 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.712 ' CE1' HD12 ' A' ' 34' ' ' ILE . 40.4 m-85 -133.72 102.5 5.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.17 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -166.47 -136.78 2.08 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.535 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.409 ' O ' ' CZ ' ' A' ' 33' ' ' PHE . 49.2 m-85 -106.91 157.96 17.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.848 0.356 . . . . 0.0 110.885 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -98.94 -71.74 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.008 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 p 169.59 -32.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.996 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -74.68 -38.3 62.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.689 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.553 HG21 ' O ' ' A' ' 37' ' ' MET . 44.7 mm -89.12 -49.48 14.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -140.01 149.9 43.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.387 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.92 157.53 26.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.12 0.486 . . . . 0.0 112.018 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -172.32 93.53 0.13 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.488 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.8 m -71.44 -39.53 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.838 0.351 . . . . 0.0 111.023 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.19 -24.02 66.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.882 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.2 m -66.39 -60.69 2.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.5 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -51.77 -39.18 58.15 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.3 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -63.88 -40.64 97.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.373 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.555 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -66.76 -50.48 62.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.059 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -49.51 -36.36 22.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.856 0.36 . . . . 0.0 110.583 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.79 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -65.42 -41.79 93.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.293 179.445 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.798 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -56.99 -53.04 62.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.251 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.798 ' N ' HD23 ' A' ' 23' ' ' LEU . 7.1 mt -57.86 -45.22 86.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.673 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 51.7 m -57.62 -34.93 69.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.046 0.451 . . . . 0.0 110.113 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.9 t -80.05 -33.96 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.603 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -11.54 60.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.053 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.62 48.56 1.07 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.061 0.457 . . . . 0.0 110.537 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -128.72 130.61 23.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.308 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.465 ' O ' ' HA ' ' A' ' 1' ' ' MET . 83.8 Cg_endo -76.81 142.93 23.06 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.444 2.096 . . . . 0.0 111.105 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.616 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 9.9 p90 -158.35 170.72 21.6 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.544 -0.462 . . . . 0.0 112.209 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -142.01 129.15 20.93 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.073 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.619 ' CE1' HG11 ' A' ' 4' ' ' VAL . 50.6 t80 -89.69 162.33 15.64 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.863 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.712 HD12 ' CE1' ' A' ' 5' ' ' TYR . 14.4 mt -146.94 122.41 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.265 0.555 . . . . 0.0 110.675 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -79.04 136.19 37.1 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.052 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.661 HD13 ' SD ' ' A' ' 65' ' ' MET . 2.6 pt -97.18 -27.15 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.172 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.553 ' O ' HG21 ' A' ' 11' ' ' ILE . 5.4 ttp -124.15 95.16 44.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' CG ' ' HB2' ' A' ' 44' ' ' ASP . 85.8 Cg_endo -80.93 4.84 6.63 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.67 2.247 . . . . 0.0 112.75 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.454 ' C ' HG23 ' A' ' 11' ' ' ILE . 1.7 mt-10 -139.44 137.79 35.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.661 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.426 ' N ' HG23 ' A' ' 11' ' ' ILE . 24.3 tttp -65.18 -9.0 19.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.206 0.527 . . . . 0.0 111.909 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.04 -65.18 1.28 Allowed Glycine 0 C--N 1.311 -0.811 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.247 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 43' ' ' PHE . 20.3 t -139.63 155.93 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.751 0.31 . . . . 0.0 111.17 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -75.18 168.1 20.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.821 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.431 ' HB2' ' CG ' ' A' ' 38' ' ' PRO . 19.0 t70 -100.42 114.51 28.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.255 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -54.83 -23.37 18.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.449 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.92 -53.41 58.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.883 0.373 . . . . 0.0 110.795 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -71.11 -28.52 64.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.385 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.7 mm -71.92 -39.65 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.659 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.42 -55.63 22.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.168 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -56.13 -33.49 65.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.57 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.427 HD13 ' CG ' ' A' ' 5' ' ' TYR . 24.1 tp -63.1 -49.47 74.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.075 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.1 mt -52.25 -44.21 64.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.207 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -64.8 -32.3 73.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.091 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.439 ' HD3' ' CD2' ' A' ' 69' ' ' PHE . 2.3 ttmm -67.15 -29.5 69.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.368 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.477 HD21 ' NE2' ' A' ' 67' ' ' GLN . 1.2 mt -68.18 -58.03 5.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.683 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.13 -108.69 0.27 Allowed Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.059 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -150.48 33.1 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.034 0.445 . . . . 0.0 110.653 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -120.85 -148.05 0.4 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.378 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 t -116.63 170.19 8.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.812 0.339 . . . . 0.0 110.641 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -86.75 98.44 11.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.298 0.57 . . . . 0.0 110.575 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 pt -80.49 83.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.173 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.9 26.66 41.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.58 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.642 HD12 ' OE1' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -53.15 150.09 6.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.752 0.311 . . . . 0.0 111.074 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 p -127.62 170.07 13.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.214 0.53 . . . . 0.0 111.742 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.661 ' SD ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -122.38 158.12 56.87 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.576 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.4 Cg_exo -79.29 143.53 70.03 Favored 'Cis proline' 0 C--N 1.344 0.32 0 C-N-CA 124.084 -1.215 . . . . 0.0 112.866 0.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.642 ' OE1' HD12 ' A' ' 63' ' ' LEU . 9.9 tt0 -104.08 123.11 46.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.466 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.996 HG22 HG22 ' A' ' 4' ' ' VAL . 16.5 t -100.31 162.22 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.934 0.397 . . . . 0.0 111.659 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.527 ' N ' HG12 ' A' ' 68' ' ' VAL . 85.9 m-85 -142.24 141.84 32.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.073 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.914 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.87 146.65 36.29 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.447 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.602 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 50.1 Cg_exo -56.44 -26.61 63.99 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.132 2.555 . . . . 0.0 112.215 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -93.48 -28.58 16.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.227 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.3 91.53 0.6 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.702 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 2.6 m -178.8 163.86 1.47 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.684 0.278 . . . . 0.0 110.596 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.422 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 14.3 t-160 -90.19 108.7 19.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.113 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.914 HD11 ' HA ' ' A' ' 70' ' ' ALA . 37.1 mt -86.3 -53.39 10.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.765 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 130.61 -153.16 20.1 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.08 -137.72 7.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.155 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.555 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -76.29 -70.19 0.46 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.702 0.251 . . . . 0.0 110.773 179.597 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -49.26 -44.03 43.46 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.256 0.55 . . . . 0.0 110.32 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -36.53 81.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.482 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.719 HD21 ' CE2' ' A' ' 86' ' ' PHE . 2.0 tt -79.47 -38.52 34.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.594 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.91 -32.75 21.61 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -67.53 -35.62 79.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.237 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 82' ' ' LEU . 8.6 t80 -63.44 -34.44 77.75 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.31 178.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.719 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.8 m-85 -89.3 -21.93 22.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.341 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.991 -179.945 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.626 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.39 0.138 . . . . 0.0 111.045 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.414 ' HB3' ' CG1' ' A' ' 68' ' ' VAL . 75.1 m-85 -39.71 120.9 1.17 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.694 0.759 . . . . 0.0 111.867 -177.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.738 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -90.8 124.1 34.87 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.147 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.629 HG22 HG22 ' A' ' 68' ' ' VAL . 7.7 t -102.15 128.31 54.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.238 0.542 . . . . 0.0 111.47 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 2.8 m-30 -104.96 98.92 8.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.969 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.54 -139.71 2.71 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.293 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.596 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 91.6 m-85 -124.36 153.75 41.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.891 0.377 . . . . 0.0 111.582 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.88 -77.24 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.915 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 170.07 -32.63 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.017 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -80.43 -30.19 37.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.983 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.592 ' H ' HD12 ' A' ' 11' ' ' ILE . 3.6 mp -90.39 -47.15 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.117 0.484 . . . . 0.0 110.59 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.414 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 6.4 t-80 -147.76 153.81 39.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.558 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.3 149.61 50.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.077 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 7' ' ' TYR . 42.6 t -164.99 87.56 0.44 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.063 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.39 -27.52 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -64.1 -32.37 73.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.331 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.1 p -77.92 -45.46 23.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.329 . . . . 0.0 110.543 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.08 -37.98 36.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.627 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -69.12 -55.05 11.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.724 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.413 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . . . -52.08 -38.32 56.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.19 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 15.3 ttmt -58.32 -52.36 65.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.342 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.845 ' O ' HG23 ' A' ' 26' ' ' VAL . 30.3 mmt180 -61.14 -37.26 82.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.155 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.797 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -59.82 -53.85 53.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.103 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.797 ' N ' HD23 ' A' ' 23' ' ' LEU . 7.1 mt -56.22 -44.12 79.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.665 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 m -60.09 -41.55 92.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.109 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 22' ' ' ARG . 44.8 t -72.93 -35.82 49.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.595 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 2.6 tmtm? -75.23 -13.0 60.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.31 52.65 0.18 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.888 0.375 . . . . 0.0 110.736 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -145.2 111.52 4.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.239 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.626 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 82.2 Cg_exo -49.53 178.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.324 2.016 . . . . 0.0 111.628 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.477 ' HB3' HD13 ' A' ' 24' ' ' LEU . 5.3 p90 -164.25 170.18 16.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.983 0.42 . . . . 0.0 111.227 178.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.593 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 5.4 mm-40 -136.39 121.0 18.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.625 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.526 ' HE1' HG11 ' A' ' 4' ' ' VAL . 9.9 t80 -89.71 152.96 21.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.111 0.481 . . . . 0.0 111.639 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 3' ' ' LYS . 29.0 mt -150.1 126.54 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.407 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -92.58 129.4 38.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.08 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.596 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 2.0 pp -87.4 -19.53 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.268 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.6 ttp -124.19 94.74 44.82 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.761 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.17 -14.63 28.76 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.421 2.081 . . . . 0.0 112.653 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -139.83 142.25 36.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 110.844 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -65.23 -8.77 19.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.227 0.536 . . . . 0.0 111.877 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.4 -60.22 2.26 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.178 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.6 t -150.1 129.83 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.713 0.292 . . . . 0.0 111.157 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -59.15 169.65 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.941 0.4 . . . . 0.0 110.921 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.467 ' O ' HD12 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -84.28 93.5 8.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.127 -179.609 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -52.4 -22.2 4.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.891 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -55.54 -50.21 70.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 0.0 110.898 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -75.02 -40.74 60.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.571 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 44' ' ' ASP . 2.6 mp -52.67 -30.5 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.762 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.95 -57.72 3.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.722 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -61.07 -29.84 69.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.276 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.962 HD13 HD11 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -61.46 -57.92 10.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.951 179.315 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.564 ' HA ' HD13 ' A' ' 55' ' ' LEU . 72.2 mt -43.14 -45.91 5.66 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.316 0.579 . . . . 0.0 110.919 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.2 m -70.42 -32.4 70.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.272 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.15 -39.93 93.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.328 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.962 HD11 HD13 ' A' ' 51' ' ' LEU . 4.4 mp -59.58 -64.36 0.97 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.868 0.366 . . . . 0.0 110.945 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.65 -48.02 0.21 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.229 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.424 ' HD2' HG22 ' A' ' 59' ' ' THR . 0.3 OUTLIER -99.42 -165.11 1.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 110.865 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -105.43 -30.6 9.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.927 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.424 HG22 ' HD2' ' A' ' 57' ' ' ARG . 10.3 t -95.71 168.51 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.18 99.76 7.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.772 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.1 mt -79.05 84.6 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.047 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 64' ' ' THR . . . 62.37 26.29 67.8 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.316 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.06 125.15 22.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 111.002 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.468 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 34.4 p -128.23 170.14 13.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.994 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.88 159.06 31.29 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.746 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.628 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.9 Cg_endo -84.26 144.75 45.24 Favored 'Cis proline' 0 C--N 1.345 0.343 0 C-N-CA 124.326 -1.114 . . . . 0.0 112.933 0.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.468 ' NE2' ' O ' ' A' ' 64' ' ' THR . 67.6 mm-40 -112.41 121.19 44.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.104 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.738 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -95.23 160.06 2.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.446 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 46.1 m-85 -141.97 138.3 31.82 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.264 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.931 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -52.47 142.73 29.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.181 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -31.9 -37.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.718 2.945 . . . . 0.0 112.835 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.29 34.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.111 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.78 -105.12 2.58 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.921 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.5 t -131.84 178.04 7.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.167 0.508 . . . . 0.0 111.269 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.435 ' HE1' ' HB3' ' A' ' 67' ' ' GLN . 15.3 t60 -65.36 129.65 40.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.674 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.931 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.3 mp -103.87 -40.89 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.674 0.273 . . . . 0.0 110.94 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' A' ' 81' ' ' GLN . . . 130.95 -166.92 22.5 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.898 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.6 -137.12 4.74 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.907 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.413 ' HD1' ' HB2' ' A' ' 20' ' ' ALA . 30.1 t80 -72.13 -67.96 0.5 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 0.0 111.261 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -54.16 -44.4 71.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.007 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.421 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -57.34 -48.35 79.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.81 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.691 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -67.09 -42.7 84.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.531 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -51.09 -30.25 15.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.52 -35.86 68.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.219 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 82' ' ' LEU . 11.0 t80 -63.72 -33.67 76.17 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.691 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.3 m-85 -87.96 -28.26 21.58 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.068 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.919 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.591 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.7 ttp . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.746 0.308 . . . . 0.0 111.633 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.523 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 86.0 m-85 -58.9 154.4 15.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.937 0.399 . . . . 0.0 110.427 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.679 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -130.31 123.09 29.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.713 -179.359 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.984 HG22 HG22 ' A' ' 68' ' ' VAL . 54.8 t -113.64 145.05 20.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.377 0.608 . . . . 0.0 111.881 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.904 ' CE1' HD12 ' A' ' 34' ' ' ILE . 8.2 m-85 -123.78 102.97 8.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.792 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.78 -137.98 2.31 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.098 -1.048 . . . . 0.0 112.769 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.415 ' CE1' ' SD ' ' A' ' 37' ' ' MET . 56.7 m-85 -112.34 152.66 28.31 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.742 0.306 . . . . 0.0 110.899 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 9' ' ' SER . 19.1 m-20 -88.54 3.75 49.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.709 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.3 OUTLIER 81.09 -10.94 1.16 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.56 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.663 ' OD1' HD12 ' A' ' 11' ' ' ILE . 19.8 p-10 -85.14 -35.08 21.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.908 0.385 . . . . 0.0 110.753 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.73 HG23 ' HA ' ' A' ' 40' ' ' LYS . 2.5 mp -94.32 -42.61 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.52 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -139.34 147.04 41.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.518 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -76.46 159.6 30.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.0 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 p -174.29 122.12 0.28 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.629 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.8 m -90.09 -29.87 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.844 0.354 . . . . 0.0 111.175 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -77.84 -22.08 50.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.101 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.3 p -73.27 -41.88 63.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 110.92 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -28.42 57.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.324 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 81.4 m-20 -74.88 -39.46 61.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.223 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.18 -38.14 78.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.044 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -60.13 -55.94 27.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.648 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.859 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -61.48 -30.45 70.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.362 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.823 HD12 ' CE1' ' A' ' 79' ' ' PHE . 4.0 tt -53.79 -46.18 70.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.333 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.718 HD13 ' CG ' ' A' ' 31' ' ' PHE . 2.6 mt -66.23 -48.58 70.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.635 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.4 m -56.2 -36.52 68.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.505 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 22' ' ' ARG . 49.0 t -72.69 -31.93 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.733 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.22 -9.87 57.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.201 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm 71.24 57.91 0.19 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.983 0.42 . . . . 0.0 110.903 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -135.63 139.03 29.79 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.082 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 1' ' ' MET . 91.8 Cg_endo -79.59 142.08 16.03 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.569 2.179 . . . . 0.0 111.572 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.718 ' CG ' HD13 ' A' ' 24' ' ' LEU . 32.0 p90 -158.69 170.62 21.75 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -141.48 135.56 30.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.162 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CE1' HG11 ' A' ' 4' ' ' VAL . 32.1 t80 -89.81 159.8 16.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.086 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.904 HD12 ' CE1' ' A' ' 5' ' ' TYR . 19.0 mt -139.23 116.53 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.436 0.636 . . . . 0.0 110.431 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -87.24 121.23 29.41 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.474 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.5 HG22 ' HB3' ' A' ' 47' ' ' LYS . 4.2 pt -100.2 32.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.849 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.432 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.0 mtt -142.64 84.39 11.0 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.157 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.511 ' HD2' ' O ' ' A' ' 42' ' ' VAL . 39.9 Cg_endo -67.33 -8.48 22.16 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.684 2.256 . . . . 0.0 112.62 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -138.8 170.58 15.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.881 0.372 . . . . 0.0 111.011 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.73 ' HA ' HG23 ' A' ' 11' ' ' ILE . 4.4 mptp? -65.4 -6.62 10.75 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.52 35.02 0.25 Allowed Glycine 0 C--N 1.313 -0.733 0 C-N-CA 120.711 -0.756 . . . . 0.0 113.043 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.511 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 t -149.22 125.91 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.635 0.255 . . . . 0.0 110.738 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 1.3 m-85 -76.25 169.91 17.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.041 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.449 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -99.91 112.02 24.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.856 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -54.49 -33.09 59.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.826 0.346 . . . . 0.0 110.612 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.26 -51.37 61.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.595 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.5 ' HB3' HG22 ' A' ' 36' ' ' ILE . 22.7 mmtm -64.61 -43.47 93.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.41 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 44' ' ' ASP . 1.7 mp -64.93 -36.17 77.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.184 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.87 -58.32 4.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.093 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.74 -34.75 71.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.781 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.447 HD13 ' CD2' ' A' ' 5' ' ' TYR . 9.5 tp -58.18 -51.49 69.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.38 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.7 -45.88 63.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.166 0.508 . . . . 0.0 111.204 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.7 m -70.2 -35.15 73.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.149 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -29.98 71.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.395 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.66 -70.05 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.781 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.58 -41.2 0.59 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.196 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -98.52 -168.59 1.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 110.847 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -96.65 -30.92 12.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.2 t -109.54 167.5 10.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -104.58 99.52 9.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.553 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.617 ' O ' HG23 ' A' ' 61' ' ' ILE . 7.7 tp -62.88 81.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.261 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.22 23.26 39.86 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.773 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.511 HD12 ' CG ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -65.13 140.7 58.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 110.783 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.34 166.3 16.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.247 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.7 mmt -105.67 152.21 40.04 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.61 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.1 Cg_exo -80.79 144.8 67.73 Favored 'Cis proline' 0 C--N 1.345 0.352 0 C-N-CA 123.985 -1.256 . . . . 0.0 112.894 0.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.614 ' HG2' ' CE1' ' A' ' 75' ' ' HIS . 5.2 mt-30 -99.05 119.57 38.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.641 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.984 HG22 HG22 ' A' ' 4' ' ' VAL . 4.6 t -97.51 162.71 2.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.744 0.307 . . . . 0.0 111.428 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 89.3 m-85 -142.22 142.69 32.66 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.24 0.543 . . . . 0.0 111.464 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.47 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.66 137.95 62.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.264 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.508 ' HB3' ' N ' ' A' ' 1' ' ' MET . 84.3 Cg_exo -46.61 -28.07 6.01 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.104 2.536 . . . . 0.0 112.001 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.79 37.05 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.043 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.29 -109.85 1.1 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.949 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.442 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 2.0 p -135.67 -178.07 4.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.122 0.487 . . . . 0.0 111.318 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.614 ' CE1' ' HG2' ' A' ' 67' ' ' GLN . 86.3 t60 -60.4 122.79 15.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.036 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.49 HG23 ' HD2' ' A' ' 85' ' ' TYR . 2.3 mt -85.24 -45.68 17.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.963 0.411 . . . . 0.0 111.159 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.04 -147.92 18.29 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.392 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.1 -149.88 24.11 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.927 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.823 ' CE1' HD12 ' A' ' 23' ' ' LEU . 18.9 t80 -71.8 -70.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.833 0.349 . . . . 0.0 111.008 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -55.9 -48.97 74.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -53.56 -35.12 60.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.08 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.728 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.5 tt -83.45 -30.79 26.98 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.042 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.1 ttp85 -50.73 -33.13 21.75 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -66.19 -35.0 79.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.49 ' HD2' HG23 ' A' ' 76' ' ' ILE . 5.2 t80 -63.04 -34.9 78.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.189 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.728 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.6 m-85 -92.4 -13.68 29.73 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.657 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.923 179.913 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.627 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 50.3 ttp . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -74.69 153.15 39.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.201 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -114.22 120.81 41.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.714 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 66' ' ' PRO . 7.0 t -104.41 128.02 58.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.202 0.525 . . . . 0.0 111.498 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.622 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 4.3 m-30 -103.83 98.84 8.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.154 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.29 -138.4 2.43 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.471 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.625 ' CD2' ' CD2' ' A' ' 12' ' ' HIS . 11.5 m-85 -120.35 144.49 47.84 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 120.676 0.274 . . . . 0.0 111.578 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.586 ' HB3' ' CE2' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -136.81 64.22 1.55 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.337 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.898 ' HB3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER 177.88 -179.01 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.271 0.558 . . . . 0.0 112.016 179.675 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -86.39 1.51 50.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.62 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.898 HG22 ' HB3' ' A' ' 9' ' ' SER . 2.5 tt -86.54 -6.58 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.061 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.625 ' CD2' ' CD2' ' A' ' 7' ' ' TYR . 6.0 t60 -156.98 161.92 39.59 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.015 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.76 166.0 24.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.615 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 176.67 73.03 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.888 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.492 HG23 ' N ' ' A' ' 16' ' ' TYR . 29.3 m -89.22 -49.03 14.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.726 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.492 ' N ' HG23 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -70.8 -12.88 61.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 110.972 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.3 m -70.37 -53.0 18.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.534 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -53.65 -26.22 21.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.103 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -70.53 -59.41 2.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.032 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.46 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . . . -53.82 -38.26 64.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.489 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -52.92 63.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 110.658 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.673 ' O ' HG23 ' A' ' 26' ' ' VAL . 14.7 tpt180 -60.75 -37.63 82.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.482 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.641 ' C ' HD23 ' A' ' 23' ' ' LEU . 3.3 tt -60.18 -53.33 58.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.64 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.593 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.2 mt -56.99 -48.71 77.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.951 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.2 m -54.53 -37.93 65.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.106 0.479 . . . . 0.0 110.244 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 22' ' ' ARG . 67.1 t -79.54 -32.58 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.598 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -72.91 -11.59 60.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.112 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm 72.86 43.93 0.39 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.892 0.377 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -132.17 127.96 21.14 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.002 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.601 ' O ' ' HA ' ' A' ' 1' ' ' MET . 96.9 Cg_endo -77.98 158.56 30.81 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.476 2.118 . . . . 0.0 110.876 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 6.1 p90 -161.51 171.26 18.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.997 0.427 . . . . 0.0 112.021 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.39 133.5 38.75 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.488 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.586 ' CE2' ' HB3' ' A' ' 8' ' ' ASP . 12.2 t80 -89.15 159.79 17.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.168 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.615 HG21 ' HE2' ' A' ' 47' ' ' LYS . 12.5 mt -149.29 122.26 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.229 0.537 . . . . 0.0 110.753 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -86.25 120.5 27.68 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.829 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.43 HD13 ' H ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -94.53 0.31 10.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.476 179.772 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.434 ' HE1' ' CD1' ' A' ' 43' ' ' PHE . 6.9 tpp -120.08 97.25 49.36 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.627 0.251 . . . . 0.0 111.332 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 76.7 Cg_endo -77.35 -23.21 10.32 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.295 1.996 . . . . 0.0 111.339 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -142.52 148.52 37.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.384 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -7.72 11.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.304 0.573 . . . . 0.0 111.738 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.67 -57.32 2.75 Favored Glycine 0 C--N 1.313 -0.737 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.722 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.7 t -148.27 146.38 17.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.885 0.374 . . . . 0.0 111.791 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.434 ' CD1' ' HE1' ' A' ' 37' ' ' MET . 0.5 OUTLIER -59.85 170.32 1.19 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.631 179.365 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.414 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -74.5 98.67 3.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -50.69 -23.99 3.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.553 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -64.94 -59.21 4.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.337 . . . . 0.0 110.799 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.615 ' HE2' HG21 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -69.84 -39.06 76.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.502 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.487 ' O ' HD12 ' A' ' 52' ' ' LEU . 29.1 mm -50.08 -46.76 24.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.639 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.408 ' O ' HD12 ' A' ' 52' ' ' LEU . . . -63.04 -54.44 38.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.131 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -64.08 -21.25 66.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.664 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.51 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 3.4 tt -62.34 -61.01 2.75 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.159 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 60' ' ' GLN . 0.8 OUTLIER -51.34 -49.28 61.71 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.196 0.522 . . . . 0.0 110.241 179.622 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.3 m -53.19 -40.59 64.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.242 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -38.92 84.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.249 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.417 HD22 ' CG ' ' A' ' 75' ' ' HIS . 1.4 mt -59.89 -38.11 81.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.284 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.82 -111.83 0.38 Allowed Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.686 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.3 ttm-85 -150.38 27.11 0.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.075 0.464 . . . . 0.0 110.709 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -121.77 -144.85 0.35 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.415 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.6 t -120.05 170.64 9.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.639 0.257 . . . . 0.0 110.381 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.559 ' N ' HD23 ' A' ' 52' ' ' LEU . 1.6 pt20 -73.85 98.06 2.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.274 0.559 . . . . 0.0 110.42 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.3 mt -80.11 80.37 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.223 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.67 26.11 7.43 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.555 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.787 HD22 ' N ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -48.27 166.79 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.845 0.355 . . . . 0.0 111.308 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.787 ' N ' HD22 ' A' ' 63' ' ' LEU . 30.0 p -127.09 160.31 31.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.109 0.48 . . . . 0.0 111.391 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.2 mtm -120.23 155.39 55.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.619 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.622 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.9 Cg_exo -76.23 142.97 75.04 Favored 'Cis proline' 0 C--N 1.345 0.354 0 C-N-CA 123.874 -1.303 . . . . 0.0 112.762 0.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.629 ' NE2' HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -98.03 120.24 38.08 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.711 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -92.52 158.83 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.426 0.631 . . . . 0.0 112.31 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.492 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 74.6 m-85 -142.53 148.39 37.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.005 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.917 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -61.24 153.75 66.13 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.854 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.627 ' HB3' ' N ' ' A' ' 1' ' ' MET . 19.6 Cg_exo -68.09 59.44 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.344 2.696 . . . . 0.0 112.044 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 71' ' ' PRO . 0.3 OUTLIER 100.37 25.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.85 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -112.18 -97.15 2.33 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.525 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.523 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 8.5 t -147.5 -174.9 4.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.803 0.335 . . . . 0.0 110.612 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.417 ' CG ' HD22 ' A' ' 55' ' ' LEU . 20.6 t-80 -71.82 132.34 44.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.835 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.917 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.4 mp -109.09 -41.33 4.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.627 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 135.87 -165.04 24.94 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.741 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.32 -136.52 4.93 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.737 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.46 ' HD1' ' HB2' ' A' ' 20' ' ' ALA . 31.7 t80 -72.33 -70.57 0.33 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.708 0.29 . . . . 0.0 111.332 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -56.4 -47.3 79.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.99 0.424 . . . . 0.0 110.857 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -51.06 -44.14 61.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.472 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.724 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.0 tt -74.77 -32.92 62.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.243 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.5 ttt85 -51.37 -30.08 17.67 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.93 -35.39 76.74 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.155 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LEU . 22.3 t80 -62.28 -34.3 76.3 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.273 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.724 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.7 m-85 -86.14 -38.84 17.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.266 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.2 mttm . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.952 -179.999 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.634 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 49.3 ttm . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -77.0 144.31 38.78 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.183 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -106.45 121.21 43.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.662 -179.325 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.609 HG22 HG22 ' A' ' 68' ' ' VAL . 40.6 t -107.83 138.25 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.285 0.564 . . . . 0.0 111.887 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.745 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.1 m-85 -113.43 99.62 7.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.816 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.44 -139.6 2.71 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.296 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.679 ' OH ' HD11 ' A' ' 36' ' ' ILE . 84.1 m-85 -125.18 148.34 48.65 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.796 0.332 . . . . 0.0 111.253 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -64.55 -75.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.705 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 167.07 -32.87 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.974 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -82.92 -23.9 33.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.839 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.643 HD12 ' N ' ' A' ' 11' ' ' ILE . 2.6 mp -93.41 -46.03 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.476 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -147.44 153.64 39.83 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 pttm -62.39 165.26 6.25 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.877 0.37 . . . . 0.0 111.284 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.4 t -176.6 82.23 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.306 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.43 -19.23 7.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.065 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -76.19 -28.23 57.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.508 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.6 p -77.5 -46.03 23.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.715 0.293 . . . . 0.0 110.831 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.23 -35.39 17.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 110.718 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -70.78 -60.78 2.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.572 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 79' ' ' PHE . . . -53.16 -33.3 51.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.181 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -59.14 -54.96 41.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.54 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.837 ' O ' HG23 ' A' ' 26' ' ' VAL . 33.2 ttt180 -59.73 -35.19 74.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.554 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.641 HD23 ' N ' ' A' ' 24' ' ' LEU . 3.1 tt -60.81 -54.61 43.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.565 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.641 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.9 mt -55.48 -48.05 75.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.855 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.0 m -56.03 -37.74 69.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.166 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 22' ' ' ARG . 61.4 t -77.08 -36.09 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.646 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -72.54 -10.03 59.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.096 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.65 50.8 0.17 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.861 0.362 . . . . 0.0 110.693 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -139.53 128.53 13.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.27 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.634 ' O ' ' HA ' ' A' ' 1' ' ' MET . 81.0 Cg_endo -79.61 161.81 24.77 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.581 2.187 . . . . 0.0 110.749 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 6.9 p90 -161.23 171.16 18.9 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -135.36 136.79 41.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.292 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.503 ' HE1' HG11 ' A' ' 4' ' ' VAL . 8.6 t80 -89.28 157.0 18.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.174 0.512 . . . . 0.0 111.732 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.745 HD12 ' CE1' ' A' ' 5' ' ' TYR . 14.7 mt -143.88 119.47 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.714 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -98.26 135.98 39.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.737 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.679 HD11 ' OH ' ' A' ' 7' ' ' TYR . 1.4 pp -97.65 -14.22 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.018 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -123.48 80.39 54.02 Favored Pre-proline 0 N--CA 1.455 -0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.403 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 64.8 Cg_endo -88.44 31.08 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.032 2.488 . . . . 0.0 112.449 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.431 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 2.2 tp10 -139.08 164.78 28.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.534 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.65 -8.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.49 53.8 0.02 OUTLIER Glycine 0 C--N 1.312 -0.776 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.231 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.3 t -149.83 125.95 2.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.029 0.442 . . . . 0.0 111.944 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.75 ' HB3' HD11 ' A' ' 48' ' ' ILE . 2.0 m-85 -63.78 143.94 57.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.358 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.521 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -99.04 121.79 41.43 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.822 0.344 . . . . 0.0 111.505 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.402 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 46.5 m-20 -66.84 -24.62 66.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.332 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -58.42 -52.17 66.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.794 0.33 . . . . 0.0 110.816 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -38.31 54.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.364 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.75 HD11 ' HB3' ' A' ' 43' ' ' PHE . 41.2 mt -59.32 -40.5 81.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.855 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.47 -58.0 6.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.269 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -60.15 -28.16 67.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.973 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.489 HD11 HD21 ' A' ' 55' ' ' LEU . 2.5 tp -59.32 -56.26 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.381 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.635 ' N ' HD23 ' A' ' 52' ' ' LEU . 3.0 mt -51.94 -47.51 64.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.984 0.421 . . . . 0.0 110.886 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.6 m -66.04 -35.0 79.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.291 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -66.49 -39.86 88.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.504 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.489 HD21 HD11 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -59.82 -49.1 79.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.439 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.58 -106.25 0.25 Allowed Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.818 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.2 mtt180 -150.62 27.6 0.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.02 0.438 . . . . 0.0 110.84 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.59 -156.71 0.7 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.207 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -121.24 161.73 21.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.676 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.423 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 7.3 pt20 -120.14 98.89 6.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.992 0.425 . . . . 0.0 110.694 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.5 mt -81.55 88.32 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.707 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.94 32.73 5.77 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.536 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.563 HD11 ' HG3' ' A' ' 67' ' ' GLN . 2.8 tm? -47.73 121.91 4.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.824 0.345 . . . . 0.0 110.77 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.504 ' N ' HD13 ' A' ' 63' ' ' LEU . 1.1 p -103.86 151.51 23.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.28 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -112.71 156.4 42.54 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.908 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -86.97 141.52 24.14 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.067 -1.222 . . . . 0.0 112.56 0.503 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.563 ' HG3' HD11 ' A' ' 63' ' ' LEU . 2.7 mm-40 -100.24 124.19 45.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.138 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.609 HG22 HG22 ' A' ' 4' ' ' VAL . 3.3 t -96.61 159.69 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.33 0.586 . . . . 0.0 112.478 -178.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.471 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 80.1 m-85 -143.73 146.62 33.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.289 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.567 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -58.49 156.3 23.71 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.616 ' HB3' ' N ' ' A' ' 1' ' ' MET . 3.0 Cg_exo -73.71 -3.72 14.22 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.876 2.384 . . . . 0.0 112.566 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -115.33 -9.65 12.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.226 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.23 89.08 1.67 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.548 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 t -179.2 152.12 0.53 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -90.19 116.62 28.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 70' ' ' ALA . 26.2 mt -96.8 -48.45 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.879 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 138.17 -156.02 23.69 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.726 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.07 -138.69 8.88 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.668 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CD1' ' HB2' ' A' ' 20' ' ' ALA . 19.4 t80 -70.89 -70.66 0.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.782 0.325 . . . . 0.0 110.918 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -59.43 -45.3 91.94 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.023 0.44 . . . . 0.0 110.551 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -50.87 -40.0 55.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.437 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.737 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.4 tt -78.65 -31.93 47.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.265 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -51.13 -30.9 17.75 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -35.43 79.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.093 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 82' ' ' LEU . 10.8 t80 -62.68 -34.14 76.51 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.344 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.737 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.0 m-85 -88.96 -70.24 0.66 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.312 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.939 179.951 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.683 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 17.5 ttm . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.424 ' CE2' HD13 ' A' ' 76' ' ' ILE . 79.5 m-85 -78.13 147.26 34.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.308 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -106.9 121.45 44.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.337 -179.697 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.555 HG11 ' HE1' ' A' ' 33' ' ' PHE . 52.3 t -112.99 131.95 63.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.56 0.695 . . . . 0.0 112.62 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.885 ' HA ' HD11 ' A' ' 36' ' ' ILE . 17.3 m-85 -110.09 99.13 8.27 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.181 177.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.444 ' O ' HG12 ' A' ' 36' ' ' ILE . . . -153.91 -139.82 2.92 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.006 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.503 ' CD1' ' HB3' ' A' ' 37' ' ' MET . 43.7 m-85 -147.28 99.84 3.2 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.55 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 27.7 t70 -108.87 55.95 0.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.422 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.78 -168.04 2.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.165 0.507 . . . . 0.0 111.637 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -85.96 0.61 52.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.839 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.463 HG23 ' HB3' ' A' ' 40' ' ' LYS . 1.3 mm -88.26 -13.51 9.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.981 0.419 . . . . 0.0 109.901 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -175.72 118.09 0.15 Allowed 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.704 0.764 . . . . 0.0 111.172 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -82.52 168.56 17.27 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.885 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -176.58 107.79 0.07 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.24 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 m -70.32 -16.56 20.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.671 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -82.96 -25.69 32.08 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.846 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.2 m -59.85 -55.27 36.28 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.35 0.595 . . . . 0.0 109.647 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.27 -18.58 64.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.503 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.67 -62.51 1.35 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.851 0.357 . . . . 0.0 110.89 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.0 -38.37 67.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.09 -50.4 72.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.74 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.805 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -61.65 -38.75 88.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.624 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.748 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.2 tt -59.16 -53.0 63.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.532 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.748 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.4 mt -56.97 -49.28 76.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.792 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.9 m -54.32 -38.44 65.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.075 0.464 . . . . 0.0 110.161 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.8 t -78.06 -32.36 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.622 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HB3' ' NE2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -74.14 -15.72 61.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.976 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 76.11 49.85 0.07 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.055 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.534 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 1.2 mp0 -138.04 131.85 16.84 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.13 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.635 ' O ' ' HA ' ' A' ' 1' ' ' MET . 77.6 Cg_endo -79.52 161.26 25.25 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.408 2.072 . . . . 0.0 111.027 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.459 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 6.5 p90 -161.23 171.56 18.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.753 0.311 . . . . 0.0 111.716 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -133.28 123.83 26.21 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.094 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.555 ' HE1' HG11 ' A' ' 4' ' ' VAL . 10.6 t80 -89.12 157.91 18.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.445 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.471 HD12 ' CE1' ' A' ' 5' ' ' TYR . 24.0 mt -148.1 125.21 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.283 0.564 . . . . 0.0 111.143 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -75.58 115.81 15.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.639 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.885 HD11 ' HA ' ' A' ' 5' ' ' TYR . 4.6 mm -90.2 -19.06 7.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.921 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.503 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -120.28 84.41 34.53 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.696 0.284 . . . . 0.0 111.181 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 53.1 Cg_endo -69.24 -16.49 39.78 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.46 2.107 . . . . 0.0 111.904 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -139.99 136.64 33.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.395 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.463 ' HB3' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -59.33 -9.06 1.99 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.164 0.507 . . . . 0.0 111.956 -179.731 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.12 -59.65 3.32 Favored Glycine 0 C--N 1.312 -0.797 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.355 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 43' ' ' PHE . 21.2 t -150.62 154.36 8.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.981 0.42 . . . . 0.0 111.852 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.411 ' N ' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -63.92 170.63 3.35 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.384 179.255 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.421 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 1.9 t70 -89.35 100.83 13.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -52.51 -27.92 18.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.481 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -61.8 -58.04 9.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.96 0.409 . . . . 0.0 110.556 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -65.07 -32.96 74.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.302 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.64 HD11 ' CG2' ' A' ' 36' ' ' ILE . 35.8 mm -69.8 -37.42 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.573 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.72 71.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.623 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -61.82 -34.08 75.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.334 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.585 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.4 tt -58.95 -52.51 65.43 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.309 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 52' ' ' LEU . 85.9 mt -53.16 -41.35 65.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.589 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.1 m -58.49 -47.53 83.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.605 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' CB ' ' CE1' ' A' ' 69' ' ' PHE . 4.0 mtpp -61.74 -33.27 73.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.784 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.71 HD11 HD21 ' A' ' 63' ' ' LEU . 2.1 mt -59.92 -54.25 48.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.781 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 166.8 -112.69 0.51 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.186 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -150.23 31.24 0.68 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.071 0.462 . . . . 0.0 110.596 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -121.0 -142.27 0.34 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.335 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 t -117.0 170.4 8.66 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.793 0.33 . . . . 0.0 110.645 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -69.57 98.35 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.358 0.599 . . . . 0.0 110.359 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 pt -80.12 87.31 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.439 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.33 30.92 72.28 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.326 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.71 HD21 HD11 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -41.31 129.47 2.98 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.894 0.378 . . . . 0.0 111.331 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.83 153.65 45.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.359 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.5 mmt -113.63 146.48 35.55 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.628 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.3 Cg_endo -84.63 134.55 20.57 Favored 'Cis proline' 0 N--CA 1.46 -0.454 0 C-N-CA 124.006 -1.248 . . . . 0.0 112.57 0.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.561 ' OE1' HD13 ' A' ' 63' ' ' LEU . 4.5 tp60 -90.11 133.33 34.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.96 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.7 t -107.46 156.53 7.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.263 0.554 . . . . 0.0 111.851 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.434 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 39.2 m-85 -142.95 136.43 28.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.665 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.609 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -51.57 149.22 8.33 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.368 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.683 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 9.3 Cg_exo -68.86 -11.61 32.31 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.709 2.273 . . . . 0.0 112.133 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -106.42 -18.74 13.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.994 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.2 85.31 0.96 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.63 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -179.75 117.71 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.793 0.33 . . . . 0.0 110.833 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -58.51 116.63 3.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.971 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.609 HD11 ' HA ' ' A' ' 70' ' ' ALA . 13.4 mt -91.81 -46.51 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.811 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.68 -156.38 22.75 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.491 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.6 -140.95 8.2 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.505 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -70.12 -69.02 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.698 0.285 . . . . 0.0 110.906 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -54.37 -43.48 71.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.963 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -55.32 -37.92 68.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.678 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.692 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -71.99 -41.58 67.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.378 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.01 -29.95 23.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -72.85 -35.31 67.2 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' LEU . 34.2 t80 -63.49 -33.95 76.7 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.206 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.692 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.3 m-85 -87.14 -26.88 23.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.133 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.878 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.677 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 40.0 ttp . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.423 ' CD1' ' CD2' ' A' ' 24' ' ' LEU . 87.0 m-85 -77.39 147.58 35.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.054 179.001 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.704 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.5 mptt -111.5 121.0 44.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.589 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.641 HG22 HG22 ' A' ' 68' ' ' VAL . 8.4 t -103.4 129.22 55.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.24 0.543 . . . . 0.0 111.676 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.613 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.9 m-30 -105.68 99.4 9.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.504 178.733 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.36 -136.58 2.03 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.64 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 90.0 m-85 -116.44 144.28 44.5 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.918 0.39 . . . . 0.0 111.518 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' A' ' 9' ' ' SER . 22.6 t0 -73.1 -9.16 58.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.2 t 84.8 -14.11 0.63 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.577 0.351 . . . . 0.0 111.507 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -85.27 -31.19 23.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.693 0.282 . . . . 0.0 111.324 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.675 HD12 ' N ' ' A' ' 11' ' ' ILE . 2.4 mp -100.0 -38.38 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.645 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.425 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 4.0 t-80 -139.41 179.47 6.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.355 -179.015 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -70.07 166.21 20.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.619 0.247 . . . . 0.0 110.8 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 t -176.91 71.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.19 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.0 m -90.64 -21.1 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.722 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -81.08 -23.11 38.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.3 p -77.68 -45.14 25.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 110.573 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -50.78 -34.07 25.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.704 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -73.07 -59.7 2.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.67 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.53 -41.32 69.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HG3' ' CZ ' ' A' ' 31' ' ' PHE . 70.3 tttt -54.57 -49.73 69.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.328 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.869 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.5 tpp180 -64.62 -31.43 72.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.276 179.428 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.799 HD12 ' CE1' ' A' ' 79' ' ' PHE . 3.3 tt -56.45 -51.05 69.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.394 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.741 HD23 ' HZ ' ' A' ' 86' ' ' PHE . 2.9 mt -60.02 -51.94 67.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.72 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.3 m -51.03 -38.95 54.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.584 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 22' ' ' ARG . 58.0 t -66.81 -31.58 54.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.677 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -86.59 -9.2 56.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.138 179.709 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 3.2 mptp? 70.59 52.33 0.32 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.067 0.461 . . . . 0.0 110.831 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -130.77 136.03 28.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.72 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.677 ' O ' ' HA ' ' A' ' 1' ' ' MET . 58.1 Cg_endo -80.96 157.09 20.58 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.596 2.197 . . . . 0.0 111.381 179.443 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.439 ' CZ ' ' HG3' ' A' ' 21' ' ' LYS . 8.4 p90 -161.51 171.31 18.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.823 0.344 . . . . 0.0 111.774 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -133.98 134.55 42.64 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.488 ' HE1' HG11 ' A' ' 4' ' ' VAL . 23.0 t80 -89.36 154.54 19.99 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.093 0.473 . . . . 0.0 111.54 -179.566 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.613 HD12 ' CE1' ' A' ' 5' ' ' TYR . 8.4 mt -146.41 119.36 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.187 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -100.15 135.66 41.24 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.244 -179.491 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 44' ' ' ASP . 31.8 pt -97.91 20.43 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.191 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.479 ' CG ' HG21 ' A' ' 11' ' ' ILE . 15.1 tpp -144.33 70.94 16.07 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.658 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -87.82 34.2 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.026 2.484 . . . . 0.0 112.818 -179.482 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -139.74 170.42 15.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.612 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -63.22 -7.82 6.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.203 0.525 . . . . 0.0 111.931 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.73 55.24 0.02 OUTLIER Glycine 0 C--N 1.312 -0.757 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.403 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.9 t -150.02 131.7 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.001 0.429 . . . . 0.0 111.413 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.0 160.4 33.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.818 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.54 ' C ' HD12 ' A' ' 48' ' ' ILE . 3.7 t70 -97.63 89.25 4.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.081 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.81 -20.85 38.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.614 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -64.34 -59.2 4.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.816 0.341 . . . . 0.0 110.67 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -71.12 -41.05 71.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.399 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.54 HD12 ' C ' ' A' ' 44' ' ' ASP . 54.8 mt -51.91 -44.08 37.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.694 179.601 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.62 -55.78 26.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.435 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.77 -31.84 71.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.296 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.501 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 1.5 tt -56.34 -52.94 62.68 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.008 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.676 ' N ' HD23 ' A' ' 52' ' ' LEU . 2.2 mt -52.91 -48.62 67.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.722 179.152 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -62.33 -44.49 96.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.295 179.345 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.79 -39.09 83.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.552 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.439 HD21 ' CD2' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -59.74 -53.9 52.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.32 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.3 -108.99 0.27 Allowed Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.773 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -150.45 26.56 0.76 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.073 0.463 . . . . 0.0 110.862 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -121.62 -150.78 0.46 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.265 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.2 t -120.8 170.27 9.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.594 179.602 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -82.52 98.35 8.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.24 0.543 . . . . 0.0 110.314 179.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.685 ' O ' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -80.09 87.23 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.879 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.67 28.06 56.04 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.478 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.87 143.54 16.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.8 p -111.55 158.17 19.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.16 0.505 . . . . 0.0 111.312 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.91 153.01 47.03 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.611 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.55 ' HB2' HG13 ' A' ' 4' ' ' VAL . 6.0 Cg_exo -81.1 156.12 83.38 Favored 'Cis proline' 0 C--N 1.344 0.309 0 C-N-CA 124.025 -1.24 . . . . 0.0 112.806 0.29 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -113.29 115.83 28.78 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.859 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -87.57 164.19 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.035 0.445 . . . . 0.0 111.792 -178.615 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.456 ' H ' HG12 ' A' ' 68' ' ' VAL . 45.1 m-85 -142.33 140.49 32.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.528 -179.683 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.651 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -53.43 132.77 53.55 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.285 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.615 ' HB3' ' N ' ' A' ' 1' ' ' MET . 31.6 Cg_exo -53.25 -22.37 19.93 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.594 2.196 . . . . 0.0 112.133 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.95 39.77 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.341 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.23 -109.86 0.68 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.987 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.489 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 86.8 p -138.91 178.41 7.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.075 0.464 . . . . 0.0 111.211 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.456 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 32.8 t-80 -55.84 127.09 28.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.061 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.651 HD11 ' HA ' ' A' ' 70' ' ' ALA . 12.3 mt -96.03 -45.02 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.987 0.422 . . . . 0.0 110.734 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 133.87 -158.44 23.3 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.462 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.74 -141.13 9.06 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.688 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.799 ' CE1' HD12 ' A' ' 23' ' ' LEU . 17.4 t80 -71.08 -61.14 1.87 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.73 0.3 . . . . 0.0 110.825 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -56.94 -48.3 78.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.85 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -56.99 -45.7 82.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.793 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.695 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -66.42 -41.62 88.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.398 179.918 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -51.76 -31.66 27.65 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -71.94 -35.8 69.72 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.104 178.324 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 82' ' ' LEU . 23.8 t80 -63.37 -33.78 76.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.165 178.33 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.741 ' HZ ' HD23 ' A' ' 24' ' ' LEU . 6.2 m-85 -87.96 -27.31 22.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.135 179.472 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.961 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.647 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 28.0 ttm . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.75 0.31 . . . . 0.0 111.756 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.488 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 77.6 m-85 -66.83 152.11 46.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.96 0.409 . . . . 0.0 110.445 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 3.0 mptt -126.6 124.29 39.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.224 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.655 HG11 ' CE1' ' A' ' 33' ' ' PHE . 16.9 t -103.43 132.45 49.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.273 0.558 . . . . 0.0 111.528 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.733 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.1 m-85 -109.23 98.98 8.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.066 178.42 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.23 -137.99 2.39 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 119.995 -1.098 . . . . 0.0 112.355 -179.362 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.675 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 3.4 m-85 -128.86 120.69 26.7 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 120.54 0.209 . . . . 0.0 111.296 -178.642 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.462 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -117.52 69.32 0.77 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.595 0.236 . . . . 0.0 111.62 -179.601 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 36.9 t 177.87 -172.0 0.11 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.085 0.469 . . . . 0.0 111.767 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.87 7.59 26.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.831 179.434 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.44 HG12 ' HB3' ' A' ' 9' ' ' SER . 1.0 OUTLIER -87.53 -17.87 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.905 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.675 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 5.3 t60 -165.41 122.7 1.5 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.658 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.57 154.09 32.68 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.993 -178.1 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.6 t -159.64 95.31 1.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.925 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.7 m -74.61 -35.99 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.955 0.407 . . . . 0.0 110.563 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -65.9 -20.14 66.12 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.534 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.7 m -66.94 -60.94 2.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.791 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.42 -42.57 67.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.169 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -61.91 -52.75 62.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.081 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.516 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -58.87 -49.66 76.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.979 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -50.01 -32.67 15.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.58 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.751 ' O ' HG23 ' A' ' 26' ' ' VAL . 5.6 tpm_? -69.68 -38.62 77.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.629 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.822 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -58.23 -54.09 50.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.659 179.491 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.822 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.9 mt -54.69 -43.31 72.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.928 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.3 m -58.47 -33.09 69.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.031 0.443 . . . . 0.0 109.974 179.145 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 22' ' ' ARG . 41.0 t -78.81 -30.65 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.711 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -9.78 59.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.137 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt 64.68 56.87 1.13 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.071 0.462 . . . . 0.0 110.611 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -132.6 130.33 21.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.089 -179.601 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.453 ' O ' ' HA ' ' A' ' 1' ' ' MET . 86.3 Cg_endo -73.84 138.28 25.84 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.24 1.96 . . . . 0.0 110.924 178.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.647 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 48.1 p90 -155.1 170.64 21.33 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -141.63 144.0 33.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.048 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.655 ' CE1' HG11 ' A' ' 4' ' ' VAL . 33.2 t80 -89.71 162.1 15.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.05 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.733 HD12 ' CE1' ' A' ' 5' ' ' TYR . 7.1 mt -148.75 119.81 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.258 0.551 . . . . 0.0 110.816 179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -89.81 139.34 30.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.042 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.632 HD11 ' OH ' ' A' ' 7' ' ' TYR . 1.0 OUTLIER -99.72 -26.11 3.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.215 -179.989 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.604 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 10.2 ttm -119.38 88.93 39.24 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.753 0.311 . . . . 0.0 111.64 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.49 -6.95 15.74 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.525 2.15 . . . . 0.0 112.245 179.44 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -139.39 141.87 37.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.57 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -69.2 -7.78 39.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.282 0.563 . . . . 0.0 111.964 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.25 -60.46 1.92 Allowed Glycine 0 C--N 1.311 -0.853 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.895 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 t -150.48 128.87 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.553 0.216 . . . . 0.0 110.561 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -57.94 170.09 0.68 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.207 -179.641 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.429 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -78.87 87.24 4.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.476 -179.066 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -54.15 -22.67 11.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.275 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -56.0 -51.48 67.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.891 0.377 . . . . 0.0 110.572 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -73.06 -32.81 65.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.276 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 44' ' ' ASP . 40.0 mm -57.2 -50.89 75.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.79 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.25 70.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.536 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.26 -32.14 69.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.318 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.936 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.99 -57.22 13.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.236 179.933 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.51 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 16.4 mt -44.54 -45.84 9.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.265 0.555 . . . . 0.0 111.125 178.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.2 m -70.11 -30.59 67.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.362 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -66.46 -41.28 89.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.121 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.936 HD12 ' O ' ' A' ' 51' ' ' LEU . 3.3 mp -62.28 -54.75 36.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.057 0.456 . . . . 0.0 110.81 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.33 -115.17 0.37 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.061 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -150.64 30.92 0.65 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.065 0.46 . . . . 0.0 110.687 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -121.04 -145.75 0.36 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.352 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.8 t -115.85 170.25 8.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.677 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.41 ' HG2' HD22 ' A' ' 52' ' ' LEU . 42.9 mt-30 -70.03 98.14 1.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.314 0.578 . . . . 0.0 110.55 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -80.26 84.41 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.861 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.4 27.37 47.35 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.184 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.433 HD11 ' CD2' ' A' ' 55' ' ' LEU . 1.6 mm? -55.5 135.65 50.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.892 0.377 . . . . 0.0 111.349 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.75 159.9 40.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.161 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -102.19 152.14 38.21 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.958 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.9 Cg_exo -81.48 143.29 57.89 Favored 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 123.945 -1.273 . . . . 0.0 112.666 0.18 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -108.17 118.22 36.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.014 179.06 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.3 t -92.34 166.32 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.029 0.442 . . . . 0.0 111.899 -178.734 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.52 ' H ' HG12 ' A' ' 68' ' ' VAL . 24.9 m-85 -141.91 134.78 28.71 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.788 -179.57 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.501 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -49.67 150.15 3.86 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.529 -179.211 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.568 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . 45.6 Cg_exo -58.67 -33.77 98.48 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.216 2.611 . . . . 0.0 112.268 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -90.16 -21.67 22.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.365 -179.654 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.76 88.98 0.86 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.73 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -171.23 162.1 6.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.337 . . . . 0.0 110.543 179.841 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.496 ' CE1' HD23 ' A' ' 55' ' ' LEU . 8.0 t-160 -90.52 115.64 27.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.102 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.501 HD11 ' HA ' ' A' ' 70' ' ' ALA . 6.8 mt -91.78 -49.41 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.011 0.434 . . . . 0.0 110.983 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.61 -154.01 16.53 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.276 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.12 -143.54 5.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.294 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.555 ' CE1' HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -77.01 -69.57 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.58 0.19 . . . . 0.0 110.738 179.76 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -48.2 -45.46 33.87 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.25 0.548 . . . . 0.0 110.327 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -35.37 76.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.175 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.702 HD21 ' CE2' ' A' ' 86' ' ' PHE . 4.0 tt -78.38 -38.13 42.48 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.406 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 87' ' ' LYS . 11.4 mtm180 -50.78 -32.14 18.99 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.675 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -68.43 -34.8 76.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.16 178.117 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 82' ' ' LEU . 8.0 t80 -63.67 -34.36 77.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.36 178.415 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.702 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.1 m-85 -89.91 -70.48 0.66 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.392 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.906 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.768 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 6.3 tpt . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.58 ' CE2' ' HE2' ' A' ' 1' ' ' MET . 92.4 m-85 -39.56 116.99 0.68 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.74 0.781 . . . . 0.0 111.455 -177.276 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -90.16 128.53 36.37 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.39 -179.163 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 68' ' ' VAL . 37.1 t -115.81 127.12 73.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.26 0.552 . . . . 0.0 111.548 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.574 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 18.6 m-85 -103.93 98.13 8.02 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.778 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.978 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -155.56 -139.8 2.85 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.891 -179.004 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.612 ' CE2' HG23 ' A' ' 36' ' ' ILE . 17.1 m-85 -131.75 158.39 41.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -178.3 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.403 ' O ' ' CB ' ' A' ' 9' ' ' SER . 41.9 t0 -70.74 -69.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.595 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 3.2 t 164.09 -31.41 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.606 179.642 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -83.0 -26.88 30.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.546 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 11' ' ' ILE . 4.2 mp -88.21 -49.3 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.997 179.391 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -144.49 153.97 42.42 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.901 179.052 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -48.55 156.58 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.642 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.27 62.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.916 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.446 HG23 ' N ' ' A' ' 16' ' ' TYR . 14.5 m -80.11 -48.8 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.049 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.446 ' N ' HG23 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -67.29 -20.46 65.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.513 179.544 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 m -65.34 -47.68 75.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.291 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -55.53 -26.01 40.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.737 179.511 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -73.08 -42.97 62.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.471 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.558 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . . . -69.05 -40.74 78.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.098 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -62.81 -56.76 14.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.737 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.792 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -58.95 -34.22 71.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.221 179.632 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.728 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -57.87 -51.48 69.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.896 179.146 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.728 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.7 mt -57.9 -42.84 85.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.638 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.7 m -60.54 -39.26 87.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.932 179.377 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 22' ' ' ARG . 41.1 t -74.25 -39.24 49.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.534 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 1.7 tmtm? -74.29 -12.79 60.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.949 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt 68.56 49.16 0.77 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.938 0.399 . . . . 0.0 110.643 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -137.56 102.31 8.74 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.378 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.768 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 86.8 Cg_exo -44.91 171.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.518 2.145 . . . . 0.0 112.65 179.409 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.64 ' CG ' HD13 ' A' ' 24' ' ' LEU . 4.0 p90 -163.28 170.29 17.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.6 178.466 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 3.4 tt0 -132.54 112.49 12.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.686 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.517 ' HE1' HG11 ' A' ' 4' ' ' VAL . 9.9 t80 -89.1 153.84 20.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.17 0.51 . . . . 0.0 111.266 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.469 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.9 mt -149.98 121.74 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.331 179.731 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -70.56 109.4 4.83 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.499 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.978 HG22 ' O ' ' A' ' 6' ' ' GLY . 18.7 tt -72.4 -19.29 19.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.606 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.5 ttp -134.59 94.94 16.44 Favored Pre-proline 0 N--CA 1.454 -0.227 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.974 179.347 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -85.93 24.06 0.78 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.677 2.251 . . . . 0.0 112.105 179.517 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.45 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 6.7 tt0 -139.49 165.82 26.2 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.754 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -62.72 -7.54 5.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -179.054 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.65 35.58 0.06 OUTLIER Glycine 0 C--N 1.313 -0.705 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.825 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.464 ' N ' ' SD ' ' A' ' 37' ' ' MET . 4.3 t -147.72 121.13 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.906 0.384 . . . . 0.0 111.081 178.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.606 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -79.28 150.78 31.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.742 179.752 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -78.11 99.82 6.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.132 -179.612 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -48.52 -29.75 4.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.537 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -60.52 -54.38 46.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.959 0.409 . . . . 0.0 110.773 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HD3' ' CG2' ' A' ' 34' ' ' ILE . 25.0 mttm -68.92 -41.91 77.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.847 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.491 ' CD1' ' HB2' ' A' ' 43' ' ' PHE . 2.7 mp -63.22 -36.06 74.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.129 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.24 -52.49 65.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.659 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.01 -33.07 72.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.302 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.574 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 4.1 tt -60.15 -51.98 67.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.308 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.685 ' N ' HD23 ' A' ' 52' ' ' LEU . 1.9 mt -52.38 -44.49 65.33 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.344 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.7 m -58.19 -49.19 77.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.734 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.6 mtpp -59.53 -36.59 76.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.689 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.96 -52.23 66.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.567 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.05 -118.5 0.66 Allowed Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.054 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -141.35 27.9 1.88 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.199 0.524 . . . . 0.0 110.589 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -121.5 -147.23 0.38 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.257 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.4 t -120.26 170.19 9.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.695 0.283 . . . . 0.0 110.603 179.633 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -69.95 98.01 1.22 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.348 0.594 . . . . 0.0 110.423 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -80.36 84.25 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.084 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.72 26.51 60.28 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.395 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -50.33 148.24 3.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 111.072 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.1 p -122.92 165.22 17.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.427 -179.766 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -118.46 153.64 51.96 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.734 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.0 OUTLIER -86.81 136.28 17.8 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.318 -1.117 . . . . 0.0 112.495 0.203 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -91.76 129.6 37.7 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 4' ' ' VAL . 3.4 t -103.2 154.29 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.123 0.487 . . . . 0.0 112.006 -179.176 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.459 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 44.5 m-85 -142.63 138.08 30.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.801 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.672 ' HB1' ' HD2' ' A' ' 71' ' ' PRO . . . -48.16 164.04 0.28 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.755 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.672 ' HD2' ' HB1' ' A' ' 70' ' ' ALA . 32.5 Cg_endo -62.88 58.93 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.742 2.294 . . . . 0.0 111.453 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 86.61 29.96 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.88 -178.665 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.66 -91.07 2.11 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.857 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.542 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -143.68 -169.19 3.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.015 0.436 . . . . 0.0 110.998 -179.734 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.459 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 17.1 t-80 -83.31 125.07 31.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.162 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.627 HD11 ' HA ' ' A' ' 70' ' ' ALA . 13.7 mt -96.92 -45.89 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.95 0.405 . . . . 0.0 110.741 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 137.97 -156.62 23.9 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.659 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.01 -139.97 8.54 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.733 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.558 ' HD1' ' HB2' ' A' ' 20' ' ' ALA . 60.6 t80 -72.53 -70.57 0.34 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.718 0.294 . . . . 0.0 111.048 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -56.42 -48.01 77.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.917 0.389 . . . . 0.0 110.809 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -52.09 -41.44 62.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.644 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.74 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.2 tt -76.57 -34.23 58.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.208 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -51.52 -28.95 15.05 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -69.22 -34.07 74.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.216 178.127 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 82' ' ' LEU . 6.8 t80 -64.75 -33.25 75.54 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.446 178.508 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.74 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.1 m-85 -90.52 -66.89 0.89 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.584 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.8 pttt . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.137 -0.935 . . . . 0.0 110.917 -179.906 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.61 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 25.7 ttp . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.774 0.321 . . . . 0.0 111.669 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.489 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 80.9 m-85 -67.32 151.26 47.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.95 0.405 . . . . 0.0 110.529 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.669 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 3.3 mptt -127.11 120.39 28.77 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.569 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.91 HG22 HG22 ' A' ' 68' ' ' VAL . 14.5 t -106.79 130.82 58.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.251 0.548 . . . . 0.0 111.805 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.638 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.6 m-30 -106.39 99.4 8.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.408 178.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.41 -137.36 2.17 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.842 -1.17 . . . . 0.0 112.985 -179.388 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -118.5 147.25 43.84 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.825 0.345 . . . . 0.0 110.936 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -90.73 13.13 17.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.607 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 0.3 OUTLIER 71.95 4.88 5.18 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.629 0.252 . . . . 0.0 111.44 179.931 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -85.79 -58.21 2.74 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.906 0.384 . . . . 0.0 111.033 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.673 HD12 ' O ' ' A' ' 37' ' ' MET . 29.5 mt -91.65 -27.03 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.544 -179.465 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.484 ' O ' ' HA ' ' A' ' 9' ' ' SER . 7.0 t-80 -139.49 145.21 38.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.676 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.39 158.07 34.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.566 -179.464 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.5 t -175.78 96.11 0.06 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -80.88 -32.15 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.011 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -70.47 -23.17 62.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.596 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.5 m -62.52 -52.81 62.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.268 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.02 -27.28 52.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.301 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -71.16 -49.59 42.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.254 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.06 -47.22 71.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.177 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HD3' ' CE2' ' A' ' 31' ' ' PHE . 1.1 tppt? -59.65 -52.95 63.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.715 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.829 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -57.36 -41.25 79.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.767 180.0 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 24' ' ' LEU . 3.1 tt -58.49 -54.25 49.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.388 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.679 HD13 ' CG ' ' A' ' 31' ' ' PHE . 5.9 mt -57.31 -46.42 83.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.769 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 m -57.73 -37.09 72.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.093 0.473 . . . . 0.0 110.228 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 22' ' ' ARG . 62.1 t -77.96 -29.6 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.695 179.479 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -16.8 54.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.142 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.54 56.36 0.11 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.926 0.393 . . . . 0.0 110.9 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -136.96 141.62 35.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.47 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.9 Cg_endo -80.43 137.13 11.54 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.584 2.189 . . . . 0.0 111.647 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.679 ' CG ' HD13 ' A' ' 24' ' ' LEU . 32.0 p90 -158.32 170.61 21.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.847 0.356 . . . . 0.0 111.773 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -147.26 145.68 29.5 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.035 0.445 . . . . 0.0 111.167 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.49 ' CE1' HG11 ' A' ' 4' ' ' VAL . 10.2 t80 -89.5 163.58 15.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.168 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.638 HD12 ' CE1' ' A' ' 5' ' ' TYR . 11.5 mt -148.22 121.3 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.527 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -81.84 127.67 33.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.263 -179.592 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 pt -95.57 -16.27 7.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.185 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.673 ' O ' HD12 ' A' ' 11' ' ' ILE . 43.9 ttm -119.0 102.99 48.58 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.933 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 76.9 Cg_endo -76.2 -25.89 9.61 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.632 2.221 . . . . 0.0 112.035 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -139.96 151.01 45.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.767 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.21 -8.48 24.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.262 0.553 . . . . 0.0 111.656 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.71 -57.81 2.65 Favored Glycine 0 C--N 1.313 -0.725 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.671 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -148.73 139.11 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.642 0.258 . . . . 0.0 111.523 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -60.07 170.55 1.2 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.598 179.648 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.446 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 28.8 t0 -86.34 104.16 15.59 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -57.02 -22.65 40.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.434 179.679 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -58.05 -51.74 68.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.799 0.333 . . . . 0.0 110.686 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HZ2' HG22 ' A' ' 34' ' ' ILE . 53.0 mttt -74.86 -40.63 60.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.346 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 44' ' ' ASP . 38.7 mm -55.13 -47.48 77.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.771 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.03 -47.08 78.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.435 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.78 -37.88 85.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.381 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.463 HD13 ' CD2' ' A' ' 5' ' ' TYR . 19.8 tp -56.01 -51.27 68.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.732 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.9 mt -53.43 -47.58 69.52 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.227 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.7 m -65.24 -38.06 89.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.274 179.333 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.7 mtpp -63.91 -39.11 93.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.588 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -47.32 86.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.397 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 166.28 -109.64 0.36 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.987 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -150.72 31.54 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.034 0.445 . . . . 0.0 110.527 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.98 -149.96 0.44 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.7 t -120.38 170.33 9.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.694 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -80.4 98.44 7.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.271 0.558 . . . . 0.0 110.408 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.6 mm -78.6 83.65 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.78 24.79 50.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.369 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.427 HD12 ' CD ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -60.21 141.05 56.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.874 0.368 . . . . 0.0 110.872 -179.959 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.7 p -125.63 169.0 12.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.1 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.26 157.19 36.98 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.664 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.0 Cg_exo -81.82 143.45 56.38 Favored 'Cis proline' 0 C--N 1.344 0.292 0 C-N-CA 123.843 -1.315 . . . . 0.0 112.933 0.565 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.427 ' CD ' HD12 ' A' ' 63' ' ' LEU . 19.0 mt-30 -99.85 114.73 28.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.106 178.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.91 HG22 HG22 ' A' ' 4' ' ' VAL . 3.8 t -90.28 164.19 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.073 0.463 . . . . 0.0 111.712 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.482 ' N ' HG12 ' A' ' 68' ' ' VAL . 41.3 m-85 -142.48 131.49 23.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.62 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.707 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -48.38 152.28 1.63 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.439 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.558 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . 45.0 Cg_exo -58.39 -22.53 58.93 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.116 2.544 . . . . 0.0 112.218 179.168 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.0 -24.79 14.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.13 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.26 94.29 0.99 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.75 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 41.1 t -179.61 143.5 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.82 0.343 . . . . 0.0 110.774 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -72.9 106.13 4.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.965 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.707 HD11 ' HA ' ' A' ' 70' ' ' ALA . 33.6 mt -79.97 -52.06 15.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.65 -153.77 20.99 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.471 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.62 -147.3 12.41 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.335 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -69.95 -58.09 4.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.805 0.336 . . . . 0.0 110.624 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -55.88 -44.56 78.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.794 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -57.86 -43.36 85.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.471 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.623 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -61.83 -48.8 78.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.391 179.636 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -51.13 -30.21 15.81 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.831 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.98 -34.77 62.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.261 178.484 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.438 ' CD2' HG23 ' A' ' 76' ' ' ILE . 12.7 t80 -65.99 -32.39 73.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.343 178.439 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.623 ' HE2' HD21 ' A' ' 82' ' ' LEU . 8.1 m-85 -90.02 -70.15 0.68 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.212 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.918 -179.941 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.662 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 15.5 ttm . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.408 ' HB2' ' CD1' ' A' ' 24' ' ' LEU . 88.8 m-85 -75.45 146.68 40.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.992 178.713 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.5 mptm? -110.5 122.01 46.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.719 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.522 HG22 HG22 ' A' ' 68' ' ' VAL . 67.8 t -114.26 133.72 59.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.329 0.585 . . . . 0.0 112.316 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.594 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 18.5 m-85 -111.68 100.72 9.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.176 178.088 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.406 ' N ' HG23 ' A' ' 36' ' ' ILE . . . -162.09 -141.57 3.16 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.51 -179.37 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 1.026 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 52.5 m-85 -117.27 159.18 23.09 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.236 0.214 . . . . 0.0 110.426 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -106.29 17.12 23.91 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.074 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 1.0 OUTLIER 73.18 -1.81 2.93 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 179.936 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -84.99 -46.82 10.85 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.18 0.514 . . . . 0.0 110.507 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.608 HD13 ' O ' ' A' ' 37' ' ' MET . 0.7 OUTLIER -111.4 0.6 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.589 -179.839 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.596 ' CB ' ' CD2' ' A' ' 7' ' ' TYR . 2.2 t60 -166.96 135.17 2.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.397 -177.784 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.48 164.51 22.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.945 -179.066 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 p 177.73 125.65 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.96 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.2 m -91.4 -30.44 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.123 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -77.2 -21.9 53.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.351 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.1 p -72.95 -41.46 64.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.974 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.67 -36.93 84.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.072 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -63.61 -55.48 23.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.69 -28.92 36.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.88 0.371 . . . . 0.0 110.908 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -61.95 -55.14 32.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.021 0.439 . . . . 0.0 110.11 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.778 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -67.21 -29.4 69.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.565 179.402 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.735 ' O ' HD12 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -53.39 -50.74 64.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.536 179.445 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.809 HD12 ' CG ' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -64.55 -50.21 68.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.603 179.846 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 m -56.71 -41.25 77.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.807 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 22' ' ' ARG . 99.7 t -69.94 -35.16 63.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.931 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 3.9 mmtt -74.02 -10.96 60.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.303 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt 70.87 36.99 1.38 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.08 0.467 . . . . 0.0 110.724 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -126.37 138.26 31.96 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.549 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.633 ' O ' ' HA ' ' A' ' 1' ' ' MET . 86.8 Cg_endo -78.34 161.55 28.69 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.458 2.106 . . . . 0.0 111.456 179.601 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.809 ' CG ' HD12 ' A' ' 24' ' ' LEU . 6.5 p90 -161.61 171.31 18.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.328 . . . . 0.0 111.513 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -134.29 121.79 21.78 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.768 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.486 ' HE1' HG11 ' A' ' 4' ' ' VAL . 18.2 t80 -89.44 157.96 17.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.549 HG21 ' HG2' ' A' ' 47' ' ' LYS . 20.1 mt -148.49 120.64 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.635 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -71.24 110.87 6.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.379 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.026 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 1.1 pp -74.0 -29.35 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.398 -179.429 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.651 ' HE3' ' CE2' ' A' ' 7' ' ' TYR . 20.7 ttm -118.28 86.7 27.95 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.661 0.267 . . . . 0.0 110.598 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.465 ' HG3' ' HB3' ' A' ' 44' ' ' ASP . 93.0 Cg_endo -79.54 5.15 6.06 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.571 2.181 . . . . 0.0 112.674 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -139.79 141.25 36.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.113 0.482 . . . . 0.0 111.357 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -63.68 -7.41 7.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.019 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.25 -67.22 0.64 Allowed Glycine 0 C--N 1.314 -0.67 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.188 -179.227 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.6 t -125.59 136.92 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.726 0.298 . . . . 0.0 111.62 -179.259 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.601 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -71.61 170.35 13.62 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.052 179.783 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.648 ' OD1' HD13 ' A' ' 48' ' ' ILE . 4.8 p30 -77.78 124.66 28.24 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.089 0.471 . . . . 0.0 111.711 -179.428 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 4.0 m-20 -80.24 -26.39 39.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.71 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -61.19 -51.44 68.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 111.291 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.549 ' HG2' HG21 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -72.95 -37.55 67.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.858 179.957 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.659 HD11 ' HB ' ' A' ' 36' ' ' ILE . 1.2 mp -72.09 -25.81 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 179.614 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -66.84 -52.68 40.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.563 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.87 -34.71 73.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.185 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.594 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 3.4 tt -57.52 -52.04 67.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.478 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 52' ' ' LEU . 77.1 mt -52.78 -45.0 66.94 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.586 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.7 m -63.42 -44.82 93.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.418 179.702 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -59.62 -33.09 71.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.711 179.7 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.412 HD11 HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -62.33 -66.66 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 179.763 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.25 -28.48 0.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.598 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.28 -165.09 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.742 0.306 . . . . 0.0 110.808 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -103.65 -25.83 13.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.038 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -87.33 164.69 16.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.871 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.427 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . 13.0 mt-30 -109.44 99.28 8.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.001 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pt -80.25 84.39 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.126 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.08 26.01 74.21 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.283 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.738 HD13 ' N ' ' A' ' 64' ' ' THR . 1.7 tm? -62.57 130.59 45.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.861 0.362 . . . . 0.0 110.965 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.738 ' N ' HD13 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -136.68 152.79 50.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 -179.978 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -104.43 152.91 39.39 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.624 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.8 Cg_exo -82.4 140.52 43.29 Favored 'Cis proline' 0 C--N 1.344 0.305 0 C-N-CA 124.025 -1.24 . . . . 0.0 112.817 0.32 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.519 ' CD ' HD21 ' A' ' 63' ' ' LEU . 1.1 mm-40 -99.97 135.85 40.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.078 179.096 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.632 HG11 ' CD1' ' A' ' 82' ' ' LEU . 3.3 t -106.85 158.73 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.05 0.452 . . . . 0.0 111.875 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 75' ' ' HIS . 34.0 m-85 -143.08 138.51 29.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.192 -179.582 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.772 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -53.19 133.05 51.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.171 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.662 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 39.1 Cg_exo -54.38 -21.46 23.52 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.543 2.162 . . . . 0.0 112.133 179.745 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.24 40.08 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.337 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.34 -109.38 0.66 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.884 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.467 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -140.68 -178.07 5.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.11 0.481 . . . . 0.0 111.236 -179.54 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.48 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 29.7 t-80 -56.61 122.64 12.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.053 -179.829 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.772 HD11 ' HA ' ' A' ' 70' ' ' ALA . 24.3 mt -91.08 -47.31 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.689 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 136.11 -155.49 22.44 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.673 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.65 -141.03 9.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.663 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -70.39 -70.76 0.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.72 0.295 . . . . 0.0 110.982 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.76 -49.45 77.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.981 0.419 . . . . 0.0 110.439 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -50.73 -36.18 35.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.445 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.714 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.2 tt -82.23 -32.04 29.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.292 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -50.95 -30.6 15.33 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -35.7 79.41 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.134 178.287 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LEU . 16.1 t80 -63.55 -33.53 75.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.399 178.437 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.714 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.5 m-85 -86.11 -70.34 0.61 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.113 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.954 179.939 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.589 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 35.8 ttp . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.78 0.324 . . . . 0.0 111.562 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 70.2 m-85 -59.46 148.79 31.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 -179.292 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -119.0 123.39 44.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.209 -179.057 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.769 HG11 ' CE1' ' A' ' 33' ' ' PHE . 8.0 t -114.72 139.6 39.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.319 0.581 . . . . 0.0 111.688 179.424 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.47 ' CE1' HD12 ' A' ' 34' ' ' ILE . 23.6 m-85 -122.49 99.77 6.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.454 178.491 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 66' ' ' PRO . . . -158.52 -141.71 3.22 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.435 -179.454 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.963 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 54.8 m-85 -123.13 160.4 26.52 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.826 0.346 . . . . 0.0 111.467 -179.091 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.7 p-10 -93.66 -65.47 0.99 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.9 OUTLIER 162.28 -37.71 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.251 179.88 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -63.82 -45.08 91.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.806 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 40' ' ' LYS . 4.2 mm -89.02 -41.47 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.059 0.456 . . . . 0.0 110.544 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -147.75 138.23 23.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.255 179.183 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.72 155.09 26.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.716 -178.782 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.5 p -162.5 119.11 1.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.392 179.382 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.4 m -88.78 -22.98 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.534 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -90.45 -15.47 30.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.453 -179.749 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.3 p -74.62 -43.65 54.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.79 0.328 . . . . 0.0 110.859 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.48 -46.61 82.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.929 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -55.94 -45.35 78.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.116 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.76 -38.82 92.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.924 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.22 -42.62 61.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.033 0.444 . . . . 0.0 110.379 179.424 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.5 ttt180 -73.24 -26.1 60.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.566 179.466 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.669 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -57.26 -55.94 28.29 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.327 179.657 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.576 HD12 ' CG ' ' A' ' 31' ' ' PHE . 10.6 mt -62.42 -46.82 86.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.628 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.0 m -53.5 -33.08 53.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.042 0.448 . . . . 0.0 110.266 179.462 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 22' ' ' ARG . 69.0 t -75.7 -30.29 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.653 179.54 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 3.4 mmtm -78.21 -9.86 59.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.402 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 64.62 40.49 5.91 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 111.386 179.818 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -122.35 145.17 43.73 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.287 179.332 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.43 ' O ' ' HA ' ' A' ' 1' ' ' MET . 92.6 Cg_endo -78.59 135.43 13.03 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.287 1.991 . . . . 0.0 111.908 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.589 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 17.0 p90 -146.25 167.66 22.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.907 0.384 . . . . 0.0 111.797 179.681 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -136.11 122.06 20.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.2 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.769 ' CE1' HG11 ' A' ' 4' ' ' VAL . 42.0 t80 -89.76 150.38 22.31 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.229 179.437 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.673 HG21 ' HG2' ' A' ' 47' ' ' LYS . 8.4 mt -143.77 119.53 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.157 0.503 . . . . 0.0 110.936 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -78.13 109.65 12.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.869 179.206 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.963 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 13.9 pt -59.64 -29.01 41.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.397 -179.291 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.589 ' HB2' ' HB3' ' A' ' 43' ' ' PHE . 3.2 ttp -121.82 87.04 46.22 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.706 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.43 -4.04 14.74 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.732 2.288 . . . . 0.0 112.797 -179.85 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -139.58 135.61 33.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.817 0.341 . . . . 0.0 110.694 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.465 ' N ' HG23 ' A' ' 11' ' ' ILE . 5.4 ttmt -65.16 -7.65 13.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.291 0.567 . . . . 0.0 112.055 -179.595 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.47 -64.6 1.38 Allowed Glycine 0 C--N 1.312 -0.766 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.815 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.7 t -141.03 129.91 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.066 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.589 ' HB3' ' HB2' ' A' ' 37' ' ' MET . 0.0 OUTLIER -69.0 166.76 17.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.138 0.494 . . . . 0.0 112.184 -178.719 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.86 ' O ' HD12 ' A' ' 48' ' ' ILE . 10.4 t70 -82.24 97.2 8.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.886 -178.764 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -67.49 -15.89 63.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.837 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' HB2' ' OD1' ' A' ' 44' ' ' ASP . 2.9 mm-40 -63.53 -51.05 67.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.71 0.291 . . . . 0.0 110.647 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.673 ' HG2' HG21 ' A' ' 34' ' ' ILE . 2.9 mptp? -71.11 -37.67 72.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.348 179.522 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.86 HD12 ' O ' ' A' ' 44' ' ' ASP . 1.5 mp -67.58 -35.36 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.882 179.239 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.38 -47.12 86.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.712 179.723 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.8 -39.08 87.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.316 179.674 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.595 HD13 ' CE1' ' A' ' 69' ' ' PHE . 10.5 tp -56.75 -51.41 68.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.443 179.686 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.613 HD21 ' HG2' ' A' ' 60' ' ' GLN . 80.3 mt -50.82 -45.71 59.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.489 179.715 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.0 m -61.57 -42.22 98.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.614 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.403 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -60.61 -38.57 85.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.704 179.819 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.91 -59.04 6.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.924 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.09 -26.2 0.62 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.06 -179.612 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -135.83 -162.12 1.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -115.55 23.24 12.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.58 0.229 . . . . 0.0 111.293 -179.811 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.7 t -120.89 143.16 49.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.911 0.386 . . . . 0.0 111.804 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.613 ' HG2' HD21 ' A' ' 52' ' ' LEU . 12.3 mt-30 -96.7 99.57 11.17 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.575 178.897 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 61' ' ' ILE . 0.8 OUTLIER -72.27 77.52 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.43 -178.403 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 36.09 30.03 0.02 OUTLIER Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.056 178.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 61' ' ' ILE . 0.8 OUTLIER -65.74 162.23 19.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.008 0.432 . . . . 0.0 111.265 -179.466 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.2 158.6 17.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.081 -179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.2 mtm -116.2 156.93 46.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.564 179.596 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.457 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . 4.8 Cg_exo -80.92 147.26 73.45 Favored 'Cis proline' 0 C--N 1.346 0.406 0 C-N-CA 124.244 -1.149 . . . . 0.0 112.991 0.511 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.54 135.66 34.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.039 178.748 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.726 HG22 HG22 ' A' ' 4' ' ' VAL . 3.1 t -113.5 159.09 13.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.948 0.404 . . . . 0.0 111.659 -179.494 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.595 ' CE1' HD13 ' A' ' 51' ' ' LEU . 40.0 m-85 -142.43 147.02 35.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.637 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.932 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -56.11 157.97 7.91 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.55 -178.464 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.507 ' HB3' ' N ' ' A' ' 1' ' ' MET . 32.3 Cg_exo -60.67 -25.98 82.01 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.262 2.642 . . . . 0.0 112.258 179.288 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -20.67 17.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.443 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.23 89.01 1.11 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.665 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.442 ' O ' HD12 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -169.25 145.76 3.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.655 0.264 . . . . 0.0 110.386 179.845 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -78.43 115.41 18.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.835 0.35 . . . . 0.0 110.937 -179.787 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.932 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.8 mp -102.13 -46.05 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.711 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.32 -159.47 22.39 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.874 179.359 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.53 -123.24 3.24 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.5 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.669 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -83.39 -67.72 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.779 -0.247 . . . . 0.0 110.947 179.769 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -50.51 -48.02 57.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.274 0.559 . . . . 0.0 110.463 179.766 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -60.5 -47.43 86.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.847 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.435 HD21 ' CE2' ' A' ' 86' ' ' PHE . 1.1 tt -66.62 -41.77 87.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.551 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 87' ' ' LYS . 7.1 ttt180 -51.67 -31.38 25.53 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.826 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -71.25 -32.78 69.15 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.513 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.47 ' CD2' HG12 ' A' ' 76' ' ' ILE . 49.2 t80 -70.26 -29.22 65.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.016 178.853 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.435 ' CE2' HD21 ' A' ' 82' ' ' LEU . 26.4 m-85 -99.66 -70.85 0.72 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.558 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.451 ' N ' ' O ' ' A' ' 83' ' ' ARG . 15.2 pttp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.413 179.983 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.667 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 10.5 ttm . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.829 0.347 . . . . 0.0 111.675 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.488 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 85.4 m-85 -83.85 145.81 28.44 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.226 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.712 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -123.99 126.51 46.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 -179.26 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 68' ' ' VAL . 70.2 t -114.04 132.52 62.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.393 0.616 . . . . 0.0 111.49 179.273 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.516 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 18.6 m-85 -110.57 99.64 8.58 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.06 178.256 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.0 -144.31 3.93 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.979 -179.092 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.471 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 29.6 m-85 -125.8 150.16 48.02 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 120.744 0.307 . . . . 0.0 111.123 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.95 -74.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.995 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.3 t 175.29 -34.34 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.761 0.315 . . . . 0.0 111.321 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -81.2 -24.36 37.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.298 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.679 HD12 ' N ' ' A' ' 11' ' ' ILE . 2.6 mp -91.12 -42.12 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.897 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.414 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 5.7 t-80 -155.8 153.3 29.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.271 -179.62 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -55.71 145.37 24.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.079 0.466 . . . . 0.0 111.518 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 t -167.49 75.67 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.028 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.1 m -90.61 -20.38 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.272 179.559 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -75.47 -27.53 58.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.393 -179.525 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.8 p -79.87 -40.91 27.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.324 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.04 -41.81 48.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.112 0.482 . . . . 0.0 110.786 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -72.78 -49.23 32.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.65 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.29 -41.73 72.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.964 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -52.38 65.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.619 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.786 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.7 tpt180 -59.05 -36.61 75.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.656 179.698 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.687 HD23 ' N ' ' A' ' 24' ' ' LEU . 2.4 tt -60.4 -54.82 41.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.466 179.535 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.687 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.4 mt -54.78 -45.6 74.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.71 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.9 m -56.81 -35.58 68.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.173 0.511 . . . . 0.0 109.96 179.291 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 22' ' ' ARG . 50.0 t -79.99 -29.86 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.683 179.304 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.49 -11.74 59.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.031 179.742 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt 67.97 56.61 0.53 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.876 0.369 . . . . 0.0 110.951 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -134.33 135.85 24.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.76 132.75 12.18 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.461 2.108 . . . . 0.0 111.705 179.36 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.667 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 22.9 p90 -156.03 169.76 23.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.65 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -148.16 139.06 23.14 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.438 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.655 ' HE1' HG12 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -89.88 150.96 21.97 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.708 179.916 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.443 HG21 ' HD3' ' A' ' 47' ' ' LYS . 17.2 mt -140.95 121.96 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.063 0.458 . . . . 0.0 110.387 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -78.35 109.49 12.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.587 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.511 ' HB ' HD11 ' A' ' 48' ' ' ILE . 1.8 pt -73.71 -7.05 9.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.43 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.477 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -126.21 80.52 68.38 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-O 120.844 0.354 . . . . 0.0 111.076 -179.679 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.51 -20.38 69.55 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.705 2.27 . . . . 0.0 111.817 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 37' ' ' MET . 34.1 mt-10 -139.65 140.09 36.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.369 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.25 -8.75 2.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.217 0.532 . . . . 0.0 111.881 -179.647 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.4 -58.35 3.37 Favored Glycine 0 C--N 1.312 -0.772 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.706 179.803 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -150.55 150.13 13.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.81 0.338 . . . . 0.0 111.754 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -63.14 170.68 2.7 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.484 179.266 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -86.15 100.59 12.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.873 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -55.78 -25.29 40.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.488 -179.647 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -65.49 -60.43 2.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.943 0.401 . . . . 0.0 110.542 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.443 ' HD3' HG21 ' A' ' 34' ' ' ILE . 24.2 mttt -65.22 -33.74 76.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.345 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.511 HD11 ' HB ' ' A' ' 36' ' ' ILE . 15.8 mm -73.79 -29.69 26.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.647 179.64 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -61.68 -55.85 26.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.991 -179.645 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -62.47 -35.26 78.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.308 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.516 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 2.9 tt -56.72 -50.89 70.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.273 179.603 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.3 mt -52.82 -48.82 66.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.115 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.0 m -63.72 -38.14 89.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.023 179.302 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.5 -43.01 88.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.382 179.436 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 mt -59.94 -47.24 86.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.668 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 172.37 -113.93 0.5 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.053 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -150.53 30.56 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.047 0.451 . . . . 0.0 110.745 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.04 -148.33 0.41 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.324 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 t -120.21 165.78 14.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.715 0.293 . . . . 0.0 110.626 179.624 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.482 ' O ' ' NE2' ' A' ' 60' ' ' GLN . 0.7 OUTLIER -69.69 98.82 1.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.726 0.774 . . . . 0.0 110.594 179.96 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.1 mt -79.68 83.08 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.037 -179.746 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.29 24.44 44.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.458 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.618 HD12 ' CD ' ' A' ' 67' ' ' GLN . 1.0 OUTLIER -64.76 152.11 43.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.927 -179.988 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.8 p -133.72 170.12 16.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.493 . . . . 0.0 111.691 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.86 160.46 26.73 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.31 179.405 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -82.7 144.46 54.37 Favored 'Cis proline' 0 C--N 1.344 0.312 0 C-N-CA 124.406 -1.081 . . . . 0.0 113.188 0.608 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.618 ' CD ' HD12 ' A' ' 63' ' ' LEU . 2.1 mm100 -105.74 125.55 51.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.969 178.815 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 4' ' ' VAL . 4.0 t -98.9 160.72 3.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.909 0.385 . . . . 0.0 111.746 -179.301 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.449 ' N ' HG12 ' A' ' 68' ' ' VAL . 28.5 m-85 -142.95 131.54 22.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.895 -179.843 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.568 ' N ' HD11 ' A' ' 76' ' ' ILE . . . -64.0 142.78 98.22 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.463 -178.742 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.585 ' HB3' ' N ' ' A' ' 1' ' ' MET . 45.3 Cg_exo -41.37 -30.97 0.92 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.28 2.653 . . . . 0.0 112.677 179.234 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -164.26 35.16 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.594 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.02 -97.84 1.89 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.566 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.8 m -165.32 175.6 9.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.96 0.41 . . . . 0.0 110.889 -179.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.422 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 14.2 t-80 -50.04 101.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.997 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.568 HD11 ' N ' ' A' ' 70' ' ' ALA . 3.3 mt -67.32 -52.78 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.405 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.533 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 138.64 -150.83 21.31 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.753 -179.69 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.4 -142.01 11.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.748 -179.719 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -70.12 -70.81 0.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.771 0.32 . . . . 0.0 110.948 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -58.97 -44.03 91.44 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.018 0.437 . . . . 0.0 110.437 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -53.11 -36.01 60.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.417 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.741 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.6 tt -80.42 -34.63 36.02 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.296 179.639 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -51.23 -29.81 15.45 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.647 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -69.0 -35.06 76.26 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.22 178.159 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 82' ' ' LEU . 9.1 t80 -63.24 -34.19 77.13 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.288 178.397 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.741 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.4 m-85 -88.0 -70.16 0.65 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.276 179.761 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.864 -179.996 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.647 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 59.0 ttp . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 120.713 0.292 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.509 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 76.9 m-85 -80.15 154.51 27.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.02 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.72 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -133.6 130.46 38.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.484 -178.794 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.922 HG22 HG22 ' A' ' 68' ' ' VAL . 27.0 t -114.09 138.31 44.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.195 0.522 . . . . 0.0 111.694 179.306 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.791 ' CE1' HD12 ' A' ' 34' ' ' ILE . 4.2 m-85 -115.89 99.47 7.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.997 178.276 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 35' ' ' ASN . . . -158.61 -138.58 2.5 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.446 -179.228 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.707 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 64.7 m-85 -117.92 154.67 31.51 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 120.865 0.364 . . . . 0.0 111.021 -179.517 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.49 -77.9 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.788 -179.853 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 t 170.78 -37.88 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.955 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.49 -29.56 52.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.26 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.496 HG23 ' N ' ' A' ' 40' ' ' LYS . 10.4 mm -89.03 -40.36 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.059 0.457 . . . . 0.0 110.631 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -150.32 148.54 28.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.573 179.518 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -78.37 160.04 28.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.302 -179.599 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.1 t -174.63 103.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.722 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 m -79.98 -37.88 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.217 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.46 -22.92 66.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.16 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.2 m -65.77 -57.72 7.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.909 0.385 . . . . 0.0 110.837 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -53.44 -25.98 18.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.316 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -70.39 -63.29 1.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.611 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.538 ' HB2' ' HB2' ' A' ' 79' ' ' PHE . . . -57.4 -27.04 62.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.796 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.2 tttm -59.59 -56.53 20.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.475 179.726 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.638 ' O ' HG23 ' A' ' 26' ' ' VAL . 8.9 ttt85 -61.51 -25.5 67.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.523 179.456 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.555 HD11 ' HG2' ' A' ' 83' ' ' ARG . 1.0 OUTLIER -59.53 -55.42 34.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.451 179.626 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.5 mt -63.52 -43.0 98.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.8 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.2 m -58.75 -41.25 86.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.175 0.512 . . . . 0.0 109.986 179.243 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 22' ' ' ARG . 95.8 t -78.86 -25.03 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.456 179.25 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.535 ' HG2' ' CE1' ' A' ' 86' ' ' PHE . 12.4 tppt? -71.75 -18.81 62.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.226 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt 69.86 53.76 0.37 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 111.11 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -143.7 145.92 33.01 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.996 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.33 138.88 22.81 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.557 2.171 . . . . 0.0 111.919 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.647 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 4.2 p90 -158.36 169.6 24.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.058 0.456 . . . . 0.0 112.154 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -144.18 143.14 30.94 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.789 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.51 ' HE1' HG11 ' A' ' 4' ' ' VAL . 21.0 t80 -89.41 158.45 17.74 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.318 -179.749 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.791 HD12 ' CE1' ' A' ' 5' ' ' TYR . 11.7 mt -145.67 119.75 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.168 179.26 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.0 p30 -90.6 133.04 35.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.544 -179.176 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.707 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 6.8 pt -90.28 -22.5 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.056 179.529 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.61 ' HB2' ' HB3' ' A' ' 43' ' ' PHE . 2.9 ttp -123.68 91.34 49.8 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.406 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 6.1 Cg_exo -74.05 -4.36 15.3 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.891 2.394 . . . . 0.0 112.569 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 37' ' ' MET . 0.1 OUTLIER -139.62 136.98 34.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.74 0.305 . . . . 0.0 110.805 -179.837 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.496 ' N ' HG23 ' A' ' 11' ' ' ILE . 4.0 ttpm? -63.69 -8.9 11.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.144 0.497 . . . . 0.0 112.102 -179.749 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.56 -64.6 1.43 Allowed Glycine 0 C--N 1.312 -0.774 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.164 179.583 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.8 t -141.24 139.91 32.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.611 0.243 . . . . 0.0 110.86 179.717 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.61 ' HB3' ' HB2' ' A' ' 37' ' ' MET . 0.1 OUTLIER -68.83 169.92 10.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.986 0.422 . . . . 0.0 111.379 -179.73 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.406 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -93.58 107.94 19.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.161 -179.678 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 1.8 p30 -56.29 -22.01 27.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.304 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -57.44 -51.19 70.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.838 0.351 . . . . 0.0 110.928 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -76.85 -35.15 57.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.308 179.632 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.534 HD11 ' HB ' ' A' ' 36' ' ' ILE . 32.6 mm -62.46 -44.36 99.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.873 179.672 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.96 -56.81 9.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.245 -179.487 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -57.75 -33.16 68.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.585 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.695 HD13 ' CD2' ' A' ' 5' ' ' TYR . 10.4 tp -57.72 -51.74 68.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.382 179.574 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.2 mt -52.47 -45.85 66.27 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.196 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.6 m -67.19 -35.63 80.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.32 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -62.67 -32.16 73.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.495 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.08 -53.54 48.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.84 179.747 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.62 -41.93 1.24 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.297 -179.848 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -98.76 -165.5 1.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.882 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -104.0 -32.83 9.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 t -110.54 166.32 11.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 18.4 mt-30 -110.62 99.47 8.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 pt -68.17 80.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.199 179.926 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.95 17.75 73.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.668 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.832 HD12 ' NE2' ' A' ' 67' ' ' GLN . 0.3 OUTLIER -79.96 139.28 37.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.908 180.0 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.67 171.35 14.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.489 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.43 ' SD ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -89.72 156.37 47.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.651 179.475 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.0 Cg_exo -76.58 147.66 87.27 Favored 'Cis proline' 0 C--N 1.345 0.36 0 C-N-CA 123.865 -1.306 . . . . 0.0 113.073 0.4 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.832 ' NE2' HD12 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -107.73 111.55 23.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.406 179.314 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.922 HG22 HG22 ' A' ' 4' ' ' VAL . 5.6 t -93.65 161.1 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.933 0.397 . . . . 0.0 111.821 -179.319 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.473 ' N ' HG12 ' A' ' 68' ' ' VAL . 96.0 m-85 -142.05 146.6 35.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.622 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -84.31 137.68 39.44 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.242 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.553 ' HB3' ' N ' ' A' ' 1' ' ' MET . 39.0 Cg_exo -34.94 -36.88 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.634 2.889 . . . . 0.0 112.183 178.674 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -166.6 31.02 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.124 179.683 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.72 15.91 9.01 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.761 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 p 73.36 179.93 0.21 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.125 0.488 . . . . 0.0 111.412 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.473 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 24.4 t-80 -52.57 125.71 17.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.502 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.622 HD11 ' HA ' ' A' ' 70' ' ' ALA . 26.7 mt -94.76 -47.9 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.657 179.538 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.5 -151.71 20.95 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.657 -179.71 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.44 -144.95 17.87 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.592 -179.792 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.538 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 11.1 t80 -70.65 -70.6 0.29 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.771 0.32 . . . . 0.0 110.775 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -59.18 -47.22 86.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.958 0.408 . . . . 0.0 110.477 179.926 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -41.15 63.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.264 179.582 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.587 HD21 ' CD2' ' A' ' 86' ' ' PHE . 4.5 tt -76.23 -35.39 59.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.051 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.555 ' HG2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.52 -28.05 12.5 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.755 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -72.29 -33.61 67.55 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.367 178.352 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.616 ' CD2' HG23 ' A' ' 76' ' ' ILE . 6.2 t80 -65.64 -32.85 74.64 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.399 178.568 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.587 ' CD2' HD21 ' A' ' 82' ' ' LEU . 10.7 m-85 -95.13 -70.19 0.72 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.521 179.718 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.818 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.645 ' HG3' ' HA ' ' A' ' 31' ' ' PHE . 2.5 tpp . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.799 0.333 . . . . 0.0 111.637 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.521 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 82.9 m-85 -68.82 148.42 50.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.958 0.408 . . . . 0.0 110.538 -179.786 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.683 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -120.25 118.51 30.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.157 -179.973 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.647 HG22 HG22 ' A' ' 68' ' ' VAL . 6.2 t -105.28 122.74 58.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.343 0.592 . . . . 0.0 111.921 -179.607 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.596 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.6 m-30 -99.95 99.39 10.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.923 178.659 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.74 -138.07 2.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.369 -179.068 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -131.07 104.09 6.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.56 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 8' ' ' ASP . 0.5 OUTLIER -108.8 22.84 15.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.604 0.24 . . . . 0.0 110.465 178.53 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.1 t -116.07 175.16 5.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.42 0.629 . . . . 0.0 111.774 -179.103 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -87.37 8.26 25.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.22 179.059 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.2 mm -87.66 -16.28 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.382 179.333 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -153.51 144.92 23.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.471 179.18 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.34 166.79 20.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.048 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.3 p 179.19 116.9 0.04 OUTLIER 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.831 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.7 m -90.84 -35.8 7.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.87 0.367 . . . . 0.0 111.134 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -77.41 -19.32 56.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.49 -179.647 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.6 p -65.76 -43.41 88.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 0.0 110.634 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.31 -38.24 63.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.858 179.752 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -68.74 -41.14 79.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.432 -179.428 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.491 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -67.04 -40.03 87.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.774 0.321 . . . . 0.0 111.487 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HD2' ' CZ ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -57.3 -48.55 78.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.836 0.35 . . . . 0.0 110.491 179.753 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.832 ' O ' HG23 ' A' ' 26' ' ' VAL . 41.7 ptt85 -64.93 -33.42 75.99 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.979 0.418 . . . . 0.0 110.503 179.624 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.734 HD13 ' N ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.45 -49.75 71.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.325 179.285 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.734 ' N ' HD13 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -64.4 -47.51 78.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.447 179.266 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 m -54.24 -36.98 64.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.003 179.328 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 22' ' ' ARG . 59.5 t -77.46 -27.92 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.414 179.251 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 -11.57 57.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.093 179.787 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 70.27 57.71 0.27 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.907 0.384 . . . . 0.0 111.245 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -135.37 137.75 27.14 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.113 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.461 ' O ' ' HA ' ' A' ' 1' ' ' MET . 54.8 Cg_endo -80.8 134.32 9.58 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.598 2.199 . . . . 0.0 111.123 179.111 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.645 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 28.9 p90 -159.44 169.88 22.97 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.12 -0.632 . . . . 0.0 112.547 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -144.56 142.68 30.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.27 -179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.505 ' HD1' ' N ' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -89.8 133.9 34.47 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.071 -179.935 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.596 HD12 ' CE1' ' A' ' 5' ' ' TYR . 7.6 mt -115.42 109.93 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.174 0.511 . . . . 0.0 110.22 178.939 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -74.1 134.08 42.88 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.048 -179.774 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 pt -100.12 -6.93 9.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.987 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 30.7 ttm -122.93 95.29 46.42 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.653 0.263 . . . . 0.0 111.62 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.0 -24.46 17.32 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.475 2.117 . . . . 0.0 111.842 179.485 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -140.86 147.72 39.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.644 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -64.4 -8.42 13.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.253 0.549 . . . . 0.0 111.801 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.0 -56.37 3.08 Favored Glycine 0 C--N 1.312 -0.753 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.61 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -147.95 145.09 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.981 0.42 . . . . 0.0 111.815 -179.614 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -68.21 170.66 8.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.559 179.434 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.29 84.1 5.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.45 -27.92 7.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.362 179.889 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -56.73 -50.3 72.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.939 0.4 . . . . 0.0 110.574 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -40.03 64.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.226 179.343 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 mm -52.24 -44.61 42.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.851 179.607 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.4 -56.74 12.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.57 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -57.76 -34.74 69.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.355 179.507 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.034 HD13 HD11 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -59.86 -56.69 18.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.238 179.863 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.588 ' HA ' HD13 ' A' ' 55' ' ' LEU . 66.8 mt -43.4 -45.5 6.23 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.384 0.611 . . . . 0.0 110.884 179.11 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.4 m -70.39 -33.33 71.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.166 178.85 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -64.32 -39.86 94.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.305 179.918 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.034 HD11 HD13 ' A' ' 51' ' ' LEU . 4.4 mp -59.76 -66.99 0.43 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.899 0.38 . . . . 0.0 111.08 -179.739 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 158.24 -34.95 0.52 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.405 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.58 -164.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.774 0.321 . . . . 0.0 110.903 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -99.74 -33.12 10.71 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.787 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 t -119.65 170.11 9.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.815 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.424 ' HB2' ' CB ' ' A' ' 63' ' ' LEU . 4.0 pt20 -113.17 99.81 8.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.0 0.428 . . . . 0.0 110.909 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mt -79.93 80.85 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.389 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.36 -18.63 56.75 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.854 179.683 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.424 ' CB ' ' HB2' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -59.48 136.17 57.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 0.0 110.915 -179.959 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 65' ' ' MET . 0.5 OUTLIER -143.06 171.33 14.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.353 -179.465 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.436 ' H ' HG22 ' A' ' 64' ' ' THR . 0.0 OUTLIER -89.45 153.2 48.19 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.565 179.56 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.9 Cg_exo -77.13 138.78 55.53 Favored 'Cis proline' 0 C--N 1.344 0.339 0 C-N-CA 123.877 -1.301 . . . . 0.0 112.954 0.263 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.68 ' OE1' HD11 ' A' ' 51' ' ' LEU . 5.3 mt-30 -100.91 112.96 25.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.996 179.054 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.9 t -91.08 163.74 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 0.0 111.752 -179.213 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.515 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 28.5 m-85 -142.1 132.1 24.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.348 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.823 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -48.56 149.45 2.92 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.635 -178.663 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.6 ' HB3' ' N ' ' A' ' 1' ' ' MET . 52.9 Cg_exo -57.27 -29.02 82.35 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.106 2.537 . . . . 0.0 111.882 179.156 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -94.41 -23.13 17.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.034 179.818 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.56 79.02 0.51 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.568 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.491 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -164.5 119.13 1.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.833 0.349 . . . . 0.0 110.904 179.931 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -51.37 111.3 0.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.051 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.823 HD11 ' HA ' ' A' ' 70' ' ' ALA . 27.0 mt -88.51 -50.43 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.987 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 126.99 -154.48 19.39 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.624 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -87.1 -144.83 8.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.281 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.491 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -72.81 -68.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.725 0.262 . . . . 0.0 110.849 179.75 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -47.09 -42.33 18.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.156 0.503 . . . . 0.0 110.39 179.611 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -40.03 95.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.372 179.507 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.633 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -72.49 -43.68 63.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.346 179.741 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.13 -33.42 18.8 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.792 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -69.9 -36.55 75.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.202 178.339 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 82' ' ' LEU . 10.2 t80 -63.51 -33.77 76.3 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.465 178.39 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.633 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.4 m-85 -86.34 -70.36 0.61 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.047 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.885 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.596 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 11.2 tpp . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.307 0.098 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 76.8 m-85 -39.53 123.75 1.53 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.61 0.719 . . . . 0.0 111.74 -177.243 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.673 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -89.54 125.22 35.12 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.152 -179.316 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 68' ' ' VAL . 51.5 t -116.77 147.24 20.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.253 0.549 . . . . 0.0 110.959 179.187 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.668 ' CZ ' HD12 ' A' ' 34' ' ' ILE . 85.7 m-85 -129.06 99.67 5.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.061 178.761 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.414 ' O ' HD13 ' A' ' 36' ' ' ILE . . . -159.68 -142.38 3.38 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.13 -179.06 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.686 ' CE1' HD11 ' A' ' 36' ' ' ILE . 60.2 m-85 -115.37 145.17 42.78 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.565 0.221 . . . . 0.0 110.831 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -106.05 27.57 8.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.942 0.401 . . . . 0.0 110.438 179.738 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.2 p 64.02 10.74 5.59 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.313 -179.722 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -86.19 -63.88 1.24 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.894 0.378 . . . . 0.0 110.891 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.426 HG21 ' N ' ' A' ' 40' ' ' LYS . 18.4 mm -96.62 -17.66 6.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.376 -179.051 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.51 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 6.1 t-80 -153.32 160.52 42.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.984 0.421 . . . . 0.0 111.644 -179.441 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -46.55 156.94 0.16 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.188 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.9 t -153.64 69.28 0.8 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.037 -179.76 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.444 HG23 ' N ' ' A' ' 16' ' ' TYR . 27.5 m -91.78 -43.15 13.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.444 ' N ' HG23 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -70.75 -22.65 62.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.453 -179.204 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.07 -42.71 14.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.692 179.826 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -52.28 -31.56 33.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.408 179.548 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -78.49 -56.46 4.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.644 179.605 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.448 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . . . -55.39 -45.26 76.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.875 0.369 . . . . 0.0 111.076 179.841 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 27.2 ttpt -58.92 -45.7 89.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.598 179.744 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.801 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.6 tmm_? -63.21 -37.27 86.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.556 179.737 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.791 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -56.98 -53.03 62.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.239 179.499 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.791 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.7 mt -56.51 -44.86 81.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.602 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.0 m -58.27 -39.07 78.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.967 179.353 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.7 t -73.0 -39.96 58.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.555 179.334 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -10.14 59.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.999 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 69.41 49.95 0.56 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.935 0.398 . . . . 0.0 110.375 -179.674 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.17 112.26 8.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.394 -179.634 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.596 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 83.4 Cg_exo -49.96 179.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.341 2.027 . . . . 0.0 111.585 179.052 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CE2' ' HG3' ' A' ' 21' ' ' LYS . 4.8 p90 -164.54 170.13 16.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.077 0.465 . . . . 0.0 111.346 178.111 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 2.7 tt0 -134.55 109.49 8.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.628 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.574 ' CE1' HG11 ' A' ' 4' ' ' VAL . 7.9 t80 -91.94 159.89 15.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.206 0.527 . . . . 0.0 111.82 -179.446 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.668 HD12 ' CZ ' ' A' ' 5' ' ' TYR . 20.6 mt -150.1 122.93 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.075 179.152 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -80.0 124.39 28.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.09 -179.639 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.686 HD11 ' CE1' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -88.7 -18.04 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.17 179.652 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -125.22 83.4 60.92 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.667 179.864 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.5 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 57.7 Cg_endo -70.82 -12.98 31.67 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.62 2.213 . . . . 0.0 111.708 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -139.55 136.93 34.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.912 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.426 ' N ' HG21 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -61.63 -8.28 4.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.312 0.577 . . . . 0.0 111.543 -179.59 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.5 -60.43 3.24 Favored Glycine 0 C--N 1.313 -0.737 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.543 179.659 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 43' ' ' PHE . 20.3 t -151.41 160.44 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.425 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.521 ' N ' HG12 ' A' ' 42' ' ' VAL . 1.7 m-30 -60.05 170.4 1.24 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.587 178.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.5 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 66.6 t0 -99.91 96.96 7.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.513 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -48.66 -34.35 11.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.273 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -65.5 -58.09 6.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.817 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -32.26 71.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.651 179.749 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.4 mp -75.4 -29.67 21.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.523 179.761 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.35 -54.4 46.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.877 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -64.17 -35.19 79.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 110.224 179.615 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.779 HD22 HD11 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -62.03 -59.47 5.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.476 179.057 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.576 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 69.2 mt -44.88 -41.3 7.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.114 179.092 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.6 m -70.62 -32.29 69.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.575 -179.561 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 19.8 mtpp -64.84 -45.08 87.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.75 -179.193 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.779 HD11 HD22 ' A' ' 51' ' ' LEU . 1.3 mp -59.52 -39.4 83.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.859 0.361 . . . . 0.0 111.168 -179.645 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.86 -120.46 0.83 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.343 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -146.99 30.27 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.054 0.454 . . . . 0.0 110.619 179.522 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -121.18 -146.29 0.37 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.258 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -120.39 168.55 11.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.689 0.281 . . . . 0.0 110.599 179.663 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.409 ' OE1' HD21 ' A' ' 52' ' ' LEU . 68.8 mt-30 -87.73 98.89 11.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.254 0.55 . . . . 0.0 110.484 179.628 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pt -79.9 84.68 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.161 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.52 26.2 64.16 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.382 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.598 HD12 ' OE1' ' A' ' 67' ' ' GLN . 1.4 mm? -54.02 153.12 5.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.872 0.368 . . . . 0.0 110.787 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.5 p -119.19 161.08 20.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.133 0.492 . . . . 0.0 111.466 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.7 mmt -108.69 153.68 42.12 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.393 179.552 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.557 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.4 Cg_endo -86.17 146.01 36.2 Favored 'Cis proline' 0 N--CA 1.461 -0.396 0 C-N-CA 124.268 -1.138 . . . . 0.0 112.912 0.517 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.598 ' OE1' HD12 ' A' ' 63' ' ' LEU . 29.2 tp60 -97.05 122.29 39.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.877 178.768 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 4' ' ' VAL . 8.2 t -104.46 157.79 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.759 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.627 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 92.7 m-85 -142.49 164.26 30.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.039 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.634 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -64.49 157.59 71.57 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.771 -179.519 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.26 -21.62 67.41 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.896 2.397 . . . . 0.0 112.418 179.593 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -109.72 -16.46 13.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.617 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.69 97.76 1.11 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.798 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 15.2 t -178.57 151.74 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.674 0.273 . . . . 0.0 110.34 179.623 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.483 ' NE2' ' NE2' ' A' ' 67' ' ' GLN . 9.1 t-160 -85.63 113.73 22.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.146 -179.603 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.634 HD12 ' N ' ' A' ' 70' ' ' ALA . 1.7 mp -103.17 -39.54 6.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.865 0.364 . . . . 0.0 110.658 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.04 -160.4 23.88 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.704 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.16 -134.53 7.99 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.615 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 9.2 t80 -70.63 -70.67 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.72 0.295 . . . . 0.0 111.422 -179.597 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -60.51 -44.49 95.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.994 0.426 . . . . 0.0 110.999 -179.813 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -52.14 -41.15 62.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.698 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.737 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.2 tt -74.85 -34.04 62.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.217 179.786 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -51.15 -31.46 19.89 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.618 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.64 -35.16 79.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.208 178.257 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.462 ' N ' ' O ' ' A' ' 82' ' ' LEU . 13.5 t80 -63.59 -33.57 75.89 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.337 178.459 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.737 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.6 m-85 -86.76 -70.24 0.62 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.275 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.975 -179.956 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.688 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 31.4 ttp . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.872 0.368 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.465 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 96.3 m-85 -82.71 143.35 30.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.068 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.71 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -117.14 122.56 44.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.719 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.064 HG22 HG22 ' A' ' 68' ' ' VAL . 7.7 t -111.03 130.06 65.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.464 0.65 . . . . 0.0 111.7 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.512 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 20.1 m-85 -111.95 101.76 10.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.651 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 66' ' ' PRO . . . -163.89 -139.42 2.63 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.653 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.492 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 85.1 m-85 -123.19 159.52 28.45 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.711 0.291 . . . . 0.0 111.254 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.8 -65.76 1.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.254 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 t 168.79 -32.53 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 110.792 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -65.53 -47.27 76.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.122 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.563 ' H ' HD12 ' A' ' 11' ' ' ILE . 3.7 mp -91.32 -44.99 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.019 0.437 . . . . 0.0 110.934 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.492 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 23.4 t60 -143.2 155.96 44.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.39 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -80.98 171.24 15.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.854 0.359 . . . . 0.0 111.264 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.0 p -179.37 115.36 0.06 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.973 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 m -90.86 -36.67 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.298 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -80.25 -15.45 56.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.655 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.0 p -66.25 -42.4 88.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.928 0.394 . . . . 0.0 110.621 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.2 -41.92 66.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.409 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -56.86 -48.14 78.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.484 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.88 -47.32 83.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.134 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -49.66 -31.72 11.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.944 0.402 . . . . 0.0 110.376 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.874 ' O ' HG23 ' A' ' 26' ' ' VAL . 22.0 ttp180 -74.33 -34.6 63.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.195 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.686 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -55.52 -51.72 66.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.254 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.29 -54.17 49.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.848 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 m -49.22 -36.01 18.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.718 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 22' ' ' ARG . 74.6 t -69.33 -29.75 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.802 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -16.84 27.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.347 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt 71.67 65.05 0.15 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.987 0.422 . . . . 0.0 110.682 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -130.81 142.3 45.04 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.65 128.58 11.08 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.414 2.076 . . . . 0.0 111.641 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.688 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 16.0 p90 -158.88 167.7 28.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.97 147.04 27.39 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.105 0.479 . . . . 0.0 111.35 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.651 ' CE1' HG11 ' A' ' 4' ' ' VAL . 7.8 t80 -89.47 156.42 18.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.007 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.2 mt -145.85 119.99 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.409 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -74.92 109.81 8.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.687 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.7 pt -72.84 -13.64 16.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.301 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.522 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -119.86 80.66 25.48 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.76 0.314 . . . . 0.0 111.088 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 60.8 Cg_endo -72.37 -9.86 24.79 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.632 2.221 . . . . 0.0 111.9 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -139.53 136.67 34.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.469 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -60.94 -8.74 3.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.232 0.539 . . . . 0.0 112.0 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.09 -62.06 2.15 Favored Glycine 0 C--N 1.312 -0.774 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.338 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 43' ' ' PHE . 21.2 t -150.4 154.91 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.765 0.316 . . . . 0.0 111.45 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -59.75 169.97 1.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.613 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.418 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 6.3 t0 -82.32 100.44 9.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.943 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -55.27 -27.01 43.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.05 -54.98 29.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 110.875 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -73.81 -33.29 64.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.526 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.2 mm -71.57 -31.67 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.649 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -66.31 -56.32 11.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -59.37 -30.01 68.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.939 0.399 . . . . 0.0 110.226 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.651 ' O ' HD12 ' A' ' 55' ' ' LEU . 2.0 tt -59.67 -58.59 7.92 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.571 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.569 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 73.9 mt -45.93 -42.59 13.02 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.593 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 m -70.92 -31.12 67.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.661 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 1.8 tttp -60.8 -48.34 82.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.419 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.2 mp -59.32 -59.63 5.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.049 0.452 . . . . 0.0 111.065 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.35 -114.2 0.29 Allowed Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.048 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.9 mtt85 -150.64 28.07 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.98 0.419 . . . . 0.0 111.004 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -121.7 -156.63 0.69 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.113 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.5 t -121.17 167.41 12.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.686 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.832 ' CB ' HD23 ' A' ' 63' ' ' LEU . 6.2 pt20 -130.2 98.84 4.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 110.828 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.654 ' O ' HG23 ' A' ' 61' ' ' ILE . 8.5 tp -82.07 85.57 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.177 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.09 23.8 5.97 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.485 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.832 HD23 ' CB ' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -60.84 127.02 29.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.34 . . . . 0.0 110.557 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 p -92.28 163.42 13.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.241 0.543 . . . . 0.0 111.481 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.48 160.77 38.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.665 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.495 ' HB2' HG13 ' A' ' 4' ' ' VAL . 4.2 Cg_exo -83.94 149.75 60.35 Favored 'Cis proline' 0 C--N 1.344 0.335 0 C-N-CA 124.428 -1.072 . . . . 0.0 113.123 0.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -101.77 120.18 39.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.903 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.064 HG22 HG22 ' A' ' 4' ' ' VAL . 6.2 t -98.72 159.65 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.035 0.445 . . . . 0.0 111.615 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.459 ' N ' HG12 ' A' ' 68' ' ' VAL . 31.8 m-85 -142.9 133.15 24.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.765 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.612 ' CA ' HD11 ' A' ' 76' ' ' ILE . . . -62.95 149.62 89.84 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.604 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.58 ' HB3' ' N ' ' A' ' 1' ' ' MET . 68.0 Cg_exo -44.8 -52.54 6.07 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.37 2.714 . . . . 0.0 112.747 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -30.03 65.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.189 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.26 67.95 0.44 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.388 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.4 m -147.79 157.07 43.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.84 0.353 . . . . 0.0 110.648 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -84.09 115.1 22.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.973 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.612 HD11 ' CA ' ' A' ' 70' ' ' ALA . 19.8 mt -93.58 -49.14 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.972 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 123.15 -154.18 17.14 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.93 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -90.97 -132.24 5.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.472 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.686 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -79.66 -70.08 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.654 0.227 . . . . 0.0 111.114 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -51.08 -49.12 61.26 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.331 0.586 . . . . 0.0 110.478 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -57.41 -42.2 81.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.701 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.691 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.3 tt -76.3 -32.26 58.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.582 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -33.78 40.6 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -66.47 -35.87 81.34 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.164 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 82' ' ' LEU . 14.7 t80 -63.2 -34.08 76.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.35 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.691 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.4 m-85 -84.29 -66.39 0.9 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.995 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.91 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.632 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 30.1 ttm . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.784 0.326 . . . . 0.0 111.527 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.517 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 69.3 m-85 -61.8 169.57 2.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.357 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -143.72 116.29 8.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.743 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.0 HG22 HG22 ' A' ' 68' ' ' VAL . 87.5 t -110.44 141.27 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.168 0.508 . . . . 0.0 111.02 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.685 ' CE1' HD12 ' A' ' 34' ' ' ILE . 6.6 m-85 -123.31 99.3 6.27 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.89 -144.54 4.05 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.541 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.831 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 34.4 m-85 -113.51 151.07 32.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.748 0.309 . . . . 0.0 111.426 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.5 t70 -81.98 0.46 40.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.983 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.3 OUTLIER 83.81 -13.76 0.73 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -85.33 -39.12 18.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.759 0.314 . . . . 0.0 111.082 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.419 HD12 ' O ' ' A' ' 37' ' ' MET . 3.7 mt -92.56 -31.1 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.283 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.436 ' O ' ' HA ' ' A' ' 9' ' ' SER . 7.8 t60 -142.07 142.15 32.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.099 0.476 . . . . 0.0 110.987 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.2 145.02 11.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.315 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.3 t -179.26 88.93 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.13 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.8 m -79.01 -27.08 13.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.897 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -75.1 -21.53 58.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.798 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.5 m -59.71 -58.59 7.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.205 0.526 . . . . 0.0 110.265 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.96 -23.59 13.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.334 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 3.9 m-80 -77.14 -54.08 6.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.091 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.49 -48.7 76.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 111.078 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HD2' ' CE2' ' A' ' 31' ' ' PHE . 2.2 tptt -58.23 -54.06 51.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.697 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.836 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.4 mmp_? -60.84 -36.76 79.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.554 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 24' ' ' LEU . 3.1 tt -58.88 -52.97 63.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.509 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.618 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.9 mt -57.78 -46.86 83.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.794 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 m -57.63 -36.28 71.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.478 . . . . 0.0 110.234 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 22' ' ' ARG . 53.3 t -79.71 -30.7 13.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.766 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -77.77 -11.08 59.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.131 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt 70.34 54.07 0.32 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.996 0.427 . . . . 0.0 111.045 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -134.42 132.77 21.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.092 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.434 ' O ' ' HA ' ' A' ' 1' ' ' MET . 98.5 Cg_endo -78.41 137.33 14.77 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.474 2.116 . . . . 0.0 111.114 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.632 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 17.1 p90 -156.21 170.19 22.8 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -136.79 131.63 33.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.011 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.612 ' CE1' HG12 ' A' ' 4' ' ' VAL . 1.2 t80 -95.74 129.81 42.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.97 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.685 HD12 ' CE1' ' A' ' 5' ' ' TYR . 7.3 mt -113.33 110.39 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.383 0.611 . . . . 0.0 110.432 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -77.46 113.76 15.59 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.105 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.831 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 6.3 pt -71.94 -28.48 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.002 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.559 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 22.2 ttm -121.45 91.13 48.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.891 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.8 Cg_endo -82.59 1.66 9.0 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.693 2.262 . . . . 0.0 112.692 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -139.81 140.29 36.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 110.875 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -66.68 -7.09 18.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.254 0.549 . . . . 0.0 111.779 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.77 -67.13 1.01 Allowed Glycine 0 C--N 1.315 -0.608 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.694 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 t -136.21 133.82 50.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.71 0.29 . . . . 0.0 111.07 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -63.37 170.29 3.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.466 -179.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.45 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -94.65 99.94 11.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.064 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -54.37 -19.93 6.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.782 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -58.47 -56.28 24.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.031 0.444 . . . . 0.0 110.521 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -67.75 -31.69 71.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.307 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.405 HD11 ' HB ' ' A' ' 36' ' ' ILE . 25.1 mm -59.84 -48.34 88.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.611 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.11 -49.27 77.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.805 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.31 -35.89 70.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.579 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.47 HD13 ' CG ' ' A' ' 5' ' ' TYR . 26.4 tp -61.32 -52.99 62.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.652 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.5 mt -49.72 -45.16 48.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.131 0.491 . . . . 0.0 111.277 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.5 m -64.08 -32.47 74.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.108 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.427 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 9.3 tttp -68.9 -29.99 68.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.465 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.724 HD11 HD11 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -71.06 -37.62 72.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.048 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.83 33.58 6.32 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.278 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -150.07 -176.9 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.8 0.334 . . . . 0.0 110.742 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -105.11 -30.8 9.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.025 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 t -111.05 163.79 13.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.052 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.609 ' CA ' HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -106.47 99.14 8.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.596 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.5 mm -80.67 87.82 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.556 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.92 31.55 79.94 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.44 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.724 HD11 HD11 ' A' ' 55' ' ' LEU . 1.3 mm? -42.35 134.71 2.87 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.83 0.347 . . . . 0.0 111.207 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.58 153.11 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.088 0.47 . . . . 0.0 111.671 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.12 152.12 72.84 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.406 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.1 Cg_exo -79.31 128.72 16.86 Favored 'Cis proline' 0 C--N 1.344 0.328 0 C-N-CA 124.053 -1.228 . . . . 0.0 112.934 0.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.412 ' HG3' ' NE2' ' A' ' 75' ' ' HIS . 3.7 tp60 -90.6 117.87 29.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.225 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.0 HG22 HG22 ' A' ' 4' ' ' VAL . 10.2 t -97.48 161.24 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.95 0.405 . . . . 0.0 111.906 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.537 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 97.0 m-85 -142.84 149.26 38.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.022 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.583 ' HB3' ' H ' ' A' ' 74' ' ' SER . . . -61.81 159.35 35.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.773 -0.648 . . . . 0.0 112.411 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.535 ' HB3' ' N ' ' A' ' 1' ' ' MET . 31.7 Cg_exo -63.74 58.85 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.577 2.851 . . . . 0.0 111.547 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER 90.49 29.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.345 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -111.75 -92.65 2.1 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.526 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.583 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -152.39 -175.97 5.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.033 0.444 . . . . 0.0 110.96 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.423 ' HA ' ' CD1' ' A' ' 69' ' ' PHE . 16.4 t-80 -68.14 126.62 30.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.156 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.569 HG23 ' CD2' ' A' ' 85' ' ' TYR . 4.8 mt -91.82 -45.43 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.177 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.16 -150.04 19.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.635 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.83 -150.74 22.47 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.62 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 40.4 t80 -70.79 -70.55 0.3 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.68 0.276 . . . . 0.0 110.951 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -55.46 -45.53 76.88 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.009 0.433 . . . . 0.0 110.579 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -54.91 -33.93 62.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.298 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.744 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.3 tt -80.08 -36.58 35.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.368 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -51.51 -29.98 18.64 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.3 -35.0 73.41 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.129 178.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.569 ' CD2' HG23 ' A' ' 76' ' ' ILE . 11.9 t80 -63.12 -34.35 77.42 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.267 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.744 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.9 m-85 -87.87 -70.18 0.65 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.292 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.8 mttm . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.044 -179.98 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.628 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 49.7 ttm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.861 0.362 . . . . 0.0 111.639 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.516 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 74.6 m-85 -58.33 155.22 12.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.866 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.638 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -128.19 120.43 27.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.669 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.909 HG22 HG22 ' A' ' 68' ' ' VAL . 55.4 t -116.09 142.18 30.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.333 0.587 . . . . 0.0 111.813 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.789 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.1 m-85 -121.67 99.89 6.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.58 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.24 -137.96 2.36 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.75 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.929 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 31.5 m-85 -122.95 144.15 49.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 120.591 0.234 . . . . 0.0 110.962 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -108.47 29.02 7.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.336 . . . . 0.0 110.863 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m 63.04 14.57 7.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -85.77 -56.98 3.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.1 0.476 . . . . 0.0 110.622 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.599 HG21 ' C ' ' A' ' 39' ' ' GLU . 13.4 mm -104.15 -27.23 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.017 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -141.45 152.12 43.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.613 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.77 171.69 12.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.178 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.4 t -178.68 108.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.952 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.2 m -85.66 -32.8 7.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.956 0.407 . . . . 0.0 111.207 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -71.23 -16.08 62.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.289 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.9 m -72.13 -55.92 6.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.996 0.426 . . . . 0.0 110.683 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -52.18 -28.04 16.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.094 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 74.8 m-20 -75.52 -51.77 12.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.016 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.88 -48.6 79.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.243 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -59.89 -55.43 34.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.781 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -55.4 -44.93 76.63 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.346 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.754 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -59.04 -50.59 73.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.16 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.754 ' N ' HD23 ' A' ' 23' ' ' LEU . 8.7 mt -60.51 -43.61 96.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.065 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.6 m -57.17 -40.15 76.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.107 0.48 . . . . 0.0 109.82 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.7 t -80.13 -27.17 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.449 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.537 ' HG2' ' CE1' ' A' ' 86' ' ' PHE . 3.3 tptp -73.42 -13.31 61.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.081 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt 66.53 54.72 0.86 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.448 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -137.12 134.44 18.92 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.019 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.436 ' O ' ' HA ' ' A' ' 1' ' ' MET . 85.9 Cg_endo -78.58 134.09 12.11 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.337 2.024 . . . . 0.0 110.909 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.628 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 26.9 p90 -148.51 170.0 19.03 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -136.91 133.23 35.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.729 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.513 ' HE1' HG11 ' A' ' 4' ' ' VAL . 9.4 t80 -89.43 163.01 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.25 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.789 HD12 ' CE1' ' A' ' 5' ' ' TYR . 19.1 mt -145.69 119.61 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.444 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -82.22 122.76 28.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.098 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.929 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 7.2 pt -93.4 -16.7 7.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.479 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -124.84 85.65 57.06 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.735 0.302 . . . . 0.0 111.556 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 97.0 Cg_endo -79.05 -5.82 14.68 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.851 2.368 . . . . 0.0 111.73 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.599 ' C ' HG21 ' A' ' 11' ' ' ILE . 28.0 mt-10 -139.66 135.33 33.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.288 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.445 ' HA ' HG22 ' A' ' 11' ' ' ILE . 20.0 tttp -61.34 -8.45 3.93 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.26 0.552 . . . . 0.0 111.873 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.3 -63.72 2.11 Favored Glycine 0 C--N 1.312 -0.786 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.067 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 43' ' ' PHE . 21.2 t -150.7 159.03 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.759 0.314 . . . . 0.0 111.548 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.708 ' HB2' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -63.47 159.31 18.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.33 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.46 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -82.18 125.6 31.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.88 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.526 ' HA ' HD12 ' A' ' 48' ' ' ILE . 2.1 p30 -68.07 -23.85 64.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.761 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -60.04 -55.5 33.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.37 . . . . 0.0 110.651 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.48 -39.6 85.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.271 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.708 HD11 ' HB2' ' A' ' 43' ' ' PHE . 46.3 mt -54.12 -46.39 66.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.441 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.48 -50.33 71.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.636 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -59.82 -31.96 70.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.577 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.888 ' O ' HD12 ' A' ' 55' ' ' LEU . 18.7 tp -66.28 -63.92 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.292 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 58' ' ' ASP . 62.2 mt -45.66 -40.81 9.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.153 0.502 . . . . 0.0 111.314 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.1 m -67.34 -34.29 77.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.872 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 69' ' ' PHE . 50.0 tptt -66.47 -49.27 67.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.486 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.888 HD12 ' O ' ' A' ' 51' ' ' LEU . 4.9 mp -59.31 -25.07 63.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.248 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.1 30.17 13.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.499 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.15 -178.04 6.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.781 0.324 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.454 ' O ' HD13 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -108.43 -47.36 3.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.997 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.2 t -92.73 160.1 15.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.54 99.36 8.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.678 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -79.91 83.61 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.255 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.81 23.1 78.21 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.513 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.443 HD11 ' CG ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -70.61 131.42 43.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.875 0.369 . . . . 0.0 110.809 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 65' ' ' MET . 0.4 OUTLIER -131.29 170.55 14.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.282 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.497 ' SD ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -106.78 154.15 40.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.762 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.4 Cg_exo -81.08 135.31 31.12 Favored 'Cis proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.701 -1.374 . . . . 0.0 112.846 0.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.443 ' CG ' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -90.7 117.01 29.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.503 179.321 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.909 HG22 HG22 ' A' ' 4' ' ' VAL . 2.7 t -103.19 160.72 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.157 0.503 . . . . 0.0 112.142 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.477 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 95.3 m-85 -142.8 155.65 44.85 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.982 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.517 ' HB3' ' N ' ' A' ' 74' ' ' SER . . . -66.3 156.41 85.23 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.356 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.46 ' HB3' ' N ' ' A' ' 1' ' ' MET . 44.9 Cg_exo -58.28 -38.92 88.7 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.055 2.504 . . . . 0.0 111.808 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -91.42 -16.18 27.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.094 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.76 87.95 1.16 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.651 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.517 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -164.04 124.04 2.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.945 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.525 ' CE1' HD23 ' A' ' 55' ' ' LEU . 20.0 t-160 -58.17 110.83 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.006 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.472 HD11 ' HA ' ' A' ' 70' ' ' ALA . 18.7 mt -89.95 -49.9 13.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.51 -154.25 19.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.434 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.29 -144.16 7.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.299 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 32.7 t80 -71.17 -60.42 2.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 0.0 110.764 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -54.44 -37.21 64.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.829 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -60.77 -41.21 95.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.58 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.428 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -64.04 -50.87 66.73 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.351 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -51.62 -28.38 14.14 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -79.79 -33.76 40.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 82' ' ' LEU . 17.1 t80 -67.57 -32.14 72.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.323 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.537 ' CE1' ' HG2' ' A' ' 27' ' ' LYS . 30.3 m-85 -96.17 -70.74 0.7 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.487 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.4 tttt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.634 -179.941 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.602 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 40.6 ttp . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -76.51 152.04 36.2 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.244 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.5 mptp? -113.34 119.99 39.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.466 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.68 HG22 HG22 ' A' ' 68' ' ' VAL . 39.9 t -113.13 134.19 56.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.363 0.601 . . . . 0.0 112.066 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.61 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 18.9 m-85 -111.66 99.51 8.22 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.959 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.11 -139.64 2.73 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.517 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.62 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 63.5 m-85 -123.28 157.38 33.3 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.858 0.361 . . . . 0.0 111.376 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.41 -76.21 0.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.976 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 174.53 -34.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.907 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -71.34 -24.64 62.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.267 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.666 ' H ' HD12 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -106.94 -40.15 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.86 0.362 . . . . 0.0 110.864 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -155.87 160.63 40.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.4 pttp -80.39 173.65 12.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.997 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 9.2 p -163.99 120.37 1.65 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.962 0.41 . . . . 0.0 110.758 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.4 -43.39 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.944 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -88.9 -9.01 53.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.936 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -87.41 -36.43 17.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.758 0.313 . . . . 0.0 110.672 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -68.09 -36.06 79.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.718 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -75.71 -48.38 22.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.125 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.22 69.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.056 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -60.33 -54.18 48.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.617 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.857 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -59.03 -34.58 72.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.679 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.631 ' C ' HD23 ' A' ' 23' ' ' LEU . 4.9 tt -60.14 -54.99 39.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.613 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.517 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.6 mt -55.25 -46.04 76.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.948 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.1 m -57.8 -36.5 72.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.041 0.448 . . . . 0.0 110.157 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.3 t -79.03 -35.46 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.682 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.426 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -72.85 -9.97 59.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.184 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.16 42.48 0.34 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.861 0.363 . . . . 0.0 110.792 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -131.89 133.44 24.07 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.025 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.587 ' O ' ' HA ' ' A' ' 1' ' ' MET . 58.9 Cg_endo -81.93 158.82 18.39 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.567 2.178 . . . . 0.0 111.481 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.492 ' CG ' HD13 ' A' ' 24' ' ' LEU . 5.6 p90 -161.47 171.25 18.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.801 0.334 . . . . 0.0 111.663 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -129.55 119.71 24.12 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.564 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.528 ' HE1' HG11 ' A' ' 4' ' ' VAL . 17.4 t80 -89.34 153.12 21.12 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.185 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.435 HD12 ' CE1' ' A' ' 5' ' ' TYR . 15.9 mt -147.4 121.61 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.509 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -81.17 109.74 16.01 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.539 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.62 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 10.7 pt -63.86 -19.65 24.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 2.8 ttp -123.08 90.27 50.45 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.812 0.339 . . . . 0.0 111.52 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.4 Cg_endo -80.86 0.98 9.65 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.697 2.265 . . . . 0.0 112.289 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -139.68 140.4 36.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.696 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -67.9 -8.55 37.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.226 0.536 . . . . 0.0 111.842 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.71 -64.76 1.25 Allowed Glycine 0 C--N 1.313 -0.74 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.347 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 t -140.82 139.47 34.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.733 0.301 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -65.56 169.49 6.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 0.0 111.112 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.523 ' O ' HD12 ' A' ' 48' ' ' ILE . 1.4 t0 -86.71 115.18 23.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.033 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -74.83 -22.91 58.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.298 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.3 -52.77 63.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.756 0.312 . . . . 0.0 110.804 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -69.64 -38.31 77.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.128 0.49 . . . . 0.0 110.022 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.523 HD12 ' O ' ' A' ' 44' ' ' ASP . 55.1 mt -64.79 -34.87 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.369 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.44 -48.7 80.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.394 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.83 -34.39 69.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.998 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.61 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.7 tt -58.58 -53.01 63.17 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.2 mt -50.33 -41.87 51.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.453 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.5 m -56.6 -49.14 75.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.523 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -61.03 -39.98 91.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.313 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.13 -48.48 81.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.589 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.99 -165.97 31.84 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.162 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 64.3 mtt-85 -95.51 35.33 1.35 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.972 0.415 . . . . 0.0 110.817 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -120.88 -147.21 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.459 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -120.49 170.9 8.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.766 0.317 . . . . 0.0 110.786 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -69.19 98.21 1.0 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.402 0.62 . . . . 0.0 110.207 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 61' ' ' ILE . 17.2 tt -73.58 79.16 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.133 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 43.09 26.24 0.48 Allowed Glycine 0 C--N 1.333 0.398 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.862 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.447 HD12 ' CG ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -57.57 144.19 38.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.838 0.351 . . . . 0.0 110.887 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 p -110.45 156.94 20.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.428 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -105.28 152.47 39.84 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.654 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.48 ' HB2' HG13 ' A' ' 4' ' ' VAL . 3.8 Cg_exo -82.34 144.28 56.12 Favored 'Cis proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.969 -1.263 . . . . 0.0 112.702 0.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.447 ' CG ' HD12 ' A' ' 63' ' ' LEU . 1.7 mp0 -98.63 132.24 44.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.826 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.68 HG22 HG22 ' A' ' 4' ' ' VAL . 3.5 t -104.23 157.02 5.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.171 0.51 . . . . 0.0 111.992 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.432 ' CZ ' ' CD2' ' A' ' 75' ' ' HIS . 46.2 m-85 -143.67 139.14 29.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.685 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.588 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -53.27 152.45 8.21 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.406 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.602 ' HB3' ' N ' ' A' ' 1' ' ' MET . 7.4 Cg_exo -70.14 -8.99 24.96 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.855 2.37 . . . . 0.0 112.353 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.61 -17.7 14.03 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.098 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.6 89.27 1.1 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.663 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.0 t 179.92 152.76 0.47 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.777 0.323 . . . . 0.0 110.723 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.432 ' CD2' ' CZ ' ' A' ' 69' ' ' PHE . 6.0 t-160 -90.22 113.37 25.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.865 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.588 HD11 ' HA ' ' A' ' 70' ' ' ALA . 19.9 mt -92.58 -48.68 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.977 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.558 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 138.9 -155.42 23.77 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.709 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.82 -136.82 8.9 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.641 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -71.56 -70.66 0.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.82 0.343 . . . . 0.0 111.223 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -59.67 -48.68 80.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.983 0.421 . . . . 0.0 110.729 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -51.3 -39.48 56.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.605 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.75 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.1 tt -78.66 -33.86 46.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.336 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -50.64 -30.13 12.73 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -68.08 -35.79 78.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.229 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 82' ' ' LEU . 13.5 t80 -63.02 -34.05 76.74 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.262 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.75 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.9 m-85 -90.06 -19.65 24.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.304 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.268 -0.873 . . . . 0.0 111.021 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.624 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 49.5 ttm . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.91 0.386 . . . . 0.0 111.561 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.582 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 84.3 m-85 -53.53 158.27 1.86 Allowed 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -135.23 117.44 15.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.486 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.52 HG11 ' CE1' ' A' ' 33' ' ' PHE . 30.9 t -99.87 127.18 53.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.656 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.553 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.9 m-30 -104.39 99.08 8.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.351 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.94 -139.62 2.7 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.45 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.527 ' CD2' ' HD2' ' A' ' 12' ' ' HIS . 85.6 m-85 -120.71 159.79 24.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.075 0.464 . . . . 0.0 111.733 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.15 -81.08 0.06 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.746 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 p 174.12 -41.91 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.227 0.536 . . . . 0.0 111.042 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -74.12 -31.72 62.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.236 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.699 HD12 ' HA ' ' A' ' 40' ' ' LYS . 50.9 mm -93.07 -35.7 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.733 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.527 ' HD2' ' CD2' ' A' ' 7' ' ' TYR . 31.3 t60 -154.76 152.39 29.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.33 159.68 3.45 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 t -174.66 73.82 0.03 OUTLIER 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.49 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.8 m -91.28 -37.82 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.571 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -62.5 -28.93 70.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.721 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.8 p -72.19 -44.18 63.4 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.651 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.32 -32.51 49.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.816 0.341 . . . . 0.0 110.921 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -70.16 -55.99 7.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.848 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.443 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . . . -57.69 -31.09 66.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.035 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HG2' ' CE1' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -60.94 -56.19 24.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.665 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.755 ' O ' HG23 ' A' ' 26' ' ' VAL . 23.6 ptt180 -60.42 -34.2 73.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.59 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.697 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.8 tt -59.05 -53.82 54.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.317 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.697 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.3 mt -55.47 -44.15 76.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.671 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 m -57.52 -35.92 70.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.176 0.513 . . . . 0.0 109.925 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 22' ' ' ARG . 43.5 t -79.72 -29.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.431 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.61 -13.14 59.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.052 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt 69.4 62.28 0.29 Allowed 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.95 0.405 . . . . 0.0 110.841 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -142.3 138.87 16.98 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.023 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.448 ' O ' ' HA ' ' A' ' 1' ' ' MET . 77.2 Cg_endo -79.97 136.29 11.69 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.536 2.157 . . . . 0.0 111.43 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.624 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 33.9 p90 -152.37 170.54 19.84 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -148.1 146.04 28.65 Favored 'General case' 0 N--CA 1.46 0.048 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.864 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.52 ' CE1' HG11 ' A' ' 4' ' ' VAL . 25.5 t80 -89.34 159.5 17.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.16 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.553 HD12 ' CE1' ' A' ' 5' ' ' TYR . 10.9 mt -145.37 120.56 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.521 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -94.42 118.85 32.26 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.063 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.576 HD12 ' CE2' ' A' ' 43' ' ' PHE . 35.6 pt -78.33 -17.71 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.032 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.488 ' HE3' ' HE1' ' A' ' 43' ' ' PHE . 31.6 ttm -122.11 92.01 48.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.524 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 98.6 Cg_endo -84.23 18.21 1.58 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.884 2.389 . . . . 0.0 113.028 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.525 ' O ' HG21 ' A' ' 11' ' ' ILE . 9.8 mt-10 -139.53 165.44 27.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.374 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.699 ' HA ' HD12 ' A' ' 11' ' ' ILE . 30.8 tttt -61.13 -7.76 2.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.88 48.17 0.07 OUTLIER Glycine 0 C--N 1.313 -0.737 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.877 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' A' ' 39' ' ' GLU . 5.7 t -150.48 115.21 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.327 0.584 . . . . 0.0 112.33 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.576 ' CE2' HD12 ' A' ' 36' ' ' ILE . 1.1 m-85 -68.44 153.14 44.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.822 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.662 ' O ' HD12 ' A' ' 48' ' ' ILE . 3.6 t0 -97.48 93.67 6.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.951 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -49.93 -26.24 3.98 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.716 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.93 -48.81 78.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.851 0.358 . . . . 0.0 110.812 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -77.5 -46.12 23.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.42 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 44' ' ' ASP . 3.0 mp -55.03 -42.36 64.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.76 -54.71 34.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 110.653 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.78 -38.28 87.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.48 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.467 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -57.43 -51.27 70.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.535 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.4 mt -50.09 -47.25 53.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.197 0.522 . . . . 0.0 110.586 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -70.21 -35.14 73.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.754 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -61.39 -31.37 71.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.411 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 mt -72.65 -38.72 67.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.683 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.33 -107.14 0.31 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.99 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.7 mtt-85 -150.53 30.87 0.66 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.929 0.395 . . . . 0.0 110.542 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.0 -151.34 0.48 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.355 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -120.61 170.17 9.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.696 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.93 98.37 10.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.241 0.544 . . . . 0.0 110.098 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pt -79.76 84.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.431 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.47 23.95 61.07 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.705 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.574 HD12 ' HG2' ' A' ' 67' ' ' GLN . 0.3 OUTLIER -50.57 121.28 5.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.838 0.351 . . . . 0.0 110.594 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.2 p -99.84 161.39 13.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.153 0.502 . . . . 0.0 111.544 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.403 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 1.8 mpt? -110.58 154.37 43.14 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.484 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.0 Cg_exo -81.78 145.18 62.98 Favored 'Cis proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.935 -1.277 . . . . 0.0 112.82 0.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.574 ' HG2' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -106.72 115.02 29.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -87.18 164.66 2.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.236 0.541 . . . . 0.0 111.953 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.476 ' H ' HG12 ' A' ' 68' ' ' VAL . 12.2 m-85 -142.2 130.22 21.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.467 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.789 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -46.43 144.26 3.43 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.934 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.455 ' CB ' ' N ' ' A' ' 1' ' ' MET . 19.7 Cg_endo -67.76 -13.58 39.09 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.316 2.011 . . . . 0.0 111.767 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.539 ' OD1' ' HB1' ' A' ' 70' ' ' ALA . 10.3 p-10 -99.4 -23.91 14.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.573 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.02 84.94 0.6 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.866 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 70' ' ' ALA . 3.1 m -178.11 162.74 1.63 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.837 0.351 . . . . 0.0 111.133 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -90.37 110.89 21.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.789 HD11 ' HA ' ' A' ' 70' ' ' ALA . 35.3 mt -84.86 -51.38 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.004 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.565 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 128.3 -153.5 19.54 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.475 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.18 -152.08 19.42 Favored Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.556 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.443 ' HD1' ' HB2' ' A' ' 20' ' ' ALA . 15.7 t80 -63.88 -63.25 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.824 0.345 . . . . 0.0 110.776 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -53.66 -41.82 67.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -56.04 -42.29 76.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.465 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.59 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -63.3 -48.19 79.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.428 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -51.09 -29.15 12.36 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -76.26 -34.14 59.14 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.277 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.423 ' N ' ' O ' ' A' ' 82' ' ' LEU . 7.6 t80 -66.98 -32.57 73.9 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.319 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.59 ' HE2' HD21 ' A' ' 82' ' ' LEU . 6.5 m-85 -90.65 -69.8 0.71 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.072 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.877 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.666 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 48.0 ttm . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -77.92 145.56 36.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.267 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.2 mppp? -108.11 120.68 43.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.528 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.602 HG22 HG22 ' A' ' 68' ' ' VAL . 7.8 t -105.05 131.04 55.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.29 0.567 . . . . 0.0 111.786 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.588 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.9 m-30 -106.59 98.96 8.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.168 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.91 -137.87 2.29 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.811 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.967 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 85.1 m-85 -127.73 157.86 39.21 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 120.776 0.322 . . . . 0.0 111.425 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -88.2 -68.38 0.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.127 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 166.73 -33.15 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.998 0.428 . . . . 0.0 110.899 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -71.54 -42.14 68.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.514 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.543 HG21 ' HG2' ' A' ' 37' ' ' MET . 27.5 mm -89.47 -39.55 12.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.051 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -150.51 154.08 36.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.351 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -76.86 162.71 27.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.58 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.9 t -172.14 108.32 0.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.785 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.0 m -88.81 -36.69 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.077 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -68.64 -19.74 64.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.002 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.9 m -64.36 -55.74 19.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.938 0.399 . . . . 0.0 110.29 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -57.8 -32.77 67.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.161 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -68.43 -58.46 4.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.273 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.87 -42.37 65.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.91 0.386 . . . . 0.0 111.305 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -56.26 -50.95 69.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.751 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.841 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.1 mtt180 -60.54 -40.85 93.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.585 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.802 HD21 ' CD2' ' A' ' 86' ' ' PHE . 2.0 tt -57.36 -51.9 67.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.431 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.662 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.2 mt -59.8 -50.37 74.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.584 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 m -53.27 -38.62 63.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.324 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 22' ' ' ARG . 56.5 t -76.29 -36.64 30.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.599 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.52 ' CD ' ' HB3' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -73.7 -9.89 59.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.041 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.19 59.45 0.33 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.983 0.421 . . . . 0.0 111.006 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -144.88 132.42 10.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.142 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.616 ' O ' ' HA ' ' A' ' 1' ' ' MET . 69.6 Cg_endo -79.42 159.27 25.87 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.482 2.121 . . . . 0.0 110.972 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.442 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 7.9 p90 -161.43 171.38 18.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.86 0.362 . . . . 0.0 111.788 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -134.3 134.87 42.36 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.523 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.494 ' HE1' HG11 ' A' ' 4' ' ' VAL . 6.8 t80 -89.28 156.69 18.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.168 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.588 HD12 ' CE1' ' A' ' 5' ' ' TYR . 18.0 mt -146.03 121.05 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.468 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -85.65 114.93 23.02 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.936 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.967 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 2.1 pt -75.08 -21.05 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.967 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.543 ' HG2' HG21 ' A' ' 11' ' ' ILE . 1.7 tpp -116.35 108.67 45.2 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.809 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' N ' ' A' ' 44' ' ' ASP . 79.8 Cg_endo -76.05 -28.18 7.74 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.648 2.232 . . . . 0.0 112.101 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -139.57 151.66 46.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.623 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -64.64 -8.5 14.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.255 0.55 . . . . 0.0 111.839 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.59 -55.83 2.77 Favored Glycine 0 C--N 1.313 -0.73 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.814 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -149.06 141.99 18.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 2.2 m-85 -59.4 170.29 1.03 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.843 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.427 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 1.4 p30 -88.73 140.58 29.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.031 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -78.4 -11.07 59.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.522 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.35 -62.99 1.18 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.791 0.329 . . . . 0.0 111.261 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -42.88 66.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.961 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.424 ' N ' ' CD1' ' A' ' 48' ' ' ILE . 0.8 OUTLIER -56.64 -39.09 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.744 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.26 -55.38 6.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -36.12 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.46 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.583 HD11 HD21 ' A' ' 55' ' ' LEU . 20.1 tp -57.08 -51.66 68.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.694 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 52' ' ' LEU . 81.3 mt -52.01 -46.91 65.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.149 0.5 . . . . 0.0 111.317 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.8 m -70.16 -42.41 72.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.594 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -60.29 -40.2 89.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.941 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.583 HD21 HD11 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -60.17 -69.08 0.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.804 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.62 -40.75 0.72 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.2 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -89.78 -174.89 4.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.33 . . . . 0.0 110.709 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -103.26 -30.3 10.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.072 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.4 t -111.19 169.73 8.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.081 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.5 mp0 -110.56 99.65 8.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.564 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.4 mt -80.26 87.42 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.558 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.65 29.66 64.47 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.682 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 60' ' ' GLN . 1.3 mm? -47.0 147.41 1.37 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.804 0.335 . . . . 0.0 111.007 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.4 p -121.32 153.49 37.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.079 0.466 . . . . 0.0 111.652 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -122.47 152.8 61.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.518 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -80.92 149.7 77.37 Favored 'Cis proline' 0 C--N 1.344 0.324 0 C-N-CA 124.073 -1.22 . . . . 0.0 112.725 0.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -105.32 119.61 39.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.848 178.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -91.41 161.41 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.362 0.601 . . . . 0.0 112.193 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.432 ' N ' HG12 ' A' ' 68' ' ' VAL . 60.6 m-85 -143.13 140.74 30.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.277 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.629 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.37 147.23 28.97 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.139 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.666 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 15.7 Cg_exo -65.48 -14.45 44.95 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.694 2.262 . . . . 0.0 112.317 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.56 -23.01 13.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.018 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.36 74.61 0.28 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.568 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.64 113.08 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.757 0.313 . . . . 0.0 110.739 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -53.66 120.94 6.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.994 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.629 HD11 ' HA ' ' A' ' 70' ' ' ALA . 15.5 mt -97.41 -45.97 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.768 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 81' ' ' GLN . . . 135.13 -156.23 22.47 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.585 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.28 -138.25 7.22 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.575 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -72.87 -61.16 1.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -55.19 -45.34 75.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.04 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.404 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 8.4 mp0 -56.01 -48.28 76.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.645 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -64.28 -43.0 96.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.434 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -51.54 -29.88 18.59 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -75.01 -35.17 61.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.404 ' N ' ' O ' ' A' ' 82' ' ' LEU . 12.0 t80 -62.9 -35.38 79.87 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.802 ' CD2' HD21 ' A' ' 23' ' ' LEU . 5.3 m-85 -87.64 -70.38 0.63 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.216 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.944 179.942 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.681 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 28.4 ttp . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.85 0.357 . . . . 0.0 111.541 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.461 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 87.7 m-85 -79.19 153.35 30.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.156 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.647 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -131.59 121.44 24.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.888 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.635 HG22 HG22 ' A' ' 68' ' ' VAL . 7.0 t -104.22 124.32 58.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.147 0.498 . . . . 0.0 111.374 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.687 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.3 m-30 -100.09 99.15 9.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.324 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.34 -137.2 2.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.837 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.913 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 6.7 m-85 -123.63 146.39 48.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.372 0.13 . . . . 0.0 110.949 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.81 17.79 7.31 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 0.9 OUTLIER 71.72 2.16 4.17 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.589 0.233 . . . . 0.0 111.617 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -85.19 -53.41 5.27 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.967 0.413 . . . . 0.0 110.654 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.478 HD12 ' O ' ' A' ' 37' ' ' MET . 1.3 mt -111.33 9.5 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.385 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.574 ' CB ' ' CD2' ' A' ' 7' ' ' TYR . 11.1 t-80 -169.82 138.19 1.77 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.139 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.34 22.79 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.011 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 p -175.61 123.78 0.21 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.041 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.4 m -91.1 -37.35 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.58 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -75.52 -18.64 59.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.552 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.4 p -70.45 -36.36 73.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.813 0.34 . . . . 0.0 111.004 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.2 -27.11 62.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.335 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -76.86 -49.49 15.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.062 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.02 -46.55 71.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.267 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -60.31 -52.75 63.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.955 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.777 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -60.37 -38.9 85.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.63 ' C ' HD23 ' A' ' 23' ' ' LEU . 4.5 tt -58.37 -54.02 51.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.636 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.54 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.9 mt -56.15 -46.83 79.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.889 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.7 m -56.58 -36.78 69.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.12 0.486 . . . . 0.0 110.152 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 22' ' ' ARG . 54.3 t -78.15 -27.68 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.727 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -11.37 58.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.245 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.08 61.14 0.5 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.106 0.479 . . . . 0.0 110.716 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -136.69 140.76 32.98 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.183 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.94 131.94 11.41 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.553 2.169 . . . . 0.0 111.592 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.681 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 11.8 p90 -156.31 169.45 24.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.999 0.428 . . . . 0.0 111.957 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -147.12 148.04 31.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.804 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.481 ' HE1' HG11 ' A' ' 4' ' ' VAL . 7.5 t80 -89.42 161.15 16.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.393 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.687 HD12 ' CE1' ' A' ' 5' ' ' TYR . 21.9 mt -145.58 119.55 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.308 0.575 . . . . 0.0 110.511 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -81.21 125.34 30.18 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.025 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.913 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 2.7 pt -99.48 -11.97 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.297 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.742 ' HE3' ' HE2' ' A' ' 7' ' ' TYR . 14.5 ttm -117.57 92.2 40.22 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.742 0.306 . . . . 0.0 111.146 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 44' ' ' ASP . 54.5 Cg_endo -69.37 -28.43 27.13 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.562 2.175 . . . . 0.0 111.671 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -139.85 147.42 40.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.032 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -8.54 6.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.213 0.53 . . . . 0.0 111.783 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.16 -56.62 2.99 Favored Glycine 0 C--N 1.313 -0.72 0 CA-C-N 115.278 -0.873 . . . . 0.0 112.704 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.7 t -148.14 146.42 17.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.924 0.392 . . . . 0.0 111.967 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -61.07 166.51 3.53 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.505 179.47 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.455 ' O ' HD12 ' A' ' 48' ' ' ILE . 10.1 p30 -78.41 99.48 6.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.948 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -55.26 -22.75 19.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.554 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -60.28 -53.7 54.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.886 0.374 . . . . 0.0 110.755 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -69.45 -47.26 64.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.667 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.455 HD12 ' O ' ' A' ' 44' ' ' ASP . 1.7 mp -50.11 -37.45 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.716 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.99 -59.74 4.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.06 0.457 . . . . 0.0 110.506 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.69 -34.45 72.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.229 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.469 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -59.64 -52.63 64.7 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.505 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 52' ' ' LEU . 69.5 mt -48.28 -45.07 34.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.264 0.554 . . . . 0.0 110.734 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.7 m -67.15 -35.84 80.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.002 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -64.62 -33.91 77.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.493 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.1 mt -70.53 -50.12 40.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.605 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.08 -163.39 35.4 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.945 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 mtt180 -93.9 31.35 1.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.946 0.403 . . . . 0.0 110.921 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -121.15 -153.46 0.55 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.275 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -120.97 170.38 9.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.734 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.757 ' HB2' HD12 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -78.46 98.48 6.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.357 0.599 . . . . 0.0 110.028 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.1 mm -73.08 82.28 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.514 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 50.16 25.95 8.53 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.867 ' O ' HD13 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -55.39 156.96 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 111.157 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.713 ' N ' HD22 ' A' ' 63' ' ' LEU . 37.2 p -139.58 163.59 32.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -98.93 158.62 32.02 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.862 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.1 Cg_exo -83.88 140.79 36.82 Favored 'Cis proline' 0 C--N 1.345 0.348 0 C-N-CA 124.151 -1.187 . . . . 0.0 112.759 0.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . 15.0 mm-40 -105.39 114.05 28.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.046 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.7 t -86.93 163.64 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.264 0.554 . . . . 0.0 112.087 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.452 ' N ' HG12 ' A' ' 68' ' ' VAL . 20.3 m-85 -142.96 132.66 23.87 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.278 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -71.38 146.34 91.73 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.262 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.589 ' HB3' ' N ' ' A' ' 1' ' ' MET . 54.7 Cg_exo -42.15 -52.36 4.2 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.372 2.715 . . . . 0.0 113.008 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.42 -27.84 66.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.203 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.46 73.26 0.64 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.363 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.14 143.2 18.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 111.044 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -70.22 110.82 5.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.764 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 70' ' ' ALA . 19.9 mt -83.4 -49.21 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.144 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.18 -153.47 20.77 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.268 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.83 -143.35 8.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.33 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -73.07 -67.17 0.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 0.0 110.755 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -53.08 -38.74 62.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.874 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -60.37 -39.41 87.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.49 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.612 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -69.65 -45.02 69.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.35 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -51.32 -31.43 21.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.48 -35.78 65.72 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.164 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.51 ' CD2' HG23 ' A' ' 76' ' ' ILE . 12.3 t80 -63.85 -33.66 76.19 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.275 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.612 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.2 m-85 -87.97 -70.34 0.64 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.132 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.931 -179.938 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.633 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 64.3 ttp . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 120.878 0.37 . . . . 0.0 111.672 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.505 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 80.2 m-85 -60.37 153.43 22.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.646 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -129.66 122.68 29.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.458 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.695 HG22 HG22 ' A' ' 68' ' ' VAL . 10.0 t -105.37 136.79 37.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.09 0.471 . . . . 0.0 111.614 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.771 ' CE1' HD12 ' A' ' 34' ' ' ILE . 5.2 m-85 -115.42 99.62 7.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.189 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.48 -135.51 1.93 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.554 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.533 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 75.5 m-85 -120.16 146.66 45.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.948 0.404 . . . . 0.0 111.665 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -94.58 139.7 30.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.465 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.5 p -51.79 -24.71 6.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.563 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -73.16 -43.32 61.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.547 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.553 HG21 ' HG2' ' A' ' 37' ' ' MET . 9.3 mm -89.8 -43.95 14.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.785 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 78.8 t60 -144.68 158.32 43.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.744 0.307 . . . . 0.0 111.131 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.2 mmmt -80.0 161.38 25.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.174 0.512 . . . . 0.0 111.614 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.2 p -167.92 113.7 0.69 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.358 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 m -90.46 -28.75 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.422 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -85.57 -17.27 36.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.129 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.5 p -67.25 -39.84 86.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.038 0.447 . . . . 0.0 110.153 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.4 -26.68 68.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.049 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -69.47 -55.58 9.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.123 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.8 -44.16 66.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.977 0.417 . . . . 0.0 111.133 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -60.32 -52.57 64.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.879 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.8 ttt85 -56.64 -37.99 71.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.762 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -58.55 -52.58 65.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.548 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.762 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.8 mt -57.51 -47.19 82.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.875 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 m -56.13 -33.39 65.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.029 0.442 . . . . 0.0 110.375 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 22' ' ' ARG . 45.3 t -78.36 -30.42 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.794 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm -82.13 -10.85 59.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.226 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? 68.39 60.99 0.38 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.914 0.388 . . . . 0.0 110.739 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.406 ' OE1' ' HD2' ' A' ' 30' ' ' PRO . 8.1 mm100 -141.42 139.63 19.2 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.07 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.45 ' O ' ' HA ' ' A' ' 1' ' ' MET . 77.9 Cg_endo -80.28 139.89 13.45 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.52 2.146 . . . . 0.0 111.231 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.633 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 51.3 p90 -153.22 170.56 20.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -141.81 142.12 33.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.956 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.596 ' CE1' HG11 ' A' ' 4' ' ' VAL . 38.2 t80 -89.83 158.58 17.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.236 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.771 HD12 ' CE1' ' A' ' 5' ' ' TYR . 7.8 mt -147.18 120.29 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.128 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -99.63 127.31 45.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.671 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.9 pt -80.97 -8.61 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.238 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.588 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 8.2 ttp -125.98 95.3 39.83 Favored Pre-proline 0 N--CA 1.456 -0.133 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.146 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.38 1.33 9.35 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.746 2.297 . . . . 0.0 112.568 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -139.71 135.62 33.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.604 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -62.79 -9.24 8.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.175 0.512 . . . . 0.0 112.183 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.99 -63.74 1.65 Allowed Glycine 0 C--N 1.311 -0.841 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.917 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.1 t -146.83 151.89 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.692 0.282 . . . . 0.0 110.993 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.588 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -68.0 167.03 14.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 111.109 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.4 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -100.26 114.87 28.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.018 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -58.11 -18.2 23.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.471 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -57.82 -54.94 41.22 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.857 0.361 . . . . 0.0 110.696 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -70.59 -37.41 73.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.208 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 44' ' ' ASP . 36.6 mm -55.31 -46.79 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.895 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.7 -53.37 58.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.693 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -57.4 -40.68 78.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.338 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.75 HD13 ' CD2' ' A' ' 5' ' ' TYR . 9.3 tp -55.37 -48.67 73.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.653 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.1 mt -54.18 -49.42 69.38 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.06 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.3 m -61.94 -33.92 75.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.215 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.405 ' HG3' ' CE1' ' A' ' 69' ' ' PHE . 27.6 tptt -67.44 -29.65 69.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.631 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.707 HD11 HD12 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -71.93 -26.49 62.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.109 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.49 32.57 15.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.396 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.5 mtt-85 -150.06 -168.86 3.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 0.0 110.827 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.78 -50.11 2.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.032 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -102.95 165.44 11.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -95.38 98.74 10.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.122 0.487 . . . . 0.0 110.503 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.8 mt -80.33 85.53 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.275 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.48 27.05 73.53 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.455 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.707 HD12 HD11 ' A' ' 55' ' ' LEU . 7.5 tt -55.42 150.57 11.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.895 0.379 . . . . 0.0 111.191 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.0 p -148.5 164.81 33.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.405 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -119.19 146.37 40.48 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.573 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -84.63 150.71 57.05 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.993 -1.253 . . . . 0.0 112.828 0.368 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' TYR . 1.3 tp60 -109.44 117.9 35.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.221 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -92.83 166.73 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.829 0.347 . . . . 0.0 111.59 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.51 ' H ' HG12 ' A' ' 68' ' ' VAL . 73.5 m-85 -142.49 140.17 31.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.028 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.445 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -52.82 150.07 10.46 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.278 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.494 ' HB3' ' N ' ' A' ' 1' ' ' MET . 42.8 Cg_exo -58.96 -30.71 93.99 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.097 2.531 . . . . 0.0 112.026 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -91.48 -23.72 19.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.245 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.62 90.27 0.8 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.653 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 15.9 t -171.63 158.98 5.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.761 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.426 ' NE2' ' CG ' ' A' ' 67' ' ' GLN . 17.7 t-160 -88.64 110.07 20.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.985 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.445 HD11 ' HA ' ' A' ' 70' ' ' ALA . 10.8 mt -85.05 -50.84 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.093 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.85 -154.77 19.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.563 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.01 -145.75 7.74 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.669 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -71.28 -70.03 0.34 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.742 0.306 . . . . 0.0 110.892 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.99 -46.1 71.61 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.969 0.414 . . . . 0.0 110.562 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -34.43 63.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.114 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 85' ' ' TYR . 2.7 tt -74.79 -39.63 61.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.012 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 87' ' ' LYS . 24.2 ttp180 -51.77 -29.08 17.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -71.63 -33.42 68.93 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.392 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.453 ' N ' ' O ' ' A' ' 82' ' ' LEU . 9.0 t80 -66.62 -31.64 72.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.588 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.486 ' CD2' HD21 ' A' ' 23' ' ' LEU . 25.1 m-85 -95.62 -70.37 0.72 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.498 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 83' ' ' ARG . 15.2 mtmt . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.954 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.616 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 4.6 ttm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -80.4 149.15 30.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.187 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -109.87 117.14 33.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.413 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.472 HG11 ' HE1' ' A' ' 33' ' ' PHE . 8.1 t -102.16 125.21 56.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.242 0.544 . . . . 0.0 111.347 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.688 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.3 m-30 -101.95 99.09 9.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.402 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.94 -137.12 2.12 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.287 -0.959 . . . . 0.0 112.647 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.454 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 87.5 m-85 -126.02 147.25 49.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.736 0.303 . . . . 0.0 110.932 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -101.92 21.39 14.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.415 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.2 t 66.83 9.14 6.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.567 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -85.55 -46.43 10.83 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.868 0.366 . . . . 0.0 110.667 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.794 HG21 ' O ' ' A' ' 39' ' ' GLU . 1.3 mp -109.33 -33.36 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.974 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.454 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 20.4 t60 -139.35 152.4 47.13 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.653 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.36 173.16 12.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.481 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.5 p -175.04 119.0 0.19 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.774 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 m -90.34 -26.33 5.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.307 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -86.72 -16.47 36.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.413 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.3 p -72.54 -41.66 65.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.934 0.397 . . . . 0.0 110.644 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -66.75 -33.23 75.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 86.5 m-20 -73.54 -52.78 12.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.506 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.76 -42.42 68.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.382 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -60.61 -52.36 65.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.766 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.809 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.8 ttt180 -58.44 -34.54 70.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.747 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.734 ' CD2' HD23 ' A' ' 24' ' ' LEU . 1.6 tt -59.46 -56.63 19.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.327 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.734 HD23 ' CD2' ' A' ' 23' ' ' LEU . 46.5 mt -61.47 -40.25 93.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.711 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.2 m -60.71 -35.5 76.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.155 0.503 . . . . 0.0 109.7 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 22' ' ' ARG . 91.9 t -80.09 -33.11 14.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.467 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 9.3 mmtt -72.23 -10.19 59.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.211 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER 68.99 40.87 1.54 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.881 0.372 . . . . 0.0 111.125 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.93 136.64 29.31 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.432 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.585 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.1 Cg_endo -78.84 155.77 26.94 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.543 2.162 . . . . 0.0 111.867 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.4 ' HA ' ' HG2' ' A' ' 1' ' ' MET . 11.7 p90 -161.35 170.84 19.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.802 0.334 . . . . 0.0 111.338 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -132.51 137.36 47.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.625 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.472 ' HE1' HG11 ' A' ' 4' ' ' VAL . 6.1 t80 -89.22 158.35 17.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.296 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.688 HD12 ' CE1' ' A' ' 5' ' ' TYR . 20.4 mt -147.27 122.56 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.468 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -92.4 126.02 37.3 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.985 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.518 ' HB ' HD11 ' A' ' 48' ' ' ILE . 41.5 pt -92.11 -6.31 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.448 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.3 tpp -127.63 82.59 68.02 Favored Pre-proline 0 N--CA 1.454 -0.271 0 CA-C-O 120.76 0.314 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 97.2 Cg_endo -89.86 27.34 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.047 2.498 . . . . 0.0 112.648 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.794 ' O ' HG21 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -139.32 165.25 27.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.382 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -58.79 -8.0 1.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 169.77 47.59 0.03 OUTLIER Glycine 0 C--N 1.312 -0.791 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.848 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.9 t -150.59 127.2 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.959 0.409 . . . . 0.0 111.397 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -63.22 168.74 4.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.645 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.433 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 7.5 t70 -98.93 106.69 18.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.914 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -60.99 -23.95 65.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.542 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.6 -59.22 3.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.684 0.278 . . . . 0.0 111.287 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -67.3 -45.14 77.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 110.885 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.518 HD11 ' HB ' ' A' ' 36' ' ' ILE . 1.5 mp -57.06 -29.42 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.814 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.65 -61.78 1.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.956 0.408 . . . . 0.0 110.887 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -59.61 -32.42 70.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.31 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -59.72 -53.03 62.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.341 179.49 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 52' ' ' LEU . 69.2 mt -47.72 -44.99 28.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.356 0.598 . . . . 0.0 110.628 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.8 m -70.15 -35.67 74.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.83 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.405 ' HG2' ' CE1' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -62.65 -29.34 70.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.61 179.401 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -74.33 -65.82 0.8 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.009 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.89 -29.18 0.26 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.511 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.25 -167.6 1.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.883 0.373 . . . . 0.0 110.806 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.428 ' O ' HD22 ' A' ' 52' ' ' LEU . 1.5 p30 -98.35 -29.88 12.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.944 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -94.5 162.69 13.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.968 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -102.37 99.25 9.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.0 110.611 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pt -79.16 84.3 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.342 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.77 23.3 76.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.621 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.695 HD13 ' N ' ' A' ' 64' ' ' THR . 2.6 tm? -61.29 131.11 49.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.309 . . . . 0.0 110.682 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.695 ' N ' HD13 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -130.89 170.01 15.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.079 0.466 . . . . 0.0 111.348 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -118.87 150.21 48.1 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.649 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.3 Cg_endo -83.29 139.04 34.89 Favored 'Cis proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.923 -1.282 . . . . 0.0 112.559 0.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -101.7 118.69 37.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.875 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.6 t -90.75 159.76 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.417 0.627 . . . . 0.0 112.499 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.504 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 30.7 m-85 -143.36 145.98 33.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.255 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.738 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -61.17 156.68 48.19 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.25 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.616 ' HB3' ' N ' ' A' ' 1' ' ' MET . 3.0 Cg_exo -73.87 -5.37 16.92 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.97 2.447 . . . . 0.0 112.425 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.19 -8.15 11.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.208 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.2 89.6 1.86 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.55 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.2 m -179.23 156.53 0.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.83 0.348 . . . . 0.0 110.925 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -90.2 120.81 31.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.738 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.2 mp -102.11 -36.04 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.625 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 122.5 -161.78 16.55 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.714 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.9 -134.75 6.97 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.619 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 10.9 t80 -74.36 -70.2 0.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 111.017 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -55.95 -48.63 75.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.936 0.398 . . . . 0.0 110.557 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.25 -38.98 66.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.601 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.511 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.8 tt -74.8 -38.3 62.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.077 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 87' ' ' LYS . 8.0 ttt85 -51.34 -29.27 14.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -71.91 -34.3 68.99 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.409 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.444 ' N ' ' O ' ' A' ' 82' ' ' LEU . 18.8 t80 -67.01 -30.68 70.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.483 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.511 ' CE2' HD21 ' A' ' 82' ' ' LEU . 30.3 m-85 -96.33 -16.6 21.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.563 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 83' ' ' ARG . 11.8 mtmm . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.98 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.64 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 40.0 ttp . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -76.14 147.35 38.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.319 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 3.7 mptt -107.85 119.35 39.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.405 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.664 HG11 ' CE2' ' A' ' 33' ' ' PHE . 38.4 t -109.26 133.58 53.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.403 0.621 . . . . 0.0 112.104 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.588 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 19.7 m-85 -113.73 99.16 7.5 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.592 177.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.63 -127.18 1.16 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.149 -1.024 . . . . 0.0 112.946 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.424 ' CD2' ' CD2' ' A' ' 12' ' ' HIS . 28.3 m-85 -137.15 108.31 6.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 120.901 0.382 . . . . 0.0 111.926 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.454 ' HB2' ' CE1' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -105.08 -27.25 11.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.257 179.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.636 ' HB3' HG23 ' A' ' 11' ' ' ILE . 21.1 m -60.49 163.7 5.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.54 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.02 3.86 44.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.64 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.912 HD11 ' HG3' ' A' ' 37' ' ' MET . 0.1 OUTLIER -88.55 -17.49 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.424 ' CD2' ' CD2' ' A' ' 7' ' ' TYR . 1.9 t60 -140.96 141.13 34.49 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.503 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.29 177.27 9.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.839 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 p -175.95 111.65 0.11 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.035 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 m -90.64 -34.23 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.576 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-30 -82.71 -16.45 48.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.381 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.9 p -63.04 -37.36 86.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.07 0.462 . . . . 0.0 110.262 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.87 -27.01 63.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.316 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -74.1 -54.68 7.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.375 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.24 -45.28 72.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.304 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.65 -52.81 63.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.761 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.825 ' O ' HG23 ' A' ' 26' ' ' VAL . 37.7 ttp180 -58.67 -42.64 88.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.461 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.688 HD23 ' N ' ' A' ' 24' ' ' LEU . 2.2 tt -58.89 -54.73 43.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.179 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.688 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.9 mt -56.7 -48.16 78.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.72 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.4 m -55.91 -39.87 72.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.146 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 22' ' ' ARG . 59.9 t -75.97 -32.47 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.593 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -73.76 -9.36 58.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.073 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 68.69 42.57 1.43 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.051 0.453 . . . . 0.0 110.63 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -127.97 132.5 24.38 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.902 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.633 ' O ' ' HA ' ' A' ' 1' ' ' MET . 64.2 Cg_endo -79.92 154.17 22.76 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.479 2.119 . . . . 0.0 111.217 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 5.5 p90 -161.51 171.26 18.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.717 0.294 . . . . 0.0 111.446 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -137.35 121.7 18.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.899 0.38 . . . . 0.0 110.759 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.664 ' CE2' HG11 ' A' ' 4' ' ' VAL . 35.1 t80 -89.32 157.9 18.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.44 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.636 HG21 ' HG2' ' A' ' 47' ' ' LYS . 21.8 mt -143.95 120.38 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.27 0.557 . . . . 0.0 111.038 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -83.99 109.27 17.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.08 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.612 HG22 ' HB2' ' A' ' 47' ' ' LYS . 11.6 pt -97.72 66.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.05 0.453 . . . . 0.0 111.605 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.912 ' HG3' HD11 ' A' ' 11' ' ' ILE . 22.0 tpp -160.73 73.4 2.79 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.413 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.97 -22.61 69.74 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.128 1.885 . . . . 0.0 110.859 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -151.2 152.77 33.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.052 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.617 ' HG3' HD12 ' A' ' 11' ' ' ILE . 14.3 mttt -64.1 -7.54 9.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.344 0.592 . . . . 0.0 111.622 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.79 -55.42 3.36 Favored Glycine 0 C--N 1.311 -0.827 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.953 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -149.19 147.13 16.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 12.3 m-85 -59.74 170.45 1.11 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.088 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -77.89 108.4 11.12 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.687 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.03 -24.25 23.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.723 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.65 -56.36 14.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.817 0.341 . . . . 0.0 111.323 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.636 ' HG2' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -66.58 -34.37 77.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.157 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.85 -31.38 30.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.552 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.64 -55.01 39.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.962 0.41 . . . . 0.0 110.287 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.14 -33.31 75.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.045 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.588 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.1 tt -59.11 -51.69 68.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.284 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.411 HD21 ' CG ' ' A' ' 60' ' ' GLN . 84.1 mt -52.68 -44.51 66.27 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.999 0.428 . . . . 0.0 111.381 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.6 m -57.9 -48.79 78.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.576 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -58.78 -38.77 79.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.618 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.9 -56.04 26.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.722 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.93 -115.6 0.58 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.097 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.6 ttp-105 -150.33 31.03 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 110.662 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -121.07 -143.72 0.35 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.321 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 t -120.02 170.29 9.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.692 0.282 . . . . 0.0 110.671 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.411 ' CG ' HD21 ' A' ' 52' ' ' LEU . 3.4 mm100 -77.83 98.34 5.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.271 0.558 . . . . 0.0 110.649 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -80.13 84.32 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.115 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.1 25.45 66.3 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.449 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.694 HD11 ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -52.81 134.63 36.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.9 0.381 . . . . 0.0 110.893 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.516 ' H ' HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -117.54 164.1 15.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.101 0.477 . . . . 0.0 111.419 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.07 154.74 47.18 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.66 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.506 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.3 Cg_endo -87.54 136.82 16.61 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.116 -1.202 . . . . 0.0 112.679 0.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.694 ' NE2' HD11 ' A' ' 63' ' ' LEU . 4.0 tp60 -90.01 142.79 27.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.927 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -115.97 158.06 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.077 0.465 . . . . 0.0 111.56 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.456 ' CE2' ' HB2' ' A' ' 75' ' ' HIS . 46.6 m-85 -142.83 138.66 30.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.146 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.659 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -50.92 133.36 29.21 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.409 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.64 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 33.4 Cg_exo -52.92 -21.96 16.97 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.555 2.17 . . . . 0.0 111.948 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.23 39.79 0.1 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.19 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.4 -110.16 0.8 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.957 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.461 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -137.07 -172.4 3.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.168 0.509 . . . . 0.0 111.321 -179.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.456 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 24.4 t-80 -65.18 126.1 27.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.068 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.659 HD11 ' HA ' ' A' ' 70' ' ' ALA . 14.6 mt -95.91 -45.26 13.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.784 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.569 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 134.02 -155.32 21.77 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.521 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.77 -142.07 9.1 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.572 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -70.56 -68.76 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.778 0.323 . . . . 0.0 110.943 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -54.74 -46.46 74.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.838 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -54.41 -36.26 63.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.627 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.723 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.9 OUTLIER -75.27 -38.93 60.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.28 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -51.93 -29.63 21.05 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -71.25 -35.47 71.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.154 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 82' ' ' LEU . 20.7 t80 -63.46 -33.63 75.98 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.275 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.723 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.5 m-85 -87.15 -69.53 0.68 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.122 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.684 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 16.1 ttm . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.782 0.325 . . . . 0.0 111.682 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.477 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 91.8 m-85 -85.62 142.38 29.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.991 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.644 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -117.04 127.69 54.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.909 -179.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.722 HG11 ' CE1' ' A' ' 33' ' ' PHE . 15.7 t -110.76 133.81 55.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.391 0.615 . . . . 0.0 111.559 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.537 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 21.6 m-30 -116.39 99.86 7.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.368 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.544 ' N ' HG23 ' A' ' 36' ' ' ILE . . . -161.8 -139.13 2.57 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.771 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.727 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 45.4 m-85 -123.71 156.22 36.37 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 120.889 0.376 . . . . 0.0 111.364 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -74.38 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 t 173.62 -36.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.734 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -85.11 -20.7 29.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.533 HD12 ' N ' ' A' ' 11' ' ' ILE . 4.2 mp -89.28 -38.22 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.004 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -150.29 151.6 33.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.464 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 14' ' ' CYS . 13.7 tptt -75.74 157.33 33.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.18 0.514 . . . . 0.0 112.177 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 28.3 p 177.43 113.15 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.545 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.447 ' CG2' ' N ' ' A' ' 16' ' ' TYR . 1.3 m -90.88 -39.11 11.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.899 0.857 . . . . 0.0 110.026 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.569 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -77.97 -10.74 59.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.698 -179.212 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 14' ' ' CYS . 20.5 p -73.76 -41.72 62.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.047 0.451 . . . . 0.0 110.045 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.53 -34.09 71.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.747 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -65.06 -46.74 79.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.97 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.79 -50.39 72.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.962 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.0 ttpt -53.16 -44.09 67.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.841 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.768 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -60.47 -40.89 92.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.801 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -57.78 -53.1 61.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.564 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.801 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.0 mt -56.52 -47.5 79.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.85 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.2 m -55.18 -36.51 65.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.136 0.493 . . . . 0.0 110.091 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.4 t -78.14 -28.14 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.675 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.7 -21.25 44.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.927 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt 71.65 63.52 0.15 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.962 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -132.02 142.31 44.65 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.053 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.65 124.49 8.24 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.477 2.118 . . . . 0.0 111.266 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.684 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 6.3 p90 -157.17 164.56 37.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.046 0.451 . . . . 0.0 112.168 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.66 144.03 31.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.993 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.722 ' CE1' HG11 ' A' ' 4' ' ' VAL . 17.9 t80 -89.2 152.76 21.41 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.004 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 mt -143.92 119.62 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.358 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -72.94 109.93 6.86 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.776 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.727 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 1.2 pp -69.79 -24.8 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.618 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 5.8 ttp -126.69 91.44 47.3 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.111 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.71 0.61 9.9 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.57 2.18 . . . . 0.0 112.231 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -139.65 138.45 36.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.652 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -66.28 -8.71 26.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.246 0.546 . . . . 0.0 111.852 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.13 -63.75 1.64 Allowed Glycine 0 C--N 1.311 -0.815 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.098 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -150.28 139.42 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.617 0.246 . . . . 0.0 111.118 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.6 OUTLIER -58.79 169.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.932 0.396 . . . . 0.0 111.353 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.406 ' O ' ' CD1' ' A' ' 48' ' ' ILE . 1.2 t0 -80.07 105.86 11.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.302 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 6.1 t70 -59.88 -17.63 38.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.815 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.33 -61.22 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 111.212 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.55 -36.21 83.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.054 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.406 ' CD1' ' O ' ' A' ' 44' ' ' ASP . 1.9 mp -70.48 -29.85 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.409 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -61.7 -54.69 39.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.435 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.54 -34.51 74.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.134 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.537 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 2.9 tt -55.84 -51.13 68.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.264 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.6 mt -54.03 -47.24 71.75 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.331 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.1 m -62.54 -45.16 94.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.612 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -56.56 -40.73 75.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.587 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 mt -59.96 -47.88 83.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.572 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.49 -112.48 0.49 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.196 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.34 33.64 0.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.055 0.455 . . . . 0.0 110.433 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -120.92 -146.88 0.38 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.9 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.3 t -120.26 172.99 7.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.741 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.28 98.61 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.494 0.664 . . . . 0.0 109.755 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.5 mt -75.08 78.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.875 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.59 26.88 0.45 Allowed Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.007 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.2 139.88 46.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.873 0.368 . . . . 0.0 111.022 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.5 p -106.42 170.7 7.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.398 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.663 ' CE ' HD13 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -108.15 156.29 38.64 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.896 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.8 Cg_exo -84.08 143.2 42.08 Favored 'Cis proline' 0 C--N 1.346 0.4 0 C-N-CA 124.258 -1.142 . . . . 0.0 113.064 0.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -96.33 132.29 41.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.565 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -102.5 162.51 3.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.441 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.43 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 19.5 m-85 -142.25 130.88 22.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.7 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.552 ' N ' HD11 ' A' ' 76' ' ' ILE . . . -65.76 147.46 98.72 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.385 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.562 ' HB3' ' N ' ' A' ' 1' ' ' MET . 74.6 Cg_exo -45.44 -38.72 16.13 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.292 2.662 . . . . 0.0 112.615 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.66 -38.84 70.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.158 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.83 78.53 0.31 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.505 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.3 m -164.05 148.3 10.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.73 0.3 . . . . 0.0 110.878 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -75.94 106.97 7.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.552 HD11 ' N ' ' A' ' 70' ' ' ALA . 4.7 mt -74.8 -50.46 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.191 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 131.59 -153.06 20.27 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.799 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.06 -136.34 8.75 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.772 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.484 ' HB2' ' CE1' ' A' ' 16' ' ' TYR . 46.3 t80 -72.05 -70.76 0.31 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.755 0.312 . . . . 0.0 111.13 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -57.43 -40.97 79.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.979 0.418 . . . . 0.0 110.722 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -58.58 -38.46 77.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.831 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.716 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -75.37 -41.63 55.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.368 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.23 -30.34 17.17 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -70.9 -36.22 72.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.253 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.503 ' CD2' HG23 ' A' ' 76' ' ' ILE . 11.4 t80 -63.99 -33.29 75.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.216 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.716 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.6 m-85 -89.58 -13.21 37.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.257 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 68.0 mttt . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.796 179.918 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.646 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 22.9 ttm . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.816 0.341 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.496 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 77.0 m-85 -76.66 158.73 30.82 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.635 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -138.86 120.6 15.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.786 -179.408 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.8 HG22 HG22 ' A' ' 68' ' ' VAL . 7.8 t -104.79 133.02 50.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.294 0.569 . . . . 0.0 111.681 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.679 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.3 m-85 -109.33 99.21 8.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.139 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.53 -137.34 2.19 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.878 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.755 ' HE1' ' HE2' ' A' ' 37' ' ' MET . 88.6 m-85 -115.8 160.13 20.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 111.888 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -83.47 -73.0 0.43 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.606 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 p 171.79 -38.75 0.0 OUTLIER 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.963 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -85.82 -19.66 30.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.726 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 mt -95.19 -38.79 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.606 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 2.7 t-80 -150.9 174.08 13.52 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -79.65 157.68 27.2 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.949 -0.469 . . . . 0.0 111.75 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -165.97 87.35 0.37 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.3 m -90.5 -41.93 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.757 0.313 . . . . 0.0 111.165 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -77.64 -15.67 59.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.638 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.7 m -70.56 -50.63 35.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.106 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -55.99 -30.66 62.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 111.07 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -70.71 -50.67 33.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.026 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.6 -46.88 80.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.107 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.8 tttt -59.9 -53.42 58.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.74 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.798 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -59.32 -35.45 73.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.567 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.717 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.3 tt -58.3 -53.31 59.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.41 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.717 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.7 mt -55.77 -45.71 78.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.69 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.38 -35.26 67.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.17 0.509 . . . . 0.0 110.094 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 22' ' ' ARG . 42.1 t -78.05 -30.59 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.558 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -19.35 50.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.948 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 73.81 63.75 0.09 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.932 0.396 . . . . 0.0 110.904 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -142.27 139.27 17.53 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.11 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 1' ' ' MET . 80.9 Cg_endo -74.6 136.11 20.83 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.423 2.082 . . . . 0.0 111.616 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.646 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 21.3 p90 -158.3 170.66 21.75 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -146.05 147.09 31.25 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.968 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.464 ' HE1' HG11 ' A' ' 4' ' ' VAL . 13.6 t80 -89.53 158.56 17.61 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.166 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.679 HD12 ' CE1' ' A' ' 5' ' ' TYR . 19.8 mt -147.25 121.65 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.456 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -91.79 122.81 34.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.069 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 pp -89.0 -23.24 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.755 ' HE2' ' HE1' ' A' ' 7' ' ' TYR . 2.5 ttp -119.25 92.99 46.51 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.306 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.4 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 72.6 Cg_endo -76.12 0.52 9.27 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.745 2.297 . . . . 0.0 113.295 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -139.11 140.85 38.08 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -9.2 12.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.232 0.539 . . . . 0.0 111.645 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.95 -67.0 0.9 Allowed Glycine 0 C--N 1.315 -0.625 0 CA-C-N 115.272 -0.876 . . . . 0.0 113.147 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.1 t -128.73 138.47 54.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -72.57 170.51 14.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.501 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.4 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 2.5 t70 -87.86 115.32 25.23 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.147 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.78 ' HA ' HD12 ' A' ' 48' ' ' ILE . 16.3 p30 -66.92 -18.89 65.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.605 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -58.58 -55.08 39.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.923 0.392 . . . . 0.0 110.702 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 mmtm -69.35 -39.06 78.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.144 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.78 HD12 ' HA ' ' A' ' 45' ' ' ASP . 66.7 mt -54.12 -44.88 65.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.87 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.66 -55.17 36.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.54 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.72 -38.5 81.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.218 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.479 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -59.57 -50.62 73.19 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.477 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 58' ' ' ASP . 72.7 mt -47.78 -43.11 27.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.299 0.571 . . . . 0.0 110.701 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.1 m -68.55 -35.78 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.827 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.434 ' HE3' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -65.86 -30.6 71.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.428 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.694 ' CD1' HD21 ' A' ' 63' ' ' LEU . 1.1 mt -75.98 -48.47 21.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.658 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.25 -39.95 1.59 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.111 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -97.26 169.11 10.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 110.823 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.467 ' O ' HD13 ' A' ' 52' ' ' LEU . 70.4 m-20 -94.05 -25.87 17.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.763 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -98.72 161.24 13.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.75 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -110.48 99.83 8.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.805 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.6 mt -79.62 84.61 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 64' ' ' THR . . . 60.78 25.8 64.21 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.51 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.752 HD11 ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -54.17 126.65 23.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.866 0.365 . . . . 0.0 110.857 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 62' ' ' GLY . 59.6 p -128.67 170.38 13.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.161 0.505 . . . . 0.0 111.59 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.56 157.15 38.25 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.625 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.2 Cg_endo -86.67 149.78 40.72 Favored 'Cis proline' 0 C--N 1.346 0.395 0 C-N-CA 124.384 -1.09 . . . . 0.0 112.94 0.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.752 ' NE2' HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -119.27 115.59 24.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.98 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.8 HG22 HG22 ' A' ' 4' ' ' VAL . 2.9 t -91.59 165.92 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.219 0.533 . . . . 0.0 112.24 -178.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.5 ' H ' HG12 ' A' ' 68' ' ' VAL . 34.5 m-85 -142.29 133.51 26.2 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.155 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.695 ' HB3' ' H ' ' A' ' 74' ' ' SER . . . -72.24 138.02 81.51 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.603 ' HB3' ' N ' ' A' ' 1' ' ' MET . 21.2 Cg_exo -34.61 -56.14 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.799 2.999 . . . . 0.0 113.195 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -140.38 29.35 1.99 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.615 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.13 -87.93 1.85 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.549 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.695 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 1.0 OUTLIER -177.45 175.47 1.43 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.893 0.378 . . . . 0.0 110.571 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.413 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 20.0 t-80 -49.95 109.18 0.26 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.687 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.559 HD11 ' HA ' ' A' ' 70' ' ' ALA . 14.3 mt -73.86 -48.77 37.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.493 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 128.7 -154.29 20.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.598 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.52 -149.66 7.17 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.604 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -72.04 -53.97 11.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.78 0.324 . . . . 0.0 110.769 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -54.78 -44.39 73.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.846 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -58.67 -45.59 89.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.67 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.639 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -61.85 -49.47 76.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.595 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -51.11 -30.71 16.98 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -75.37 -34.5 61.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.177 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.422 ' N ' ' O ' ' A' ' 82' ' ' LEU . 6.3 t80 -65.45 -32.97 74.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.278 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.639 ' HE2' HD21 ' A' ' 82' ' ' LEU . 9.4 m-85 -91.85 -24.27 19.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.348 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.9 pttt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.317 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.679 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 4.5 tpp . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -77.53 143.92 38.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.879 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -105.59 121.97 45.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 -179.159 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.814 HG22 HG22 ' A' ' 68' ' ' VAL . 53.9 t -111.66 140.94 28.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.348 0.594 . . . . 0.0 111.934 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.844 ' CE1' HD12 ' A' ' 34' ' ' ILE . 4.9 m-85 -119.88 99.62 6.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.453 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.8 -140.18 2.87 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.124 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.826 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 30.0 m-85 -126.06 159.93 31.47 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.626 -0.287 . . . . 0.0 111.228 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.406 ' O ' ' CB ' ' A' ' 9' ' ' SER . 11.3 t70 -69.87 -67.41 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.527 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.7 OUTLIER 166.36 -39.35 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.129 179.641 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -85.55 -17.93 34.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.174 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.684 HD12 ' N ' ' A' ' 11' ' ' ILE . 2.6 mp -89.11 -42.51 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.042 0.449 . . . . 0.0 109.799 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.412 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 5.3 t60 -149.52 158.17 43.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.201 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.37 146.65 2.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.831 0.348 . . . . 0.0 111.454 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -175.15 65.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.274 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.6 m -90.57 -48.12 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -76.87 -11.35 59.81 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.465 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 27.4 p -73.95 -45.04 52.79 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -55.31 -24.86 31.0 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.477 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 10.2 m-80 -73.3 -45.79 53.43 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.989 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.42 ' HB2' ' CD1' ' A' ' 79' ' ' PHE . . . -60.91 -29.69 69.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.335 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? -70.35 -62.45 1.38 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.808 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.706 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.6 OUTLIER -54.24 -30.29 49.73 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.93 0.395 . . . . 0.0 110.379 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.743 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.4 tt -58.16 -54.26 48.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.817 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.743 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.0 mt -54.44 -45.41 73.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.455 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 m -54.79 -36.28 64.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.655 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 22' ' ' ARG . 44.3 t -79.67 -32.28 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.308 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.601 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -73.19 -11.95 60.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.834 179.516 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.37 45.52 0.1 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.948 0.404 . . . . 0.0 110.95 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -144.04 134.04 11.85 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.338 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.596 ' O ' ' HA ' ' A' ' 1' ' ' MET . 64.5 Cg_endo -81.54 166.19 17.87 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.611 2.207 . . . . 0.0 111.308 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.552 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 8.4 p90 -161.49 171.08 18.75 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.89 0.329 . . . . 0.0 111.89 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.72 136.64 39.16 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.806 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.512 ' HE1' HG11 ' A' ' 4' ' ' VAL . 6.0 t80 -89.22 160.77 16.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.502 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.844 HD12 ' CE1' ' A' ' 5' ' ' TYR . 20.3 mt -144.52 119.41 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.259 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -83.09 121.89 27.63 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.481 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.826 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 1.3 pt -98.1 -20.06 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.796 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.45 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 32.6 ttm -124.75 83.26 59.23 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.811 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.454 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 55.7 Cg_endo -70.17 -13.94 34.23 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.653 2.236 . . . . 0.0 111.981 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -139.8 145.27 37.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.747 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.84 -8.0 44.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.304 0.573 . . . . 0.0 111.498 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.26 -58.54 2.57 Favored Glycine 0 C--N 1.312 -0.799 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.4 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.1 t -149.48 140.71 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 111.374 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.4 OUTLIER -60.01 160.18 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.533 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.454 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 62.6 t0 -71.78 132.2 44.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.952 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -71.54 -28.26 63.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 0.0 110.761 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.93 -56.43 10.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.984 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -65.31 -46.18 81.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.836 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 44' ' ' ASP . 1.1 mp -58.1 -38.14 65.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.372 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.46 -56.57 5.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.152 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -60.21 -31.31 70.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.629 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.442 HD13 ' CD2' ' A' ' 5' ' ' TYR . 13.3 tp -59.71 -52.18 66.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.288 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.5 mt -51.59 -45.82 63.29 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.107 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.0 m -65.53 -31.44 72.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.331 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.424 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 19.8 tttp -66.96 -31.87 72.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.556 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.443 ' N ' HD23 ' A' ' 55' ' ' LEU . 1.3 mt -64.91 -42.7 94.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.8 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.75 -106.47 0.29 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.05 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -149.68 28.65 0.78 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.112 0.482 . . . . 0.0 110.679 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -121.3 -147.14 0.38 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.401 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.5 t -120.28 170.24 9.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.69 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.29 98.26 8.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.271 0.558 . . . . 0.0 110.355 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.3 mt -80.06 84.52 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.191 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.77 25.76 45.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.469 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.412 HD12 ' NE2' ' A' ' 67' ' ' GLN . 1.1 mm? -57.64 144.3 38.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.897 0.379 . . . . 0.0 110.85 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.9 p -123.53 168.51 12.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.229 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.593 ' CE ' HD13 ' A' ' 36' ' ' ILE . 1.2 mpt? -113.12 156.12 43.36 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.791 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -80.59 140.57 52.0 Favored 'Cis proline' 0 C--N 1.344 0.298 0 C-N-CA 123.741 -1.358 . . . . 0.0 112.978 0.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.412 ' NE2' HD12 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -96.42 123.16 39.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.055 179.051 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.814 HG22 HG22 ' A' ' 4' ' ' VAL . 10.1 t -99.39 159.42 3.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.174 0.512 . . . . 0.0 111.97 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.525 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 90.9 m-85 -143.35 148.53 36.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.54 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.609 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -60.72 146.69 85.74 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.665 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.679 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 14.6 Cg_exo -65.6 -13.4 39.61 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.534 2.156 . . . . 0.0 112.087 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.72 -25.8 14.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.765 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.98 92.72 0.7 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.783 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.9 m 176.67 155.67 0.25 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 111.005 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.413 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 7.2 t-160 -90.68 113.52 25.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.609 HD11 ' HA ' ' A' ' 70' ' ' ALA . 29.2 mt -94.42 -49.37 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.981 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 135.03 -154.66 21.65 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.698 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.81 -142.66 12.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.674 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 20' ' ' ALA . 24.1 t80 -67.71 -70.87 0.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.694 0.283 . . . . 0.0 110.917 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -58.74 -45.54 89.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.998 0.428 . . . . 0.0 110.707 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -52.47 -38.98 60.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.573 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.705 HD21 ' CE2' ' A' ' 86' ' ' PHE . 4.8 tt -79.41 -33.56 42.56 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.313 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -51.21 -29.51 14.41 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -70.33 -35.39 73.58 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.454 ' N ' ' O ' ' A' ' 82' ' ' LEU . 6.6 t80 -63.19 -34.46 77.69 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.705 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.1 m-85 -87.98 -70.46 0.63 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.296 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.981 -179.972 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.746 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 7.1 tpp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -77.67 146.63 35.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.89 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.9 mptt -109.66 122.03 46.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.787 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 66' ' ' PRO . 50.7 t -110.33 129.59 65.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.277 0.56 . . . . 0.0 111.854 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.564 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 17.5 m-85 -107.68 99.32 8.82 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.833 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.6 -143.7 3.73 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.246 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.746 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 5.0 m-85 -127.9 154.98 44.9 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 120.619 0.247 . . . . 0.0 111.239 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.07 -79.56 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.008 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 m 175.42 -34.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.835 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -62.57 -50.89 69.5 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.223 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.587 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -89.92 -39.79 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.936 0.398 . . . . 0.0 111.177 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.746 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 57.0 t-80 -139.88 139.65 36.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.005 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.95 174.23 11.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.257 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.8 p 175.11 113.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.896 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.0 m -90.08 -30.14 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.839 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -83.87 -15.91 46.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 p -71.31 -43.65 66.65 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.811 0.338 . . . . 0.0 110.714 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.1 -38.3 78.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.752 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -57.65 -48.53 79.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.899 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.411 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -64.59 -40.01 94.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.81 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HD2' ' CE2' ' A' ' 31' ' ' PHE . 2.2 mmmm -49.97 -37.75 33.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.14 0.495 . . . . 0.0 110.188 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.78 ' O ' HG23 ' A' ' 26' ' ' VAL . 61.3 ttt180 -75.07 -29.24 60.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.312 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.672 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -54.56 -55.7 26.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.304 179.386 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.694 HD12 ' CG ' ' A' ' 31' ' ' PHE . 3.0 mt -62.77 -47.49 83.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.766 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.3 m -56.01 -35.26 66.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.461 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 22' ' ' ARG . 87.8 t -78.06 -27.56 14.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.965 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HD3' ' CG ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -78.81 -11.45 59.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.308 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 72.59 38.43 0.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.929 0.395 . . . . 0.0 110.812 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.01 142.43 44.41 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.567 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' O ' ' HA ' ' A' ' 1' ' ' MET . 67.5 Cg_endo -79.5 155.81 24.79 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.526 2.151 . . . . 0.0 111.616 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.694 ' CG ' HD12 ' A' ' 24' ' ' LEU . 46.1 p90 -161.46 170.83 19.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.278 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -137.11 129.48 29.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.833 0.349 . . . . 0.0 110.943 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.513 ' HE1' HG11 ' A' ' 4' ' ' VAL . 17.3 t80 -89.22 154.94 19.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.005 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.478 HG21 ' HD3' ' A' ' 47' ' ' LYS . 13.0 mt -147.11 119.69 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.261 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -86.26 109.7 19.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.786 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 43' ' ' PHE . 11.8 pt -85.69 58.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.31 0.576 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.499 ' HE3' ' CE2' ' A' ' 7' ' ' TYR . 26.6 ttm -173.21 89.49 0.38 Allowed Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.334 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 51.9 Cg_endo -69.1 -22.42 35.14 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.29 1.993 . . . . 0.0 111.408 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -145.04 143.07 30.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.381 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.4 pttt -57.08 -9.07 0.78 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.171 0.51 . . . . 0.0 112.139 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.42 -55.2 4.37 Favored Glycine 0 C--N 1.312 -0.783 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.042 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -148.94 144.23 18.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 1.0 OUTLIER -58.77 170.97 0.71 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.029 179.157 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.402 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -87.32 103.81 15.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.908 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 2.9 t70 -58.11 -25.2 61.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.361 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -64.62 -59.14 4.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.897 0.379 . . . . 0.0 110.635 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.478 ' HD3' HG21 ' A' ' 34' ' ' ILE . 11.3 mttp -65.01 -35.6 81.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.27 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.3 mm -70.27 -32.85 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.343 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -58.18 -51.93 67.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.636 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.27 -36.52 83.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.928 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 3.5 tt -59.43 -53.19 60.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.392 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.0 mt -51.42 -44.59 62.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.149 0.5 . . . . 0.0 111.517 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.0 m -64.18 -49.41 72.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.571 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -54.87 -34.95 63.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.793 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -61.8 2.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.97 -26.71 0.25 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.549 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.74 -173.75 4.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.698 0.285 . . . . 0.0 110.684 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -98.9 19.29 15.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.308 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 t -120.19 158.63 26.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.881 0.372 . . . . 0.0 110.969 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -116.7 99.84 7.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.014 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 pt -78.84 84.13 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.999 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.73 26.61 57.81 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.195 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -56.81 135.74 55.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.899 0.381 . . . . 0.0 111.077 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.7 p -124.99 167.1 15.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.172 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.4 ' HG2' HD11 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -118.3 154.24 51.91 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.799 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.536 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.6 Cg_endo -85.72 142.43 31.56 Favored 'Cis proline' 0 N--CA 1.461 -0.388 0 C-N-CA 124.098 -1.209 . . . . 0.0 112.745 0.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -99.79 139.95 34.7 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -107.88 159.47 7.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.407 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 75' ' ' HIS . 30.8 m-85 -143.06 135.83 27.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.127 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.623 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -49.73 133.32 20.39 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.286 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.746 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 29.3 Cg_exo -54.65 -21.11 23.7 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.48 2.12 . . . . 0.0 111.851 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.3 38.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.189 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.3 -109.63 0.78 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.988 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.48 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 87.4 p -142.76 -176.33 4.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.135 0.493 . . . . 0.0 111.291 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.496 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 19.5 t-80 -57.85 123.42 15.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.203 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.623 HD11 ' HA ' ' A' ' 70' ' ' ALA . 14.5 mt -91.88 -46.27 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.733 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 129.37 -156.29 21.22 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.828 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -89.27 -139.3 7.14 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.332 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.672 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -75.49 -70.11 0.44 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.769 0.285 . . . . 0.0 110.871 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -49.1 -42.9 40.57 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.239 0.542 . . . . 0.0 110.437 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -64.01 -43.84 94.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.847 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.704 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -71.79 -40.87 68.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.605 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -51.43 -34.06 33.28 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -67.72 -35.94 79.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.16 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.428 ' N ' ' O ' ' A' ' 82' ' ' LEU . 35.2 t80 -62.94 -34.02 76.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.432 178.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.704 ' CE2' HD21 ' A' ' 82' ' ' LEU . 8.8 m-85 -87.32 -70.32 0.63 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.194 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 69.6 mttt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.962 179.939 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.616 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.9 ttm . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.669 0.271 . . . . 0.0 111.662 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.508 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 83.1 m-85 -59.17 161.29 5.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.875 0.369 . . . . 0.0 110.122 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -137.78 120.67 16.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.827 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.996 HG22 HG22 ' A' ' 68' ' ' VAL . 75.3 t -110.74 150.99 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.418 0.628 . . . . 0.0 111.703 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.712 ' CE1' HD12 ' A' ' 34' ' ' ILE . 40.4 m-85 -133.72 102.5 5.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.17 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -166.47 -136.78 2.08 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.535 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.409 ' O ' ' CZ ' ' A' ' 33' ' ' PHE . 49.2 m-85 -106.91 157.96 17.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.848 0.356 . . . . 0.0 110.885 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -98.94 -71.74 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.008 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 p 169.59 -32.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.996 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -74.68 -38.3 62.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.689 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.553 HG21 ' O ' ' A' ' 37' ' ' MET . 44.7 mm -89.12 -49.48 14.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -140.01 149.9 43.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.387 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.92 157.53 26.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.12 0.486 . . . . 0.0 112.018 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -172.32 93.53 0.13 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.488 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.8 m -71.44 -39.53 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.838 0.351 . . . . 0.0 111.023 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.19 -24.02 66.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.882 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.2 m -66.39 -60.69 2.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.5 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -51.77 -39.18 58.15 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.3 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -63.88 -40.64 97.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.373 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.555 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -66.76 -50.48 62.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.059 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -49.51 -36.36 22.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.856 0.36 . . . . 0.0 110.583 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.79 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -65.42 -41.79 93.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.293 179.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.798 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -56.99 -53.04 62.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.251 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.798 ' N ' HD23 ' A' ' 23' ' ' LEU . 7.1 mt -57.86 -45.22 86.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.673 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 51.7 m -57.62 -34.93 69.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.046 0.451 . . . . 0.0 110.113 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.9 t -80.05 -33.96 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.603 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -11.54 60.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.053 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.62 48.56 1.07 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.061 0.457 . . . . 0.0 110.537 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.407 ' NE2' ' HD2' ' A' ' 30' ' ' PRO . 14.6 mm100 -128.72 130.61 23.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.308 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.465 ' O ' ' HA ' ' A' ' 1' ' ' MET . 83.8 Cg_endo -76.81 142.93 23.06 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.444 2.096 . . . . 0.0 111.105 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.616 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 9.9 p90 -158.35 170.72 21.6 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.544 -0.462 . . . . 0.0 112.209 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -142.01 129.15 20.93 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.073 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.619 ' CE1' HG11 ' A' ' 4' ' ' VAL . 50.6 t80 -89.69 162.33 15.64 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.863 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.712 HD12 ' CE1' ' A' ' 5' ' ' TYR . 14.4 mt -146.94 122.41 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.265 0.555 . . . . 0.0 110.675 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -79.04 136.19 37.1 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.052 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.661 HD13 ' SD ' ' A' ' 65' ' ' MET . 2.6 pt -97.18 -27.15 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.172 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.553 ' O ' HG21 ' A' ' 11' ' ' ILE . 5.4 ttp -124.15 95.16 44.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.431 ' CG ' ' HB2' ' A' ' 44' ' ' ASP . 85.8 Cg_endo -80.93 4.84 6.63 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.67 2.247 . . . . 0.0 112.75 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.454 ' C ' HG23 ' A' ' 11' ' ' ILE . 1.7 mt-10 -139.44 137.79 35.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.661 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.426 ' N ' HG23 ' A' ' 11' ' ' ILE . 24.3 tttp -65.18 -9.0 19.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.206 0.527 . . . . 0.0 111.909 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.04 -65.18 1.28 Allowed Glycine 0 C--N 1.311 -0.811 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.247 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 43' ' ' PHE . 20.3 t -139.63 155.93 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.751 0.31 . . . . 0.0 111.17 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -75.18 168.1 20.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.821 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.431 ' HB2' ' CG ' ' A' ' 38' ' ' PRO . 19.0 t70 -100.42 114.51 28.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.255 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -54.83 -23.37 18.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.449 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.92 -53.41 58.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.883 0.373 . . . . 0.0 110.795 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -71.11 -28.52 64.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.385 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.7 mm -71.92 -39.65 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.659 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.42 -55.63 22.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.168 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -56.13 -33.49 65.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.57 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.427 HD13 ' CG ' ' A' ' 5' ' ' TYR . 24.1 tp -63.1 -49.47 74.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.075 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.1 mt -52.25 -44.21 64.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.207 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -64.8 -32.3 73.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.091 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.439 ' HD3' ' CD2' ' A' ' 69' ' ' PHE . 2.3 ttmm -67.15 -29.5 69.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.368 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.477 HD21 ' NE2' ' A' ' 67' ' ' GLN . 1.2 mt -68.18 -58.03 5.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.683 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.13 -108.69 0.27 Allowed Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.059 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -150.48 33.1 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.034 0.445 . . . . 0.0 110.653 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -120.85 -148.05 0.4 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.378 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 t -116.63 170.19 8.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.812 0.339 . . . . 0.0 110.641 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -86.75 98.44 11.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.298 0.57 . . . . 0.0 110.575 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 pt -80.49 83.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.173 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.9 26.66 41.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.58 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.642 HD12 ' OE1' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -53.15 150.09 6.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.752 0.311 . . . . 0.0 111.074 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 p -127.62 170.07 13.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.214 0.53 . . . . 0.0 111.742 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.661 ' SD ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -122.38 158.12 56.87 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.576 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.4 Cg_exo -79.29 143.53 70.03 Favored 'Cis proline' 0 C--N 1.344 0.32 0 C-N-CA 124.084 -1.215 . . . . 0.0 112.866 0.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.642 ' OE1' HD12 ' A' ' 63' ' ' LEU . 9.9 tt0 -104.08 123.11 46.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.466 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.996 HG22 HG22 ' A' ' 4' ' ' VAL . 16.5 t -100.31 162.22 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.934 0.397 . . . . 0.0 111.659 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.527 ' N ' HG12 ' A' ' 68' ' ' VAL . 85.9 m-85 -142.24 141.84 32.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.073 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.914 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.87 146.65 36.29 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.447 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.602 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 50.1 Cg_exo -56.44 -26.61 63.99 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.132 2.555 . . . . 0.0 112.215 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -93.48 -28.58 16.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.227 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.3 91.53 0.6 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.702 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 2.6 m -178.8 163.86 1.47 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.684 0.278 . . . . 0.0 110.596 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.422 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 14.3 t-160 -90.19 108.7 19.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.113 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.914 HD11 ' HA ' ' A' ' 70' ' ' ALA . 37.1 mt -86.3 -53.39 10.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.765 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 130.61 -153.16 20.1 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.08 -137.72 7.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.155 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.555 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -76.29 -70.19 0.46 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.702 0.251 . . . . 0.0 110.773 179.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -49.26 -44.03 43.46 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.256 0.55 . . . . 0.0 110.32 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -36.53 81.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.482 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.719 HD21 ' CE2' ' A' ' 86' ' ' PHE . 2.0 tt -79.47 -38.52 34.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.594 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.91 -32.75 21.61 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -67.53 -35.62 79.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.237 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 82' ' ' LEU . 8.6 t80 -63.44 -34.44 77.75 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.31 178.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.719 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.8 m-85 -89.3 -21.93 22.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.341 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.991 -179.945 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.626 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.39 0.138 . . . . 0.0 111.045 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.414 ' HB3' ' CG1' ' A' ' 68' ' ' VAL . 75.1 m-85 -39.71 120.9 1.17 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.694 0.759 . . . . 0.0 111.867 -177.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.738 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -90.8 124.1 34.87 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.147 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.629 HG22 HG22 ' A' ' 68' ' ' VAL . 7.7 t -102.15 128.31 54.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.238 0.542 . . . . 0.0 111.47 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 2.8 m-30 -104.96 98.92 8.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.969 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.54 -139.71 2.71 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.293 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.596 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 91.6 m-85 -124.36 153.75 41.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.891 0.377 . . . . 0.0 111.582 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.88 -77.24 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.915 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 170.07 -32.63 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.017 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -80.43 -30.19 37.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.983 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.592 ' H ' HD12 ' A' ' 11' ' ' ILE . 3.6 mp -90.39 -47.15 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.117 0.484 . . . . 0.0 110.59 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.414 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 33.7 t60 -147.76 153.81 39.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.558 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.3 149.61 50.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.077 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 7' ' ' TYR . 42.6 t -164.99 87.56 0.44 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.063 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.39 -27.52 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -64.1 -32.37 73.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.331 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.1 p -77.92 -45.46 23.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.329 . . . . 0.0 110.543 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.08 -37.98 36.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.627 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -69.12 -55.05 11.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.724 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.413 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . . . -52.08 -38.32 56.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.19 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 15.3 ttmt -58.32 -52.36 65.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.342 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.845 ' O ' HG23 ' A' ' 26' ' ' VAL . 30.3 mmt180 -61.14 -37.26 82.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.155 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.797 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -59.82 -53.85 53.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.103 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.797 ' N ' HD23 ' A' ' 23' ' ' LEU . 7.1 mt -56.22 -44.12 79.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.665 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 m -60.09 -41.55 92.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.109 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 22' ' ' ARG . 44.8 t -72.93 -35.82 49.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.595 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 2.6 tmtm? -75.23 -13.0 60.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.31 52.65 0.18 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.888 0.375 . . . . 0.0 110.736 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -145.2 111.52 4.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.239 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.626 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 82.2 Cg_exo -49.53 178.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.324 2.016 . . . . 0.0 111.628 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.477 ' HB3' HD13 ' A' ' 24' ' ' LEU . 5.3 p90 -164.25 170.18 16.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.983 0.42 . . . . 0.0 111.227 178.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.593 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 5.4 mm-40 -136.39 121.0 18.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.625 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.526 ' HE1' HG11 ' A' ' 4' ' ' VAL . 9.9 t80 -89.71 152.96 21.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.111 0.481 . . . . 0.0 111.639 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 3' ' ' LYS . 29.0 mt -150.1 126.54 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.407 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -92.58 129.4 38.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.08 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.596 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 2.0 pp -87.4 -19.53 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.268 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.6 ttp -124.19 94.74 44.82 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.761 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.17 -14.63 28.76 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.421 2.081 . . . . 0.0 112.653 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -139.83 142.25 36.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 110.844 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -65.23 -8.77 19.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.227 0.536 . . . . 0.0 111.877 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.4 -60.22 2.26 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.178 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.6 t -150.1 129.83 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.713 0.292 . . . . 0.0 111.157 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -59.15 169.65 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.941 0.4 . . . . 0.0 110.921 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.467 ' O ' HD12 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -84.28 93.5 8.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.127 -179.609 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -52.4 -22.2 4.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.891 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -55.54 -50.21 70.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 0.0 110.898 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -75.02 -40.74 60.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.571 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 44' ' ' ASP . 2.6 mp -52.67 -30.5 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.762 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.95 -57.72 3.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.722 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -61.07 -29.84 69.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.276 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.962 HD13 HD11 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -61.46 -57.92 10.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.951 179.315 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.564 ' HA ' HD13 ' A' ' 55' ' ' LEU . 72.2 mt -43.14 -45.91 5.66 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.316 0.579 . . . . 0.0 110.919 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.2 m -70.42 -32.4 70.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.272 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.15 -39.93 93.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.328 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.962 HD11 HD13 ' A' ' 51' ' ' LEU . 4.4 mp -59.58 -64.36 0.97 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.868 0.366 . . . . 0.0 110.945 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.65 -48.02 0.21 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.229 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.424 ' HD2' HG22 ' A' ' 59' ' ' THR . 0.3 OUTLIER -99.42 -165.11 1.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 110.865 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -105.43 -30.6 9.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.927 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.424 HG22 ' HD2' ' A' ' 57' ' ' ARG . 10.3 t -95.71 168.51 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.18 99.76 7.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.772 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.1 mt -79.05 84.6 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.047 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 64' ' ' THR . . . 62.37 26.29 67.8 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.316 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.528 HD11 ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -62.06 125.15 22.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 111.002 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 62' ' ' GLY . 34.4 p -128.23 170.14 13.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.994 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.88 159.06 31.29 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.746 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.628 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.9 Cg_endo -84.26 144.75 45.24 Favored 'Cis proline' 0 C--N 1.345 0.343 0 C-N-CA 124.326 -1.114 . . . . 0.0 112.933 0.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.528 ' NE2' HD11 ' A' ' 63' ' ' LEU . 16.3 mm100 -112.41 121.19 44.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.104 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.738 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -95.23 160.06 2.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.446 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 46.1 m-85 -141.97 138.3 31.82 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.264 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.931 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -52.47 142.73 29.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.181 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -31.9 -37.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.718 2.945 . . . . 0.0 112.835 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.29 34.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.111 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.78 -105.12 2.58 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.921 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.5 t -131.84 178.04 7.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.167 0.508 . . . . 0.0 111.269 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -65.36 129.65 40.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.674 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.931 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.3 mp -103.87 -40.89 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.674 0.273 . . . . 0.0 110.94 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' A' ' 81' ' ' GLN . . . 130.95 -166.92 22.5 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.898 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.6 -137.12 4.74 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.907 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.413 ' HD1' ' HB2' ' A' ' 20' ' ' ALA . 30.1 t80 -72.13 -67.96 0.5 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 0.0 111.261 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -54.16 -44.4 71.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.007 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.421 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -57.34 -48.35 79.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.81 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.691 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -67.09 -42.7 84.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.531 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -51.09 -30.25 15.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.52 -35.86 68.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.219 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 82' ' ' LEU . 11.0 t80 -63.72 -33.67 76.17 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.691 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.3 m-85 -87.96 -28.26 21.58 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.068 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.919 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.591 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.7 ttp . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.746 0.308 . . . . 0.0 111.633 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.523 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 86.0 m-85 -58.9 154.4 15.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.937 0.399 . . . . 0.0 110.427 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.679 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -130.31 123.09 29.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.713 -179.359 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.984 HG22 HG22 ' A' ' 68' ' ' VAL . 54.8 t -113.64 145.05 20.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.377 0.608 . . . . 0.0 111.881 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.904 ' CE1' HD12 ' A' ' 34' ' ' ILE . 8.2 m-85 -123.78 102.97 8.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.792 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.78 -137.98 2.31 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.098 -1.048 . . . . 0.0 112.769 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.415 ' CE1' ' SD ' ' A' ' 37' ' ' MET . 56.7 m-85 -112.34 152.66 28.31 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.742 0.306 . . . . 0.0 110.899 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 9' ' ' SER . 19.1 m-20 -88.54 3.75 49.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.709 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.3 OUTLIER 81.09 -10.94 1.16 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.56 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.663 ' OD1' HD12 ' A' ' 11' ' ' ILE . 19.8 p-10 -85.14 -35.08 21.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.908 0.385 . . . . 0.0 110.753 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.73 HG23 ' HA ' ' A' ' 40' ' ' LYS . 2.5 mp -94.32 -42.61 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.52 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -139.34 147.04 41.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.518 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -76.46 159.6 30.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.0 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 p -174.29 122.12 0.28 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.629 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.8 m -90.09 -29.87 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.844 0.354 . . . . 0.0 111.175 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -77.84 -22.08 50.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.101 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.3 p -73.27 -41.88 63.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 110.92 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -28.42 57.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.324 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 81.4 m-20 -74.88 -39.46 61.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.223 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.18 -38.14 78.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.044 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -60.13 -55.94 27.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.648 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.859 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -61.48 -30.45 70.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.362 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.823 HD12 ' CE1' ' A' ' 79' ' ' PHE . 4.0 tt -53.79 -46.18 70.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.333 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.718 HD13 ' CG ' ' A' ' 31' ' ' PHE . 2.6 mt -66.23 -48.58 70.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.635 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.4 m -56.2 -36.52 68.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.505 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 22' ' ' ARG . 49.0 t -72.69 -31.93 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.733 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.22 -9.87 57.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.201 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm 71.24 57.91 0.19 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.983 0.42 . . . . 0.0 110.903 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -135.63 139.03 29.79 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.082 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 1' ' ' MET . 91.8 Cg_endo -79.59 142.08 16.03 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.569 2.179 . . . . 0.0 111.572 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.718 ' CG ' HD13 ' A' ' 24' ' ' LEU . 32.0 p90 -158.69 170.62 21.75 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -141.48 135.56 30.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.162 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CE1' HG11 ' A' ' 4' ' ' VAL . 32.1 t80 -89.81 159.8 16.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.086 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.904 HD12 ' CE1' ' A' ' 5' ' ' TYR . 19.0 mt -139.23 116.53 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.436 0.636 . . . . 0.0 110.431 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -87.24 121.23 29.41 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.474 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.5 HG22 ' HB3' ' A' ' 47' ' ' LYS . 4.2 pt -100.2 32.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.849 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.432 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.0 mtt -142.64 84.39 11.0 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.157 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.511 ' HD2' ' O ' ' A' ' 42' ' ' VAL . 39.9 Cg_endo -67.33 -8.48 22.16 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.684 2.256 . . . . 0.0 112.62 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -138.8 170.58 15.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.881 0.372 . . . . 0.0 111.011 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.73 ' HA ' HG23 ' A' ' 11' ' ' ILE . 4.4 mptp? -65.4 -6.62 10.75 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.52 35.02 0.25 Allowed Glycine 0 C--N 1.313 -0.733 0 C-N-CA 120.711 -0.756 . . . . 0.0 113.043 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.511 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 t -149.22 125.91 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.635 0.255 . . . . 0.0 110.738 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 1.3 m-85 -76.25 169.91 17.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.041 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.449 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -99.91 112.02 24.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.856 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -54.49 -33.09 59.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.826 0.346 . . . . 0.0 110.612 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.26 -51.37 61.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.595 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.5 ' HB3' HG22 ' A' ' 36' ' ' ILE . 22.7 mmtm -64.61 -43.47 93.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.41 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 44' ' ' ASP . 1.7 mp -64.93 -36.17 77.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.184 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.87 -58.32 4.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.093 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.74 -34.75 71.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.781 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.447 HD13 ' CD2' ' A' ' 5' ' ' TYR . 9.5 tp -58.18 -51.49 69.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.38 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.7 -45.88 63.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.166 0.508 . . . . 0.0 111.204 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.7 m -70.2 -35.15 73.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.149 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -29.98 71.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.395 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.66 -70.05 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.781 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.58 -41.2 0.59 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.196 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -98.52 -168.59 1.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 110.847 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -96.65 -30.92 12.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.2 t -109.54 167.5 10.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -104.58 99.52 9.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.553 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.617 ' O ' HG23 ' A' ' 61' ' ' ILE . 7.7 tp -62.88 81.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.261 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.22 23.26 39.86 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.773 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.511 HD12 ' CG ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -65.13 140.7 58.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 110.783 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.34 166.3 16.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.247 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.7 mmt -105.67 152.21 40.04 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.61 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.1 Cg_exo -80.79 144.8 67.73 Favored 'Cis proline' 0 C--N 1.345 0.352 0 C-N-CA 123.985 -1.256 . . . . 0.0 112.894 0.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.511 ' CG ' HD12 ' A' ' 63' ' ' LEU . 5.2 mt-30 -99.05 119.57 38.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.641 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.984 HG22 HG22 ' A' ' 4' ' ' VAL . 4.6 t -97.51 162.71 2.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.744 0.307 . . . . 0.0 111.428 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 89.3 m-85 -142.22 142.69 32.66 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.24 0.543 . . . . 0.0 111.464 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.47 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.66 137.95 62.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.264 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.508 ' HB3' ' N ' ' A' ' 1' ' ' MET . 84.3 Cg_exo -46.61 -28.07 6.01 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.104 2.536 . . . . 0.0 112.001 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.79 37.05 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.043 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.29 -109.85 1.1 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.949 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.442 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 2.0 p -135.67 -178.07 4.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.122 0.487 . . . . 0.0 111.318 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.437 ' CD2' ' O ' ' A' ' 68' ' ' VAL . 41.2 t-80 -60.4 122.79 15.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.036 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.49 HG23 ' HD2' ' A' ' 85' ' ' TYR . 2.3 mt -85.24 -45.68 17.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.963 0.411 . . . . 0.0 111.159 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.04 -147.92 18.29 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.392 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.1 -149.88 24.11 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.927 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.823 ' CE1' HD12 ' A' ' 23' ' ' LEU . 18.9 t80 -71.8 -70.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.833 0.349 . . . . 0.0 111.008 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -55.9 -48.97 74.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -53.56 -35.12 60.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.08 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.728 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.5 tt -83.45 -30.79 26.98 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.042 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.1 ttp85 -50.73 -33.13 21.75 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -66.19 -35.0 79.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.49 ' HD2' HG23 ' A' ' 76' ' ' ILE . 5.2 t80 -63.04 -34.9 78.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.189 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.728 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.6 m-85 -92.4 -13.68 29.73 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.657 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.923 179.913 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.627 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 50.3 ttp . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -74.69 153.15 39.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.201 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -114.22 120.81 41.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.714 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 66' ' ' PRO . 7.0 t -104.41 128.02 58.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.202 0.525 . . . . 0.0 111.498 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.622 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 4.3 m-30 -103.83 98.84 8.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.154 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.29 -138.4 2.43 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.471 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.62 ' CD2' ' CG ' ' A' ' 12' ' ' HIS . 11.5 m-85 -120.35 144.49 47.84 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 120.676 0.274 . . . . 0.0 111.578 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.586 ' HB3' ' CE2' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -136.81 64.22 1.55 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.337 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.898 ' HB3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER 177.88 -179.01 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.271 0.558 . . . . 0.0 112.016 179.675 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -86.39 1.51 50.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.62 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.898 HG22 ' HB3' ' A' ' 9' ' ' SER . 2.5 tt -86.54 -6.58 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.061 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.625 ' CD2' ' HE2' ' A' ' 37' ' ' MET . 30.0 t-80 -156.98 161.92 39.59 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.015 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.76 166.0 24.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.615 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 176.67 73.03 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.888 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.492 HG23 ' N ' ' A' ' 16' ' ' TYR . 29.3 m -89.22 -49.03 14.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.726 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.492 ' N ' HG23 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -70.8 -12.88 61.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 110.972 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.3 m -70.37 -53.0 18.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.534 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -53.65 -26.22 21.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.103 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.53 -59.41 2.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.032 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.46 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . . . -53.82 -38.26 64.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.489 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -52.92 63.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 110.658 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.673 ' O ' HG23 ' A' ' 26' ' ' VAL . 14.7 tpt180 -60.75 -37.63 82.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.482 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.641 ' C ' HD23 ' A' ' 23' ' ' LEU . 3.3 tt -60.18 -53.33 58.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.64 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.593 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.2 mt -56.99 -48.71 77.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.951 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.2 m -54.53 -37.93 65.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.106 0.479 . . . . 0.0 110.244 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 22' ' ' ARG . 67.1 t -79.54 -32.58 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.598 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -72.91 -11.59 60.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.112 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm 72.86 43.93 0.39 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.892 0.377 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -132.17 127.96 21.14 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.002 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.601 ' O ' ' HA ' ' A' ' 1' ' ' MET . 96.9 Cg_endo -77.98 158.56 30.81 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.476 2.118 . . . . 0.0 110.876 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 6.1 p90 -161.51 171.26 18.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.997 0.427 . . . . 0.0 112.021 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.39 133.5 38.75 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.488 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.586 ' CE2' ' HB3' ' A' ' 8' ' ' ASP . 12.2 t80 -89.15 159.79 17.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.168 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.615 HG21 ' HE2' ' A' ' 47' ' ' LYS . 12.5 mt -149.29 122.26 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.229 0.537 . . . . 0.0 110.753 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -86.25 120.5 27.68 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.829 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.43 HD13 ' H ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -94.53 0.31 10.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.476 179.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.625 ' HE2' ' CD2' ' A' ' 12' ' ' HIS . 6.9 tpp -120.08 97.25 49.36 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.627 0.251 . . . . 0.0 111.332 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 76.7 Cg_endo -77.35 -23.21 10.32 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.295 1.996 . . . . 0.0 111.339 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -142.52 148.52 37.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.384 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -7.72 11.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.304 0.573 . . . . 0.0 111.738 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.67 -57.32 2.75 Favored Glycine 0 C--N 1.313 -0.737 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.722 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.7 t -148.27 146.38 17.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.885 0.374 . . . . 0.0 111.791 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.434 ' CD1' ' HE1' ' A' ' 37' ' ' MET . 0.5 OUTLIER -59.85 170.32 1.19 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.631 179.365 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.414 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -74.5 98.67 3.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -50.69 -23.99 3.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.553 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -64.94 -59.21 4.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.337 . . . . 0.0 110.799 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.615 ' HE2' HG21 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -69.84 -39.06 76.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.502 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.487 ' O ' HD12 ' A' ' 52' ' ' LEU . 29.1 mm -50.08 -46.76 24.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.639 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.408 ' O ' HD12 ' A' ' 52' ' ' LEU . . . -63.04 -54.44 38.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.131 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -64.08 -21.25 66.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.664 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.51 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 3.4 tt -62.34 -61.01 2.75 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.159 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 60' ' ' GLN . 0.8 OUTLIER -51.34 -49.28 61.71 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.196 0.522 . . . . 0.0 110.241 179.622 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.3 m -53.19 -40.59 64.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.242 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -38.92 84.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.249 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.417 HD22 ' CG ' ' A' ' 75' ' ' HIS . 1.4 mt -59.89 -38.11 81.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.284 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.82 -111.83 0.38 Allowed Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.686 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.3 ttm-85 -150.38 27.11 0.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.075 0.464 . . . . 0.0 110.709 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -121.77 -144.85 0.35 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.415 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.6 t -120.05 170.64 9.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.639 0.257 . . . . 0.0 110.381 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.559 ' N ' HD23 ' A' ' 52' ' ' LEU . 1.6 pt20 -73.85 98.06 2.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.274 0.559 . . . . 0.0 110.42 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.3 mt -80.11 80.37 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.223 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.67 26.11 7.43 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.555 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.787 HD22 ' N ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -48.27 166.79 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.845 0.355 . . . . 0.0 111.308 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.787 ' N ' HD22 ' A' ' 63' ' ' LEU . 30.0 p -127.09 160.31 31.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.109 0.48 . . . . 0.0 111.391 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.2 mtm -120.23 155.39 55.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.619 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.622 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.9 Cg_exo -76.23 142.97 75.04 Favored 'Cis proline' 0 C--N 1.345 0.354 0 C-N-CA 123.874 -1.303 . . . . 0.0 112.762 0.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.629 ' NE2' HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -98.03 120.24 38.08 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -92.52 158.83 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.426 0.631 . . . . 0.0 112.31 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.492 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 74.6 m-85 -142.53 148.39 37.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.005 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.917 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -61.24 153.75 66.13 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.854 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.627 ' HB3' ' N ' ' A' ' 1' ' ' MET . 19.6 Cg_exo -68.09 59.44 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.344 2.696 . . . . 0.0 112.044 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 71' ' ' PRO . 0.3 OUTLIER 100.37 25.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.85 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -112.18 -97.15 2.33 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.525 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.523 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 8.5 t -147.5 -174.9 4.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.803 0.335 . . . . 0.0 110.612 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.417 ' CG ' HD22 ' A' ' 55' ' ' LEU . 20.6 t-80 -71.82 132.34 44.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.835 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.917 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.4 mp -109.09 -41.33 4.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.627 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 135.87 -165.04 24.94 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.741 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.32 -136.52 4.93 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.737 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.46 ' HD1' ' HB2' ' A' ' 20' ' ' ALA . 31.7 t80 -72.33 -70.57 0.33 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.708 0.29 . . . . 0.0 111.332 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -56.4 -47.3 79.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.99 0.424 . . . . 0.0 110.857 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -51.06 -44.14 61.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.472 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.724 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.0 tt -74.77 -32.92 62.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.243 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.5 ttt85 -51.37 -30.08 17.67 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.93 -35.39 76.74 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.155 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LEU . 22.3 t80 -62.28 -34.3 76.3 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.273 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.724 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.7 m-85 -86.14 -38.84 17.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.266 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.2 mttm . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.952 -179.999 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.634 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 49.3 ttm . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -77.0 144.31 38.78 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.183 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -106.45 121.21 43.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.662 -179.325 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.609 HG22 HG22 ' A' ' 68' ' ' VAL . 40.6 t -107.83 138.25 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.285 0.564 . . . . 0.0 111.887 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.745 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.1 m-85 -113.43 99.62 7.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.816 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.44 -139.6 2.71 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.296 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.679 ' OH ' HD11 ' A' ' 36' ' ' ILE . 84.1 m-85 -125.18 148.34 48.65 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.796 0.332 . . . . 0.0 111.253 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -64.55 -75.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.705 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 167.07 -32.87 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.974 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -82.92 -23.9 33.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.839 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.643 HD12 ' N ' ' A' ' 11' ' ' ILE . 2.6 mp -93.41 -46.03 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.476 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -147.44 153.64 39.83 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 pttm -62.39 165.26 6.25 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.877 0.37 . . . . 0.0 111.284 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.4 t -176.6 82.23 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.306 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.43 -19.23 7.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.065 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -76.19 -28.23 57.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.508 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.6 p -77.5 -46.03 23.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.715 0.293 . . . . 0.0 110.831 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.23 -35.39 17.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 110.718 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -70.78 -60.78 2.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.572 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 79' ' ' PHE . . . -53.16 -33.3 51.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.181 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -59.14 -54.96 41.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.54 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.837 ' O ' HG23 ' A' ' 26' ' ' VAL . 33.2 ttt180 -59.73 -35.19 74.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.554 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.641 HD23 ' N ' ' A' ' 24' ' ' LEU . 3.1 tt -60.81 -54.61 43.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.565 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.641 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.9 mt -55.48 -48.05 75.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.855 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.0 m -56.03 -37.74 69.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.166 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 22' ' ' ARG . 61.4 t -77.08 -36.09 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.646 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -72.54 -10.03 59.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.096 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.65 50.8 0.17 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.861 0.362 . . . . 0.0 110.693 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -139.53 128.53 13.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.27 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.634 ' O ' ' HA ' ' A' ' 1' ' ' MET . 81.0 Cg_endo -79.61 161.81 24.77 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.581 2.187 . . . . 0.0 110.749 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 6.9 p90 -161.23 171.16 18.9 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -135.36 136.79 41.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.292 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.503 ' HE1' HG11 ' A' ' 4' ' ' VAL . 8.6 t80 -89.28 157.0 18.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.174 0.512 . . . . 0.0 111.732 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.745 HD12 ' CE1' ' A' ' 5' ' ' TYR . 14.7 mt -143.88 119.47 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.714 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -98.26 135.98 39.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.737 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.679 HD11 ' OH ' ' A' ' 7' ' ' TYR . 1.4 pp -97.65 -14.22 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.018 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -123.48 80.39 54.02 Favored Pre-proline 0 N--CA 1.455 -0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.403 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 64.8 Cg_endo -88.44 31.08 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.032 2.488 . . . . 0.0 112.449 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.431 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 2.2 tp10 -139.08 164.78 28.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.534 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.65 -8.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.49 53.8 0.02 OUTLIER Glycine 0 C--N 1.312 -0.776 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.231 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.3 t -149.83 125.95 2.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.029 0.442 . . . . 0.0 111.944 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.75 ' HB3' HD11 ' A' ' 48' ' ' ILE . 2.0 m-85 -63.78 143.94 57.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.358 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.521 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -99.04 121.79 41.43 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.822 0.344 . . . . 0.0 111.505 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.402 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 46.5 m-20 -66.84 -24.62 66.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.332 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -58.42 -52.17 66.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.794 0.33 . . . . 0.0 110.816 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -38.31 54.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.364 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.75 HD11 ' HB3' ' A' ' 43' ' ' PHE . 41.2 mt -59.32 -40.5 81.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.855 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.47 -58.0 6.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.269 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -60.15 -28.16 67.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.973 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.489 HD11 HD21 ' A' ' 55' ' ' LEU . 2.5 tp -59.32 -56.26 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.381 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.635 ' N ' HD23 ' A' ' 52' ' ' LEU . 3.0 mt -51.94 -47.51 64.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.984 0.421 . . . . 0.0 110.886 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.6 m -66.04 -35.0 79.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.291 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -66.49 -39.86 88.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.504 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.489 HD21 HD11 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -59.82 -49.1 79.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.439 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.58 -106.25 0.25 Allowed Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.818 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.2 mtt180 -150.62 27.6 0.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.02 0.438 . . . . 0.0 110.84 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.59 -156.71 0.7 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.207 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -121.24 161.73 21.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.676 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.423 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 7.3 pt20 -120.14 98.89 6.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.992 0.425 . . . . 0.0 110.694 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.5 mt -81.55 88.32 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.707 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.94 32.73 5.77 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.536 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.563 HD11 ' HG3' ' A' ' 67' ' ' GLN . 2.8 tm? -47.73 121.91 4.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.824 0.345 . . . . 0.0 110.77 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.504 ' N ' HD13 ' A' ' 63' ' ' LEU . 1.1 p -103.86 151.51 23.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.28 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -112.71 156.4 42.54 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.908 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -86.97 141.52 24.14 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.067 -1.222 . . . . 0.0 112.56 0.503 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.563 ' HG3' HD11 ' A' ' 63' ' ' LEU . 2.7 mm-40 -100.24 124.19 45.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.138 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.609 HG22 HG22 ' A' ' 4' ' ' VAL . 3.3 t -96.61 159.69 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.33 0.586 . . . . 0.0 112.478 -178.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.471 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 80.1 m-85 -143.73 146.62 33.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.289 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.567 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -58.49 156.3 23.71 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.616 ' HB3' ' N ' ' A' ' 1' ' ' MET . 3.0 Cg_exo -73.71 -3.72 14.22 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.876 2.384 . . . . 0.0 112.566 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -115.33 -9.65 12.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.226 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.23 89.08 1.67 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.548 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 t -179.2 152.12 0.53 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -90.19 116.62 28.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 70' ' ' ALA . 26.2 mt -96.8 -48.45 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.879 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 138.17 -156.02 23.69 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.726 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.07 -138.69 8.88 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.668 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CD1' ' HB2' ' A' ' 20' ' ' ALA . 19.4 t80 -70.89 -70.66 0.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.782 0.325 . . . . 0.0 110.918 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -59.43 -45.3 91.94 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.023 0.44 . . . . 0.0 110.551 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -50.87 -40.0 55.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.437 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.737 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.4 tt -78.65 -31.93 47.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.265 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -51.13 -30.9 17.75 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -35.43 79.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.093 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 82' ' ' LEU . 10.8 t80 -62.68 -34.14 76.51 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.344 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.737 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.0 m-85 -88.96 -70.24 0.66 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.312 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.939 179.951 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.683 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 17.5 ttm . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.424 ' CE2' HD13 ' A' ' 76' ' ' ILE . 79.5 m-85 -78.13 147.26 34.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.308 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -106.9 121.45 44.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.337 -179.697 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.555 HG11 ' HE1' ' A' ' 33' ' ' PHE . 52.3 t -112.99 131.95 63.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.56 0.695 . . . . 0.0 112.62 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.885 ' HA ' HD11 ' A' ' 36' ' ' ILE . 17.3 m-85 -110.09 99.13 8.27 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.181 177.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.444 ' O ' HG12 ' A' ' 36' ' ' ILE . . . -153.91 -139.82 2.92 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.006 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.503 ' CD1' ' HB3' ' A' ' 37' ' ' MET . 43.7 m-85 -147.28 99.84 3.2 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.55 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 27.7 t70 -108.87 55.95 0.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.422 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.78 -168.04 2.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.165 0.507 . . . . 0.0 111.637 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -85.96 0.61 52.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.839 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.463 HG23 ' HB3' ' A' ' 40' ' ' LYS . 1.3 mm -88.26 -13.51 9.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.981 0.419 . . . . 0.0 109.901 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -175.72 118.09 0.15 Allowed 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.704 0.764 . . . . 0.0 111.172 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -82.52 168.56 17.27 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.885 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -176.58 107.79 0.07 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.24 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 m -70.32 -16.56 20.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.671 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -82.96 -25.69 32.08 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.846 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.2 m -59.85 -55.27 36.28 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.35 0.595 . . . . 0.0 109.647 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.27 -18.58 64.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.503 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.67 -62.51 1.35 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.851 0.357 . . . . 0.0 110.89 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.0 -38.37 67.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.09 -50.4 72.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.74 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.805 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -61.65 -38.75 88.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.624 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.748 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.2 tt -59.16 -53.0 63.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.532 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.748 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.4 mt -56.97 -49.28 76.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.792 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.9 m -54.32 -38.44 65.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.075 0.464 . . . . 0.0 110.161 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.8 t -78.06 -32.36 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.622 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.14 -15.72 61.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.976 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 76.11 49.85 0.07 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.055 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -138.04 131.85 16.84 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.13 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.635 ' O ' ' HA ' ' A' ' 1' ' ' MET . 77.6 Cg_endo -79.52 161.26 25.25 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.408 2.072 . . . . 0.0 111.027 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.459 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 6.5 p90 -161.23 171.56 18.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.753 0.311 . . . . 0.0 111.716 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -133.28 123.83 26.21 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.094 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.555 ' HE1' HG11 ' A' ' 4' ' ' VAL . 10.6 t80 -89.12 157.91 18.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.445 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.471 HD12 ' CE1' ' A' ' 5' ' ' TYR . 24.0 mt -148.1 125.21 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.283 0.564 . . . . 0.0 111.143 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -75.58 115.81 15.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.639 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.885 HD11 ' HA ' ' A' ' 5' ' ' TYR . 4.6 mm -90.2 -19.06 7.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.921 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.503 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -120.28 84.41 34.53 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.696 0.284 . . . . 0.0 111.181 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 53.1 Cg_endo -69.24 -16.49 39.78 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.46 2.107 . . . . 0.0 111.904 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -139.99 136.64 33.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.395 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.463 ' HB3' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -59.33 -9.06 1.99 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.164 0.507 . . . . 0.0 111.956 -179.731 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.12 -59.65 3.32 Favored Glycine 0 C--N 1.312 -0.797 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.355 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 43' ' ' PHE . 21.2 t -150.62 154.36 8.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.981 0.42 . . . . 0.0 111.852 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.411 ' N ' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -63.92 170.63 3.35 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.384 179.255 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.421 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 1.9 t70 -89.35 100.83 13.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -52.51 -27.92 18.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.481 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -61.8 -58.04 9.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.96 0.409 . . . . 0.0 110.556 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -65.07 -32.96 74.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.302 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.64 HD11 ' CG2' ' A' ' 36' ' ' ILE . 35.8 mm -69.8 -37.42 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.573 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.72 71.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.623 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -61.82 -34.08 75.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.334 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.585 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.4 tt -58.95 -52.51 65.43 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.309 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 52' ' ' LEU . 85.9 mt -53.16 -41.35 65.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.589 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.1 m -58.49 -47.53 83.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.605 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.41 ' CB ' ' CE1' ' A' ' 69' ' ' PHE . 4.0 mtpp -61.74 -33.27 73.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.784 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.71 HD11 HD21 ' A' ' 63' ' ' LEU . 2.1 mt -59.92 -54.25 48.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.781 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 166.8 -112.69 0.51 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.186 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -150.23 31.24 0.68 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.071 0.462 . . . . 0.0 110.596 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -121.0 -142.27 0.34 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.335 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 t -117.0 170.4 8.66 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.793 0.33 . . . . 0.0 110.645 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -69.57 98.35 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.358 0.599 . . . . 0.0 110.359 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 pt -80.12 87.31 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.439 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.33 30.92 72.28 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.326 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.71 HD21 HD11 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -41.31 129.47 2.98 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.894 0.378 . . . . 0.0 111.331 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.83 153.65 45.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.359 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.5 mmt -113.63 146.48 35.55 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.628 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.3 Cg_endo -84.63 134.55 20.57 Favored 'Cis proline' 0 N--CA 1.46 -0.454 0 C-N-CA 124.006 -1.248 . . . . 0.0 112.57 0.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.561 ' OE1' HD13 ' A' ' 63' ' ' LEU . 4.5 tp60 -90.11 133.33 34.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.96 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.7 t -107.46 156.53 7.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.263 0.554 . . . . 0.0 111.851 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.434 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 39.2 m-85 -142.95 136.43 28.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.665 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.609 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -51.57 149.22 8.33 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.368 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.683 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 9.3 Cg_exo -68.86 -11.61 32.31 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.709 2.273 . . . . 0.0 112.133 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -106.42 -18.74 13.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.994 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.2 85.31 0.96 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.63 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -179.75 117.71 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.793 0.33 . . . . 0.0 110.833 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -58.51 116.63 3.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.971 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.609 HD11 ' HA ' ' A' ' 70' ' ' ALA . 13.4 mt -91.81 -46.51 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.811 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.68 -156.38 22.75 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.491 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.6 -140.95 8.2 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.505 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -70.12 -69.02 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.698 0.285 . . . . 0.0 110.906 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -54.37 -43.48 71.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.963 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -55.32 -37.92 68.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.678 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.692 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -71.99 -41.58 67.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.378 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.01 -29.95 23.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -72.85 -35.31 67.2 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' LEU . 34.2 t80 -63.49 -33.95 76.7 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.206 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.692 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.3 m-85 -87.14 -26.88 23.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.133 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.878 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.677 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 40.0 ttp . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.423 ' CD1' ' CD2' ' A' ' 24' ' ' LEU . 87.0 m-85 -77.39 147.58 35.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.054 179.001 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.704 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.5 mptt -111.5 121.0 44.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.589 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.641 HG22 HG22 ' A' ' 68' ' ' VAL . 8.4 t -103.4 129.22 55.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.24 0.543 . . . . 0.0 111.676 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.613 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.9 m-30 -105.68 99.4 9.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.504 178.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.36 -136.58 2.03 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.64 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 90.0 m-85 -116.44 144.28 44.5 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.918 0.39 . . . . 0.0 111.518 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' A' ' 9' ' ' SER . 22.6 t0 -73.1 -9.16 58.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.2 t 84.8 -14.11 0.63 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.577 0.351 . . . . 0.0 111.507 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -85.27 -31.19 23.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.693 0.282 . . . . 0.0 111.324 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.675 HD12 ' N ' ' A' ' 11' ' ' ILE . 2.4 mp -100.0 -38.38 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.645 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.425 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 15.2 t60 -139.41 179.47 6.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.355 -179.015 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -70.07 166.21 20.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.619 0.247 . . . . 0.0 110.8 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 t -176.91 71.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.19 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.0 m -90.64 -21.1 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.722 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -81.08 -23.11 38.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.3 p -77.68 -45.14 25.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 110.573 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -50.78 -34.07 25.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.704 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -73.07 -59.7 2.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.67 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.53 -41.32 69.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HG3' ' CZ ' ' A' ' 31' ' ' PHE . 70.3 tttt -54.57 -49.73 69.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.328 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.869 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.5 tpp180 -64.62 -31.43 72.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.276 179.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.799 HD12 ' CE1' ' A' ' 79' ' ' PHE . 3.3 tt -56.45 -51.05 69.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.394 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.741 HD23 ' HZ ' ' A' ' 86' ' ' PHE . 2.9 mt -60.02 -51.94 67.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.72 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.3 m -51.03 -38.95 54.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.584 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 22' ' ' ARG . 58.0 t -66.81 -31.58 54.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.677 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -86.59 -9.2 56.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.138 179.709 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 3.2 mptp? 70.59 52.33 0.32 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.067 0.461 . . . . 0.0 110.831 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -130.77 136.03 28.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.72 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.677 ' O ' ' HA ' ' A' ' 1' ' ' MET . 58.1 Cg_endo -80.96 157.09 20.58 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.596 2.197 . . . . 0.0 111.381 179.443 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.439 ' CZ ' ' HG3' ' A' ' 21' ' ' LYS . 8.4 p90 -161.51 171.31 18.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.823 0.344 . . . . 0.0 111.774 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -133.98 134.55 42.64 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.488 ' HE1' HG11 ' A' ' 4' ' ' VAL . 23.0 t80 -89.36 154.54 19.99 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.093 0.473 . . . . 0.0 111.54 -179.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.613 HD12 ' CE1' ' A' ' 5' ' ' TYR . 8.4 mt -146.41 119.36 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.187 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -100.15 135.66 41.24 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.244 -179.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 44' ' ' ASP . 31.8 pt -97.91 20.43 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.191 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.479 ' CG ' HG21 ' A' ' 11' ' ' ILE . 15.1 tpp -144.33 70.94 16.07 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.658 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -87.82 34.2 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.026 2.484 . . . . 0.0 112.818 -179.482 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -139.74 170.42 15.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.612 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -63.22 -7.82 6.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.203 0.525 . . . . 0.0 111.931 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.73 55.24 0.02 OUTLIER Glycine 0 C--N 1.312 -0.757 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.403 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.9 t -150.02 131.7 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.001 0.429 . . . . 0.0 111.413 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.0 160.4 33.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.818 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.54 ' C ' HD12 ' A' ' 48' ' ' ILE . 3.7 t70 -97.63 89.25 4.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.081 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.81 -20.85 38.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.614 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -64.34 -59.2 4.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.816 0.341 . . . . 0.0 110.67 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -71.12 -41.05 71.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.399 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.54 HD12 ' C ' ' A' ' 44' ' ' ASP . 54.8 mt -51.91 -44.08 37.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.694 179.601 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.62 -55.78 26.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.435 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.77 -31.84 71.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.296 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.501 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 1.5 tt -56.34 -52.94 62.68 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.008 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.676 ' N ' HD23 ' A' ' 52' ' ' LEU . 2.2 mt -52.91 -48.62 67.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.722 179.152 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -62.33 -44.49 96.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.295 179.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.79 -39.09 83.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.552 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.439 HD21 ' CD2' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -59.74 -53.9 52.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.32 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.3 -108.99 0.27 Allowed Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.773 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -150.45 26.56 0.76 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.073 0.463 . . . . 0.0 110.862 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -121.62 -150.78 0.46 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.265 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.2 t -120.8 170.27 9.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.594 179.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -82.52 98.35 8.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.24 0.543 . . . . 0.0 110.314 179.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.685 ' O ' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -80.09 87.23 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.879 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.67 28.06 56.04 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.478 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.87 143.54 16.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.8 p -111.55 158.17 19.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.16 0.505 . . . . 0.0 111.312 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.91 153.01 47.03 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.611 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.55 ' HB2' HG13 ' A' ' 4' ' ' VAL . 6.0 Cg_exo -81.1 156.12 83.38 Favored 'Cis proline' 0 C--N 1.344 0.309 0 C-N-CA 124.025 -1.24 . . . . 0.0 112.806 0.29 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -113.29 115.83 28.78 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.859 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -87.57 164.19 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.035 0.445 . . . . 0.0 111.792 -178.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.456 ' H ' HG12 ' A' ' 68' ' ' VAL . 45.1 m-85 -142.33 140.49 32.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.528 -179.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.651 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -53.43 132.77 53.55 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.285 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.615 ' HB3' ' N ' ' A' ' 1' ' ' MET . 31.6 Cg_exo -53.25 -22.37 19.93 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.594 2.196 . . . . 0.0 112.133 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.95 39.77 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.341 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.23 -109.86 0.68 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.987 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.489 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 86.8 p -138.91 178.41 7.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.075 0.464 . . . . 0.0 111.211 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.456 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 32.8 t-80 -55.84 127.09 28.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.061 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.651 HD11 ' HA ' ' A' ' 70' ' ' ALA . 12.3 mt -96.03 -45.02 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.987 0.422 . . . . 0.0 110.734 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 133.87 -158.44 23.3 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.462 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.74 -141.13 9.06 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.688 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.799 ' CE1' HD12 ' A' ' 23' ' ' LEU . 17.4 t80 -71.08 -61.14 1.87 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.73 0.3 . . . . 0.0 110.825 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -56.94 -48.3 78.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.85 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -56.99 -45.7 82.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.793 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.695 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -66.42 -41.62 88.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.398 179.918 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -51.76 -31.66 27.65 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -71.94 -35.8 69.72 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.104 178.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 82' ' ' LEU . 23.8 t80 -63.37 -33.78 76.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.165 178.33 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.741 ' HZ ' HD23 ' A' ' 24' ' ' LEU . 6.2 m-85 -87.96 -27.31 22.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.135 179.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.961 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.647 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 28.0 ttm . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.75 0.31 . . . . 0.0 111.756 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.488 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 77.6 m-85 -66.83 152.11 46.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.96 0.409 . . . . 0.0 110.445 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 3.0 mptt -126.6 124.29 39.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.224 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.655 HG11 ' CE1' ' A' ' 33' ' ' PHE . 16.9 t -103.43 132.45 49.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.273 0.558 . . . . 0.0 111.528 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.733 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.1 m-85 -109.23 98.98 8.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.066 178.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.23 -137.99 2.39 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 119.995 -1.098 . . . . 0.0 112.355 -179.362 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.675 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 3.4 m-85 -128.86 120.69 26.7 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 120.54 0.209 . . . . 0.0 111.296 -178.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.462 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -117.52 69.32 0.77 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.595 0.236 . . . . 0.0 111.62 -179.601 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 36.9 t 177.87 -172.0 0.11 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.085 0.469 . . . . 0.0 111.767 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.87 7.59 26.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.831 179.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.44 HG12 ' HB3' ' A' ' 9' ' ' SER . 1.0 OUTLIER -87.53 -17.87 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.905 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.675 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 37.3 t-80 -165.41 122.7 1.5 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.658 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.57 154.09 32.68 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.993 -178.1 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.6 t -159.64 95.31 1.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.925 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.7 m -74.61 -35.99 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.955 0.407 . . . . 0.0 110.563 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -65.9 -20.14 66.12 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.534 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.7 m -66.94 -60.94 2.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.791 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.42 -42.57 67.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.169 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -61.91 -52.75 62.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.081 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.516 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -58.87 -49.66 76.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.979 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -50.01 -32.67 15.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.58 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.751 ' O ' HG23 ' A' ' 26' ' ' VAL . 5.6 tpm_? -69.68 -38.62 77.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.629 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.822 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -58.23 -54.09 50.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.659 179.491 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.822 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.9 mt -54.69 -43.31 72.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.928 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.3 m -58.47 -33.09 69.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.031 0.443 . . . . 0.0 109.974 179.145 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 22' ' ' ARG . 41.0 t -78.81 -30.65 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.711 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -9.78 59.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.137 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt 64.68 56.87 1.13 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.071 0.462 . . . . 0.0 110.611 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.429 ' NE2' ' HD2' ' A' ' 30' ' ' PRO . 11.1 mm100 -132.6 130.33 21.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.089 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.453 ' O ' ' HA ' ' A' ' 1' ' ' MET . 86.3 Cg_endo -73.84 138.28 25.84 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.24 1.96 . . . . 0.0 110.924 178.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.647 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 48.1 p90 -155.1 170.64 21.33 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -141.63 144.0 33.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.048 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.655 ' CE1' HG11 ' A' ' 4' ' ' VAL . 33.2 t80 -89.71 162.1 15.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.05 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.733 HD12 ' CE1' ' A' ' 5' ' ' TYR . 7.1 mt -148.75 119.81 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.258 0.551 . . . . 0.0 110.816 179.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -89.81 139.34 30.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.042 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.632 HD11 ' OH ' ' A' ' 7' ' ' TYR . 1.0 OUTLIER -99.72 -26.11 3.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.215 -179.989 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.604 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 10.2 ttm -119.38 88.93 39.24 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.753 0.311 . . . . 0.0 111.64 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.49 -6.95 15.74 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.525 2.15 . . . . 0.0 112.245 179.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -139.39 141.87 37.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.57 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -69.2 -7.78 39.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.282 0.563 . . . . 0.0 111.964 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.25 -60.46 1.92 Allowed Glycine 0 C--N 1.311 -0.853 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.895 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 t -150.48 128.87 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.553 0.216 . . . . 0.0 110.561 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -57.94 170.09 0.68 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.207 -179.641 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.429 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -78.87 87.24 4.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.476 -179.066 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -54.15 -22.67 11.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.275 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -56.0 -51.48 67.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.891 0.377 . . . . 0.0 110.572 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -73.06 -32.81 65.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.276 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 44' ' ' ASP . 40.0 mm -57.2 -50.89 75.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.79 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.25 70.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.536 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.26 -32.14 69.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.318 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.936 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.99 -57.22 13.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.236 179.933 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.51 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 16.4 mt -44.54 -45.84 9.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.265 0.555 . . . . 0.0 111.125 178.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.2 m -70.11 -30.59 67.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.362 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -66.46 -41.28 89.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.121 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.936 HD12 ' O ' ' A' ' 51' ' ' LEU . 3.3 mp -62.28 -54.75 36.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.057 0.456 . . . . 0.0 110.81 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.33 -115.17 0.37 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.061 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -150.64 30.92 0.65 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.065 0.46 . . . . 0.0 110.687 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -121.04 -145.75 0.36 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.352 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.8 t -115.85 170.25 8.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.677 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.41 ' HG2' HD22 ' A' ' 52' ' ' LEU . 42.9 mt-30 -70.03 98.14 1.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.314 0.578 . . . . 0.0 110.55 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -80.26 84.41 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.861 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.4 27.37 47.35 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.184 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.433 HD11 ' CD2' ' A' ' 55' ' ' LEU . 1.6 mm? -55.5 135.65 50.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.892 0.377 . . . . 0.0 111.349 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.75 159.9 40.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.161 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -102.19 152.14 38.21 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.958 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.9 Cg_exo -81.48 143.29 57.89 Favored 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 123.945 -1.273 . . . . 0.0 112.666 0.18 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -108.17 118.22 36.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.014 179.06 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.3 t -92.34 166.32 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.029 0.442 . . . . 0.0 111.899 -178.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.52 ' H ' HG12 ' A' ' 68' ' ' VAL . 24.9 m-85 -141.91 134.78 28.71 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.788 -179.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.501 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -49.67 150.15 3.86 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.529 -179.211 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.568 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . 45.6 Cg_exo -58.67 -33.77 98.48 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.216 2.611 . . . . 0.0 112.268 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -90.16 -21.67 22.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.365 -179.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.76 88.98 0.86 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.73 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -171.23 162.1 6.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.337 . . . . 0.0 110.543 179.841 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.496 ' CE1' HD23 ' A' ' 55' ' ' LEU . 8.0 t-160 -90.52 115.64 27.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.102 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.501 HD11 ' HA ' ' A' ' 70' ' ' ALA . 6.8 mt -91.78 -49.41 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.011 0.434 . . . . 0.0 110.983 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.61 -154.01 16.53 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.276 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.12 -143.54 5.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.294 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.555 ' CE1' HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -77.01 -69.57 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.58 0.19 . . . . 0.0 110.738 179.76 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -48.2 -45.46 33.87 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.25 0.548 . . . . 0.0 110.327 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -35.37 76.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.175 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.702 HD21 ' CE2' ' A' ' 86' ' ' PHE . 4.0 tt -78.38 -38.13 42.48 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.406 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 87' ' ' LYS . 11.4 mtm180 -50.78 -32.14 18.99 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -68.43 -34.8 76.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.16 178.117 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 82' ' ' LEU . 8.0 t80 -63.67 -34.36 77.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.36 178.415 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.702 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.1 m-85 -89.91 -70.48 0.66 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.392 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.906 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.768 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 6.3 tpt . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.58 ' CE2' ' HE2' ' A' ' 1' ' ' MET . 92.4 m-85 -39.56 116.99 0.68 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.74 0.781 . . . . 0.0 111.455 -177.276 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -90.16 128.53 36.37 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.39 -179.163 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 68' ' ' VAL . 37.1 t -115.81 127.12 73.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.26 0.552 . . . . 0.0 111.548 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.574 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 18.6 m-85 -103.93 98.13 8.02 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.978 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -155.56 -139.8 2.85 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.891 -179.004 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.612 ' CE2' HG23 ' A' ' 36' ' ' ILE . 17.1 m-85 -131.75 158.39 41.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -178.3 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.403 ' O ' ' CB ' ' A' ' 9' ' ' SER . 41.9 t0 -70.74 -69.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.595 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 3.2 t 164.09 -31.41 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.606 179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -83.0 -26.88 30.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.546 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 11' ' ' ILE . 4.2 mp -88.21 -49.3 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.997 179.391 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -144.49 153.97 42.42 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.901 179.052 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -48.55 156.58 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.642 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.27 62.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.916 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.446 HG23 ' N ' ' A' ' 16' ' ' TYR . 14.5 m -80.11 -48.8 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.049 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.446 ' N ' HG23 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -67.29 -20.46 65.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.513 179.544 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 m -65.34 -47.68 75.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.291 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -55.53 -26.01 40.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.737 179.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -73.08 -42.97 62.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.471 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.558 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . . . -69.05 -40.74 78.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.098 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -62.81 -56.76 14.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.737 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.792 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -58.95 -34.22 71.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.221 179.632 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.728 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -57.87 -51.48 69.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.896 179.146 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.728 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.7 mt -57.9 -42.84 85.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.638 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.7 m -60.54 -39.26 87.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.932 179.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 22' ' ' ARG . 41.1 t -74.25 -39.24 49.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.534 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 1.7 tmtm? -74.29 -12.79 60.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.949 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt 68.56 49.16 0.77 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.938 0.399 . . . . 0.0 110.643 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -137.56 102.31 8.74 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.378 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.768 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 86.8 Cg_exo -44.91 171.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.518 2.145 . . . . 0.0 112.65 179.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.64 ' CG ' HD13 ' A' ' 24' ' ' LEU . 4.0 p90 -163.28 170.29 17.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.6 178.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 3.4 tt0 -132.54 112.49 12.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.686 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.517 ' HE1' HG11 ' A' ' 4' ' ' VAL . 9.9 t80 -89.1 153.84 20.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.17 0.51 . . . . 0.0 111.266 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.469 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.9 mt -149.98 121.74 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.331 179.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -70.56 109.4 4.83 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.499 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.978 HG22 ' O ' ' A' ' 6' ' ' GLY . 18.7 tt -72.4 -19.29 19.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.606 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.5 ttp -134.59 94.94 16.44 Favored Pre-proline 0 N--CA 1.454 -0.227 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.974 179.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -85.93 24.06 0.78 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.677 2.251 . . . . 0.0 112.105 179.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.45 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 6.7 tt0 -139.49 165.82 26.2 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.754 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -62.72 -7.54 5.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -179.054 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.65 35.58 0.06 OUTLIER Glycine 0 C--N 1.313 -0.705 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.825 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.464 ' N ' ' SD ' ' A' ' 37' ' ' MET . 4.3 t -147.72 121.13 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.906 0.384 . . . . 0.0 111.081 178.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.606 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -79.28 150.78 31.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.742 179.752 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -78.11 99.82 6.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.132 -179.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -48.52 -29.75 4.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.537 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -60.52 -54.38 46.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.959 0.409 . . . . 0.0 110.773 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HD3' ' CG2' ' A' ' 34' ' ' ILE . 25.0 mttm -68.92 -41.91 77.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.847 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.491 ' CD1' ' HB2' ' A' ' 43' ' ' PHE . 2.7 mp -63.22 -36.06 74.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.129 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.24 -52.49 65.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.659 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.01 -33.07 72.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.302 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.574 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 4.1 tt -60.15 -51.98 67.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.308 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.685 ' N ' HD23 ' A' ' 52' ' ' LEU . 1.9 mt -52.38 -44.49 65.33 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.344 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.7 m -58.19 -49.19 77.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.734 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.6 mtpp -59.53 -36.59 76.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.689 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.96 -52.23 66.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.567 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.05 -118.5 0.66 Allowed Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.054 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -141.35 27.9 1.88 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.199 0.524 . . . . 0.0 110.589 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -121.5 -147.23 0.38 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.257 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.4 t -120.26 170.19 9.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.695 0.283 . . . . 0.0 110.603 179.633 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -69.95 98.01 1.22 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.348 0.594 . . . . 0.0 110.423 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -80.36 84.25 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.084 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.72 26.51 60.28 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.395 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -50.33 148.24 3.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 111.072 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.1 p -122.92 165.22 17.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.427 -179.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -118.46 153.64 51.96 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.734 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.0 OUTLIER -86.81 136.28 17.8 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.318 -1.117 . . . . 0.0 112.495 0.203 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -91.76 129.6 37.7 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 4' ' ' VAL . 3.4 t -103.2 154.29 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.123 0.487 . . . . 0.0 112.006 -179.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.459 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 44.5 m-85 -142.63 138.08 30.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.801 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.672 ' HB1' ' HD2' ' A' ' 71' ' ' PRO . . . -48.16 164.04 0.28 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.755 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.672 ' HD2' ' HB1' ' A' ' 70' ' ' ALA . 32.5 Cg_endo -62.88 58.93 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.742 2.294 . . . . 0.0 111.453 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 86.61 29.96 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.88 -178.665 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.66 -91.07 2.11 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.857 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.542 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -143.68 -169.19 3.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.015 0.436 . . . . 0.0 110.998 -179.734 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.459 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 17.1 t-80 -83.31 125.07 31.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.162 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.627 HD11 ' HA ' ' A' ' 70' ' ' ALA . 13.7 mt -96.92 -45.89 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.95 0.405 . . . . 0.0 110.741 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 137.97 -156.62 23.9 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.659 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.01 -139.97 8.54 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.733 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.558 ' HD1' ' HB2' ' A' ' 20' ' ' ALA . 60.6 t80 -72.53 -70.57 0.34 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.718 0.294 . . . . 0.0 111.048 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -56.42 -48.01 77.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.917 0.389 . . . . 0.0 110.809 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -52.09 -41.44 62.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.644 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.74 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.2 tt -76.57 -34.23 58.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.208 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -51.52 -28.95 15.05 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -69.22 -34.07 74.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.216 178.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 82' ' ' LEU . 6.8 t80 -64.75 -33.25 75.54 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.446 178.508 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.74 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.1 m-85 -90.52 -66.89 0.89 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.584 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.8 pttt . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.137 -0.935 . . . . 0.0 110.917 -179.906 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.61 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 25.7 ttp . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.774 0.321 . . . . 0.0 111.669 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.489 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 80.9 m-85 -67.32 151.26 47.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.95 0.405 . . . . 0.0 110.529 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.669 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 3.3 mptt -127.11 120.39 28.77 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.569 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.91 HG22 HG22 ' A' ' 68' ' ' VAL . 14.5 t -106.79 130.82 58.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.251 0.548 . . . . 0.0 111.805 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.638 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.6 m-30 -106.39 99.4 8.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.408 178.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.41 -137.36 2.17 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.842 -1.17 . . . . 0.0 112.985 -179.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -118.5 147.25 43.84 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.825 0.345 . . . . 0.0 110.936 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -90.73 13.13 17.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.607 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 0.3 OUTLIER 71.95 4.88 5.18 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.629 0.252 . . . . 0.0 111.44 179.931 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -85.79 -58.21 2.74 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.906 0.384 . . . . 0.0 111.033 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.673 HD12 ' O ' ' A' ' 37' ' ' MET . 29.5 mt -91.65 -27.03 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.544 -179.465 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.484 ' O ' ' HA ' ' A' ' 9' ' ' SER . 30.9 t60 -139.49 145.21 38.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.676 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.39 158.07 34.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.566 -179.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.5 t -175.78 96.11 0.06 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -80.88 -32.15 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.011 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -70.47 -23.17 62.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.596 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.5 m -62.52 -52.81 62.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.268 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.02 -27.28 52.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.301 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -71.16 -49.59 42.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.254 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.06 -47.22 71.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.177 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HD3' ' CE2' ' A' ' 31' ' ' PHE . 1.1 tppt? -59.65 -52.95 63.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.715 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.829 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -57.36 -41.25 79.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.767 180.0 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 24' ' ' LEU . 3.1 tt -58.49 -54.25 49.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.388 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.679 HD13 ' CG ' ' A' ' 31' ' ' PHE . 5.9 mt -57.31 -46.42 83.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.769 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 m -57.73 -37.09 72.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.093 0.473 . . . . 0.0 110.228 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 22' ' ' ARG . 62.1 t -77.96 -29.6 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.695 179.479 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -16.8 54.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.142 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.54 56.36 0.11 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.926 0.393 . . . . 0.0 110.9 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -136.96 141.62 35.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.47 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.9 Cg_endo -80.43 137.13 11.54 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.584 2.189 . . . . 0.0 111.647 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.679 ' CG ' HD13 ' A' ' 24' ' ' LEU . 32.0 p90 -158.32 170.61 21.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.847 0.356 . . . . 0.0 111.773 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -147.26 145.68 29.5 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.035 0.445 . . . . 0.0 111.167 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.49 ' CE1' HG11 ' A' ' 4' ' ' VAL . 10.2 t80 -89.5 163.58 15.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.168 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.638 HD12 ' CE1' ' A' ' 5' ' ' TYR . 11.5 mt -148.22 121.3 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.527 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -81.84 127.67 33.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.263 -179.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 pt -95.57 -16.27 7.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.185 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.673 ' O ' HD12 ' A' ' 11' ' ' ILE . 43.9 ttm -119.0 102.99 48.58 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.933 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 76.9 Cg_endo -76.2 -25.89 9.61 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.632 2.221 . . . . 0.0 112.035 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -139.96 151.01 45.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.767 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.21 -8.48 24.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.262 0.553 . . . . 0.0 111.656 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.71 -57.81 2.65 Favored Glycine 0 C--N 1.313 -0.725 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.671 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -148.73 139.11 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.642 0.258 . . . . 0.0 111.523 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -60.07 170.55 1.2 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.598 179.648 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.446 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 28.8 t0 -86.34 104.16 15.59 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -57.02 -22.65 40.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.434 179.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -58.05 -51.74 68.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.799 0.333 . . . . 0.0 110.686 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HZ2' HG22 ' A' ' 34' ' ' ILE . 53.0 mttt -74.86 -40.63 60.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.346 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 44' ' ' ASP . 38.7 mm -55.13 -47.48 77.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.771 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.03 -47.08 78.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.435 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.78 -37.88 85.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.381 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.463 HD13 ' CD2' ' A' ' 5' ' ' TYR . 19.8 tp -56.01 -51.27 68.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.732 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.9 mt -53.43 -47.58 69.52 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.227 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.7 m -65.24 -38.06 89.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.274 179.333 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.7 mtpp -63.91 -39.11 93.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.588 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -47.32 86.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.397 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 166.28 -109.64 0.36 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.987 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -150.72 31.54 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.034 0.445 . . . . 0.0 110.527 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.98 -149.96 0.44 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.7 t -120.38 170.33 9.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.694 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -80.4 98.44 7.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.271 0.558 . . . . 0.0 110.408 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.6 mm -78.6 83.65 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.78 24.79 50.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.369 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.427 HD12 ' CD ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -60.21 141.05 56.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.874 0.368 . . . . 0.0 110.872 -179.959 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.7 p -125.63 169.0 12.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.1 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.26 157.19 36.98 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.664 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.0 Cg_exo -81.82 143.45 56.38 Favored 'Cis proline' 0 C--N 1.344 0.292 0 C-N-CA 123.843 -1.315 . . . . 0.0 112.933 0.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.427 ' CD ' HD12 ' A' ' 63' ' ' LEU . 19.0 mt-30 -99.85 114.73 28.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.106 178.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.91 HG22 HG22 ' A' ' 4' ' ' VAL . 3.8 t -90.28 164.19 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.073 0.463 . . . . 0.0 111.712 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.482 ' N ' HG12 ' A' ' 68' ' ' VAL . 41.3 m-85 -142.48 131.49 23.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.62 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.707 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -48.38 152.28 1.63 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.439 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.558 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . 45.0 Cg_exo -58.39 -22.53 58.93 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.116 2.544 . . . . 0.0 112.218 179.168 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.0 -24.79 14.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.13 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.26 94.29 0.99 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.75 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 41.1 t -179.61 143.5 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.82 0.343 . . . . 0.0 110.774 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -72.9 106.13 4.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.965 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.707 HD11 ' HA ' ' A' ' 70' ' ' ALA . 33.6 mt -79.97 -52.06 15.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.65 -153.77 20.99 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.471 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.62 -147.3 12.41 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.335 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -69.95 -58.09 4.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.805 0.336 . . . . 0.0 110.624 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -55.88 -44.56 78.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.794 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -57.86 -43.36 85.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.471 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.623 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -61.83 -48.8 78.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.391 179.636 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -51.13 -30.21 15.81 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.98 -34.77 62.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.261 178.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.438 ' CD2' HG23 ' A' ' 76' ' ' ILE . 12.7 t80 -65.99 -32.39 73.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.343 178.439 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.623 ' HE2' HD21 ' A' ' 82' ' ' LEU . 8.1 m-85 -90.02 -70.15 0.68 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.212 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.918 -179.941 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.662 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 15.5 ttm . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.408 ' HB2' ' CD1' ' A' ' 24' ' ' LEU . 88.8 m-85 -75.45 146.68 40.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.992 178.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.5 mptm? -110.5 122.01 46.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.719 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.522 HG22 HG22 ' A' ' 68' ' ' VAL . 67.8 t -114.26 133.72 59.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.329 0.585 . . . . 0.0 112.316 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.594 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 18.5 m-85 -111.68 100.72 9.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.176 178.088 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.406 ' N ' HG23 ' A' ' 36' ' ' ILE . . . -162.09 -141.57 3.16 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.51 -179.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 1.026 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 52.5 m-85 -117.27 159.18 23.09 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.236 0.214 . . . . 0.0 110.426 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -106.29 17.12 23.91 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.074 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 1.0 OUTLIER 73.18 -1.81 2.93 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 179.936 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -84.99 -46.82 10.85 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.18 0.514 . . . . 0.0 110.507 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.608 HD13 ' O ' ' A' ' 37' ' ' MET . 0.7 OUTLIER -111.4 0.6 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.589 -179.839 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.596 ' CB ' ' CD2' ' A' ' 7' ' ' TYR . 11.9 t-80 -166.96 135.17 2.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.397 -177.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.48 164.51 22.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.945 -179.066 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 p 177.73 125.65 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.96 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.2 m -91.4 -30.44 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.123 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -77.2 -21.9 53.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.351 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.1 p -72.95 -41.46 64.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.974 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.67 -36.93 84.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.072 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -63.61 -55.48 23.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.69 -28.92 36.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.88 0.371 . . . . 0.0 110.908 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -61.95 -55.14 32.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.021 0.439 . . . . 0.0 110.11 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.778 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -67.21 -29.4 69.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.565 179.402 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.735 ' O ' HD12 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -53.39 -50.74 64.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.536 179.445 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.809 HD12 ' CG ' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -64.55 -50.21 68.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.603 179.846 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 m -56.71 -41.25 77.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.807 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 22' ' ' ARG . 99.7 t -69.94 -35.16 63.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.931 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 3.9 mmtt -74.02 -10.96 60.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.303 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt 70.87 36.99 1.38 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.08 0.467 . . . . 0.0 110.724 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -126.37 138.26 31.96 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.549 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.633 ' O ' ' HA ' ' A' ' 1' ' ' MET . 86.8 Cg_endo -78.34 161.55 28.69 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.458 2.106 . . . . 0.0 111.456 179.601 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.809 ' CG ' HD12 ' A' ' 24' ' ' LEU . 6.5 p90 -161.61 171.31 18.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.328 . . . . 0.0 111.513 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -134.29 121.79 21.78 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.768 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.486 ' HE1' HG11 ' A' ' 4' ' ' VAL . 18.2 t80 -89.44 157.96 17.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.549 HG21 ' HG2' ' A' ' 47' ' ' LYS . 20.1 mt -148.49 120.64 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.635 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -71.24 110.87 6.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.379 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.026 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 1.1 pp -74.0 -29.35 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.398 -179.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.651 ' HE3' ' CE2' ' A' ' 7' ' ' TYR . 20.7 ttm -118.28 86.7 27.95 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.661 0.267 . . . . 0.0 110.598 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.465 ' HG3' ' HB3' ' A' ' 44' ' ' ASP . 93.0 Cg_endo -79.54 5.15 6.06 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.571 2.181 . . . . 0.0 112.674 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -139.79 141.25 36.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.113 0.482 . . . . 0.0 111.357 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -63.68 -7.41 7.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.019 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.25 -67.22 0.64 Allowed Glycine 0 C--N 1.314 -0.67 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.188 -179.227 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.6 t -125.59 136.92 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.726 0.298 . . . . 0.0 111.62 -179.259 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.601 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -71.61 170.35 13.62 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.052 179.783 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.648 ' OD1' HD13 ' A' ' 48' ' ' ILE . 4.8 p30 -77.78 124.66 28.24 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.089 0.471 . . . . 0.0 111.711 -179.428 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 4.0 m-20 -80.24 -26.39 39.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.71 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -61.19 -51.44 68.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 111.291 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.549 ' HG2' HG21 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -72.95 -37.55 67.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.858 179.957 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.659 HD11 ' HB ' ' A' ' 36' ' ' ILE . 1.2 mp -72.09 -25.81 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 179.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -66.84 -52.68 40.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.563 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.87 -34.71 73.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.185 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.594 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 3.4 tt -57.52 -52.04 67.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.478 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 52' ' ' LEU . 77.1 mt -52.78 -45.0 66.94 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.586 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.7 m -63.42 -44.82 93.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.418 179.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -59.62 -33.09 71.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.711 179.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.412 HD11 HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -62.33 -66.66 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 179.763 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.25 -28.48 0.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.598 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.28 -165.09 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.742 0.306 . . . . 0.0 110.808 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -103.65 -25.83 13.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.038 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -87.33 164.69 16.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.871 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.427 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . 13.0 mt-30 -109.44 99.28 8.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.001 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pt -80.25 84.39 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.126 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.08 26.01 74.21 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.283 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.738 HD13 ' N ' ' A' ' 64' ' ' THR . 1.7 tm? -62.57 130.59 45.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.861 0.362 . . . . 0.0 110.965 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.738 ' N ' HD13 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -136.68 152.79 50.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 -179.978 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -104.43 152.91 39.39 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.624 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.8 Cg_exo -82.4 140.52 43.29 Favored 'Cis proline' 0 C--N 1.344 0.305 0 C-N-CA 124.025 -1.24 . . . . 0.0 112.817 0.32 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.519 ' CD ' HD21 ' A' ' 63' ' ' LEU . 1.1 mm-40 -99.97 135.85 40.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.078 179.096 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.632 HG11 ' CD1' ' A' ' 82' ' ' LEU . 3.3 t -106.85 158.73 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.05 0.452 . . . . 0.0 111.875 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 75' ' ' HIS . 34.0 m-85 -143.08 138.51 29.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.192 -179.582 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.772 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -53.19 133.05 51.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.171 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.662 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 39.1 Cg_exo -54.38 -21.46 23.52 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.543 2.162 . . . . 0.0 112.133 179.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.24 40.08 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.337 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.34 -109.38 0.66 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.884 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.467 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -140.68 -178.07 5.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.11 0.481 . . . . 0.0 111.236 -179.54 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.48 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 29.7 t-80 -56.61 122.64 12.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.053 -179.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.772 HD11 ' HA ' ' A' ' 70' ' ' ALA . 24.3 mt -91.08 -47.31 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.689 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 136.11 -155.49 22.44 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.673 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.65 -141.03 9.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.663 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -70.39 -70.76 0.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.72 0.295 . . . . 0.0 110.982 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.76 -49.45 77.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.981 0.419 . . . . 0.0 110.439 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -50.73 -36.18 35.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.445 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.714 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.2 tt -82.23 -32.04 29.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.292 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -50.95 -30.6 15.33 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -35.7 79.41 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.134 178.287 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LEU . 16.1 t80 -63.55 -33.53 75.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.399 178.437 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.714 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.5 m-85 -86.11 -70.34 0.61 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.113 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.954 179.939 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.589 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 35.8 ttp . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.78 0.324 . . . . 0.0 111.562 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 70.2 m-85 -59.46 148.79 31.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 -179.292 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -119.0 123.39 44.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.209 -179.057 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.769 HG11 ' CE1' ' A' ' 33' ' ' PHE . 8.0 t -114.72 139.6 39.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.319 0.581 . . . . 0.0 111.688 179.424 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.47 ' CE1' HD12 ' A' ' 34' ' ' ILE . 23.6 m-85 -122.49 99.77 6.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.454 178.491 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 66' ' ' PRO . . . -158.52 -141.71 3.22 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.435 -179.454 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.963 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 54.8 m-85 -123.13 160.4 26.52 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.826 0.346 . . . . 0.0 111.467 -179.091 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.7 p-10 -93.66 -65.47 0.99 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.9 OUTLIER 162.28 -37.71 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.251 179.88 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -63.82 -45.08 91.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.806 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 40' ' ' LYS . 4.2 mm -89.02 -41.47 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.059 0.456 . . . . 0.0 110.544 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -147.75 138.23 23.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.255 179.183 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.72 155.09 26.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.716 -178.782 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.5 p -162.5 119.11 1.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.392 179.382 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.4 m -88.78 -22.98 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.534 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -90.45 -15.47 30.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.453 -179.749 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.3 p -74.62 -43.65 54.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.79 0.328 . . . . 0.0 110.859 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.48 -46.61 82.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.929 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -55.94 -45.35 78.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.116 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.76 -38.82 92.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.924 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.22 -42.62 61.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.033 0.444 . . . . 0.0 110.379 179.424 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.5 ttt180 -73.24 -26.1 60.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.566 179.466 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.669 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -57.26 -55.94 28.29 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.327 179.657 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.576 HD12 ' CG ' ' A' ' 31' ' ' PHE . 10.6 mt -62.42 -46.82 86.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.628 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.0 m -53.5 -33.08 53.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.042 0.448 . . . . 0.0 110.266 179.462 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 22' ' ' ARG . 69.0 t -75.7 -30.29 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.653 179.54 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 3.4 mmtm -78.21 -9.86 59.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.402 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 64.62 40.49 5.91 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 111.386 179.818 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -122.35 145.17 43.73 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.287 179.332 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.43 ' O ' ' HA ' ' A' ' 1' ' ' MET . 92.6 Cg_endo -78.59 135.43 13.03 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.287 1.991 . . . . 0.0 111.908 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.589 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 17.0 p90 -146.25 167.66 22.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.907 0.384 . . . . 0.0 111.797 179.681 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -136.11 122.06 20.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.2 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.769 ' CE1' HG11 ' A' ' 4' ' ' VAL . 42.0 t80 -89.76 150.38 22.31 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.229 179.437 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.673 HG21 ' HG2' ' A' ' 47' ' ' LYS . 8.4 mt -143.77 119.53 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.157 0.503 . . . . 0.0 110.936 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -78.13 109.65 12.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.869 179.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.963 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 13.9 pt -59.64 -29.01 41.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.397 -179.291 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.589 ' HB2' ' HB3' ' A' ' 43' ' ' PHE . 3.2 ttp -121.82 87.04 46.22 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.706 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.43 -4.04 14.74 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.732 2.288 . . . . 0.0 112.797 -179.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -139.58 135.61 33.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.817 0.341 . . . . 0.0 110.694 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.465 ' N ' HG23 ' A' ' 11' ' ' ILE . 5.4 ttmt -65.16 -7.65 13.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.291 0.567 . . . . 0.0 112.055 -179.595 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.47 -64.6 1.38 Allowed Glycine 0 C--N 1.312 -0.766 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.815 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.7 t -141.03 129.91 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.589 ' HB3' ' HB2' ' A' ' 37' ' ' MET . 0.0 OUTLIER -69.0 166.76 17.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.138 0.494 . . . . 0.0 112.184 -178.719 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.86 ' O ' HD12 ' A' ' 48' ' ' ILE . 10.4 t70 -82.24 97.2 8.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.886 -178.764 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -67.49 -15.89 63.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.837 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' HB2' ' OD1' ' A' ' 44' ' ' ASP . 2.9 mm-40 -63.53 -51.05 67.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.71 0.291 . . . . 0.0 110.647 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.673 ' HG2' HG21 ' A' ' 34' ' ' ILE . 2.9 mptp? -71.11 -37.67 72.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.348 179.522 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.86 HD12 ' O ' ' A' ' 44' ' ' ASP . 1.5 mp -67.58 -35.36 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.882 179.239 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.38 -47.12 86.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.712 179.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.8 -39.08 87.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.316 179.674 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.595 HD13 ' CE1' ' A' ' 69' ' ' PHE . 10.5 tp -56.75 -51.41 68.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.443 179.686 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.613 HD21 ' HG2' ' A' ' 60' ' ' GLN . 80.3 mt -50.82 -45.71 59.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.489 179.715 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.0 m -61.57 -42.22 98.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.614 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.403 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -60.61 -38.57 85.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.704 179.819 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.91 -59.04 6.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.924 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.09 -26.2 0.62 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.06 -179.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -135.83 -162.12 1.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -115.55 23.24 12.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.58 0.229 . . . . 0.0 111.293 -179.811 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.7 t -120.89 143.16 49.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.911 0.386 . . . . 0.0 111.804 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.613 ' HG2' HD21 ' A' ' 52' ' ' LEU . 12.3 mt-30 -96.7 99.57 11.17 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.575 178.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 61' ' ' ILE . 0.8 OUTLIER -72.27 77.52 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.43 -178.403 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 36.09 30.03 0.02 OUTLIER Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.056 178.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 61' ' ' ILE . 0.8 OUTLIER -65.74 162.23 19.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.008 0.432 . . . . 0.0 111.265 -179.466 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.2 158.6 17.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.081 -179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.2 mtm -116.2 156.93 46.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.564 179.596 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.457 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . 4.8 Cg_exo -80.92 147.26 73.45 Favored 'Cis proline' 0 C--N 1.346 0.406 0 C-N-CA 124.244 -1.149 . . . . 0.0 112.991 0.511 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.54 135.66 34.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.039 178.748 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.726 HG22 HG22 ' A' ' 4' ' ' VAL . 3.1 t -113.5 159.09 13.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.948 0.404 . . . . 0.0 111.659 -179.494 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.595 ' CE1' HD13 ' A' ' 51' ' ' LEU . 40.0 m-85 -142.43 147.02 35.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.637 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.932 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -56.11 157.97 7.91 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.55 -178.464 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.507 ' HB3' ' N ' ' A' ' 1' ' ' MET . 32.3 Cg_exo -60.67 -25.98 82.01 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.262 2.642 . . . . 0.0 112.258 179.288 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -20.67 17.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.443 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.23 89.01 1.11 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.665 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.442 ' O ' HD12 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -169.25 145.76 3.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.655 0.264 . . . . 0.0 110.386 179.845 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -78.43 115.41 18.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.835 0.35 . . . . 0.0 110.937 -179.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.932 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.8 mp -102.13 -46.05 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.711 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.32 -159.47 22.39 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.874 179.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.53 -123.24 3.24 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.5 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.669 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -83.39 -67.72 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.779 -0.247 . . . . 0.0 110.947 179.769 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -50.51 -48.02 57.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.274 0.559 . . . . 0.0 110.463 179.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -60.5 -47.43 86.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.847 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.435 HD21 ' CE2' ' A' ' 86' ' ' PHE . 1.1 tt -66.62 -41.77 87.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.551 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 87' ' ' LYS . 7.1 ttt180 -51.67 -31.38 25.53 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.826 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -71.25 -32.78 69.15 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.513 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.47 ' CD2' HG12 ' A' ' 76' ' ' ILE . 49.2 t80 -70.26 -29.22 65.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.016 178.853 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.435 ' CE2' HD21 ' A' ' 82' ' ' LEU . 26.4 m-85 -99.66 -70.85 0.72 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.558 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.451 ' N ' ' O ' ' A' ' 83' ' ' ARG . 15.2 pttp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.413 179.983 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.667 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 10.5 ttm . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.829 0.347 . . . . 0.0 111.675 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.488 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 85.4 m-85 -83.85 145.81 28.44 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.226 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.712 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -123.99 126.51 46.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 -179.26 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 68' ' ' VAL . 70.2 t -114.04 132.52 62.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.393 0.616 . . . . 0.0 111.49 179.273 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.516 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 18.6 m-85 -110.57 99.64 8.58 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.06 178.256 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.0 -144.31 3.93 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.979 -179.092 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.471 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 29.6 m-85 -125.8 150.16 48.02 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 120.744 0.307 . . . . 0.0 111.123 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.95 -74.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.995 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.3 t 175.29 -34.34 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.761 0.315 . . . . 0.0 111.321 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -81.2 -24.36 37.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.298 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.679 HD12 ' N ' ' A' ' 11' ' ' ILE . 2.6 mp -91.12 -42.12 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.897 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.414 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 29.2 t60 -155.8 153.3 29.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.271 -179.62 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -55.71 145.37 24.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.079 0.466 . . . . 0.0 111.518 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 t -167.49 75.67 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.028 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.1 m -90.61 -20.38 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.272 179.559 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -75.47 -27.53 58.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.393 -179.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.8 p -79.87 -40.91 27.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.324 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.04 -41.81 48.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.112 0.482 . . . . 0.0 110.786 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -72.78 -49.23 32.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.65 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.29 -41.73 72.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.964 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -52.38 65.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.619 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.786 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.7 tpt180 -59.05 -36.61 75.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.656 179.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.687 HD23 ' N ' ' A' ' 24' ' ' LEU . 2.4 tt -60.4 -54.82 41.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.466 179.535 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.687 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.4 mt -54.78 -45.6 74.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.71 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.9 m -56.81 -35.58 68.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.173 0.511 . . . . 0.0 109.96 179.291 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 22' ' ' ARG . 50.0 t -79.99 -29.86 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.683 179.304 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.49 -11.74 59.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.031 179.742 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt 67.97 56.61 0.53 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.876 0.369 . . . . 0.0 110.951 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -134.33 135.85 24.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.76 132.75 12.18 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.461 2.108 . . . . 0.0 111.705 179.36 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.667 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 22.9 p90 -156.03 169.76 23.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.65 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -148.16 139.06 23.14 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.438 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.655 ' HE1' HG12 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -89.88 150.96 21.97 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.708 179.916 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.443 HG21 ' HD3' ' A' ' 47' ' ' LYS . 17.2 mt -140.95 121.96 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.063 0.458 . . . . 0.0 110.387 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -78.35 109.49 12.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.587 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.511 ' HB ' HD11 ' A' ' 48' ' ' ILE . 1.8 pt -73.71 -7.05 9.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.43 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.477 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -126.21 80.52 68.38 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-O 120.844 0.354 . . . . 0.0 111.076 -179.679 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.51 -20.38 69.55 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.705 2.27 . . . . 0.0 111.817 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 37' ' ' MET . 34.1 mt-10 -139.65 140.09 36.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.369 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.25 -8.75 2.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.217 0.532 . . . . 0.0 111.881 -179.647 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.4 -58.35 3.37 Favored Glycine 0 C--N 1.312 -0.772 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.706 179.803 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -150.55 150.13 13.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.81 0.338 . . . . 0.0 111.754 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -63.14 170.68 2.7 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.484 179.266 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -86.15 100.59 12.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.873 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -55.78 -25.29 40.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.488 -179.647 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -65.49 -60.43 2.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.943 0.401 . . . . 0.0 110.542 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.443 ' HD3' HG21 ' A' ' 34' ' ' ILE . 24.2 mttt -65.22 -33.74 76.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.345 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.511 HD11 ' HB ' ' A' ' 36' ' ' ILE . 15.8 mm -73.79 -29.69 26.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.647 179.64 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -61.68 -55.85 26.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.991 -179.645 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -62.47 -35.26 78.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.308 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.516 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 2.9 tt -56.72 -50.89 70.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.273 179.603 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.3 mt -52.82 -48.82 66.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.115 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.0 m -63.72 -38.14 89.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.023 179.302 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.5 -43.01 88.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.382 179.436 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 mt -59.94 -47.24 86.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 172.37 -113.93 0.5 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.053 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -150.53 30.56 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.047 0.451 . . . . 0.0 110.745 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.04 -148.33 0.41 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.324 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 t -120.21 165.78 14.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.715 0.293 . . . . 0.0 110.626 179.624 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.444 ' CG ' ' O ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -69.69 98.82 1.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.726 0.774 . . . . 0.0 110.594 179.96 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.1 mt -79.68 83.08 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.037 -179.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.29 24.44 44.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.458 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.618 HD12 ' CD ' ' A' ' 67' ' ' GLN . 1.0 OUTLIER -64.76 152.11 43.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.927 -179.988 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.8 p -133.72 170.12 16.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.493 . . . . 0.0 111.691 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.86 160.46 26.73 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.31 179.405 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -82.7 144.46 54.37 Favored 'Cis proline' 0 C--N 1.344 0.312 0 C-N-CA 124.406 -1.081 . . . . 0.0 113.188 0.608 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.618 ' CD ' HD12 ' A' ' 63' ' ' LEU . 2.1 mm100 -105.74 125.55 51.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.969 178.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 4' ' ' VAL . 4.0 t -98.9 160.72 3.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.909 0.385 . . . . 0.0 111.746 -179.301 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.449 ' N ' HG12 ' A' ' 68' ' ' VAL . 28.5 m-85 -142.95 131.54 22.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.895 -179.843 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.568 ' N ' HD11 ' A' ' 76' ' ' ILE . . . -64.0 142.78 98.22 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.463 -178.742 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.585 ' HB3' ' N ' ' A' ' 1' ' ' MET . 45.3 Cg_exo -41.37 -30.97 0.92 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.28 2.653 . . . . 0.0 112.677 179.234 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -164.26 35.16 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.594 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.02 -97.84 1.89 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.566 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.8 m -165.32 175.6 9.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.96 0.41 . . . . 0.0 110.889 -179.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.422 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 14.2 t-80 -50.04 101.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.997 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.568 HD11 ' N ' ' A' ' 70' ' ' ALA . 3.3 mt -67.32 -52.78 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.405 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.533 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 138.64 -150.83 21.31 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.753 -179.69 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.4 -142.01 11.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.748 -179.719 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -70.12 -70.81 0.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.771 0.32 . . . . 0.0 110.948 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -58.97 -44.03 91.44 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.018 0.437 . . . . 0.0 110.437 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -53.11 -36.01 60.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.417 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.741 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.6 tt -80.42 -34.63 36.02 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.296 179.639 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -51.23 -29.81 15.45 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.647 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -69.0 -35.06 76.26 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.22 178.159 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 82' ' ' LEU . 9.1 t80 -63.24 -34.19 77.13 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.288 178.397 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.741 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.4 m-85 -88.0 -70.16 0.65 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.276 179.761 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.864 -179.996 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.647 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 59.0 ttp . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 120.713 0.292 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.509 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 76.9 m-85 -80.15 154.51 27.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.02 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.72 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -133.6 130.46 38.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.484 -178.794 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.922 HG22 HG22 ' A' ' 68' ' ' VAL . 27.0 t -114.09 138.31 44.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.195 0.522 . . . . 0.0 111.694 179.306 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.791 ' CE1' HD12 ' A' ' 34' ' ' ILE . 4.2 m-85 -115.89 99.47 7.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.997 178.276 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 35' ' ' ASN . . . -158.61 -138.58 2.5 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.446 -179.228 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.707 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 64.7 m-85 -117.92 154.67 31.51 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 120.865 0.364 . . . . 0.0 111.021 -179.517 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.49 -77.9 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.788 -179.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 t 170.78 -37.88 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.955 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.49 -29.56 52.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.26 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.496 HG23 ' N ' ' A' ' 40' ' ' LYS . 10.4 mm -89.03 -40.36 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.059 0.457 . . . . 0.0 110.631 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -150.32 148.54 28.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.573 179.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -78.37 160.04 28.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.302 -179.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.1 t -174.63 103.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.722 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 m -79.98 -37.88 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.217 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.46 -22.92 66.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.16 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.2 m -65.77 -57.72 7.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.909 0.385 . . . . 0.0 110.837 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -53.44 -25.98 18.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.316 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -70.39 -63.29 1.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.611 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.538 ' HB2' ' HB2' ' A' ' 79' ' ' PHE . . . -57.4 -27.04 62.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.796 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.2 tttm -59.59 -56.53 20.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.475 179.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.638 ' O ' HG23 ' A' ' 26' ' ' VAL . 8.9 ttt85 -61.51 -25.5 67.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.523 179.456 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.555 HD11 ' HG2' ' A' ' 83' ' ' ARG . 1.0 OUTLIER -59.53 -55.42 34.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.451 179.626 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.5 mt -63.52 -43.0 98.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.8 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.2 m -58.75 -41.25 86.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.175 0.512 . . . . 0.0 109.986 179.243 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 22' ' ' ARG . 95.8 t -78.86 -25.03 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.456 179.25 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.535 ' HG2' ' CE1' ' A' ' 86' ' ' PHE . 12.4 tppt? -71.75 -18.81 62.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.226 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt 69.86 53.76 0.37 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 111.11 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -143.7 145.92 33.01 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.996 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.33 138.88 22.81 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.557 2.171 . . . . 0.0 111.919 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.647 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 4.2 p90 -158.36 169.6 24.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.058 0.456 . . . . 0.0 112.154 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -144.18 143.14 30.94 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.789 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.51 ' HE1' HG11 ' A' ' 4' ' ' VAL . 21.0 t80 -89.41 158.45 17.74 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.318 -179.749 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.791 HD12 ' CE1' ' A' ' 5' ' ' TYR . 11.7 mt -145.67 119.75 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.168 179.26 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.0 p30 -90.6 133.04 35.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.544 -179.176 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.707 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 6.8 pt -90.28 -22.5 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.056 179.529 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.61 ' HB2' ' HB3' ' A' ' 43' ' ' PHE . 2.9 ttp -123.68 91.34 49.8 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.406 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 6.1 Cg_exo -74.05 -4.36 15.3 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.891 2.394 . . . . 0.0 112.569 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 37' ' ' MET . 0.1 OUTLIER -139.62 136.98 34.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.74 0.305 . . . . 0.0 110.805 -179.837 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.496 ' N ' HG23 ' A' ' 11' ' ' ILE . 4.0 ttpm? -63.69 -8.9 11.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.144 0.497 . . . . 0.0 112.102 -179.749 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.56 -64.6 1.43 Allowed Glycine 0 C--N 1.312 -0.774 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.164 179.583 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.8 t -141.24 139.91 32.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.611 0.243 . . . . 0.0 110.86 179.717 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.61 ' HB3' ' HB2' ' A' ' 37' ' ' MET . 0.1 OUTLIER -68.83 169.92 10.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.986 0.422 . . . . 0.0 111.379 -179.73 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.406 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -93.58 107.94 19.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.161 -179.678 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 1.8 p30 -56.29 -22.01 27.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.304 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -57.44 -51.19 70.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.838 0.351 . . . . 0.0 110.928 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -76.85 -35.15 57.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.308 179.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.534 HD11 ' HB ' ' A' ' 36' ' ' ILE . 32.6 mm -62.46 -44.36 99.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.873 179.672 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.96 -56.81 9.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.245 -179.487 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -57.75 -33.16 68.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.585 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.695 HD13 ' CD2' ' A' ' 5' ' ' TYR . 10.4 tp -57.72 -51.74 68.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.382 179.574 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.2 mt -52.47 -45.85 66.27 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.196 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.6 m -67.19 -35.63 80.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.32 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -62.67 -32.16 73.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.495 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.08 -53.54 48.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.84 179.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.62 -41.93 1.24 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.297 -179.848 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -98.76 -165.5 1.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.882 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -104.0 -32.83 9.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 t -110.54 166.32 11.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 18.4 mt-30 -110.62 99.47 8.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 pt -68.17 80.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.199 179.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.95 17.75 73.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.668 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.699 HD12 ' CD ' ' A' ' 67' ' ' GLN . 0.3 OUTLIER -79.96 139.28 37.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.908 180.0 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.67 171.35 14.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.489 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.43 ' SD ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -89.72 156.37 47.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.651 179.475 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.0 Cg_exo -76.58 147.66 87.27 Favored 'Cis proline' 0 C--N 1.345 0.36 0 C-N-CA 123.865 -1.306 . . . . 0.0 113.073 0.4 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.699 ' CD ' HD12 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -107.73 111.55 23.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.406 179.314 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.922 HG22 HG22 ' A' ' 4' ' ' VAL . 5.6 t -93.65 161.1 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.933 0.397 . . . . 0.0 111.821 -179.319 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.473 ' N ' HG12 ' A' ' 68' ' ' VAL . 96.0 m-85 -142.05 146.6 35.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.622 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -84.31 137.68 39.44 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.242 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.553 ' HB3' ' N ' ' A' ' 1' ' ' MET . 39.0 Cg_exo -34.94 -36.88 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.634 2.889 . . . . 0.0 112.183 178.674 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -166.6 31.02 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.124 179.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.72 15.91 9.01 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.761 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 p 73.36 179.93 0.21 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.125 0.488 . . . . 0.0 111.412 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.473 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 24.4 t-80 -52.57 125.71 17.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.502 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.622 HD11 ' HA ' ' A' ' 70' ' ' ALA . 26.7 mt -94.76 -47.9 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.657 179.538 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.5 -151.71 20.95 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.657 -179.71 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.44 -144.95 17.87 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.592 -179.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.538 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 11.1 t80 -70.65 -70.6 0.29 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.771 0.32 . . . . 0.0 110.775 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -59.18 -47.22 86.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.958 0.408 . . . . 0.0 110.477 179.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -41.15 63.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.264 179.582 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.587 HD21 ' CD2' ' A' ' 86' ' ' PHE . 4.5 tt -76.23 -35.39 59.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.051 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.555 ' HG2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.52 -28.05 12.5 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.755 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -72.29 -33.61 67.55 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.367 178.352 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.616 ' CD2' HG23 ' A' ' 76' ' ' ILE . 6.2 t80 -65.64 -32.85 74.64 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.399 178.568 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.587 ' CD2' HD21 ' A' ' 82' ' ' LEU . 10.7 m-85 -95.13 -70.19 0.72 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.521 179.718 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.818 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.645 ' HG3' ' HA ' ' A' ' 31' ' ' PHE . 2.5 tpp . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.799 0.333 . . . . 0.0 111.637 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.521 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 82.9 m-85 -68.82 148.42 50.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.958 0.408 . . . . 0.0 110.538 -179.786 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.683 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -120.25 118.51 30.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.157 -179.973 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.647 HG22 HG22 ' A' ' 68' ' ' VAL . 6.2 t -105.28 122.74 58.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.343 0.592 . . . . 0.0 111.921 -179.607 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.596 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.6 m-30 -99.95 99.39 10.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.923 178.659 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.74 -138.07 2.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.369 -179.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -131.07 104.09 6.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.56 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 8' ' ' ASP . 0.5 OUTLIER -108.8 22.84 15.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.604 0.24 . . . . 0.0 110.465 178.53 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.1 t -116.07 175.16 5.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.42 0.629 . . . . 0.0 111.774 -179.103 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -87.37 8.26 25.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.22 179.059 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.2 mm -87.66 -16.28 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.382 179.333 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -153.51 144.92 23.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.471 179.18 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.34 166.79 20.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.048 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.3 p 179.19 116.9 0.04 OUTLIER 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.831 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.7 m -90.84 -35.8 7.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.87 0.367 . . . . 0.0 111.134 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -77.41 -19.32 56.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.49 -179.647 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.6 p -65.76 -43.41 88.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 0.0 110.634 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.31 -38.24 63.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.858 179.752 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -68.74 -41.14 79.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.432 -179.428 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.491 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -67.04 -40.03 87.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.774 0.321 . . . . 0.0 111.487 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HD2' ' CZ ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -57.3 -48.55 78.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.836 0.35 . . . . 0.0 110.491 179.753 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.832 ' O ' HG23 ' A' ' 26' ' ' VAL . 41.7 ptt85 -64.93 -33.42 75.99 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.979 0.418 . . . . 0.0 110.503 179.624 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.734 HD13 ' N ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.45 -49.75 71.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.325 179.285 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.734 ' N ' HD13 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -64.4 -47.51 78.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.447 179.266 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 m -54.24 -36.98 64.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.003 179.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 22' ' ' ARG . 59.5 t -77.46 -27.92 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.414 179.251 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 -11.57 57.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.093 179.787 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 70.27 57.71 0.27 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.907 0.384 . . . . 0.0 111.245 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -135.37 137.75 27.14 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.113 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.461 ' O ' ' HA ' ' A' ' 1' ' ' MET . 54.8 Cg_endo -80.8 134.32 9.58 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.598 2.199 . . . . 0.0 111.123 179.111 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.645 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 28.9 p90 -159.44 169.88 22.97 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.12 -0.632 . . . . 0.0 112.547 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -144.56 142.68 30.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.27 -179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.505 ' HD1' ' N ' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -89.8 133.9 34.47 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.071 -179.935 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.596 HD12 ' CE1' ' A' ' 5' ' ' TYR . 7.6 mt -115.42 109.93 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.174 0.511 . . . . 0.0 110.22 178.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -74.1 134.08 42.88 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.048 -179.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 pt -100.12 -6.93 9.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.987 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 30.7 ttm -122.93 95.29 46.42 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.653 0.263 . . . . 0.0 111.62 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.0 -24.46 17.32 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.475 2.117 . . . . 0.0 111.842 179.485 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -140.86 147.72 39.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.644 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -64.4 -8.42 13.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.253 0.549 . . . . 0.0 111.801 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.0 -56.37 3.08 Favored Glycine 0 C--N 1.312 -0.753 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.61 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -147.95 145.09 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.981 0.42 . . . . 0.0 111.815 -179.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -68.21 170.66 8.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.559 179.434 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.29 84.1 5.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.45 -27.92 7.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.362 179.889 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -56.73 -50.3 72.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.939 0.4 . . . . 0.0 110.574 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -40.03 64.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.226 179.343 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 mm -52.24 -44.61 42.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.851 179.607 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.4 -56.74 12.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.57 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -57.76 -34.74 69.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.355 179.507 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.034 HD13 HD11 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -59.86 -56.69 18.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.238 179.863 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.588 ' HA ' HD13 ' A' ' 55' ' ' LEU . 66.8 mt -43.4 -45.5 6.23 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.384 0.611 . . . . 0.0 110.884 179.11 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.4 m -70.39 -33.33 71.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.166 178.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -64.32 -39.86 94.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.305 179.918 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.034 HD11 HD13 ' A' ' 51' ' ' LEU . 4.4 mp -59.76 -66.99 0.43 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.899 0.38 . . . . 0.0 111.08 -179.739 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 158.24 -34.95 0.52 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.405 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.58 -164.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.774 0.321 . . . . 0.0 110.903 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -99.74 -33.12 10.71 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.787 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 t -119.65 170.11 9.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.815 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.424 ' HB2' ' CB ' ' A' ' 63' ' ' LEU . 4.0 pt20 -113.17 99.81 8.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.0 0.428 . . . . 0.0 110.909 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mt -79.93 80.85 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.389 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.36 -18.63 56.75 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.854 179.683 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.424 ' CB ' ' HB2' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -59.48 136.17 57.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 0.0 110.915 -179.959 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 65' ' ' MET . 0.5 OUTLIER -143.06 171.33 14.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.353 -179.465 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.436 ' H ' HG22 ' A' ' 64' ' ' THR . 0.0 OUTLIER -89.45 153.2 48.19 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.565 179.56 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.9 Cg_exo -77.13 138.78 55.53 Favored 'Cis proline' 0 C--N 1.344 0.339 0 C-N-CA 123.877 -1.301 . . . . 0.0 112.954 0.263 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.68 ' OE1' HD11 ' A' ' 51' ' ' LEU . 5.3 mt-30 -100.91 112.96 25.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.996 179.054 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.9 t -91.08 163.74 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 0.0 111.752 -179.213 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.515 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 28.5 m-85 -142.1 132.1 24.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.348 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.823 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -48.56 149.45 2.92 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.635 -178.663 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.6 ' HB3' ' N ' ' A' ' 1' ' ' MET . 52.9 Cg_exo -57.27 -29.02 82.35 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.106 2.537 . . . . 0.0 111.882 179.156 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -94.41 -23.13 17.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.034 179.818 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.56 79.02 0.51 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.568 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.491 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -164.5 119.13 1.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.833 0.349 . . . . 0.0 110.904 179.931 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -51.37 111.3 0.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.051 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.823 HD11 ' HA ' ' A' ' 70' ' ' ALA . 27.0 mt -88.51 -50.43 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.987 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 126.99 -154.48 19.39 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.624 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -87.1 -144.83 8.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.281 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.491 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -72.81 -68.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.725 0.262 . . . . 0.0 110.849 179.75 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -47.09 -42.33 18.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.156 0.503 . . . . 0.0 110.39 179.611 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -40.03 95.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.372 179.507 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.633 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -72.49 -43.68 63.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.346 179.741 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.13 -33.42 18.8 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -69.9 -36.55 75.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.202 178.339 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 82' ' ' LEU . 10.2 t80 -63.51 -33.77 76.3 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.465 178.39 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.633 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.4 m-85 -86.34 -70.36 0.61 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.047 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.885 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.596 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 11.2 tpp . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.307 0.098 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 76.8 m-85 -39.53 123.75 1.53 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.61 0.719 . . . . 0.0 111.74 -177.243 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.673 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -89.54 125.22 35.12 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.152 -179.316 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 68' ' ' VAL . 51.5 t -116.77 147.24 20.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.253 0.549 . . . . 0.0 110.959 179.187 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.668 ' CZ ' HD12 ' A' ' 34' ' ' ILE . 85.7 m-85 -129.06 99.67 5.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.061 178.761 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.414 ' O ' HD13 ' A' ' 36' ' ' ILE . . . -159.68 -142.38 3.38 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.13 -179.06 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.686 ' CE1' HD11 ' A' ' 36' ' ' ILE . 60.2 m-85 -115.37 145.17 42.78 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.565 0.221 . . . . 0.0 110.831 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -106.05 27.57 8.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.942 0.401 . . . . 0.0 110.438 179.738 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.2 p 64.02 10.74 5.59 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.313 -179.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -86.19 -63.88 1.24 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.894 0.378 . . . . 0.0 110.891 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.426 HG21 ' N ' ' A' ' 40' ' ' LYS . 18.4 mm -96.62 -17.66 6.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.376 -179.051 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.51 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 30.7 t60 -153.32 160.52 42.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.984 0.421 . . . . 0.0 111.644 -179.441 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -46.55 156.94 0.16 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.188 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.9 t -153.64 69.28 0.8 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.037 -179.76 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.444 HG23 ' N ' ' A' ' 16' ' ' TYR . 27.5 m -91.78 -43.15 13.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.444 ' N ' HG23 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -70.75 -22.65 62.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.453 -179.204 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.07 -42.71 14.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.692 179.826 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -52.28 -31.56 33.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.408 179.548 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -78.49 -56.46 4.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.644 179.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.448 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . . . -55.39 -45.26 76.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.875 0.369 . . . . 0.0 111.076 179.841 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 27.2 ttpt -58.92 -45.7 89.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.598 179.744 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.801 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.6 tmm_? -63.21 -37.27 86.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.556 179.737 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.791 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -56.98 -53.03 62.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.239 179.499 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.791 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.7 mt -56.51 -44.86 81.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.602 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.0 m -58.27 -39.07 78.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.967 179.353 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.7 t -73.0 -39.96 58.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.555 179.334 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -10.14 59.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.999 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 69.41 49.95 0.56 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.935 0.398 . . . . 0.0 110.375 -179.674 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.17 112.26 8.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.394 -179.634 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.596 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 83.4 Cg_exo -49.96 179.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.341 2.027 . . . . 0.0 111.585 179.052 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CE2' ' HG3' ' A' ' 21' ' ' LYS . 4.8 p90 -164.54 170.13 16.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.077 0.465 . . . . 0.0 111.346 178.111 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 2.7 tt0 -134.55 109.49 8.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.628 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.574 ' CE1' HG11 ' A' ' 4' ' ' VAL . 7.9 t80 -91.94 159.89 15.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.206 0.527 . . . . 0.0 111.82 -179.446 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.668 HD12 ' CZ ' ' A' ' 5' ' ' TYR . 20.6 mt -150.1 122.93 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.075 179.152 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -80.0 124.39 28.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.09 -179.639 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.686 HD11 ' CE1' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -88.7 -18.04 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.17 179.652 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -125.22 83.4 60.92 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.667 179.864 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.5 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 57.7 Cg_endo -70.82 -12.98 31.67 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.62 2.213 . . . . 0.0 111.708 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -139.55 136.93 34.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.912 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.426 ' N ' HG21 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -61.63 -8.28 4.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.312 0.577 . . . . 0.0 111.543 -179.59 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.5 -60.43 3.24 Favored Glycine 0 C--N 1.313 -0.737 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.543 179.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 43' ' ' PHE . 20.3 t -151.41 160.44 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.425 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.521 ' N ' HG12 ' A' ' 42' ' ' VAL . 1.7 m-30 -60.05 170.4 1.24 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.587 178.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.5 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 66.6 t0 -99.91 96.96 7.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.513 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -48.66 -34.35 11.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.273 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -65.5 -58.09 6.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.817 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -32.26 71.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.651 179.749 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.4 mp -75.4 -29.67 21.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.523 179.761 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.35 -54.4 46.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.877 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -64.17 -35.19 79.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 110.224 179.615 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.779 HD22 HD11 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -62.03 -59.47 5.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.476 179.057 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.576 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 69.2 mt -44.88 -41.3 7.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.114 179.092 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.6 m -70.62 -32.29 69.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.575 -179.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 19.8 mtpp -64.84 -45.08 87.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.75 -179.193 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.779 HD11 HD22 ' A' ' 51' ' ' LEU . 1.3 mp -59.52 -39.4 83.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.859 0.361 . . . . 0.0 111.168 -179.645 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.86 -120.46 0.83 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.343 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -146.99 30.27 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.054 0.454 . . . . 0.0 110.619 179.522 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -121.18 -146.29 0.37 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.258 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -120.39 168.55 11.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.689 0.281 . . . . 0.0 110.599 179.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.553 ' NE2' HD21 ' A' ' 52' ' ' LEU . 17.3 mt-30 -87.73 98.89 11.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.254 0.55 . . . . 0.0 110.484 179.628 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pt -79.9 84.68 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.161 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.52 26.2 64.16 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.382 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.74 HD12 ' NE2' ' A' ' 67' ' ' GLN . 1.4 mm? -54.02 153.12 5.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.872 0.368 . . . . 0.0 110.787 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.5 p -119.19 161.08 20.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.133 0.492 . . . . 0.0 111.466 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.7 mmt -108.69 153.68 42.12 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.393 179.552 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.557 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.4 Cg_endo -86.17 146.01 36.2 Favored 'Cis proline' 0 N--CA 1.461 -0.396 0 C-N-CA 124.268 -1.138 . . . . 0.0 112.912 0.517 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.74 ' NE2' HD12 ' A' ' 63' ' ' LEU . 5.3 tp-100 -97.05 122.29 39.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.877 178.768 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 4' ' ' VAL . 8.2 t -104.46 157.79 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.759 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.627 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 92.7 m-85 -142.49 164.26 30.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.039 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.634 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -64.49 157.59 71.57 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.771 -179.519 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.26 -21.62 67.41 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.896 2.397 . . . . 0.0 112.418 179.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -109.72 -16.46 13.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.617 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.69 97.76 1.11 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.798 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 15.2 t -178.57 151.74 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.674 0.273 . . . . 0.0 110.34 179.623 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.476 ' CE1' HD23 ' A' ' 55' ' ' LEU . 9.1 t-160 -85.63 113.73 22.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.146 -179.603 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.634 HD12 ' N ' ' A' ' 70' ' ' ALA . 1.7 mp -103.17 -39.54 6.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.865 0.364 . . . . 0.0 110.658 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.04 -160.4 23.88 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.704 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.16 -134.53 7.99 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.615 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 9.2 t80 -70.63 -70.67 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.72 0.295 . . . . 0.0 111.422 -179.597 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -60.51 -44.49 95.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.994 0.426 . . . . 0.0 110.999 -179.813 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -52.14 -41.15 62.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.698 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.737 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.2 tt -74.85 -34.04 62.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.217 179.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -51.15 -31.46 19.89 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.618 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.64 -35.16 79.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.208 178.257 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.462 ' N ' ' O ' ' A' ' 82' ' ' LEU . 13.5 t80 -63.59 -33.57 75.89 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.337 178.459 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.737 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.6 m-85 -86.76 -70.24 0.62 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.275 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.975 -179.956 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.688 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 31.4 ttp . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.872 0.368 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.465 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 96.3 m-85 -82.71 143.35 30.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.068 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.71 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -117.14 122.56 44.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.719 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.064 HG22 HG22 ' A' ' 68' ' ' VAL . 7.7 t -111.03 130.06 65.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.464 0.65 . . . . 0.0 111.7 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.512 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 20.1 m-85 -111.95 101.76 10.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.651 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 66' ' ' PRO . . . -163.89 -139.42 2.63 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.653 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.492 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 85.1 m-85 -123.19 159.52 28.45 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.711 0.291 . . . . 0.0 111.254 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.8 -65.76 1.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.254 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 t 168.79 -32.53 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 110.792 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -65.53 -47.27 76.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.122 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.563 ' H ' HD12 ' A' ' 11' ' ' ILE . 3.7 mp -91.32 -44.99 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.019 0.437 . . . . 0.0 110.934 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.492 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 23.4 t60 -143.2 155.96 44.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.39 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -80.98 171.24 15.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.854 0.359 . . . . 0.0 111.264 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.0 p -179.37 115.36 0.06 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.973 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 m -90.86 -36.67 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.298 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -80.25 -15.45 56.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.655 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.0 p -66.25 -42.4 88.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.928 0.394 . . . . 0.0 110.621 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.2 -41.92 66.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.409 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -56.86 -48.14 78.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.484 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.88 -47.32 83.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.134 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -49.66 -31.72 11.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.944 0.402 . . . . 0.0 110.376 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.874 ' O ' HG23 ' A' ' 26' ' ' VAL . 22.0 ttp180 -74.33 -34.6 63.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.195 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.686 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -55.52 -51.72 66.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.254 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.29 -54.17 49.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.848 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 m -49.22 -36.01 18.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.718 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 22' ' ' ARG . 74.6 t -69.33 -29.75 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.802 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -16.84 27.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.347 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt 71.67 65.05 0.15 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.987 0.422 . . . . 0.0 110.682 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -130.81 142.3 45.04 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.65 128.58 11.08 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.414 2.076 . . . . 0.0 111.641 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.688 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 16.0 p90 -158.88 167.7 28.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.97 147.04 27.39 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.105 0.479 . . . . 0.0 111.35 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.651 ' CE1' HG11 ' A' ' 4' ' ' VAL . 7.8 t80 -89.47 156.42 18.67 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.007 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.2 mt -145.85 119.99 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.409 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -74.92 109.81 8.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.687 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.7 pt -72.84 -13.64 16.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.301 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.522 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -119.86 80.66 25.48 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.76 0.314 . . . . 0.0 111.088 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 60.8 Cg_endo -72.37 -9.86 24.79 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.632 2.221 . . . . 0.0 111.9 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -139.53 136.67 34.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.469 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -60.94 -8.74 3.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.232 0.539 . . . . 0.0 112.0 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.09 -62.06 2.15 Favored Glycine 0 C--N 1.312 -0.774 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.338 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 43' ' ' PHE . 21.2 t -150.4 154.91 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.765 0.316 . . . . 0.0 111.45 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -59.75 169.97 1.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.613 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.418 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 6.3 t0 -82.32 100.44 9.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.943 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -55.27 -27.01 43.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.085 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.05 -54.98 29.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 110.875 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -73.81 -33.29 64.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.526 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.2 mm -71.57 -31.67 43.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.649 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -66.31 -56.32 11.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -59.37 -30.01 68.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.939 0.399 . . . . 0.0 110.226 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.651 ' O ' HD12 ' A' ' 55' ' ' LEU . 2.0 tt -59.67 -58.59 7.92 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.571 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.569 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 73.9 mt -45.93 -42.59 13.02 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.593 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 m -70.92 -31.12 67.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.661 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 1.8 tttp -60.8 -48.34 82.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.419 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.2 mp -59.32 -59.63 5.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.049 0.452 . . . . 0.0 111.065 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.35 -114.2 0.29 Allowed Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.048 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.9 mtt85 -150.64 28.07 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.98 0.419 . . . . 0.0 111.004 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -121.7 -156.63 0.69 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.113 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.5 t -121.17 167.41 12.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.686 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.832 ' CB ' HD23 ' A' ' 63' ' ' LEU . 6.2 pt20 -130.2 98.84 4.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 110.828 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.654 ' O ' HG23 ' A' ' 61' ' ' ILE . 8.5 tp -82.07 85.57 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.177 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.09 23.8 5.97 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.485 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.832 HD23 ' CB ' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -60.84 127.02 29.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.813 0.34 . . . . 0.0 110.557 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 p -92.28 163.42 13.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.241 0.543 . . . . 0.0 111.481 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.48 160.77 38.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.665 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.495 ' HB2' HG13 ' A' ' 4' ' ' VAL . 4.2 Cg_exo -83.94 149.75 60.35 Favored 'Cis proline' 0 C--N 1.344 0.335 0 C-N-CA 124.428 -1.072 . . . . 0.0 113.123 0.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -101.77 120.18 39.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.903 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.064 HG22 HG22 ' A' ' 4' ' ' VAL . 6.2 t -98.72 159.65 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.035 0.445 . . . . 0.0 111.615 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.459 ' N ' HG12 ' A' ' 68' ' ' VAL . 31.8 m-85 -142.9 133.15 24.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.765 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.612 ' CA ' HD11 ' A' ' 76' ' ' ILE . . . -62.95 149.62 89.84 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.604 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.58 ' HB3' ' N ' ' A' ' 1' ' ' MET . 68.0 Cg_exo -44.8 -52.54 6.07 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.37 2.714 . . . . 0.0 112.747 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -30.03 65.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.189 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.26 67.95 0.44 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.388 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.4 m -147.79 157.07 43.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.84 0.353 . . . . 0.0 110.648 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -84.09 115.1 22.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.973 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.612 HD11 ' CA ' ' A' ' 70' ' ' ALA . 19.8 mt -93.58 -49.14 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.972 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 123.15 -154.18 17.14 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.93 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 82' ' ' LEU . . . -90.97 -132.24 5.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.472 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.686 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -79.66 -70.08 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.654 0.227 . . . . 0.0 111.114 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -51.08 -49.12 61.26 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.331 0.586 . . . . 0.0 110.478 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -57.41 -42.2 81.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.701 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.691 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.3 tt -76.3 -32.26 58.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.582 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -33.78 40.6 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -66.47 -35.87 81.34 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.164 178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 82' ' ' LEU . 14.7 t80 -63.2 -34.08 76.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.35 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.691 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.4 m-85 -84.29 -66.39 0.9 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.995 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.91 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.632 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 30.1 ttm . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.784 0.326 . . . . 0.0 111.527 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.517 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 69.3 m-85 -61.8 169.57 2.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.357 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -143.72 116.29 8.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.743 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.0 HG22 HG22 ' A' ' 68' ' ' VAL . 87.5 t -110.44 141.27 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.168 0.508 . . . . 0.0 111.02 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.685 ' CE1' HD12 ' A' ' 34' ' ' ILE . 6.6 m-85 -123.31 99.3 6.27 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.89 -144.54 4.05 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.541 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.831 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 34.4 m-85 -113.51 151.07 32.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.748 0.309 . . . . 0.0 111.426 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.5 t70 -81.98 0.46 40.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.983 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.3 OUTLIER 83.81 -13.76 0.73 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -85.33 -39.12 18.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.759 0.314 . . . . 0.0 111.082 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.419 HD12 ' O ' ' A' ' 37' ' ' MET . 3.7 mt -92.56 -31.1 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.283 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.436 ' O ' ' HA ' ' A' ' 9' ' ' SER . 7.8 t60 -142.07 142.15 32.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.099 0.476 . . . . 0.0 110.987 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.2 145.02 11.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.315 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.3 t -179.26 88.93 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.13 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.8 m -79.01 -27.08 13.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.897 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -75.1 -21.53 58.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.798 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.5 m -59.71 -58.59 7.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.205 0.526 . . . . 0.0 110.265 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.96 -23.59 13.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.334 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 3.9 m-80 -77.14 -54.08 6.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.091 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.49 -48.7 76.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 111.078 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HD2' ' CE2' ' A' ' 31' ' ' PHE . 2.2 tptt -58.23 -54.06 51.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.697 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.836 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.4 mmp_? -60.84 -36.76 79.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.554 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 24' ' ' LEU . 3.1 tt -58.88 -52.97 63.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.509 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.618 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.9 mt -57.78 -46.86 83.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.794 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 m -57.63 -36.28 71.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.478 . . . . 0.0 110.234 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 22' ' ' ARG . 53.3 t -79.71 -30.7 13.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.766 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -77.77 -11.08 59.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.131 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt 70.34 54.07 0.32 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.996 0.427 . . . . 0.0 111.045 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -134.42 132.77 21.08 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.092 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.434 ' O ' ' HA ' ' A' ' 1' ' ' MET . 98.5 Cg_endo -78.41 137.33 14.77 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.474 2.116 . . . . 0.0 111.114 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.632 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 17.1 p90 -156.21 170.19 22.8 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -136.79 131.63 33.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.011 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.612 ' CE1' HG12 ' A' ' 4' ' ' VAL . 1.2 t80 -95.74 129.81 42.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.97 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.685 HD12 ' CE1' ' A' ' 5' ' ' TYR . 7.3 mt -113.33 110.39 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.383 0.611 . . . . 0.0 110.432 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -77.46 113.76 15.59 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.105 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.831 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 6.3 pt -71.94 -28.48 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.002 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.559 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 22.2 ttm -121.45 91.13 48.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.891 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.8 Cg_endo -82.59 1.66 9.0 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.693 2.262 . . . . 0.0 112.692 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -139.81 140.29 36.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 110.875 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -66.68 -7.09 18.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.254 0.549 . . . . 0.0 111.779 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.77 -67.13 1.01 Allowed Glycine 0 C--N 1.315 -0.608 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.694 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 t -136.21 133.82 50.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.71 0.29 . . . . 0.0 111.07 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -63.37 170.29 3.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.466 -179.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.45 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -94.65 99.94 11.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.064 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -54.37 -19.93 6.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.782 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -58.47 -56.28 24.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.031 0.444 . . . . 0.0 110.521 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -67.75 -31.69 71.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.307 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.405 HD11 ' HB ' ' A' ' 36' ' ' ILE . 25.1 mm -59.84 -48.34 88.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.611 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.11 -49.27 77.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.805 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.31 -35.89 70.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.579 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.47 HD13 ' CG ' ' A' ' 5' ' ' TYR . 26.4 tp -61.32 -52.99 62.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.652 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.5 mt -49.72 -45.16 48.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.131 0.491 . . . . 0.0 111.277 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.5 m -64.08 -32.47 74.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.108 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.427 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 9.3 tttp -68.9 -29.99 68.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.465 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.724 HD11 HD11 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -71.06 -37.62 72.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.048 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.83 33.58 6.32 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.278 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -150.07 -176.9 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.8 0.334 . . . . 0.0 110.742 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -105.11 -30.8 9.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.025 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 t -111.05 163.79 13.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.052 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.609 ' CA ' HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -106.47 99.14 8.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.596 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.5 mm -80.67 87.82 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.556 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.92 31.55 79.94 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.44 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.724 HD11 HD11 ' A' ' 55' ' ' LEU . 1.3 mm? -42.35 134.71 2.87 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.83 0.347 . . . . 0.0 111.207 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.58 153.11 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.088 0.47 . . . . 0.0 111.671 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.12 152.12 72.84 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.406 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.1 Cg_exo -79.31 128.72 16.86 Favored 'Cis proline' 0 C--N 1.344 0.328 0 C-N-CA 124.053 -1.228 . . . . 0.0 112.934 0.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.412 ' HG3' ' NE2' ' A' ' 75' ' ' HIS . 3.7 tp60 -90.6 117.87 29.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.225 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.0 HG22 HG22 ' A' ' 4' ' ' VAL . 10.2 t -97.48 161.24 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.95 0.405 . . . . 0.0 111.906 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.537 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 97.0 m-85 -142.84 149.26 38.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.022 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.583 ' HB3' ' H ' ' A' ' 74' ' ' SER . . . -61.81 159.35 35.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.773 -0.648 . . . . 0.0 112.411 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.535 ' HB3' ' N ' ' A' ' 1' ' ' MET . 31.7 Cg_exo -63.74 58.85 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.577 2.851 . . . . 0.0 111.547 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER 90.49 29.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.345 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -111.75 -92.65 2.1 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.526 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.583 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -152.39 -175.97 5.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.033 0.444 . . . . 0.0 110.96 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.423 ' HA ' ' CD1' ' A' ' 69' ' ' PHE . 16.4 t-80 -68.14 126.62 30.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.156 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.569 HG23 ' CD2' ' A' ' 85' ' ' TYR . 4.8 mt -91.82 -45.43 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.177 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.16 -150.04 19.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.635 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.83 -150.74 22.47 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.62 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 40.4 t80 -70.79 -70.55 0.3 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.68 0.276 . . . . 0.0 110.951 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -55.46 -45.53 76.88 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.009 0.433 . . . . 0.0 110.579 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -54.91 -33.93 62.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.298 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.744 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.3 tt -80.08 -36.58 35.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.368 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -51.51 -29.98 18.64 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.3 -35.0 73.41 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.129 178.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.569 ' CD2' HG23 ' A' ' 76' ' ' ILE . 11.9 t80 -63.12 -34.35 77.42 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.267 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.744 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.9 m-85 -87.87 -70.18 0.65 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.292 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.8 mttm . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.044 -179.98 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.628 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 49.7 ttm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.861 0.362 . . . . 0.0 111.639 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.516 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 74.6 m-85 -58.33 155.22 12.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.866 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.638 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -128.19 120.43 27.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.669 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.909 HG22 HG22 ' A' ' 68' ' ' VAL . 55.4 t -116.09 142.18 30.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.333 0.587 . . . . 0.0 111.813 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.789 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.1 m-85 -121.67 99.89 6.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.58 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.24 -137.96 2.36 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.75 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.929 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 31.5 m-85 -122.95 144.15 49.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 120.591 0.234 . . . . 0.0 110.962 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -108.47 29.02 7.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.336 . . . . 0.0 110.863 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m 63.04 14.57 7.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -85.77 -56.98 3.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.1 0.476 . . . . 0.0 110.622 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.599 HG21 ' C ' ' A' ' 39' ' ' GLU . 13.4 mm -104.15 -27.23 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.017 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -141.45 152.12 43.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.613 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.77 171.69 12.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.178 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.4 t -178.68 108.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.952 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.2 m -85.66 -32.8 7.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.956 0.407 . . . . 0.0 111.207 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -71.23 -16.08 62.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.289 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.9 m -72.13 -55.92 6.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.996 0.426 . . . . 0.0 110.683 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -52.18 -28.04 16.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.094 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 74.8 m-20 -75.52 -51.77 12.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.016 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.88 -48.6 79.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.243 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -59.89 -55.43 34.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.781 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -55.4 -44.93 76.63 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.346 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.754 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -59.04 -50.59 73.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.16 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.754 ' N ' HD23 ' A' ' 23' ' ' LEU . 8.7 mt -60.51 -43.61 96.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.065 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.6 m -57.17 -40.15 76.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.107 0.48 . . . . 0.0 109.82 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.7 t -80.13 -27.17 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.449 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.537 ' HG2' ' CE1' ' A' ' 86' ' ' PHE . 3.3 tptp -73.42 -13.31 61.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.081 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt 66.53 54.72 0.86 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.448 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -137.12 134.44 18.92 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.019 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.436 ' O ' ' HA ' ' A' ' 1' ' ' MET . 85.9 Cg_endo -78.58 134.09 12.11 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.337 2.024 . . . . 0.0 110.909 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.628 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 26.9 p90 -148.51 170.0 19.03 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -136.91 133.23 35.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.729 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.513 ' HE1' HG11 ' A' ' 4' ' ' VAL . 9.4 t80 -89.43 163.01 15.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.25 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.789 HD12 ' CE1' ' A' ' 5' ' ' TYR . 19.1 mt -145.69 119.61 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.444 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -82.22 122.76 28.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.098 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.929 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 7.2 pt -93.4 -16.7 7.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.479 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -124.84 85.65 57.06 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.735 0.302 . . . . 0.0 111.556 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 97.0 Cg_endo -79.05 -5.82 14.68 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.851 2.368 . . . . 0.0 111.73 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.599 ' C ' HG21 ' A' ' 11' ' ' ILE . 28.0 mt-10 -139.66 135.33 33.13 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.288 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.445 ' HA ' HG22 ' A' ' 11' ' ' ILE . 20.0 tttp -61.34 -8.45 3.93 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.26 0.552 . . . . 0.0 111.873 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.3 -63.72 2.11 Favored Glycine 0 C--N 1.312 -0.786 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.067 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 43' ' ' PHE . 21.2 t -150.7 159.03 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.759 0.314 . . . . 0.0 111.548 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.708 ' HB2' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -63.47 159.31 18.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.33 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.46 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -82.18 125.6 31.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.88 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.526 ' HA ' HD12 ' A' ' 48' ' ' ILE . 2.1 p30 -68.07 -23.85 64.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.761 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -60.04 -55.5 33.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.37 . . . . 0.0 110.651 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.48 -39.6 85.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.271 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.708 HD11 ' HB2' ' A' ' 43' ' ' PHE . 46.3 mt -54.12 -46.39 66.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.441 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.48 -50.33 71.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.636 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -59.82 -31.96 70.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.577 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.888 ' O ' HD12 ' A' ' 55' ' ' LEU . 18.7 tp -66.28 -63.92 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.292 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 58' ' ' ASP . 62.2 mt -45.66 -40.81 9.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.153 0.502 . . . . 0.0 111.314 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.1 m -67.34 -34.29 77.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.872 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 69' ' ' PHE . 50.0 tptt -66.47 -49.27 67.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.486 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.888 HD12 ' O ' ' A' ' 51' ' ' LEU . 4.9 mp -59.31 -25.07 63.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.248 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.1 30.17 13.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.499 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.15 -178.04 6.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.781 0.324 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.454 ' O ' HD13 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -108.43 -47.36 3.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.997 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.2 t -92.73 160.1 15.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.54 99.36 8.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.678 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -79.91 83.61 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.255 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.81 23.1 78.21 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.513 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.443 HD11 ' CG ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -70.61 131.42 43.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.875 0.369 . . . . 0.0 110.809 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 65' ' ' MET . 0.4 OUTLIER -131.29 170.55 14.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.282 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.497 ' SD ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -106.78 154.15 40.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.762 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.4 Cg_exo -81.08 135.31 31.12 Favored 'Cis proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.701 -1.374 . . . . 0.0 112.846 0.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.443 ' CG ' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -90.7 117.01 29.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.503 179.321 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.909 HG22 HG22 ' A' ' 4' ' ' VAL . 2.7 t -103.19 160.72 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.157 0.503 . . . . 0.0 112.142 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.477 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 95.3 m-85 -142.8 155.65 44.85 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.982 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.517 ' HB3' ' N ' ' A' ' 74' ' ' SER . . . -66.3 156.41 85.23 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.356 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.46 ' HB3' ' N ' ' A' ' 1' ' ' MET . 44.9 Cg_exo -58.28 -38.92 88.7 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.055 2.504 . . . . 0.0 111.808 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -91.42 -16.18 27.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.094 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.76 87.95 1.16 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.651 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.517 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -164.04 124.04 2.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.945 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.525 ' CE1' HD23 ' A' ' 55' ' ' LEU . 20.0 t-160 -58.17 110.83 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.006 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.472 HD11 ' HA ' ' A' ' 70' ' ' ALA . 18.7 mt -89.95 -49.9 13.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.51 -154.25 19.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.434 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.29 -144.16 7.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.299 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 32.7 t80 -71.17 -60.42 2.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 0.0 110.764 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -54.44 -37.21 64.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.829 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -60.77 -41.21 95.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.58 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.428 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -64.04 -50.87 66.73 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.351 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -51.62 -28.38 14.14 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -79.79 -33.76 40.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 82' ' ' LEU . 17.1 t80 -67.57 -32.14 72.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.323 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.537 ' CE1' ' HG2' ' A' ' 27' ' ' LYS . 30.3 m-85 -96.17 -70.74 0.7 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.487 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.4 tttt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.634 -179.941 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.602 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 40.6 ttp . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -76.51 152.04 36.2 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.244 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.5 mptp? -113.34 119.99 39.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.466 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.68 HG22 HG22 ' A' ' 68' ' ' VAL . 39.9 t -113.13 134.19 56.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.363 0.601 . . . . 0.0 112.066 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.61 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 18.9 m-85 -111.66 99.51 8.22 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.959 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.11 -139.64 2.73 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.517 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.62 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 63.5 m-85 -123.28 157.38 33.3 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.858 0.361 . . . . 0.0 111.376 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.41 -76.21 0.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.976 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 174.53 -34.5 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.907 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -71.34 -24.64 62.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.267 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.666 ' H ' HD12 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -106.94 -40.15 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.86 0.362 . . . . 0.0 110.864 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -155.87 160.63 40.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.4 pttp -80.39 173.65 12.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.997 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 9.2 p -163.99 120.37 1.65 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.962 0.41 . . . . 0.0 110.758 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.4 -43.39 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.944 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -88.9 -9.01 53.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.936 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -87.41 -36.43 17.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.758 0.313 . . . . 0.0 110.672 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -68.09 -36.06 79.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.718 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -75.71 -48.38 22.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.125 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.22 69.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.056 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -60.33 -54.18 48.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.617 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.857 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -59.03 -34.58 72.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.679 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.631 ' C ' HD23 ' A' ' 23' ' ' LEU . 4.9 tt -60.14 -54.99 39.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.613 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.517 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.6 mt -55.25 -46.04 76.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.948 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.1 m -57.8 -36.5 72.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.041 0.448 . . . . 0.0 110.157 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.3 t -79.03 -35.46 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.682 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.426 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 0.3 OUTLIER -72.85 -9.97 59.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.184 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.16 42.48 0.34 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.861 0.363 . . . . 0.0 110.792 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -131.89 133.44 24.07 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.025 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.587 ' O ' ' HA ' ' A' ' 1' ' ' MET . 58.9 Cg_endo -81.93 158.82 18.39 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.567 2.178 . . . . 0.0 111.481 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.492 ' CG ' HD13 ' A' ' 24' ' ' LEU . 5.6 p90 -161.47 171.25 18.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.801 0.334 . . . . 0.0 111.663 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -129.55 119.71 24.12 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.564 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.528 ' HE1' HG11 ' A' ' 4' ' ' VAL . 17.4 t80 -89.34 153.12 21.12 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.185 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.435 HD12 ' CE1' ' A' ' 5' ' ' TYR . 15.9 mt -147.4 121.61 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.509 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -81.17 109.74 16.01 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.539 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.62 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 10.7 pt -63.86 -19.65 24.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 2.8 ttp -123.08 90.27 50.45 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.812 0.339 . . . . 0.0 111.52 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 83.4 Cg_endo -80.86 0.98 9.65 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.697 2.265 . . . . 0.0 112.289 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -139.68 140.4 36.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.696 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -67.9 -8.55 37.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.226 0.536 . . . . 0.0 111.842 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.71 -64.76 1.25 Allowed Glycine 0 C--N 1.313 -0.74 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.347 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 t -140.82 139.47 34.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.733 0.301 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -65.56 169.49 6.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 0.0 111.112 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.523 ' O ' HD12 ' A' ' 48' ' ' ILE . 1.4 t0 -86.71 115.18 23.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.033 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -74.83 -22.91 58.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.298 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.3 -52.77 63.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.756 0.312 . . . . 0.0 110.804 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -69.64 -38.31 77.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.128 0.49 . . . . 0.0 110.022 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.523 HD12 ' O ' ' A' ' 44' ' ' ASP . 55.1 mt -64.79 -34.87 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.369 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.44 -48.7 80.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.394 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.83 -34.39 69.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.998 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.61 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.7 tt -58.58 -53.01 63.17 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.2 mt -50.33 -41.87 51.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.453 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.5 m -56.6 -49.14 75.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.523 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -61.03 -39.98 91.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.313 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.13 -48.48 81.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.589 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.99 -165.97 31.84 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.162 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 64.3 mtt-85 -95.51 35.33 1.35 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.972 0.415 . . . . 0.0 110.817 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -120.88 -147.21 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.459 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -120.49 170.9 8.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.766 0.317 . . . . 0.0 110.786 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -69.19 98.21 1.0 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.402 0.62 . . . . 0.0 110.207 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 61' ' ' ILE . 17.2 tt -73.58 79.16 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.133 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 43.09 26.24 0.48 Allowed Glycine 0 C--N 1.333 0.398 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.862 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.447 HD12 ' CG ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -57.57 144.19 38.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.838 0.351 . . . . 0.0 110.887 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 p -110.45 156.94 20.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.428 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -105.28 152.47 39.84 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.654 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.48 ' HB2' HG13 ' A' ' 4' ' ' VAL . 3.8 Cg_exo -82.34 144.28 56.12 Favored 'Cis proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.969 -1.263 . . . . 0.0 112.702 0.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.447 ' CG ' HD12 ' A' ' 63' ' ' LEU . 1.7 mp0 -98.63 132.24 44.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.826 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.68 HG22 HG22 ' A' ' 4' ' ' VAL . 3.5 t -104.23 157.02 5.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.171 0.51 . . . . 0.0 111.992 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.432 ' CZ ' ' CD2' ' A' ' 75' ' ' HIS . 46.2 m-85 -143.67 139.14 29.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.685 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.588 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -53.27 152.45 8.21 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.406 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.602 ' HB3' ' N ' ' A' ' 1' ' ' MET . 7.4 Cg_exo -70.14 -8.99 24.96 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.855 2.37 . . . . 0.0 112.353 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.61 -17.7 14.03 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.098 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.6 89.27 1.1 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.663 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.0 t 179.92 152.76 0.47 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.777 0.323 . . . . 0.0 110.723 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.432 ' CD2' ' CZ ' ' A' ' 69' ' ' PHE . 6.0 t-160 -90.22 113.37 25.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.865 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.588 HD11 ' HA ' ' A' ' 70' ' ' ALA . 19.9 mt -92.58 -48.68 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.977 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.558 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 138.9 -155.42 23.77 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.709 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.82 -136.82 8.9 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.641 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -71.56 -70.66 0.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.82 0.343 . . . . 0.0 111.223 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -59.67 -48.68 80.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.983 0.421 . . . . 0.0 110.729 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -51.3 -39.48 56.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.605 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.75 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.1 tt -78.66 -33.86 46.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.336 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -50.64 -30.13 12.73 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -68.08 -35.79 78.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.229 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 82' ' ' LEU . 13.5 t80 -63.02 -34.05 76.74 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.262 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.75 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.9 m-85 -90.06 -19.65 24.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.304 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.268 -0.873 . . . . 0.0 111.021 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.624 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 49.5 ttm . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.91 0.386 . . . . 0.0 111.561 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.582 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 84.3 m-85 -53.53 158.27 1.86 Allowed 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -135.23 117.44 15.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.486 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.52 HG11 ' CE1' ' A' ' 33' ' ' PHE . 30.9 t -99.87 127.18 53.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.656 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.553 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.9 m-30 -104.39 99.08 8.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.351 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.94 -139.62 2.7 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.45 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.527 ' CD2' ' HD2' ' A' ' 12' ' ' HIS . 85.6 m-85 -120.71 159.79 24.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.075 0.464 . . . . 0.0 111.733 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.15 -81.08 0.06 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.746 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 p 174.12 -41.91 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.227 0.536 . . . . 0.0 111.042 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -74.12 -31.72 62.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.236 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.699 HD12 ' HA ' ' A' ' 40' ' ' LYS . 50.9 mm -93.07 -35.7 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.733 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.527 ' HD2' ' CD2' ' A' ' 7' ' ' TYR . 31.3 t60 -154.76 152.39 29.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.33 159.68 3.45 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 t -174.66 73.82 0.03 OUTLIER 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.49 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.8 m -91.28 -37.82 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.571 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -62.5 -28.93 70.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.721 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.8 p -72.19 -44.18 63.4 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.651 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.32 -32.51 49.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.816 0.341 . . . . 0.0 110.921 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -70.16 -55.99 7.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.848 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.443 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . . . -57.69 -31.09 66.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.035 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HG2' ' CE1' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -60.94 -56.19 24.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.665 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.755 ' O ' HG23 ' A' ' 26' ' ' VAL . 23.6 ptt180 -60.42 -34.2 73.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.59 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.697 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.8 tt -59.05 -53.82 54.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.317 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.697 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.3 mt -55.47 -44.15 76.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.671 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 m -57.52 -35.92 70.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.176 0.513 . . . . 0.0 109.925 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 22' ' ' ARG . 43.5 t -79.72 -29.61 13.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.431 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.61 -13.14 59.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.052 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt 69.4 62.28 0.29 Allowed 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.95 0.405 . . . . 0.0 110.841 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -142.3 138.87 16.98 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.023 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.448 ' O ' ' HA ' ' A' ' 1' ' ' MET . 77.2 Cg_endo -79.97 136.29 11.69 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.536 2.157 . . . . 0.0 111.43 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.624 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 33.9 p90 -152.37 170.54 19.84 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -148.1 146.04 28.65 Favored 'General case' 0 N--CA 1.46 0.048 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.864 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.52 ' CE1' HG11 ' A' ' 4' ' ' VAL . 25.5 t80 -89.34 159.5 17.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.16 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.553 HD12 ' CE1' ' A' ' 5' ' ' TYR . 10.9 mt -145.37 120.56 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.521 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -94.42 118.85 32.26 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.063 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.576 HD12 ' CE2' ' A' ' 43' ' ' PHE . 35.6 pt -78.33 -17.71 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.032 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.488 ' HE3' ' HE1' ' A' ' 43' ' ' PHE . 31.6 ttm -122.11 92.01 48.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.524 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 98.6 Cg_endo -84.23 18.21 1.58 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.884 2.389 . . . . 0.0 113.028 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.525 ' O ' HG21 ' A' ' 11' ' ' ILE . 9.8 mt-10 -139.53 165.44 27.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.374 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.699 ' HA ' HD12 ' A' ' 11' ' ' ILE . 30.8 tttt -61.13 -7.76 2.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.88 48.17 0.07 OUTLIER Glycine 0 C--N 1.313 -0.737 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.877 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' A' ' 39' ' ' GLU . 5.7 t -150.48 115.21 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.327 0.584 . . . . 0.0 112.33 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.576 ' CE2' HD12 ' A' ' 36' ' ' ILE . 1.1 m-85 -68.44 153.14 44.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.822 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.662 ' O ' HD12 ' A' ' 48' ' ' ILE . 3.6 t0 -97.48 93.67 6.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.951 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -49.93 -26.24 3.98 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.716 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.93 -48.81 78.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.851 0.358 . . . . 0.0 110.812 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -77.5 -46.12 23.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.42 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 44' ' ' ASP . 3.0 mp -55.03 -42.36 64.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.76 -54.71 34.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 110.653 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.78 -38.28 87.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.48 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.467 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -57.43 -51.27 70.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.535 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.4 mt -50.09 -47.25 53.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.197 0.522 . . . . 0.0 110.586 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -70.21 -35.14 73.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.754 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -61.39 -31.37 71.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.411 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 mt -72.65 -38.72 67.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.683 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.33 -107.14 0.31 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.99 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 38.7 mtt-85 -150.53 30.87 0.66 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.929 0.395 . . . . 0.0 110.542 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.0 -151.34 0.48 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.355 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -120.61 170.17 9.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.696 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.93 98.37 10.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.241 0.544 . . . . 0.0 110.098 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 pt -79.76 84.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.431 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.47 23.95 61.07 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.705 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.574 HD12 ' HG2' ' A' ' 67' ' ' GLN . 0.3 OUTLIER -50.57 121.28 5.55 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.838 0.351 . . . . 0.0 110.594 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.2 p -99.84 161.39 13.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.153 0.502 . . . . 0.0 111.544 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.403 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 1.8 mpt? -110.58 154.37 43.14 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.484 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 5.0 Cg_exo -81.78 145.18 62.98 Favored 'Cis proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.935 -1.277 . . . . 0.0 112.82 0.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.574 ' HG2' HD12 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -106.72 115.02 29.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -87.18 164.66 2.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.236 0.541 . . . . 0.0 111.953 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.476 ' H ' HG12 ' A' ' 68' ' ' VAL . 12.2 m-85 -142.2 130.22 21.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.467 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.789 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -46.43 144.26 3.43 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.934 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.455 ' CB ' ' N ' ' A' ' 1' ' ' MET . 19.7 Cg_endo -67.76 -13.58 39.09 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.316 2.011 . . . . 0.0 111.767 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.539 ' OD1' ' HB1' ' A' ' 70' ' ' ALA . 10.3 p-10 -99.4 -23.91 14.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.573 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.02 84.94 0.6 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.866 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 70' ' ' ALA . 3.1 m -178.11 162.74 1.63 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.837 0.351 . . . . 0.0 111.133 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -90.37 110.89 21.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.789 HD11 ' HA ' ' A' ' 70' ' ' ALA . 35.3 mt -84.86 -51.38 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.004 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.565 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 128.3 -153.5 19.54 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.475 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.18 -152.08 19.42 Favored Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.556 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.443 ' HD1' ' HB2' ' A' ' 20' ' ' ALA . 15.7 t80 -63.88 -63.25 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.824 0.345 . . . . 0.0 110.776 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -53.66 -41.82 67.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -56.04 -42.29 76.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.465 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.59 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -63.3 -48.19 79.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.428 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -51.09 -29.15 12.36 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -76.26 -34.14 59.14 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.277 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.423 ' N ' ' O ' ' A' ' 82' ' ' LEU . 7.6 t80 -66.98 -32.57 73.9 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.319 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.59 ' HE2' HD21 ' A' ' 82' ' ' LEU . 6.5 m-85 -90.65 -69.8 0.71 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.072 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.877 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.666 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 48.0 ttm . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -77.92 145.56 36.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.267 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.2 mppp? -108.11 120.68 43.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.528 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.602 HG22 HG22 ' A' ' 68' ' ' VAL . 7.8 t -105.05 131.04 55.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.29 0.567 . . . . 0.0 111.786 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.588 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.9 m-30 -106.59 98.96 8.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.168 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.91 -137.87 2.29 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.811 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.967 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 85.1 m-85 -127.73 157.86 39.21 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 120.776 0.322 . . . . 0.0 111.425 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -88.2 -68.38 0.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.127 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 166.73 -33.15 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.998 0.428 . . . . 0.0 110.899 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -71.54 -42.14 68.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.514 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.543 HG21 ' HG2' ' A' ' 37' ' ' MET . 27.5 mm -89.47 -39.55 12.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.051 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -150.51 154.08 36.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.351 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -76.86 162.71 27.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.58 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.9 t -172.14 108.32 0.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.785 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.0 m -88.81 -36.69 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.077 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -68.64 -19.74 64.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.002 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.9 m -64.36 -55.74 19.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.938 0.399 . . . . 0.0 110.29 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -57.8 -32.77 67.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.161 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -68.43 -58.46 4.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.273 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.87 -42.37 65.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.91 0.386 . . . . 0.0 111.305 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -56.26 -50.95 69.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.751 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.841 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.1 mtt180 -60.54 -40.85 93.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.585 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.802 HD21 ' CD2' ' A' ' 86' ' ' PHE . 2.0 tt -57.36 -51.9 67.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.431 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.662 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.2 mt -59.8 -50.37 74.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.584 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 m -53.27 -38.62 63.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.324 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 22' ' ' ARG . 56.5 t -76.29 -36.64 30.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.599 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.52 ' CD ' ' HB3' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -73.7 -9.89 59.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.041 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.19 59.45 0.33 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.983 0.421 . . . . 0.0 111.006 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -144.88 132.42 10.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.142 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.616 ' O ' ' HA ' ' A' ' 1' ' ' MET . 69.6 Cg_endo -79.42 159.27 25.87 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.482 2.121 . . . . 0.0 110.972 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.442 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 7.9 p90 -161.43 171.38 18.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.86 0.362 . . . . 0.0 111.788 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -134.3 134.87 42.36 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.523 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.494 ' HE1' HG11 ' A' ' 4' ' ' VAL . 6.8 t80 -89.28 156.69 18.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.168 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.588 HD12 ' CE1' ' A' ' 5' ' ' TYR . 18.0 mt -146.03 121.05 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.468 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -85.65 114.93 23.02 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.936 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.967 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 2.1 pt -75.08 -21.05 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.967 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.543 ' HG2' HG21 ' A' ' 11' ' ' ILE . 1.7 tpp -116.35 108.67 45.2 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.809 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' N ' ' A' ' 44' ' ' ASP . 79.8 Cg_endo -76.05 -28.18 7.74 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.648 2.232 . . . . 0.0 112.101 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -139.57 151.66 46.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.623 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -64.64 -8.5 14.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.255 0.55 . . . . 0.0 111.839 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.59 -55.83 2.77 Favored Glycine 0 C--N 1.313 -0.73 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.814 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -149.06 141.99 18.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 2.2 m-85 -59.4 170.29 1.03 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.843 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.427 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 1.4 p30 -88.73 140.58 29.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.031 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -78.4 -11.07 59.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.522 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.35 -62.99 1.18 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.791 0.329 . . . . 0.0 111.261 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -42.88 66.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.961 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.424 ' N ' ' CD1' ' A' ' 48' ' ' ILE . 0.8 OUTLIER -56.64 -39.09 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.744 179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.26 -55.38 6.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -36.12 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.46 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.583 HD11 HD21 ' A' ' 55' ' ' LEU . 20.1 tp -57.08 -51.66 68.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.694 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 52' ' ' LEU . 81.3 mt -52.01 -46.91 65.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.149 0.5 . . . . 0.0 111.317 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.8 m -70.16 -42.41 72.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.594 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -60.29 -40.2 89.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.941 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.583 HD21 HD11 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -60.17 -69.08 0.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.804 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.62 -40.75 0.72 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.2 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -89.78 -174.89 4.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.33 . . . . 0.0 110.709 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -103.26 -30.3 10.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.072 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.4 t -111.19 169.73 8.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.081 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 3.5 mp0 -110.56 99.65 8.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.564 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.4 mt -80.26 87.42 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.558 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.65 29.66 64.47 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.682 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 60' ' ' GLN . 1.3 mm? -47.0 147.41 1.37 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.804 0.335 . . . . 0.0 111.007 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.4 p -121.32 153.49 37.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.079 0.466 . . . . 0.0 111.652 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -122.47 152.8 61.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.518 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -80.92 149.7 77.37 Favored 'Cis proline' 0 C--N 1.344 0.324 0 C-N-CA 124.073 -1.22 . . . . 0.0 112.725 0.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -105.32 119.61 39.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.848 178.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -91.41 161.41 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.362 0.601 . . . . 0.0 112.193 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.432 ' N ' HG12 ' A' ' 68' ' ' VAL . 60.6 m-85 -143.13 140.74 30.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.277 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.629 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.37 147.23 28.97 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.139 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.666 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 15.7 Cg_exo -65.48 -14.45 44.95 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.694 2.262 . . . . 0.0 112.317 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.56 -23.01 13.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.018 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.36 74.61 0.28 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.568 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.64 113.08 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.757 0.313 . . . . 0.0 110.739 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -53.66 120.94 6.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.994 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.629 HD11 ' HA ' ' A' ' 70' ' ' ALA . 15.5 mt -97.41 -45.97 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.768 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 81' ' ' GLN . . . 135.13 -156.23 22.47 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.585 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.28 -138.25 7.22 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.575 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -72.87 -61.16 1.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -55.19 -45.34 75.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.04 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.404 ' CB ' ' HA3' ' A' ' 77' ' ' GLY . 8.4 mp0 -56.01 -48.28 76.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.645 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -64.28 -43.0 96.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.434 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -51.54 -29.88 18.59 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -75.01 -35.17 61.98 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.404 ' N ' ' O ' ' A' ' 82' ' ' LEU . 12.0 t80 -62.9 -35.38 79.87 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.802 ' CD2' HD21 ' A' ' 23' ' ' LEU . 5.3 m-85 -87.64 -70.38 0.63 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.216 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.944 179.942 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.681 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 28.4 ttp . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.85 0.357 . . . . 0.0 111.541 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.461 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 87.7 m-85 -79.19 153.35 30.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.156 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.647 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -131.59 121.44 24.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.888 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.635 HG22 HG22 ' A' ' 68' ' ' VAL . 7.0 t -104.22 124.32 58.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.147 0.498 . . . . 0.0 111.374 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.687 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.3 m-30 -100.09 99.15 9.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.324 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.34 -137.2 2.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.837 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.913 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 6.7 m-85 -123.63 146.39 48.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.372 0.13 . . . . 0.0 110.949 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.81 17.79 7.31 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 0.9 OUTLIER 71.72 2.16 4.17 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.589 0.233 . . . . 0.0 111.617 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -85.19 -53.41 5.27 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.967 0.413 . . . . 0.0 110.654 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.478 HD12 ' O ' ' A' ' 37' ' ' MET . 1.3 mt -111.33 9.5 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.385 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.574 ' CB ' ' CD2' ' A' ' 7' ' ' TYR . 11.1 t-80 -169.82 138.19 1.77 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.139 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.34 22.79 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.011 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 p -175.61 123.78 0.21 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.041 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.4 m -91.1 -37.35 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.58 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -75.52 -18.64 59.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.552 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.4 p -70.45 -36.36 73.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.813 0.34 . . . . 0.0 111.004 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.2 -27.11 62.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.335 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -76.86 -49.49 15.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.062 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.02 -46.55 71.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.267 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -60.31 -52.75 63.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.955 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.777 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -60.37 -38.9 85.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.63 ' C ' HD23 ' A' ' 23' ' ' LEU . 4.5 tt -58.37 -54.02 51.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.636 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.54 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.9 mt -56.15 -46.83 79.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.889 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.7 m -56.58 -36.78 69.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.12 0.486 . . . . 0.0 110.152 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 22' ' ' ARG . 54.3 t -78.15 -27.68 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.727 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -11.37 58.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.245 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.08 61.14 0.5 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.106 0.479 . . . . 0.0 110.716 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -136.69 140.76 32.98 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.183 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.94 131.94 11.41 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.553 2.169 . . . . 0.0 111.592 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.681 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 11.8 p90 -156.31 169.45 24.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.999 0.428 . . . . 0.0 111.957 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -147.12 148.04 31.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.804 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.481 ' HE1' HG11 ' A' ' 4' ' ' VAL . 7.5 t80 -89.42 161.15 16.43 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.393 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.687 HD12 ' CE1' ' A' ' 5' ' ' TYR . 21.9 mt -145.58 119.55 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.308 0.575 . . . . 0.0 110.511 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -81.21 125.34 30.18 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.025 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.913 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 2.7 pt -99.48 -11.97 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.297 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.742 ' HE3' ' HE2' ' A' ' 7' ' ' TYR . 14.5 ttm -117.57 92.2 40.22 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.742 0.306 . . . . 0.0 111.146 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 44' ' ' ASP . 54.5 Cg_endo -69.37 -28.43 27.13 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.562 2.175 . . . . 0.0 111.671 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -139.85 147.42 40.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.032 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -8.54 6.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.213 0.53 . . . . 0.0 111.783 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.16 -56.62 2.99 Favored Glycine 0 C--N 1.313 -0.72 0 CA-C-N 115.278 -0.873 . . . . 0.0 112.704 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.7 t -148.14 146.42 17.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.924 0.392 . . . . 0.0 111.967 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -61.07 166.51 3.53 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.505 179.47 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.455 ' O ' HD12 ' A' ' 48' ' ' ILE . 10.1 p30 -78.41 99.48 6.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.948 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -55.26 -22.75 19.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.554 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -60.28 -53.7 54.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.886 0.374 . . . . 0.0 110.755 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -69.45 -47.26 64.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.667 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.455 HD12 ' O ' ' A' ' 44' ' ' ASP . 1.7 mp -50.11 -37.45 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.716 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.99 -59.74 4.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.06 0.457 . . . . 0.0 110.506 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.69 -34.45 72.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.229 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.469 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -59.64 -52.63 64.7 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.505 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 52' ' ' LEU . 69.5 mt -48.28 -45.07 34.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.264 0.554 . . . . 0.0 110.734 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.7 m -67.15 -35.84 80.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.002 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -64.62 -33.91 77.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.493 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.1 mt -70.53 -50.12 40.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.605 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.08 -163.39 35.4 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.945 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 mtt180 -93.9 31.35 1.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.946 0.403 . . . . 0.0 110.921 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -121.15 -153.46 0.55 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.275 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -120.97 170.38 9.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.734 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.757 ' HB2' HD12 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -78.46 98.48 6.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.357 0.599 . . . . 0.0 110.028 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.1 mm -73.08 82.28 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.514 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 50.16 25.95 8.53 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.718 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.867 ' O ' HD13 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -55.39 156.96 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 111.157 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.713 ' N ' HD22 ' A' ' 63' ' ' LEU . 37.2 p -139.58 163.59 32.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -98.93 158.62 32.02 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.862 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.1 Cg_exo -83.88 140.79 36.82 Favored 'Cis proline' 0 C--N 1.345 0.348 0 C-N-CA 124.151 -1.187 . . . . 0.0 112.759 0.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . 15.0 mm-40 -105.39 114.05 28.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.046 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.7 t -86.93 163.64 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.264 0.554 . . . . 0.0 112.087 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.452 ' N ' HG12 ' A' ' 68' ' ' VAL . 20.3 m-85 -142.96 132.66 23.87 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.278 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -71.38 146.34 91.73 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.262 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.589 ' HB3' ' N ' ' A' ' 1' ' ' MET . 54.7 Cg_exo -42.15 -52.36 4.2 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.372 2.715 . . . . 0.0 113.008 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.42 -27.84 66.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.203 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.46 73.26 0.64 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.363 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.14 143.2 18.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 111.044 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -70.22 110.82 5.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.764 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 70' ' ' ALA . 19.9 mt -83.4 -49.21 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.144 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.18 -153.47 20.77 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.268 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.83 -143.35 8.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.33 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -73.07 -67.17 0.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 0.0 110.755 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -53.08 -38.74 62.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.874 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -60.37 -39.41 87.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.49 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.612 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -69.65 -45.02 69.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.35 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -51.32 -31.43 21.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.48 -35.78 65.72 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.164 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.51 ' CD2' HG23 ' A' ' 76' ' ' ILE . 12.3 t80 -63.85 -33.66 76.19 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.275 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.612 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.2 m-85 -87.97 -70.34 0.64 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.132 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.931 -179.938 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.633 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 64.3 ttp . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 120.878 0.37 . . . . 0.0 111.672 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.505 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 80.2 m-85 -60.37 153.43 22.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.646 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -129.66 122.68 29.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.458 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.695 HG22 HG22 ' A' ' 68' ' ' VAL . 10.0 t -105.37 136.79 37.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.09 0.471 . . . . 0.0 111.614 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.771 ' CE1' HD12 ' A' ' 34' ' ' ILE . 5.2 m-85 -115.42 99.62 7.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.189 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.48 -135.51 1.93 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.554 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.533 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 75.5 m-85 -120.16 146.66 45.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.948 0.404 . . . . 0.0 111.665 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -94.58 139.7 30.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.465 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.5 p -51.79 -24.71 6.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.563 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -73.16 -43.32 61.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.547 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.553 HG21 ' HG2' ' A' ' 37' ' ' MET . 9.3 mm -89.8 -43.95 14.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.785 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 78.8 t60 -144.68 158.32 43.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.744 0.307 . . . . 0.0 111.131 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.2 mmmt -80.0 161.38 25.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.174 0.512 . . . . 0.0 111.614 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.2 p -167.92 113.7 0.69 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.358 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 m -90.46 -28.75 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.422 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -85.57 -17.27 36.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.129 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.5 p -67.25 -39.84 86.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.038 0.447 . . . . 0.0 110.153 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.4 -26.68 68.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.049 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -69.47 -55.58 9.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.123 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.8 -44.16 66.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.977 0.417 . . . . 0.0 111.133 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -60.32 -52.57 64.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.879 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.8 ttt85 -56.64 -37.99 71.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.762 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -58.55 -52.58 65.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.548 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.762 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.8 mt -57.51 -47.19 82.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.875 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.1 m -56.13 -33.39 65.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.029 0.442 . . . . 0.0 110.375 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 22' ' ' ARG . 45.3 t -78.36 -30.42 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.794 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm -82.13 -10.85 59.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.226 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? 68.39 60.99 0.38 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.914 0.388 . . . . 0.0 110.739 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.406 ' OE1' ' HD2' ' A' ' 30' ' ' PRO . 8.1 mm100 -141.42 139.63 19.2 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.07 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.45 ' O ' ' HA ' ' A' ' 1' ' ' MET . 77.9 Cg_endo -80.28 139.89 13.45 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.52 2.146 . . . . 0.0 111.231 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.633 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 51.3 p90 -153.22 170.56 20.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -141.81 142.12 33.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.956 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.596 ' CE1' HG11 ' A' ' 4' ' ' VAL . 38.2 t80 -89.83 158.58 17.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.236 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.771 HD12 ' CE1' ' A' ' 5' ' ' TYR . 7.8 mt -147.18 120.29 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.128 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.0 p-10 -99.63 127.31 45.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.671 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.9 pt -80.97 -8.61 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.238 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.588 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 8.2 ttp -125.98 95.3 39.83 Favored Pre-proline 0 N--CA 1.456 -0.133 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.146 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.38 1.33 9.35 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.746 2.297 . . . . 0.0 112.568 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -139.71 135.62 33.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.604 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.7 mtpt -62.79 -9.24 8.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.175 0.512 . . . . 0.0 112.183 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -83.99 -63.74 1.65 Allowed Glycine 0 C--N 1.311 -0.841 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.917 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.1 t -146.83 151.89 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.692 0.282 . . . . 0.0 110.993 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.588 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -68.0 167.03 14.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 111.109 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.4 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -100.26 114.87 28.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.018 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -58.11 -18.2 23.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.471 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -57.82 -54.94 41.22 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.857 0.361 . . . . 0.0 110.696 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -70.59 -37.41 73.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.208 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 44' ' ' ASP . 36.6 mm -55.31 -46.79 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.895 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.7 -53.37 58.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.693 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -57.4 -40.68 78.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.338 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.75 HD13 ' CD2' ' A' ' 5' ' ' TYR . 9.3 tp -55.37 -48.67 73.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.653 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.1 mt -54.18 -49.42 69.38 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.06 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.3 m -61.94 -33.92 75.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.215 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' HG3' ' CE1' ' A' ' 69' ' ' PHE . 27.6 tptt -67.44 -29.65 69.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.631 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.707 HD11 HD12 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -71.93 -26.49 62.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.109 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.49 32.57 15.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.396 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.5 mtt-85 -150.06 -168.86 3.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 0.0 110.827 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -110.78 -50.11 2.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.032 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -102.95 165.44 11.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -95.38 98.74 10.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.122 0.487 . . . . 0.0 110.503 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.8 mt -80.33 85.53 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.275 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.48 27.05 73.53 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.455 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.707 HD12 HD11 ' A' ' 55' ' ' LEU . 7.5 tt -55.42 150.57 11.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.895 0.379 . . . . 0.0 111.191 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.0 p -148.5 164.81 33.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.405 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -119.19 146.37 40.48 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.573 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -84.63 150.71 57.05 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.993 -1.253 . . . . 0.0 112.828 0.368 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' TYR . 1.3 tp60 -109.44 117.9 35.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.221 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -92.83 166.73 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.829 0.347 . . . . 0.0 111.59 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.51 ' H ' HG12 ' A' ' 68' ' ' VAL . 73.5 m-85 -142.49 140.17 31.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.028 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.445 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -52.82 150.07 10.46 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.278 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.494 ' HB3' ' N ' ' A' ' 1' ' ' MET . 42.8 Cg_exo -58.96 -30.71 93.99 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.097 2.531 . . . . 0.0 112.026 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -91.48 -23.72 19.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.245 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.62 90.27 0.8 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.653 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 15.9 t -171.63 158.98 5.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.761 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.426 ' NE2' ' CG ' ' A' ' 67' ' ' GLN . 17.7 t-160 -88.64 110.07 20.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.985 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.445 HD11 ' HA ' ' A' ' 70' ' ' ALA . 10.8 mt -85.05 -50.84 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.093 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.85 -154.77 19.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.563 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.01 -145.75 7.74 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.669 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -71.28 -70.03 0.34 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.742 0.306 . . . . 0.0 110.892 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -53.99 -46.1 71.61 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.969 0.414 . . . . 0.0 110.562 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -34.43 63.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.114 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 85' ' ' TYR . 2.7 tt -74.79 -39.63 61.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.012 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 87' ' ' LYS . 24.2 ttp180 -51.77 -29.08 17.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -71.63 -33.42 68.93 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.392 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.453 ' N ' ' O ' ' A' ' 82' ' ' LEU . 9.0 t80 -66.62 -31.64 72.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.588 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.486 ' CD2' HD21 ' A' ' 23' ' ' LEU . 25.1 m-85 -95.62 -70.37 0.72 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.498 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 83' ' ' ARG . 15.2 mtmt . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.954 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.616 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 4.6 ttm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -80.4 149.15 30.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.187 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -109.87 117.14 33.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.413 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.472 HG11 ' HE1' ' A' ' 33' ' ' PHE . 8.1 t -102.16 125.21 56.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.242 0.544 . . . . 0.0 111.347 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.688 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.3 m-30 -101.95 99.09 9.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.402 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.94 -137.12 2.12 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.287 -0.959 . . . . 0.0 112.647 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.454 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 87.5 m-85 -126.02 147.25 49.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.736 0.303 . . . . 0.0 110.932 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -101.92 21.39 14.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.415 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.2 t 66.83 9.14 6.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.567 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -85.55 -46.43 10.83 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.868 0.366 . . . . 0.0 110.667 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.794 HG21 ' O ' ' A' ' 39' ' ' GLU . 1.3 mp -109.33 -33.36 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.974 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.454 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 20.4 t60 -139.35 152.4 47.13 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.653 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.36 173.16 12.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.481 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.5 p -175.04 119.0 0.19 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.774 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 m -90.34 -26.33 5.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.307 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -86.72 -16.47 36.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.413 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.3 p -72.54 -41.66 65.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.934 0.397 . . . . 0.0 110.644 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -66.75 -33.23 75.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 86.5 m-20 -73.54 -52.78 12.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.506 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.76 -42.42 68.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.382 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -60.61 -52.36 65.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.766 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.809 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.8 ttt180 -58.44 -34.54 70.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.747 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.734 ' CD2' HD23 ' A' ' 24' ' ' LEU . 1.6 tt -59.46 -56.63 19.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.327 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.734 HD23 ' CD2' ' A' ' 23' ' ' LEU . 46.5 mt -61.47 -40.25 93.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.711 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.2 m -60.71 -35.5 76.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.155 0.503 . . . . 0.0 109.7 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 22' ' ' ARG . 91.9 t -80.09 -33.11 14.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.467 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 9.3 mmtt -72.23 -10.19 59.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.211 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER 68.99 40.87 1.54 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.881 0.372 . . . . 0.0 111.125 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.93 136.64 29.31 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.432 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.585 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.1 Cg_endo -78.84 155.77 26.94 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.543 2.162 . . . . 0.0 111.867 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.4 ' HA ' ' HG2' ' A' ' 1' ' ' MET . 11.7 p90 -161.35 170.84 19.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.802 0.334 . . . . 0.0 111.338 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -132.51 137.36 47.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.625 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.472 ' HE1' HG11 ' A' ' 4' ' ' VAL . 6.1 t80 -89.22 158.35 17.91 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.296 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.688 HD12 ' CE1' ' A' ' 5' ' ' TYR . 20.4 mt -147.27 122.56 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.468 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -92.4 126.02 37.3 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.985 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.518 ' HB ' HD11 ' A' ' 48' ' ' ILE . 41.5 pt -92.11 -6.31 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.448 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.3 tpp -127.63 82.59 68.02 Favored Pre-proline 0 N--CA 1.454 -0.271 0 CA-C-O 120.76 0.314 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 97.2 Cg_endo -89.86 27.34 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.047 2.498 . . . . 0.0 112.648 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.794 ' O ' HG21 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -139.32 165.25 27.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.382 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -58.79 -8.0 1.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 169.77 47.59 0.03 OUTLIER Glycine 0 C--N 1.312 -0.791 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.848 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.9 t -150.59 127.2 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.959 0.409 . . . . 0.0 111.397 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -63.22 168.74 4.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.645 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.433 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 7.5 t70 -98.93 106.69 18.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.914 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -60.99 -23.95 65.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.542 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.6 -59.22 3.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.684 0.278 . . . . 0.0 111.287 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -67.3 -45.14 77.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 110.885 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.518 HD11 ' HB ' ' A' ' 36' ' ' ILE . 1.5 mp -57.06 -29.42 31.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.814 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.65 -61.78 1.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.956 0.408 . . . . 0.0 110.887 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -59.61 -32.42 70.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.31 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -59.72 -53.03 62.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.341 179.49 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 52' ' ' LEU . 69.2 mt -47.72 -44.99 28.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.356 0.598 . . . . 0.0 110.628 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.8 m -70.15 -35.67 74.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.83 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' HG2' ' CE1' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -62.65 -29.34 70.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.61 179.401 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -74.33 -65.82 0.8 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.009 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.89 -29.18 0.26 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.511 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.25 -167.6 1.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.883 0.373 . . . . 0.0 110.806 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.428 ' O ' HD22 ' A' ' 52' ' ' LEU . 1.5 p30 -98.35 -29.88 12.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.944 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -94.5 162.69 13.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.968 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -102.37 99.25 9.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.0 110.611 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pt -79.16 84.3 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.342 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.77 23.3 76.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.621 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.695 HD13 ' N ' ' A' ' 64' ' ' THR . 2.6 tm? -61.29 131.11 49.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.309 . . . . 0.0 110.682 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.695 ' N ' HD13 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -130.89 170.01 15.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.079 0.466 . . . . 0.0 111.348 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -118.87 150.21 48.1 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.649 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.3 Cg_endo -83.29 139.04 34.89 Favored 'Cis proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.923 -1.282 . . . . 0.0 112.559 0.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -101.7 118.69 37.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.875 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.6 t -90.75 159.76 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.417 0.627 . . . . 0.0 112.499 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.504 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 30.7 m-85 -143.36 145.98 33.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.255 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.738 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -61.17 156.68 48.19 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.25 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.616 ' HB3' ' N ' ' A' ' 1' ' ' MET . 3.0 Cg_exo -73.87 -5.37 16.92 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.97 2.447 . . . . 0.0 112.425 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.19 -8.15 11.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.208 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.2 89.6 1.86 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.55 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.2 m -179.23 156.53 0.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.83 0.348 . . . . 0.0 110.925 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -90.2 120.81 31.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.738 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.2 mp -102.11 -36.04 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.625 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 122.5 -161.78 16.55 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.714 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.9 -134.75 6.97 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.619 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 19' ' ' ASN . 10.9 t80 -74.36 -70.2 0.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 111.017 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -55.95 -48.63 75.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.936 0.398 . . . . 0.0 110.557 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.25 -38.98 66.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.601 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.511 HD21 ' CE2' ' A' ' 86' ' ' PHE . 3.8 tt -74.8 -38.3 62.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.077 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 87' ' ' LYS . 8.0 ttt85 -51.34 -29.27 14.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -71.91 -34.3 68.99 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.409 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.444 ' N ' ' O ' ' A' ' 82' ' ' LEU . 18.8 t80 -67.01 -30.68 70.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.483 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.511 ' CE2' HD21 ' A' ' 82' ' ' LEU . 30.3 m-85 -96.33 -16.6 21.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.563 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 83' ' ' ARG . 11.8 mtmm . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.98 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.64 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 40.0 ttp . . . . . 0 N--CA 1.488 1.425 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -76.14 147.35 38.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.319 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 3.7 mptt -107.85 119.35 39.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.405 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.664 HG11 ' CE2' ' A' ' 33' ' ' PHE . 38.4 t -109.26 133.58 53.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.403 0.621 . . . . 0.0 112.104 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.588 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 19.7 m-85 -113.73 99.16 7.5 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.592 177.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.63 -127.18 1.16 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.149 -1.024 . . . . 0.0 112.946 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.424 ' CD2' ' CD2' ' A' ' 12' ' ' HIS . 28.3 m-85 -137.15 108.31 6.79 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 120.901 0.382 . . . . 0.0 111.926 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.454 ' HB2' ' CE1' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -105.08 -27.25 11.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.257 179.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.636 ' HB3' HG23 ' A' ' 11' ' ' ILE . 21.1 m -60.49 163.7 5.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.54 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.02 3.86 44.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.64 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.912 HD11 ' HG3' ' A' ' 37' ' ' MET . 0.1 OUTLIER -88.55 -17.49 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.424 ' CD2' ' CD2' ' A' ' 7' ' ' TYR . 1.9 t60 -140.96 141.13 34.49 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.503 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.29 177.27 9.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.839 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 p -175.95 111.65 0.11 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.035 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 m -90.64 -34.23 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.576 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-30 -82.71 -16.45 48.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.381 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.9 p -63.04 -37.36 86.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.07 0.462 . . . . 0.0 110.262 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.87 -27.01 63.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.316 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -74.1 -54.68 7.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.375 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.24 -45.28 72.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.304 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.65 -52.81 63.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.761 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.825 ' O ' HG23 ' A' ' 26' ' ' VAL . 37.7 ttp180 -58.67 -42.64 88.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.461 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.688 HD23 ' N ' ' A' ' 24' ' ' LEU . 2.2 tt -58.89 -54.73 43.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.179 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.688 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.9 mt -56.7 -48.16 78.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.72 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.4 m -55.91 -39.87 72.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.146 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 22' ' ' ARG . 59.9 t -75.97 -32.47 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.593 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -73.76 -9.36 58.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.073 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 68.69 42.57 1.43 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.051 0.453 . . . . 0.0 110.63 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -127.97 132.5 24.38 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.902 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.633 ' O ' ' HA ' ' A' ' 1' ' ' MET . 64.2 Cg_endo -79.92 154.17 22.76 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.479 2.119 . . . . 0.0 111.217 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 5.5 p90 -161.51 171.26 18.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.717 0.294 . . . . 0.0 111.446 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -137.35 121.7 18.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.899 0.38 . . . . 0.0 110.759 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.664 ' CE2' HG11 ' A' ' 4' ' ' VAL . 35.1 t80 -89.32 157.9 18.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.44 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.636 HG21 ' HG2' ' A' ' 47' ' ' LYS . 21.8 mt -143.95 120.38 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.27 0.557 . . . . 0.0 111.038 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -83.99 109.27 17.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.08 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.612 HG22 ' HB2' ' A' ' 47' ' ' LYS . 11.6 pt -97.72 66.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.05 0.453 . . . . 0.0 111.605 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.912 ' HG3' HD11 ' A' ' 11' ' ' ILE . 22.0 tpp -160.73 73.4 2.79 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.413 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.97 -22.61 69.74 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.128 1.885 . . . . 0.0 110.859 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -151.2 152.77 33.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.052 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.617 ' HG3' HD12 ' A' ' 11' ' ' ILE . 14.3 mttt -64.1 -7.54 9.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.344 0.592 . . . . 0.0 111.622 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.79 -55.42 3.36 Favored Glycine 0 C--N 1.311 -0.827 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.953 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -149.19 147.13 16.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 12.3 m-85 -59.74 170.45 1.11 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.088 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -77.89 108.4 11.12 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.687 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.03 -24.25 23.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.723 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.65 -56.36 14.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.817 0.341 . . . . 0.0 111.323 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.636 ' HG2' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -66.58 -34.37 77.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.157 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.85 -31.38 30.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.552 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.64 -55.01 39.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.962 0.41 . . . . 0.0 110.287 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.14 -33.31 75.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.045 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.588 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.1 tt -59.11 -51.69 68.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.284 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.411 HD21 ' CG ' ' A' ' 60' ' ' GLN . 84.1 mt -52.68 -44.51 66.27 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.999 0.428 . . . . 0.0 111.381 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.6 m -57.9 -48.79 78.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.576 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -58.78 -38.77 79.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.618 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.9 -56.04 26.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.722 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.93 -115.6 0.58 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.097 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.6 ttp-105 -150.33 31.03 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 110.662 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -121.07 -143.72 0.35 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.321 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 t -120.02 170.29 9.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.692 0.282 . . . . 0.0 110.671 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.411 ' CG ' HD21 ' A' ' 52' ' ' LEU . 3.4 mm100 -77.83 98.34 5.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.271 0.558 . . . . 0.0 110.649 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mp -80.13 84.32 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.115 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.1 25.45 66.3 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.449 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.694 HD11 ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -52.81 134.63 36.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.9 0.381 . . . . 0.0 110.893 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.516 ' H ' HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -117.54 164.1 15.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.101 0.477 . . . . 0.0 111.419 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.07 154.74 47.18 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.66 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.506 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.3 Cg_endo -87.54 136.82 16.61 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.116 -1.202 . . . . 0.0 112.679 0.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.694 ' NE2' HD11 ' A' ' 63' ' ' LEU . 4.0 tp60 -90.01 142.79 27.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.927 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -115.97 158.06 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.077 0.465 . . . . 0.0 111.56 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.456 ' CE2' ' HB2' ' A' ' 75' ' ' HIS . 46.6 m-85 -142.83 138.66 30.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.146 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.659 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -50.92 133.36 29.21 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.409 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.64 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 33.4 Cg_exo -52.92 -21.96 16.97 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.555 2.17 . . . . 0.0 111.948 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.23 39.79 0.1 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.19 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.4 -110.16 0.8 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.957 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.461 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -137.07 -172.4 3.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.168 0.509 . . . . 0.0 111.321 -179.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.456 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 24.4 t-80 -65.18 126.1 27.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.068 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.659 HD11 ' HA ' ' A' ' 70' ' ' ALA . 14.6 mt -95.91 -45.26 13.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.784 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.569 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 134.02 -155.32 21.77 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.521 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.77 -142.07 9.1 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.572 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -70.56 -68.76 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.778 0.323 . . . . 0.0 110.943 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -54.74 -46.46 74.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.838 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -54.41 -36.26 63.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.627 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.723 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.9 OUTLIER -75.27 -38.93 60.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.28 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -51.93 -29.63 21.05 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -71.25 -35.47 71.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.154 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 82' ' ' LEU . 20.7 t80 -63.46 -33.63 75.98 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.275 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.723 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.5 m-85 -87.15 -69.53 0.68 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.122 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.684 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 16.1 ttm . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.782 0.325 . . . . 0.0 111.682 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.477 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 91.8 m-85 -85.62 142.38 29.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.991 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.644 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -117.04 127.69 54.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.909 -179.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.722 HG11 ' CE1' ' A' ' 33' ' ' PHE . 15.7 t -110.76 133.81 55.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.391 0.615 . . . . 0.0 111.559 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.537 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 21.6 m-30 -116.39 99.86 7.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.368 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.544 ' N ' HG23 ' A' ' 36' ' ' ILE . . . -161.8 -139.13 2.57 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.771 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.727 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 45.4 m-85 -123.71 156.22 36.37 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 120.889 0.376 . . . . 0.0 111.364 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -74.38 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 t 173.62 -36.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.734 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -85.11 -20.7 29.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.533 HD12 ' N ' ' A' ' 11' ' ' ILE . 4.2 mp -89.28 -38.22 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.004 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -150.29 151.6 33.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.464 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 14' ' ' CYS . 13.7 tptt -75.74 157.33 33.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.18 0.514 . . . . 0.0 112.177 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 28.3 p 177.43 113.15 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.545 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.447 ' CG2' ' N ' ' A' ' 16' ' ' TYR . 1.3 m -90.88 -39.11 11.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.899 0.857 . . . . 0.0 110.026 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.569 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -77.97 -10.74 59.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.698 -179.212 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 14' ' ' CYS . 20.5 p -73.76 -41.72 62.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.047 0.451 . . . . 0.0 110.045 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.53 -34.09 71.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.747 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -65.06 -46.74 79.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.97 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.79 -50.39 72.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.962 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.0 ttpt -53.16 -44.09 67.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.841 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.768 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -60.47 -40.89 92.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.801 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -57.78 -53.1 61.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.564 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.801 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.0 mt -56.52 -47.5 79.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.85 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.2 m -55.18 -36.51 65.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.136 0.493 . . . . 0.0 110.091 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.4 t -78.14 -28.14 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.675 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.7 -21.25 44.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.927 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt 71.65 63.52 0.15 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.962 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -132.02 142.31 44.65 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.053 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.65 124.49 8.24 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.477 2.118 . . . . 0.0 111.266 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.684 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 6.3 p90 -157.17 164.56 37.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.046 0.451 . . . . 0.0 112.168 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.66 144.03 31.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.993 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.722 ' CE1' HG11 ' A' ' 4' ' ' VAL . 17.9 t80 -89.2 152.76 21.41 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.004 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.9 mt -143.92 119.62 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.358 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -72.94 109.93 6.86 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.776 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.727 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 1.2 pp -69.79 -24.8 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.618 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 5.8 ttp -126.69 91.44 47.3 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.111 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.71 0.61 9.9 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.57 2.18 . . . . 0.0 112.231 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -139.65 138.45 36.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.652 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -66.28 -8.71 26.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.246 0.546 . . . . 0.0 111.852 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.13 -63.75 1.64 Allowed Glycine 0 C--N 1.311 -0.815 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.098 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -150.28 139.42 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.617 0.246 . . . . 0.0 111.118 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.6 OUTLIER -58.79 169.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.932 0.396 . . . . 0.0 111.353 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.406 ' O ' ' CD1' ' A' ' 48' ' ' ILE . 1.2 t0 -80.07 105.86 11.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.302 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 6.1 t70 -59.88 -17.63 38.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.815 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.33 -61.22 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 111.212 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.55 -36.21 83.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.054 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.406 ' CD1' ' O ' ' A' ' 44' ' ' ASP . 1.9 mp -70.48 -29.85 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.409 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -61.7 -54.69 39.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.435 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.54 -34.51 74.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.134 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.537 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 2.9 tt -55.84 -51.13 68.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.264 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.6 mt -54.03 -47.24 71.75 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.331 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.1 m -62.54 -45.16 94.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.612 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -56.56 -40.73 75.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.587 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 mt -59.96 -47.88 83.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.572 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.49 -112.48 0.49 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.196 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.34 33.64 0.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.055 0.455 . . . . 0.0 110.433 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -120.92 -146.88 0.38 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.9 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.3 t -120.26 172.99 7.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.741 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.28 98.61 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.494 0.664 . . . . 0.0 109.755 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.5 mt -75.08 78.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.875 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 42.59 26.88 0.45 Allowed Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.007 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.2 139.88 46.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.873 0.368 . . . . 0.0 111.022 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.5 p -106.42 170.7 7.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.398 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.663 ' CE ' HD13 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -108.15 156.29 38.64 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.896 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.8 Cg_exo -84.08 143.2 42.08 Favored 'Cis proline' 0 C--N 1.346 0.4 0 C-N-CA 124.258 -1.142 . . . . 0.0 113.064 0.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -96.33 132.29 41.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.565 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -102.5 162.51 3.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.441 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.43 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 19.5 m-85 -142.25 130.88 22.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.7 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.552 ' N ' HD11 ' A' ' 76' ' ' ILE . . . -65.76 147.46 98.72 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.385 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.562 ' HB3' ' N ' ' A' ' 1' ' ' MET . 74.6 Cg_exo -45.44 -38.72 16.13 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.292 2.662 . . . . 0.0 112.615 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.66 -38.84 70.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.158 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.83 78.53 0.31 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.505 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.3 m -164.05 148.3 10.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.73 0.3 . . . . 0.0 110.878 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -75.94 106.97 7.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.552 HD11 ' N ' ' A' ' 70' ' ' ALA . 4.7 mt -74.8 -50.46 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.191 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 131.59 -153.06 20.27 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.799 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.06 -136.34 8.75 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.772 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.484 ' HB2' ' CE1' ' A' ' 16' ' ' TYR . 46.3 t80 -72.05 -70.76 0.31 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.755 0.312 . . . . 0.0 111.13 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -57.43 -40.97 79.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.979 0.418 . . . . 0.0 110.722 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -58.58 -38.46 77.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.831 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.716 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -75.37 -41.63 55.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.368 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.23 -30.34 17.17 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -70.9 -36.22 72.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.253 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.503 ' CD2' HG23 ' A' ' 76' ' ' ILE . 11.4 t80 -63.99 -33.29 75.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.216 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.716 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.6 m-85 -89.58 -13.21 37.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.257 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 68.0 mttt . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.796 179.918 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.646 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 22.9 ttm . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.816 0.341 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.496 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 77.0 m-85 -76.66 158.73 30.82 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.635 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -138.86 120.6 15.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.786 -179.408 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.8 HG22 HG22 ' A' ' 68' ' ' VAL . 7.8 t -104.79 133.02 50.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.294 0.569 . . . . 0.0 111.681 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.679 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.3 m-85 -109.33 99.21 8.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.139 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.53 -137.34 2.19 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.878 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.755 ' HE1' ' HE2' ' A' ' 37' ' ' MET . 88.6 m-85 -115.8 160.13 20.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 111.888 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -83.47 -73.0 0.43 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.606 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 p 171.79 -38.75 0.0 OUTLIER 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.963 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -85.82 -19.66 30.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.726 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 mt -95.19 -38.79 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.606 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 2.7 t-80 -150.9 174.08 13.52 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -79.65 157.68 27.2 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.949 -0.469 . . . . 0.0 111.75 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -165.97 87.35 0.37 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.3 m -90.5 -41.93 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.757 0.313 . . . . 0.0 111.165 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -77.64 -15.67 59.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.638 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.7 m -70.56 -50.63 35.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.106 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -55.99 -30.66 62.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 111.07 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -70.71 -50.67 33.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.026 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.6 -46.88 80.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.107 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.8 tttt -59.9 -53.42 58.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.74 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.798 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -59.32 -35.45 73.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.567 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.717 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.3 tt -58.3 -53.31 59.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.41 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.717 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.7 mt -55.77 -45.71 78.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.69 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.38 -35.26 67.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.17 0.509 . . . . 0.0 110.094 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 22' ' ' ARG . 42.1 t -78.05 -30.59 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.558 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -19.35 50.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.948 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 73.81 63.75 0.09 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.932 0.396 . . . . 0.0 110.904 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -142.27 139.27 17.53 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.11 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 1' ' ' MET . 80.9 Cg_endo -74.6 136.11 20.83 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.423 2.082 . . . . 0.0 111.616 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.646 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 21.3 p90 -158.3 170.66 21.75 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -146.05 147.09 31.25 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.968 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.464 ' HE1' HG11 ' A' ' 4' ' ' VAL . 13.6 t80 -89.53 158.56 17.61 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.166 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.679 HD12 ' CE1' ' A' ' 5' ' ' TYR . 19.8 mt -147.25 121.65 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.456 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -91.79 122.81 34.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.069 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 pp -89.0 -23.24 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.755 ' HE2' ' HE1' ' A' ' 7' ' ' TYR . 2.5 ttp -119.25 92.99 46.51 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.306 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.4 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 72.6 Cg_endo -76.12 0.52 9.27 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.745 2.297 . . . . 0.0 113.295 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -139.11 140.85 38.08 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -9.2 12.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.232 0.539 . . . . 0.0 111.645 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.95 -67.0 0.9 Allowed Glycine 0 C--N 1.315 -0.625 0 CA-C-N 115.272 -0.876 . . . . 0.0 113.147 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.1 t -128.73 138.47 54.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.642 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -72.57 170.51 14.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.501 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.4 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 2.5 t70 -87.86 115.32 25.23 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.147 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.78 ' HA ' HD12 ' A' ' 48' ' ' ILE . 16.3 p30 -66.92 -18.89 65.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.605 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -58.58 -55.08 39.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.923 0.392 . . . . 0.0 110.702 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 mmtm -69.35 -39.06 78.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.144 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.78 HD12 ' HA ' ' A' ' 45' ' ' ASP . 66.7 mt -54.12 -44.88 65.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.87 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.66 -55.17 36.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.54 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.72 -38.5 81.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.218 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.479 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -59.57 -50.62 73.19 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.477 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 58' ' ' ASP . 72.7 mt -47.78 -43.11 27.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.299 0.571 . . . . 0.0 110.701 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.1 m -68.55 -35.78 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.827 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.434 ' HE3' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -65.86 -30.6 71.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.428 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.694 ' CD1' HD21 ' A' ' 63' ' ' LEU . 1.1 mt -75.98 -48.47 21.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.658 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.25 -39.95 1.59 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.111 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -97.26 169.11 10.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 110.823 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.467 ' O ' HD13 ' A' ' 52' ' ' LEU . 70.4 m-20 -94.05 -25.87 17.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.763 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.9 t -98.72 161.24 13.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.75 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -110.48 99.83 8.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.805 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.6 mt -79.62 84.61 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.148 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 64' ' ' THR . . . 60.78 25.8 64.21 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.51 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.752 HD11 ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -54.17 126.65 23.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.866 0.365 . . . . 0.0 110.857 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 62' ' ' GLY . 59.6 p -128.67 170.38 13.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.161 0.505 . . . . 0.0 111.59 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.56 157.15 38.25 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.625 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.2 Cg_endo -86.67 149.78 40.72 Favored 'Cis proline' 0 C--N 1.346 0.395 0 C-N-CA 124.384 -1.09 . . . . 0.0 112.94 0.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.752 ' NE2' HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -119.27 115.59 24.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.98 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.8 HG22 HG22 ' A' ' 4' ' ' VAL . 2.9 t -91.59 165.92 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.219 0.533 . . . . 0.0 112.24 -178.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.5 ' H ' HG12 ' A' ' 68' ' ' VAL . 34.5 m-85 -142.29 133.51 26.2 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.155 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.695 ' HB3' ' H ' ' A' ' 74' ' ' SER . . . -72.24 138.02 81.51 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.603 ' HB3' ' N ' ' A' ' 1' ' ' MET . 21.2 Cg_exo -34.61 -56.14 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.799 2.999 . . . . 0.0 113.195 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -140.38 29.35 1.99 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.615 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.13 -87.93 1.85 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.549 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.695 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 1.0 OUTLIER -177.45 175.47 1.43 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.893 0.378 . . . . 0.0 110.571 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.413 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 20.0 t-80 -49.95 109.18 0.26 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.687 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.559 HD11 ' HA ' ' A' ' 70' ' ' ALA . 14.3 mt -73.86 -48.77 37.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.493 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 128.7 -154.29 20.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.598 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.52 -149.66 7.17 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.604 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -72.04 -53.97 11.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.78 0.324 . . . . 0.0 110.769 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -54.78 -44.39 73.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.846 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -58.67 -45.59 89.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.67 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.639 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -61.85 -49.47 76.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.595 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -51.11 -30.71 16.98 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -75.37 -34.5 61.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.177 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.422 ' N ' ' O ' ' A' ' 82' ' ' LEU . 6.3 t80 -65.45 -32.97 74.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.278 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.639 ' HE2' HD21 ' A' ' 82' ' ' LEU . 9.4 m-85 -91.85 -24.27 19.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.348 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.9 pttt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.317 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.679 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 4.5 tpp . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -77.53 143.92 38.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.879 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -105.59 121.97 45.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 -179.159 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.814 HG22 HG22 ' A' ' 68' ' ' VAL . 53.9 t -111.66 140.94 28.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.348 0.594 . . . . 0.0 111.934 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.844 ' CE1' HD12 ' A' ' 34' ' ' ILE . 4.9 m-85 -119.88 99.62 6.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.453 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.8 -140.18 2.87 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.124 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.826 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 30.0 m-85 -126.06 159.93 31.47 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.626 -0.287 . . . . 0.0 111.228 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.406 ' O ' ' CB ' ' A' ' 9' ' ' SER . 11.3 t70 -69.87 -67.41 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.527 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.7 OUTLIER 166.36 -39.35 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.129 179.641 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -85.55 -17.93 34.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.174 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.684 HD12 ' N ' ' A' ' 11' ' ' ILE . 2.6 mp -89.11 -42.51 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.042 0.449 . . . . 0.0 109.799 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.412 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 5.3 t60 -149.52 158.17 43.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.201 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.37 146.65 2.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.831 0.348 . . . . 0.0 111.454 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -175.15 65.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.274 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.6 m -90.57 -48.12 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -76.87 -11.35 59.81 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.465 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 27.4 p -73.95 -45.04 52.79 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -55.31 -24.86 31.0 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.477 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 10.2 m-80 -73.3 -45.79 53.43 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.989 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.42 ' HB2' ' CD1' ' A' ' 79' ' ' PHE . . . -60.91 -29.69 69.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.335 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? -70.35 -62.45 1.38 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.808 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.706 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.6 OUTLIER -54.24 -30.29 49.73 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.93 0.395 . . . . 0.0 110.379 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.743 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.4 tt -58.16 -54.26 48.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.817 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.743 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.0 mt -54.44 -45.41 73.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.455 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 m -54.79 -36.28 64.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.655 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 22' ' ' ARG . 44.3 t -79.67 -32.28 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.308 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.601 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -73.19 -11.95 60.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.834 179.516 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.37 45.52 0.1 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.948 0.404 . . . . 0.0 110.95 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -144.04 134.04 11.85 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.338 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.596 ' O ' ' HA ' ' A' ' 1' ' ' MET . 64.5 Cg_endo -81.54 166.19 17.87 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.611 2.207 . . . . 0.0 111.308 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.552 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 8.4 p90 -161.49 171.08 18.75 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.89 0.329 . . . . 0.0 111.89 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.72 136.64 39.16 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.806 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.512 ' HE1' HG11 ' A' ' 4' ' ' VAL . 6.0 t80 -89.22 160.77 16.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.502 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.844 HD12 ' CE1' ' A' ' 5' ' ' TYR . 20.3 mt -144.52 119.41 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.259 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -83.09 121.89 27.63 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.481 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.826 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 1.3 pt -98.1 -20.06 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.796 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.45 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 32.6 ttm -124.75 83.26 59.23 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.811 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.454 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 55.7 Cg_endo -70.17 -13.94 34.23 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.653 2.236 . . . . 0.0 111.981 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -139.8 145.27 37.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.747 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.84 -8.0 44.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.304 0.573 . . . . 0.0 111.498 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.26 -58.54 2.57 Favored Glycine 0 C--N 1.312 -0.799 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.4 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.1 t -149.48 140.71 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 111.374 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.4 OUTLIER -60.01 160.18 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.533 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.454 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 62.6 t0 -71.78 132.2 44.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.952 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -71.54 -28.26 63.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 0.0 110.761 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.93 -56.43 10.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.984 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -65.31 -46.18 81.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.836 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 44' ' ' ASP . 1.1 mp -58.1 -38.14 65.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.372 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.46 -56.57 5.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.152 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -60.21 -31.31 70.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.629 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.442 HD13 ' CD2' ' A' ' 5' ' ' TYR . 13.3 tp -59.71 -52.18 66.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.288 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.5 mt -51.59 -45.82 63.29 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.107 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.0 m -65.53 -31.44 72.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.331 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.424 ' HG2' ' CD1' ' A' ' 69' ' ' PHE . 19.8 tttp -66.96 -31.87 72.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.556 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.443 ' N ' HD23 ' A' ' 55' ' ' LEU . 1.3 mt -64.91 -42.7 94.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.8 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.75 -106.47 0.29 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.05 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -149.68 28.65 0.78 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.112 0.482 . . . . 0.0 110.679 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -121.3 -147.14 0.38 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.401 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.5 t -120.28 170.24 9.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.69 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.29 98.26 8.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.271 0.558 . . . . 0.0 110.355 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.3 mt -80.06 84.52 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.191 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.77 25.76 45.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.469 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.412 HD12 ' NE2' ' A' ' 67' ' ' GLN . 1.1 mm? -57.64 144.3 38.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.897 0.379 . . . . 0.0 110.85 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.9 p -123.53 168.51 12.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.229 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.593 ' CE ' HD13 ' A' ' 36' ' ' ILE . 1.2 mpt? -113.12 156.12 43.36 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.791 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -80.59 140.57 52.0 Favored 'Cis proline' 0 C--N 1.344 0.298 0 C-N-CA 123.741 -1.358 . . . . 0.0 112.978 0.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.412 ' NE2' HD12 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -96.42 123.16 39.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.055 179.051 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.814 HG22 HG22 ' A' ' 4' ' ' VAL . 10.1 t -99.39 159.42 3.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.174 0.512 . . . . 0.0 111.97 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.525 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 90.9 m-85 -143.35 148.53 36.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.54 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.609 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -60.72 146.69 85.74 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.665 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.679 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 14.6 Cg_exo -65.6 -13.4 39.61 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.534 2.156 . . . . 0.0 112.087 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.72 -25.8 14.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.765 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.98 92.72 0.7 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.783 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.9 m 176.67 155.67 0.25 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 111.005 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.413 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 7.2 t-160 -90.68 113.52 25.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.609 HD11 ' HA ' ' A' ' 70' ' ' ALA . 29.2 mt -94.42 -49.37 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.981 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 135.03 -154.66 21.65 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.698 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.81 -142.66 12.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.674 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 20' ' ' ALA . 24.1 t80 -67.71 -70.87 0.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.694 0.283 . . . . 0.0 110.917 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -58.74 -45.54 89.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.998 0.428 . . . . 0.0 110.707 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -52.47 -38.98 60.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.573 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.705 HD21 ' CE2' ' A' ' 86' ' ' PHE . 4.8 tt -79.41 -33.56 42.56 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.313 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -51.21 -29.51 14.41 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -70.33 -35.39 73.58 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.454 ' N ' ' O ' ' A' ' 82' ' ' LEU . 6.6 t80 -63.19 -34.46 77.69 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.705 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.1 m-85 -87.98 -70.46 0.63 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.296 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.981 -179.972 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.746 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 7.1 tpp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -77.67 146.63 35.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.89 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.9 mptt -109.66 122.03 46.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.787 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 66' ' ' PRO . 50.7 t -110.33 129.59 65.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.277 0.56 . . . . 0.0 111.854 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.564 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 17.5 m-85 -107.68 99.32 8.82 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.833 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.6 -143.7 3.73 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.246 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.746 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 5.0 m-85 -127.9 154.98 44.9 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 120.619 0.247 . . . . 0.0 111.239 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.07 -79.56 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.008 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 m 175.42 -34.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.835 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -62.57 -50.89 69.5 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.223 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.587 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -89.92 -39.79 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.936 0.398 . . . . 0.0 111.177 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.746 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 57.0 t-80 -139.88 139.65 36.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.005 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.95 174.23 11.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.257 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.8 p 175.11 113.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.896 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.0 m -90.08 -30.14 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.839 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -83.87 -15.91 46.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.163 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 p -71.31 -43.65 66.65 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.811 0.338 . . . . 0.0 110.714 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.1 -38.3 78.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.752 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -57.65 -48.53 79.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.899 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.411 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -64.59 -40.01 94.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.81 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HD2' ' CE2' ' A' ' 31' ' ' PHE . 2.2 mmmm -49.97 -37.75 33.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.14 0.495 . . . . 0.0 110.188 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.78 ' O ' HG23 ' A' ' 26' ' ' VAL . 61.3 ttt180 -75.07 -29.24 60.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.312 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.672 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -54.56 -55.7 26.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.304 179.386 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.694 HD12 ' CG ' ' A' ' 31' ' ' PHE . 3.0 mt -62.77 -47.49 83.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.766 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.3 m -56.01 -35.26 66.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.461 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 22' ' ' ARG . 87.8 t -78.06 -27.56 14.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.965 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HD3' ' CG ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -78.81 -11.45 59.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.308 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 72.59 38.43 0.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.929 0.395 . . . . 0.0 110.812 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.01 142.43 44.41 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.567 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' O ' ' HA ' ' A' ' 1' ' ' MET . 67.5 Cg_endo -79.5 155.81 24.79 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.526 2.151 . . . . 0.0 111.616 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.694 ' CG ' HD12 ' A' ' 24' ' ' LEU . 46.1 p90 -161.46 170.83 19.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.278 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -137.11 129.48 29.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.833 0.349 . . . . 0.0 110.943 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.513 ' HE1' HG11 ' A' ' 4' ' ' VAL . 17.3 t80 -89.22 154.94 19.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.005 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.478 HG21 ' HD3' ' A' ' 47' ' ' LYS . 13.0 mt -147.11 119.69 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.261 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -86.26 109.7 19.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.786 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 43' ' ' PHE . 11.8 pt -85.69 58.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.31 0.576 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.499 ' HE3' ' CE2' ' A' ' 7' ' ' TYR . 26.6 ttm -173.21 89.49 0.38 Allowed Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.334 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 51.9 Cg_endo -69.1 -22.42 35.14 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.29 1.993 . . . . 0.0 111.408 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -145.04 143.07 30.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.381 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.4 pttt -57.08 -9.07 0.78 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.171 0.51 . . . . 0.0 112.139 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.42 -55.2 4.37 Favored Glycine 0 C--N 1.312 -0.783 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.042 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -148.94 144.23 18.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 1.0 OUTLIER -58.77 170.97 0.71 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.029 179.157 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.402 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -87.32 103.81 15.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.908 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 2.9 t70 -58.11 -25.2 61.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.361 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -64.62 -59.14 4.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.897 0.379 . . . . 0.0 110.635 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.478 ' HD3' HG21 ' A' ' 34' ' ' ILE . 11.3 mttp -65.01 -35.6 81.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.27 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.3 mm -70.27 -32.85 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.343 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -58.18 -51.93 67.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.636 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.27 -36.52 83.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.928 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 3.5 tt -59.43 -53.19 60.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.392 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.0 mt -51.42 -44.59 62.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.149 0.5 . . . . 0.0 111.517 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.0 m -64.18 -49.41 72.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.571 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -54.87 -34.95 63.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.793 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -61.8 2.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.97 -26.71 0.25 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.549 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.74 -173.75 4.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.698 0.285 . . . . 0.0 110.684 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -98.9 19.29 15.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.308 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 t -120.19 158.63 26.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.881 0.372 . . . . 0.0 110.969 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -116.7 99.84 7.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.014 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 pt -78.84 84.13 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.999 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.73 26.61 57.81 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.195 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -56.81 135.74 55.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.899 0.381 . . . . 0.0 111.077 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.7 p -124.99 167.1 15.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.172 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.4 ' HG2' HD11 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -118.3 154.24 51.91 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.799 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.536 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.6 Cg_endo -85.72 142.43 31.56 Favored 'Cis proline' 0 N--CA 1.461 -0.388 0 C-N-CA 124.098 -1.209 . . . . 0.0 112.745 0.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -99.79 139.95 34.7 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -107.88 159.47 7.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.407 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 75' ' ' HIS . 30.8 m-85 -143.06 135.83 27.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.127 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.623 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -49.73 133.32 20.39 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.286 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.746 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 29.3 Cg_exo -54.65 -21.11 23.7 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.48 2.12 . . . . 0.0 111.851 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.3 38.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.189 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.3 -109.63 0.78 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.988 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.48 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 87.4 p -142.76 -176.33 4.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.135 0.493 . . . . 0.0 111.291 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.496 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 19.5 t-80 -57.85 123.42 15.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.203 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.623 HD11 ' HA ' ' A' ' 70' ' ' ALA . 14.5 mt -91.88 -46.27 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.733 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 129.37 -156.29 21.22 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.828 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -89.27 -139.3 7.14 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.332 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.672 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -75.49 -70.11 0.44 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.769 0.285 . . . . 0.0 110.871 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -49.1 -42.9 40.57 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.239 0.542 . . . . 0.0 110.437 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -64.01 -43.84 94.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.847 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.704 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -71.79 -40.87 68.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.605 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -51.43 -34.06 33.28 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -67.72 -35.94 79.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.16 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.428 ' N ' ' O ' ' A' ' 82' ' ' LEU . 35.2 t80 -62.94 -34.02 76.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.432 178.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.704 ' CE2' HD21 ' A' ' 82' ' ' LEU . 8.8 m-85 -87.32 -70.32 0.63 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.194 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 69.6 mttt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.962 179.939 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.616 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.9 ttm . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.669 0.271 . . . . 0.0 111.662 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.508 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 83.1 m-85 -59.17 161.29 5.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.875 0.369 . . . . 0.0 110.122 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -137.78 120.67 16.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.827 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.996 HG22 HG22 ' A' ' 68' ' ' VAL . 75.3 t -110.74 150.99 13.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.418 0.628 . . . . 0.0 111.703 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.712 ' CE1' HD12 ' A' ' 34' ' ' ILE . 40.4 m-85 -133.72 102.5 5.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.17 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -166.47 -136.78 2.08 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.535 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.409 ' O ' ' CZ ' ' A' ' 33' ' ' PHE . 49.2 m-85 -106.91 157.96 17.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.848 0.356 . . . . 0.0 110.885 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -98.94 -71.74 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.008 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 p 169.59 -32.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.996 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -74.68 -38.3 62.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.689 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.553 HG21 ' O ' ' A' ' 37' ' ' MET . 44.7 mm -89.12 -49.48 14.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -140.01 149.9 43.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.387 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.92 157.53 26.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.12 0.486 . . . . 0.0 112.018 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -172.32 93.53 0.13 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.488 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.8 m -71.44 -39.53 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.838 0.351 . . . . 0.0 111.023 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.19 -24.02 66.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.882 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.2 m -66.39 -60.69 2.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.5 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -51.77 -39.18 58.15 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.3 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -63.88 -40.64 97.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.373 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.555 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -66.76 -50.48 62.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.059 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -49.51 -36.36 22.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.856 0.36 . . . . 0.0 110.583 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.79 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -65.42 -41.79 93.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.293 179.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.798 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -56.99 -53.04 62.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.251 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.798 ' N ' HD23 ' A' ' 23' ' ' LEU . 7.1 mt -57.86 -45.22 86.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.673 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 51.7 m -57.62 -34.93 69.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.046 0.451 . . . . 0.0 110.113 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.9 t -80.05 -33.96 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.603 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -11.54 60.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.053 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.62 48.56 1.07 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.061 0.457 . . . . 0.0 110.537 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.407 ' NE2' ' HD2' ' A' ' 30' ' ' PRO . 14.6 mm100 -128.72 130.61 23.49 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.308 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.465 ' O ' ' HA ' ' A' ' 1' ' ' MET . 83.8 Cg_endo -76.81 142.93 23.06 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.444 2.096 . . . . 0.0 111.105 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.616 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 9.9 p90 -158.35 170.72 21.6 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.544 -0.462 . . . . 0.0 112.209 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -142.01 129.15 20.93 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.073 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.619 ' CE1' HG11 ' A' ' 4' ' ' VAL . 50.6 t80 -89.69 162.33 15.64 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.863 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.712 HD12 ' CE1' ' A' ' 5' ' ' TYR . 14.4 mt -146.94 122.41 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.265 0.555 . . . . 0.0 110.675 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -79.04 136.19 37.1 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.052 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.661 HD13 ' SD ' ' A' ' 65' ' ' MET . 2.6 pt -97.18 -27.15 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.172 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.553 ' O ' HG21 ' A' ' 11' ' ' ILE . 5.4 ttp -124.15 95.16 44.22 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' CG ' ' HB2' ' A' ' 44' ' ' ASP . 85.8 Cg_endo -80.93 4.84 6.63 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.67 2.247 . . . . 0.0 112.75 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.454 ' C ' HG23 ' A' ' 11' ' ' ILE . 1.7 mt-10 -139.44 137.79 35.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.661 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.426 ' N ' HG23 ' A' ' 11' ' ' ILE . 24.3 tttp -65.18 -9.0 19.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.206 0.527 . . . . 0.0 111.909 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.04 -65.18 1.28 Allowed Glycine 0 C--N 1.311 -0.811 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.247 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 43' ' ' PHE . 20.3 t -139.63 155.93 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.751 0.31 . . . . 0.0 111.17 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -75.18 168.1 20.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.821 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.431 ' HB2' ' CG ' ' A' ' 38' ' ' PRO . 19.0 t70 -100.42 114.51 28.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.255 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -54.83 -23.37 18.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.449 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.92 -53.41 58.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.883 0.373 . . . . 0.0 110.795 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -71.11 -28.52 64.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.385 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.7 mm -71.92 -39.65 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.659 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.42 -55.63 22.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.168 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -56.13 -33.49 65.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.57 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.427 HD13 ' CG ' ' A' ' 5' ' ' TYR . 24.1 tp -63.1 -49.47 74.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.075 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.1 mt -52.25 -44.21 64.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.207 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -64.8 -32.3 73.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.091 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.439 ' HD3' ' CD2' ' A' ' 69' ' ' PHE . 2.3 ttmm -67.15 -29.5 69.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.368 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.477 HD21 ' NE2' ' A' ' 67' ' ' GLN . 1.2 mt -68.18 -58.03 5.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.683 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.13 -108.69 0.27 Allowed Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.059 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -150.48 33.1 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.034 0.445 . . . . 0.0 110.653 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -120.85 -148.05 0.4 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.378 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 t -116.63 170.19 8.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.812 0.339 . . . . 0.0 110.641 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -86.75 98.44 11.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.298 0.57 . . . . 0.0 110.575 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 pt -80.49 83.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.173 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.9 26.66 41.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.58 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.642 HD12 ' OE1' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -53.15 150.09 6.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.752 0.311 . . . . 0.0 111.074 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.7 p -127.62 170.07 13.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.214 0.53 . . . . 0.0 111.742 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.661 ' SD ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -122.38 158.12 56.87 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.576 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.4 Cg_exo -79.29 143.53 70.03 Favored 'Cis proline' 0 C--N 1.344 0.32 0 C-N-CA 124.084 -1.215 . . . . 0.0 112.866 0.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.642 ' OE1' HD12 ' A' ' 63' ' ' LEU . 9.9 tt0 -104.08 123.11 46.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.466 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.996 HG22 HG22 ' A' ' 4' ' ' VAL . 16.5 t -100.31 162.22 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.934 0.397 . . . . 0.0 111.659 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.527 ' N ' HG12 ' A' ' 68' ' ' VAL . 85.9 m-85 -142.24 141.84 32.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.073 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.914 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.87 146.65 36.29 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.447 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.602 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 50.1 Cg_exo -56.44 -26.61 63.99 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.132 2.555 . . . . 0.0 112.215 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -93.48 -28.58 16.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.227 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.3 91.53 0.6 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.702 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 2.6 m -178.8 163.86 1.47 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.684 0.278 . . . . 0.0 110.596 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.422 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 14.3 t-160 -90.19 108.7 19.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.113 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.914 HD11 ' HA ' ' A' ' 70' ' ' ALA . 37.1 mt -86.3 -53.39 10.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.765 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 130.61 -153.16 20.1 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.08 -137.72 7.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.155 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.555 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -76.29 -70.19 0.46 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.702 0.251 . . . . 0.0 110.773 179.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -49.26 -44.03 43.46 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.256 0.55 . . . . 0.0 110.32 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -36.53 81.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.482 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.719 HD21 ' CE2' ' A' ' 86' ' ' PHE . 2.0 tt -79.47 -38.52 34.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.594 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.91 -32.75 21.61 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -67.53 -35.62 79.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.237 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 82' ' ' LEU . 8.6 t80 -63.44 -34.44 77.75 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.31 178.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.719 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.8 m-85 -89.3 -21.93 22.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.341 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.991 -179.945 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.626 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.39 0.138 . . . . 0.0 111.045 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.414 ' HB3' ' CG1' ' A' ' 68' ' ' VAL . 75.1 m-85 -39.71 120.9 1.17 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.694 0.759 . . . . 0.0 111.867 -177.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.738 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -90.8 124.1 34.87 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.147 -179.538 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.629 HG22 HG22 ' A' ' 68' ' ' VAL . 7.7 t -102.15 128.31 54.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.238 0.542 . . . . 0.0 111.47 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 2.8 m-30 -104.96 98.92 8.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.969 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.54 -139.71 2.71 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.293 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.596 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 91.6 m-85 -124.36 153.75 41.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.891 0.377 . . . . 0.0 111.582 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.88 -77.24 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.915 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 170.07 -32.63 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.017 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -80.43 -30.19 37.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.983 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.592 ' H ' HD12 ' A' ' 11' ' ' ILE . 3.6 mp -90.39 -47.15 14.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.117 0.484 . . . . 0.0 110.59 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.414 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 33.7 t60 -147.76 153.81 39.71 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.558 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.3 149.61 50.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.077 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 7' ' ' TYR . 42.6 t -164.99 87.56 0.44 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.063 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.39 -27.52 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -64.1 -32.37 73.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.331 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.1 p -77.92 -45.46 23.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.329 . . . . 0.0 110.543 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.08 -37.98 36.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.627 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -69.12 -55.05 11.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.724 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.413 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . . . -52.08 -38.32 56.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.19 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 15.3 ttmt -58.32 -52.36 65.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.342 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.845 ' O ' HG23 ' A' ' 26' ' ' VAL . 30.3 mmt180 -61.14 -37.26 82.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.155 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.797 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -59.82 -53.85 53.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.103 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.797 ' N ' HD23 ' A' ' 23' ' ' LEU . 7.1 mt -56.22 -44.12 79.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.665 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.8 m -60.09 -41.55 92.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.109 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 22' ' ' ARG . 44.8 t -72.93 -35.82 49.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.595 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 2.6 tmtm? -75.23 -13.0 60.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.045 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.31 52.65 0.18 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.888 0.375 . . . . 0.0 110.736 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -145.2 111.52 4.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.239 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.626 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 82.2 Cg_exo -49.53 178.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.324 2.016 . . . . 0.0 111.628 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.477 ' HB3' HD13 ' A' ' 24' ' ' LEU . 5.3 p90 -164.25 170.18 16.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.983 0.42 . . . . 0.0 111.227 178.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.593 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 5.4 mm-40 -136.39 121.0 18.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.625 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.526 ' HE1' HG11 ' A' ' 4' ' ' VAL . 9.9 t80 -89.71 152.96 21.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.111 0.481 . . . . 0.0 111.639 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 3' ' ' LYS . 29.0 mt -150.1 126.54 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.407 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -92.58 129.4 38.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.08 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.596 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 2.0 pp -87.4 -19.53 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.268 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.6 ttp -124.19 94.74 44.82 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.761 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.17 -14.63 28.76 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.421 2.081 . . . . 0.0 112.653 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -139.83 142.25 36.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 0.0 110.844 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -65.23 -8.77 19.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.227 0.536 . . . . 0.0 111.877 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.4 -60.22 2.26 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.178 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.6 t -150.1 129.83 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.713 0.292 . . . . 0.0 111.157 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -59.15 169.65 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.941 0.4 . . . . 0.0 110.921 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.467 ' O ' HD12 ' A' ' 48' ' ' ILE . 0.5 OUTLIER -84.28 93.5 8.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.127 -179.609 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -52.4 -22.2 4.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.891 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -55.54 -50.21 70.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 0.0 110.898 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -75.02 -40.74 60.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.571 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 44' ' ' ASP . 2.6 mp -52.67 -30.5 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.762 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.95 -57.72 3.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.722 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -61.07 -29.84 69.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.276 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.962 HD13 HD11 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -61.46 -57.92 10.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.951 179.315 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.564 ' HA ' HD13 ' A' ' 55' ' ' LEU . 72.2 mt -43.14 -45.91 5.66 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.316 0.579 . . . . 0.0 110.919 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.2 m -70.42 -32.4 70.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.272 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.15 -39.93 93.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.328 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.962 HD11 HD13 ' A' ' 51' ' ' LEU . 4.4 mp -59.58 -64.36 0.97 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.868 0.366 . . . . 0.0 110.945 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.65 -48.02 0.21 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.229 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.424 ' HD2' HG22 ' A' ' 59' ' ' THR . 0.3 OUTLIER -99.42 -165.11 1.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 110.865 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -105.43 -30.6 9.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.927 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.424 HG22 ' HD2' ' A' ' 57' ' ' ARG . 10.3 t -95.71 168.51 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.18 99.76 7.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.772 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.1 mt -79.05 84.6 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.047 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 64' ' ' THR . . . 62.37 26.29 67.8 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.316 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.528 HD11 ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -62.06 125.15 22.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 111.002 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 62' ' ' GLY . 34.4 p -128.23 170.14 13.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.994 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.88 159.06 31.29 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.746 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.628 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.9 Cg_endo -84.26 144.75 45.24 Favored 'Cis proline' 0 C--N 1.345 0.343 0 C-N-CA 124.326 -1.114 . . . . 0.0 112.933 0.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.528 ' NE2' HD11 ' A' ' 63' ' ' LEU . 16.3 mm100 -112.41 121.19 44.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.104 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.738 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -95.23 160.06 2.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.446 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 46.1 m-85 -141.97 138.3 31.82 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.264 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.931 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -52.47 142.73 29.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.181 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -31.9 -37.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.718 2.945 . . . . 0.0 112.835 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.29 34.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.111 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.78 -105.12 2.58 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.921 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.5 t -131.84 178.04 7.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.167 0.508 . . . . 0.0 111.269 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -65.36 129.65 40.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.674 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.931 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.3 mp -103.87 -40.89 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.674 0.273 . . . . 0.0 110.94 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' A' ' 81' ' ' GLN . . . 130.95 -166.92 22.5 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.898 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.6 -137.12 4.74 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.907 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.413 ' HD1' ' HB2' ' A' ' 20' ' ' ALA . 30.1 t80 -72.13 -67.96 0.5 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 0.0 111.261 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -54.16 -44.4 71.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.007 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.421 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -57.34 -48.35 79.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.81 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.691 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -67.09 -42.7 84.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.531 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -51.09 -30.25 15.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.52 -35.86 68.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.219 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 82' ' ' LEU . 11.0 t80 -63.72 -33.67 76.17 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.691 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.3 m-85 -87.96 -28.26 21.58 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.068 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.919 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.591 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 32.7 ttp . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.746 0.308 . . . . 0.0 111.633 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.523 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 86.0 m-85 -58.9 154.4 15.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.937 0.399 . . . . 0.0 110.427 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.679 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -130.31 123.09 29.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.713 -179.359 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.984 HG22 HG22 ' A' ' 68' ' ' VAL . 54.8 t -113.64 145.05 20.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.377 0.608 . . . . 0.0 111.881 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.904 ' CE1' HD12 ' A' ' 34' ' ' ILE . 8.2 m-85 -123.78 102.97 8.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.792 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.78 -137.98 2.31 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.098 -1.048 . . . . 0.0 112.769 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.415 ' CE1' ' SD ' ' A' ' 37' ' ' MET . 56.7 m-85 -112.34 152.66 28.31 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.742 0.306 . . . . 0.0 110.899 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 9' ' ' SER . 19.1 m-20 -88.54 3.75 49.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.709 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.3 OUTLIER 81.09 -10.94 1.16 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.56 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.663 ' OD1' HD12 ' A' ' 11' ' ' ILE . 19.8 p-10 -85.14 -35.08 21.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.908 0.385 . . . . 0.0 110.753 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.73 HG23 ' HA ' ' A' ' 40' ' ' LYS . 2.5 mp -94.32 -42.61 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.52 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -139.34 147.04 41.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.518 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -76.46 159.6 30.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.0 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 p -174.29 122.12 0.28 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.629 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.8 m -90.09 -29.87 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.844 0.354 . . . . 0.0 111.175 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -77.84 -22.08 50.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.101 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.3 p -73.27 -41.88 63.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 110.92 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -28.42 57.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.324 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 81.4 m-20 -74.88 -39.46 61.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.223 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.18 -38.14 78.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.044 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -60.13 -55.94 27.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.648 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.859 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -61.48 -30.45 70.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.362 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.823 HD12 ' CE1' ' A' ' 79' ' ' PHE . 4.0 tt -53.79 -46.18 70.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.333 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.718 HD13 ' CG ' ' A' ' 31' ' ' PHE . 2.6 mt -66.23 -48.58 70.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.635 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.4 m -56.2 -36.52 68.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.505 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 22' ' ' ARG . 49.0 t -72.69 -31.93 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.733 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.22 -9.87 57.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.201 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm 71.24 57.91 0.19 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.983 0.42 . . . . 0.0 110.903 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -135.63 139.03 29.79 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.082 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 1' ' ' MET . 91.8 Cg_endo -79.59 142.08 16.03 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.569 2.179 . . . . 0.0 111.572 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.718 ' CG ' HD13 ' A' ' 24' ' ' LEU . 32.0 p90 -158.69 170.62 21.75 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -141.48 135.56 30.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.162 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CE1' HG11 ' A' ' 4' ' ' VAL . 32.1 t80 -89.81 159.8 16.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.086 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.904 HD12 ' CE1' ' A' ' 5' ' ' TYR . 19.0 mt -139.23 116.53 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.436 0.636 . . . . 0.0 110.431 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -87.24 121.23 29.41 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.474 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.5 HG22 ' HB3' ' A' ' 47' ' ' LYS . 4.2 pt -100.2 32.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.849 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.432 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.0 mtt -142.64 84.39 11.0 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.157 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.511 ' HD2' ' O ' ' A' ' 42' ' ' VAL . 39.9 Cg_endo -67.33 -8.48 22.16 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.684 2.256 . . . . 0.0 112.62 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -138.8 170.58 15.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.881 0.372 . . . . 0.0 111.011 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.73 ' HA ' HG23 ' A' ' 11' ' ' ILE . 4.4 mptp? -65.4 -6.62 10.75 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.52 35.02 0.25 Allowed Glycine 0 C--N 1.313 -0.733 0 C-N-CA 120.711 -0.756 . . . . 0.0 113.043 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.511 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 5.2 t -149.22 125.91 2.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.635 0.255 . . . . 0.0 110.738 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 1.3 m-85 -76.25 169.91 17.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.041 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.449 ' O ' HD13 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -99.91 112.02 24.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.856 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -54.49 -33.09 59.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.826 0.346 . . . . 0.0 110.612 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -65.26 -51.37 61.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.595 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.5 ' HB3' HG22 ' A' ' 36' ' ' ILE . 22.7 mmtm -64.61 -43.47 93.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.41 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 44' ' ' ASP . 1.7 mp -64.93 -36.17 77.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.184 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.87 -58.32 4.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.093 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -58.74 -34.75 71.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.781 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.447 HD13 ' CD2' ' A' ' 5' ' ' TYR . 9.5 tp -58.18 -51.49 69.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.38 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.7 -45.88 63.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.166 0.508 . . . . 0.0 111.204 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.7 m -70.2 -35.15 73.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.149 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -29.98 71.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.395 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.66 -70.05 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.781 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.58 -41.2 0.59 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.196 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -98.52 -168.59 1.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 110.847 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -96.65 -30.92 12.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.2 t -109.54 167.5 10.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -104.58 99.52 9.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.553 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.617 ' O ' HG23 ' A' ' 61' ' ' ILE . 7.7 tp -62.88 81.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.261 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.22 23.26 39.86 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.773 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.511 HD12 ' CG ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -65.13 140.7 58.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 0.0 110.783 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.34 166.3 16.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.247 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.7 mmt -105.67 152.21 40.04 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.61 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.1 Cg_exo -80.79 144.8 67.73 Favored 'Cis proline' 0 C--N 1.345 0.352 0 C-N-CA 123.985 -1.256 . . . . 0.0 112.894 0.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.511 ' CG ' HD12 ' A' ' 63' ' ' LEU . 5.2 mt-30 -99.05 119.57 38.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.641 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.984 HG22 HG22 ' A' ' 4' ' ' VAL . 4.6 t -97.51 162.71 2.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.744 0.307 . . . . 0.0 111.428 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 89.3 m-85 -142.22 142.69 32.66 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.24 0.543 . . . . 0.0 111.464 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.47 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -54.66 137.95 62.27 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.264 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.508 ' HB3' ' N ' ' A' ' 1' ' ' MET . 84.3 Cg_exo -46.61 -28.07 6.01 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.104 2.536 . . . . 0.0 112.001 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.79 37.05 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.043 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.29 -109.85 1.1 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.949 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.442 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 2.0 p -135.67 -178.07 4.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.122 0.487 . . . . 0.0 111.318 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.437 ' CD2' ' O ' ' A' ' 68' ' ' VAL . 41.2 t-80 -60.4 122.79 15.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.036 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.49 HG23 ' HD2' ' A' ' 85' ' ' TYR . 2.3 mt -85.24 -45.68 17.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.963 0.411 . . . . 0.0 111.159 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.04 -147.92 18.29 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.392 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.1 -149.88 24.11 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.927 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.823 ' CE1' HD12 ' A' ' 23' ' ' LEU . 18.9 t80 -71.8 -70.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.833 0.349 . . . . 0.0 111.008 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -55.9 -48.97 74.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -53.56 -35.12 60.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.08 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.728 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.5 tt -83.45 -30.79 26.98 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.042 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.1 ttp85 -50.73 -33.13 21.75 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -66.19 -35.0 79.3 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.49 ' HD2' HG23 ' A' ' 76' ' ' ILE . 5.2 t80 -63.04 -34.9 78.56 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.189 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.728 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.6 m-85 -92.4 -13.68 29.73 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.657 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.923 179.913 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.627 ' N ' ' HB3' ' A' ' 71' ' ' PRO . 50.3 ttp . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -74.69 153.15 39.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.201 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -114.22 120.81 41.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.714 -179.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 66' ' ' PRO . 7.0 t -104.41 128.02 58.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.202 0.525 . . . . 0.0 111.498 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.622 ' O ' ' HA ' ' A' ' 66' ' ' PRO . 4.3 m-30 -103.83 98.84 8.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.154 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.29 -138.4 2.43 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.471 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.62 ' CD2' ' CG ' ' A' ' 12' ' ' HIS . 11.5 m-85 -120.35 144.49 47.84 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 120.676 0.274 . . . . 0.0 111.578 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.586 ' HB3' ' CE2' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -136.81 64.22 1.55 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.337 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.898 ' HB3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER 177.88 -179.01 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.271 0.558 . . . . 0.0 112.016 179.675 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -86.39 1.51 50.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.62 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.898 HG22 ' HB3' ' A' ' 9' ' ' SER . 2.5 tt -86.54 -6.58 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.874 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.061 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.625 ' CD2' ' HE2' ' A' ' 37' ' ' MET . 30.0 t-80 -156.98 161.92 39.59 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.015 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.76 166.0 24.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.615 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 176.67 73.03 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.888 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.492 HG23 ' N ' ' A' ' 16' ' ' TYR . 29.3 m -89.22 -49.03 14.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.726 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.492 ' N ' HG23 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -70.8 -12.88 61.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 110.972 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.3 m -70.37 -53.0 18.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.534 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -53.65 -26.22 21.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.103 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.53 -59.41 2.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.032 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.46 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . . . -53.82 -38.26 64.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.489 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -52.92 63.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 110.658 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.673 ' O ' HG23 ' A' ' 26' ' ' VAL . 14.7 tpt180 -60.75 -37.63 82.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.482 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.641 ' C ' HD23 ' A' ' 23' ' ' LEU . 3.3 tt -60.18 -53.33 58.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.64 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.593 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.2 mt -56.99 -48.71 77.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.951 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.2 m -54.53 -37.93 65.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.106 0.479 . . . . 0.0 110.244 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 22' ' ' ARG . 67.1 t -79.54 -32.58 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.598 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HG2' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -72.91 -11.59 60.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.112 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm 72.86 43.93 0.39 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.892 0.377 . . . . 0.0 110.997 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -132.17 127.96 21.14 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.002 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.601 ' O ' ' HA ' ' A' ' 1' ' ' MET . 96.9 Cg_endo -77.98 158.56 30.81 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.476 2.118 . . . . 0.0 110.876 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 6.1 p90 -161.51 171.26 18.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.997 0.427 . . . . 0.0 112.021 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.39 133.5 38.75 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.488 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.586 ' CE2' ' HB3' ' A' ' 8' ' ' ASP . 12.2 t80 -89.15 159.79 17.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.168 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.615 HG21 ' HE2' ' A' ' 47' ' ' LYS . 12.5 mt -149.29 122.26 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.229 0.537 . . . . 0.0 110.753 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -86.25 120.5 27.68 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.829 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.43 HD13 ' H ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -94.53 0.31 10.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.476 179.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.625 ' HE2' ' CD2' ' A' ' 12' ' ' HIS . 6.9 tpp -120.08 97.25 49.36 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.627 0.251 . . . . 0.0 111.332 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 76.7 Cg_endo -77.35 -23.21 10.32 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.295 1.996 . . . . 0.0 111.339 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -142.52 148.52 37.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.384 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -7.72 11.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.304 0.573 . . . . 0.0 111.738 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.67 -57.32 2.75 Favored Glycine 0 C--N 1.313 -0.737 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.722 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.7 t -148.27 146.38 17.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.885 0.374 . . . . 0.0 111.791 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.434 ' CD1' ' HE1' ' A' ' 37' ' ' MET . 0.5 OUTLIER -59.85 170.32 1.19 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.631 179.365 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.414 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -74.5 98.67 3.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -50.69 -23.99 3.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.553 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -64.94 -59.21 4.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.337 . . . . 0.0 110.799 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.615 ' HE2' HG21 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -69.84 -39.06 76.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.502 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.487 ' O ' HD12 ' A' ' 52' ' ' LEU . 29.1 mm -50.08 -46.76 24.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.639 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.408 ' O ' HD12 ' A' ' 52' ' ' LEU . . . -63.04 -54.44 38.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.131 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -64.08 -21.25 66.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.664 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.51 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 3.4 tt -62.34 -61.01 2.75 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.159 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 60' ' ' GLN . 0.8 OUTLIER -51.34 -49.28 61.71 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.196 0.522 . . . . 0.0 110.241 179.622 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.3 m -53.19 -40.59 64.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.242 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -38.92 84.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.249 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.417 HD22 ' CG ' ' A' ' 75' ' ' HIS . 1.4 mt -59.89 -38.11 81.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.284 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.82 -111.83 0.38 Allowed Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.686 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.3 ttm-85 -150.38 27.11 0.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.075 0.464 . . . . 0.0 110.709 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -121.77 -144.85 0.35 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.415 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.6 t -120.05 170.64 9.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.639 0.257 . . . . 0.0 110.381 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.559 ' N ' HD23 ' A' ' 52' ' ' LEU . 1.6 pt20 -73.85 98.06 2.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.274 0.559 . . . . 0.0 110.42 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.3 mt -80.11 80.37 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.223 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 49.67 26.11 7.43 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.555 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.787 HD22 ' N ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -48.27 166.79 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.845 0.355 . . . . 0.0 111.308 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.787 ' N ' HD22 ' A' ' 63' ' ' LEU . 30.0 p -127.09 160.31 31.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.109 0.48 . . . . 0.0 111.391 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.2 mtm -120.23 155.39 55.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.619 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.622 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.9 Cg_exo -76.23 142.97 75.04 Favored 'Cis proline' 0 C--N 1.345 0.354 0 C-N-CA 123.874 -1.303 . . . . 0.0 112.762 0.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.629 ' NE2' HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -98.03 120.24 38.08 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.5 t -92.52 158.83 2.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.426 0.631 . . . . 0.0 112.31 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.492 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 74.6 m-85 -142.53 148.39 37.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.005 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.917 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -61.24 153.75 66.13 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.854 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.627 ' HB3' ' N ' ' A' ' 1' ' ' MET . 19.6 Cg_exo -68.09 59.44 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.344 2.696 . . . . 0.0 112.044 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 71' ' ' PRO . 0.3 OUTLIER 100.37 25.06 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.85 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -112.18 -97.15 2.33 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.525 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.523 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 8.5 t -147.5 -174.9 4.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.803 0.335 . . . . 0.0 110.612 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.417 ' CG ' HD22 ' A' ' 55' ' ' LEU . 20.6 t-80 -71.82 132.34 44.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.835 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.917 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.4 mp -109.09 -41.33 4.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.627 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 135.87 -165.04 24.94 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.741 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.32 -136.52 4.93 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.737 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.46 ' HD1' ' HB2' ' A' ' 20' ' ' ALA . 31.7 t80 -72.33 -70.57 0.33 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.708 0.29 . . . . 0.0 111.332 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -56.4 -47.3 79.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.99 0.424 . . . . 0.0 110.857 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -51.06 -44.14 61.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.472 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.724 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.0 tt -74.77 -32.92 62.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.243 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.5 ttt85 -51.37 -30.08 17.67 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.93 -35.39 76.74 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.155 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LEU . 22.3 t80 -62.28 -34.3 76.3 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.273 178.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.724 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.7 m-85 -86.14 -38.84 17.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.266 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.2 mttm . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.952 -179.999 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.634 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 49.3 ttm . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -77.0 144.31 38.78 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.183 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -106.45 121.21 43.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.662 -179.325 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.609 HG22 HG22 ' A' ' 68' ' ' VAL . 40.6 t -107.83 138.25 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.285 0.564 . . . . 0.0 111.887 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.745 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.1 m-85 -113.43 99.62 7.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.816 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.44 -139.6 2.71 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.296 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.679 ' OH ' HD11 ' A' ' 36' ' ' ILE . 84.1 m-85 -125.18 148.34 48.65 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.796 0.332 . . . . 0.0 111.253 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -64.55 -75.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.705 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 167.07 -32.87 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.974 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -82.92 -23.9 33.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.839 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.643 HD12 ' N ' ' A' ' 11' ' ' ILE . 2.6 mp -93.41 -46.03 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.476 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -147.44 153.64 39.83 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 pttm -62.39 165.26 6.25 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.877 0.37 . . . . 0.0 111.284 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.4 t -176.6 82.23 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.306 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.1 m -90.43 -19.23 7.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.065 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -76.19 -28.23 57.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.508 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.6 p -77.5 -46.03 23.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.715 0.293 . . . . 0.0 110.831 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.23 -35.39 17.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.966 0.412 . . . . 0.0 110.718 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -70.78 -60.78 2.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.572 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 79' ' ' PHE . . . -53.16 -33.3 51.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.181 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -59.14 -54.96 41.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.54 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.837 ' O ' HG23 ' A' ' 26' ' ' VAL . 33.2 ttt180 -59.73 -35.19 74.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.554 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.641 HD23 ' N ' ' A' ' 24' ' ' LEU . 3.1 tt -60.81 -54.61 43.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.565 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.641 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.9 mt -55.48 -48.05 75.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.855 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.0 m -56.03 -37.74 69.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.166 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 22' ' ' ARG . 61.4 t -77.08 -36.09 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.646 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -72.54 -10.03 59.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.096 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.65 50.8 0.17 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.861 0.362 . . . . 0.0 110.693 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -139.53 128.53 13.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.27 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.634 ' O ' ' HA ' ' A' ' 1' ' ' MET . 81.0 Cg_endo -79.61 161.81 24.77 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.581 2.187 . . . . 0.0 110.749 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 6.9 p90 -161.23 171.16 18.9 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -135.36 136.79 41.78 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.292 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.503 ' HE1' HG11 ' A' ' 4' ' ' VAL . 8.6 t80 -89.28 157.0 18.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.174 0.512 . . . . 0.0 111.732 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.745 HD12 ' CE1' ' A' ' 5' ' ' TYR . 14.7 mt -143.88 119.47 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.714 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -98.26 135.98 39.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.737 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.679 HD11 ' OH ' ' A' ' 7' ' ' TYR . 1.4 pp -97.65 -14.22 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.018 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -123.48 80.39 54.02 Favored Pre-proline 0 N--CA 1.455 -0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.403 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 64.8 Cg_endo -88.44 31.08 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.032 2.488 . . . . 0.0 112.449 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.431 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 2.2 tp10 -139.08 164.78 28.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.534 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.65 -8.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.49 53.8 0.02 OUTLIER Glycine 0 C--N 1.312 -0.776 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.231 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.3 t -149.83 125.95 2.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.029 0.442 . . . . 0.0 111.944 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.75 ' HB3' HD11 ' A' ' 48' ' ' ILE . 2.0 m-85 -63.78 143.94 57.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.358 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.521 ' C ' HD12 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -99.04 121.79 41.43 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.822 0.344 . . . . 0.0 111.505 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.402 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 46.5 m-20 -66.84 -24.62 66.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.332 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -58.42 -52.17 66.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.794 0.33 . . . . 0.0 110.816 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -38.31 54.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.364 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.75 HD11 ' HB3' ' A' ' 43' ' ' PHE . 41.2 mt -59.32 -40.5 81.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.855 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.47 -58.0 6.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.269 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -60.15 -28.16 67.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.973 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.489 HD11 HD21 ' A' ' 55' ' ' LEU . 2.5 tp -59.32 -56.26 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.381 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.635 ' N ' HD23 ' A' ' 52' ' ' LEU . 3.0 mt -51.94 -47.51 64.69 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.984 0.421 . . . . 0.0 110.886 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.6 m -66.04 -35.0 79.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.291 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -66.49 -39.86 88.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.504 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.489 HD21 HD11 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -59.82 -49.1 79.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.439 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.58 -106.25 0.25 Allowed Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.818 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.2 mtt180 -150.62 27.6 0.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.02 0.438 . . . . 0.0 110.84 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.59 -156.71 0.7 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.207 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -121.24 161.73 21.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.676 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.423 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 7.3 pt20 -120.14 98.89 6.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.992 0.425 . . . . 0.0 110.694 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.5 mt -81.55 88.32 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.707 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.94 32.73 5.77 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.536 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.563 HD11 ' HG3' ' A' ' 67' ' ' GLN . 2.8 tm? -47.73 121.91 4.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.824 0.345 . . . . 0.0 110.77 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.504 ' N ' HD13 ' A' ' 63' ' ' LEU . 1.1 p -103.86 151.51 23.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.28 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -112.71 156.4 42.54 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.908 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -86.97 141.52 24.14 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 C-N-CA 124.067 -1.222 . . . . 0.0 112.56 0.503 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.563 ' HG3' HD11 ' A' ' 63' ' ' LEU . 2.7 mm-40 -100.24 124.19 45.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.138 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.609 HG22 HG22 ' A' ' 4' ' ' VAL . 3.3 t -96.61 159.69 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.33 0.586 . . . . 0.0 112.478 -178.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.471 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 80.1 m-85 -143.73 146.62 33.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.289 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.567 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -58.49 156.3 23.71 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.616 ' HB3' ' N ' ' A' ' 1' ' ' MET . 3.0 Cg_exo -73.71 -3.72 14.22 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.876 2.384 . . . . 0.0 112.566 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -115.33 -9.65 12.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.226 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.23 89.08 1.67 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.548 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 t -179.2 152.12 0.53 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -90.19 116.62 28.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 70' ' ' ALA . 26.2 mt -96.8 -48.45 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.879 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 138.17 -156.02 23.69 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.726 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.07 -138.69 8.88 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.668 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CD1' ' HB2' ' A' ' 20' ' ' ALA . 19.4 t80 -70.89 -70.66 0.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.782 0.325 . . . . 0.0 110.918 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -59.43 -45.3 91.94 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.023 0.44 . . . . 0.0 110.551 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -50.87 -40.0 55.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.437 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.737 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.4 tt -78.65 -31.93 47.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.265 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -51.13 -30.9 17.75 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -35.43 79.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.093 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 82' ' ' LEU . 10.8 t80 -62.68 -34.14 76.51 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.344 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.737 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.0 m-85 -88.96 -70.24 0.66 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.312 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.939 179.951 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.683 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 17.5 ttm . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.424 ' CE2' HD13 ' A' ' 76' ' ' ILE . 79.5 m-85 -78.13 147.26 34.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.308 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -106.9 121.45 44.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.337 -179.697 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.555 HG11 ' HE1' ' A' ' 33' ' ' PHE . 52.3 t -112.99 131.95 63.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.56 0.695 . . . . 0.0 112.62 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.885 ' HA ' HD11 ' A' ' 36' ' ' ILE . 17.3 m-85 -110.09 99.13 8.27 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.181 177.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.444 ' O ' HG12 ' A' ' 36' ' ' ILE . . . -153.91 -139.82 2.92 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.006 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.503 ' CD1' ' HB3' ' A' ' 37' ' ' MET . 43.7 m-85 -147.28 99.84 3.2 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.55 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 27.7 t70 -108.87 55.95 0.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.422 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.78 -168.04 2.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.165 0.507 . . . . 0.0 111.637 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -85.96 0.61 52.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.839 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.463 HG23 ' HB3' ' A' ' 40' ' ' LYS . 1.3 mm -88.26 -13.51 9.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.981 0.419 . . . . 0.0 109.901 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -175.72 118.09 0.15 Allowed 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.704 0.764 . . . . 0.0 111.172 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -82.52 168.56 17.27 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.885 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -176.58 107.79 0.07 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.24 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 m -70.32 -16.56 20.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.671 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -82.96 -25.69 32.08 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.846 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 76.2 m -59.85 -55.27 36.28 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.35 0.595 . . . . 0.0 109.647 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.27 -18.58 64.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.503 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.67 -62.51 1.35 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.851 0.357 . . . . 0.0 110.89 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.0 -38.37 67.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.036 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.09 -50.4 72.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.74 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.805 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -61.65 -38.75 88.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.624 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.748 HD23 ' N ' ' A' ' 24' ' ' LEU . 1.2 tt -59.16 -53.0 63.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.532 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.748 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.4 mt -56.97 -49.28 76.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.792 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.9 m -54.32 -38.44 65.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.075 0.464 . . . . 0.0 110.161 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.8 t -78.06 -32.36 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.622 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.14 -15.72 61.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.976 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 76.11 49.85 0.07 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.055 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -138.04 131.85 16.84 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.13 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.635 ' O ' ' HA ' ' A' ' 1' ' ' MET . 77.6 Cg_endo -79.52 161.26 25.25 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.408 2.072 . . . . 0.0 111.027 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.459 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 6.5 p90 -161.23 171.56 18.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.753 0.311 . . . . 0.0 111.716 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -133.28 123.83 26.21 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.094 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.555 ' HE1' HG11 ' A' ' 4' ' ' VAL . 10.6 t80 -89.12 157.91 18.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.445 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.471 HD12 ' CE1' ' A' ' 5' ' ' TYR . 24.0 mt -148.1 125.21 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.283 0.564 . . . . 0.0 111.143 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -75.58 115.81 15.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.639 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.885 HD11 ' HA ' ' A' ' 5' ' ' TYR . 4.6 mm -90.2 -19.06 7.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.921 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.503 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -120.28 84.41 34.53 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.696 0.284 . . . . 0.0 111.181 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 53.1 Cg_endo -69.24 -16.49 39.78 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.46 2.107 . . . . 0.0 111.904 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -139.99 136.64 33.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.395 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.463 ' HB3' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -59.33 -9.06 1.99 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.164 0.507 . . . . 0.0 111.956 -179.731 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.12 -59.65 3.32 Favored Glycine 0 C--N 1.312 -0.797 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.355 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 43' ' ' PHE . 21.2 t -150.62 154.36 8.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.981 0.42 . . . . 0.0 111.852 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.411 ' N ' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -63.92 170.63 3.35 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.384 179.255 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.421 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 1.9 t70 -89.35 100.83 13.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -52.51 -27.92 18.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.481 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -61.8 -58.04 9.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.96 0.409 . . . . 0.0 110.556 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -65.07 -32.96 74.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.302 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.64 HD11 ' CG2' ' A' ' 36' ' ' ILE . 35.8 mm -69.8 -37.42 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.573 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.72 71.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.623 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -61.82 -34.08 75.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.334 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.585 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 4.4 tt -58.95 -52.51 65.43 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.309 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 52' ' ' LEU . 85.9 mt -53.16 -41.35 65.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.589 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.1 m -58.49 -47.53 83.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.605 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' CB ' ' CE1' ' A' ' 69' ' ' PHE . 4.0 mtpp -61.74 -33.27 73.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.784 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.71 HD11 HD21 ' A' ' 63' ' ' LEU . 2.1 mt -59.92 -54.25 48.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.781 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 166.8 -112.69 0.51 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.186 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -150.23 31.24 0.68 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.071 0.462 . . . . 0.0 110.596 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -121.0 -142.27 0.34 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.335 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 t -117.0 170.4 8.66 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.793 0.33 . . . . 0.0 110.645 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -69.57 98.35 1.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.358 0.599 . . . . 0.0 110.359 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 pt -80.12 87.31 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.439 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.33 30.92 72.28 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.326 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.71 HD21 HD11 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -41.31 129.47 2.98 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.894 0.378 . . . . 0.0 111.331 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.83 153.65 45.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.359 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.5 mmt -113.63 146.48 35.55 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.628 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 1.3 Cg_endo -84.63 134.55 20.57 Favored 'Cis proline' 0 N--CA 1.46 -0.454 0 C-N-CA 124.006 -1.248 . . . . 0.0 112.57 0.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.561 ' OE1' HD13 ' A' ' 63' ' ' LEU . 4.5 tp60 -90.11 133.33 34.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.96 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 3.7 t -107.46 156.53 7.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.263 0.554 . . . . 0.0 111.851 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.434 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 39.2 m-85 -142.95 136.43 28.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.665 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.609 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -51.57 149.22 8.33 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.368 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.683 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 9.3 Cg_exo -68.86 -11.61 32.31 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.709 2.273 . . . . 0.0 112.133 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -106.42 -18.74 13.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.994 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.2 85.31 0.96 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.63 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -179.75 117.71 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.793 0.33 . . . . 0.0 110.833 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -58.51 116.63 3.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.971 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.609 HD11 ' HA ' ' A' ' 70' ' ' ALA . 13.4 mt -91.81 -46.51 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.811 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 135.68 -156.38 22.75 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.491 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.6 -140.95 8.2 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.505 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -70.12 -69.02 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.698 0.285 . . . . 0.0 110.906 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -54.37 -43.48 71.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.963 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -55.32 -37.92 68.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.678 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.692 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -71.99 -41.58 67.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.378 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.01 -29.95 23.18 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -72.85 -35.31 67.2 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' LEU . 34.2 t80 -63.49 -33.95 76.7 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.206 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.692 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.3 m-85 -87.14 -26.88 23.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.133 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.878 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.677 ' HA ' ' O ' ' A' ' 30' ' ' PRO . 40.0 ttp . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.423 ' CD1' ' CD2' ' A' ' 24' ' ' LEU . 87.0 m-85 -77.39 147.58 35.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.054 179.001 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.704 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.5 mptt -111.5 121.0 44.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.589 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.641 HG22 HG22 ' A' ' 68' ' ' VAL . 8.4 t -103.4 129.22 55.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.24 0.543 . . . . 0.0 111.676 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.613 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.9 m-30 -105.68 99.4 9.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.504 178.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.36 -136.58 2.03 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.26 -0.972 . . . . 0.0 112.64 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 12' ' ' HIS . 90.0 m-85 -116.44 144.28 44.5 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 120.918 0.39 . . . . 0.0 111.518 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' A' ' 9' ' ' SER . 22.6 t0 -73.1 -9.16 58.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.2 t 84.8 -14.11 0.63 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.577 0.351 . . . . 0.0 111.507 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -85.27 -31.19 23.23 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.693 0.282 . . . . 0.0 111.324 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.675 HD12 ' N ' ' A' ' 11' ' ' ILE . 2.4 mp -100.0 -38.38 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.645 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.425 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 15.2 t60 -139.41 179.47 6.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.355 -179.015 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -70.07 166.21 20.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.619 0.247 . . . . 0.0 110.8 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 t -176.91 71.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.19 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.0 m -90.64 -21.1 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.722 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -81.08 -23.11 38.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.3 p -77.68 -45.14 25.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 0.0 110.573 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -50.78 -34.07 25.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.704 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -73.07 -59.7 2.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.67 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.53 -41.32 69.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HG3' ' CZ ' ' A' ' 31' ' ' PHE . 70.3 tttt -54.57 -49.73 69.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.328 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.869 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.5 tpp180 -64.62 -31.43 72.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.276 179.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.799 HD12 ' CE1' ' A' ' 79' ' ' PHE . 3.3 tt -56.45 -51.05 69.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.394 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.741 HD23 ' HZ ' ' A' ' 86' ' ' PHE . 2.9 mt -60.02 -51.94 67.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.72 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.3 m -51.03 -38.95 54.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.584 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 22' ' ' ARG . 58.0 t -66.81 -31.58 54.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.677 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -86.59 -9.2 56.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.138 179.709 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 3.2 mptp? 70.59 52.33 0.32 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.067 0.461 . . . . 0.0 110.831 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -130.77 136.03 28.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.72 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.677 ' O ' ' HA ' ' A' ' 1' ' ' MET . 58.1 Cg_endo -80.96 157.09 20.58 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.596 2.197 . . . . 0.0 111.381 179.443 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.439 ' CZ ' ' HG3' ' A' ' 21' ' ' LYS . 8.4 p90 -161.51 171.31 18.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.823 0.344 . . . . 0.0 111.774 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -133.98 134.55 42.64 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.488 ' HE1' HG11 ' A' ' 4' ' ' VAL . 23.0 t80 -89.36 154.54 19.99 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.093 0.473 . . . . 0.0 111.54 -179.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.613 HD12 ' CE1' ' A' ' 5' ' ' TYR . 8.4 mt -146.41 119.36 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.187 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -100.15 135.66 41.24 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.244 -179.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 44' ' ' ASP . 31.8 pt -97.91 20.43 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.191 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.479 ' CG ' HG21 ' A' ' 11' ' ' ILE . 15.1 tpp -144.33 70.94 16.07 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.658 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -87.82 34.2 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.026 2.484 . . . . 0.0 112.818 -179.482 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -139.74 170.42 15.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.612 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -63.22 -7.82 6.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.203 0.525 . . . . 0.0 111.931 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.73 55.24 0.02 OUTLIER Glycine 0 C--N 1.312 -0.757 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.403 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.9 t -150.02 131.7 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.001 0.429 . . . . 0.0 111.413 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.0 160.4 33.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.818 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.54 ' C ' HD12 ' A' ' 48' ' ' ILE . 3.7 t70 -97.63 89.25 4.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.081 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.81 -20.85 38.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.614 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -64.34 -59.2 4.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.816 0.341 . . . . 0.0 110.67 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -71.12 -41.05 71.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.399 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.54 HD12 ' C ' ' A' ' 44' ' ' ASP . 54.8 mt -51.91 -44.08 37.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.694 179.601 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.62 -55.78 26.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.435 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.77 -31.84 71.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.296 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.501 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 1.5 tt -56.34 -52.94 62.68 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.008 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.676 ' N ' HD23 ' A' ' 52' ' ' LEU . 2.2 mt -52.91 -48.62 67.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.722 179.152 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -62.33 -44.49 96.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.295 179.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.79 -39.09 83.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.552 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.439 HD21 ' CD2' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -59.74 -53.9 52.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.32 179.622 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.3 -108.99 0.27 Allowed Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.773 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -150.45 26.56 0.76 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.073 0.463 . . . . 0.0 110.862 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -121.62 -150.78 0.46 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.265 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.2 t -120.8 170.27 9.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.594 179.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -82.52 98.35 8.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.24 0.543 . . . . 0.0 110.314 179.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.685 ' O ' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -80.09 87.23 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.879 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.67 28.06 56.04 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.478 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.87 143.54 16.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.8 p -111.55 158.17 19.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.16 0.505 . . . . 0.0 111.312 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.91 153.01 47.03 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.611 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.55 ' HB2' HG13 ' A' ' 4' ' ' VAL . 6.0 Cg_exo -81.1 156.12 83.38 Favored 'Cis proline' 0 C--N 1.344 0.309 0 C-N-CA 124.025 -1.24 . . . . 0.0 112.806 0.29 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -113.29 115.83 28.78 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.859 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.4 t -87.57 164.19 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.035 0.445 . . . . 0.0 111.792 -178.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.456 ' H ' HG12 ' A' ' 68' ' ' VAL . 45.1 m-85 -142.33 140.49 32.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.528 -179.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.651 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -53.43 132.77 53.55 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.285 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.615 ' HB3' ' N ' ' A' ' 1' ' ' MET . 31.6 Cg_exo -53.25 -22.37 19.93 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.594 2.196 . . . . 0.0 112.133 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.95 39.77 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.341 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.23 -109.86 0.68 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.987 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.489 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 86.8 p -138.91 178.41 7.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.075 0.464 . . . . 0.0 111.211 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.456 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 32.8 t-80 -55.84 127.09 28.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.061 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.651 HD11 ' HA ' ' A' ' 70' ' ' ALA . 12.3 mt -96.03 -45.02 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.987 0.422 . . . . 0.0 110.734 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 133.87 -158.44 23.3 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.462 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.74 -141.13 9.06 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.688 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.799 ' CE1' HD12 ' A' ' 23' ' ' LEU . 17.4 t80 -71.08 -61.14 1.87 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.73 0.3 . . . . 0.0 110.825 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -56.94 -48.3 78.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.85 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -56.99 -45.7 82.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.793 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.695 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -66.42 -41.62 88.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.398 179.918 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -51.76 -31.66 27.65 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -71.94 -35.8 69.72 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.104 178.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 82' ' ' LEU . 23.8 t80 -63.37 -33.78 76.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.165 178.33 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.741 ' HZ ' HD23 ' A' ' 24' ' ' LEU . 6.2 m-85 -87.96 -27.31 22.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.135 179.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.961 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.647 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 28.0 ttm . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.75 0.31 . . . . 0.0 111.756 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.488 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 77.6 m-85 -66.83 152.11 46.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.96 0.409 . . . . 0.0 110.445 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 3.0 mptt -126.6 124.29 39.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.224 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.655 HG11 ' CE1' ' A' ' 33' ' ' PHE . 16.9 t -103.43 132.45 49.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.273 0.558 . . . . 0.0 111.528 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.733 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.1 m-85 -109.23 98.98 8.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.066 178.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.23 -137.99 2.39 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 119.995 -1.098 . . . . 0.0 112.355 -179.362 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.675 ' HB3' ' HB3' ' A' ' 12' ' ' HIS . 3.4 m-85 -128.86 120.69 26.7 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 120.54 0.209 . . . . 0.0 111.296 -178.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.462 ' HB2' ' CE2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -117.52 69.32 0.77 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.595 0.236 . . . . 0.0 111.62 -179.601 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 36.9 t 177.87 -172.0 0.11 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.085 0.469 . . . . 0.0 111.767 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.87 7.59 26.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.831 179.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.44 HG12 ' HB3' ' A' ' 9' ' ' SER . 1.0 OUTLIER -87.53 -17.87 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.905 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.675 ' HB3' ' HB3' ' A' ' 7' ' ' TYR . 37.3 t-80 -165.41 122.7 1.5 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.658 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.57 154.09 32.68 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.993 -178.1 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.6 t -159.64 95.31 1.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.925 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.7 m -74.61 -35.99 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.955 0.407 . . . . 0.0 110.563 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -65.9 -20.14 66.12 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.534 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.7 m -66.94 -60.94 2.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.791 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.42 -42.57 67.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.169 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -61.91 -52.75 62.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.081 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.516 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -58.87 -49.66 76.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.979 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -50.01 -32.67 15.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.58 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.751 ' O ' HG23 ' A' ' 26' ' ' VAL . 5.6 tpm_? -69.68 -38.62 77.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.629 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.822 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -58.23 -54.09 50.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.659 179.491 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.822 ' N ' HD23 ' A' ' 23' ' ' LEU . 4.9 mt -54.69 -43.31 72.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.928 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.3 m -58.47 -33.09 69.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.031 0.443 . . . . 0.0 109.974 179.145 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 22' ' ' ARG . 41.0 t -78.81 -30.65 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.711 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -9.78 59.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.137 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt 64.68 56.87 1.13 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.071 0.462 . . . . 0.0 110.611 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.429 ' NE2' ' HD2' ' A' ' 30' ' ' PRO . 11.1 mm100 -132.6 130.33 21.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.089 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.453 ' O ' ' HA ' ' A' ' 1' ' ' MET . 86.3 Cg_endo -73.84 138.28 25.84 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.24 1.96 . . . . 0.0 110.924 178.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.647 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 48.1 p90 -155.1 170.64 21.33 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -141.63 144.0 33.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.048 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.655 ' CE1' HG11 ' A' ' 4' ' ' VAL . 33.2 t80 -89.71 162.1 15.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.05 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.733 HD12 ' CE1' ' A' ' 5' ' ' TYR . 7.1 mt -148.75 119.81 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.258 0.551 . . . . 0.0 110.816 179.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -89.81 139.34 30.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.042 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.632 HD11 ' OH ' ' A' ' 7' ' ' TYR . 1.0 OUTLIER -99.72 -26.11 3.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.215 -179.989 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.604 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 10.2 ttm -119.38 88.93 39.24 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.753 0.311 . . . . 0.0 111.64 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.49 -6.95 15.74 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.525 2.15 . . . . 0.0 112.245 179.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -139.39 141.87 37.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.57 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -69.2 -7.78 39.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.282 0.563 . . . . 0.0 111.964 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.25 -60.46 1.92 Allowed Glycine 0 C--N 1.311 -0.853 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.895 179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.7 t -150.48 128.87 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.553 0.216 . . . . 0.0 110.561 179.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -57.94 170.09 0.68 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.207 -179.641 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.429 ' O ' HG12 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -78.87 87.24 4.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.476 -179.066 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -54.15 -22.67 11.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.275 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -56.0 -51.48 67.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.891 0.377 . . . . 0.0 110.572 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -73.06 -32.81 65.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.276 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 44' ' ' ASP . 40.0 mm -57.2 -50.89 75.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.79 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.25 70.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.536 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.26 -32.14 69.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.318 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.936 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.99 -57.22 13.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.236 179.933 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.51 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 16.4 mt -44.54 -45.84 9.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.265 0.555 . . . . 0.0 111.125 178.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.2 m -70.11 -30.59 67.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.362 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -66.46 -41.28 89.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.121 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.936 HD12 ' O ' ' A' ' 51' ' ' LEU . 3.3 mp -62.28 -54.75 36.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.057 0.456 . . . . 0.0 110.81 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.33 -115.17 0.37 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.061 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -150.64 30.92 0.65 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.065 0.46 . . . . 0.0 110.687 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -121.04 -145.75 0.36 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.352 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.8 t -115.85 170.25 8.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.677 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.41 ' HG2' HD22 ' A' ' 52' ' ' LEU . 42.9 mt-30 -70.03 98.14 1.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.314 0.578 . . . . 0.0 110.55 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -80.26 84.41 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.861 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.4 27.37 47.35 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.184 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.433 HD11 ' CD2' ' A' ' 55' ' ' LEU . 1.6 mm? -55.5 135.65 50.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.892 0.377 . . . . 0.0 111.349 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.75 159.9 40.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.161 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -102.19 152.14 38.21 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.958 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.9 Cg_exo -81.48 143.29 57.89 Favored 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 123.945 -1.273 . . . . 0.0 112.666 0.18 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -108.17 118.22 36.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.014 179.06 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.3 t -92.34 166.32 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.029 0.442 . . . . 0.0 111.899 -178.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.52 ' H ' HG12 ' A' ' 68' ' ' VAL . 24.9 m-85 -141.91 134.78 28.71 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.788 -179.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.501 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -49.67 150.15 3.86 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.529 -179.211 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.568 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . 45.6 Cg_exo -58.67 -33.77 98.48 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.216 2.611 . . . . 0.0 112.268 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -90.16 -21.67 22.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.365 -179.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.76 88.98 0.86 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.73 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -171.23 162.1 6.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.337 . . . . 0.0 110.543 179.841 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.496 ' CE1' HD23 ' A' ' 55' ' ' LEU . 8.0 t-160 -90.52 115.64 27.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.102 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.501 HD11 ' HA ' ' A' ' 70' ' ' ALA . 6.8 mt -91.78 -49.41 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.011 0.434 . . . . 0.0 110.983 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.61 -154.01 16.53 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.276 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.12 -143.54 5.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.294 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.555 ' CE1' HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -77.01 -69.57 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.58 0.19 . . . . 0.0 110.738 179.76 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -48.2 -45.46 33.87 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.25 0.548 . . . . 0.0 110.327 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -35.37 76.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.175 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.702 HD21 ' CE2' ' A' ' 86' ' ' PHE . 4.0 tt -78.38 -38.13 42.48 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.406 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 87' ' ' LYS . 11.4 mtm180 -50.78 -32.14 18.99 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -68.43 -34.8 76.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.16 178.117 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 82' ' ' LEU . 8.0 t80 -63.67 -34.36 77.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.36 178.415 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.702 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.1 m-85 -89.91 -70.48 0.66 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.392 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.906 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.768 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 6.3 tpt . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.58 ' CE2' ' HE2' ' A' ' 1' ' ' MET . 92.4 m-85 -39.56 116.99 0.68 Allowed 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.74 0.781 . . . . 0.0 111.455 -177.276 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -90.16 128.53 36.37 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.39 -179.163 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 68' ' ' VAL . 37.1 t -115.81 127.12 73.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.26 0.552 . . . . 0.0 111.548 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.574 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 18.6 m-85 -103.93 98.13 8.02 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.978 ' O ' HG22 ' A' ' 36' ' ' ILE . . . -155.56 -139.8 2.85 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.891 -179.004 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.612 ' CE2' HG23 ' A' ' 36' ' ' ILE . 17.1 m-85 -131.75 158.39 41.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -178.3 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.403 ' O ' ' CB ' ' A' ' 9' ' ' SER . 41.9 t0 -70.74 -69.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.595 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 3.2 t 164.09 -31.41 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.606 179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -83.0 -26.88 30.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.546 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 11' ' ' ILE . 4.2 mp -88.21 -49.3 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.997 179.391 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -144.49 153.97 42.42 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.901 179.052 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -48.55 156.58 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.642 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.27 62.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.916 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.446 HG23 ' N ' ' A' ' 16' ' ' TYR . 14.5 m -80.11 -48.8 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.049 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.446 ' N ' HG23 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -67.29 -20.46 65.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.513 179.544 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 m -65.34 -47.68 75.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.291 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -55.53 -26.01 40.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.737 179.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -73.08 -42.97 62.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.471 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.558 ' HB2' ' HD1' ' A' ' 79' ' ' PHE . . . -69.05 -40.74 78.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.098 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -62.81 -56.76 14.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.737 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.792 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -58.95 -34.22 71.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.221 179.632 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.728 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -57.87 -51.48 69.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.896 179.146 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.728 ' N ' HD23 ' A' ' 23' ' ' LEU . 6.7 mt -57.9 -42.84 85.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.638 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.7 m -60.54 -39.26 87.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.932 179.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 22' ' ' ARG . 41.1 t -74.25 -39.24 49.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.534 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 1.7 tmtm? -74.29 -12.79 60.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.949 179.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt 68.56 49.16 0.77 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.938 0.399 . . . . 0.0 110.643 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -137.56 102.31 8.74 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.378 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.768 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 86.8 Cg_exo -44.91 171.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.518 2.145 . . . . 0.0 112.65 179.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.64 ' CG ' HD13 ' A' ' 24' ' ' LEU . 4.0 p90 -163.28 170.29 17.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.6 178.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 3.4 tt0 -132.54 112.49 12.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.686 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.517 ' HE1' HG11 ' A' ' 4' ' ' VAL . 9.9 t80 -89.1 153.84 20.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.17 0.51 . . . . 0.0 111.266 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.469 HD12 ' CE1' ' A' ' 5' ' ' TYR . 16.9 mt -149.98 121.74 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.331 179.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.6 p-10 -70.56 109.4 4.83 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.499 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.978 HG22 ' O ' ' A' ' 6' ' ' GLY . 18.7 tt -72.4 -19.29 19.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.606 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 3.5 ttp -134.59 94.94 16.44 Favored Pre-proline 0 N--CA 1.454 -0.227 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.974 179.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -85.93 24.06 0.78 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.677 2.251 . . . . 0.0 112.105 179.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.45 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 6.7 tt0 -139.49 165.82 26.2 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.754 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -62.72 -7.54 5.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -179.054 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.65 35.58 0.06 OUTLIER Glycine 0 C--N 1.313 -0.705 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.825 179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.464 ' N ' ' SD ' ' A' ' 37' ' ' MET . 4.3 t -147.72 121.13 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.906 0.384 . . . . 0.0 111.081 178.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.606 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -79.28 150.78 31.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.742 179.752 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -78.11 99.82 6.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.132 -179.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -48.52 -29.75 4.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.537 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -60.52 -54.38 46.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.959 0.409 . . . . 0.0 110.773 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HD3' ' CG2' ' A' ' 34' ' ' ILE . 25.0 mttm -68.92 -41.91 77.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.847 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.491 ' CD1' ' HB2' ' A' ' 43' ' ' PHE . 2.7 mp -63.22 -36.06 74.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.129 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.24 -52.49 65.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.659 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.01 -33.07 72.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.302 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.574 ' HG ' ' CE2' ' A' ' 5' ' ' TYR . 4.1 tt -60.15 -51.98 67.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.308 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.685 ' N ' HD23 ' A' ' 52' ' ' LEU . 1.9 mt -52.38 -44.49 65.33 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.344 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.7 m -58.19 -49.19 77.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.734 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.6 mtpp -59.53 -36.59 76.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.689 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.96 -52.23 66.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.567 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.05 -118.5 0.66 Allowed Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.054 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -141.35 27.9 1.88 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.199 0.524 . . . . 0.0 110.589 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -121.5 -147.23 0.38 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.257 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.4 t -120.26 170.19 9.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.695 0.283 . . . . 0.0 110.603 179.633 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -69.95 98.01 1.22 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.348 0.594 . . . . 0.0 110.423 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -80.36 84.25 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.084 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.72 26.51 60.28 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.395 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -50.33 148.24 3.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.329 . . . . 0.0 111.072 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.1 p -122.92 165.22 17.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.427 -179.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -118.46 153.64 51.96 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.734 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.0 OUTLIER -86.81 136.28 17.8 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.318 -1.117 . . . . 0.0 112.495 0.203 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -91.76 129.6 37.7 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 4' ' ' VAL . 3.4 t -103.2 154.29 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.123 0.487 . . . . 0.0 112.006 -179.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.459 ' CE1' ' HB2' ' A' ' 75' ' ' HIS . 44.5 m-85 -142.63 138.08 30.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.801 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.672 ' HB1' ' HD2' ' A' ' 71' ' ' PRO . . . -48.16 164.04 0.28 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.755 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.672 ' HD2' ' HB1' ' A' ' 70' ' ' ALA . 32.5 Cg_endo -62.88 58.93 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.742 2.294 . . . . 0.0 111.453 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 86.61 29.96 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.88 -178.665 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.66 -91.07 2.11 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.857 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.542 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -143.68 -169.19 3.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.015 0.436 . . . . 0.0 110.998 -179.734 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.459 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 17.1 t-80 -83.31 125.07 31.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.162 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.627 HD11 ' HA ' ' A' ' 70' ' ' ALA . 13.7 mt -96.92 -45.89 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.95 0.405 . . . . 0.0 110.741 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 137.97 -156.62 23.9 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.659 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.01 -139.97 8.54 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.733 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.558 ' HD1' ' HB2' ' A' ' 20' ' ' ALA . 60.6 t80 -72.53 -70.57 0.34 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.718 0.294 . . . . 0.0 111.048 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -56.42 -48.01 77.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.917 0.389 . . . . 0.0 110.809 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -52.09 -41.44 62.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.644 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.74 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.2 tt -76.57 -34.23 58.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.208 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -51.52 -28.95 15.05 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -69.22 -34.07 74.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.216 178.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 82' ' ' LEU . 6.8 t80 -64.75 -33.25 75.54 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.446 178.508 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.74 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.1 m-85 -90.52 -66.89 0.89 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.584 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.8 pttt . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.137 -0.935 . . . . 0.0 110.917 -179.906 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.61 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 25.7 ttp . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.774 0.321 . . . . 0.0 111.669 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.489 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 80.9 m-85 -67.32 151.26 47.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.95 0.405 . . . . 0.0 110.529 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.669 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 3.3 mptt -127.11 120.39 28.77 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.569 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.91 HG22 HG22 ' A' ' 68' ' ' VAL . 14.5 t -106.79 130.82 58.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.251 0.548 . . . . 0.0 111.805 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.638 ' CE1' HD12 ' A' ' 34' ' ' ILE . 3.6 m-30 -106.39 99.4 8.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.408 178.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.41 -137.36 2.17 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.842 -1.17 . . . . 0.0 112.985 -179.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -118.5 147.25 43.84 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.825 0.345 . . . . 0.0 110.936 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -90.73 13.13 17.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.607 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 0.3 OUTLIER 71.95 4.88 5.18 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.629 0.252 . . . . 0.0 111.44 179.931 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -85.79 -58.21 2.74 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.906 0.384 . . . . 0.0 111.033 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.673 HD12 ' O ' ' A' ' 37' ' ' MET . 29.5 mt -91.65 -27.03 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.544 -179.465 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.484 ' O ' ' HA ' ' A' ' 9' ' ' SER . 30.9 t60 -139.49 145.21 38.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.676 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.39 158.07 34.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.566 -179.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.5 t -175.78 96.11 0.06 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -80.88 -32.15 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.011 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -70.47 -23.17 62.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.596 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.5 m -62.52 -52.81 62.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.268 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.02 -27.28 52.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.301 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -71.16 -49.59 42.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.254 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.06 -47.22 71.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.177 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HD3' ' CE2' ' A' ' 31' ' ' PHE . 1.1 tppt? -59.65 -52.95 63.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.715 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.829 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -57.36 -41.25 79.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.767 180.0 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 24' ' ' LEU . 3.1 tt -58.49 -54.25 49.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.388 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.679 HD13 ' CG ' ' A' ' 31' ' ' PHE . 5.9 mt -57.31 -46.42 83.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.769 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 m -57.73 -37.09 72.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.093 0.473 . . . . 0.0 110.228 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 22' ' ' ARG . 62.1 t -77.96 -29.6 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.695 179.479 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -16.8 54.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.142 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.54 56.36 0.11 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.926 0.393 . . . . 0.0 110.9 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -136.96 141.62 35.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.47 ' O ' ' HA ' ' A' ' 1' ' ' MET . 78.9 Cg_endo -80.43 137.13 11.54 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.584 2.189 . . . . 0.0 111.647 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.679 ' CG ' HD13 ' A' ' 24' ' ' LEU . 32.0 p90 -158.32 170.61 21.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.847 0.356 . . . . 0.0 111.773 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -147.26 145.68 29.5 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.035 0.445 . . . . 0.0 111.167 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.49 ' CE1' HG11 ' A' ' 4' ' ' VAL . 10.2 t80 -89.5 163.58 15.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.168 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.638 HD12 ' CE1' ' A' ' 5' ' ' TYR . 11.5 mt -148.22 121.3 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.209 0.528 . . . . 0.0 110.527 179.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -81.84 127.67 33.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.263 -179.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 pt -95.57 -16.27 7.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.185 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.673 ' O ' HD12 ' A' ' 11' ' ' ILE . 43.9 ttm -119.0 102.99 48.58 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.933 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 44' ' ' ASP . 76.9 Cg_endo -76.2 -25.89 9.61 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.632 2.221 . . . . 0.0 112.035 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -139.96 151.01 45.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.767 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.21 -8.48 24.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.262 0.553 . . . . 0.0 111.656 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.71 -57.81 2.65 Favored Glycine 0 C--N 1.313 -0.725 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.671 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -148.73 139.11 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.642 0.258 . . . . 0.0 111.523 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -60.07 170.55 1.2 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.598 179.648 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.446 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 28.8 t0 -86.34 104.16 15.59 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -57.02 -22.65 40.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.434 179.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -58.05 -51.74 68.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.799 0.333 . . . . 0.0 110.686 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HZ2' HG22 ' A' ' 34' ' ' ILE . 53.0 mttt -74.86 -40.63 60.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.346 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 44' ' ' ASP . 38.7 mm -55.13 -47.48 77.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.771 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.03 -47.08 78.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.435 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.78 -37.88 85.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.381 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.463 HD13 ' CD2' ' A' ' 5' ' ' TYR . 19.8 tp -56.01 -51.27 68.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.732 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.9 mt -53.43 -47.58 69.52 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.227 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.7 m -65.24 -38.06 89.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.274 179.333 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.7 mtpp -63.91 -39.11 93.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.588 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -47.32 86.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.397 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 166.28 -109.64 0.36 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.987 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -150.72 31.54 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.034 0.445 . . . . 0.0 110.527 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -120.98 -149.96 0.44 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.406 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.7 t -120.38 170.33 9.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.694 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -80.4 98.44 7.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.271 0.558 . . . . 0.0 110.408 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.6 mm -78.6 83.65 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.78 24.79 50.16 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.369 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.427 HD12 ' CD ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -60.21 141.05 56.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.874 0.368 . . . . 0.0 110.872 -179.959 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.7 p -125.63 169.0 12.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.1 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.26 157.19 36.98 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.664 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.0 Cg_exo -81.82 143.45 56.38 Favored 'Cis proline' 0 C--N 1.344 0.292 0 C-N-CA 123.843 -1.315 . . . . 0.0 112.933 0.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.427 ' CD ' HD12 ' A' ' 63' ' ' LEU . 19.0 mt-30 -99.85 114.73 28.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.106 178.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.91 HG22 HG22 ' A' ' 4' ' ' VAL . 3.8 t -90.28 164.19 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.073 0.463 . . . . 0.0 111.712 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.482 ' N ' HG12 ' A' ' 68' ' ' VAL . 41.3 m-85 -142.48 131.49 23.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.62 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.707 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -48.38 152.28 1.63 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.439 -178.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.558 ' HB3' ' H2 ' ' A' ' 1' ' ' MET . 45.0 Cg_exo -58.39 -22.53 58.93 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.116 2.544 . . . . 0.0 112.218 179.168 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.0 -24.79 14.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.13 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.26 94.29 0.99 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.75 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 41.1 t -179.61 143.5 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.82 0.343 . . . . 0.0 110.774 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -72.9 106.13 4.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.965 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.707 HD11 ' HA ' ' A' ' 70' ' ' ALA . 33.6 mt -79.97 -52.06 15.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.65 -153.77 20.99 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.471 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.62 -147.3 12.41 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.335 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -69.95 -58.09 4.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.805 0.336 . . . . 0.0 110.624 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -55.88 -44.56 78.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.794 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -57.86 -43.36 85.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.471 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.623 HD21 ' HE2' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -61.83 -48.8 78.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.391 179.636 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 ttp180 -51.13 -30.21 15.81 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.98 -34.77 62.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.261 178.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.438 ' CD2' HG23 ' A' ' 76' ' ' ILE . 12.7 t80 -65.99 -32.39 73.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.343 178.439 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.623 ' HE2' HD21 ' A' ' 82' ' ' LEU . 8.1 m-85 -90.02 -70.15 0.68 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.212 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.918 -179.941 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.662 ' H3 ' ' HB3' ' A' ' 71' ' ' PRO . 15.5 ttm . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.408 ' HB2' ' CD1' ' A' ' 24' ' ' LEU . 88.8 m-85 -75.45 146.68 40.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.992 178.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 1.5 mptm? -110.5 122.01 46.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.719 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.522 HG22 HG22 ' A' ' 68' ' ' VAL . 67.8 t -114.26 133.72 59.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.329 0.585 . . . . 0.0 112.316 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.594 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 18.5 m-85 -111.68 100.72 9.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.176 178.088 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.406 ' N ' HG23 ' A' ' 36' ' ' ILE . . . -162.09 -141.57 3.16 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.51 -179.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 1.026 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 52.5 m-85 -117.27 159.18 23.09 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.236 0.214 . . . . 0.0 110.426 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -106.29 17.12 23.91 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.074 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 1.0 OUTLIER 73.18 -1.81 2.93 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 179.936 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -84.99 -46.82 10.85 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.18 0.514 . . . . 0.0 110.507 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.608 HD13 ' O ' ' A' ' 37' ' ' MET . 0.7 OUTLIER -111.4 0.6 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.589 -179.839 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.596 ' CB ' ' CD2' ' A' ' 7' ' ' TYR . 11.9 t-80 -166.96 135.17 2.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.397 -177.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.48 164.51 22.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.945 -179.066 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 p 177.73 125.65 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.96 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.2 m -91.4 -30.44 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.123 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -77.2 -21.9 53.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.351 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.1 p -72.95 -41.46 64.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.974 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.67 -36.93 84.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.072 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -63.61 -55.48 23.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.69 -28.92 36.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.88 0.371 . . . . 0.0 110.908 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -61.95 -55.14 32.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.021 0.439 . . . . 0.0 110.11 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.778 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -67.21 -29.4 69.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.565 179.402 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.735 ' O ' HD12 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -53.39 -50.74 64.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.536 179.445 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.809 HD12 ' CG ' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -64.55 -50.21 68.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.603 179.846 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 m -56.71 -41.25 77.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.807 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 22' ' ' ARG . 99.7 t -69.94 -35.16 63.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.931 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 3.9 mmtt -74.02 -10.96 60.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.303 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt 70.87 36.99 1.38 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.08 0.467 . . . . 0.0 110.724 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -126.37 138.26 31.96 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.549 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.633 ' O ' ' HA ' ' A' ' 1' ' ' MET . 86.8 Cg_endo -78.34 161.55 28.69 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.458 2.106 . . . . 0.0 111.456 179.601 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.809 ' CG ' HD12 ' A' ' 24' ' ' LEU . 6.5 p90 -161.61 171.31 18.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.328 . . . . 0.0 111.513 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -134.29 121.79 21.78 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.768 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.486 ' HE1' HG11 ' A' ' 4' ' ' VAL . 18.2 t80 -89.44 157.96 17.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.549 HG21 ' HG2' ' A' ' 47' ' ' LYS . 20.1 mt -148.49 120.64 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.635 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -71.24 110.87 6.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.379 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.026 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 1.1 pp -74.0 -29.35 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.398 -179.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.651 ' HE3' ' CE2' ' A' ' 7' ' ' TYR . 20.7 ttm -118.28 86.7 27.95 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.661 0.267 . . . . 0.0 110.598 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.465 ' HG3' ' HB3' ' A' ' 44' ' ' ASP . 93.0 Cg_endo -79.54 5.15 6.06 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.571 2.181 . . . . 0.0 112.674 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -139.79 141.25 36.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.113 0.482 . . . . 0.0 111.357 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -63.68 -7.41 7.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.019 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.25 -67.22 0.64 Allowed Glycine 0 C--N 1.314 -0.67 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.188 -179.227 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.6 t -125.59 136.92 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.726 0.298 . . . . 0.0 111.62 -179.259 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.601 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.3 OUTLIER -71.61 170.35 13.62 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.052 179.783 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.648 ' OD1' HD13 ' A' ' 48' ' ' ILE . 4.8 p30 -77.78 124.66 28.24 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.089 0.471 . . . . 0.0 111.711 -179.428 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 4.0 m-20 -80.24 -26.39 39.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.71 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -61.19 -51.44 68.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 111.291 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.549 ' HG2' HG21 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -72.95 -37.55 67.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.858 179.957 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.659 HD11 ' HB ' ' A' ' 36' ' ' ILE . 1.2 mp -72.09 -25.81 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 179.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -66.84 -52.68 40.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.563 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.87 -34.71 73.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.185 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.594 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 3.4 tt -57.52 -52.04 67.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.478 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 52' ' ' LEU . 77.1 mt -52.78 -45.0 66.94 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.586 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.7 m -63.42 -44.82 93.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.418 179.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -59.62 -33.09 71.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.711 179.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.412 HD11 HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -62.33 -66.66 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 179.763 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.25 -28.48 0.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.598 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.28 -165.09 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.742 0.306 . . . . 0.0 110.808 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -103.65 -25.83 13.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.038 -179.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -87.33 164.69 16.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.871 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.427 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . 13.0 mt-30 -109.44 99.28 8.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.001 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pt -80.25 84.39 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.126 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.08 26.01 74.21 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.283 -179.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.738 HD13 ' N ' ' A' ' 64' ' ' THR . 1.7 tm? -62.57 130.59 45.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.861 0.362 . . . . 0.0 110.965 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.738 ' N ' HD13 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -136.68 152.79 50.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 -179.978 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -104.43 152.91 39.39 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.624 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 3.8 Cg_exo -82.4 140.52 43.29 Favored 'Cis proline' 0 C--N 1.344 0.305 0 C-N-CA 124.025 -1.24 . . . . 0.0 112.817 0.32 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.519 ' CD ' HD21 ' A' ' 63' ' ' LEU . 1.1 mm-40 -99.97 135.85 40.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.078 179.096 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.632 HG11 ' CD1' ' A' ' 82' ' ' LEU . 3.3 t -106.85 158.73 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.05 0.452 . . . . 0.0 111.875 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 75' ' ' HIS . 34.0 m-85 -143.08 138.51 29.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.192 -179.582 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.772 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -53.19 133.05 51.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.171 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.662 ' HB3' ' H3 ' ' A' ' 1' ' ' MET . 39.1 Cg_exo -54.38 -21.46 23.52 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.543 2.162 . . . . 0.0 112.133 179.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.24 40.08 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.337 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.34 -109.38 0.66 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.884 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.467 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -140.68 -178.07 5.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.11 0.481 . . . . 0.0 111.236 -179.54 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.48 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 29.7 t-80 -56.61 122.64 12.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.053 -179.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.772 HD11 ' HA ' ' A' ' 70' ' ' ALA . 24.3 mt -91.08 -47.31 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.689 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 136.11 -155.49 22.44 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.673 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.65 -141.03 9.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.663 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -70.39 -70.76 0.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.72 0.295 . . . . 0.0 110.982 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.76 -49.45 77.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.981 0.419 . . . . 0.0 110.439 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -50.73 -36.18 35.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.445 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.714 HD21 ' CE2' ' A' ' 86' ' ' PHE . 6.2 tt -82.23 -32.04 29.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.292 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -50.95 -30.6 15.33 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -35.7 79.41 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.134 178.287 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' LEU . 16.1 t80 -63.55 -33.53 75.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.399 178.437 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.714 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.5 m-85 -86.11 -70.34 0.61 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.113 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.954 179.939 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.589 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 35.8 ttp . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.78 0.324 . . . . 0.0 111.562 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 70.2 m-85 -59.46 148.79 31.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 -179.292 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -119.0 123.39 44.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.209 -179.057 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.769 HG11 ' CE1' ' A' ' 33' ' ' PHE . 8.0 t -114.72 139.6 39.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.319 0.581 . . . . 0.0 111.688 179.424 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.47 ' CE1' HD12 ' A' ' 34' ' ' ILE . 23.6 m-85 -122.49 99.77 6.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.454 178.491 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 66' ' ' PRO . . . -158.52 -141.71 3.22 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.435 -179.454 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.963 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 54.8 m-85 -123.13 160.4 26.52 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.826 0.346 . . . . 0.0 111.467 -179.091 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.7 p-10 -93.66 -65.47 0.99 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 0.9 OUTLIER 162.28 -37.71 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.251 179.88 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -63.82 -45.08 91.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.806 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 40' ' ' LYS . 4.2 mm -89.02 -41.47 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.059 0.456 . . . . 0.0 110.544 179.685 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -147.75 138.23 23.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.255 179.183 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.72 155.09 26.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.716 -178.782 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.5 p -162.5 119.11 1.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.392 179.382 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.4 m -88.78 -22.98 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.534 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -90.45 -15.47 30.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.453 -179.749 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.3 p -74.62 -43.65 54.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.79 0.328 . . . . 0.0 110.859 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.48 -46.61 82.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.929 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -55.94 -45.35 78.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.116 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.76 -38.82 92.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.924 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.22 -42.62 61.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.033 0.444 . . . . 0.0 110.379 179.424 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.5 ttt180 -73.24 -26.1 60.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.566 179.466 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.669 HD12 ' CE1' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -57.26 -55.94 28.29 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.327 179.657 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.576 HD12 ' CG ' ' A' ' 31' ' ' PHE . 10.6 mt -62.42 -46.82 86.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.628 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.0 m -53.5 -33.08 53.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.042 0.448 . . . . 0.0 110.266 179.462 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 22' ' ' ARG . 69.0 t -75.7 -30.29 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.653 179.54 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 3.4 mmtm -78.21 -9.86 59.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.402 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 64.62 40.49 5.91 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 111.386 179.818 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -122.35 145.17 43.73 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.287 179.332 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.43 ' O ' ' HA ' ' A' ' 1' ' ' MET . 92.6 Cg_endo -78.59 135.43 13.03 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.287 1.991 . . . . 0.0 111.908 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.589 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 17.0 p90 -146.25 167.66 22.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.907 0.384 . . . . 0.0 111.797 179.681 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -136.11 122.06 20.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.2 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.769 ' CE1' HG11 ' A' ' 4' ' ' VAL . 42.0 t80 -89.76 150.38 22.31 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.229 179.437 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.673 HG21 ' HG2' ' A' ' 47' ' ' LYS . 8.4 mt -143.77 119.53 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.157 0.503 . . . . 0.0 110.936 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -78.13 109.65 12.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.869 179.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.963 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 13.9 pt -59.64 -29.01 41.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.397 -179.291 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.589 ' HB2' ' HB3' ' A' ' 43' ' ' PHE . 3.2 ttp -121.82 87.04 46.22 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.706 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.43 -4.04 14.74 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.732 2.288 . . . . 0.0 112.797 -179.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -139.58 135.61 33.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.817 0.341 . . . . 0.0 110.694 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.465 ' N ' HG23 ' A' ' 11' ' ' ILE . 5.4 ttmt -65.16 -7.65 13.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.291 0.567 . . . . 0.0 112.055 -179.595 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.47 -64.6 1.38 Allowed Glycine 0 C--N 1.312 -0.766 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.815 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.7 t -141.03 129.91 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.589 ' HB3' ' HB2' ' A' ' 37' ' ' MET . 0.0 OUTLIER -69.0 166.76 17.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.138 0.494 . . . . 0.0 112.184 -178.719 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.86 ' O ' HD12 ' A' ' 48' ' ' ILE . 10.4 t70 -82.24 97.2 8.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.886 -178.764 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -67.49 -15.89 63.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.837 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' HB2' ' OD1' ' A' ' 44' ' ' ASP . 2.9 mm-40 -63.53 -51.05 67.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.71 0.291 . . . . 0.0 110.647 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.673 ' HG2' HG21 ' A' ' 34' ' ' ILE . 2.9 mptp? -71.11 -37.67 72.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.348 179.522 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.86 HD12 ' O ' ' A' ' 44' ' ' ASP . 1.5 mp -67.58 -35.36 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.882 179.239 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.38 -47.12 86.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.712 179.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.8 -39.08 87.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.316 179.674 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.595 HD13 ' CE1' ' A' ' 69' ' ' PHE . 10.5 tp -56.75 -51.41 68.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.443 179.686 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.613 HD21 ' HG2' ' A' ' 60' ' ' GLN . 80.3 mt -50.82 -45.71 59.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.489 179.715 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.0 m -61.57 -42.22 98.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.614 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.403 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -60.61 -38.57 85.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.704 179.819 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.91 -59.04 6.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.924 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.09 -26.2 0.62 Allowed Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.06 -179.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -135.83 -162.12 1.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -115.55 23.24 12.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.58 0.229 . . . . 0.0 111.293 -179.811 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.7 t -120.89 143.16 49.08 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.911 0.386 . . . . 0.0 111.804 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.613 ' HG2' HD21 ' A' ' 52' ' ' LEU . 12.3 mt-30 -96.7 99.57 11.17 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.575 178.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 61' ' ' ILE . 0.8 OUTLIER -72.27 77.52 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.43 -178.403 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 36.09 30.03 0.02 OUTLIER Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.056 178.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 61' ' ' ILE . 0.8 OUTLIER -65.74 162.23 19.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.008 0.432 . . . . 0.0 111.265 -179.466 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.2 158.6 17.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.081 -179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.2 mtm -116.2 156.93 46.45 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.564 179.596 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.457 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . 4.8 Cg_exo -80.92 147.26 73.45 Favored 'Cis proline' 0 C--N 1.346 0.406 0 C-N-CA 124.244 -1.149 . . . . 0.0 112.991 0.511 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.54 135.66 34.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.039 178.748 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.726 HG22 HG22 ' A' ' 4' ' ' VAL . 3.1 t -113.5 159.09 13.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.948 0.404 . . . . 0.0 111.659 -179.494 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.595 ' CE1' HD13 ' A' ' 51' ' ' LEU . 40.0 m-85 -142.43 147.02 35.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.637 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.932 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -56.11 157.97 7.91 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.55 -178.464 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.507 ' HB3' ' N ' ' A' ' 1' ' ' MET . 32.3 Cg_exo -60.67 -25.98 82.01 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.262 2.642 . . . . 0.0 112.258 179.288 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.15 -20.67 17.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.443 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.23 89.01 1.11 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.665 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.442 ' O ' HD12 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -169.25 145.76 3.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.655 0.264 . . . . 0.0 110.386 179.845 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -78.43 115.41 18.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.835 0.35 . . . . 0.0 110.937 -179.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.932 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.8 mp -102.13 -46.05 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.711 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.32 -159.47 22.39 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.874 179.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.53 -123.24 3.24 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.5 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.669 ' CE1' HD12 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -83.39 -67.72 0.77 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.779 -0.247 . . . . 0.0 110.947 179.769 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -50.51 -48.02 57.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.274 0.559 . . . . 0.0 110.463 179.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -60.5 -47.43 86.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.847 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.435 HD21 ' CE2' ' A' ' 86' ' ' PHE . 1.1 tt -66.62 -41.77 87.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.551 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 87' ' ' LYS . 7.1 ttt180 -51.67 -31.38 25.53 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.826 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -71.25 -32.78 69.15 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.513 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.47 ' CD2' HG12 ' A' ' 76' ' ' ILE . 49.2 t80 -70.26 -29.22 65.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.016 178.853 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.435 ' CE2' HD21 ' A' ' 82' ' ' LEU . 26.4 m-85 -99.66 -70.85 0.72 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.558 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.451 ' N ' ' O ' ' A' ' 83' ' ' ARG . 15.2 pttp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.413 179.983 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.667 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 10.5 ttm . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 120.829 0.347 . . . . 0.0 111.675 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.488 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 85.4 m-85 -83.85 145.81 28.44 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.226 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.712 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -123.99 126.51 46.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 -179.26 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 68' ' ' VAL . 70.2 t -114.04 132.52 62.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.393 0.616 . . . . 0.0 111.49 179.273 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.516 ' CD2' ' HG ' ' A' ' 51' ' ' LEU . 18.6 m-85 -110.57 99.64 8.58 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.06 178.256 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.0 -144.31 3.93 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.979 -179.092 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.471 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 29.6 m-85 -125.8 150.16 48.02 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 120.744 0.307 . . . . 0.0 111.123 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.95 -74.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.995 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.3 t 175.29 -34.34 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.761 0.315 . . . . 0.0 111.321 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -81.2 -24.36 37.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.298 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.679 HD12 ' N ' ' A' ' 11' ' ' ILE . 2.6 mp -91.12 -42.12 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.897 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.414 ' HB3' ' CG ' ' A' ' 7' ' ' TYR . 29.2 t60 -155.8 153.3 29.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.271 -179.62 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -55.71 145.37 24.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.079 0.466 . . . . 0.0 111.518 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.7 t -167.49 75.67 0.14 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.028 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.1 m -90.61 -20.38 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.272 179.559 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -75.47 -27.53 58.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.393 -179.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.8 p -79.87 -40.91 27.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.324 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.04 -41.81 48.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.112 0.482 . . . . 0.0 110.786 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -72.78 -49.23 32.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.65 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.29 -41.73 72.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.964 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -52.38 65.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.619 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.786 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.7 tpt180 -59.05 -36.61 75.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.656 179.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.687 HD23 ' N ' ' A' ' 24' ' ' LEU . 2.4 tt -60.4 -54.82 41.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.466 179.535 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.687 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.4 mt -54.78 -45.6 74.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.71 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.9 m -56.81 -35.58 68.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.173 0.511 . . . . 0.0 109.96 179.291 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 22' ' ' ARG . 50.0 t -79.99 -29.86 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.683 179.304 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.49 -11.74 59.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.031 179.742 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt 67.97 56.61 0.53 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.876 0.369 . . . . 0.0 110.951 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -134.33 135.85 24.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.76 132.75 12.18 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.461 2.108 . . . . 0.0 111.705 179.36 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.667 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 22.9 p90 -156.03 169.76 23.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.65 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -148.16 139.06 23.14 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.438 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.655 ' HE1' HG12 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -89.88 150.96 21.97 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.708 179.916 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.443 HG21 ' HD3' ' A' ' 47' ' ' LYS . 17.2 mt -140.95 121.96 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.063 0.458 . . . . 0.0 110.387 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -78.35 109.49 12.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.587 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.511 ' HB ' HD11 ' A' ' 48' ' ' ILE . 1.8 pt -73.71 -7.05 9.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.43 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.477 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -126.21 80.52 68.38 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-O 120.844 0.354 . . . . 0.0 111.076 -179.679 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.51 -20.38 69.55 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.705 2.27 . . . . 0.0 111.817 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 37' ' ' MET . 34.1 mt-10 -139.65 140.09 36.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.369 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.25 -8.75 2.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.217 0.532 . . . . 0.0 111.881 -179.647 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.4 -58.35 3.37 Favored Glycine 0 C--N 1.312 -0.772 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.706 179.803 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -150.55 150.13 13.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.81 0.338 . . . . 0.0 111.754 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 37' ' ' MET . 0.1 OUTLIER -63.14 170.68 2.7 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.484 179.266 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -86.15 100.59 12.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.873 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -55.78 -25.29 40.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.488 -179.647 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -65.49 -60.43 2.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.943 0.401 . . . . 0.0 110.542 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.443 ' HD3' HG21 ' A' ' 34' ' ' ILE . 24.2 mttt -65.22 -33.74 76.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.345 179.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.511 HD11 ' HB ' ' A' ' 36' ' ' ILE . 15.8 mm -73.79 -29.69 26.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.647 179.64 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 45' ' ' ASP . . . -61.68 -55.85 26.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.991 -179.645 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -62.47 -35.26 78.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.308 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.516 ' HG ' ' CD2' ' A' ' 5' ' ' TYR . 2.9 tt -56.72 -50.89 70.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.273 179.603 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.3 mt -52.82 -48.82 66.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.115 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.0 m -63.72 -38.14 89.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.023 179.302 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.5 -43.01 88.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.382 179.436 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 mt -59.94 -47.24 86.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 172.37 -113.93 0.5 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.053 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -150.53 30.56 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.047 0.451 . . . . 0.0 110.745 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.04 -148.33 0.41 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.324 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 t -120.21 165.78 14.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.715 0.293 . . . . 0.0 110.626 179.624 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.444 ' CG ' ' O ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -69.69 98.82 1.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.726 0.774 . . . . 0.0 110.594 179.96 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.1 mt -79.68 83.08 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.037 -179.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 56.29 24.44 44.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.458 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.618 HD12 ' CD ' ' A' ' 67' ' ' GLN . 1.0 OUTLIER -64.76 152.11 43.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.927 -179.988 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.8 p -133.72 170.12 16.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.493 . . . . 0.0 111.691 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.86 160.46 26.73 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.31 179.405 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 6.3 Cg_exo -82.7 144.46 54.37 Favored 'Cis proline' 0 C--N 1.344 0.312 0 C-N-CA 124.406 -1.081 . . . . 0.0 113.188 0.608 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.618 ' CD ' HD12 ' A' ' 63' ' ' LEU . 2.1 mm100 -105.74 125.55 51.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.969 178.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 4' ' ' VAL . 4.0 t -98.9 160.72 3.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.909 0.385 . . . . 0.0 111.746 -179.301 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.449 ' N ' HG12 ' A' ' 68' ' ' VAL . 28.5 m-85 -142.95 131.54 22.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.895 -179.843 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.568 ' N ' HD11 ' A' ' 76' ' ' ILE . . . -64.0 142.78 98.22 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.463 -178.742 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.585 ' HB3' ' N ' ' A' ' 1' ' ' MET . 45.3 Cg_exo -41.37 -30.97 0.92 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.28 2.653 . . . . 0.0 112.677 179.234 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -164.26 35.16 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.594 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.02 -97.84 1.89 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.566 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.8 m -165.32 175.6 9.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.96 0.41 . . . . 0.0 110.889 -179.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.422 ' HB2' ' CE1' ' A' ' 69' ' ' PHE . 14.2 t-80 -50.04 101.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.997 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.568 HD11 ' N ' ' A' ' 70' ' ' ALA . 3.3 mt -67.32 -52.78 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.405 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.533 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 138.64 -150.83 21.31 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.753 -179.69 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.4 -142.01 11.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.748 -179.719 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -70.12 -70.81 0.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.771 0.32 . . . . 0.0 110.948 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -58.97 -44.03 91.44 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.018 0.437 . . . . 0.0 110.437 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -53.11 -36.01 60.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.417 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.741 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.6 tt -80.42 -34.63 36.02 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.296 179.639 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -51.23 -29.81 15.45 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.647 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -69.0 -35.06 76.26 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.22 178.159 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 82' ' ' LEU . 9.1 t80 -63.24 -34.19 77.13 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.288 178.397 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.741 ' CE2' HD21 ' A' ' 82' ' ' LEU . 6.4 m-85 -88.0 -70.16 0.65 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.276 179.761 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.864 -179.996 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.647 ' CG ' ' HA ' ' A' ' 31' ' ' PHE . 59.0 ttp . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 120.713 0.292 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.509 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 76.9 m-85 -80.15 154.51 27.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.02 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.72 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -133.6 130.46 38.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.484 -178.794 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.922 HG22 HG22 ' A' ' 68' ' ' VAL . 27.0 t -114.09 138.31 44.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.195 0.522 . . . . 0.0 111.694 179.306 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.791 ' CE1' HD12 ' A' ' 34' ' ' ILE . 4.2 m-85 -115.89 99.47 7.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.997 178.276 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 35' ' ' ASN . . . -158.61 -138.58 2.5 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.446 -179.228 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.707 ' CZ ' HD11 ' A' ' 36' ' ' ILE . 64.7 m-85 -117.92 154.67 31.51 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 120.865 0.364 . . . . 0.0 111.021 -179.517 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.49 -77.9 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.788 -179.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 t 170.78 -37.88 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.955 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.49 -29.56 52.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.26 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.496 HG23 ' N ' ' A' ' 40' ' ' LYS . 10.4 mm -89.03 -40.36 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.059 0.457 . . . . 0.0 110.631 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -150.32 148.54 28.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.573 179.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -78.37 160.04 28.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.302 -179.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.1 t -174.63 103.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.722 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 m -79.98 -37.88 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.217 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.46 -22.92 66.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.16 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.2 m -65.77 -57.72 7.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.909 0.385 . . . . 0.0 110.837 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -53.44 -25.98 18.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.316 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -70.39 -63.29 1.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.611 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.538 ' HB2' ' HB2' ' A' ' 79' ' ' PHE . . . -57.4 -27.04 62.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.796 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.2 tttm -59.59 -56.53 20.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.475 179.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.638 ' O ' HG23 ' A' ' 26' ' ' VAL . 8.9 ttt85 -61.51 -25.5 67.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.523 179.456 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.555 HD11 ' HG2' ' A' ' 83' ' ' ARG . 1.0 OUTLIER -59.53 -55.42 34.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.451 179.626 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.5 mt -63.52 -43.0 98.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.8 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.2 m -58.75 -41.25 86.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.175 0.512 . . . . 0.0 109.986 179.243 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 22' ' ' ARG . 95.8 t -78.86 -25.03 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.456 179.25 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.535 ' HG2' ' CE1' ' A' ' 86' ' ' PHE . 12.4 tppt? -71.75 -18.81 62.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.226 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt 69.86 53.76 0.37 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.887 0.375 . . . . 0.0 111.11 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -143.7 145.92 33.01 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.996 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.33 138.88 22.81 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.557 2.171 . . . . 0.0 111.919 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.647 ' HA ' ' CG ' ' A' ' 1' ' ' MET . 4.2 p90 -158.36 169.6 24.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.058 0.456 . . . . 0.0 112.154 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -144.18 143.14 30.94 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.789 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.51 ' HE1' HG11 ' A' ' 4' ' ' VAL . 21.0 t80 -89.41 158.45 17.74 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.318 -179.749 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.791 HD12 ' CE1' ' A' ' 5' ' ' TYR . 11.7 mt -145.67 119.75 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.168 179.26 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 32.0 p30 -90.6 133.04 35.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.544 -179.176 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.707 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 6.8 pt -90.28 -22.5 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.056 179.529 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.61 ' HB2' ' HB3' ' A' ' 43' ' ' PHE . 2.9 ttp -123.68 91.34 49.8 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.406 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 6.1 Cg_exo -74.05 -4.36 15.3 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.891 2.394 . . . . 0.0 112.569 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 37' ' ' MET . 0.1 OUTLIER -139.62 136.98 34.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.74 0.305 . . . . 0.0 110.805 -179.837 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.496 ' N ' HG23 ' A' ' 11' ' ' ILE . 4.0 ttpm? -63.69 -8.9 11.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.144 0.497 . . . . 0.0 112.102 -179.749 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.56 -64.6 1.43 Allowed Glycine 0 C--N 1.312 -0.774 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.164 179.583 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.8 t -141.24 139.91 32.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.611 0.243 . . . . 0.0 110.86 179.717 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.61 ' HB3' ' HB2' ' A' ' 37' ' ' MET . 0.1 OUTLIER -68.83 169.92 10.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.986 0.422 . . . . 0.0 111.379 -179.73 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.406 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -93.58 107.94 19.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.161 -179.678 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HA ' ' HB ' ' A' ' 48' ' ' ILE . 1.8 p30 -56.29 -22.01 27.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.304 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -57.44 -51.19 70.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.838 0.351 . . . . 0.0 110.928 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -76.85 -35.15 57.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.308 179.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.534 HD11 ' HB ' ' A' ' 36' ' ' ILE . 32.6 mm -62.46 -44.36 99.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.873 179.672 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.96 -56.81 9.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.245 -179.487 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -57.75 -33.16 68.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.585 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.695 HD13 ' CD2' ' A' ' 5' ' ' TYR . 10.4 tp -57.72 -51.74 68.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.382 179.574 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.2 mt -52.47 -45.85 66.27 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.196 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.6 m -67.19 -35.63 80.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.32 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -62.67 -32.16 73.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.495 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.08 -53.54 48.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.84 179.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.62 -41.93 1.24 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.297 -179.848 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -98.76 -165.5 1.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.882 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -104.0 -32.83 9.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.3 t -110.54 166.32 11.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . 18.4 mt-30 -110.62 99.47 8.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 pt -68.17 80.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.199 179.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.95 17.75 73.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.668 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.699 HD12 ' CD ' ' A' ' 67' ' ' GLN . 0.3 OUTLIER -79.96 139.28 37.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.908 180.0 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.67 171.35 14.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.489 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.43 ' SD ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -89.72 156.37 47.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.651 179.475 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 4.0 Cg_exo -76.58 147.66 87.27 Favored 'Cis proline' 0 C--N 1.345 0.36 0 C-N-CA 123.865 -1.306 . . . . 0.0 113.073 0.4 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.699 ' CD ' HD12 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -107.73 111.55 23.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.406 179.314 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.922 HG22 HG22 ' A' ' 4' ' ' VAL . 5.6 t -93.65 161.1 2.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.933 0.397 . . . . 0.0 111.821 -179.319 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.473 ' N ' HG12 ' A' ' 68' ' ' VAL . 96.0 m-85 -142.05 146.6 35.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.551 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.622 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -84.31 137.68 39.44 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.242 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.553 ' HB3' ' N ' ' A' ' 1' ' ' MET . 39.0 Cg_exo -34.94 -36.88 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.634 2.889 . . . . 0.0 112.183 178.674 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -166.6 31.02 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.124 179.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.72 15.91 9.01 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.761 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.1 p 73.36 179.93 0.21 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.125 0.488 . . . . 0.0 111.412 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.473 ' NE2' ' HG3' ' A' ' 67' ' ' GLN . 24.4 t-80 -52.57 125.71 17.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.502 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.622 HD11 ' HA ' ' A' ' 70' ' ' ALA . 26.7 mt -94.76 -47.9 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.657 179.538 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 136.5 -151.71 20.95 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.657 -179.71 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -95.44 -144.95 17.87 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.592 -179.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.538 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 11.1 t80 -70.65 -70.6 0.29 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.771 0.32 . . . . 0.0 110.775 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -59.18 -47.22 86.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.958 0.408 . . . . 0.0 110.477 179.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -41.15 63.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.264 179.582 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.587 HD21 ' CD2' ' A' ' 86' ' ' PHE . 4.5 tt -76.23 -35.39 59.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.051 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.555 ' HG2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.52 -28.05 12.5 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.755 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -72.29 -33.61 67.55 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.367 178.352 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.616 ' CD2' HG23 ' A' ' 76' ' ' ILE . 6.2 t80 -65.64 -32.85 74.64 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.399 178.568 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.587 ' CD2' HD21 ' A' ' 82' ' ' LEU . 10.7 m-85 -95.13 -70.19 0.72 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.521 179.718 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 83' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.818 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.645 ' HG3' ' HA ' ' A' ' 31' ' ' PHE . 2.5 tpp . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.799 0.333 . . . . 0.0 111.637 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.521 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 82.9 m-85 -68.82 148.42 50.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.958 0.408 . . . . 0.0 110.538 -179.786 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.683 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -120.25 118.51 30.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.157 -179.973 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.647 HG22 HG22 ' A' ' 68' ' ' VAL . 6.2 t -105.28 122.74 58.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.343 0.592 . . . . 0.0 111.921 -179.607 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.596 ' CE1' HD12 ' A' ' 34' ' ' ILE . 2.6 m-30 -99.95 99.39 10.15 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.923 178.659 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.74 -138.07 2.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.369 -179.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -131.07 104.09 6.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.56 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 8' ' ' ASP . 0.5 OUTLIER -108.8 22.84 15.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.604 0.24 . . . . 0.0 110.465 178.53 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.1 t -116.07 175.16 5.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.42 0.629 . . . . 0.0 111.774 -179.103 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -87.37 8.26 25.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.22 179.059 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.2 mm -87.66 -16.28 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.382 179.333 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -153.51 144.92 23.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.471 179.18 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.34 166.79 20.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.048 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.3 p 179.19 116.9 0.04 OUTLIER 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.831 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.7 m -90.84 -35.8 7.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.87 0.367 . . . . 0.0 111.134 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -77.41 -19.32 56.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.49 -179.647 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.6 p -65.76 -43.41 88.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 0.0 110.634 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.31 -38.24 63.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.858 179.752 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -68.74 -41.14 79.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.432 -179.428 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.491 ' HA ' ' CE2' ' A' ' 79' ' ' PHE . . . -67.04 -40.03 87.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.774 0.321 . . . . 0.0 111.487 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HD2' ' CZ ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -57.3 -48.55 78.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.836 0.35 . . . . 0.0 110.491 179.753 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.832 ' O ' HG23 ' A' ' 26' ' ' VAL . 41.7 ptt85 -64.93 -33.42 75.99 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.979 0.418 . . . . 0.0 110.503 179.624 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.734 HD13 ' N ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.45 -49.75 71.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.325 179.285 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.734 ' N ' HD13 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -64.4 -47.51 78.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.447 179.266 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 m -54.24 -36.98 64.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.003 179.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 22' ' ' ARG . 59.5 t -77.46 -27.92 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.414 179.251 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 -11.57 57.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.093 179.787 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 70.27 57.71 0.27 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.907 0.384 . . . . 0.0 111.245 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -135.37 137.75 27.14 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.113 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.461 ' O ' ' HA ' ' A' ' 1' ' ' MET . 54.8 Cg_endo -80.8 134.32 9.58 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.598 2.199 . . . . 0.0 111.123 179.111 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.645 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 28.9 p90 -159.44 169.88 22.97 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.12 -0.632 . . . . 0.0 112.547 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -144.56 142.68 30.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.27 -179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.505 ' HD1' ' N ' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -89.8 133.9 34.47 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.071 -179.935 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.596 HD12 ' CE1' ' A' ' 5' ' ' TYR . 7.6 mt -115.42 109.93 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.174 0.511 . . . . 0.0 110.22 178.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -74.1 134.08 42.88 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.048 -179.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.6 pt -100.12 -6.93 9.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.987 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 30.7 ttm -122.93 95.29 46.42 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.653 0.263 . . . . 0.0 111.62 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.0 -24.46 17.32 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.475 2.117 . . . . 0.0 111.842 179.485 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -140.86 147.72 39.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.644 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -64.4 -8.42 13.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.253 0.549 . . . . 0.0 111.801 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.0 -56.37 3.08 Favored Glycine 0 C--N 1.312 -0.753 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.61 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -147.95 145.09 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.981 0.42 . . . . 0.0 111.815 -179.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -68.21 170.66 8.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.559 179.434 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.29 84.1 5.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.45 -27.92 7.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.362 179.889 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -56.73 -50.3 72.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.939 0.4 . . . . 0.0 110.574 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -40.03 64.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.226 179.343 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 mm -52.24 -44.61 42.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.851 179.607 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.4 -56.74 12.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.57 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -57.76 -34.74 69.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.355 179.507 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.034 HD13 HD11 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -59.86 -56.69 18.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.238 179.863 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.588 ' HA ' HD13 ' A' ' 55' ' ' LEU . 66.8 mt -43.4 -45.5 6.23 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.384 0.611 . . . . 0.0 110.884 179.11 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.4 m -70.39 -33.33 71.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.166 178.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -64.32 -39.86 94.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.305 179.918 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.034 HD11 HD13 ' A' ' 51' ' ' LEU . 4.4 mp -59.76 -66.99 0.43 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.899 0.38 . . . . 0.0 111.08 -179.739 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 158.24 -34.95 0.52 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.405 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.58 -164.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.774 0.321 . . . . 0.0 110.903 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -99.74 -33.12 10.71 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.787 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 t -119.65 170.11 9.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.815 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.424 ' HB2' ' CB ' ' A' ' 63' ' ' LEU . 4.0 pt20 -113.17 99.81 8.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.0 0.428 . . . . 0.0 110.909 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mt -79.93 80.85 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.389 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.36 -18.63 56.75 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.854 179.683 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.424 ' CB ' ' HB2' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -59.48 136.17 57.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 0.0 110.915 -179.959 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 65' ' ' MET . 0.5 OUTLIER -143.06 171.33 14.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.353 -179.465 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.436 ' H ' HG22 ' A' ' 64' ' ' THR . 0.0 OUTLIER -89.45 153.2 48.19 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.565 179.56 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 5' ' ' TYR . 2.9 Cg_exo -77.13 138.78 55.53 Favored 'Cis proline' 0 C--N 1.344 0.339 0 C-N-CA 123.877 -1.301 . . . . 0.0 112.954 0.263 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.68 ' OE1' HD11 ' A' ' 51' ' ' LEU . 5.3 mt-30 -100.91 112.96 25.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.996 179.054 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 3' ' ' LYS . 2.9 t -91.08 163.74 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 0.0 111.752 -179.213 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.515 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 28.5 m-85 -142.1 132.1 24.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.348 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.823 ' HA ' HD11 ' A' ' 76' ' ' ILE . . . -48.56 149.45 2.92 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.635 -178.663 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.6 ' HB3' ' N ' ' A' ' 1' ' ' MET . 52.9 Cg_exo -57.27 -29.02 82.35 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.106 2.537 . . . . 0.0 111.882 179.156 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -94.41 -23.13 17.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.034 179.818 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.56 79.02 0.51 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.568 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.491 ' N ' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -164.5 119.13 1.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.833 0.349 . . . . 0.0 110.904 179.931 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -51.37 111.3 0.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.051 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.823 HD11 ' HA ' ' A' ' 70' ' ' ALA . 27.0 mt -88.51 -50.43 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.987 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 68' ' ' VAL . . . 126.99 -154.48 19.39 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.624 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 82' ' ' LEU . . . -87.1 -144.83 8.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.281 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.491 ' CE2' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -72.81 -68.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.725 0.262 . . . . 0.0 110.849 179.75 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -47.09 -42.33 18.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.156 0.503 . . . . 0.0 110.39 179.611 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -40.03 95.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.372 179.507 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.633 HD21 ' CE2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -72.49 -43.68 63.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.346 179.741 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.13 -33.42 18.8 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -69.9 -36.55 75.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.202 178.339 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.44 ' N ' ' O ' ' A' ' 82' ' ' LEU . 10.2 t80 -63.51 -33.77 76.3 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.465 178.39 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.633 ' CE2' HD21 ' A' ' 82' ' ' LEU . 5.4 m-85 -86.34 -70.36 0.61 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.047 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.885 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.596 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 11.2 tpp . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.307 0.098 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 76.8 m-85 -39.53 123.75 1.53 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.61 0.719 . . . . 0.0 111.74 -177.243 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.673 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -89.54 125.22 35.12 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.152 -179.316 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 68' ' ' VAL . 51.5 t -116.77 147.24 20.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.253 0.549 . . . . 0.0 110.959 179.187 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.668 ' CZ ' HD12 ' A' ' 34' ' ' ILE . 85.7 m-85 -129.06 99.67 5.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.061 178.761 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.414 ' O ' HD13 ' A' ' 36' ' ' ILE . . . -159.68 -142.38 3.38 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.13 -179.06 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.686 ' CE1' HD11 ' A' ' 36' ' ' ILE . 60.2 m-85 -115.37 145.17 42.78 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 120.565 0.221 . . . . 0.0 110.831 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -106.05 27.57 8.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.942 0.401 . . . . 0.0 110.438 179.738 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.2 p 64.02 10.74 5.59 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.313 -179.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -86.19 -63.88 1.24 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.894 0.378 . . . . 0.0 110.891 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.426 HG21 ' N ' ' A' ' 40' ' ' LYS . 18.4 mm -96.62 -17.66 6.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.376 -179.051 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.51 ' HB3' ' CD1' ' A' ' 7' ' ' TYR . 30.7 t60 -153.32 160.52 42.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.984 0.421 . . . . 0.0 111.644 -179.441 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -46.55 156.94 0.16 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.188 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.9 t -153.64 69.28 0.8 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.037 -179.76 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.444 HG23 ' N ' ' A' ' 16' ' ' TYR . 27.5 m -91.78 -43.15 13.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.444 ' N ' HG23 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -70.75 -22.65 62.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.453 -179.204 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.07 -42.71 14.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.692 179.826 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -52.28 -31.56 33.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.915 0.388 . . . . 0.0 110.408 179.548 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -78.49 -56.46 4.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.644 179.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.448 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . . . -55.39 -45.26 76.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.875 0.369 . . . . 0.0 111.076 179.841 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 27.2 ttpt -58.92 -45.7 89.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.598 179.744 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.801 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.6 tmm_? -63.21 -37.27 86.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.556 179.737 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.791 HD23 ' N ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -56.98 -53.03 62.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.239 179.499 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.791 ' N ' HD23 ' A' ' 23' ' ' LEU . 5.7 mt -56.51 -44.86 81.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.602 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.0 m -58.27 -39.07 78.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.967 179.353 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 22' ' ' ARG . 46.7 t -73.0 -39.96 58.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.555 179.334 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -10.14 59.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.999 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 69.41 49.95 0.56 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.935 0.398 . . . . 0.0 110.375 -179.674 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.17 112.26 8.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.394 -179.634 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.596 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 83.4 Cg_exo -49.96 179.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.341 2.027 . . . . 0.0 111.585 179.052 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CE2' ' HG3' ' A' ' 21' ' ' LYS . 4.8 p90 -164.54 170.13 16.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.077 0.465 . . . . 0.0 111.346 178.111 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 3' ' ' LYS . 2.7 tt0 -134.55 109.49 8.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.628 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.574 ' CE1' HG11 ' A' ' 4' ' ' VAL . 7.9 t80 -91.94 159.89 15.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.206 0.527 . . . . 0.0 111.82 -179.446 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.668 HD12 ' CZ ' ' A' ' 5' ' ' TYR . 20.6 mt -150.1 122.93 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.075 179.152 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -80.0 124.39 28.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.09 -179.639 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.686 HD11 ' CE1' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -88.7 -18.04 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.17 179.652 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -125.22 83.4 60.92 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.667 179.864 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.5 ' CD ' ' HB2' ' A' ' 44' ' ' ASP . 57.7 Cg_endo -70.82 -12.98 31.67 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.62 2.213 . . . . 0.0 111.708 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -139.55 136.93 34.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.912 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.426 ' N ' HG21 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -61.63 -8.28 4.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.312 0.577 . . . . 0.0 111.543 -179.59 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.5 -60.43 3.24 Favored Glycine 0 C--N 1.313 -0.737 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.543 179.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 43' ' ' PHE . 20.3 t -151.41 160.44 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.425 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.521 ' N ' HG12 ' A' ' 42' ' ' VAL . 1.7 m-30 -60.05 170.4 1.24 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.587 178.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.5 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 66.6 t0 -99.91 96.96 7.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.513 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -48.66 -34.35 11.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.273 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -65.5 -58.09 6.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.817 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -32.26 71.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.651 179.749 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.4 mp -75.4 -29.67 21.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.523 179.761 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.35 -54.4 46.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.877 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -64.17 -35.19 79.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 110.224 179.615 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.779 HD22 HD11 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -62.03 -59.47 5.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.476 179.057 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.576 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 69.2 mt -44.88 -41.3 7.01 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.114 179.092 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.6 m -70.62 -32.29 69.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.575 -179.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 19.8 mtpp -64.84 -45.08 87.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.75 -179.193 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.779 HD11 HD22 ' A' ' 51' ' ' LEU . 1.3 mp -59.52 -39.4 83.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.859 0.361 . . . . 0.0 111.168 -179.645 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.86 -120.46 0.83 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.343 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -146.99 30.27 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.054 0.454 . . . . 0.0 110.619 179.522 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -121.18 -146.29 0.37 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.258 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -120.39 168.55 11.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.689 0.281 . . . . 0.0 110.599 179.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.553 ' NE2' HD21 ' A' ' 52' ' ' LEU . 17.3 mt-30 -87.73 98.89 11.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.254 0.55 . . . . 0.0 110.484 179.628 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pt -79.9 84.68 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.161 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.52 26.2 64.16 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.382 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.74 HD12 ' NE2' ' A' ' 67' ' ' GLN . 1.4 mm? -54.02 153.12 5.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.872 0.368 . . . . 0.0 110.787 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.5 p -119.19 161.08 20.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.133 0.492 . . . . 0.0 111.466 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.7 mmt -108.69 153.68 42.12 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.393 179.552 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.557 ' HB2' HG13 ' A' ' 4' ' ' VAL . 1.4 Cg_endo -86.17 146.01 36.2 Favored 'Cis proline' 0 N--CA 1.461 -0.396 0 C-N-CA 124.268 -1.138 . . . . 0.0 112.912 0.517 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.74 ' NE2' HD12 ' A' ' 63' ' ' LEU . 5.3 tp-100 -97.05 122.29 39.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.877 178.768 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 4' ' ' VAL . 8.2 t -104.46 157.79 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.759 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.627 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . 92.7 m-85 -142.49 164.26 30.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.039 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.634 ' N ' HD12 ' A' ' 76' ' ' ILE . . . -64.49 157.59 71.57 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.771 -179.519 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.26 -21.62 67.41 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.896 2.397 . . . . 0.0 112.418 179.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -109.72 -16.46 13.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.617 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.69 97.76 1.11 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.798 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 15.2 t -178.57 151.74 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.674 0.273 . . . . 0.0 110.34 179.623 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.476 ' CE1' HD23 ' A' ' 55' ' ' LEU . 9.1 t-160 -85.63 113.73 22.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.146 -179.603 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.634 HD12 ' N ' ' A' ' 70' ' ' ALA . 1.7 mp -103.17 -39.54 6.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.865 0.364 . . . . 0.0 110.658 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 133.04 -160.4 23.88 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.704 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.16 -134.53 7.99 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.615 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 9.2 t80 -70.63 -70.67 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.72 0.295 . . . . 0.0 111.422 -179.597 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -60.51 -44.49 95.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.994 0.426 . . . . 0.0 110.999 -179.813 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -52.14 -41.15 62.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.698 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.737 HD21 ' CE2' ' A' ' 86' ' ' PHE . 5.2 tt -74.85 -34.04 62.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.217 179.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -51.15 -31.46 19.89 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.618 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.64 -35.16 79.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.208 178.257 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.462 ' N ' ' O ' ' A' ' 82' ' ' LEU . 13.5 t80 -63.59 -33.57 75.89 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.337 178.459 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.737 ' CE2' HD21 ' A' ' 82' ' ' LEU . 7.6 m-85 -86.76 -70.24 0.62 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.275 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.975 -179.956 . . . . . . . . 0 0 . 1 stop_ save_